form_name|feature_name|feature_value
Demographic|Gender|F
Demographic|Race|White
ALSHX|onset_site|Bulbar
Lab Test|Urine Protein|-
Lab Test|Bilirubin (Direct)|-
Lab Test|Urine Amorphous Crystals|+
Lab Test|Urine Glucose|-
Lab Test|Normocytic|+
Lab Test|WAS PATIENT FASTING?|NO
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Mild;Continuing
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Mild;Continuing
Concomitant Medication|AMITRIPTYLINE|NULL;NULL;NULL
Concomitant Medication|ATENOLOL|NULL;NULL;NULL
Concomitant Medication|BACLOFEN|NULL;NULL;NULL
Concomitant Medication|CALCIUM|NULL;NULL;NULL
Concomitant Medication|CREATINE|NULL;NULL;NULL
Concomitant Medication|ESTROGEN|NULL;NULL;NULL
Concomitant Medication|IMODIUM|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM|NULL;NULL;NULL
Concomitant Medication|MULTIVITAMIN|NULL;NULL;NULL
Concomitant Medication|PROVERA|NULL;NULL;NULL
Concomitant Medication|ULTRACAL|NULL;NULL;NULL
Concomitant Medication|VITAMIN B12|NULL;NULL;NULL
Concomitant Medication|VITAMIN C|NULL;NULL;NULL
Concomitant Medication|VITAMIN E|NULL;NULL;NULL
Riluzole|if_use_Riluzole|Yes
Treatment|treatment_group|Active
Lab Test|RBC Morphology|Normal
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;MILD;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin lesion;Skin lesion;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hiccough;Hiccups;Lower respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngospasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Tennis elbow;Epicondylitis;Muscle, tendon and ligament injuries;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;MILD;RECOVERED
Concomitant Medication|ALLEGRA|NULL;NULL;NULL
Concomitant Medication|ELAVIL|NULL;NULL;NULL
Concomitant Medication|ESTRACE|NULL;NULL;NULL
Concomitant Medication|ESTRADIOL|NULL;NULL;NULL
Concomitant Medication|IBUPROFEN|NULL;NULL;NULL
Concomitant Medication|LOTENSIN|NULL;NULL;NULL
Concomitant Medication|PREMARIN|NULL;NULL;NULL
Concomitant Medication|PRILOSEC|NULL;NULL;NULL
Concomitant Medication|PROZAC|NULL;NULL;NULL
Concomitant Medication|RILUTEK|NULL;NULL;NULL
Concomitant Medication|ROBINUL|NULL;NULL;NULL
Concomitant Medication|SYNTHROID|NULL;NULL;NULL
Concomitant Medication|VANCENASE|NULL;NULL;NULL
Concomitant Medication|ZITHROMYCIN|NULL;NULL;NULL
Concomitant Medication|ZOLOFT|NULL;NULL;NULL
Demographic|Gender|M
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruising of chest;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Generalized muscle weakness;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Reproductive tract disorders NEC|Genital rash;Genital rash;Reproductive tract signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|ALPRAZOLAM|NULL;NULL;NULL
Concomitant Medication|ASPIRIN|NULL;NULL;NULL
Concomitant Medication|AUGMENTIN|NULL;NULL;NULL
Concomitant Medication|BIAXIN|NULL;NULL;NULL
Concomitant Medication|CEFTIN|NULL;NULL;NULL
Concomitant Medication|CORTISONE|NULL;NULL;NULL
Concomitant Medication|FLUMIDIN|NULL;NULL;NULL
Concomitant Medication|GUIATUSS|NULL;NULL;NULL
Concomitant Medication|LORABID|NULL;NULL;NULL
ALSHX|onset_site|Limb
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Mild;NULL
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Marked;NULL
Adverse Event|Bone and joint injuries|Rib fracture;Rib fracture;Thoracic cage fractures and dislocations;Mild;NULL
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;Moderate;NULL
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Mild;NULL
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;Moderate;NULL
Concomitant Medication|CELEXA|NULL;NULL;NULL
Concomitant Medication|CIPRO|NULL;NULL;NULL
Concomitant Medication|PERCOCET|NULL;NULL;NULL
Concomitant Medication|PREVACID|NULL;NULL;NULL
Concomitant Medication|RILUZOLE|NULL;NULL;NULL
Riluzole|if_use_Riluzole|No
Treatment|treatment_group|Placebo
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Cholesterol total increased;Blood cholesterol increased;Cholesterol analyses;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor of hands;Tremor;Tremor (excl congenital);MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness trunk;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BETACAROTENE|NULL;NULL;NULL
Concomitant Medication|NEURONTIN|NULL;NULL;NULL
Concomitant Medication|NORVASC|NULL;NULL;NULL
Concomitant Medication|PAXIL|NULL;NULL;NULL
Concomitant Medication|SERZONE|NULL;NULL;NULL
Lab Test|HbA1c (Glycated Hemoglobin)|Normal
Adverse Event|Bone and joint injuries|Wrist injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Congestion nasal;Nasal congestion;Nasal congestion and inflammations;MILD;RECOVERED
Adverse Event|Injuries NEC|Laceration of leg;Skin laceration;Skin injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Bacterial infectious disorders|Streptococcal sore throat;Pharyngitis streptococcal;Streptococcal infections;MILD;RECOVERED
Concomitant Medication|AMOXICILLIN|NULL;NULL;NULL
Concomitant Medication|CAROTENOIDS NOS|NULL;NULL;NULL
Concomitant Medication|COPPER|NULL;NULL;NULL
Concomitant Medication|GUAIFENESIN|NULL;NULL;NULL
Concomitant Medication|PENICILLIN V POTASSIUM|NULL;NULL;NULL
Concomitant Medication|SUDAFED|NULL;NULL;NULL
Concomitant Medication|ZINC|NULL;NULL;NULL
Concomitant Medication|ZITHROMAX|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Increased salivation;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Lyme's disease;Lyme disease;Borrelial infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Presyncope;Presyncope;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Male reproductive tract infections and inflammations|Prostatitis;Prostatitis;Prostate and seminal vesicles infections and inflammations;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cranial nerve disorders (excl neoplasms)|Tongue paralysis;Tongue paralysis;Hypoglossal nerve disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Wt loss;Weight decreased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BACTRIM DS|NULL;NULL;NULL
Concomitant Medication|BENTYL|NULL;NULL;NULL
Concomitant Medication|DOXYCYCLINE|NULL;NULL;NULL
Concomitant Medication|FENTANYL|NULL;NULL;NULL
Concomitant Medication|FLAGYL|NULL;NULL;NULL
Concomitant Medication|GAVISCON|NULL;NULL;NULL
Concomitant Medication|GLUCAGON|NULL;NULL;NULL
Concomitant Medication|HEPARIN|NULL;NULL;NULL
Concomitant Medication|MEPRON|NULL;NULL;NULL
Concomitant Medication|MYLICON|NULL;NULL;NULL
Concomitant Medication|PROPULSID|NULL;NULL;NULL
Concomitant Medication|TABAS|NULL;NULL;NULL
Concomitant Medication|TRANXENE|NULL;NULL;NULL
Concomitant Medication|TYLENOL|NULL;NULL;NULL
Concomitant Medication|VERSED|NULL;NULL;NULL
Concomitant Medication|VITAMIN A|NULL;NULL;NULL
Concomitant Medication|ZANTAC|NULL;NULL;NULL
Adverse Event|Administration site reactions|Injection site swelling;Injection site swelling;Injection site reactions;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Moderate;Resolved
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved with Residual
Adverse Event|Administration site reactions|Injection site induration;Injection site induration;Injection site reactions;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Moderate;Continuing
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Mild;Continuing
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;Mild;Continuing
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Mild;Resolved
Adverse Event|Administration site reactions|Injection site pruritus;Injection site pruritus;Injection site reactions;Mild;Resolved
Adverse Event|Administration site reactions|Injection site tenderness;Injection site pain;Injection site reactions;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Watery diarrhea;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved with Residual
Adverse Event|Gastrointestinal motility and defaecation conditions|Watery diarrhea;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved with Residual
Concomitant Medication|ACETAMINOPHEN|NULL;NULL;NULL
Concomitant Medication|CORICIDIN|NULL;NULL;NULL
Concomitant Medication|DIPHENHYDRAMINE|NULL;NULL;NULL
Concomitant Medication|PSEUDOEPHEDRINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ROBITUSSIN DM|NULL;NULL;NULL
Lab Test|Beta HCG|Normal
Adverse Event|Allergic conditions|Allergy to insect sting;Allergy to arthropod sting;Allergic conditions NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dandruff;Dandruff;Scaly conditions;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Tinea versicolor;Tinea versicolour;Tinea infections;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Defect conduction intraventricular;Conduction disorder;Cardiac conduction disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Malaise;Malaise;Asthenic conditions;MODERATE;RECOVERED
Concomitant Medication|SELENIUM SULFIDE|NULL;NULL;NULL
Concomitant Medication|VACCINE, INFLUENZA|NULL;NULL;NULL
Lab Test|Stool Occult Blood|-
Lab Test|H. Pylori Antibody|-
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;Mild;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Lumbar puncture headache;Post lumbar puncture syndrome;Neurological and psychiatric procedural complications;Moderate;NULL
Concomitant Medication|BACLOFEN|10;TID (three times a day);Oral
Concomitant Medication|CALCIUM|400;QD (every day);Oral
Concomitant Medication|COENZYME Q10|150;TID (three times a day);Oral
Concomitant Medication|CREATINE|5;QD (every day);Oral
Concomitant Medication|DARVOCET|100;QD (every day);Oral
Concomitant Medication|DITROPAN|10;QD (every day);Oral
Concomitant Medication|VITAMIN E|1200;QD (every day);Oral
Lab Test|Absolute Basophil Count|Normal
Lab Test|Absolute Eosinophil Count|Normal
Adverse Event|Movement disorders (incl parkinsonism)|Dystonic reaction;Dystonia;Dystonias;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Herpes zoster;Herpes zoster;Herpes viral infections;MODERATE;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;MODERATE;RECOVERED
Concomitant Medication|AMILORIDE|NULL;NULL;NULL
Concomitant Medication|HYDROCHLOROTHIAZIDE|NULL;NULL;NULL
Concomitant Medication|LORAZEPAM|NULL;NULL;NULL
Concomitant Medication|OTILONIUM|NULL;NULL;NULL
Concomitant Medication|SERTRALINE|NULL;NULL;NULL
Concomitant Medication|THIETHYLPERAZINE MALEATE|NULL;NULL;NULL
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Finger cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MODERATE;RECOVERED
Concomitant Medication|ACCUPRIL|NULL;NULL;NULL
Concomitant Medication|CENTRUM|NULL;NULL;NULL
Concomitant Medication|EXCEDRIN P.M.|NULL;NULL;NULL
Concomitant Medication|FUROSEMIDE|NULL;NULL;NULL
Concomitant Medication|GUAIFENESIN DM|NULL;NULL;NULL
Concomitant Medication|QUININE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle cramp;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood urea increased;Blood urea increased;Renal function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Myogelosis;Myosclerosis;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Spinal pain;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|ARELIX|NULL;NULL;NULL
Concomitant Medication|CODIPRONT|NULL;NULL;NULL
Concomitant Medication|EUTHYROX|NULL;NULL;NULL
Concomitant Medication|GINKGO BILOBA|NULL;NULL;NULL
Concomitant Medication|LACTOCUR|NULL;NULL;NULL
Concomitant Medication|LIORESAL|NULL;NULL;NULL
Concomitant Medication|MUCOSOLVAN|NULL;NULL;NULL
Concomitant Medication|NOVALGIN|NULL;NULL;NULL
Concomitant Medication|OSPUR D3|NULL;NULL;NULL
Concomitant Medication|TRAMAL|NULL;NULL;NULL
Concomitant Medication|VOLTAREN|NULL;NULL;NULL
Concomitant Medication|WOBENZYM|NULL;NULL;NULL
FamilyHx|family_ALS_hist|N
Adverse Event|Neurological disorders NEC|Drooling;Drooling;Neurological signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Hemorrhage from throat;Pharyngeal haemorrhage;Pharyngeal disorders (excl infections and neoplasms);MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Increased salivation;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Concomitant Medication|AMITRIPTYLINE HCL|NULL;NULL;NULL
Concomitant Medication|BROMHEXINE|NULL;NULL;NULL
Concomitant Medication|LACTULOSE|NULL;NULL;NULL
Concomitant Medication|NITRAZEPAM|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine glucose;Glucose urine;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Gum infection;Gingival infection;Dental and oral soft tissue infections;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in toe;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Wrist sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Concomitant Medication|ACETYLSALICYLIC ACID|NULL;NULL;NULL
Concomitant Medication|CLARITHROMYCIN|NULL;NULL;NULL
Concomitant Medication|CLOXACILLIN SODIUM|NULL;NULL;NULL
Concomitant Medication|GLYBURIDE|NULL;NULL;NULL
Concomitant Medication|INDOMETHACIN|NULL;NULL;NULL
Concomitant Medication|B12|100;Monthly or once a month;Intramuscular
Concomitant Medication|COENZYME Q10|50;QD (every day);Oral
Concomitant Medication|GINSENG|U;QD (every day);Oral
Concomitant Medication|POTASSIUM|100;PRN (as needed);Oral
Concomitant Medication|BETACAROTENE|25000;QD (every day);Oral
Concomitant Medication|FOLIC ACID|800;QD (every day);Oral
Concomitant Medication|MULTIVITAMIN|1;QD (every day);Oral
Concomitant Medication|RILUTEK|50;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|1-2;QD (every day);Oral
Concomitant Medication|VITAMIN E|2000;QD (every day);Oral
Lab Test|Urine blood|-
Lab Test|Urine blood|Hemolyzed Trace
Lab Test|Urine Leukesterase|-
Lab Test|Urine Leukesterase|Small
Lab Test|Urine Ketones|-
Lab Test|Lithium|-
Adverse Event|Infections - pathogen unspecified|Common cold;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Cystitis;Cystitis;Urinary tract infections;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|AMITRIPTYLINE|10;QD (every day);Oral
Concomitant Medication|BIFITERAL|1;PRN (as needed);Oral
Concomitant Medication|CITALOPRAM|20;QD (every day);Oral
Concomitant Medication|COD LIVER OIL|211;QD (every day);Oral
Concomitant Medication|COTRIM|1;BID (twice a day);Oral
Concomitant Medication|GABAPENTIN|900;TID (three times a day);Oral
Concomitant Medication|HALOPERIDOL|1;PRN (as needed);Oral
Concomitant Medication|HALOPERIDOL|2;BID (twice a day);Oral
Concomitant Medication|L-POLAMIDON|10;BID (twice a day);Oral
Concomitant Medication|MAGNESIUM|300;QD (every day);Oral
Concomitant Medication|RILUTEK|100;BID (twice a day);Oral
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Tooth infection;Tooth infection;Dental and oral soft tissue infections;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Epigastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hair loss;Alopecia;Alopecias;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;MILD;RECOVERED
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|HbA1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Hepatic enzymes increased;Hepatic enzyme increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema lower limb;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AGIOLAX|NULL;NULL;NULL
Concomitant Medication|CLAMOXYL|NULL;NULL;NULL
Concomitant Medication|DAFLON|NULL;NULL;NULL
Concomitant Medication|HEXAPNEUMINE|NULL;NULL;NULL
Concomitant Medication|HUMEX|NULL;NULL;NULL
Concomitant Medication|MUCOMYST|NULL;NULL;NULL
Concomitant Medication|NORMACOL LAVEMENT|NULL;NULL;NULL
Concomitant Medication|PREPULSID|NULL;NULL;NULL
Concomitant Medication|ROCEPHINE|NULL;NULL;NULL
Concomitant Medication|SOLUDECADRON|NULL;NULL;NULL
Concomitant Medication|SPAGULAX|NULL;NULL;NULL
Concomitant Medication|TRANSIPEG|NULL;NULL;NULL
Concomitant Medication|XANAX|NULL;NULL;NULL
Adverse Event|Cranial nerve disorders (excl neoplasms)|Strange smell sensation;Parosmia;Olfactory nerve disorders;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|FIBERCON|NULL;NULL;NULL
Concomitant Medication|PRINZIDE|NULL;NULL;NULL
Concomitant Medication|SAL-TROPINE|NULL;NULL;NULL
Concomitant Medication|VITAMIN B|NULL;NULL;NULL
Concomitant Medication|ZESTRIL|NULL;NULL;NULL
Lab Test|Urine RBCs|-
Lab Test|Urine WBCs|-
Lab Test|Urine Casts|-
Lab Test|Urine RBCs|1+
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;NULL
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Moderate;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Mild;NULL
Lab Test|RBC Morphology: Anisocytosis|1+
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Injuries NEC|Excoriation;Excoriation;Skin injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Neuromuscular weakness;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural pain;Procedural pain;Non-site specific procedural complications;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ARTANE|NULL;NULL;NULL
Concomitant Medication|COLACE|NULL;NULL;NULL
Concomitant Medication|DILANTIN|NULL;NULL;NULL
Concomitant Medication|DULCOLAX|NULL;NULL;NULL
Concomitant Medication|ENSURE PLUS|NULL;NULL;NULL
Concomitant Medication|GLYCOPYRROLATE|NULL;NULL;NULL
Concomitant Medication|LECITHIN|NULL;NULL;NULL
Concomitant Medication|PNEUMOVAX|NULL;NULL;NULL
Concomitant Medication|QUININE SULFATE|NULL;NULL;NULL
Concomitant Medication|TYLENOL W/CODEINE NO. 3|NULL;NULL;NULL
Concomitant Medication|ZANAFLEX|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Diverticulitis;Diverticulitis;Abdominal and gastrointestinal infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Thyroid gland disorders|Hypothyroidism;Hypothyroidism;Thyroid hypofunction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Soft stools;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Concomitant Medication|DAYPRO|NULL;NULL;NULL
Concomitant Medication|ECOTRIN|NULL;NULL;NULL
Concomitant Medication|LEVOXYL|NULL;NULL;NULL
Concomitant Medication|LUVOX|NULL;NULL;NULL
Concomitant Medication|MOTRIN|NULL;NULL;NULL
Concomitant Medication|VASOTEC|NULL;NULL;NULL
Concomitant Medication|VITAMIN B COMPLEX|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Lipid analyses|Raised triglycerides;Blood triglycerides increased;Triglyceride analyses;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Increased urinary frequency;Pollakiuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine increased;White blood cells urine positive;Urinalysis NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Twitching of limbs;Muscle twitching;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of lower extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ACIDAL|NULL;NULL;NULL
Concomitant Medication|ALPHA LIPOIC ACID|NULL;NULL;NULL
Concomitant Medication|CASTOR OIL|NULL;NULL;NULL
Concomitant Medication|CHAMOMILE|NULL;NULL;NULL
Concomitant Medication|COENZYME Q10|NULL;NULL;NULL
Concomitant Medication|FLAXSEED OIL|NULL;NULL;NULL
Concomitant Medication|GRAPE SEED EXTRACT|NULL;NULL;NULL
Concomitant Medication|LOPID|NULL;NULL;NULL
Concomitant Medication|LUGOL'S SOLUTION|NULL;NULL;NULL
Concomitant Medication|MELATONIN|NULL;NULL;NULL
Concomitant Medication|MSM|NULL;NULL;NULL
Concomitant Medication|N ACETYL CYSTEIN|NULL;NULL;NULL
Concomitant Medication|NASACORT|NULL;NULL;NULL
Concomitant Medication|NIACIN|NULL;NULL;NULL
Concomitant Medication|PANCREATIN|NULL;NULL;NULL
Concomitant Medication|PHOSPHATIDYL SERINE|NULL;NULL;NULL
Concomitant Medication|POTASSIUM|NULL;NULL;NULL
Concomitant Medication|SINGULAIR|NULL;NULL;NULL
Concomitant Medication|THREONINE|NULL;NULL;NULL
Concomitant Medication|THYROID|NULL;NULL;NULL
Concomitant Medication|VANCERIL|NULL;NULL;NULL
Concomitant Medication|ZOVIRAX|NULL;NULL;NULL
Demographic|Race|Black
Lab Test|Urine blood|Hemolyzed Moderate
Lab Test|Urine Protein|Trace
Lab Test|Urine blood|Hemolyzed Small
Lab Test|Urine blood|Moderate
Lab Test|Urine blood|Hemolyzed Large
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED
Adverse Event|Skin appendage conditions|Clammy;Cold sweat;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal motility and defaecation conditions|GERD;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Headaches|Headache;Headache;Headaches NEC;SEVERE;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Increased blood pressure;Blood pressure increased;Vascular tests NEC (incl blood pressure);MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Upper abdominal pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Chest tightness;Chest discomfort;Pain and discomfort NEC;MILD;RECOVERED
Concomitant Medication|AMLODIPINE|5;QD (every day);Oral
Concomitant Medication|AZITHROMYCIN|UNK;Unknown;Oral
Concomitant Medication|CARAFATE|1;PRN (as needed);Oral
Concomitant Medication|COFSOLIN WITH ANTIHISTAMINE.|UNK;Unknown;Oral
Concomitant Medication|COMBIVENT|2;QD (every day);Other (specify)
Concomitant Medication|LORAZEPAM|1;PRN (as needed);Oral
Concomitant Medication|MAALOX|UNK;PRN (as needed);Oral
Concomitant Medication|NASAL DECONGESTANT|UNK;Unknown;Oral
Concomitant Medication|OMEPRAZOLE|20;QD (every day);Oral
Concomitant Medication|PREDNISONE|UNK;Unknown;Oral
Concomitant Medication|PROTONIX|20;QD (every day);Oral
Concomitant Medication|REGLAN|5;Other (specify);Oral
Concomitant Medication|RESTORIL|15;QHS (at bedtime);Oral
Concomitant Medication|TAMIFLU|75;QD (every day);Oral
Concomitant Medication|ZYRTEC|1;QD (every day);Oral
Concomitant Medication|FLONASE|2;PRN (as needed);Inhalation
Concomitant Medication|TYLENOL|1-2;PRN (as needed);Oral
Lab Test|Urine RBCs|2++
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Adverse Event|Joint disorders|Arthritic pains;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;Mild;NULL
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BACLOFEN|20;BID (twice a day);Oral
Concomitant Medication|CITALOPRAM|30;QHS (at bedtime);Oral
Concomitant Medication|ESCITALOPRAM|5;QD (every day);Oral
Concomitant Medication|PREGABALIN|150;BID (twice a day);Oral
Concomitant Medication|PREGABALIN|75;QD (every day);Oral
Concomitant Medication|RILUZOLE|100;BID (twice a day);Oral
Concomitant Medication|TIZANIDINE|6;TID (three times a day);Oral
Concomitant Medication|TOCOPHERYL ACETATE-D-ALPHA|400;QD (every day);Oral
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Menstrual cycle and uterine bleeding disorders|Break through bleeding;Metrorrhagia;Menstruation and uterine bleeding NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Daytime sleepiness;Somnolence;Disturbances in consciousness NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Airway secretion excessive;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MILD;RECOVERED
Concomitant Medication|EX-LAX|NULL;NULL;NULL
Concomitant Medication|ORAL CONTRACEPTIVE NOS|NULL;NULL;NULL
Concomitant Medication|VICODIN|NULL;NULL;NULL
Demographic|Race|Hispanic
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood in urine;Blood urine present;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Bradycardia;Bradycardia;Rate and rhythm disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Hoarseness of voice;Dysphonia;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MILD;RECOVERED
Adverse Event|Lipid analyses|Triglyceride increased;Blood triglycerides increased;Triglyceride analyses;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin sensitization;Skin sensitisation;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ADVIL|NULL;NULL;NULL
Concomitant Medication|ALBUTEROL|NULL;NULL;NULL
Concomitant Medication|TRAZODONE|NULL;NULL;NULL
Adverse Event|Personality disorders and disturbances in behaviour|Aggressiveness;Aggression;Behaviour and socialisation disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatic and hepatobiliary disorders|Bilirubinemia aggravated;Hyperbilirubinaemia;Cholestasis and jaundice;MILD;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|CPK increase;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of lower extremities;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CELECTOL|NULL;NULL;NULL
Concomitant Medication|CELESTENE|NULL;NULL;NULL
Concomitant Medication|ETIOVEN|NULL;NULL;NULL
Concomitant Medication|IMPORTAL|NULL;NULL;NULL
Concomitant Medication|LASILIX|NULL;NULL;NULL
Concomitant Medication|LYSANXIA|NULL;NULL;NULL
Concomitant Medication|NETROMYCINE|NULL;NULL;NULL
Concomitant Medication|SURBRONC|NULL;NULL;NULL
Lab Test|Glucose|-
Lab Test|Urine Bacteria|Moderate
Lab Test|Protein|-
Lab Test|Red Blood Cells (RBC)|-
Lab Test|Urine Color|YELLOW
Lab Test|Urine Mucus|Small
Lab Test|Urine Squamous Epithelial Cells|Moderate
Lab Test|Urine Appearance|Normal
Lab Test|Urine Appearance|CLOUDY
Lab Test|Urine Calcium Oxalate Crystals|Moderate
Lab Test|Urine Uric Acid Crystals|Moderate
Lab Test|Urine Bacteria|Small
Lab Test|Urine Appearance|HAZY
Lab Test|White Blood Cell (WBC)|-
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;NULL;NULL
Adverse Event|Oral soft tissue conditions|Canker sores oral;Aphthous stomatitis;Stomatitis and ulceration;NULL;NULL
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;NULL;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;NULL;NULL
Adverse Event|Neurological disorders NEC|Light-headed feeling;Dizziness;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|General system disorders NEC|Malaise;Malaise;Asthenic conditions;NULL;NULL
Adverse Event|Administration site reactions|Injection site redness;Injection site erythema;Injection site reactions;NULL;NULL
Adverse Event|Respiratory disorders NEC|Throat irritation;Throat irritation;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;NULL;NULL
Adverse Event|Body temperature conditions|Slight temperature;Pyrexia;Febrile disorders;NULL;NULL
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;NULL;NULL
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;NULL;NULL
Adverse Event|Body temperature conditions|Slight fever;Pyrexia;Febrile disorders;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;NULL;NULL
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Low blood pressure;Hypotension;Vascular hypotensive disorders;NULL;NULL
Adverse Event|Oral soft tissue conditions|Mouth pain;Oral pain;Oral soft tissue pain and paraesthesia;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;NULL;NULL
Adverse Event|Muscle disorders|Twitching of limbs;Muscle twitching;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;NULL;NULL
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Psoriasis facial;Psoriasis;Psoriatic conditions;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;NULL;NULL
Adverse Event|Injuries NEC|Scalp laceration;Skin laceration;Skin injuries NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;NULL;NULL
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Psoriasis flare-up;Psoriasis;Psoriatic conditions;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Skin peeling;Skin exfoliation;Exfoliative conditions;NULL;NULL
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;NULL;NULL
Concomitant Medication|ASCORBIC ACID|NULL;NULL;NULL
Concomitant Medication|CEFADROXIL|NULL;NULL;NULL
Concomitant Medication|CYANOCOBALAMIN|NULL;NULL;NULL
Concomitant Medication|DIPYRIDAMOLE|NULL;NULL;NULL
Concomitant Medication|ENDAL|NULL;NULL;NULL
Concomitant Medication|MEPIVACAINE|NULL;NULL;NULL
Concomitant Medication|METOCLOPRAMIDE|NULL;NULL;NULL
Concomitant Medication|MICONAZOLE|NULL;NULL;NULL
Concomitant Medication|NAPROXEN|NULL;NULL;NULL
Concomitant Medication|NORGESIC|NULL;NULL;NULL
Concomitant Medication|OCTOCAINE WITH EPINEPHRINE|NULL;NULL;NULL
Concomitant Medication|PARACETAMOL|NULL;NULL;NULL
Concomitant Medication|PHENERGAN WITH CODEINE|NULL;NULL;NULL
Concomitant Medication|POLY-HISTINE|NULL;NULL;NULL
Concomitant Medication|PSYLLIUM HYDROPHILIC MUCILLOID|NULL;NULL;NULL
Concomitant Medication|PYRIDOXINE|NULL;NULL;NULL
Concomitant Medication|RANITIDINE|NULL;NULL;NULL
Concomitant Medication|TEARS PLUS|NULL;NULL;NULL
Concomitant Medication|TOCOPHEROL|NULL;NULL;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;Mild;NULL
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Moderate;NULL
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Adverse Event|White blood cell disorders|Neutropenia;Neutropenia;Neutropenias;Marked;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Shakiness;Tremor;Tremor (excl congenital);Mild;NULL
Adverse Event|Dental and gingival conditions|Sore gums;Gingival pain;Gingival pains;Mild;NULL
Concomitant Medication|ASA|NULL;NULL;NULL
Concomitant Medication|BEE POLLEN|NULL;NULL;NULL
Concomitant Medication|BECONASE|NULL;NULL;NULL
Concomitant Medication|GELATIN|NULL;NULL;NULL
Concomitant Medication|MAXAIR|NULL;NULL;NULL
Concomitant Medication|PAMELOR|NULL;NULL;NULL
Concomitant Medication|RIBOSE|NULL;NULL;NULL
Concomitant Medication|VITAMIN D|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Chronic bronchitis;Bronchitis chronic;Bronchospasm and obstruction;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Seborrhoeic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MILD;RECOVERED
Concomitant Medication|ALDALIX|1;QD (every day);Oral
Concomitant Medication|ALPRAZOLAM|0.25;QHS (at bedtime);Oral
Concomitant Medication|ALPRAZOLAM|0.375;BID (twice a day);Oral
Concomitant Medication|AMOXICILLIN|2;BID (twice a day);Oral
Concomitant Medication|BACLOFEN|15;BID (twice a day);Oral
Concomitant Medication|BACLOFEN|15;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|30;BID (twice a day);Oral
Concomitant Medication|BETAMETHASONE|4;BID (twice a day);Sublingual
Concomitant Medication|CALCIUM CHLORIDE DIHYDRATE|6;TID (three times a day);Oral
Concomitant Medication|CARBOCISTEINE|3;TID (three times a day);Oral
Concomitant Medication|CEFUROXIME AXETIL|500;BID (twice a day);Oral
Concomitant Medication|CELECOXIB|200;QD (every day);Oral
Concomitant Medication|CLARITHROMYCIN|500;QD (every day);Oral
Concomitant Medication|CORTIVAZOL|3.75;QD (every day);Intra-articular (joints)
Concomitant Medication|D-ALPHA TOCOPHEROL|1;BID (twice a day);Oral
Concomitant Medication|DEXTROMETHORPHAN|2;BID (twice a day);Oral
Concomitant Medication|DICLOFENAC SODIUM|150;BID (twice a day);Oral
Concomitant Medication|ENDOTELON|300;BID (twice a day);Oral
Concomitant Medication|ESOMEPRAZOLE|40;QD (every day);Oral
Concomitant Medication|FLUTICASONE W/SALMETEROL|250;BID (twice a day);Inhalation
Concomitant Medication|FOSFOMYCIN TROMETAMOL|1;Other (specify);Oral
Concomitant Medication|HELICIDINE|3;TID (three times a day);Oral
Concomitant Medication|IBUPROFEN W/PSEUDOEPHEDRINE|2;BID (twice a day);Oral
Concomitant Medication|IXPRIM|1 TO 3;TID (three times a day);Oral
Concomitant Medication|IXPRIM|3;TID (three times a day);Oral
Concomitant Medication|KETOCONAZOLE|2;QD (every day);Topical
Concomitant Medication|KETOCONAZOLE|2;Other (specify);Topical
Concomitant Medication|KETOPROFENE|300;BID (twice a day);Oral
Concomitant Medication|LANSOPRAZOLE|15;QD (every day);Oral
Concomitant Medication|MACROGOL|39;PRN (as needed);Oral
Concomitant Medication|MACROGOL|40;BID (twice a day);Oral
Concomitant Medication|MOXIFLOXACINE|400;QD (every day);Oral
Concomitant Medication|NAPHAZOLINE|3;TID (three times a day);Intranasal
Concomitant Medication|NIFLUGEL|1;QD (every day);Topical
Concomitant Medication|PARACETAMOL|1500;PRN (as needed);Oral
Concomitant Medication|PARACETAMOL|3;PRN (as needed);Oral
Concomitant Medication|PREDNISOLONE|3;TID (three times a day);Intranasal
Concomitant Medication|PREDNISOLONE|60 TO 20;;Oral
Concomitant Medication|RHINADVIL|2;BID (twice a day);Oral
Concomitant Medication|SALBUTAMOL|2;PRN (as needed);Oral
Concomitant Medication|SALBUTAMOL|8;QID (four times a day);Oral
Concomitant Medication|SPIRONOLACTONE|25;QD (every day);Oral
Concomitant Medication|SYMBICORT|800;BID (twice a day);Inhalation
Concomitant Medication|THIOCOLCHICOSIDE|4;QD (every day);Oral
Concomitant Medication|THIOCOLCHICOSIDE|8;BID (twice a day);Oral
Concomitant Medication|TRAMADOL|50;PRN (as needed);Oral
Concomitant Medication|TRIMEBUTINE|600;TID (three times a day);Oral
Concomitant Medication|TROSPIUM|20;QD (every day);Oral
Concomitant Medication|TROSPIUM|40;BID (twice a day);Oral
Concomitant Medication|VACCINE, INFLUENZA|1;QD (every day);Subcutaneous
Concomitant Medication|VENLAFAXINE|37.5;QD (every day);Oral
Concomitant Medication|VENLAFAXINE|75;QD (every day);Oral
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;Mild;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Spastic paraparesis;Paresis;Paralysis and paresis (excl cranial nerve);Marked;NULL
Adverse Event|Respiratory disorders NEC|Rhinorrhea;Rhinorrhoea;Upper respiratory tract signs and symptoms;Mild;NULL
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;Mild;NULL
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;NULL
Adverse Event|Vision disorders|Vision double;Diplopia;Visual disorders NEC;Moderate;NULL
Concomitant Medication|BACLOFEN|30;QD (every day);Oral
Concomitant Medication|BACLOFEN|40;BID (twice a day);Oral
Concomitant Medication|BACLOFEN|40;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|5;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|50;QD (every day);Other (specify)
Concomitant Medication|BACLOFEN|100;Continuous IV;
Concomitant Medication|BACLOFEN|85;Continuous IV;
Concomitant Medication|BENADRYL|100;QHS (at bedtime);Oral
Concomitant Medication|CELEXA|20;QD (every day);Oral
Concomitant Medication|CHLORTRIMETON|12;BID (twice a day);Oral
Concomitant Medication|GLUCOPHAGE|500;BID (twice a day);Oral
Concomitant Medication|HYDROCORTISONE/IODOQUINOL|1;QD (every day);Topical
Concomitant Medication|LACTATED RINGERS|600;Continuous IV;Intravenous
Concomitant Medication|LIPITOR|10;QD (every day);Oral
Concomitant Medication|NIZORAL|2;Three times per week;Topical
Concomitant Medication|VITAMIN C|1000;QD (every day);Oral
Concomitant Medication|ZANAFLEX|4;QHS (at bedtime);Oral
Adverse Event|Coronary artery disorders|Coronary artery disease;Coronary artery disease;Coronary artery disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Lower respiratory tract infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Prostatic disorders (excl infections and inflammations)|Hyperplasia of prostate;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMBROXOL|NULL;NULL;NULL
Concomitant Medication|BERODUAL|NULL;NULL;NULL
Concomitant Medication|CAPTOPRIL|NULL;NULL;NULL
Concomitant Medication|CHLORAL HYDRATE|NULL;NULL;NULL
Concomitant Medication|DECORTIN-H|NULL;NULL;NULL
Concomitant Medication|LASIX|NULL;NULL;NULL
Concomitant Medication|LOPIRIN|NULL;NULL;NULL
Concomitant Medication|LOSARTAN|NULL;NULL;NULL
Concomitant Medication|MARCUMAR|NULL;NULL;NULL
Concomitant Medication|NOVODIGAL|NULL;NULL;NULL
Concomitant Medication|PULMICORT|NULL;NULL;NULL
Concomitant Medication|ZOPICLONE|NULL;NULL;NULL
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Orthostatic hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ACETYLSALICYLATE CALCIUM|NULL;NULL;NULL
Concomitant Medication|SULFAMETHOXAZOLE W/TRIMETHOPRIM|NULL;NULL;NULL
Concomitant Medication|TOCOPHEROL ACETATE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety aggravated;Anxiety;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnea exacerbated;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Neuropathic pain;Neuralgia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Cough nonproductive;Cough;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CEFTAZIDIME|NULL;NULL;NULL
Concomitant Medication|CIPROFLOXACIN|NULL;NULL;NULL
Concomitant Medication|CLARITIN|NULL;NULL;NULL
Concomitant Medication|CLONAZEPAM|NULL;NULL;NULL
Concomitant Medication|DALMANE|NULL;NULL;NULL
Concomitant Medication|DOCUSATE|NULL;NULL;NULL
Concomitant Medication|FISH OIL|NULL;NULL;NULL
Concomitant Medication|GAS X|NULL;NULL;NULL
Concomitant Medication|METAMUCIL|NULL;NULL;NULL
Concomitant Medication|NEUROTIN|NULL;NULL;NULL
Concomitant Medication|OXYCODONE/APAP|NULL;NULL;NULL
Concomitant Medication|SORBITOL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Chest infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Chest X-ray abnormal;Chest X-ray abnormal;Respiratory tract and thoracic imaging procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Use of accessory respiratory muscles;Use of accessory respiratory muscles;Respiratory signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Central nervous system vascular disorders|CVA;Cerebrovascular accident;Central nervous system haemorrhages and cerebrovascular accidents;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Dementia;Dementia;Dementia (excl Alzheimer's type);MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Eye tired;Asthenopia;Ocular sensation disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;MODERATE;RECOVERED
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Central nervous system vascular disorders|Lacunar infarction;Lacunar infarction;Central nervous system haemorrhages and cerebrovascular accidents;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Eyes sensitive to sunlight;Photophobia;Ocular sensation disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Malaise;Malaise;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Hemorrhage nasal;Epistaxis;Nasal disorders NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness of upper extremities;Hypoaesthesia;Sensory abnormalities NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Abdominal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness trunk;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness trunk;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ANCEF|NULL;NULL;NULL
Concomitant Medication|ATIVAN|NULL;NULL;NULL
Concomitant Medication|ATROVENT|NULL;NULL;NULL
Concomitant Medication|B12|NULL;NULL;NULL
Concomitant Medication|BETHANECHOL|NULL;NULL;NULL
Concomitant Medication|BISACODYL|NULL;NULL;NULL
Concomitant Medication|CEFOTAXIME|NULL;NULL;NULL
Concomitant Medication|CEFTAZIN|NULL;NULL;NULL
Concomitant Medication|CISAPRIDE|NULL;NULL;NULL
Concomitant Medication|ENALAPRIL|NULL;NULL;NULL
Concomitant Medication|ENSURE|NULL;NULL;NULL
Concomitant Medication|FLEET|NULL;NULL;NULL
Concomitant Medication|FLUVOXAMINE|NULL;NULL;NULL
Concomitant Medication|GINSENG|NULL;NULL;NULL
Concomitant Medication|GLYCERIN|NULL;NULL;NULL
Concomitant Medication|ISOPTO TEARS|NULL;NULL;NULL
Concomitant Medication|JEVITY|NULL;NULL;NULL
Concomitant Medication|KEFLEX|NULL;NULL;NULL
Concomitant Medication|LACTATED RINGERS|NULL;NULL;NULL
Concomitant Medication|METRONIDAZOLE|NULL;NULL;NULL
Concomitant Medication|MILK OF MAGNESIA|NULL;NULL;NULL
Concomitant Medication|MORPHINE|NULL;NULL;NULL
Concomitant Medication|NORFLOXACINE|NULL;NULL;NULL
Concomitant Medication|NORMAL SALINE|NULL;NULL;NULL
Concomitant Medication|OTRIVIN|NULL;NULL;NULL
Concomitant Medication|OXYGEN|NULL;NULL;NULL
Concomitant Medication|PENICILLIN|NULL;NULL;NULL
Concomitant Medication|PENICILLIN G POTASSIUM|NULL;NULL;NULL
Concomitant Medication|PYRIDIUM|NULL;NULL;NULL
Concomitant Medication|SEPTRA DS|NULL;NULL;NULL
Concomitant Medication|SERAX|NULL;NULL;NULL
Concomitant Medication|SODIUM CHLORIDE|NULL;NULL;NULL
Concomitant Medication|SOLUCORTEF|NULL;NULL;NULL
Concomitant Medication|SOLUMEDROL|NULL;NULL;NULL
Concomitant Medication|TERAZOSIN|NULL;NULL;NULL
Concomitant Medication|URECHOLINE|NULL;NULL;NULL
Concomitant Medication|VENTOLIN|NULL;NULL;NULL
Demographic|Race|Unknown
Adverse Event|General system disorders NEC|Shivering;Chills;Feelings and sensations NEC;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;Mild;         .
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;Severe;Resolved
Adverse Event|Neurological disorders NEC|Extremities burning sensation of;Burning sensation;Paraesthesias and dysaesthesias;Severe;Resolved
Adverse Event|Physical examination topics|Breath sounds decreased;Breath sounds abnormal;Physical examination procedures;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Discoloration skin;Skin discolouration;Dermal and epidermal conditions NEC;Mild;Continuing
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Mild;Resolved
Adverse Event|Neurological disorders NEC|Faint;Syncope;Disturbances in consciousness NEC;Moderate;Resolved
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Severe;Resolved
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site redness;Injection site erythema;Injection site reactions;Mild;Resolved
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;Mild;         .
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;Mild;Continuing
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;Severe;Continuing
Concomitant Medication|FEXOFENADINE|NULL;NULL;NULL
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Seborrheic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|General system disorders NEC|Feeling sick;Malaise;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MILD;RECOVERED
Concomitant Medication|ANAFRANIL|NULL;NULL;NULL
Concomitant Medication|LEXOMIL|NULL;NULL;NULL
Concomitant Medication|RHINADVIL|NULL;NULL;NULL
Concomitant Medication|VAXIGRIP|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Herpes simplex;Herpes simplex;Herpes viral infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|PCO2 increased;PCO2 increased;Blood gas and acid base analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ATARAX|NULL;NULL;NULL
Concomitant Medication|ATROPINE|NULL;NULL;NULL
Concomitant Medication|DETURGYLONE|NULL;NULL;NULL
Concomitant Medication|DITROPAN|NULL;NULL;NULL
Concomitant Medication|DOGMATIL|NULL;NULL;NULL
Concomitant Medication|HEXAQUINE|NULL;NULL;NULL
Concomitant Medication|ROCEPHIN IM.|NULL;NULL;NULL
Concomitant Medication|STILNOX|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Exanthema facial;Rash;Rashes, eruptions and exanthems NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Faint;Syncope;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Exanthema;Rash;Rashes, eruptions and exanthems NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Exanthema facial;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Exanthema;Rash;Rashes, eruptions and exanthems NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Limb paresis;Monoparesis;Paralysis and paresis (excl cranial nerve);MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Exanthema facial;Rash;Rashes, eruptions and exanthems NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ACETYLSALICYLIC ACID W/ALUMINIUM HYDROXIDE/CODEINE/PARACETAMOL|NULL;NULL;NULL
Concomitant Medication|CLEXANE|NULL;NULL;NULL
Concomitant Medication|DIURETICS|NULL;NULL;NULL
Concomitant Medication|JODID|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;Continuing
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;Severe;Continuing
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Mild;Continuing
Adverse Event|Neurological disorders NEC|Groggy;Somnolence;Disturbances in consciousness NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;Mild;Resolved
Adverse Event|Vascular disorders NEC|Hot flushes;Hot flush;Peripheral vascular disorders NEC;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Continuing
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site burning;Injection site pain;Injection site reactions;Mild;Resolved
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Resolved
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Mild;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Soft stools;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Vasovagal attack;Presyncope;Neurological signs and symptoms NEC;Mild;Resolved
Adverse Event|Neurological disorders NEC|Vasovagal attack;Presyncope;Neurological signs and symptoms NEC;Moderate;Resolved
Concomitant Medication|BACTRIM|NULL;NULL;NULL
Concomitant Medication|TUMS|NULL;NULL;NULL
Concomitant Medication|ULTRAM|NULL;NULL;NULL
Concomitant Medication|VIOXX|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AFRIN|NULL;NULL;NULL
Concomitant Medication|AZMACORT|NULL;NULL;NULL
Concomitant Medication|DURATUSS|NULL;NULL;NULL
Concomitant Medication|SELENIUM|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Feeling of warmth;Feeling hot;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Injuries by physical agents|Burn;Thermal burn;Thermal burns;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Ocular sensory symptoms NEC|Photophobia;Photophobia;Ocular sensation disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Concomitant Medication|ACEBUTOLOL|NULL;NULL;NULL
Concomitant Medication|BLUE ICE|NULL;NULL;NULL
Concomitant Medication|CEPHALEXIN|NULL;NULL;NULL
Concomitant Medication|VOLMAX|NULL;NULL;NULL
Lab Test|URINE MICROSCOPIC|-
Lab Test|WAS PATIENT FASTING?|-
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;Resolved
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Distress gastrointestinal;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Moderate;Resolved
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Severe;Resolved
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Mild;Resolved with Residual
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;Mild;Resolved
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;Moderate;Resolved with Residual
Adverse Event|General system disorders NEC|Sensation of warmth;Feeling hot;Feelings and sensations NEC;Moderate;Resolved
Concomitant Medication|BENADRYL|NULL;NULL;NULL
Concomitant Medication|DIAZEPAM|NULL;NULL;NULL
Concomitant Medication|GABAPENTIN|NULL;NULL;NULL
Concomitant Medication|LOPERAMIDE|NULL;NULL;NULL
Concomitant Medication|NEFAZODONE HCL|NULL;NULL;NULL
Concomitant Medication|OXYCODONE AND ACETAMINOPHEN|NULL;NULL;NULL
Adverse Event|Gastrointestinal investigations|Gastric acid increased;Gastric pH decreased;Gastrointestinal function diagnostic procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ANTAGEL|NULL;NULL;NULL
Concomitant Medication|CARDURA|NULL;NULL;NULL
Concomitant Medication|CHLORTALIDONE|NULL;NULL;NULL
Concomitant Medication|EMCOR|NULL;NULL;NULL
Concomitant Medication|RENNIES|NULL;NULL;NULL
Concomitant Medication|RHINOCORT|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gas pain;Flatulence;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Enzyme investigations NEC|CK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Cardiac valve disorders|Mitral valve prolapse;Mitral valve prolapse;Mitral valvular disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Pharyngitis NOS;Pharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Concomitant Medication|TRIFLUSAL|NULL;NULL;NULL
Lab Test|WAS PATIENT FASTING?|YES
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;Moderate;Resolved with Residual
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Mild;         .
Adverse Event|Administration site reactions|Injection site itching;Injection site pruritus;Injection site reactions;Mild;         .
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Mild;         .
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Mild;Resolved
Concomitant Medication|CODEINE W/PROMETHAZINE|NULL;NULL;NULL
Concomitant Medication|ECHINACEA|NULL;NULL;NULL
Concomitant Medication|SUCCIN|NULL;NULL;NULL
Concomitant Medication|TUSSIN|NULL;NULL;NULL
Concomitant Medication|TYLENOL PM|NULL;NULL;NULL
Concomitant Medication|VITAMIN C WITH BIOFLAVONOIDS|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhoea;Diarrhoea;Diarrhoea (excl infective);SEVERE;RECOVERED
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urgency urination;Micturition urgency;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|DIORALYTE|NULL;NULL;NULL
Adverse Event|Head and neck therapeutic procedures|Tooth extraction;Tooth extraction;Dental and gingival therapeutic procedures;Mild;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Marked;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Adverse Event|Joint disorders|Osteoarthritis;Osteoarthritis;Osteoarthropathies;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Eye disorders NEC|Eye swelling;Eye swelling;Ocular disorders NEC;Mild;NULL
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;Mild;NULL
Concomitant Medication|HYTIN|NULL;NULL;NULL
Concomitant Medication|IMODIUM AD|NULL;NULL;NULL
Concomitant Medication|REMERON|NULL;NULL;NULL
Concomitant Medication|RITALIN|NULL;NULL;NULL
Concomitant Medication|WELLBUTRIN|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Moderate;NULL
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;Moderate;NULL
Concomitant Medication|AMOXICILLIN|500;TID (three times a day);Oral
Concomitant Medication|B COMPLEX WITH B-12|14;QD (every day);Oral
Concomitant Medication|CALCIUM VITAMIN D|600/200;QD (every day);Oral
Concomitant Medication|COENZYME Q10|100;BID (twice a day);Oral
Concomitant Medication|GINKGO BILOBA|60;BID (twice a day);Oral
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|750/600;BID (twice a day);Oral
Concomitant Medication|LISINOPRIL|10;QD (every day);Oral
Concomitant Medication|LISINOPRIL|20;QD (every day);Oral
Concomitant Medication|MESTINON|30;TID (three times a day);Oral
Concomitant Medication|PREMPRO|2.5;Five times per week;Oral
Concomitant Medication|PROZAC|20;QD (every day);Oral
Concomitant Medication|TRINALIN|1/120;PRN (as needed);Oral
Concomitant Medication|TYLENOL|0-2000;PRN (as needed);Oral
Concomitant Medication|TYLENOL|600;PRN (as needed);Oral
Concomitant Medication|VITAMIN C|500;QD (every day);Oral
Concomitant Medication|VITAMIN E|400;BID (twice a day);Oral
Concomitant Medication|ZYRTEC|10;QD (every day);Oral
Concomitant Medication|GRAPE SEED EXTRACT|50;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|25;QHS (at bedtime);Oral
Concomitant Medication|BACLOFEN|5;BID (twice a day);Oral
Concomitant Medication|CORAL CALCIUM|1;QD (every day);Oral
Concomitant Medication|ENDURA|1;QD (every day);Oral
Concomitant Medication|FLAXSEED OIL|500;BID (twice a day);Oral
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|1500/1200;QD (every day);Oral
Concomitant Medication|HYZAAR|50/12.5;QD (every day);Oral
Concomitant Medication|OMEGA 3|2;QD (every day);Oral
Concomitant Medication|PAXIL|25;QD (every day);Oral
Concomitant Medication|PREMARIN|0.625;QD (every day);Oral
Concomitant Medication|ROBINUL|1;BID (twice a day);Oral
Adverse Event|General system disorders NEC|Pitting edema;Oedema;Oedema NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Tibia fracture;Tibia fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Joint disorders|Arthritis;Arthritis;Arthropathies NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Breath sounds decreased;Breath sounds abnormal;Physical examination procedures;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Hepatic and hepatobiliary disorders|Hepatic cyst;Hepatic cyst;Hepatic and hepatobiliary disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal disorders (excl nephropathies)|Renal cyst;Renal cyst;Renal neoplasms;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Tendon, ligament and cartilage disorders|Tendonitis;Tendonitis;Tendon disorders;MILD;RECOVERED
Concomitant Medication|KEFTAB|NULL;NULL;NULL
Concomitant Medication|PROCARDIA|NULL;NULL;NULL
Concomitant Medication|TYLENOL SINUS|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia lower limb;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle atrophy;Muscle atrophy;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Arrhythmia;Arrhythmia;Rate and rhythm disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain (with radiation);Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cutaneous neoplasms benign|Warts;Skin papilloma;Skin neoplasms benign;MILD;RECOVERED
Concomitant Medication|FUROSEMID|NULL;NULL;NULL
Concomitant Medication|KREON|NULL;NULL;NULL
Concomitant Medication|METOPROLOL|NULL;NULL;NULL
Concomitant Medication|PHENYTOIN|NULL;NULL;NULL
Concomitant Medication|TRAMADOL|NULL;NULL;NULL
Concomitant Medication|TRIDIN|NULL;NULL;NULL
Concomitant Medication|VALSARTAN AND HYDROCHLOROTHIAZIDE|NULL;NULL;NULL
Lab Test|Stool Occult Blood|+
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;NULL
Adverse Event|Hepatobiliary investigations|Bilirubin increased;Blood bilirubin increased;Liver function analyses;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Mild;NULL
Concomitant Medication|ALPHA LIPOIC ACID|50;BID (twice a day);Oral
Concomitant Medication|ATENOLOL|25;QD (every day);Oral
Concomitant Medication|ATENOLOL|25;QD (every day);PEG
Concomitant Medication|BETACAROTENE|10000;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|200;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|75;TID (three times a day);Oral
Concomitant Medication|COLACE|2;QD (every day);Oral
Concomitant Medication|COLACE|2;QD (every day);PEG
Concomitant Medication|CREATINE|5;QD (every day);PEG
Concomitant Medication|PERI-COLACE|1;PRN (as needed);Oral
Concomitant Medication|RILUTEK|50;QD (every day);Oral
Concomitant Medication|VITAMIN C|2000;QD (every day);PEG
Concomitant Medication|VITAMIN C|2000;QD (every day);Oral
Concomitant Medication|VITAMIN E|1200;QD (every day);PEG
Concomitant Medication|ZOLOFT|100;QD (every day);Oral
Concomitant Medication|ZOLOFT|100;QD (every day);PEG
Concomitant Medication|FOLIC ACID|400;QD (every day);Oral
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Generalized muscle aches;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Headache;Headache;Headaches NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Ocular sensory symptoms NEC|Eyes sensitive to sunlight;Photophobia;Ocular sensation disorders;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness of limbs;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Tendon, ligament and cartilage disorders|Tendonitis;Tendonitis;Tendon disorders;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;MODERATE;RECOVERED
Concomitant Medication|LODINE|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM CALCIUM|NULL;NULL;NULL
Concomitant Medication|MIDRIN|NULL;NULL;NULL
Concomitant Medication|PRIMATENE|NULL;NULL;NULL
Concomitant Medication|TERAZOL 3|NULL;NULL;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BETAINE CITRATE|NULL;NULL;NULL
Concomitant Medication|CANTABILINE|NULL;NULL;NULL
Concomitant Medication|DIBENCOZAN|NULL;NULL;NULL
Concomitant Medication|EUPHYTOSE|NULL;NULL;NULL
Concomitant Medication|ISKEDYL|NULL;NULL;NULL
Concomitant Medication|LEGALON|NULL;NULL;NULL
Concomitant Medication|MAXEPA|NULL;NULL;NULL
Concomitant Medication|RENUTRYL|NULL;NULL;NULL
Concomitant Medication|SERC|NULL;NULL;NULL
Concomitant Medication|TENORMINE|NULL;NULL;NULL
Concomitant Medication|TOCO|NULL;NULL;NULL
Concomitant Medication|VOGALENE|NULL;NULL;NULL
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Deliria (incl confusion)|Confusion;Confusional state;Confusion and disorientation;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;MILD;RECOVERED
Concomitant Medication|NORETHIN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Catarrh;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Flu symptoms;Influenza;Influenza viral infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Light-headed;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Orthopnoea;Orthopnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Body temperature conditions|Pyrexia;Pyrexia;Febrile disorders;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Voice alteration;Dysphonia;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MILD;RECOVERED
Concomitant Medication|BETNOVATE|NULL;NULL;NULL
Concomitant Medication|BINOVUM|NULL;NULL;NULL
Concomitant Medication|CITIRIZINE|NULL;NULL;NULL
Concomitant Medication|LOSEC|NULL;NULL;NULL
Concomitant Medication|MINERALS|NULL;NULL;NULL
Concomitant Medication|MINI-PILL|NULL;NULL;NULL
Concomitant Medication|SENNA|NULL;NULL;NULL
Concomitant Medication|UBIQUINONE|NULL;NULL;NULL
Concomitant Medication|ZIRTEK|NULL;NULL;NULL
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Libido decreased;Libido decreased;Sexual desire disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Exanthema;Rash;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Yawning;Yawning;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness in extremity;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Concomitant Medication|INNOHEP|NULL;NULL;NULL
Concomitant Medication|LIMPTAR N|NULL;NULL;NULL
Concomitant Medication|NOVADRAL|NULL;NULL;NULL
Concomitant Medication|SEROXAT|NULL;NULL;NULL
Concomitant Medication|SPONDYVIT|NULL;NULL;NULL
Concomitant Medication|VIAGRA|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Edema glottis;Laryngeal oedema;Laryngeal spasm, oedema and obstruction;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Femur fracture;Femur fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Gait instability;Gait disturbance;Gait disturbances;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Mood disorder NOS;Affective disorder;Mood disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in limb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Injuries NEC|Injury;Injury;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATENOLOL|100;QD (every day);Oral
Concomitant Medication|AZITHROMYCIN|500;QD (every day);Oral
Concomitant Medication|CEFAZOLIN|3000;TID (three times a day);Intravenous
Concomitant Medication|CETOPROFENO|320;QD (every day);Oral
Concomitant Medication|D-ALPHA TOCOPHEROL|300;QD (every day);Oral
Concomitant Medication|DEXAMETHASONE|4;BID (twice a day);
Concomitant Medication|DOXAZOSIN|1;QD (every day);Oral
Concomitant Medication|ENALAPRIL/HYDROCHLOROTHIAZIDE|20+12.5;QD (every day);Oral
Concomitant Medication|ENOXAPARIN|4000;QD (every day);Subcutaneous
Concomitant Medication|EPINEPHRINE|0.5;QD (every day);Subcutaneous
Concomitant Medication|ESCITALOPRAM|10;QD (every day);Oral
Concomitant Medication|FLURBIPROFEN|6;TID (three times a day);
Concomitant Medication|METHYLPREDNISOLONE|60;QD (every day);Intravenous
Concomitant Medication|NETILMICIN|4;BID (twice a day);
Concomitant Medication|NORFLOXACIN|8;QID (four times a day);
Concomitant Medication|OXATOMIDE|30;QD (every day);Oral
Concomitant Medication|OXYGEN|10000;QD (every day);Inhalation
Concomitant Medication|PARACETAMOL|1;QD (every day);Intravenous
Concomitant Medication|PARACETAMOL|1000;QD (every day);Oral
Concomitant Medication|PREDNISONE|12.5;QD (every day);Oral
Concomitant Medication|PREDNISONE|25;QD (every day);Oral
Concomitant Medication|SALBUTAMOL|400;QID (four times a day);Inhalation
Concomitant Medication|TEICOPLANIN|200;QD (every day);Intravenous
Concomitant Medication|TICLOPIDINE|500;BID (twice a day);Oral
Concomitant Medication|TRAMADOL|37.5;BID (twice a day);Oral
Concomitant Medication|TRAMADOL|50;BID (twice a day);Oral
Concomitant Medication|VACCINE, INFLUENZA|UNK;PRN (as needed);Intramuscular
Concomitant Medication|VANCOMYCIN|2000;QID (four times a day);Intravenous
Concomitant Medication|AMITRIPTYLINE|6;BID (twice a day);Oral
Concomitant Medication|FENTANYL|12.5;Other (specify);Topical
Concomitant Medication|LEVOFLOXACIN|500;QD (every day);Oral
Adverse Event|Enzyme investigations NEC|CPK increase;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of lower extremities;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbar pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MODERATE;RECOVERED
Adverse Event|Lipid analyses|Triglyceride increased;Blood triglycerides increased;Triglyceride analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|DIOVENOR|NULL;NULL;NULL
Concomitant Medication|FLODIL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Common cold syndrome;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Abnormal touch sensation;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Abnormal touch sensation;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Fever blister;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Sensory aberrations;Sensory disturbance;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;SEVERE;RECOVERED
Concomitant Medication|ACTIFED|NULL;NULL;NULL
Concomitant Medication|ANTIOXIDANT|NULL;NULL;NULL
Concomitant Medication|GUAIFED|NULL;NULL;NULL
Concomitant Medication|LACTINEX|NULL;NULL;NULL
Concomitant Medication|MEDROXYPROGESTERONE|NULL;NULL;NULL
Concomitant Medication|NOW BRANCHED CHAIN AMINO ACIDS|NULL;NULL;NULL
Concomitant Medication|PREMPRO|NULL;NULL;NULL
Concomitant Medication|TAVIST -D|NULL;NULL;NULL
Concomitant Medication|TYLENOL EXTRA STRENGTH|NULL;NULL;NULL
Concomitant Medication|ZYRTEK|NULL;NULL;NULL
Adverse Event|Lipid metabolism disorders|Hypertriglyceridemia;Hypertriglyceridaemia;Elevated triglycerides;MILD;RECOVERED
Adverse Event|Headaches|Migraine;Migraine;Migraine headaches;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Osteoarthritis;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|NIMODIPINE|NULL;NULL;NULL
Lab Test|H. Pylori Antibody|+
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Mild;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Mild;NULL
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;Mild;NULL
Concomitant Medication|AMOXICILLIN|1000;BID (twice a day);Oral
Concomitant Medication|CLARITHROMYCIN|500;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|400;QD (every day);Oral
Concomitant Medication|MICARDIS|40;QD (every day);Oral
Concomitant Medication|OMEPRAZOLE|20;BID (twice a day);Oral
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;Mild;Resolved
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);Fatal;Fatal
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Severe;Resolved
Concomitant Medication|AMOXICILLIN TRIHYDRATE|NULL;NULL;NULL
Concomitant Medication|LIPITOR|NULL;NULL;NULL
Concomitant Medication|LEVAQUIN|NULL;NULL;NULL
Concomitant Medication|TOLTERODINE TARTRATE|NULL;NULL;NULL
Concomitant Medication|VERAPAMIL|NULL;NULL;NULL
Concomitant Medication|VITAMIN B1|NULL;NULL;NULL
Concomitant Medication|VITAMIN B6|NULL;NULL;NULL
Adverse Event|Administration site reactions|Catheter site hematoma;Catheter site haematoma;Implant and catheter site reactions;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Bed sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;Moderate;NULL
Adverse Event|Headaches|Frontal headache;Headache;Headaches NEC;Mild;NULL
Adverse Event|Bacterial infectious disorders|Catheter site cellulitis;Catheter site cellulitis;Bacterial infections NEC;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Moderate;NULL
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;Mild;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;Moderate;NULL
Adverse Event|Bacterial infectious disorders|Folliculitis;Folliculitis;Bacterial infections NEC;Moderate;NULL
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Pain abdominal;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Pharyngitis;Pharyngitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;Moderate;NULL
Concomitant Medication|AMARYL|1;QD (every day);Oral
Concomitant Medication|AMBIEN|10;PRN (as needed);Oral
Concomitant Medication|AMBIEN|5;PRN (as needed);Oral
Concomitant Medication|AMBIEN|5;QHS (at bedtime);PEG
Concomitant Medication|AMITRIPTYLINE|50;QHS (at bedtime);PEG
Concomitant Medication|AMOXICILLIN|250;TID (three times a day);Oral
Concomitant Medication|AMOXICILLIN|500;QID (four times a day);Oral
Concomitant Medication|AUGMENTIN|250;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|10;QD (every day);PEG
Concomitant Medication|BACLOFEN|10;TID (three times a day);PEG
Concomitant Medication|CEPHALEXIN|500;QID (four times a day);PEG
Concomitant Medication|CEPHALEXIN|250;QID (four times a day);PEG
Concomitant Medication|COMPAZINE|25;PRN (as needed);PEG
Concomitant Medication|DEMEROL|50;QD (every day);Intravenous
Concomitant Medication|DOXEPIN|20;BID (twice a day);PEG
Concomitant Medication|DURAGESIC|0-50;PRN (as needed);Transdermal
Concomitant Medication|ELAVIL|100;QHS (at bedtime);Oral
Concomitant Medication|FENTANYL|100;QD (every day);Intravenous
Concomitant Medication|LIDOCAINE|1;QD (every day);Intramuscular
Concomitant Medication|MILK OF MAGNESIUM|2/15;PRN (as needed);Oral
Concomitant Medication|MARINOL|2.5;PRN (as needed);PEG
Concomitant Medication|METAMUCIL|1/7;PRN (as needed);PEG
Concomitant Medication|MORPHINE SULFATE|20;QD (every day);PEG
Concomitant Medication|PERCOCET|0-5/325;PRN (as needed);PEG
Concomitant Medication|ROBINUL|0.2;QD (every day);Intravenous
Concomitant Medication|ROBINUL|1;TID (three times a day);PEG
Concomitant Medication|SENNA|0.45;PRN (as needed);PEG
Concomitant Medication|SCOPOLAMINE|1.5;;Transdermal
Concomitant Medication|TYLENOL|500;PRN (as needed);PEG
Concomitant Medication|TYLENOL|500;PRN (as needed);Oral
Concomitant Medication|TYLENOL W/CODEINE NO. 3|600/60;PRN (as needed);Oral
Concomitant Medication|VERSED|2;QD (every day);Intravenous
Concomitant Medication|Z-PAK|250;QD (every day);PEG
Concomitant Medication|Z-PAK|250;PRN (as needed);PEG
Concomitant Medication|ZOLOFT|50;QD (every day);PEG
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Common cold;Nasopharyngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Mild;NULL
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;NULL
Concomitant Medication|CALCIUM|500;BID (twice a day);Oral
Concomitant Medication|CITRUCEL|2;QD (every day);Oral
Concomitant Medication|DICYCLOMINE|20;PRN (as needed);Oral
Concomitant Medication|DIOVAN|80;QD (every day);Oral
Concomitant Medication|FOSAMAX|35;Once per week;Oral
Concomitant Medication|IMODIUM AD|2;PRN (as needed);Oral
Concomitant Medication|PRILOSEC|20;QD (every day);Oral
Concomitant Medication|ROBITUSSIN-DM|15;PRN (as needed);Oral
Concomitant Medication|TYLENOL SINUS|1000;BID (twice a day);Oral
Concomitant Medication|VITAMIN A|5000;QD (every day);Oral
Concomitant Medication|VITAMIN E|800;QD (every day);Oral
Concomitant Medication|CITRACAL + D|500;QD (every day);Oral
Concomitant Medication|METAMUCIL|15;QD (every day);Oral
Concomitant Medication|MYLANTA|30;PRN (as needed);Oral
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervicodynia;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;MODERATE;RECOVERED
Adverse Event|Breast disorders|Gynecomastia;Gynaecomastia;Breast disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Pleural disorders|Pleural effusion;Pleural effusion;Pneumothorax and pleural effusions NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Concomitant Medication|ASPEGIC|NULL;NULL;NULL
Concomitant Medication|CELESTAMINE|NULL;NULL;NULL
Concomitant Medication|JUSTOR|NULL;NULL;NULL
Concomitant Medication|OFLOCET|NULL;NULL;NULL
Concomitant Medication|VISCERALGINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dizzy;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Cornification and dystrophic skin disorders|Keratosis;Hyperkeratosis;Hyperkeratoses;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin scaly;Skin exfoliation;Exfoliative conditions;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|GGT increased;Gamma-glutamyltransferase increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|Bilirubin increased;Blood bilirubin increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Eye discharge;Eye discharge;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Hearing disorders|Hearing loss;Deafness;Hearing losses;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hypercholesteremia;Hypercholesterolaemia;Elevated cholesterol;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Neuromuscular weakness;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Hepatic and hepatobiliary disorders|Jaundice;Jaundice;Cholestasis and jaundice;MILD;RECOVERED
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Light-headed;Dizziness;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram QTc interval prolonged;Electrocardiogram QT prolonged;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;MILD;RECOVERED
Concomitant Medication|AMBIEN|NULL;NULL;NULL
Concomitant Medication|CODEINE|NULL;NULL;NULL
Concomitant Medication|HYDROCODONE|NULL;NULL;NULL
Concomitant Medication|HYDROXYZINE|NULL;NULL;NULL
Concomitant Medication|MECLIZINE|NULL;NULL;NULL
Concomitant Medication|RESTORIL|NULL;NULL;NULL
Concomitant Medication|SENOKOT|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Thoracic pain;Chest pain;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|DILTIAZEM HYDROCHLORIDE|200;QD (every day);Oral
Concomitant Medication|DILTIAZEM HYDROCHLORIDE|60;QD (every day);Oral
Concomitant Medication|EZETIMIBE W/SIMVASTATIN|10/20;QD (every day);Oral
Concomitant Medication|LITHIUM ACETYLSALICYLATE|160;QD (every day);Oral
Concomitant Medication|NICORANDIL|20;BID (twice a day);Oral
Concomitant Medication|TOCOPHEROL|1000;BID (twice a day);Oral
ALSHX|onset_site|Limb and Bulbar
Adverse Event|Gastrointestinal signs and symptoms|Abdominal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Foot cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Dumping syndrome;Post gastric surgery syndrome;Gastrointestinal and hepatobiliary procedural complications;SEVERE;RECOVERED
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Injuries NEC|Excoriation;Excoriation;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Water, electrolyte and mineral investigations|Potassium low;Blood potassium decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Presyncope;Presyncope;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Suicidal and self-injurious behaviours NEC|Suicidal ideation;Suicidal ideation;Suicidal and self-injurious behaviour;SEVERE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pneumonitis;Pneumonitis;Lower respiratory tract inflammatory and immunologic conditions;MODERATE;RECOVERED
Concomitant Medication|ADVIL|200;PRN (as needed);Oral
Concomitant Medication|ADVIL|400;QHS (at bedtime);Other (specify)
Concomitant Medication|AERIUS|5;PRN (as needed);Other (specify)
Concomitant Medication|AMITRIPTYLINE|25;QHS (at bedtime);Other (specify)
Concomitant Medication|AMITRIPTYLINE|50;BID (twice a day);Other (specify)
Concomitant Medication|AMOXICILLIN|12.5;QD (every day);Other (specify)
Concomitant Medication|AMOXICILLIN|6.25;QD (every day);Other (specify)
Concomitant Medication|ASA|81;QD (every day);Oral
Concomitant Medication|ASA|81;QD (every day);Other (specify)
Concomitant Medication|ATIVAN|.5;PRN (as needed);Oral
Concomitant Medication|ATIVAN|.5;PRN (as needed);Other (specify)
Concomitant Medication|ATIVAN|0.5;QHS (at bedtime);Other (specify)
Concomitant Medication|ATIVAN|1;PRN (as needed);Other (specify)
Concomitant Medication|ATIVAN|1;QHS (at bedtime);Other (specify)
Concomitant Medication|ATIVAN|1;QHS (at bedtime);Sublingual
Concomitant Medication|ATIVAN|1-2;PRN (as needed);Other (specify)
Concomitant Medication|BACLOFEN|10;BID (twice a day);Oral
Concomitant Medication|BACLOFEN|10;BID (twice a day);Other (specify)
Concomitant Medication|BACLOFEN|10;Other (specify);Other (specify)
Concomitant Medication|BACLOFEN|20;BID (twice a day);Other (specify)
Concomitant Medication|BACLOFEN|40;QID (four times a day);Other (specify)
Concomitant Medication|BENEFIBER|1;PRN (as needed);Other (specify)
Concomitant Medication|BOTOX|60;Other (specify);Other (specify)
Concomitant Medication|COTAZYM|1;PRN (as needed);Other (specify)
Concomitant Medication|COVERSYL|4;QD (every day);Oral
Concomitant Medication|COVERSYL|4;QD (every day);Other (specify)
Concomitant Medication|DOMPERIDONE|20;BID (twice a day);Other (specify)
Concomitant Medication|DOMPERIDONE|40;QID (four times a day);Other (specify)
Concomitant Medication|DOMPERIDONE|60;QID (four times a day);Other (specify)
Concomitant Medication|ELAVIL|25;QHS (at bedtime);Other (specify)
Concomitant Medication|ELAVIL|37.5;BID (twice a day);Other (specify)
Concomitant Medication|GLYCOPYRROLATE|.2;PRN (as needed);Sublingual
Concomitant Medication|INDAPAMIDE|1.25;QD (every day);Oral
Concomitant Medication|INDAPAMIDE|1.25;QD (every day);Other (specify)
Concomitant Medication|LORATADINE|10;;Other (specify)
Concomitant Medication|LORATADINE|10;QD (every day);Other (specify)
Concomitant Medication|LORATINE|10;PRN (as needed);Oral
Concomitant Medication|METOCLOPRAMIDE|40;PRN (as needed);Other (specify)
Concomitant Medication|METOCLOPRAMIDE|40;QID (four times a day);Other (specify)
Concomitant Medication|MOI-STIR|1-2;PRN (as needed);Other (specify)
Concomitant Medication|MULTIVITAMIN|2;BID (twice a day);Oral
Concomitant Medication|NORMAL SALINE|1000;Other (specify);Intravenous
Concomitant Medication|NORMAL SALINE|2400;Other (specify);Intravenous
Concomitant Medication|OMNIPAQUE|15;Other (specify);Other (specify)
Concomitant Medication|ONDANSETRON|32;Other (specify);Intravenous
Concomitant Medication|PNEUMOVAX|1;QD (every day);Subcutaneous
Concomitant Medication|RILUTEK|100;BID (twice a day);Other (specify)
Concomitant Medication|RILUTEK|100;Other (specify);Other (specify)
Concomitant Medication|RILUTEK|200;BID (twice a day);Other (specify)
Concomitant Medication|SCOPOLAMINE|1.5;Other (specify);Topical
Concomitant Medication|SCOPOLAMINE|1.5;Three times per week;Topical
Concomitant Medication|SELENIUM|50;QD (every day);Oral
Concomitant Medication|TORADOL|30;PRN (as needed);Intravenous
Concomitant Medication|TORADOL|30;PRN (as needed);Other (specify)
Concomitant Medication|TYLENOL|8;PRN (as needed);Other (specify)
Concomitant Medication|VACCINE, INFLUENZA|.5;QD (every day);Subcutaneous
Concomitant Medication|VITAMIN D|1000;QD (every day);Other (specify)
Concomitant Medication|VITAMIN E|1600;BID (twice a day);Oral
Concomitant Medication|ZYOCAINE|10;Other (specify);Subcutaneous
Concomitant Medication|CELEXA|40;QHS (at bedtime);Oral
Concomitant Medication|CELEXA|60;QHS (at bedtime);Oral
Concomitant Medication|PROVIGIL|200;QD (every day);Oral
Concomitant Medication|VITAMIN E|800;BID (twice a day);Oral
Adverse Event|Synovial and bursal disorders|Shoulder bursitis;Bursitis;Bursal disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Bruising of face;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MILD;RECOVERED
Adverse Event|Skin appendage conditions|Oily skin;Seborrhoea;Sebaceous gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Abrasions;Excoriation;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Tooth ache;Toothache;Dental pain and sensation disorders;MILD;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Tooth extraction;Tooth extraction;Dental and gingival therapeutic procedures;MODERATE;RECOVERED
Concomitant Medication|ZYBAN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Diarrhea, Clostridium difficile;Clostridium difficile colitis;Clostridia infections;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Male reproductive tract infections and inflammations|Prostatitis;Prostatitis;Prostate and seminal vesicles infections and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Worsening of tinnitus;Tinnitus;Inner ear signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|BUPROPION|NULL;NULL;NULL
Concomitant Medication|CLINDAMYCIN|NULL;NULL;NULL
Concomitant Medication|CLONIDINE|NULL;NULL;NULL
Concomitant Medication|CONTAC C|NULL;NULL;NULL
Concomitant Medication|MIDAZOLAM|NULL;NULL;NULL
Concomitant Medication|NAPROSYN|NULL;NULL;NULL
Concomitant Medication|NASOCORT|NULL;NULL;NULL
Concomitant Medication|NOVO-FAMOTIDINE|NULL;NULL;NULL
Concomitant Medication|OFLOXACIN|NULL;NULL;NULL
Concomitant Medication|PEPCID|NULL;NULL;NULL
Concomitant Medication|REACTINE|NULL;NULL;NULL
Concomitant Medication|TAMSULOSIN|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Benign paroxysmal positional vertigo;Vertigo positional;Inner ear signs and symptoms;MODERATE;RECOVERED
Adverse Event|Pleural disorders|Pleuritis;Pleurisy;Pleural infections and inflammations;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MODERATE;RECOVERED
Concomitant Medication|AFLAMIN|2;BID (twice a day);Oral
Concomitant Medication|BETASERC|3;TID (three times a day);Oral
Concomitant Medication|CATAFLAM|2;BID (twice a day);Oral
Concomitant Medication|CHINOTAL|2;BID (twice a day);Oral
Concomitant Medication|CITAPRAM|1;QD (every day);Oral
Concomitant Medication|CITAPRAM|20;QD (every day);Oral
Concomitant Medication|CITAPRAM|40;BID (twice a day);Oral
Concomitant Medication|DICLOFENAC|75;QD (every day);Intravenous
Concomitant Medication|FAMOTIDINE|2;BID (twice a day);Oral
Concomitant Medication|GLYCERIN|1000;BID (twice a day);Intravenous
Concomitant Medication|MEPROBAMATE|2;QD (every day);Oral
Concomitant Medication|MILGAMMA|1;QD (every day);Oral
Concomitant Medication|RILUTEK|2;BID (twice a day);Oral
Lab Test|Bilirubin (Total)|<0.2
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Severe;Continuing
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Dry throat;Dry throat;Upper respiratory tract signs and symptoms;Moderate;Resolved
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Moderate;Continuing
Adverse Event|Procedural and device related injuries and complications NEC|Gastrointestinal stoma complication;Gastrointestinal stoma complication;Gastrointestinal and hepatobiliary procedural complications;Mild;Continuing
Adverse Event|Procedural and device related injuries and complications NEC|Gastrointestinal stoma complication;Gastrointestinal stoma complication;Gastrointestinal and hepatobiliary procedural complications;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;Moderate;Continuing
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Resolved with Residual
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;Severe;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site reaction;Injection site reaction;Injection site reactions;Mild;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Mild;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased stool frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Mild;Resolved
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Mild;Continuing
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Moderate;Resolved
Concomitant Medication|BAKING SODA|NULL;NULL;NULL
Concomitant Medication|HYDROCORTISONE|NULL;NULL;NULL
Concomitant Medication|HYDROGEN PEROXIDE|NULL;NULL;NULL
Concomitant Medication|SCOPOLAMINE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Ankle oedema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Supine dyspnea;Orthopnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Eye discharge;Eye discharge;Ocular infections, inflammations and associated manifestations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Generalised joint pain;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Bilirubin total increased;Blood bilirubin increased;Liver function analyses;MILD;RECOVERED
Concomitant Medication|CO-DYDRAMOL|NULL;NULL;NULL
Concomitant Medication|FRUSEMIDE|NULL;NULL;NULL
Concomitant Medication|HYOSCINE|NULL;NULL;NULL
Concomitant Medication|HYOSCINE HYDROBROMIDE|NULL;NULL;NULL
Concomitant Medication|LACRI-LUBE|NULL;NULL;NULL
Concomitant Medication|POLYACRYLIC ACID|NULL;NULL;NULL
Concomitant Medication|PREDSOL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;Resolved with Residual
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Mild;Resolved
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Moderate;Continuing
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Moderate;Continuing
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Continuing
Adverse Event|Muscle disorders|Twitching;Muscle twitching;Muscle related signs and symptoms NEC;Moderate;Continuing
Adverse Event|Muscle disorders|Cramps of lower extremities;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Continuing
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;Mild;Continuing
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);Mild;Continuing
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Mild;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;Mild;Resolved
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Moderate;Continuing
Concomitant Medication|CARDENE|NULL;NULL;NULL
Concomitant Medication|CORN STARCH|NULL;NULL;NULL
Concomitant Medication|EQUATE TUSSIN DM|NULL;NULL;NULL
Concomitant Medication|GEMFIBROZIL|NULL;NULL;NULL
Concomitant Medication|MACROBID|NULL;NULL;NULL
Concomitant Medication|PEPTO BISMOL|NULL;NULL;NULL
Concomitant Medication|PINDOLOL|NULL;NULL;NULL
Concomitant Medication|PNEUMOCOCCAL VACCINE|NULL;NULL;NULL
Concomitant Medication|PRINIVIL|NULL;NULL;NULL
Concomitant Medication|PROMETH VC|NULL;NULL;NULL
Concomitant Medication|SMZ-TMP|NULL;NULL;NULL
Concomitant Medication|TYLENOL MAXIMUM STRENGTH SINUS|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;Moderate;NULL
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Decrease in coordination;Coordination abnormal;Cerebellar coordination and balance disturbances;Marked;NULL
Adverse Event|Neurological disorders NEC|Decrease in coordination;Coordination abnormal;Cerebellar coordination and balance disturbances;Mild;NULL
Adverse Event|Neurological disorders NEC|Decrease in coordination;Coordination abnormal;Cerebellar coordination and balance disturbances;Moderate;NULL
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;Mild;NULL
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;Marked;NULL
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;Moderate;NULL
Concomitant Medication|ACIPHEX|NULL;NULL;NULL
Concomitant Medication|LIBRAX|NULL;NULL;NULL
Concomitant Medication|PROFEN|NULL;NULL;NULL
Lab Test|Urine Leukesterase|Moderate
Lab Test|Urine blood|Trace
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Abnormal touch sensation;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disorders and disturbances|Insomnia exacerbated;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in hand;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Arm spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Numbness in hand;Hypoaesthesia;Sensory abnormalities NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Numbness in shoulder;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Numbness in shoulder;Hypoaesthesia;Sensory abnormalities NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Muscle spasticity aggravated;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Motor dysfunction;Motor dysfunction;Nervous system disorders NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Motor dysfunction;Motor dysfunction;Nervous system disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;RECOVERED
Concomitant Medication|ACETYLSALICYLIC ACID|80;Every morning;Oral
Concomitant Medication|FOLIC ACID|1;Every morning;Oral
Concomitant Medication|LORAZEPAM|0.5;QHS (at bedtime);Oral
Concomitant Medication|LORAZEPAM|1;QHS (at bedtime);Oral
Concomitant Medication|PREGABALIN|150;QHS (at bedtime);Oral
Concomitant Medication|PREGABALIN|75;QHS (at bedtime);Oral
Concomitant Medication|RAMIPRIL|5;Every morning;Oral
Concomitant Medication|VITAMIN B12|1200;Every morning;Oral
Concomitant Medication|VITAMIN D|1000;Every morning;Oral
Concomitant Medication|BACLOFEN|10;QHS (at bedtime);Oral
Concomitant Medication|BACLOFEN|30;TID (three times a day);Oral
Adverse Event|Enzyme investigations NEC|Alk phos raised;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Blood bicarbonate increased;Blood bicarbonate increased;Mineral and electrolyte analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Gamma GT raised;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count increased;Neutrophil count increased;White blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PROMETHAZINE|NULL;NULL;NULL
Concomitant Medication|TOPROL|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Scalp laceration;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo positional;Vertigo positional;Inner ear signs and symptoms;MODERATE;RECOVERED
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;MILD;RECOVERED
Adverse Event|Coronary artery disorders|Septal myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MODERATE;RECOVERED
Adverse Event|Lipid analyses|Raised triglycerides;Blood triglycerides increased;Triglyceride analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Muscle spasticity aggravated;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|IRON SULFATE|NULL;NULL;NULL
Concomitant Medication|B COMPLEX|1;QD (every day);Oral
Concomitant Medication|CALCIUM|500;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|400;BID (twice a day);Oral
Concomitant Medication|LOTENSIN|10;QD (every day);Oral
Concomitant Medication|METROGEL|0.5;QD (every day);Topical
Adverse Event|Anxiety disorders and symptoms|Arachnophobia;Arachnophobia;Fear symptoms and phobic disorders (incl social phobia);MILD;RECOVERED
Adverse Event|Joint disorders|Thumb osteoarthritis;Osteoarthritis;Osteoarthropathies;MODERATE;RECOVERED
Adverse Event|Joint disorders|Osteoarthritis aggravated;Osteoarthritis;Osteoarthropathies;MILD;RECOVERED
Adverse Event|Joint disorders|Osteoarthritis aggravated;Osteoarthritis;Osteoarthropathies;MODERATE;RECOVERED
Adverse Event|Gastrointestinal vascular conditions|Haemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;RECOVERED
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Ingrowing nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Ingrowing toe nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MILD;RECOVERED
Adverse Event|Bile duct disorders|Biliary colic;Biliary colic;Bile duct infections and inflammations;MILD;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Trigeminal neuralgia;Trigeminal neuralgia;Trigeminal disorders;MODERATE;RECOVERED
Adverse Event|Joint disorders|Thumb osteoarthritis;Osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in leg;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Lipid analyses|Cholesterol levels raised;Blood cholesterol increased;Cholesterol analyses;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|CARBAMAZEPINE|NULL;NULL;NULL
Concomitant Medication|CLIMARA|NULL;NULL;NULL
Concomitant Medication|DEPOMEDRONE|NULL;NULL;NULL
Concomitant Medication|DICLOFENAC|NULL;NULL;NULL
Concomitant Medication|ESTRADERM|NULL;NULL;NULL
Concomitant Medication|EVENING PRIMROSE OIL|NULL;NULL;NULL
Concomitant Medication|FLIXONASE|NULL;NULL;NULL
Concomitant Medication|FLUCLOXACILLIN|NULL;NULL;NULL
Concomitant Medication|LIGNOCAINE|NULL;NULL;NULL
Concomitant Medication|METHYLPREDNISOLONE|NULL;NULL;NULL
Concomitant Medication|PROGYNOVA|NULL;NULL;NULL
Concomitant Medication|TEMAZEPAM|NULL;NULL;NULL
Concomitant Medication|XYLOCAINE|NULL;NULL;NULL
Lab Test|Absolute Band Neutrophil Count|-
Lab Test|Beta HCG|-
Adverse Event|Vascular haemorrhagic disorders|Hematoma;Haematoma;Haemorrhages NEC;MODERATE;RECOVERED
Concomitant Medication|ACETYLCYSTEIN|NULL;NULL;NULL
Concomitant Medication|BELLADONNA ALKALOIDS|NULL;NULL;NULL
Concomitant Medication|HYOSCYAMINE|NULL;NULL;NULL
Concomitant Medication|TAVOR|NULL;NULL;NULL
Concomitant Medication|VOMEX A|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Acute bronchitis;Bronchitis;Lower respiratory tract and lung infections;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLSALICYLIC ACID|100;QD (every day);Oral
Concomitant Medication|ENALAPRIL|10;QD (every day);Oral
Concomitant Medication|NEBIVOLOL|5;QD (every day);Oral
Concomitant Medication|PAROXETINE|8;QD (every day);Oral
Concomitant Medication|RILUZOLE|50;QD (every day);Oral
Concomitant Medication|SIMVASTATIN|20;QD (every day);Oral
Concomitant Medication|SOLIFENACIN|5;QD (every day);Oral
Concomitant Medication|CIPROFLOXACIN|500;QD (every day);Oral
Concomitant Medication|METHYLPREDNISOLONE|20;QD (every day);Intravenous
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Diabetes mellitus;Diabetes mellitus;Diabetes mellitus (incl subtypes);MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Hemoglobin A1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|General system disorders NEC|Excessive thirst;Thirst;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose high;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine high;Glucose urine present;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse increased;Heart rate increased;Heart rate and pulse investigations;MILD;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Burning sensation in eye;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Concomitant Medication|ASCRIPTIN|NULL;NULL;NULL
Concomitant Medication|ERYTHROMYCIN|NULL;NULL;NULL
Concomitant Medication|HUMULIN N|NULL;NULL;NULL
Concomitant Medication|NORTRIPTYLINE|NULL;NULL;NULL
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Axillary adenopathy;Lymphadenopathy;Lymphatic system disorders NEC;MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anguish;Anxiety;Anxiety symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Anxiety disorders and symptoms|Anguish;Anxiety;Anxiety symptoms;SEVERE;RECOVERED
Adverse Event|Enzyme investigations NEC|CK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Bone, calcium, magnesium and phosphorus metabolism disorders|Magnesium deficiency;Magnesium deficiency;Magnesium metabolism disorders;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Renal colic;Renal colic;Urinary tract signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Rhinopharyngitis;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Concomitant Medication|BUSPAR|NULL;NULL;NULL
Concomitant Medication|CIMETIDINE|NULL;NULL;NULL
Concomitant Medication|EXOMUC|NULL;NULL;NULL
Concomitant Medication|LOCABIOTAL|NULL;NULL;NULL
Concomitant Medication|MAG 2|NULL;NULL;NULL
Concomitant Medication|PIPRAM|NULL;NULL;NULL
Concomitant Medication|PROFENID|NULL;NULL;NULL
Concomitant Medication|VALIUM|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|GGT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Hypernatraemia;Hypernatraemia;Sodium imbalance;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Triglyceride increased;Blood triglycerides increased;Triglyceride analyses;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|SOLUPRED|NULL;NULL;NULL
Adverse Event|Joint disorders|Hips osteoarthritis;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Disturbances in thinking and perception|Auditory hallucinations;Hallucination, auditory;Perception disturbances;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Canker sores oral;Aphthous stomatitis;Stomatitis and ulceration;MILD;RECOVERED
Adverse Event|Deliria (incl confusion)|Confusion;Confusional state;Confusion and disorientation;MILD;RECOVERED
Adverse Event|Muscle disorders|Jaw cramp;Trismus;Muscle tone abnormalities;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Neck cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;MILD;RECOVERED
Adverse Event|Eye disorders NEC|Dry eye;Dry eye;Lacrimal disorders;MILD;RECOVERED
Adverse Event|Breast disorders|Breast engorgement;Breast engorgement;Breast signs and symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Erythematous rash;Rash erythematous;Erythemas;MILD;RECOVERED
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|GGT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural related injuries and complications NEC|Stoma site redness;Procedural site reaction;Non-site specific procedural complications;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin red;Erythema;Erythemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Buttock pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Runny nose;Rhinorrhoea;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Shaking of hands;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Stomach flu;Gastroenteritis viral;Viral infections NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ARTHROTEC|NULL;NULL;NULL
Concomitant Medication|DEVIL'S CLAW|NULL;NULL;NULL
Concomitant Medication|DICETEL|NULL;NULL;NULL
Concomitant Medication|DIMENHYDRINATE|NULL;NULL;NULL
Concomitant Medication|ENTROPHEN|NULL;NULL;NULL
Concomitant Medication|FUCIDIN|NULL;NULL;NULL
Concomitant Medication|NATURE'S REMEDY|NULL;NULL;NULL
Concomitant Medication|OPC 3|NULL;NULL;NULL
Concomitant Medication|VICKS NYQUIL|NULL;NULL;NULL
Lab Test|Urine Glucose|1+
Lab Test|Urine WBCs|1+
Lab Test|Urine WBCs|2++
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;Mild;NULL
Concomitant Medication|HOMEOPATHIC PREPARATION|nk;Unknown;Oral
Concomitant Medication|KERATIN|4;;Oral
Concomitant Medication|RILUTEK|50;;Oral
Concomitant Medication|VITAMIN B KOMPLEX|50;;Oral
Concomitant Medication|VITAMIN E|3200;;Oral
Concomitant Medication|ZINC|25;;Oral
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Yawning excessive;Yawning;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Hepatitis C;Hepatitis C;Hepatitis viral infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Sensory aberrations;Sensory disturbance;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ALUPENT|NULL;NULL;NULL
Concomitant Medication|LIDOCAINE|NULL;NULL;NULL
Concomitant Medication|MESTINON|NULL;NULL;NULL
Concomitant Medication|VACCINE, PNEUMOCOCCAL|NULL;NULL;NULL
Lab Test|Urine Bacteria|+
Adverse Event|Joint disorders|Arthritis;Arthritis;Arthropathies NEC;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|Infected finger;Localised infection;Infections NEC;Mild;Resolved
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heart rate irregular;Heart rate irregular;Heart rate and pulse investigations;Mild;Resolved
Adverse Event|Joint disorders|Joint ache;Arthralgia;Joint related signs and symptoms;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Discomfort in joints;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved
Adverse Event|Tissue disorders NEC|Nodule;Nodule;Mass conditions NEC;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Restless legs;Restless legs syndrome;Sensory abnormalities NEC;Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Hand rash;Rash;Rashes, eruptions and exanthems NEC;Mild;Continuing
Adverse Event|Oral soft tissue conditions|Sore mouth;Oral pain;Oral soft tissue pain and paraesthesia;Mild;Continuing
Concomitant Medication|FERROUS SULFATE|NULL;NULL;NULL
Concomitant Medication|OXYBUTYNIN|NULL;NULL;NULL
Concomitant Medication|SINEMET|NULL;NULL;NULL
Concomitant Medication|TRIPLE ANTIBIOTIC|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac disorder signs and symptoms|Disorder circulatory system;Cardiovascular disorder;Cardiac disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count decreased;Neutrophil count decreased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Fractured wrist;Wrist fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach burning sensation of;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count increased;Lymphocyte count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema lower limb;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anemia;Anaemia;Anaemias NEC;MILD;RECOVERED
Adverse Event|White blood cell disorders|Leucopenia;Leukopenia;Leukopenias NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AGRAM|NULL;NULL;NULL
Concomitant Medication|AZANTAC|NULL;NULL;NULL
Concomitant Medication|CEFAPEROS|NULL;NULL;NULL
Concomitant Medication|DAZEN|NULL;NULL;NULL
Concomitant Medication|DIMETANE|NULL;NULL;NULL
Concomitant Medication|DOMPERIDONE|NULL;NULL;NULL
Concomitant Medication|ENDOTELON|NULL;NULL;NULL
Concomitant Medication|INFLACED|NULL;NULL;NULL
Concomitant Medication|MUCOLATOR|NULL;NULL;NULL
Concomitant Medication|PNEUMOREL|NULL;NULL;NULL
Concomitant Medication|TANAKAN|NULL;NULL;NULL
Concomitant Medication|UTEPLEX|NULL;NULL;NULL
Concomitant Medication|VADILEX|NULL;NULL;NULL
Concomitant Medication|VECTRINE|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram T wave inversion;Electrocardiogram T wave inversion;ECG investigations;MILD;RECOVERED
Adverse Event|Synovial and bursal disorders|Baker's cyst;Synovial cyst;Synovial disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramps in legs;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramps in legs;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nauseated;Nausea;Nausea and vomiting symptoms;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain neck;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Concomitant Medication|CALCIUM MAGNESIUM ZINC|NULL;NULL;NULL
Concomitant Medication|LEMSIP|NULL;NULL;NULL
Concomitant Medication|LIGNOCAINE INJECTION|NULL;NULL;NULL
Concomitant Medication|QUININE SULPHATE|NULL;NULL;NULL
Concomitant Medication|TIZANIDINE|NULL;NULL;NULL
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Cardiac arrhythmias|Bigeminy;Extrasystoles;Rate and rhythm disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Breath sounds decreased;Breath sounds abnormal;Physical examination procedures;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dysphonia;Dysphonia;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menstruation increased;Menorrhagia;Menstruation with increased bleeding;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Foot infection;Localised infection;Infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|PCO2 increased;PCO2 increased;Blood gas and acid base analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin breakdown;Skin disorder;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Bilirubin total increased;Blood bilirubin increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;MILD;RECOVERED
Concomitant Medication|CITANEST|NULL;NULL;NULL
Concomitant Medication|EVISTA|NULL;NULL;NULL
Concomitant Medication|HYZAAR|NULL;NULL;NULL
Concomitant Medication|METHENAMINE MANDELATE W/SODIUM PHOSPHATE MONOBASIC (MONOHYDRATE)|NULL;NULL;NULL
Concomitant Medication|NITROGLYCERIN|NULL;NULL;NULL
Concomitant Medication|SULAR|NULL;NULL;NULL
Concomitant Medication|TROVAN|NULL;NULL;NULL
Concomitant Medication|UROCIT K|NULL;NULL;NULL
Concomitant Medication|VALERIAN ROOT|NULL;NULL;NULL
Concomitant Medication|VITAMIN B-COMPLEX|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;Moderate;Continuing
Adverse Event|Eye disorders NEC|Tearing eyes;Lacrimation increased;Lacrimal disorders;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Severe;Resolved
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Severe;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;Moderate;Resolved with Residual
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Moderate;Resolved
Concomitant Medication|NUEDEXTA|NULL;NULL;NULL
Concomitant Medication|DHEA|NULL;NULL;NULL
Concomitant Medication|FOLIC ACID|NULL;NULL;NULL
Concomitant Medication|PREMPHASE|NULL;NULL;NULL
Lab Test|Protein|1+
Lab Test|Protein|Trace
Lab Test|Urine Bacteria|Large
Lab Test|Urine Calcium Oxalate Crystals|Small
Lab Test|Urine Calcium Oxalate Crystals|Large
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;NULL;NULL
Adverse Event|Administration site reactions|Injection site burning;Injection site pain;Injection site reactions;NULL;NULL
Adverse Event|Headaches|Headache;Headache;Headaches NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;NULL;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;NULL;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;NULL;NULL
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;NULL;NULL
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;NULL;NULL
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach ache;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);NULL;NULL
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Concomitant Medication|AMINO ACID|NULL;NULL;NULL
Concomitant Medication|AMINOXIN|NULL;NULL;NULL
Concomitant Medication|CEFALEXIN|NULL;NULL;NULL
Concomitant Medication|CEFAZOLIN|NULL;NULL;NULL
Concomitant Medication|HALOPERIDOL|NULL;NULL;NULL
Concomitant Medication|IRON|NULL;NULL;NULL
Concomitant Medication|NEOTRACIN|NULL;NULL;NULL
Concomitant Medication|PETHIDINE|NULL;NULL;NULL
Concomitant Medication|PROCHLORPERAZINE|NULL;NULL;NULL
Concomitant Medication|PSEUDOEPHEDRINE|NULL;NULL;NULL
Lab Test|Basophils|Normal
Lab Test|Eosinophils|Normal
Adverse Event|Cardiac arrhythmias|Atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Chronic obstructive pulmonary disease;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of lower extremities;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;MODERATE;RECOVERED
Adverse Event|Coronary artery disorders|Arteriosclerotic heart disease;Arteriosclerosis coronary artery;Coronary artery disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Nervousness;Nervousness;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Respiratory tract infection;Respiratory tract infection;Infections NEC;MODERATE;RECOVERED
Concomitant Medication|BROMAZEPAM|NULL;NULL;NULL
Concomitant Medication|BUDESONIDE|NULL;NULL;NULL
Concomitant Medication|CEFUROXIME|NULL;NULL;NULL
Concomitant Medication|FUROSEMIDA|NULL;NULL;NULL
Concomitant Medication|PREDNISONE|NULL;NULL;NULL
Concomitant Medication|ROXITHROMYCIN|NULL;NULL;NULL
Concomitant Medication|SALBUTAMOL|NULL;NULL;NULL
Concomitant Medication|TRIAMTERENE|NULL;NULL;NULL
Adverse Event|Injuries by physical agents|Second degree burns;Burns second degree;Thermal burns;MILD;RECOVERED
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Swollen lymph nodes;Lymphadenopathy;Lymphatic system disorders NEC;MILD;RECOVERED
Concomitant Medication|DIMETAPP|12;TID (three times a day);Oral
Concomitant Medication|OXACILIN|500;TID (three times a day);Oral
Concomitant Medication|RILUTEK|200;BID (twice a day);Oral
Concomitant Medication|ROBINUL|1;PRN (as needed);Oral
Concomitant Medication|SCOPOLAMINE|0.33;Other (specify);Other (specify)
Concomitant Medication|ATROPINE|2;PRN (as needed);Sublingual
Adverse Event|Epidermal and dermal conditions|Erythematosquamous dermatosis;Eczema;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Foot edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Rib fracture;Rib fracture;Thoracic cage fractures and dislocations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;MILD;RECOVERED
Concomitant Medication|DOLORMIN|NULL;NULL;NULL
Concomitant Medication|NOVAMIN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Generalized muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Cough nonproductive;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Peritoneal and retroperitoneal conditions|Pneumoperitoneum;Pneumoperitoneum;Peritoneal and retroperitoneal disorders;MILD;RECOVERED
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DESYREL|NULL;NULL;NULL
Concomitant Medication|DIABINESE|NULL;NULL;NULL
Concomitant Medication|DOCUSATE SODIUM|NULL;NULL;NULL
Concomitant Medication|HYTRIN|NULL;NULL;NULL
Concomitant Medication|LEVBID|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM OXIDE|NULL;NULL;NULL
Concomitant Medication|POTASSIUM GLUCONATE|NULL;NULL;NULL
Concomitant Medication|PROPANOLOL|NULL;NULL;NULL
Concomitant Medication|PROSCAR|NULL;NULL;NULL
Concomitant Medication|SEPTRA|NULL;NULL;NULL
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of lower extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|Breast disorders|Breast cyst;Breast cyst;Benign and malignant breast neoplasms;MILD;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergic reaction;Hypersensitivity;Allergic conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Facial puffiness;Swelling face;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose bleed;Epistaxis;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ringing in ears;Tinnitus;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Tissue disorders NEC|Cyst;Cyst;Mass conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Bone tenderness;Bone pain;Bone related signs and symptoms;MILD;RECOVERED
Adverse Event|General system disorders NEC|Tightness in chest;Chest discomfort;Pain and discomfort NEC;MILD;RECOVERED
Concomitant Medication|LOTREL|NULL;NULL;NULL
Concomitant Medication|MYCITRACIN PLUS|NULL;NULL;NULL
Concomitant Medication|ROBITUSSIN|NULL;NULL;NULL
Concomitant Medication|ST. JOHN'S WORT|NULL;NULL;NULL
Concomitant Medication|VANTIN|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALPRAZOLAM|0.75;TID (three times a day);Oral
Concomitant Medication|AMILORIDE W/HYDROCHLOROTHIAZIDE|5/50;QD (every day);Oral
Concomitant Medication|ATENOLOL|50;Every morning;Oral
Concomitant Medication|BACLOFEN|37.5;BID (twice a day);Oral
Concomitant Medication|CITALOPRAM|10;Every morning;Oral
Concomitant Medication|ENALAPRIL MALEATE|10;QHS (at bedtime);Oral
Concomitant Medication|ENALAPRIL MALEATE|20;BID (twice a day);Oral
Concomitant Medication|LITHIUM ACETYLSALICYLATE|75;Every morning;Oral
Concomitant Medication|RILUZOLE|50;Every morning;Oral
Concomitant Medication|ZOLPIDEM|10;QHS (at bedtime);Oral
Adverse Event|Gastrointestinal signs and symptoms|Upper abdominal pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Allergic conditions|Allergic reaction to analgesics;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal ulceration and perforation|Esophageal ulcer;Oesophageal ulcer;Oesophageal ulcers and perforation;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Scar;Scar;Skin injuries and mechanical dermatoses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Farsighted;Hypermetropia;Refractive and accommodative disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fractured metatarsal;Foot fracture;Lower limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Hiatus hernia;Hiatus hernia;Diaphragmatic hernias;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Osteoporosis;Osteoporosis;Metabolic bone disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain foot;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Foot sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Concomitant Medication|BREWERS YEAST|NULL;NULL;NULL
Concomitant Medication|FAMOTIDINE|NULL;NULL;NULL
Concomitant Medication|PANTOLOC|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Common cold;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Gastrointestinal vascular conditions|External hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal stenosis and obstruction|Volvulus of bowel;Volvulus;Large intestinal stenosis and obstruction;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|CELECOXIB|100;QD (every day);Oral
Concomitant Medication|COENZYME Q10|100;QD (every day);Oral
Concomitant Medication|DEXTROMETHORPHAN HYDROBROMIDE|15;TID (three times a day);Oral
Concomitant Medication|FESOTERODINE|4;QD (every day);Oral
Concomitant Medication|HYOSCINE BUTYLBROMIDE|20;BID (twice a day);Oral
Concomitant Medication|KALIUMCHLORIDE|46.6;QD (every day);Oral
Concomitant Medication|MACROGOL|13.125;QD (every day);Oral
Concomitant Medication|MEBEVERINEHYDROCHLORIDE|405;TID (three times a day);Oral
Concomitant Medication|NATRIUMKLORID|350.7;QD (every day);Oral
Concomitant Medication|NATRIUMPICOSULFAT|15;QD (every day);Oral
Concomitant Medication|VACCINE, INFLUENZA|0.5;QD (every day);Subcutaneous
Concomitant Medication|DOMPERIDONE|20;BID (twice a day);Oral
Concomitant Medication|SACCHAROMYCES BOULARDII|20;BID (twice a day);Oral
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Mental impairment disorders|Mental dullness;Mental impairment;Mental impairment (excl dementia and memory loss);Mild;NULL
Adverse Event|Neurological disorders NEC|Paresthesia lower limb;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Concomitant Medication|FLOMAX|NULL;NULL;NULL
Concomitant Medication|TENORMIN|NULL;NULL;NULL
Lab Test|Urine Squamous Epithelial Cells|Few
Lab Test|Urine Squamous Epithelial Cells|Trace
Adverse Event|Viral infectious disorders|Cold sores lip;Oral herpes;Herpes viral infections;NULL;NULL
Adverse Event|Joint disorders|Effusion (l) knee;Joint effusion;Joint related signs and symptoms;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Persistent cough;Cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Redness;Erythema;Erythemas;NULL;NULL
Adverse Event|General system disorders NEC|Chills;Chills;Feelings and sensations NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Muscle disorders|Cramps in legs;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;NULL;NULL
Concomitant Medication|MEDINITE|NULL;NULL;NULL
FamilyHx|family_ALS_hist|Y
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Abnormal touch sensation;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count decreased;Lymphocyte count decreased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Band neutrophil count increased;Band neutrophil count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count increased;Neutrophil count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;MODERATE;RECOVERED
Concomitant Medication|ALLOPURINOL|NULL;NULL;NULL
Lab Test|Urine Leukesterase|Large
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;SEVERE;RECOVERED
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALPRAZOLAM|0,5;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|25;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|50;QD (every day);Oral
Concomitant Medication|ANTIBIOTIC|UNK;Unknown;Unknown
Concomitant Medication|BACLOFEN|30;QID (four times a day);Oral
Concomitant Medication|CINITAPRIDE|3;QID (four times a day);Oral
Concomitant Medication|CITALOPRAM|20;QD (every day);Other (specify)
Concomitant Medication|DEXKETOPROFEN|75;TID (three times a day);Oral
Concomitant Medication|ESCITALOPRAM|20;QD (every day);Other (specify)
Concomitant Medication|HALAZEPAM|40;QD (every day);Oral
Concomitant Medication|OXYGEN|UNK;Unknown;Inhalation
Concomitant Medication|PANTOPRAZOLE|40;BID (twice a day);Other (specify)
Concomitant Medication|RABEPRAZOLE|20;QD (every day);Oral
Concomitant Medication|SERTRALINE|50;QD (every day);Oral
Concomitant Medication|SIMETICONE|300;QID (four times a day);Other (specify)
Concomitant Medication|TICLOPIDIN|250;QD (every day);Oral
Concomitant Medication|VITAMIN B12|1;Once per week;Oral
Concomitant Medication|VITAMIN E|400;QD (every day);Oral
Concomitant Medication|ZOLPIDEM|5;QHS (at bedtime);Oral
Adverse Event|Hepatobiliary investigations|Bilirubin increased;Blood bilirubin increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrooesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated hemoglobin high;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Bone, calcium, magnesium and phosphorus metabolism disorders|Hypercalcaemia;Hypercalcaemia;Calcium metabolism disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Sleep disorder;Sleep disorder;Sleep disorders NEC;MILD;RECOVERED
Concomitant Medication|CLOMIPRAMINE|NULL;NULL;NULL
Concomitant Medication|MOPROL|NULL;NULL;NULL
Concomitant Medication|OMEPRAZOL|NULL;NULL;NULL
Concomitant Medication|ZOLTUM|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Orthostatic collapse;Syncope;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Euphoria;Euphoric mood;Emotional and mood disturbances NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Orthostatic dizziness;Dizziness postural;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NOVOPROTECT|NULL;NULL;NULL
Concomitant Medication|SOTAHEXAL|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Seborrhoea;Seborrhoea;Sebaceous gland disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALMAGATE|NULL;NULL;NULL
Concomitant Medication|AMLODIPINE|NULL;NULL;NULL
Concomitant Medication|BISOPROLOL|NULL;NULL;NULL
Concomitant Medication|PANTOPRAZOLE|NULL;NULL;NULL
Adverse Event|Synovial and bursal disorders|Olecranon bursitis;Bursitis;Bursal disorders;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;MILD;RECOVERED
Adverse Event|Coronary artery disorders|Inferior myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Ingrown toe nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;MILD;RECOVERED
Adverse Event|Coronary artery disorders|Septal myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MILD;RECOVERED
Concomitant Medication|INDAPAMIDE|NULL;NULL;NULL
Concomitant Medication|NIFEDIPINE|NULL;NULL;NULL
Concomitant Medication|PERINDOPRIL|NULL;NULL;NULL
Concomitant Medication|VALSARTAN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Concomitant Medication|BREWERS YEAST|2;TID (three times a day);Oral
Concomitant Medication|CALCIUM|1200;QD (every day);Oral
Concomitant Medication|CELEBREX|800;QD (every day);Oral
Concomitant Medication|ELAVIL|10;QHS (at bedtime);Oral
Concomitant Medication|ESTRADIOL|.5;QD (every day);Oral
Concomitant Medication|HYDROCODONE/APAP|7.5/750;PRN (as needed);Oral
Concomitant Medication|LEXAPRO|10;QD (every day);Oral
Concomitant Medication|LEXAPRO|20;QD (every day);Oral
Concomitant Medication|LOTREL|10/20;QD (every day);Oral
Concomitant Medication|MEDROXYPROGESTERONE|5/12;QD (every day);Oral
Concomitant Medication|NEXIUM|40;QD (every day);Oral
Concomitant Medication|QUININE SULFATE|325;QD (every day);Oral
Concomitant Medication|SYNTHROID|.125;QD (every day);Oral
Concomitant Medication|VALIUM|5;PRN (as needed);Oral
Concomitant Medication|VITAMIN C|800;QD (every day);Oral
Concomitant Medication|XANAX|.5;QHS (at bedtime);Oral
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Drooling;Drooling;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MILD;UNKNOWN
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Concomitant Medication|B COMPLEX|NULL;NULL;NULL
Concomitant Medication|CELEBREX|NULL;NULL;NULL
Concomitant Medication|COGENTIN|NULL;NULL;NULL
Concomitant Medication|GRAVOL|NULL;NULL;NULL
Concomitant Medication|LEVOTHYROXINE|NULL;NULL;NULL
Concomitant Medication|TICLID|NULL;NULL;NULL
Concomitant Medication|TORADOL|NULL;NULL;NULL
Concomitant Medication|TRANSDERM V|NULL;NULL;NULL
Concomitant Medication|TYLENOL NO.2|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Discoloration skin;Skin discolouration;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Discoloration skin;Skin discolouration;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophils increased;Neutrophil count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Cardiac disorder;Cardiac disorder;Cardiac disorders NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Macular rash;Rash macular;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Vision disorders|Nearsighted;Myopia;Refractive and accommodative disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastric spasm;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Dysphonia;Dysphonia;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Hypotension;Hypotension;Vascular hypotensive disorders;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|Bilirubin total increased;Blood bilirubin increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight increased;Weight increased;Physical examination procedures;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Pneumopathy;Lung disorder;Respiratory tract disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ANEXATE|NULL;NULL;NULL
Concomitant Medication|CARBOMIX|NULL;NULL;NULL
Concomitant Medication|CITRATE DE BETAINE|NULL;NULL;NULL
Concomitant Medication|FRAXIPARINE|NULL;NULL;NULL
Concomitant Medication|HEPT-A-MYL|NULL;NULL;NULL
Concomitant Medication|HOMEOPATHIC PREPARATION|NULL;NULL;NULL
Concomitant Medication|VITAMIN B1 AND B6|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema legs;Oedema peripheral;Oedema NEC;Marked;NULL
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Mild;NULL
Adverse Event|Embolism and thrombosis|Left deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;Marked;NULL
Concomitant Medication|ALPRAZOLAM|1;TID (three times a day);Oral
Concomitant Medication|B COMPLEX|1;Twice per week;Intramuscular
Concomitant Medication|BACLOFEN|20;QID (four times a day);Oral
Concomitant Medication|COUMADIN|7;QD (every day);Oral
Concomitant Medication|CYANOCOBALAMIN|1;Twice per week;Intramuscular
Concomitant Medication|LIVER INJECTION|2;Twice per week;Intramuscular
Concomitant Medication|MINOCYCLINE|100;BID (twice a day);Oral
Concomitant Medication|NALTREXONE|4;QD (every day);Oral
Concomitant Medication|NEURONTIN|600;TID (three times a day);Oral
Concomitant Medication|NEURONTIN|300;TID (three times a day);Oral
Concomitant Medication|QUININE SULFATE|324/5;QHS (at bedtime);Oral
Concomitant Medication|THIAMINE|0.5;Twice per week;Intramuscular
Concomitant Medication|VITAMIN E|1600;QD (every day);Oral
Concomitant Medication|ZANAFLEX|4;TID (three times a day);Oral
Lab Test|Urine Yeast|Large
Adverse Event|Vascular disorders NEC|Flushing;Flushing;Peripheral vascular disorders NEC;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);NULL;NULL
Concomitant Medication|DIONAEA MUSCIPULA|NULL;NULL;NULL
Concomitant Medication|FLUOXETINE|NULL;NULL;NULL
Concomitant Medication|IPRATROPIUM|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM SULFATE|NULL;NULL;NULL
Concomitant Medication|PYRIDOSTIGMINE|NULL;NULL;NULL
Concomitant Medication|THYMUS EXTRACT|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;UNKNOWN
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;UNKNOWN
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Hypovolemia;Hypovolaemia;Total fluid volume decreased;MODERATE;UNKNOWN
Adverse Event|Myocardial disorders|Dilatation atrial;Dilatation atrial;Myocardial disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Tissue disorders NEC|Ulcer;Ulcer;Ulcers NEC;MODERATE;UNKNOWN
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CEFTRIAXONE|NULL;NULL;NULL
Concomitant Medication|HEXAVITAMIN|NULL;NULL;NULL
Concomitant Medication|PLENDIL|NULL;NULL;NULL
Concomitant Medication|SULCRATE|NULL;NULL;NULL
Concomitant Medication|TETANUS TOXOID|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Bloating;Abdominal distension;Flatulence, bloating and distension;Mild;Continuing
Adverse Event|General system disorders NEC|Feeling of warmth;Feeling hot;Feelings and sensations NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Mild;Resolved
Adverse Event|General system disorders NEC|Sensation of foreign body;Sensation of foreign body;Feelings and sensations NEC;Mild;Continuing
Adverse Event|Administration site reactions|Injection site swelling;Injection site swelling;Injection site reactions;Mild;Resolved
Adverse Event|Allergic conditions|Hypersensitivity reaction;Hypersensitivity;Allergic conditions NEC;Severe;Resolved
Adverse Event|Administration site reactions|Injection site warmth;Injection site warmth;Injection site reactions;Mild;Resolved
Adverse Event|Administration site reactions|Injection site itching;Injection site pruritus;Injection site reactions;Mild;Resolved
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;Mild;Resolved
Adverse Event|General system disorders NEC|Jitteriness;Feeling jittery;Feelings and sensations NEC;Mild;Continuing
Adverse Event|Injuries NEC|Bruising;Contusion;Skin injuries NEC;Mild;Resolved
Adverse Event|Injuries NEC|Kidney contusion;Renal injury;Renal and urinary tract injuries NEC;Mild;Resolved
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;Mild;Continuing
Adverse Event|Reproductive tract disorders NEC|Genital itching;Pruritus genital;Reproductive tract signs and symptoms NEC;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;Continuing
Concomitant Medication|DEPO MEDROL|NULL;NULL;NULL
Concomitant Medication|DIPHENHYDRAMINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|MILK OF MAGNESIUM|NULL;NULL;NULL
Concomitant Medication|NIASPAN|NULL;NULL;NULL
Concomitant Medication|PROMETH WITH CODEINE|NULL;NULL;NULL
Concomitant Medication|PROVENTIL|NULL;NULL;NULL
Concomitant Medication|SEREVENT|NULL;NULL;NULL
Concomitant Medication|THEOPHYLLINE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNKNOWN
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Hearing disorders|Hearing impaired;Hearing impaired;Hearing losses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;UNKNOWN
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ringing in ears;Tinnitus;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MODERATE;RECOVERED
Concomitant Medication|CEFACLOR|NULL;NULL;NULL
Concomitant Medication|CEFZIL|NULL;NULL;NULL
Concomitant Medication|DOCUSATE CALCIUM|NULL;NULL;NULL
Concomitant Medication|ENTERIC ASPIRIN|NULL;NULL;NULL
Concomitant Medication|LOPRESSOR|NULL;NULL;NULL
Concomitant Medication|UNASYN|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Nervousness;Nervousness;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Supraventricular tachycardia;Supraventricular tachycardia;Supraventricular arrhythmias;SEVERE;RECOVERED
Adverse Event|Skin appendage conditions|Sweating increased;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;RECOVERED
Concomitant Medication|CLAVULANIC ACID|NULL;NULL;NULL
Concomitant Medication|DIGOXIN|NULL;NULL;NULL
Concomitant Medication|EPRAZINONE|NULL;NULL;NULL
Concomitant Medication|MOLSIDOMINE|NULL;NULL;NULL
Concomitant Medication|NADROPARINE|NULL;NULL;NULL
Concomitant Medication|NORMACOL PLUS|NULL;NULL;NULL
Concomitant Medication|SOTALOL|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Bladder incontinence;Urinary incontinence;Bladder and urethral symptoms;Mild;NULL
Adverse Event|Neurological disorders NEC|Burning foot;Burning sensation;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;Mild;NULL
Adverse Event|Fungal infectious disorders|Fungal infection;Fungal infection;Fungal infections NEC;Mild;NULL
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;Mild;NULL
Adverse Event|Joint disorders|Joint stiffness;Joint stiffness;Joint related signs and symptoms;Mild;NULL
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;Mild;NULL
Adverse Event|General system disorders NEC|Gait instability;Gait disturbance;Gait disturbances;Mild;NULL
Concomitant Medication|GAS RELIEF|NULL;NULL;NULL
Concomitant Medication|ISORDIL|NULL;NULL;NULL
Concomitant Medication|LAMISIL|NULL;NULL;NULL
Concomitant Medication|NITROQUICK|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchospasm;Bronchospasm;Bronchospasm and obstruction;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Rhinorrhea;Rhinorrhoea;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CETIRIZINE DIHCL|NULL;NULL;NULL
Concomitant Medication|NAPROXEN SODIUM|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Infection;Infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Concomitant Medication|ANTIBIOTICS|NULL;NULL;NULL
Concomitant Medication|HEPARIN CALCIUM|NULL;NULL;NULL
Concomitant Medication|MOVICOL|NULL;NULL;NULL
Concomitant Medication|SAROTEN|NULL;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Postoperative pain;Procedural pain;Non-site specific procedural complications;Moderate;Resolved
Adverse Event|Psychiatric disorders NEC|Mental status changes;Mental status changes;Mental disorders NEC;Severe;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Apnea;Apnoea;Breathing abnormalities;         .;         .
Adverse Event|Infections - pathogen unspecified|Bilateral pneumonia;Pneumonia;Lower respiratory tract and lung infections;Severe;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Mild;Continuing
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Moderate;Continuing
Adverse Event|Gastrointestinal ulceration and perforation|Perforated bowel;Intestinal perforation;Intestinal ulcers and perforation NEC;Life Threatening;Resolved with Residual
Adverse Event|Infections - pathogen unspecified|Sepsis;Sepsis;Sepsis, bacteraemia, viraemia and fungaemia NEC;Life Threatening;Resolved
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Severe;Resolved with Residual
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;Moderate;Continuing
Concomitant Medication|EFFEXOR|NULL;NULL;NULL
Concomitant Medication|FLUCONAZOLE|NULL;NULL;NULL
Concomitant Medication|HYDROMORPHONE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|KETOROLAC|NULL;NULL;NULL
Concomitant Medication|LOTRIMIN|NULL;NULL;NULL
Concomitant Medication|MYCELEX|NULL;NULL;NULL
Concomitant Medication|SINAREST|NULL;NULL;NULL
Concomitant Medication|ZYPREXA|NULL;NULL;NULL
Adverse Event|Injuries NEC|Back strain;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Discomfort in joints;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|GERD;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;MILD;RECOVERED
Concomitant Medication|ALEVE|NULL;NULL;NULL
Concomitant Medication|CHLORASEPTIC|NULL;NULL;NULL
Concomitant Medication|COMPAZINE|NULL;NULL;NULL
Concomitant Medication|COUMADIN|NULL;NULL;NULL
Concomitant Medication|COZAAR|NULL;NULL;NULL
Concomitant Medication|ENOXAPARIN|NULL;NULL;NULL
Concomitant Medication|HUMIBID LA|NULL;NULL;NULL
Concomitant Medication|KYO-DOPHILUS|NULL;NULL;NULL
Concomitant Medication|LIPOIC ACID|NULL;NULL;NULL
Concomitant Medication|LORTAB|NULL;NULL;NULL
Concomitant Medication|MANGANESE|NULL;NULL;NULL
Concomitant Medication|PIPERACILLIN|NULL;NULL;NULL
Concomitant Medication|VANCENASE AQ|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cornification and dystrophic skin disorders|Actinic keratosis;Actinic keratosis;Skin preneoplastic conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Arthritic pains;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in calf;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Red blood cells urine;Red blood cells urine;Urinalysis NEC;MODERATE;RECOVERED
Adverse Event|Miscellaneous and site unspecified neoplasms malignant and unspecified|Squamous cell carcinoma;Squamous cell carcinoma;Neoplasms malignant site unspecified NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine;White blood cells urine;Urinalysis NEC;MODERATE;RECOVERED
Concomitant Medication|ALUMINUM ACETATE|NULL;NULL;NULL
Concomitant Medication|BECLOMETASONE DIPROPIONATE|NULL;NULL;NULL
Concomitant Medication|COTRIMOXAZOLE|NULL;NULL;NULL
Concomitant Medication|COVERA|NULL;NULL;NULL
Concomitant Medication|DIMETAPP|NULL;NULL;NULL
Concomitant Medication|FLUOROURACIL|NULL;NULL;NULL
Concomitant Medication|HYDROPHILIC|NULL;NULL;NULL
Concomitant Medication|LOVENOX|NULL;NULL;NULL
Concomitant Medication|NOVOCAINE|NULL;NULL;NULL
Concomitant Medication|POTASSIUM CHLORIDE|NULL;NULL;NULL
Concomitant Medication|SLOW-K|NULL;NULL;NULL
Concomitant Medication|TRETINOIN|NULL;NULL;NULL
Concomitant Medication|VICKS VAPORUB|NULL;NULL;NULL
Concomitant Medication|VITAMIN K|NULL;NULL;NULL
Concomitant Medication|WARFARIN|NULL;NULL;NULL
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Chest X-ray abnormal;Chest X-ray abnormal;Respiratory tract and thoracic imaging procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;MILD;RECOVERED
Adverse Event|Vision disorders|Double vision;Diplopia;Visual disorders NEC;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count decreased;Lymphocyte count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Thoracic disc degeneration;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Hernia;Hernia;Hernias NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED
Adverse Event|Cardiac arrhythmias|Left anterior hemiblock;Bundle branch block left;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramp;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Penicillin allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Right bundle branch block;Bundle branch block right;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin vascular abnormalities|Telangiectasia;Telangiectasia;Telangiectasia and related conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergic reaction to antibiotics;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular disorders NEC|Tortuous aorta;Aortic disorder;Site specific vascular disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALDACTONE|NULL;NULL;NULL
Concomitant Medication|BETA CAROTENE|NULL;NULL;NULL
Concomitant Medication|CITRUCEL|NULL;NULL;NULL
Concomitant Medication|ISOSOURCE|NULL;NULL;NULL
Concomitant Medication|VALTREX|NULL;NULL;NULL
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Groin infection;Groin infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Shoulder fracture;Upper limb fracture;Upper limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Concomitant Medication|EMETROL|NULL;NULL;NULL
Concomitant Medication|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|NULL;NULL;NULL
Concomitant Medication|OXYMETAZOLINE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Dislocated shoulder;Joint dislocation;Fractures and dislocations NEC;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Paresis;Paresis;Paralysis and paresis (excl cranial nerve);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Middle insomnia;Middle insomnia;Disturbances in initiating and maintaining sleep;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|NADOLOL|NULL;NULL;NULL
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;SEVERE;RECOVERED
Concomitant Medication|BACLOFEN|12.5;QD (every day);Oral
Lab Test|Urine Albumin|Trace
Adverse Event|Renal and urinary tract investigations and urinalyses|Casts urinary hyaline;Urinary casts;Urinalysis NEC;Mild;NULL
Adverse Event|Muscle disorders|Muscle cramp;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Physical examination topics|Weight increase;Weight increased;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|STEMETIL|NULL;NULL;NULL
Adverse Event|Prostatic disorders (excl infections and inflammations)|Enlarged prostate;Prostatomegaly;Prostatic signs, symptoms and disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hyperlipidemia;Hyperlipidaemia;Hyperlipidaemias NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Increased appetite;Increased appetite;Appetite disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|BROMELAINS|NULL;NULL;NULL
Concomitant Medication|DONNATAL|NULL;NULL;NULL
Concomitant Medication|L-TYROSINE|NULL;NULL;NULL
Concomitant Medication|MYLANTA|NULL;NULL;NULL
Concomitant Medication|PIMA|NULL;NULL;NULL
Concomitant Medication|POTASSIUM ACETATE|NULL;NULL;NULL
Concomitant Medication|SAW PALMETTO|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Herpes labialis;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Shivering;Chills;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Temperature elevation;Body temperature increased;Physical examination procedures;MILD;RECOVERED
Concomitant Medication|ACICLOVIR|NULL;NULL;NULL
Concomitant Medication|CLENBUTEROL|NULL;NULL;NULL
Concomitant Medication|CO-DIOVAN|NULL;NULL;NULL
Concomitant Medication|DIGITOXIN|NULL;NULL;NULL
Concomitant Medication|ISOSORBID DINITRATE|NULL;NULL;NULL
Concomitant Medication|THERMO-MENTHONEURIN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|Joint disorders|Hyperextension of knee;Joint hyperextension;Joint related disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;MODERATE;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Tooth extraction;Tooth extraction;Dental and gingival therapeutic procedures;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Vaginal infection;Vaginal infection;Female reproductive tract infections;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Vaginal yeast infection;Vulvovaginal mycotic infection;Fungal infections NEC;MODERATE;RECOVERED
Concomitant Medication|CONTRACEPTIVES|NULL;NULL;NULL
Concomitant Medication|DIFLUCAN|NULL;NULL;NULL
Concomitant Medication|ENTEX LA|NULL;NULL;NULL
Concomitant Medication|FLOXIN|NULL;NULL;NULL
Concomitant Medication|NASONEX|NULL;NULL;NULL
Concomitant Medication|PHENAZOPYRIDINE|NULL;NULL;NULL
Concomitant Medication|TRIPHASIL-28|NULL;NULL;NULL
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dizziness on standing up;Dizziness postural;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pressure sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin breakdown;Skin disorder;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy skin;Pruritus;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose congestion;Nasal congestion;Nasal congestion and inflammations;MILD;RECOVERED
Concomitant Medication|ALLERNIX|NULL;NULL;NULL
Concomitant Medication|ALTACE|NULL;NULL;NULL
Concomitant Medication|AMANTADINE|NULL;NULL;NULL
Concomitant Medication|CALCIUM VITAMIN D|NULL;NULL;NULL
Concomitant Medication|CELESTODERM|NULL;NULL;NULL
Concomitant Medication|CENTRUM SELECT|NULL;NULL;NULL
Concomitant Medication|FLONASE|NULL;NULL;NULL
Concomitant Medication|GARLIC|NULL;NULL;NULL
Concomitant Medication|MENTHOL|NULL;NULL;NULL
Concomitant Medication|NOVAMOXIN|NULL;NULL;NULL
Concomitant Medication|PANECTYL|NULL;NULL;NULL
Concomitant Medication|SENNOSIDE|NULL;NULL;NULL
Concomitant Medication|UREMOL HC|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Situational anxiety;Anxiety;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Labored breathing;Dyspnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation aggravated;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Mobility decreased;Mobility decreased;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Deliria (incl confusion)|Disorientation;Disorientation;Confusion and disorientation;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Fecal incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Foot edema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;RECOVERED
Adverse Event|Ocular haemorrhages and vascular disorders NEC|Broken blood vessel in eye;Eye haemorrhage;Ocular bleeding and vascular disorders NEC;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Streptococcal sore throat;Pharyngitis streptococcal;Streptococcal infections;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Thrush;Candidiasis;Candida infections;MODERATE;RECOVERED
Concomitant Medication|CECLOR|NULL;NULL;NULL
Concomitant Medication|CLAVULIN|NULL;NULL;NULL
Concomitant Medication|COVERSYL|NULL;NULL;NULL
Concomitant Medication|EPHEDRINE|NULL;NULL;NULL
Concomitant Medication|FOLATE|NULL;NULL;NULL
Concomitant Medication|HYLAZINE|NULL;NULL;NULL
Concomitant Medication|MORPHINE SULFATE|NULL;NULL;NULL
Concomitant Medication|MOTILIUM|NULL;NULL;NULL
Concomitant Medication|NOVO-TRIMEL|NULL;NULL;NULL
Concomitant Medication|NYSTATIN|NULL;NULL;NULL
Concomitant Medication|PHOSPHATE|NULL;NULL;NULL
Concomitant Medication|PROPOFOL|NULL;NULL;NULL
Concomitant Medication|THIAMINE|NULL;NULL;NULL
Concomitant Medication|THIAZIDE|NULL;NULL;NULL
Concomitant Medication|TINZAPARIN|NULL;NULL;NULL
Concomitant Medication|VENLAFAXINE|NULL;NULL;NULL
Lab Test|Urine Mucus|Moderate
Adverse Event|Neurological disorders NEC|Pricking skin sensation;Paraesthesia;Paraesthesias and dysaesthesias;NULL;NULL
Adverse Event|Headaches|Band-like headache;Tension headache;Headaches NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Skin red;Erythema;Erythemas;NULL;NULL
Adverse Event|Neurological disorders NEC|Faint;Syncope;Disturbances in consciousness NEC;NULL;NULL
Adverse Event|Muscle disorders|Muscle fatigue;Muscle fatigue;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse increased;Heart rate increased;Heart rate and pulse investigations;NULL;NULL
Adverse Event|General system disorders NEC|Tightness in chest;Chest discomfort;Pain and discomfort NEC;NULL;NULL
Adverse Event|Muscle disorders|Muscle tightness;Muscle tightness;Muscle related signs and symptoms NEC;NULL;NULL
Concomitant Medication|B-KOMPLEX|NULL;NULL;NULL
Concomitant Medication|DOXEPIN|NULL;NULL;NULL
Concomitant Medication|DYAZIDE|NULL;NULL;NULL
Concomitant Medication|GLUTATHIONE|NULL;NULL;NULL
Adverse Event|Rickettsial infectious disorders|Cat-scratch disease;Cat scratch disease;Bartonella infections;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Necrosis skin;Skin necrosis;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Dental abscess;Tooth abscess;Dental and oral soft tissue infections;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Erysipelas;Erysipelas;Streptococcal infections;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Rhinopharyngitis;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure systolic abnormal;Blood pressure systolic abnormal;Vascular tests NEC (incl blood pressure);MODERATE;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Circulatory insufficiency;Cardiovascular insufficiency;Cardiac disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Elbow injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Concomitant Medication|BISEPTINE|NULL;NULL;NULL
Concomitant Medication|BRISTOPEN|NULL;NULL;NULL
Concomitant Medication|DOLKO|NULL;NULL;NULL
Concomitant Medication|ESBERIVEN|NULL;NULL;NULL
Concomitant Medication|GIVALEX|NULL;NULL;NULL
Concomitant Medication|IMUDON|NULL;NULL;NULL
Concomitant Medication|LIPANTHYL|NULL;NULL;NULL
Concomitant Medication|NIFLURIL|NULL;NULL;NULL
Concomitant Medication|OESTRODOSE|NULL;NULL;NULL
Concomitant Medication|ORACILLINE|NULL;NULL;NULL
Concomitant Medication|PEFLACINE|NULL;NULL;NULL
Concomitant Medication|ROVAMYCIN|NULL;NULL;NULL
Concomitant Medication|TERALITHE|NULL;NULL;NULL
Concomitant Medication|TETANUS VACCINE|NULL;NULL;NULL
Concomitant Medication|ULTRA-LEVURE|NULL;NULL;NULL
Lab Test|Urine blood|1+
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Moderate;NULL
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;Mild;NULL
Adverse Event|Bone disorders (excl congenital and fractures)|Vertebral wedging;Vertebral wedging;Bone disorders NEC;Moderate;NULL
Adverse Event|Bone and joint injuries|Fracture bone;Fracture;Fractures and dislocations NEC;Moderate;NULL
Concomitant Medication|MESTINON|180;QD (every day);Oral
Concomitant Medication|VITAMIN E|1000;QD (every day);Oral
Concomitant Medication|VITAMIN E|1000;QID (four times a day);Oral
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in joint involving lower leg;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Lyme's disease;Lyme disease;Borrelial infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Lyme disease;Lyme disease;Borrelial infections;MILD;ONGOING (PERSISTENT)
Concomitant Medication|TETRACYCLINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Aural disorders NEC|Ear discharge;Otorrhoea;Ear disorders NEC;Moderate;Resolved
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Calf pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Administration site reactions|Injection site redness;Injection site erythema;Injection site reactions;Moderate;Resolved
Adverse Event|Epidermal and dermal conditions|Blisters;Blister;Bullous conditions;Moderate;Resolved
Concomitant Medication|CALCIUM PLUS|NULL;NULL;NULL
Concomitant Medication|CILOXAN|NULL;NULL;NULL
Concomitant Medication|CLOTRIMAZOLE|NULL;NULL;NULL
Concomitant Medication|CONTAC|NULL;NULL;NULL
Concomitant Medication|DONATUSSIN|NULL;NULL;NULL
Lab Test|Band Neutrophils|-
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Diabetes mellitus;Diabetes mellitus;Diabetes mellitus (incl subtypes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Eye contusion;Eye contusion;Eye injuries NEC;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness in hand;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in knee;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|GLUCOPHAGE|NULL;NULL;NULL
Concomitant Medication|KLONOPIN|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;MODERATE;RECOVERED
Concomitant Medication|CERVOXAN|NULL;NULL;NULL
Concomitant Medication|MYOLASTAN|NULL;NULL;NULL
Concomitant Medication|VASTAREL|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Groin strain;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED
Adverse Event|Uterine, pelvic and broad ligament disorders|Urogenital prolapse;Urogenital prolapse;Pelvic prolapse conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DEMADEX|NULL;NULL;NULL
Concomitant Medication|INDERAL|NULL;NULL;NULL
Lab Test|Basophillic Stippling|+
Lab Test|RBC Morphology: Macrocytosis|1+
Lab Test|Polychromasia|1+
Lab Test|Hepatitis A Antibody|-
Lab Test|Hepatitis B Antibody|-
Adverse Event|Injuries NEC|Eye contusion;Eye contusion;Eye injuries NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Generalised muscle weakness;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Light headedness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Swelling of wrists;Joint swelling;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Restless leg syndrome;Restless legs syndrome;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ALOE VERA|NULL;NULL;NULL
Concomitant Medication|FOSAMAX|NULL;NULL;NULL
Concomitant Medication|GLUCOSAMINE SULPHATE|NULL;NULL;NULL
Concomitant Medication|STRESS B|NULL;NULL;NULL
Concomitant Medication|VITAMIN E+C|NULL;NULL;NULL
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Increased blood pressure;Blood pressure increased;Vascular tests NEC (incl blood pressure);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Thorax pain;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Light-headed feeling;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|GINKOR FORT|NULL;NULL;NULL
Concomitant Medication|NUREFLEX|NULL;NULL;NULL
Concomitant Medication|SMECTA|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Skin blotches;Rash macular;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Feeling hot;Feeling hot;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;MODERATE;RECOVERED
Adverse Event|Joint disorders|Joint crepitation;Joint crepitation;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Sensation of cold;Feeling cold;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|RBC count increased;Red blood cell count increased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MILD;UNKNOWN
Adverse Event|General system disorders NEC|Flu like symptoms;Influenza like illness;General signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Dental and gingival conditions|Gingivitis;Gingivitis;Gingival disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Granuloma;Granuloma;Inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MODERATE;UNKNOWN
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ADENOSINE|NULL;NULL;NULL
Concomitant Medication|ANUSOL|NULL;NULL;NULL
Concomitant Medication|FLUTICASONE|NULL;NULL;NULL
Concomitant Medication|L-THYROXIN|NULL;NULL;NULL
Concomitant Medication|LEVSIN|NULL;NULL;NULL
Concomitant Medication|NORMO TEARS|NULL;NULL;NULL
Concomitant Medication|NOVO-PRAMINE|NULL;NULL;NULL
Concomitant Medication|NOVOLEXIN|NULL;NULL;NULL
Concomitant Medication|SILVER NITRATE|NULL;NULL;NULL
Concomitant Medication|IMOVANE|NULL;NULL;NULL
Concomitant Medication|INHIBACE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful L arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;NULL;NULL
Adverse Event|Physical examination topics|Temperature elevation;Body temperature increased;Physical examination procedures;NULL;NULL
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;NULL;NULL
Adverse Event|Respiratory disorders NEC|Sputum excretion difficulty;Sputum retention;Coughing and associated symptoms;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;NULL;NULL
Adverse Event|Neurological disorders NEC|Lethargic;Lethargy;Disturbances in consciousness NEC;NULL;NULL
Concomitant Medication|HYDROMORPHONE|NULL;NULL;NULL
Concomitant Medication|MINOCYCLINE|NULL;NULL;NULL
Concomitant Medication|NABUMETONE|NULL;NULL;NULL
Concomitant Medication|NICOTINIC ACID|NULL;NULL;NULL
Concomitant Medication|POLYCARBOPHIL|NULL;NULL;NULL
Concomitant Medication|PROPACET|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Broken jaw;Jaw fracture;Skull fractures, facial bone fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;SEVERE;RECOVERED
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;SEVERE;RECOVERED
Concomitant Medication|BRUFEN|600;PRN (as needed);Oral
Concomitant Medication|PARACETAMOL|4000;QID (four times a day);Oral
Lab Test|Urine Leukesterase|Trace
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Bone and joint injuries|Subluxation patella;Joint dislocation;Fractures and dislocations NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ASPIRIN|1;Every morning;Oral
Concomitant Medication|CITALOPRAM|1;Every morning;Oral
Concomitant Medication|LACTATED RINGERS|500;Other (specify);Intravenous
Concomitant Medication|LACTIN|2;BID (twice a day);Oral
Concomitant Medication|LAVESTRA|1;Every morning;Oral
Concomitant Medication|TAVANIC|2;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|1000;Other (specify);Intravenous
Concomitant Medication|CLEXANE|2000;QD (every day);Subcutaneous
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Muscle disorders|Jaw cramp;Trismus;Muscle tone abnormalities;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps of lower extremities;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;MILD;RECOVERED
Concomitant Medication|CYCRIN|NULL;NULL;NULL
Concomitant Medication|PHENYLPROPANOLAMINE|NULL;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count decreased;Lymphocyte count decreased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Monocytes decreased;Monocyte count decreased;White blood cell analyses;MILD;RECOVERED
Concomitant Medication|ATROPINIUM SULFURICUM STREULI|NULL;NULL;NULL
Concomitant Medication|CAROTABEN|NULL;NULL;NULL
Concomitant Medication|ITROP|NULL;NULL;NULL
Concomitant Medication|L-THYROXINE|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM VERLA|NULL;NULL;NULL
Concomitant Medication|PRESOMEN|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Bladder spasm;Bladder spasm;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|BETAMETHASONE|NULL;NULL;NULL
Concomitant Medication|CALCIUM CITRATE|NULL;NULL;NULL
Concomitant Medication|DETROL|NULL;NULL;NULL
Concomitant Medication|SALINE|NULL;NULL;NULL
Concomitant Medication|TEGRETOL|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Nail infection;Nail infection;Skin structures and soft tissue infections;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Foot cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;Moderate;NULL
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;Moderate;NULL
Concomitant Medication|ACTONEL|35;Once per week;Oral
Concomitant Medication|ADVAIR|50-100;BID (twice a day);Inhalation
Concomitant Medication|BACLOFEN|10;QD (every day);Oral
Concomitant Medication|BACLOFEN|20;;Oral
Concomitant Medication|BENADRYL|12.5-25;QHS (at bedtime);Oral
Concomitant Medication|CALCIUM|2;QD (every day);Oral
Concomitant Medication|CITRUCEL|2;PRN (as needed);Oral
Concomitant Medication|COENZYME Q10|50;BID (twice a day);Oral
Concomitant Medication|COMBIVENT|1;PRN (as needed);Inhalation
Concomitant Medication|HYDROCHLOROTHIAZIDE|25;QD (every day);Oral
Concomitant Medication|NASACORT AQ|2;QHS (at bedtime);Inhalation
Concomitant Medication|PEPCID AC|75;QHS (at bedtime);Oral
Concomitant Medication|PROTONIX|40;QD (every day);Oral
Concomitant Medication|TUMS|2;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1000;PRN (as needed);Oral
Concomitant Medication|VITAMIN C|500;TID (three times a day);Oral
Concomitant Medication|VITAMIN E|800;TID (three times a day);Oral
Concomitant Medication|WELLBUTRIN|300;QD (every day);Oral
Adverse Event|Oral soft tissue conditions|Mouth ulcer;Mouth ulceration;Stomatitis and ulceration;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Abnormal reflex;Reflexes abnormal;Abnormal reflexes;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Shaky feelings;Nervousness;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Psoriasis;Psoriasis;Psoriatic conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PIRITON|NULL;NULL;NULL
Concomitant Medication|ZIMOVANE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Weakness in extremity;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Hepatic and hepatobiliary disorders|Liver tenderness;Liver tenderness;Hepatobiliary signs and symptoms;MILD;RECOVERED
Concomitant Medication|HAWTHORN|NULL;NULL;NULL
Concomitant Medication|HYDROMET|NULL;NULL;NULL
Concomitant Medication|TYLENOL WITH CODEINE|NULL;NULL;NULL
Lab Test|Urine Glucose|Trace
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;Mild;NULL
Adverse Event|Deliria (incl confusion)|Confusion;Confusional state;Confusion and disorientation;Mild;NULL
Concomitant Medication|BETOPTIC|NULL;NULL;NULL
Concomitant Medication|MONOPRIL|NULL;NULL;NULL
Concomitant Medication|OXYCONTIN|NULL;NULL;NULL
Concomitant Medication|RANITIDINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;Marked;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Concomitant Medication|SOAP ENEMA|NULL;NULL;NULL
Demographic|Race|Asian
Adverse Event|Gastrointestinal signs and symptoms|Bad breath;Breath odour;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Cervical radiculopathy;Cervicobrachial syndrome;Cervical spinal cord and nerve root disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Gum infection;Gingival infection;Dental and oral soft tissue infections;MILD;RECOVERED
Adverse Event|Lipid analyses|Cholesterol levels raised;Blood cholesterol increased;Cholesterol analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Paraesthesia hand;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Crawling sensation of skin;Formication;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Heart fluttering;Cardiac flutter;Rate and rhythm disorders NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;MILD;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ringing in ears;Tinnitus;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose blood increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Oral herpes;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Herpes zoster;Herpes zoster;Herpes viral infections;MILD;RECOVERED
Adverse Event|Lipid analyses|Cholesterol total increased;Blood cholesterol increased;Cholesterol analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|GGT increased;Gamma-glutamyltransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Ectoparasitic disorders|Scabies;Acarodermatitis;Ectoparasitic infestations;MILD;RECOVERED
Adverse Event|Ectoparasitic disorders|Scabies;Acarodermatitis;Ectoparasitic infestations;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|QT interval shortened;Electrocardiogram QT shortened;ECG investigations;MILD;RECOVERED
Adverse Event|Injuries NEC|Soft tissue injury;Soft tissue injury;Non-site specific injuries NEC;MILD;RECOVERED
Concomitant Medication|BENZYL BENZOATE|NULL;NULL;NULL
Concomitant Medication|BLISTEZE|NULL;NULL;NULL
Concomitant Medication|CO CODAMOL|NULL;NULL;NULL
Concomitant Medication|PERMETHRIN|NULL;NULL;NULL
Concomitant Medication|SIMPLE LINCTUS|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depressive disorder;Depression;Depressive disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Hyperopia;Hypermetropia;Refractive and accommodative disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DEANXIT|NULL;NULL;NULL
Concomitant Medication|SULFAMETHOXAZOL|NULL;NULL;NULL
Concomitant Medication|TRIMETHOPRIM|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Capsulitis;Periarthritis;Joint related disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CHRONADALATE|NULL;NULL;NULL
Concomitant Medication|DEBRIDAT|NULL;NULL;NULL
Concomitant Medication|DOLIPRANE|NULL;NULL;NULL
Concomitant Medication|FRAGMIN|NULL;NULL;NULL
Concomitant Medication|GELOX|NULL;NULL;NULL
Concomitant Medication|LAROXYL|NULL;NULL;NULL
Concomitant Medication|MOGADON|NULL;NULL;NULL
Concomitant Medication|SPASFON|NULL;NULL;NULL
Concomitant Medication|ZOCOR|NULL;NULL;NULL
Lab Test|C-Reactive Protein|Normal
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Distress gastrointestinal;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flushes;Hot flush;Peripheral vascular disorders NEC;MODERATE;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flushes;Hot flush;Peripheral vascular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hyperhidrosis;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Nasal obstruction;Upper airway obstruction;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral candidiasis;Oral candidiasis;Candida infections;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ACETAZOLAMIDE|NULL;NULL;NULL
Concomitant Medication|BROMHEXINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|CEFAZOLINE|NULL;NULL;NULL
Concomitant Medication|HYOSCINE BUTYLBROMIDE|NULL;NULL;NULL
Concomitant Medication|LORMETAZEPAM|NULL;NULL;NULL
Concomitant Medication|NIFUROXAZIDE|NULL;NULL;NULL
Concomitant Medication|RHINOSPRAY|NULL;NULL;NULL
Concomitant Medication|YELLOW FEVER VACCINE|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Bilirubin elevated;Blood bilirubin increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count increased;Neutrophil count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Phosphate decreased;Blood phosphorus decreased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DYTIDE H|NULL;NULL;NULL
Concomitant Medication|SIRDALUD|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Laryngitis;Laryngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;Mild;NULL
Adverse Event|Bone and joint injuries|Sprained ankle;Joint sprain;Limb injuries NEC (incl traumatic amputation);Mild;NULL
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Buttock pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anemia;Anaemia;Anaemias NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Burning foot;Burning sensation;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Sensory disturbance;Sensory disturbance;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Heavy periods;Menorrhagia;Menstruation with increased bleeding;MODERATE;RECOVERED
Adverse Event|Menopause and related conditions|Postmenopausal bleeding;Postmenopausal haemorrhage;Menopausal effects on the genitourinary tract;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Menopause and related conditions|Postmenopausal bleeding;Postmenopausal haemorrhage;Menopausal effects on the genitourinary tract;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness in feet;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful feet;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema of extremities;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Reflux esophagitis;Reflux oesophagitis;Oesophagitis (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Taste metallic;Dysgeusia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Taste salty;Dysgeusia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Soft tissue injury;Soft tissue injury;Non-site specific injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Foot infection;Localised infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Spotting vaginal;Vaginal haemorrhage;Vulvovaginal disorders NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Wrist fracture;Wrist fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Concomitant Medication|AYGESTIN|NULL;NULL;NULL
Concomitant Medication|BACITRACIN|NULL;NULL;NULL
Concomitant Medication|DEXTROPROPOXYPHENE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ISOCET|NULL;NULL;NULL
Concomitant Medication|LUPRON|NULL;NULL;NULL
Concomitant Medication|RELAFEN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Breathlessness;Dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Feeling cold;Feeling cold;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Dysuria;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Sexual function and fertility disorders|Sexual dysfunction;Sexual dysfunction;Sexual function and fertility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Alanine aminotransferase increase;Alanine aminotransferase increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|Creatine kinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Palpitations;Palpitations;Cardiac signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Facial swelling;Swelling face;Dermal and epidermal conditions NEC;MILD;RECOVERED
Concomitant Medication|PRAZEPAM|NULL;NULL;NULL
Concomitant Medication|TITANOREINE|NULL;NULL;NULL
Concomitant Medication|VEINAMITOL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Hypoesthesia;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dysaesthesia extremity;Dysaesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Sensation of pressure in eye;Abnormal sensation in eye;Ocular sensation disorders;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Leg paresis;Monoparesis;Paralysis and paresis (excl cranial nerve);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Myalgia of lower extremities;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Oedema of legs;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|MIROTON|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|ECG abnormal;Electrocardiogram abnormal;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Abscess;Abscess;Infections NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Sweat gland infection;Sweat gland infection;Skin structures and soft tissue infections;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;SEVERE;RECOVERED
Concomitant Medication|OMEPRAZOLE|NULL;NULL;NULL
Concomitant Medication|AMOXICILLIN|1;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|30;TID (three times a day);Oral
Concomitant Medication|CREATINE|1;QD (every day);Oral
Concomitant Medication|MESTINON|60;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|1000;TID (three times a day);Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;Mild;Continuing
Adverse Event|Male reproductive tract infections and inflammations|Epididymitis;Epididymitis;Testicular and epididymal infections and inflammations;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Mild;Continuing
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;Mild;Continuing
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Mild;Resolved
Concomitant Medication|LITHIUM CARBONATE|NULL;NULL;NULL
Concomitant Medication|OLANZAPINE|NULL;NULL;NULL
Concomitant Medication|THYROXINE|NULL;NULL;NULL
Concomitant Medication|TRIMETHOPRIM SULFAMETHOXAZOLE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count decreased;Lymphocyte count decreased;White blood cell analyses;MILD;UNKNOWN
Adverse Event|Haematology investigations (incl blood groups)|Platelet count increased;Platelet count increased;Platelet analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Hypotensive;Hypotension;Vascular hypotensive disorders;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count high;Neutrophil count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;Mild;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Severe;NULL
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Concomitant Medication|DEROXAT|1;;Oral
Concomitant Medication|DEROXAT|20;;Oral
Concomitant Medication|RIVOTRIL|10;;Oral
Concomitant Medication|SEROPRAM|20;;Oral
Concomitant Medication|STABLON|1;;Oral
Concomitant Medication|TOCOPHEROL|500;;Oral
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;Moderate;Resolved
Concomitant Medication|OXYBUTYNIN CHLORIDE|NULL;NULL;NULL
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux disease;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin irritation;Skin irritation;Dermatitis and eczema;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|LYSINE|NULL;NULL;NULL
Concomitant Medication|SPIROPENT|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Retention carbon dioxide;Hypercapnia;Conditions associated with abnormal gas exchange;MODERATE;RECOVERED
Adverse Event|Deliria (incl confusion)|Confusion;Confusional state;Confusion and disorientation;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;SEVERE;RECOVERED
Concomitant Medication|AMOXICILLIN|1500;TID (three times a day);Oral
Concomitant Medication|RAMIPRIL|10;QD (every day);Oral
Concomitant Medication|VAXIGRIP|0.5;QD (every day);Intramuscular
Concomitant Medication|AMOXICILLIN|4;QID (four times a day);Intravenous
Concomitant Medication|CEFAZOLINE|2;QD (every day);Intravenous
Concomitant Medication|FLUMAZENIL|3;QD (every day);Intravenous
Concomitant Medication|MIDAZOLAM|2;QD (every day);Intravenous
Concomitant Medication|PETHIDINE HYDROCHLORIDE|25;QD (every day);Intravenous
Concomitant Medication|THIAMINE HYDROCHLORIDE|100;QD (every day);Intravenous
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Dupuytren's contracture;Dupuytren's contracture;Musculoskeletal and connective tissue infections and inflammations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Diabetes mellitus progression;Diabetes mellitus;Diabetes mellitus (incl subtypes);SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|GLICLAZIDE|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Bloating;Abdominal distension;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MAXZIDE|NULL;NULL;NULL
Concomitant Medication|TAVIST|NULL;NULL;NULL
Concomitant Medication|UNIVASC|NULL;NULL;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Moderate;Resolved
Adverse Event|Joint disorders|Joint inflammation;Arthritis;Arthropathies NEC;Moderate;Resolved
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;Mild;Resolved
Adverse Event|Administration site reactions|Pain injection site;Injection site pain;Injection site reactions;Mild;Resolved
Adverse Event|Administration site reactions|Injection site reaction;Injection site reaction;Injection site reactions;Mild;Resolved
Concomitant Medication|CALCIUM/VITAMIN D|500;QD (every day);Oral
Concomitant Medication|LEVSIN|0.125;QID (four times a day);Oral
Concomitant Medication|PERI-COLACE|100;BID (twice a day);Oral
Adverse Event|Bone and joint injuries|Fractured thumb;Hand fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Purple red macule;Rash macular;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Anterior eye structural change, deposit and degeneration|Bilateral cataracts;Cataract;Cataract conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Contusion of knee;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Degenerative joint disease;Osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Hiatal hernia;Hiatus hernia;Diaphragmatic hernias;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Triglyceride increased;Blood triglycerides increased;Triglyceride analyses;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Increased urinary frequency;Pollakiuria;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Canker sores oral;Aphthous stomatitis;Stomatitis and ulceration;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Contusion of hip;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Supraventricular tachycardia;Supraventricular tachycardia;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Upper respiratory tract congestion;Upper respiratory tract congestion;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MILD;RECOVERED
Concomitant Medication|CENTRUM SILVER|NULL;NULL;NULL
Concomitant Medication|COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS|NULL;NULL;NULL
Concomitant Medication|DIGEL|NULL;NULL;NULL
Concomitant Medication|LANOXIN|NULL;NULL;NULL
Concomitant Medication|PROTRIPTYLINE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Dermatitis;Dermatitis;Dermatitis and eczema;MILD;RECOVERED
Adverse Event|Purine and pyrimidine metabolism disorders|Gout;Gout;Purine metabolism disorders NEC;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Hyperhidrosis;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin eruption;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Concomitant Medication|REVITALOSE|NULL;NULL;NULL
Concomitant Medication|RINOMAR|NULL;NULL;NULL
Concomitant Medication|TEVAX|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Esophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine increased;Glucose urine present;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;MILD;RECOVERED
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|REZULIN|NULL;NULL;NULL
Concomitant Medication|ROXANOL|NULL;NULL;NULL
Concomitant Medication|TESTOSTERONE|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Folliculitis;Folliculitis;Bacterial infections NEC;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Light headedness;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Restless legs syndrome;Restless legs syndrome;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|TYLENOL COLD|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Decubitus;Decubitus ulcer;Skin injuries and mechanical dermatoses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fractured nose;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Facial weakness;Facial paresis;Facial cranial nerve disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|B-100|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Dry lips;Lip dry;Oral dryness and saliva altered;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Hyperhidrosis;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Irritable bowel syndrome;Irritable bowel syndrome;Gastrointestinal spastic and hypermotility disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Malleolus oedema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Seborrheic eczema;Seborrhoeic dermatitis;Dermatitis and eczema;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|AMBROXOL HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|AZITHROMYCINE|NULL;NULL;NULL
Concomitant Medication|BUMETANIDE|NULL;NULL;NULL
Concomitant Medication|BUPRENORPHINE|NULL;NULL;NULL
Concomitant Medication|BUTAMIRATE CITRATE|NULL;NULL;NULL
Concomitant Medication|CEFUROXIM|NULL;NULL;NULL
Concomitant Medication|CETIRIZINE|NULL;NULL;NULL
Concomitant Medication|CIPROFLOXACINE|NULL;NULL;NULL
Concomitant Medication|IPRATROPIUM BROMIDE|NULL;NULL;NULL
Concomitant Medication|KETOCONAZOL|NULL;NULL;NULL
Concomitant Medication|MESNA|NULL;NULL;NULL
Concomitant Medication|SOFRASOLONE|NULL;NULL;NULL
Concomitant Medication|TIAPRIDE|NULL;NULL;NULL
Concomitant Medication|ZOLPIDEM|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Bradycardia;Bradycardia;Rate and rhythm disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMINOSIDINE|NULL;NULL;NULL
Concomitant Medication|INTETRIX|NULL;NULL;NULL
Concomitant Medication|KAOLOGEAIS|NULL;NULL;NULL
Concomitant Medication|ZYRTEC|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;SEVERE;RECOVERED
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Haematuria;Haematuria;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Formication;Formication;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paresthesia of limbs;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menses painful;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Contracture of joint;Joint contracture;Joint related disorders NEC;MILD;RECOVERED
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;SEVERE;RECOVERED
Concomitant Medication|CEFALOJECT|NULL;NULL;NULL
Concomitant Medication|CIFLOX|NULL;NULL;NULL
Concomitant Medication|DAKTARIN|NULL;NULL;NULL
Concomitant Medication|FLIXOTIDE|NULL;NULL;NULL
Concomitant Medication|MORPHINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|MOSCONTIN|NULL;NULL;NULL
Concomitant Medication|ZINNAT|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Stomach virus;Gastroenteritis viral;Viral infections NEC;Mild;NULL
Concomitant Medication|EXCEDRIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Prickling of hand;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Therapeutic and nontherapeutic effects (excl toxicity)|Drug intolerance;Drug intolerance;Therapeutic and nontherapeutic responses;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Otitis;Ear infection;Ear infections;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depressive disorder;Depression;Depressive disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;MILD;RECOVERED
Concomitant Medication|AMOXICILLIN|1;QD (every day);Oral
Concomitant Medication|CIPRAMIL|20;QD (every day);Oral
Concomitant Medication|EAR DROPS RX|3;TID (three times a day);
Concomitant Medication|FLUVOXAMINE|20;QD (every day);Oral
Concomitant Medication|TIZANIDINE|16;TID (three times a day);Oral
Concomitant Medication|TIZANIDINE|32;TID (three times a day);Oral
Concomitant Medication|VIVEO|300;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Moderate;NULL
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Joint disorders|Joint stiffness;Joint stiffness;Joint related signs and symptoms;Moderate;NULL
Concomitant Medication|ACETYL L CARNITINE|600;QD (every day);Oral
Concomitant Medication|ALPHA LIPOIC ACID|400;QD (every day);Oral
Concomitant Medication|BCAA|4500;QD (every day);Oral
Concomitant Medication|COENZYME Q10|200;QD (every day);Oral
Concomitant Medication|CORAL CALCIUM|300;BID (twice a day);Oral
Concomitant Medication|DHA|2;TID (three times a day);Oral
Concomitant Medication|GINGER|2000;QD (every day);Oral
Concomitant Medication|INOSINE|1500;TID (three times a day);Oral
Concomitant Medication|INOSITOL|2100;QD (every day);Oral
Concomitant Medication|L-GLUTAMINE|2100;QD (every day);Oral
Concomitant Medication|NADH|3.6;QD (every day);Oral
Concomitant Medication|NIACIN|200;BID (twice a day);Oral
Concomitant Medication|SAM-E|750;BID (twice a day);Oral
Concomitant Medication|SERINE|2100;QD (every day);Oral
Concomitant Medication|VINPOCETIN|1200;QD (every day);Oral
Concomitant Medication|VITAMIN B12|7500;QD (every day);Sublingual
Concomitant Medication|VITAMIN D|100;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|500;QD (every day);Oral
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ANTIVERT|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Hypernatraemia;Hypernatraemia;Sodium imbalance;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngeal spasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;SEVERE;RECOVERED
Adverse Event|White blood cell disorders|Lymphopenia;Lymphopenia;Leukopenias NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Pyrosis;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|White blood cell disorders|Leucopenia;Leukopenia;Leukopenias NEC;MILD;RECOVERED
Adverse Event|Thyroid gland disorders|Thyroid hyperplasia;Goitre;Thyroid disorders NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Intertrigo;Intertrigo;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Circulatory insufficiency;Cardiovascular insufficiency;Cardiac disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CLAFORAN|NULL;NULL;NULL
Concomitant Medication|DEROXAT|NULL;NULL;NULL
Concomitant Medication|LEVOTHYROX|NULL;NULL;NULL
Concomitant Medication|PEVARYL|NULL;NULL;NULL
Concomitant Medication|POLYSILANE|NULL;NULL;NULL
Adverse Event|Tongue conditions|Tongue ulceration;Tongue ulceration;Tongue disorders;NULL;NULL
Adverse Event|Hepatobiliary investigations|Alanine aminotransferase abnormal;Alanine aminotransferase abnormal;Liver function analyses;NULL;NULL
Adverse Event|Hepatobiliary investigations|Aspartate aminotransferase abnormal;Aspartate aminotransferase abnormal;Liver function analyses;NULL;NULL
Adverse Event|Enzyme investigations NEC|Blood lactate dehydrogenase abnormal;Blood lactate dehydrogenase abnormal;Tissue enzyme analyses NEC;NULL;NULL
Adverse Event|Endocrine investigations (incl sex hormones)|T4 abnormal;Thyroxine abnormal;Thyroid analyses;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site bleeding;Post procedural haemorrhage;Non-site specific procedural complications;NULL;NULL
Adverse Event|Enzyme investigations NEC|Creatine phosphokinase abnormal;Blood creatine phosphokinase abnormal;Skeletal and cardiac muscle analyses;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Fecal impaction;Faecaloma;Faecal abnormalities NEC;NULL;NULL
Adverse Event|Bone and joint injuries|Jaw dislocation;Joint dislocation;Fractures and dislocations NEC;NULL;NULL
Adverse Event|Oral soft tissue conditions|Sores lip;Cheilitis;Oral soft tissue disorders NEC;NULL;NULL
Adverse Event|Bone and joint injuries|Hip fracture;Hip fracture;Lower limb fractures and dislocations;NULL;NULL
Adverse Event|Bone and joint injuries|Wrist fracture;Wrist fracture;Upper limb fractures and dislocations;NULL;NULL
Adverse Event|Enzyme investigations NEC|Lactic dehydrogenase increased;Blood lactate dehydrogenase increased;Tissue enzyme analyses NEC;NULL;NULL
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;NULL;NULL
Adverse Event|Enzyme investigations NEC|Blood alkaline phosphatase abnormal;Blood alkaline phosphatase abnormal;Tissue enzyme analyses NEC;NULL;NULL
Adverse Event|Head and neck therapeutic procedures|Jaw operation;Jaw operation;Facial therapeutic procedures;NULL;NULL
Adverse Event|Injuries NEC|Eye contusion;Eye contusion;Eye injuries NEC;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;NULL;NULL
Concomitant Medication|BECLOMETASONE|NULL;NULL;NULL
Concomitant Medication|MULTIVITAMINS WITH IRON|NULL;NULL;NULL
Concomitant Medication|MULTIVITAMIN WITH MINERALS|NULL;NULL;NULL
Concomitant Medication|PANADEINE CO|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Rib fracture;Rib fracture;Thoracic cage fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Radius fracture;Radius fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;MODERATE;RECOVERED
Concomitant Medication|AMITRIPTYLINE|75;BID (twice a day);Oral
Concomitant Medication|ANTIBIOTICS|UNK;QD (every day);Oral
Concomitant Medication|BETAISODONA|UNK;PRN (as needed);
Concomitant Medication|CORTISONE|NK;QD (every day);Topical
Concomitant Medication|FENTANYL|25;Other (specify);
Concomitant Medication|FURO|80;BID (twice a day);Oral
Concomitant Medication|IBUPROFEN|1800;TID (three times a day);Oral
Concomitant Medication|IBUPROFEN|400;PRN (as needed);Oral
Concomitant Medication|LACTOSE|UNK;QD (every day);Oral
Concomitant Medication|LAXOBERAL|UNK;QD (every day);Oral
Concomitant Medication|NEXIUM|20;QD (every day);Oral
Concomitant Medication|NOVALGIN|75;TID (three times a day);Oral
Concomitant Medication|REMERGIL|30;BID (twice a day);Oral
Concomitant Medication|TAVOR|1;PRN (as needed);Sublingual
Concomitant Medication|TAVOR|UNK;PRN (as needed);Oral
Concomitant Medication|TEMGESIC|0,2;PRN (as needed);Sublingual
Concomitant Medication|TEMGESIC|0.4;BID (twice a day);Oral
Adverse Event|Glaucoma and ocular hypertension|Glaucoma;Glaucoma;Glaucomas (excl congenital);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paresthesia distal;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CARTEOL|NULL;NULL;NULL
Concomitant Medication|FLEMOXINE|NULL;NULL;NULL
Concomitant Medication|PRIMPERAN|NULL;NULL;NULL
Concomitant Medication|RHINOFLUIMUCIL|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Cold sores lip;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension exacerbated;Hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Face oedema;Face oedema;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Face red;Erythema;Erythemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Productive cough;Productive cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AXID|NULL;NULL;NULL
Concomitant Medication|BAYCOL|NULL;NULL;NULL
Concomitant Medication|CATAPRES-TTS-2|NULL;NULL;NULL
Concomitant Medication|CATAPRESS|NULL;NULL;NULL
Concomitant Medication|DIFLUNISAL|NULL;NULL;NULL
Concomitant Medication|OSCAL|NULL;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Postoperative pain;Procedural pain;Non-site specific procedural complications;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MILD;RECOVERED
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Blepharitis;Blepharitis;Lid, lash and lacrimal infections, irritations and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Visual acuity decreased;Visual acuity reduced;Partial vision loss;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;SEVERE;RECOVERED
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Oral mucosa atrophy;Oral mucosa atrophy;Oral soft tissue disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Left upper quadrant pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Ocular sensory symptoms NEC|Photophobia;Photophobia;Ocular sensation disorders;MODERATE;RECOVERED
Adverse Event|Ocular sensory symptoms NEC|Photophobia;Photophobia;Ocular sensation disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Right upper quadrant pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Breathing-related sleep disorder;Breathing-related sleep disorder;Dyssomnias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;SEVERE;RECOVERED
Adverse Event|Oral soft tissue conditions|Ulcer mouth;Mouth ulceration;Stomatitis and ulceration;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BC|NULL;NULL;NULL
Concomitant Medication|BLACK COHOSH|NULL;NULL;NULL
Concomitant Medication|FLEXALL|NULL;NULL;NULL
Concomitant Medication|ICY HOT ARTHRITIS|NULL;NULL;NULL
Concomitant Medication|REFRESH TEARS|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;NULL
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Mild;NULL
Concomitant Medication|COENZYME Q10|90;QD (every day);Oral
Concomitant Medication|DECADRON|8;1 time only;Intravenous
Concomitant Medication|FENTANYL|50;1 time only;Intravenous
Concomitant Medication|VERSED|1;1 time only;Intravenous
Adverse Event|Joint disorders|Aching in knees;Arthralgia;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|HUMIBID|1;BID (twice a day);Oral
Concomitant Medication|QUININE|1 glass;PRN (as needed);Oral
Adverse Event|General system disorders NEC|Flu-like symptoms;Influenza like illness;General signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|CLODRONATE DISODIUM|NULL;NULL;NULL
Concomitant Medication|DOXYTAB|NULL;NULL;NULL
Concomitant Medication|TAMOXIFEN|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux disease;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hair loss;Alopecia;Alopecias;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Discharge eye;Eye discharge;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;MILD;RECOVERED
Concomitant Medication|DARVOCET|NULL;NULL;NULL
Concomitant Medication|GUAIFENESIN/DEXTROMETHORPHAN|NULL;NULL;NULL
Concomitant Medication|TRIAMCINOLONE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Fatigability;Fatigue;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CARNITINE|NULL;NULL;NULL
Concomitant Medication|DANTRIUM|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Congestion nasal;Nasal congestion;Nasal congestion and inflammations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Ear ache;Ear pain;Ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|RYNATAN|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;Moderate;         .
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;Mild;Resolved
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Moderate;         .
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;         .
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;         .
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Motion sickness;Motion sickness;Inner ear signs and symptoms;Moderate;Resolved
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Continuing
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;Moderate;         .
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;Resolved
Concomitant Medication|CROMOLYN SODIUM|NULL;NULL;NULL
Concomitant Medication|LORATADINE|NULL;NULL;NULL
Concomitant Medication|ZALEPLON|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Sputum bloody;Haemoptysis;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Reactive depression;Depression;Depressive disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CIPRAMIL|NULL;NULL;NULL
Concomitant Medication|ELOBACT|NULL;NULL;NULL
Concomitant Medication|LAXOBERAL|NULL;NULL;NULL
Concomitant Medication|OBSTINOL M|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Bilirubin elevated;Blood bilirubin increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Psychiatric disorders NEC|Alcoholic hangover;Alcoholic hangover;Substance-related disorders;MILD;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;MILD;RECOVERED
Adverse Event|Bone, calcium, magnesium and phosphorus metabolism disorders|Hypercalcaemia;Hypercalcaemia;Calcium metabolism disorders;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|Protein and chemistry analyses NEC|Blood albumin increased;Blood albumin increased;Protein analyses NEC;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|Liver function tests raised;Liver function test abnormal;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Raised triglycerides;Blood triglycerides increased;Triglyceride analyses;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezing;Wheezing;Bronchospasm and obstruction;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;Mild;NULL
Concomitant Medication|AMBIEN|5;QHS (at bedtime);Oral
Concomitant Medication|VITAMIN C|500;BID (twice a day);Oral
Adverse Event|Joint disorders|Arthrosis;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;MILD;RECOVERED
Adverse Event|General system disorders NEC|General physical health deterioration;General physical health deterioration;General signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbar pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|APRANAX|NULL;NULL;NULL
Concomitant Medication|NEURIPLEGE|NULL;NULL;NULL
Concomitant Medication|TOPALGIC|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;MILD;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Foot sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Concomitant Medication|DUONEB|NULL;NULL;NULL
Concomitant Medication|ELDEPRYL|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oropharyngeal candidiasis;Oropharyngeal candidiasis;Candida infections;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MILD;UNKNOWN
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Speech impairment NOS;Speech disorder;Speech and language abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular neuromuscular disorders|Strabismus;Strabismus;Ocular nerve and muscle disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|COD LIVER OIL|NULL;NULL;NULL
Concomitant Medication|COENZYME|NULL;NULL;NULL
Adverse Event|Cardiac disorder signs and symptoms|Palpitations;Palpitations;Cardiac signs and symptoms NEC;Mild;NULL
Concomitant Medication|BACLOFEN|10;PRN (as needed);Oral
Concomitant Medication|FLOMAX|0.4;QD (every day);Oral
Concomitant Medication|LIPITOR|20;QD (every day);Oral
Concomitant Medication|NEURONTIN|300;PRN (as needed);Oral
Concomitant Medication|PAXIL|10;QD (every day);Oral
Concomitant Medication|PLAVEX|40;QD (every day);Oral
Concomitant Medication|ZETIA|10;QD (every day);Oral
Adverse Event|Respiratory disorders NEC|Dyspnoea at rest;Dyspnoea at rest;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|DRIXORAL|NULL;NULL;NULL
Concomitant Medication|ISOCAL HN|NULL;NULL;NULL
Concomitant Medication|STRESSTAB|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Alternation between constipation and diarrhea;Gastrointestinal motility disorder;Gastrointestinal dyskinetic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Blister;Blister;Bullous conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnoea at rest;Dyspnoea at rest;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Serum triglycerides increased;Blood triglycerides increased;Triglyceride analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eye pain;Eye pain;Ocular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;SEVERE;RECOVERED
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngospasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Breathlessness;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal haemorrhages NEC|Rectal bleeding;Rectal haemorrhage;Intestinal haemorrhages;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Uterine, pelvic and broad ligament disorders|Uterine cramps;Uterine spasm;Uterine tone disorders;MODERATE;RECOVERED
Concomitant Medication|ALKA-SELTZER PLUS COLD|NULL;NULL;NULL
Concomitant Medication|DECONGESTANT|NULL;NULL;NULL
Concomitant Medication|DOANS|NULL;NULL;NULL
Concomitant Medication|MUCO-FEN|NULL;NULL;NULL
Concomitant Medication|NASALCROM|NULL;NULL;NULL
Concomitant Medication|NYQUIL|NULL;NULL;NULL
Concomitant Medication|ONE A DAY MULTI VITAMIN & MINERALS|NULL;NULL;NULL
Concomitant Medication|OVRAL|NULL;NULL;NULL
Concomitant Medication|ROLAIDS|NULL;NULL;NULL
Concomitant Medication|SENOKOT-S|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;Marked;NULL
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;Moderate;NULL
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;Moderate;NULL
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;Mild;NULL
Adverse Event|General system disorders NEC|Foggy feeling in head;Feeling abnormal;Feelings and sensations NEC;Moderate;NULL
Concomitant Medication|L-GLUTAMINE|NULL;NULL;NULL
Concomitant Medication|PYROXYLINE|NULL;NULL;NULL
Lab Test|Urine blood|2++
Lab Test|Urine blood|3+++
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Mild;NULL
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);Severe;NULL
Adverse Event|Skin appendage conditions|Hair loss;Alopecia;Alopecias;Mild;NULL
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;Mild;NULL
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;NULL
Concomitant Medication|DEANXIT|10;QD (every day);Oral
Concomitant Medication|DITROPAN|2,5;QD (every day);Oral
Concomitant Medication|DITROPAN|2.5;BID (twice a day);Oral
Concomitant Medication|DITROPAN|5;BID (twice a day);Oral
Concomitant Medication|DITROPAN|50;TID (three times a day);Oral
Concomitant Medication|KEFZOL|1;1 time only;Intravenous
Concomitant Medication|LYSOMUCIL|200;BID (twice a day);Oral
Concomitant Medication|MORPHINE|10;QD (every day);Intravenous
Concomitant Medication|MORPHINE|20;QD (every day);Intravenous
Concomitant Medication|PERFUSALGAN|1;PRN (as needed);Intravenous
Concomitant Medication|SERLAIN|50;QD (every day);Oral
Adverse Event|Reproductive organ and breast investigations (excl hormone analyses)|Pap smear abnormal;Smear cervix abnormal;Reproductive organ and breast histopathology procedures;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Acid indigestion;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;SEVERE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Blepharitis;Blepharitis;Lid, lash and lacrimal infections, irritations and inflammations;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Choked on food;Choking;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological, special senses and psychiatric investigations|Blink reflex abnormal;Corneal reflex decreased;Ophthalmic function diagnostic procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Epistaxis;Epistaxis;Nasal disorders NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Eye infection;Eye infection;Eye and eyelid infections;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Fever blister;Oral herpes;Herpes viral infections;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Epistaxis;Epistaxis;Nasal disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Eye therapeutic procedures|Cataract operation;Cataract operation;Lens therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Pain eye;Eye pain;Ocular disorders NEC;MODERATE;RECOVERED
Concomitant Medication|BACITRACIN OPHTHALMIC|NULL;NULL;NULL
Concomitant Medication|DIAMOX|NULL;NULL;NULL
Concomitant Medication|ECONOPRED|NULL;NULL;NULL
Concomitant Medication|FENESIN|NULL;NULL;NULL
Concomitant Medication|GENTAMICIN|NULL;NULL;NULL
Concomitant Medication|MAALOX|NULL;NULL;NULL
Concomitant Medication|PEPCID AC|NULL;NULL;NULL
Concomitant Medication|PROTEIN|NULL;NULL;NULL
Concomitant Medication|SUDAFED 12 HOUR|NULL;NULL;NULL
Concomitant Medication|VISINE|NULL;NULL;NULL
Adverse Event|Vision disorders|Astigmatism;Astigmatism;Refractive and accommodative disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Hearing loss bilateral;Deafness bilateral;Hearing losses;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Ethmoidal sinusitis;Sinusitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Sleep apnea;Sleep apnoea syndrome;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Carpal tunnel syndrome;Carpal tunnel syndrome;Mononeuropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Extremities burning sensation of;Burning sensation;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramp of limb;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Foot edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Breast disorders|Gynecomastia;Gynaecomastia;Breast disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count high;Eosinophil count increased;White blood cell analyses;SEVERE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps calf;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergic reaction to antibiotics;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness in feet;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Papular skin eruption;Rash papular;Papulosquamous conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Papular skin eruption;Rash papular;Papulosquamous conditions;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Bacterial infection due to staphylococcus aureus;Staphylococcal infection;Staphylococcal infections;MILD;RECOVERED
Concomitant Medication|ASCRIPTIN A/D|NULL;NULL;NULL
Concomitant Medication|CHONDROITIN SULFATE|NULL;NULL;NULL
Concomitant Medication|CLOBETASOL PROPIONATE|NULL;NULL;NULL
Concomitant Medication|GLUCOSAMINE HCL|NULL;NULL;NULL
Concomitant Medication|HUMIBID|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM PLUS|NULL;NULL;NULL
Concomitant Medication|MINOCYCLINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|NALDECON|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Raised LFTs;Liver function test abnormal;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary frequency aggravated;Pollakiuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Testicular and epididymal disorders|Testicular pain;Testicular pain;Testicular and epididymal disorders NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;MODERATE;RECOVERED
Concomitant Medication|CLARITIN-D|NULL;NULL;NULL
Concomitant Medication|PROBANTHINE|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Mild;Continuing
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Moderate;Continuing
Concomitant Medication|LAXATIVE|NULL;NULL;NULL
Adverse Event|Bone disorders (excl congenital and fractures)|Osteoporosis;Osteoporosis;Metabolic bone disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CALCITONINE|NULL;NULL;NULL
Concomitant Medication|LOVASTATINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;Mild;NULL
Concomitant Medication|RILUZOLE|50;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|400;TID (three times a day);Oral
Adverse Event|Respiratory disorders NEC|Dyspnea on effort;Dyspnoea exertional;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Accelerated hair loss;Alopecia;Alopecias;MILD;RECOVERED
Concomitant Medication|OVYSMEN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Sputum expectoration difficult;Sputum retention;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Farsighted;Hypermetropia;Refractive and accommodative disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Ankle deformity;Ankle deformity;Extremity deformities;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Paroxysmal nocturnal dyspnea;Dyspnoea paroxysmal nocturnal;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw disorder;Jaw disorder;Bone disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Yawning;Yawning;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ALBUTEROL SULFATE|NULL;NULL;NULL
Concomitant Medication|ENTEX|NULL;NULL;NULL
Concomitant Medication|GENACOL|NULL;NULL;NULL
Concomitant Medication|SINE-AID|NULL;NULL;NULL
Concomitant Medication|FORTISIP|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;Mild;Resolved with Residual
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose congestion;Nasal congestion;Nasal congestion and inflammations;Mild;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose bowels;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose congestion;Nasal congestion;Nasal congestion and inflammations;Mild;Resolved
Concomitant Medication|ACETAMINOPHEN PM|NULL;NULL;NULL
Concomitant Medication|TAVIST SINUS|NULL;NULL;NULL
Concomitant Medication|ZINC SULFATE|NULL;NULL;NULL
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;MODERATE;RECOVERED
Concomitant Medication|CREATINE MONOHYDRATE|NULL;NULL;NULL
Concomitant Medication|FAMVIR|NULL;NULL;NULL
Concomitant Medication|SHARK LIVER OIL|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Respiratory tract infection;Respiratory tract infection;Infections NEC;MILD;RECOVERED
Concomitant Medication|CHLOROQUINE|NULL;NULL;NULL
Concomitant Medication|FLUTAB|NULL;NULL;NULL
Concomitant Medication|PROGUANIL|NULL;NULL;NULL
Concomitant Medication|TIBOLONE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Calcaneus fracture;Foot fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Concomitant Medication|AMPICILLIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Arm discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|General system disorders NEC|Chills;Chills;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Coronary artery disorders|Coronary artery disorder;Coronary artery disease;Coronary artery disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;SEVERE;RECOVERED
Adverse Event|Disturbances in thinking and perception|Hallucinations;Hallucination;Perception disturbances;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Runny nose;Rhinorrhoea;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|CONTAC COLD|NULL;NULL;NULL
Concomitant Medication|CORDARONE|NULL;NULL;NULL
Concomitant Medication|DISOPYRAMIDE PHOSPHATE|NULL;NULL;NULL
Concomitant Medication|NITRO-DUR|NULL;NULL;NULL
Concomitant Medication|NORPACE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Tooth infection;Tooth infection;Dental and oral soft tissue infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Hearing disorders|Hypoacusis;Hypoacusis;Hearing losses;MILD;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|CK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CLOXACILLIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disturbance;Gastrointestinal disorder;Gastrointestinal disorders NEC;Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;Mild;Resolved
Concomitant Medication|SILDENAFIL CITRATE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Night sweat;Night sweats;Apocrine and eccrine gland disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint therapeutic procedures|Zygomatic arch fracture reduction;Fractured zygomatic arch elevation;Fracture treatments (excl skull and spine);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Supraventricular extrasystoles;Supraventricular extrasystoles;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Ventricular extrasystoles;Ventricular extrasystoles;Ventricular arrhythmias and cardiac arrest;MILD;RECOVERED
Concomitant Medication|CLOXIQUINE|NULL;NULL;NULL
Concomitant Medication|DIHYDROERGOTOXIN|NULL;NULL;NULL
Concomitant Medication|DIPYRIDAMOL|NULL;NULL;NULL
Concomitant Medication|FLUPREDNIDENE|NULL;NULL;NULL
Concomitant Medication|RAMIPRIL|NULL;NULL;NULL
Concomitant Medication|SULFADIAZIN|NULL;NULL;NULL
Concomitant Medication|TOLPROPAMINE|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;MODERATE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Increased bronchial secretion;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Central nervous system vascular disorders|Cerebellar haematoma;Cerebellar haematoma;Central nervous system haemorrhages and cerebrovascular accidents;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Duodenitis;Duodenitis;Gastrointestinal inflammatory disorders NEC;MODERATE;RECOVERED
Adverse Event|Body temperature conditions|Hyperthermia;Hyperthermia;Body temperature altered;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sepsis;Sepsis;Sepsis, bacteraemia, viraemia and fungaemia NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Pneumopathy;Lung disorder;Respiratory tract disorders NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Urinary infection;Urinary tract infection;Urinary tract infections;MODERATE;RECOVERED
Concomitant Medication|ALDACTAZINE|NULL;NULL;NULL
Concomitant Medication|DEPAKINE|NULL;NULL;NULL
Concomitant Medication|EQUANIL|NULL;NULL;NULL
Concomitant Medication|HALDOL|NULL;NULL;NULL
Concomitant Medication|LOXEN|NULL;NULL;NULL
Concomitant Medication|MOPRAL|NULL;NULL;NULL
Concomitant Medication|NOROXINE|NULL;NULL;NULL
Concomitant Medication|PRODAFALGAN|NULL;NULL;NULL
Concomitant Medication|SOFRAMYCIN|NULL;NULL;NULL
Concomitant Medication|TERCIAN|NULL;NULL;NULL
Concomitant Medication|TERNEURINE|NULL;NULL;NULL
Concomitant Medication|ULCAR|NULL;NULL;NULL
Concomitant Medication|RILUTEK|100;QD (every day);Oral
Concomitant Medication|ZOLPIDEM|5;PRN (as needed);Oral
Adverse Event|Gastrointestinal signs and symptoms|Fecal incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Tracheo-bronchial secretion excess;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|OSMOLITE|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urinalysis abnormal NOS;Urine analysis abnormal;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Root canal procedure;Endodontic procedure;Dental and gingival therapeutic procedures;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|ANTIPHLOGISTINE|NULL;NULL;NULL
Concomitant Medication|BENTYLOL|NULL;NULL;NULL
Concomitant Medication|DIOVOL PLUS|NULL;NULL;NULL
Concomitant Medication|IMURAN|NULL;NULL;NULL
Concomitant Medication|MACRODANTIN|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM CITRATE|NULL;NULL;NULL
Concomitant Medication|ROBAXACET|NULL;NULL;NULL
Concomitant Medication|ROBAXISAL-C|NULL;NULL;NULL
Concomitant Medication|SUPRAX|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Feeling anxious;Anxiety;Anxiety symptoms;Mild;Continuing
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;Mild;Resolved
Adverse Event|Cardiac arrhythmias|Cardiac arrhythmia;Arrhythmia;Rate and rhythm disorders NEC;Severe;Resolved
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;         .;Continuing
Adverse Event|Skin appendage conditions|Diaphoresis;Hyperhidrosis;Apocrine and eccrine gland disorders;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Mild;Continuing
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;Mild;Continuing
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Moderate;Resolved
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;Mild;Resolved
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;Mild;Resolved
Adverse Event|Lipid metabolism disorders|Hyperlipidemia;Hyperlipidaemia;Hyperlipidaemias NEC;Mild;Continuing
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Mild;Continuing
Adverse Event|Pericardial disorders|Pericarditis;Pericarditis;Noninfectious pericarditis;Severe;Resolved
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Severe;Resolved
Concomitant Medication|AZOPT|NULL;NULL;NULL
Concomitant Medication|HYDROCODONE BITARTRATE|NULL;NULL;NULL
Concomitant Medication|LEVOFLOXACIN|NULL;NULL;NULL
Concomitant Medication|OXYCODONE|NULL;NULL;NULL
Concomitant Medication|PROPOXYPHENE NAPSYLATE|NULL;NULL;NULL
Concomitant Medication|ROFECOXIB|NULL;NULL;NULL
Concomitant Medication|SLO-MAG|NULL;NULL;NULL
Concomitant Medication|TIMOLOL|NULL;NULL;NULL
Concomitant Medication|BACLOFEN|30-50;QD (every day);Oral
Concomitant Medication|SHARK LIVER OIL|3;QD (every day);Oral
Concomitant Medication|VITAMIN B COMPLEX|1;QD (every day);Oral
Adverse Event|Embolism and thrombosis|DVT of legs;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;         .
Adverse Event|Administration site reactions|Injection site reaction;Injection site reaction;Injection site reactions;Mild;         .
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Moderate;Continuing
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;Mild;Resolved
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Moderate;Resolved
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit increased;Haematocrit increased;Red blood cell analyses;Mild;Resolved
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin increased;Haemoglobin increased;Red blood cell analyses;Mild;Resolved
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;Mild;Resolved
Adverse Event|Hearing disorders|Hearing loss;Deafness;Hearing losses;Mild;Continuing
Adverse Event|Skin appendage conditions|Sweating increased;Hyperhidrosis;Apocrine and eccrine gland disorders;Moderate;Continuing
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;Severe;Resolved
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;Mild;Resolved
Adverse Event|Anterior eye structural change, deposit and degeneration|Eye color change;Eye colour change;Iris and ciliary body structural change, deposit and degeneration;Mild;Continuing
Adverse Event|Movement disorders (incl parkinsonism)|Quadriparesis;Quadriparesis;Paralysis and paresis (excl cranial nerve);Moderate;Continuing
Concomitant Medication|PRAVACHOL|NULL;NULL;NULL
Concomitant Medication|UNIPHYL|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured wrist;Wrist fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|Raised LFTs;Liver function test abnormal;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhoea;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle cramps aggravated;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urinary protein increased;Protein urine present;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Personality disorders and disturbances in behaviour|Paranoia;Paranoia;Behaviour and socialisation disturbances;MODERATE;RECOVERED
Adverse Event|Disturbances in thinking and perception|Hallucination;Hallucination;Perception disturbances;MODERATE;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Potassium low;Blood potassium decreased;Mineral and electrolyte analyses;MILD;UNKNOWN
Adverse Event|White blood cell disorders|Lymphocytopenia;Lymphopenia;Leukopenias NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MILD;RECOVERED
Adverse Event|White blood cell disorders|Neutrophilia;Neutrophilia;Leukocytoses NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Painful joints;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Personality disorders and disturbances in behaviour|Personality disorder;Personality disorder;Personality disorders NEC;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Buttock pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|ALENDRONATE|NULL;NULL;NULL
Concomitant Medication|DOTHIEPIN|NULL;NULL;NULL
Concomitant Medication|FERROUS SULPHATE|NULL;NULL;NULL
Concomitant Medication|PANADOL|NULL;NULL;NULL
Concomitant Medication|PAROVEN|NULL;NULL;NULL
Concomitant Medication|SANDO K|NULL;NULL;NULL
Concomitant Medication|TIMODINE|NULL;NULL;NULL
Concomitant Medication|ACIPHEX|20;QD (every day);Oral
Concomitant Medication|EFFEXOR|150;QD (every day);Oral
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;Moderate;NULL
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;Severe;NULL
Adverse Event|Injuries NEC|Wasp sting;Arthropod sting;Non-site specific injuries NEC;Moderate;NULL
Concomitant Medication|LAROXYL|3;;Oral
Adverse Event|Fungal infectious disorders|Tinea pedis;Tinea pedis;Tinea infections;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dry rash face;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM MAGNESIUM|NULL;NULL;NULL
Concomitant Medication|PROTEIN SUPPLEMENTS|NULL;NULL;NULL
Concomitant Medication|PYRENOL|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured toe;Foot fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Burning foot;Burning sensation;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful R arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMARYL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Concomitant Medication|AMITRIPTYLINE|10;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Chewing difficulty;Mastication disorder;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Eye contusion;Eye contusion;Eye injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Unspecified laceration of eye;Eye penetration;Eye injuries NEC;MILD;RECOVERED
Concomitant Medication|METROGEL|NULL;NULL;NULL
Concomitant Medication|ULTRAMIN|NULL;NULL;NULL
Adverse Event|Ocular structural change, deposit and degeneration NEC|Exophthalmos;Exophthalmos;Structural change, deposit and degeneration of eye NEC;MILD;RECOVERED
Adverse Event|Thyroid gland disorders|Goiter;Goitre;Thyroid disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Myopia;Myopia;Refractive and accommodative disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Ovarian and fallopian tube disorders|Ovarian cyst;Ovarian cyst;Ovarian and fallopian tube cysts and neoplasms;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Panic attacks;Panic attack;Panic attacks and disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sacral pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Injuries NEC|Muscle strain;Muscle strain;Muscle, tendon and ligament injuries;MODERATE;RECOVERED
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;MILD;RECOVERED
Concomitant Medication|ALFA-KETOGLUTARIC ACID|NULL;NULL;NULL
Concomitant Medication|L-LYSINE HCL|NULL;NULL;NULL
Concomitant Medication|PHOSPHATIDYL CHOLINE|NULL;NULL;NULL
Concomitant Medication|PROCAINE|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Exacerbation of asthma;Asthma;Bronchospasm and obstruction;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);NULL;NULL
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;NULL;NULL
Adverse Event|Administration site reactions|Injection site reaction;Injection site reaction;Injection site reactions;NULL;NULL
Adverse Event|Respiratory disorders NEC|Vocal volume disorder;Dysphonia;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;NULL;NULL
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysphasia;Aphasia;Cortical dysfunction NEC;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal stuffiness;Nasal congestion;Nasal congestion and inflammations;NULL;NULL
Adverse Event|Respiratory disorders NEC|Voice disturbance, unspecified;Dysphonia;Upper respiratory tract signs and symptoms;NULL;NULL
Concomitant Medication|EPINEPHRINE|NULL;NULL;NULL
Concomitant Medication|TERBUTALINE|NULL;NULL;NULL
Concomitant Medication|TERFENADINE|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;Severe;Resolved
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Resolved
Concomitant Medication|CETIRIZINE HCL|NULL;NULL;NULL
Concomitant Medication|FLUOXETINE HCL|NULL;NULL;NULL
Concomitant Medication|GUAIFENESIN AC|NULL;NULL;NULL
Concomitant Medication|SALICYL|NULL;NULL;NULL
Concomitant Medication|SOY ISOFLAVONES|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Moderate;NULL
Concomitant Medication|ALBUTEROL|25;TID (three times a day);Inhalation
Concomitant Medication|BACLOFEN|10;QID (four times a day);Oral
Concomitant Medication|BACLOFEN|50;QD (every day);Oral
Concomitant Medication|BACLOFEN|60;QD (every day);Oral
Concomitant Medication|CALCIUM|600;QD (every day);Oral
Concomitant Medication|DARVOCET|100;TID (three times a day);Oral
Concomitant Medication|NIACIN|100;QD (every day);Oral
Concomitant Medication|TEQUIN|400;QD (every day);Oral
Concomitant Medication|CELEXA|40;QD (every day);Oral
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Bruising of face;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Changes in physical activity|Tic;Tic;Tic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal rash;Fungal skin infection;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Tick bite;Arthropod bite;Non-site specific injuries NEC;MILD;RECOVERED
Concomitant Medication|CAPOTEN|NULL;NULL;NULL
Concomitant Medication|IMDUR|NULL;NULL;NULL
Concomitant Medication|KAOPECTATE|NULL;NULL;NULL
Concomitant Medication|NAFTIN|NULL;NULL;NULL
Concomitant Medication|NITROSTAT|NULL;NULL;NULL
Concomitant Medication|PHENERGAN|NULL;NULL;NULL
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Fluid retention;Fluid retention;Total fluid volume increased;MILD;RECOVERED
Adverse Event|Dental and gingival conditions|Gingivitis;Gingivitis;Gingival disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Bruxism;Bruxism;Stereotypies and automatisms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|FLURAZEPAM|NULL;NULL;NULL
Concomitant Medication|HYDROCHLOROTHIAZIDE W/TRIAMTERENE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Oral soft tissue conditions|Tongue tip numbness of;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;RECOVERED
Concomitant Medication|ACETYLCYSTEIN|600;PRN (as needed);Oral
Adverse Event|Respiratory disorders NEC|Cough nonproductive;Cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured coccyx;Fractured coccyx;Spinal fractures and dislocations;NULL;NULL
Concomitant Medication|GLYCEROL|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM HYDROXIDE|NULL;NULL;NULL
Concomitant Medication|METHYLCELLULOSE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Osteoarticular pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cystitis;Cystitis;Urinary tract infections;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sputum increased;Sputum increased;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Insomnia exacerbated;Insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Concomitant Medication|APTIN|NULL;NULL;NULL
Concomitant Medication|BRONCHICUM|NULL;NULL;NULL
Concomitant Medication|BUSCOPAN|NULL;NULL;NULL
Concomitant Medication|COTRIM FORTE|NULL;NULL;NULL
Concomitant Medication|ISOCILLIN|NULL;NULL;NULL
Concomitant Medication|NERVOREGIN|NULL;NULL;NULL
Concomitant Medication|PROPULSIN|NULL;NULL;NULL
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MODERATE;RECOVERED
Concomitant Medication|DIURIL|NULL;NULL;NULL
Concomitant Medication|MYDRIACYL|NULL;NULL;NULL
Concomitant Medication|RESERPINE|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|BUN increased;Blood urea increased;Renal function analyses;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood creatinine increased;Blood creatinine increased;Renal function analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit decreased;Haematocrit decreased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Decreased hemoglobin;Haemoglobin decreased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Red blood cell count decreased;Red blood cell count decreased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Creatinine increased;Blood creatinine increased;Renal function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paresthesia hand;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|BUN increased;Blood urea increased;Renal function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Panic attack;Panic attack;Panic attacks and disorders;MILD;RECOVERED
Adverse Event|Renal disorders (excl nephropathies)|Renal impairment;Renal impairment;Renal failure and impairment;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Renal disorders (excl nephropathies)|Renal impairment;Renal impairment;Renal failure and impairment;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sleep apnea;Sleep apnoea syndrome;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Temporomandibular joint dysfunction;Temporomandibular joint syndrome;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Platelet disorders|Thrombocytopenia;Thrombocytopenia;Thrombocytopenias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DEMEROL|NULL;NULL;NULL
Concomitant Medication|MEVACOR|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALEVE|1;PRN (as needed);Oral
Concomitant Medication|AMBIEN|10;QHS (at bedtime);Oral
Concomitant Medication|B-12|60;QD (every day);Oral
Concomitant Medication|CELEBREX|200;QD (every day);Oral
Concomitant Medication|COENZYME Q10|100;PRN (as needed);Oral
Concomitant Medication|LORAZEPAM|1;QD (every day);Oral
Concomitant Medication|MOTRIN|200;PRN (as needed);Oral
Concomitant Medication|ZITHROMAX|1;QD (every day);Oral
Concomitant Medication|ANACIN|200;PRN (as needed);Oral
Concomitant Medication|CELEBREX|200;PRN (as needed);Oral
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;SEQUELAE
Concomitant Medication|ACETYL L CARNITINE|1500;TID (three times a day);Oral
Concomitant Medication|ALPRAZOLAM|1;BID (twice a day);Oral
Concomitant Medication|D-ALPHA TOCOPHEROL|800;BID (twice a day);Oral
Concomitant Medication|IRBESARTAN AND HYDROCHLOROTHIAZIDE|300+25;QD (every day);Oral
Concomitant Medication|THIORIDAZINE|2;QD (every day);Oral
Concomitant Medication|TIZANIDINE|4;TID (three times a day);Oral
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|1750+250;BID (twice a day);Oral
Concomitant Medication|NADROPARINE|0.6;QD (every day);Subcutaneous
Concomitant Medication|WARFARIN SODIUM|;QD (every day);Oral
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Mental impairment disorders|Mental concentration decreased;Disturbance in attention;Mental impairment (excl dementia and memory loss);Moderate;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;Marked;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|General system disorders NEC|Malaise;Malaise;Asthenic conditions;Moderate;NULL
Adverse Event|General system disorders NEC|Sluggishness;Sluggishness;Asthenic conditions;Mild;NULL
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Hypophonia;Dysphonia;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Scalp laceration;Skin laceration;Skin injuries NEC;SEVERE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary edema;Pulmonary oedema;Pulmonary oedemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness shoulder;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CHLOR-TRIMETON|NULL;NULL;NULL
Concomitant Medication|TAGAMET|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Ankle fracture;Ankle fracture;Lower limb fractures and dislocations;Moderate;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;NULL
Adverse Event|Injuries NEC|Lip laceration;Mouth injury;Site specific injuries NEC;Mild;NULL
Adverse Event|Embolism and thrombosis|Left deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;Mild;NULL
Concomitant Medication|BETACAROTENE|1500;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|30;BID (twice a day);Oral
Concomitant Medication|COUMADIN|2;QD (every day);Oral
Concomitant Medication|COUMADIN|4;QD (every day);Oral
Concomitant Medication|COUMADIN|6;QHS (at bedtime);Oral
Concomitant Medication|LOVENOX|1;BID (twice a day);Intramuscular
Concomitant Medication|TYLENOL|2;QHS (at bedtime);Oral
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;Mild;NULL
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;Marked;NULL
Adverse Event|Injuries by physical agents|Heat exhaustion;Heat exhaustion;Heat injuries (excl thermal burns);Moderate;NULL
Concomitant Medication|ENDURA|1;BID (twice a day);Oral
Concomitant Medication|GOLDEN SEAL|1;QD (every day);Oral
Concomitant Medication|LEVSIN|2;QHS (at bedtime);Oral
Concomitant Medication|MEPERIDINE|50;QD (every day);Intravenous
Concomitant Medication|MIDAZOLAM|5;QD (every day);Intravenous
Concomitant Medication|SHARK LIVER OIL|2;BID (twice a day);Oral
Concomitant Medication|QUININE SULFATE|325;Five times per week;Oral
Concomitant Medication|SUPER C|1;QD (every day);Oral
Concomitant Medication|TETRACYCLINE|250;BID (twice a day);Oral
Concomitant Medication|TYLENOL|350;PRN (as needed);Oral
Concomitant Medication|ULTRAM|50;BID (twice a day);Oral
Concomitant Medication|ZANAFLEX|2;BID (twice a day);Oral
Concomitant Medication|ZANAFLEX|4;BID (twice a day);Oral
Concomitant Medication|ZANAFLEX|6;BID (twice a day);Oral
Concomitant Medication|ZANAFLEX|8;BID (twice a day);Oral
Concomitant Medication|ZANAFLEX|8;PRN (as needed);Oral
Concomitant Medication|DIFFERIN|0.1;PRN (as needed);Topical
Lab Test|ALT(SGPT)|Normal
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Urolithiases|Renal calculus;Nephrolithiasis;Renal lithiasis;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATENOLOL|50;BID (twice a day);Oral
Concomitant Medication|EBASTINE|10;QD (every day);Oral
Concomitant Medication|TOCOPHERYL ACETATE-D-ALPHA|300;Every morning;Oral
Concomitant Medication|ALPRAZOLAM|0,375;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|10;QHS (at bedtime);Oral
Concomitant Medication|AMITRIPTYLINE|6;QD (every day);Oral
Concomitant Medication|DILTIAZEM|2,5;QD (every day);Oral
Concomitant Medication|MACROGOL|13,8;QHS (at bedtime);Oral
Adverse Event|Renal and urinary tract investigations and urinalyses|BUN increased;Blood urea increased;Renal function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Raised triglycerides;Blood triglycerides increased;Triglyceride analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Sedation;Sedation;Disturbances in consciousness NEC;SEVERE;RECOVERED
Concomitant Medication|BRETHINE|NULL;NULL;NULL
Concomitant Medication|BUFFERED ASPIRIN|NULL;NULL;NULL
Concomitant Medication|CLINORIL|NULL;NULL;NULL
Concomitant Medication|COLCHICINE|NULL;NULL;NULL
Concomitant Medication|K-LOR|NULL;NULL;NULL
Concomitant Medication|LORCET|NULL;NULL;NULL
Concomitant Medication|PERI-COLACE|NULL;NULL;NULL
Concomitant Medication|PROBENECID|NULL;NULL;NULL
Concomitant Medication|QUINIDEX|NULL;NULL;NULL
Concomitant Medication|QUINIDINE SULFATE|NULL;NULL;NULL
Concomitant Medication|ZAROXOLYN|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Benign positional vertigo;Vertigo positional;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Glaucoma and ocular hypertension|Glaucoma;Glaucoma;Glaucomas (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Obstructive sleep apnea syndrome;Sleep apnoea syndrome;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|B COMPOUND|NULL;NULL;NULL
Concomitant Medication|CAT'S CLAW|NULL;NULL;NULL
Concomitant Medication|LOVASTATIN|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Bradycardia;Bradycardia;Rate and rhythm disorders NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Lassitude;Fatigue;Asthenic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Thoracic pain;Chest pain;Pain and discomfort NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Feeling high;Euphoric mood;Emotional and mood disturbances NEC;MILD;RECOVERED
Adverse Event|Coronary artery disorders|Cardiac pain;Angina pectoris;Ischaemic coronary artery disorders;MILD;RECOVERED
Adverse Event|Chemical injury and poisoning|Intoxication;Poisoning;Poisoning and toxicity;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|TRAMADOL|100;PRN (as needed);Oral
Concomitant Medication|TRAMADOL|100;QD (every day);Oral
Concomitant Medication|TRAMADOL|40;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;Mild;NULL
Concomitant Medication|CALCIUM MAGNESIUM|1;QD (every day);Oral
Concomitant Medication|COENZYME Q10|1;QD (every day);Oral
Concomitant Medication|INOSITOL|1;QD (every day);Oral
Concomitant Medication|KLONOPIN|0.5;QD (every day);Oral
Concomitant Medication|L-CARNITINE|500;BID (twice a day);Oral
Concomitant Medication|FISH OIL|3;QD (every day);Oral
Concomitant Medication|TAURINE|1;QD (every day);Oral
Concomitant Medication|VITAMIN B12|5;QD (every day);Oral
Concomitant Medication|WHEY PROTEIN|1;QD (every day);Oral
Concomitant Medication|BILBERRY|280;QD (every day);Oral
Concomitant Medication|CENTRUM|1;QD (every day);Oral
Concomitant Medication|CREATINE|5;BID (twice a day);Oral
Concomitant Medication|LIPOIC ACID|300;QD (every day);Oral
Concomitant Medication|OLIVE LEAVES EXTRACT|1;QD (every day);Oral
Concomitant Medication|VITAMIN C|1.5;QD (every day);Oral
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;Mild;NULL
Adverse Event|Injuries by physical agents|Burn of unspecified degree of unspecified site of hand;Thermal burn;Thermal burns;Mild;NULL
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;Mild;NULL
Adverse Event|Gastrointestinal investigations|Stool Guaiac test positive;Occult blood positive;Faecal analyses NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Upset gastrointestinal;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;NULL
Concomitant Medication|BACLOFEN|20;QD (every day);Oral
Concomitant Medication|BENEFIBER|1;QD (every day);Oral
Concomitant Medication|COLACE|200;BID (twice a day);Oral
Concomitant Medication|COLACE|100;QD (every day);Oral
Concomitant Medication|COLACE|100;BID (twice a day);Oral
Concomitant Medication|ENSURE PLUS|1;QD (every day);Oral
Concomitant Medication|FLONASE|1/0.05;BID (twice a day);Inhalation
Concomitant Medication|MAALOX|U;;PEG
Concomitant Medication|NEXIUM|40;QID (four times a day);PEG
Concomitant Medication|ONE SOURCE|1;QD (every day);Oral
Concomitant Medication|PEPCID|1;QD (every day);Oral
Concomitant Medication|PROVIGIL|300;QID (four times a day);Oral
Concomitant Medication|QUININE|130;QD (every day);Oral
Concomitant Medication|QUININE|260;QD (every day);Oral
Concomitant Medication|QUININE SULFATE|200;BID (twice a day);Oral
Concomitant Medication|QUININE SULFATE|240;QD (every day);Oral
Concomitant Medication|SYNTHROID|0.125;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|20;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|30;QD (every day);Oral
Concomitant Medication|LACTULOSE|1;QD (every day);Oral
Concomitant Medication|SCOPOLAMINE|1.5;QD (every day);Topical
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Gait disorder;Gait disturbance;Gait disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema legs;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Bigeminy;Extrasystoles;Rate and rhythm disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Epigastric discomfort;Epigastric discomfort;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Postprandial pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Muscle disorders|Weakness in extremity;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Sensation of pressure in ear;Ear discomfort;Ear disorders NEC;MILD;RECOVERED
Concomitant Medication|LANSOPRAZOLE|NULL;NULL;NULL
Concomitant Medication|POTASSIUM CITRATE|NULL;NULL;NULL
Concomitant Medication|VIVIMED|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervical pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbar pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Scapula pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|BIOSTIM|NULL;NULL;NULL
Concomitant Medication|BRUFEN|NULL;NULL;NULL
Concomitant Medication|DIANTALVIC|NULL;NULL;NULL
Concomitant Medication|MIOREL|NULL;NULL;NULL
Concomitant Medication|XENID|NULL;NULL;NULL
Lab Test|Urine Bacteria|Trace
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Systolic murmur;Cardiac murmur;Cardiac auscultatory investigations;Mild;NULL
Concomitant Medication|MELATONIN|300;QD (every day);Oral
Concomitant Medication|NORVASC|5;QD (every day);Oral
Concomitant Medication|TYLENOL PM|1000;BID (twice a day);Oral
Concomitant Medication|UNIVASC|15;QD (every day);Oral
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;MILD;RECOVERED
Concomitant Medication|CHLORAL|NULL;NULL;NULL
Concomitant Medication|EFFERALGAN|NULL;NULL;NULL
Concomitant Medication|FORLAX|NULL;NULL;NULL
Concomitant Medication|HYPNOVEL|NULL;NULL;NULL
Concomitant Medication|RIVOTRIL|NULL;NULL;NULL
Concomitant Medication|SULFARLEM|NULL;NULL;NULL
Concomitant Medication|TEMESTA|NULL;NULL;NULL
Concomitant Medication|THERALENE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in upper extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Skin rash;Rash;Rashes, eruptions and exanthems NEC;Mild;NULL
Concomitant Medication|ATROPINE|2 drops;;Other (specify)
Concomitant Medication|ELAVIL|10;PRN (as needed);Oral
Adverse Event|Mycobacterial infectious disorders|TB;Tuberculosis;Tuberculous infections;Mild;Continuing
Adverse Event|General system disorders NEC|Face oedema;Face oedema;Oedema NEC;Moderate;Resolved
Adverse Event|Viral infectious disorders|Flu symptoms;Influenza;Influenza viral infections;Moderate;Resolved
Adverse Event|Injuries NEC|Falling;Fall;Non-site specific injuries NEC;Mild;Continuing
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Mild;Continuing
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Moderate;Resolved with Residual
Adverse Event|Administration site reactions|Injection site itching;Injection site pruritus;Injection site reactions;Moderate;Resolved
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;Severe;Resolved
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;Moderate;Resolved
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Severe;Resolved
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;Mild;Resolved
Concomitant Medication|ALKA SELTZER PLUS|NULL;NULL;NULL
Concomitant Medication|AZITHROMYCIN|NULL;NULL;NULL
Concomitant Medication|CONJUGATED ESTROGENS|NULL;NULL;NULL
Concomitant Medication|ETHAMBUTOL|NULL;NULL;NULL
Concomitant Medication|GATIFLOXACIN|NULL;NULL;NULL
Concomitant Medication|HYDROCODONE/APAP|NULL;NULL;NULL
Concomitant Medication|MIRTAZAPINE|NULL;NULL;NULL
Concomitant Medication|OXYIR|NULL;NULL;NULL
Concomitant Medication|PAROXETINE|NULL;NULL;NULL
Concomitant Medication|PROCTOFOAM|NULL;NULL;NULL
Concomitant Medication|PROPOXYPHENE N/APAP|NULL;NULL;NULL
Concomitant Medication|SINE-OFF|NULL;NULL;NULL
Concomitant Medication|TYLENOL ALLERGY SINUS|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Benign positional vertigo;Vertigo positional;Inner ear signs and symptoms;MODERATE;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Concentration impaired;Disturbance in attention;Mental impairment (excl dementia and memory loss);MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps aggravated;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Malaise;Malaise;Asthenic conditions;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Sensation of warmth;Feeling hot;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|COLD EEZE|NULL;NULL;NULL
Concomitant Medication|DIOSCOREA VILLOSA|NULL;NULL;NULL
Concomitant Medication|SPECTAZOLE|NULL;NULL;NULL
Concomitant Medication|TRIMETHOBENZAMIDE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Energy decreased;Asthenia;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Increased upper airway secretion;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Neck cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|EXCEDRIN EXTRA STRENGTH|NULL;NULL;NULL
Concomitant Medication|GINSENG NOS W/HERBAL POLLEN NOS/ROYAL JELLY|NULL;NULL;NULL
Lab Test|Urine WBCs|3+++
Adverse Event|Joint disorders|Pain in knee;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Concomitant Medication|ALOE VERA|;;Oral
Concomitant Medication|FOLSAEURE|5;;Oral
Concomitant Medication|GINKGO BILOBA|50;;Oral
Concomitant Medication|KALINOR|2;;Oral
Concomitant Medication|LIORESAL|10;;Oral
Concomitant Medication|LIORESAL|5;;Oral
Concomitant Medication|MADOPAR|125;;Oral
Concomitant Medication|MAGNESIUM|40;;Oral
Concomitant Medication|VITAMIN B|35.5;;Oral
Concomitant Medication|VITAMIN E|500;;Oral
Adverse Event|Gastrointestinal signs and symptoms|Bowel incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;Mild;Resolved
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;Moderate;Resolved
Concomitant Medication|MECLOZINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchial secretion retention;Bronchial secretion retention;Bronchial conditions NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Otitis media;Otitis media;Ear infections;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLCYSTEIN|600;QD (every day);Oral
Concomitant Medication|BERODUAL|1;PRN (as needed);Inhalation
Concomitant Medication|CILOXAN|1;QD (every day);
Concomitant Medication|CITALOPRAM|40;QD (every day);Oral
Concomitant Medication|LIMPTAR|200;QD (every day);Oral
Concomitant Medication|MYDOCALM|150;TID (three times a day);Oral
Concomitant Medication|OTOBACID|3;TID (three times a day);
Concomitant Medication|PANTOZOL|40;BID (twice a day);Oral
Concomitant Medication|PARACETAMOL|1500;TID (three times a day);Oral
Concomitant Medication|THEOPHYLLINE|250;QD (every day);Oral
Concomitant Medication|TRIAMGALEN|20;BID (twice a day);Topical
Concomitant Medication|VOLTAREN RESINAT|150;BID (twice a day);Oral
Concomitant Medication|ZOP|7.5;PRN (as needed);Oral
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated haemoglobin increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of lower extremities;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness of extremities;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Post-traumatic pain;Post-traumatic pain;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|CLIMENE|NULL;NULL;NULL
Concomitant Medication|DIDRONEL|NULL;NULL;NULL
Concomitant Medication|EUPHYLLINE|NULL;NULL;NULL
Concomitant Medication|NARCOZEP|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Alopecia;Alopecia;Alopecias;MODERATE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Viral infectious disorders|Flu syndrome;Influenza;Influenza viral infections;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Flu syndrome;Influenza;Influenza viral infections;SEVERE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Frequency urinary;Pollakiuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Granuloma annulare;Granuloma annulare;Granulomatous and deep cutaneous inflammatory conditions;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Hirsutism;Hirsutism;Hypertrichoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hirsutism;Hirsutism;Hypertrichoses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Increased appetite;Increased appetite;Appetite disorders;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Flatus increased;Flatulence;Flatulence, bloating and distension;SEVERE;RECOVERED
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Increased thirst;Thirst;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Polyuria;Polyuria;Urinary tract signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema arms;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED
Concomitant Medication|BENZONATATE|NULL;NULL;NULL
Concomitant Medication|CEPHRADINE|NULL;NULL;NULL
Concomitant Medication|NASACORT AQ|NULL;NULL;NULL
Concomitant Medication|REGLAN|NULL;NULL;NULL
Concomitant Medication|SURFAK|NULL;NULL;NULL
Concomitant Medication|ZOSYN|NULL;NULL;NULL
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Urinary tract signs and symptoms|Glucosuria;Glycosuria;Urinary abnormalities;MODERATE;RECOVERED
Adverse Event|Purine and pyrimidine metabolism disorders|Gout;Gout;Purine metabolism disorders NEC;MODERATE;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful feet;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain (with radiation);Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED
Adverse Event|Synovial and bursal disorders|Elbow bursitis;Bursitis;Bursal disorders;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|ACROMICINA|NULL;NULL;NULL
Concomitant Medication|TERRAMICINA|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Knee sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;MILD;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Laceration of finger;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Thrush;Candidiasis;Candida infections;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|CRANBERRY|NULL;NULL;NULL
Concomitant Medication|DILAUDID|NULL;NULL;NULL
Concomitant Medication|DUPHALAC|NULL;NULL;NULL
Concomitant Medication|TALACEN|NULL;NULL;NULL
Concomitant Medication|CALCIUM|1000;QD (every day);Oral
Concomitant Medication|COENZYME Q10|75;QD (every day);Oral
Concomitant Medication|TRIMOX|500;QD (every day);Oral
Concomitant Medication|TYLENOL|650;PRN (as needed);Oral
Concomitant Medication|ZANTAC|150;QD (every day);Oral
Adverse Event|Anxiety disorders and symptoms|Panic attacks;Panic attack;Panic attacks and disorders;MODERATE;RECOVERED
Adverse Event|Cardiac arrhythmias|AV block first degree;Atrioventricular block first degree;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Spinal cord and nerve root disorders|Lumboischialgia;Sciatica;Lumbar spinal cord and nerve root disorders;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Perspiration excessive;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;RECOVERED
Concomitant Medication|ATORVASTATIN|NULL;NULL;NULL
Concomitant Medication|FLECAINIDE|NULL;NULL;NULL
Concomitant Medication|PRAVASTATINE|NULL;NULL;NULL
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;Severe;NULL
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Infected ingrowing toe nail;Paronychia;Skin structures and soft tissue infections;SEVERE;RECOVERED
Adverse Event|Abdominal hernias and other abdominal wall conditions|Inguinal hernia;Inguinal hernia;Inguinal hernias;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Adverse Event|Injuries NEC|Contusion of foot;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Tenderness;Tenderness;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;MILD;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands & feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|General physical health deterioration;General physical health deterioration;General signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);MILD;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Venous insufficiency;Venous insufficiency;Non-site specific necrosis and vascular insufficiency NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DOPAMINE|NULL;NULL;NULL
Concomitant Medication|FORTUM|NULL;NULL;NULL
Concomitant Medication|GARDENAL|NULL;NULL;NULL
Concomitant Medication|OSSOPAN|NULL;NULL;NULL
Concomitant Medication|STABLON|NULL;NULL;NULL
Concomitant Medication|STEROGYL|NULL;NULL;NULL
Concomitant Medication|SULFARLEM S 25|NULL;NULL;NULL
Concomitant Medication|TOBRAMYCIN|NULL;NULL;NULL
Concomitant Medication|VITAMIN B1, B6 & B12|NULL;NULL;NULL
Adverse Event|Synovial and bursal disorders|Elbow bursitis;Bursitis;Bursal disorders;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum expectoration difficult;Sputum retention;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NEOMYCIN|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Bilirubin total high;Blood bilirubin increased;Liver function analyses;Moderate;Resolved
Adverse Event|Allergic conditions|Hypersensitivity reaction;Hypersensitivity;Allergic conditions NEC;Moderate;Resolved
Concomitant Medication|CORAL CALCIUM|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Abnormal arterial blood gases;Blood gases abnormal;Blood gas and acid base analyses;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Vital capacity decreased;Vital capacity decreased;Respiratory and pulmonary function diagnostic procedures;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Decubitus;Decubitus ulcer;Skin injuries and mechanical dermatoses;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Airway secretion excessive;Increased bronchial secretion;Lower respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Upper respiratory tract congestion;Upper respiratory tract congestion;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Psychiatric disorders NEC|Mental state abnormal;Mental disorder;Mental disorders NEC;SEVERE;RECOVERED
Concomitant Medication|BIAFINE|NULL;NULL;NULL
Concomitant Medication|ROBITUSSIN WITH CODEINE|NULL;NULL;NULL
Concomitant Medication|VIROX|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Capsulitis of shoulder;Periarthritis;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DRISTAN SINUS|NULL;NULL;NULL
Concomitant Medication|SINUTAB|NULL;NULL;NULL
Concomitant Medication|ULTRADOL|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Fingernail discoloration;Nail discolouration;Nail and nail bed conditions (excl infections and infestations);Mild;Resolved
Adverse Event|Skin appendage conditions|Hair darkened;Hair colour changes;Pilar disorders NEC;Mild;Continuing
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;Mild;Continuing
Concomitant Medication|IRBESARTAN|NULL;NULL;NULL
Concomitant Medication|IRBESARTAN HYDROCHLOROTHIAZIDE|NULL;NULL;NULL
Adverse Event|External ear disorders (excl congenital)|Cerumen impaction;Cerumen impaction;External ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Kyphosis;Kyphosis;Spine and neck deformities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional reaction;Emotional disorder;Emotional and mood disturbances NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Stomach flu;Gastroenteritis viral;Viral infections NEC;MODERATE;RECOVERED
Concomitant Medication|OXAZEPAM|NULL;NULL;NULL
Concomitant Medication|PRO-BANTHINE|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Coronary artery disease;Coronary artery disease;Coronary artery disorders NEC;Moderate;NULL
Adverse Event|Coronary artery disorders|Myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;Moderate;NULL
Concomitant Medication|AVANDIA|NULL;NULL;NULL
Concomitant Medication|DIABETA|NULL;NULL;NULL
Concomitant Medication|INSULIN|NULL;NULL;NULL
Concomitant Medication|KEFZOL|NULL;NULL;NULL
Concomitant Medication|PLAVEX|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Herniated disc;Intervertebral disc protrusion;Intervertebral disc disorders NEC;MILD;RECOVERED
Concomitant Medication|OCTACOSANOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Foot edema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALKA SELTZER|NULL;NULL;NULL
Concomitant Medication|CAL-MAG|NULL;NULL;NULL
Concomitant Medication|UNISOM|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Adverse Event|Manic and bipolar mood disorders and disturbances|Cyclothymia;Cyclothymic disorder;Bipolar disorders;MODERATE;RECOVERED
Adverse Event|Gastrointestinal ulceration and perforation|Gastric ulcer;Gastric ulcer;Gastric ulcers and perforation;MILD;UNKNOWN
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Queasy;Nausea;Nausea and vomiting symptoms;MILD;RECOVERED
Adverse Event|Headaches|Occipital headache;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Neurodermatitis;Neurodermatitis;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw pain;Pain in jaw;Bone related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Headaches|Occipital headache;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Occipital headache;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep problem;Sleep disorder;Sleep disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Manic and bipolar mood disorders and disturbances|Cyclothymia;Cyclothymic disorder;Bipolar disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Stress urinary incontinence;Stress urinary incontinence;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|EUVEGAL-DRAGEES|NULL;NULL;NULL
Concomitant Medication|IMIPRAMINE|NULL;NULL;NULL
Concomitant Medication|IMIPRAMINE HCL|NULL;NULL;NULL
Concomitant Medication|IMIPRAMINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|METRONIDAZOL|NULL;NULL;NULL
Concomitant Medication|PHENYLEPHRIN|NULL;NULL;NULL
Concomitant Medication|THOMAPYRINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Concomitant Medication|DIABETASE|NULL;NULL;NULL
Concomitant Medication|EUNOVA|NULL;NULL;NULL
Concomitant Medication|GASTROZEPIN|NULL;NULL;NULL
Concomitant Medication|SOMAGEROL|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Crackles lung;Rales;Lower respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Chest infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Cholesterol levels raised;Blood cholesterol increased;Cholesterol analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Epigastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Contracture;Muscle contracture;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin scaly;Skin exfoliation;Exfoliative conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;MILD;RECOVERED
Concomitant Medication|CO-DANTHRUSATE|NULL;NULL;NULL
Concomitant Medication|GTN|NULL;NULL;NULL
Concomitant Medication|MEDICATED SHAMPOOS|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;SEVERE;NA
Adverse Event|Prostatic disorders (excl infections and inflammations)|Benign prostatic hyperplasia;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Bone and joint injuries|Ankle fracture;Ankle fracture;Lower limb fractures and dislocations;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Lipid metabolism disorders|Hypercholesteremia;Hypercholesterolaemia;Elevated cholesterol;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Central nervous system vascular disorders|Intracranial hemorrhage;Haemorrhage intracranial;Central nervous system haemorrhages and cerebrovascular accidents;SEVERE;DEATH
Adverse Event|Central nervous system vascular disorders|Intracranial hemorrhage;Haemorrhage intracranial;Central nervous system haemorrhages and cerebrovascular accidents;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;SEVERE;NA
Adverse Event|Bone and joint injuries|Skull fracture;Skull fracture;Skull fractures, facial bone fractures and dislocations;SEVERE;NA
Adverse Event|Central nervous system vascular disorders|Stroke;Cerebrovascular accident;Central nervous system haemorrhages and cerebrovascular accidents;MODERATE;RECOVERED
Concomitant Medication|HEPARIN|UNK;QD (every day);Subcutaneous
Concomitant Medication|MAGNESIUM VERLA|UNK;BID (twice a day);Oral
Concomitant Medication|RAMIPRIL|2.5;QD (every day);Oral
Concomitant Medication|SIMVASTATIN|40;QD (every day);Oral
Concomitant Medication|TAMSULOSIN|0.4;QD (every day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Marked;NULL
Concomitant Medication|BOTOX|150;QD (every day);Subcutaneous
Concomitant Medication|BOTOX|100;1 time only;Subcutaneous
Concomitant Medication|CARNITINE|1000;TID (three times a day);Oral
Concomitant Medication|CURCUMIN|2;QD (every day);Oral
Concomitant Medication|DHEA|25;PRN (as needed);Oral
Concomitant Medication|LEVSIN|0.125;PRN (as needed);Oral
Concomitant Medication|MINOCYCLINE|200;BID (twice a day);Oral
Concomitant Medication|MORPHINE|2;Continuous IV;Intravenous
Concomitant Medication|OMEGA-3 FATTY ACIDS|1000;BID (twice a day);Oral
Concomitant Medication|PANTOPRAZOLE SODIUM|40;QD (every day);Oral
Concomitant Medication|PAXIL|40;QD (every day);Oral
Concomitant Medication|PREMPRO|2.5;QD (every day);Oral
Concomitant Medication|SAL-TROPINE|0.4;PRN (as needed);Oral
Concomitant Medication|SAL-TROPINE|0.8;TID (three times a day);Oral
Concomitant Medication|TYLENOL WITH CODEINE|500/30;PRN (as needed);Oral
Concomitant Medication|VALIUM|5;TID (three times a day);Oral
Concomitant Medication|SHARK LIVER OIL|2;TID (three times a day);Oral
Adverse Event|Neurological disorders NEC|Dysphasia;Aphasia;Cortical dysfunction NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Redness;Erythema;Erythemas;MILD;ONGOING (PERSISTENT)
Concomitant Medication|LERCANIDIPINE HYDROCHLORIDE|10;Every morning;Oral
Concomitant Medication|PERINDOPRIL ERBUMINE|4;Every morning;Oral
Concomitant Medication|TOCOPHEROL|800;BID (twice a day);Oral
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Tissue disorders NEC|Cyst;Cyst;Mass conditions NEC;MILD;RECOVERED
Adverse Event|Neuromuscular disorders|Increased muscle tone;Hypertonia;Muscle tone abnormal;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MEGAVIT|NULL;NULL;NULL
Concomitant Medication|METHYLCOBALAMIN|NULL;NULL;NULL
Concomitant Medication|METHYLSULFONYLMETHANE|NULL;NULL;NULL
Concomitant Medication|TEA, GREEN|NULL;NULL;NULL
Demographic|Race|Other
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Pityriasis versicolor;Tinea versicolour;Tinea infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness of lower extremities;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urge incontinence;Urge incontinence;Bladder and urethral symptoms;MODERATE;RECOVERED
Concomitant Medication|ANESTHETICS, GENERAL|NULL;NULL;NULL
Concomitant Medication|DANDRUFF PLUS|NULL;NULL;NULL
Concomitant Medication|HYDROCODONE/ACETAMINOPHEN|NULL;NULL;NULL
Concomitant Medication|SOMA|NULL;NULL;NULL
Concomitant Medication|VICOPROFEN|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Hepatic enzymes increased;Hepatic enzyme increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|Liver function tests raised;Liver function test abnormal;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary granuloma;Pulmonary granuloma;Lower respiratory tract inflammatory and immunologic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Loss of vision;Blindness;Blindness (excl colour blindness);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sexual function and fertility disorders|Sexual dysfunction;Sexual dysfunction;Sexual function and fertility disorders NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Sleepy;Somnolence;Disturbances in consciousness NEC;MILD;RECOVERED
Concomitant Medication|CONTAC COLD/FLU|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning sensation in eye;Eye irritation;Ocular infections, inflammations and associated manifestations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Breath sounds decreased;Breath sounds abnormal;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular structural change, deposit and degeneration NEC|Floaters in eye;Myodesopsia;Choroid and vitreous structural change, deposit and degeneration;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|HbA1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin high;Haemoglobin increased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Red blood cell count high;Red blood cell count increased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Cornification and dystrophic skin disorders|Keratosis;Hyperkeratosis;Hyperkeratoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Premature ventricular contractions;Ventricular extrasystoles;Ventricular arrhythmias and cardiac arrest;MILD;RECOVERED
Concomitant Medication|KELP|NULL;NULL;NULL
Concomitant Medication|SUPEROXIDE DISMUTASE|NULL;NULL;NULL
Concomitant Medication|CITRACAL|400;BID (twice a day);Oral
Concomitant Medication|DITROPAN|15;QD (every day);Oral
Concomitant Medication|DITROPAN|5;QD (every day);Oral
Concomitant Medication|ELAVIL|25;QHS (at bedtime);Oral
Concomitant Medication|ELAVIL|50;QHS (at bedtime);Oral
Concomitant Medication|FOLIC ACID|400;TID (three times a day);Oral
Concomitant Medication|FOSAMAX|70;Once per week;Oral
Concomitant Medication|LUTEIN|6;BID (twice a day);Oral
Concomitant Medication|LUTEIN|6;QD (every day);Oral
Concomitant Medication|MELATONIN|3;QHS (at bedtime);Oral
Concomitant Medication|MELATONIN|6;QHS (at bedtime);Oral
Concomitant Medication|MIACALCIN|200;QD (every day);Inhalation
Concomitant Medication|PREMPRO|1.5;QD (every day);Oral
Concomitant Medication|PREMPRO|2.5;Every other day;Oral
Concomitant Medication|TYLENOL EXTRA STRENGTH|1000;PRN (as needed);Oral
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Dental and gingival conditions|Gum bleeding;Gingival bleeding;Gingival haemorrhages;MILD;RECOVERED
Adverse Event|Injuries by physical agents|Burn of face, unspecified degree;Thermal burn;Thermal burns;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal haemorrhages NEC|Hematochezia;Haematochezia;Non-site specific gastrointestinal haemorrhages;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash trunk;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Loss of smell;Anosmia;Olfactory nerve disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Restless legs;Restless legs syndrome;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Restless legs;Restless legs syndrome;Sensory abnormalities NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|LOPERAMIDE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|TRIAMCINOLONE ACETONIDE|NULL;NULL;NULL
Concomitant Medication|BISOLVON|NULL;NULL;NULL
Concomitant Medication|CORSODYL|NULL;NULL;NULL
Concomitant Medication|DAGRAVIT|NULL;NULL;NULL
Concomitant Medication|TRYPTIZOL|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;Mild;NULL
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Marked;NULL
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;Mild;NULL
Concomitant Medication|DIGEST|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Dribbling of urine;Urinary incontinence;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|BETADINE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;Mild;Resolved
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;Mild;Resolved
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Concomitant Medication|BENAZEPRIL HCL|NULL;NULL;NULL
Concomitant Medication|DOXAZOSIN|NULL;NULL;NULL
Adverse Event|Electrolyte and fluid balance conditions|Electrolyte imbalance;Electrolyte imbalance;Electrolyte imbalance NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral fungal infection;Oral fungal infection;Fungal infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Helicobacter pylori infection;Helicobacter infection;Helicobacter infections;MILD;RECOVERED
Adverse Event|Muscle disorders|Myalgia of lower extremities;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling sensation;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Moderate;Resolved
Concomitant Medication|MOEXIPRIL HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|TRIAZOLAM|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Acute retention of urine;Urinary retention;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Aerophagia;Aerophagia;Flatulence, bloating and distension;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disturbances (incl subtypes)|Hypersomnia;Hypersomnia;Narcolepsy and hypersomnia;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Hypophonia;Dysphonia;Upper respiratory tract signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETAMINOPHEN|1;QD (every day);Oral
Concomitant Medication|CIPROFLOXACINE|1000;BID (twice a day);Oral
Concomitant Medication|ENALAPRIL|5;QD (every day);Oral
Concomitant Medication|SIMETICONE|40;BID (twice a day);Oral
Concomitant Medication|CAL D VITA|1;QD (every day);Oral
Concomitant Medication|DOMPERIDONE|3;TID (three times a day);Oral
Concomitant Medication|ESCITALOPRAM|15;QD (every day);Oral
Adverse Event|Respiratory disorders NEC|Throat constriction;Throat tightness;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disorder;Gastrointestinal disorder;Gastrointestinal disorders NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Hair growth abnormal;Hair growth abnormal;Pilar disorders NEC;MILD;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw pain;Pain in jaw;Bone related signs and symptoms;MILD;RECOVERED
Concomitant Medication|CHLORELLA VULGARIS|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM W/POTASSIUM|NULL;NULL;NULL
Concomitant Medication|SPIRULINA|NULL;NULL;NULL
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Burning mouth;Oral discomfort;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Fainting;Syncope;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Malleolus oedema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder blade pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paresthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paresthesia of scalp;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disorder;Sleep disorder;Sleep disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ARNICA|NULL;NULL;NULL
Concomitant Medication|FLUNITRAZEPAM|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Marked;NULL
Adverse Event|Viral infectious disorders|Herpes zoster;Herpes zoster;Herpes viral infections;Marked;NULL
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);Marked;NULL
Concomitant Medication|ACICLOVIR|800;QID (four times a day);Oral
Concomitant Medication|ACICLOVIR|800;TID (three times a day);Intravenous
Concomitant Medication|AMITRIPTYLINE|25;QID (four times a day);Oral
Concomitant Medication|AUGMENTIN|875;BID (twice a day);Oral
Concomitant Medication|BETACAROTENE|1/1;QD (every day);Oral
Concomitant Medication|TEGRETOL|200;BID (twice a day);Oral
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;SEVERE;RECOVERED
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;SEVERE;RECOVERED
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;SEVERE;RECOVERED
Adverse Event|Skin appendage conditions|Clammy;Cold sweat;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|General discomfort;Discomfort;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Effusion (l) knee;Joint effusion;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram T wave abnormal;Electrocardiogram T wave abnormal;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Ankle effusion;Joint effusion;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Sprained ankle;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Concomitant Medication|AGAROL|NULL;NULL;NULL
Concomitant Medication|CALPLEX|NULL;NULL;NULL
Concomitant Medication|GLUCOSAMINE|NULL;NULL;NULL
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataracts;Cataract;Cataract conditions;Mild;NULL
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;Moderate;NULL
Concomitant Medication|BACLOFEN|250;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|280;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|310;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|340;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|370;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|400;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|202;Continuous IV;Other (specify)
Concomitant Medication|BACLOFEN|225;Continuous IV;Other (specify)
Concomitant Medication|BENADRYL|25;PRN (as needed);Oral
Concomitant Medication|CIPRO|500;BID (twice a day);Oral
Concomitant Medication|CIPRO|500;QD (every day);PEG
Concomitant Medication|DANTRIUM|25;QID (four times a day);Oral
Concomitant Medication|DITROPAN|5;TID (three times a day);Oral
Concomitant Medication|LEVAQUIN|500;QD (every day);Oral
Concomitant Medication|PERIDIUM|200;TID (three times a day);Oral
Concomitant Medication|V CON|0.4/35;QD (every day);Oral
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anemia;Anaemia;Anaemias NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Gastrointestinal ulceration and perforation|Gastric ulcer;Gastric ulcer;Gastric ulcers and perforation;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pharyngitis;Pharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;MILD;RECOVERED
Concomitant Medication|CORTANCYL|NULL;NULL;NULL
Concomitant Medication|DENORAL|NULL;NULL;NULL
Concomitant Medication|HYDROCORTANCYL|NULL;NULL;NULL
Concomitant Medication|KETODERM|NULL;NULL;NULL
Concomitant Medication|NAXY|NULL;NULL;NULL
Concomitant Medication|TIMOPTOL|NULL;NULL;NULL
Concomitant Medication|ZECLAR|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis of abdominal wall;Cellulitis;Bacterial infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;ONGOING (PERSISTENT)
Concomitant Medication|ANUSOL HC|NULL;NULL;NULL
Concomitant Medication|BOOST|NULL;NULL;NULL
Concomitant Medication|CHLORPHENIRAMINE|NULL;NULL;NULL
Concomitant Medication|ZIAC|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;MODERATE;RECOVERED
Adverse Event|White blood cell disorders|Neutropenia;Neutropenia;Neutropenias;MILD;RECOVERED
Adverse Event|Lipid analyses|Cholesterol blood increased;Blood cholesterol increased;Cholesterol analyses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DIPROSONE|NULL;NULL;NULL
Concomitant Medication|SEPTIVON|NULL;NULL;NULL
Concomitant Medication|SERMION|NULL;NULL;NULL
Concomitant Medication|TEMGESIC|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heartbeats irregular;Heart rate irregular;Heart rate and pulse investigations;Mild;NULL
Concomitant Medication|QUININE|325;PRN (as needed);Oral
Concomitant Medication|QUININE|325;QHS (at bedtime);Oral
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Mild;NULL
Concomitant Medication|ALBUTEROL|2;TID (three times a day);Inhalation
Concomitant Medication|BACLOFEN|5;QD (every day);Oral
Concomitant Medication|BIAXIN|500;BID (twice a day);Oral
Concomitant Medication|GUAIFENESIN|300;BID (twice a day);Oral
Concomitant Medication|ROBINUL|1;TID (three times a day);Oral
Concomitant Medication|TIMOPTIC|1/1;BID (twice a day);Otic (ear)
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED
Adverse Event|Administration site reactions|Injection site bleeding;Injection site haemorrhage;Injection site reactions;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Mild;         .
Adverse Event|Administration site reactions|Injection site ecchymosis;Injection site haemorrhage;Injection site reactions;Mild;Resolved
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;Mild;Resolved
Adverse Event|Anal and rectal conditions NEC|Rectal pain;Proctalgia;Anal and rectal pains;Mild;Resolved
Adverse Event|Anal and rectal conditions NEC|Anorectal discomfort;Anorectal discomfort;Anal and rectal signs and symptoms;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Stools watery;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved
Concomitant Medication|DEXTROMETHORPHAN HYDROBROMIDE|NULL;NULL;NULL
Concomitant Medication|FLOVENT|NULL;NULL;NULL
Concomitant Medication|MOMETASONE FUROATE|NULL;NULL;NULL
Concomitant Medication|PROBIOTIC|NULL;NULL;NULL
Concomitant Medication|RETIN A|NULL;NULL;NULL
Concomitant Medication|ZIRTEC|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysaesthesia extremity;Dysaesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycaemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MILD;RECOVERED
Concomitant Medication|DIMERCAPTOSUCCINIC ACID|NULL;NULL;NULL
Concomitant Medication|JUNIPER|NULL;NULL;NULL
Concomitant Medication|LEGAPAS|NULL;NULL;NULL
Concomitant Medication|VITAMIN B COMPOUND|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhoea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Raised blood pressure;Blood pressure increased;Vascular tests NEC (incl blood pressure);MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Maculo-papular rash;Rash maculo-papular;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Concomitant Medication|CALCIUM LACTATE|NULL;NULL;NULL
Concomitant Medication|CILEST|NULL;NULL;NULL
Concomitant Medication|MEBENDAZOLE|NULL;NULL;NULL
Concomitant Medication|PSEUDOEPHEDRINE W/TRIPROLIDINE|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Panic attack;Panic attack;Panic attacks and disorders;SEVERE;RECOVERED
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatism;Prostatism;Prostatic signs, symptoms and disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Stomach ache;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALFUZOSINE HCL|10;QD (every day);Oral
Concomitant Medication|CLOPIDOGREL HYDROGEN SULFATE|75;QD (every day);Oral
Concomitant Medication|FLUVASTATIN SODIUM|80;QD (every day);Oral
Concomitant Medication|TADALAFIL|20;PRN (as needed);Oral
Concomitant Medication|TIANEPTINE SODIUM|37.5;TID (three times a day);Oral
Concomitant Medication|TRAMADOL|300;TID (three times a day);Oral
Concomitant Medication|TRIMETAZIDINE|70;BID (twice a day);Oral
Concomitant Medication|VENLAFAXINE|37.5;BID (twice a day);Oral
Concomitant Medication|VENLAFAXINE|75;BID (twice a day);Oral
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Fungal infectious disorders|Fungal infection;Fungal infection;Fungal infections NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Bruise of head;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Capsulitis of shoulder;Periarthritis;Joint related disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramps of lower extremities;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dry heaves;Retching;Nausea and vomiting symptoms;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Fecal impaction;Faecaloma;Faecal abnormalities NEC;SEVERE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Hoarseness;Dysphonia;Upper respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Ocular infections, irritations and inflammations|Burning in eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Deliria (incl confusion)|Nocturnal disorientation;Disorientation;Confusion and disorientation;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Soft tissue injury;Soft tissue injury;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|FIORICET|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;         .;Resolved
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain back;Back pain;Musculoskeletal and connective tissue pain and discomfort;         .;Resolved
Adverse Event|General system disorders NEC|Pain chest;Chest pain;Pain and discomfort NEC;         .;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Severe;Resolved
Adverse Event|General system disorders NEC|Chest pain (non-cardiac);Non-cardiac chest pain;Pain and discomfort NEC;Severe;Resolved
Adverse Event|Joint disorders|Pain knee;Arthralgia;Joint related signs and symptoms;Mild;Resolved
Concomitant Medication|ARICEPT|NULL;NULL;NULL
Concomitant Medication|VISINE A|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Energy decreased;Asthenia;Asthenic conditions;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Dysequilibrium;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Mood swings;Mood swings;Fluctuating mood symptoms;MILD;RECOVERED
Concomitant Medication|DRISTAN|NULL;NULL;NULL
Concomitant Medication|SERTRALINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Flu syndrome;Influenza;Influenza viral infections;MILD;RECOVERED
Adverse Event|General system disorders NEC|Energy increased;Energy increased;General signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Abnormal touch sensation;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Legs restless;Restless legs syndrome;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|CHROMIUM PICOLINATE|NULL;NULL;NULL
Concomitant Medication|DEHYDROEPIANDROSTERONE|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis;Cellulitis;Bacterial infections NEC;Mild;NULL
Concomitant Medication|BACLOFEN|20;BID (twice a day);PEG
Concomitant Medication|COLACE|100;BID (twice a day);PEG
Concomitant Medication|FENTANYL|100;QD (every day);Topical
Concomitant Medication|KEFLEX|250;QID (four times a day);Oral
Concomitant Medication|LEVSIN|0.125;TID (three times a day);Oral
Concomitant Medication|LEVSIN|0.125;TID (three times a day);PEG
Concomitant Medication|RILUTEK|50;BID (twice a day);PEG
Concomitant Medication|VITAMIN E|1000;QD (every day);PEG
Adverse Event|Neurological disorders NEC|Clonus;Clonus;Neurological signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Finger cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular neuromuscular disorders|Eyelid twitching;Blepharospasm;Eyelid movement disorders;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Injury to finger NOS;Limb injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menstrual cramp;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Thoracogenic scoliosis;Scoliosis;Spine and neck deformities;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Nearsighted;Myopia;Refractive and accommodative disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Nervous system neoplasms malignant and unspecified NEC|Secretory adenoma of pituitary;Secretory adenoma of pituitary;Nervous system neoplasms unspecified malignancy NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Clonus;Clonus;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Sinus pressure;Sinus headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;MODERATE;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Spinal cord and nerve root disorders|Cervicobrachialgia;Cervical root pain;Cervical spinal cord and nerve root disorders;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ADALAT|NULL;NULL;NULL
Concomitant Medication|ADANCOR|NULL;NULL;NULL
Concomitant Medication|CATALGINE|NULL;NULL;NULL
Concomitant Medication|FLOXYFRAL|NULL;NULL;NULL
Concomitant Medication|HUMORYL|NULL;NULL;NULL
Concomitant Medication|NATISPRAY|NULL;NULL;NULL
Concomitant Medication|NOROXIN|NULL;NULL;NULL
Concomitant Medication|PHYSIOSTAT|NULL;NULL;NULL
Concomitant Medication|RISORDAN|NULL;NULL;NULL
Concomitant Medication|SECTRAL|NULL;NULL;NULL
Adverse Event|Injuries NEC|Falling;Fall;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Peripheral vertigo, unspecified;Vertigo;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Hypertonus;Hypertonia;Muscle tone abnormal;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Bacteremia;Bacteraemia;Sepsis, bacteraemia, viraemia and fungaemia NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Queasy;Nausea;Nausea and vomiting symptoms;MODERATE;RECOVERED
Concomitant Medication|ACERCOMP|NULL;NULL;NULL
Concomitant Medication|DOXAZOSIN MESILATE|NULL;NULL;NULL
Concomitant Medication|LEVOTHYROXINE SODIUM|NULL;NULL;NULL
Concomitant Medication|LORZAAR PLUS|NULL;NULL;NULL
Concomitant Medication|METOCLOPRAMID|NULL;NULL;NULL
Concomitant Medication|MOXONIDIN|NULL;NULL;NULL
Concomitant Medication|VERAPAMIL HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Bradykinesia;Bradykinesia;Dyskinesias and movement disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Epigastric distress;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Fecal impaction;Faecaloma;Faecal abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Throat irritation;Throat irritation;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Reflux gastritis;Reflux gastritis;Gastritis (excl infective);SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CARAFATE|NULL;NULL;NULL
Concomitant Medication|MINERAL OIL|NULL;NULL;NULL
Concomitant Medication|PHAZYME|NULL;NULL;NULL
Concomitant Medication|PHILLIPS|NULL;NULL;NULL
Concomitant Medication|SIMETHICONE|NULL;NULL;NULL
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;Mild;Continuing
Adverse Event|General system disorders NEC|Sensation of warmth;Feeling hot;Feelings and sensations NEC;Mild;         .
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Moderate;NULL
Adverse Event|Angioedema and urticaria|Hives;Urticaria;Urticarias;Mild;NULL
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Concomitant Medication|ATIVAN|.5;TID (three times a day);Oral
Concomitant Medication|BENADRYL|50;1 time only;Oral
Concomitant Medication|CALTRATE|600;BID (twice a day);Oral
Concomitant Medication|CLARITIN|10;PRN (as needed);Oral
Concomitant Medication|FIBERCON|1;QD (every day);Oral
Concomitant Medication|FISH OIL|1;QD (every day);Oral
Concomitant Medication|METAMUCIL|1;Every morning;Oral
Concomitant Medication|PEPCID AC|10;PRN (as needed);Oral
Concomitant Medication|TYLENOL PM|1;QHS (at bedtime);Oral
Concomitant Medication|VITAMIN B12|250;QD (every day);Oral
Concomitant Medication|ZOLOFT|50;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Chest cold;Lower respiratory tract infection;Lower respiratory tract and lung infections;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;Moderate;NULL
Adverse Event|Body temperature conditions|Slight fever;Pyrexia;Febrile disorders;Mild;NULL
Concomitant Medication|COMPAZINE|10;QD (every day);Oral
Concomitant Medication|CORAL CALCIUM|3;PRN (as needed);Oral
Concomitant Medication|MORPHINE|100;QHS (at bedtime);Oral
Concomitant Medication|MORPHINE|30;QD (every day);Oral
Concomitant Medication|MORPHINE|60;QD (every day);Oral
Concomitant Medication|ORTHO TRI-CYCLEN|1;QD (every day);Oral
Concomitant Medication|RESTORIL|60;QHS (at bedtime);Oral
Concomitant Medication|SENOKOT|2;BID (twice a day);Oral
Concomitant Medication|ZANTAC|150;BID (twice a day);Oral
Adverse Event|Cardiac arrhythmias|Atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Bacterial infection;Bacterial infection;Bacterial infections NEC;SEVERE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Carpal tunnel syndrome;Carpal tunnel syndrome;Mononeuropathies;MILD;RECOVERED
Adverse Event|Physical examination topics|Diminished lung sounds;Breath sounds abnormal;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Fear;Fear;Fear symptoms and phobic disorders (incl social phobia);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Catheter infection;Catheter related infection;Infections NEC;SEVERE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ringing in ears;Tinnitus;Inner ear signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);SEVERE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Shakiness;Tremor;Tremor (excl congenital);MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|GOLDEN SEAL|NULL;NULL;NULL
Concomitant Medication|PYCNOGENOL|NULL;NULL;NULL
Concomitant Medication|TRIHEXYPHENIDYL|NULL;NULL;NULL
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disorder;Gastrointestinal disorder;Gastrointestinal disorders NEC;Moderate;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menses irregular;Menstruation irregular;Menstruation and uterine bleeding NEC;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Lower abdominal pain;Abdominal pain lower;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;Mild;NULL
Concomitant Medication|AFRIN|1;PRN (as needed);Inhalation
Adverse Event|Cardiac arrhythmias|Paroxysmal atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;Marked;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Mild;NULL
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;Marked;NULL
Concomitant Medication|LOPRESSOR|50;QD (every day);Intravenous
Concomitant Medication|LOVENOX|100;BID (twice a day);Subcutaneous
Concomitant Medication|METOPROLOL|25;QD (every day);Oral
Concomitant Medication|MONOPRIL-HCT|20/12.5;QD (every day);Oral
Concomitant Medication|NEUROTIN|300;QD (every day);Oral
Concomitant Medication|PAXIL|20;QD (every day);Oral
Concomitant Medication|VASOTEC|5;QD (every day);Oral
Concomitant Medication|WARFARIN|5;QD (every day);Oral
Concomitant Medication|WARFARIN|2.5;QD (every day);Oral
Concomitant Medication|MSM|2;QD (every day);Oral
Concomitant Medication|AMOXICILLIN|500;BID (twice a day);Oral
Concomitant Medication|PNEUMOVAX|1;;Intramuscular
Adverse Event|Infections - pathogen unspecified|Acute bronchitis;Bronchitis;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Subluxation;Joint dislocation;Fractures and dislocations NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Wrist pain;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|HYPERIUM|NULL;NULL;NULL
Concomitant Medication|KETUM|NULL;NULL;NULL
Concomitant Medication|ODRIK|NULL;NULL;NULL
Concomitant Medication|SOFRAMYCINE|NULL;NULL;NULL
Concomitant Medication|SOLU-MEDROL|NULL;NULL;NULL
Concomitant Medication|UTROGESTAN|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Gait instability;Gait disturbance;Gait disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sore feet;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Blister;Blister;Bullous conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of lower extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Earache;Ear pain;Ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;SEVERE;RECOVERED
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Yawning excessive;Yawning;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Yawning excessive;Yawning;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Yawning excessive;Yawning;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Grunting;Grunting;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Patella fracture;Patella fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Mood swings;Mood swings;Fluctuating mood symptoms;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Mood swings;Mood swings;Fluctuating mood symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Mood disorders and disturbances NEC|Mood swings;Mood swings;Fluctuating mood symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Discomfort;Discomfort;Pain and discomfort NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Hepatic enzymes increased;Hepatic enzyme increased;Liver function analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|PREPARATION H|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension worsened;Hypertension;Vascular hypertensive disorders NEC;Mild;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Concomitant Medication|TOCO|500;;Oral
Concomitant Medication|AMBROTOSE|NULL;NULL;NULL
Concomitant Medication|GRAPE SEED|NULL;NULL;NULL
Adverse Event|Injuries NEC|Face injury;Face injury;Site specific injuries NEC;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Gum swelling;Gingival swelling;Oral soft tissue swelling and oedema;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Haematuria;Haematuria;Urinary abnormalities;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Haematuria;Haematuria;Urinary abnormalities;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Low platelets;Platelet count decreased;Platelet analyses;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Axillary pain;Axillary pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Thrush vaginal;Vulvovaginal candidiasis;Candida infections;MILD;RECOVERED
Concomitant Medication|CICATRIN|NULL;NULL;NULL
Concomitant Medication|CO-FLUAMPICIL|NULL;NULL;NULL
Concomitant Medication|FLOXAPEN|NULL;NULL;NULL
Concomitant Medication|SPORANOX|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Near syncope;Presyncope;Neurological signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|DARVOCET-N|NULL;NULL;NULL
Concomitant Medication|DARVON|NULL;NULL;NULL
Concomitant Medication|NICODERM|NULL;NULL;NULL
Concomitant Medication|VANCOMYCIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema of legs;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fibula fracture;Fibula fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Calcium low;Blood calcium decreased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|ANTABUSE|NULL;NULL;NULL
Concomitant Medication|DEPAKOTE|NULL;NULL;NULL
Concomitant Medication|LEVOQUIN|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Erythematous rash;Rash erythematous;Erythemas;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Uncontrollable crying;Crying;Neurological signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|METHYLPREDNISOLONE ACETATE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Pyrosis;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ACETYLSALICYLZUUR|NULL;NULL;NULL
Concomitant Medication|PREZAL|NULL;NULL;NULL
Concomitant Medication|SELOKEEN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Lipid analyses|Blood cholesterol increased;Blood cholesterol increased;Cholesterol analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Migraine;Migraine;Migraine headaches;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Respiratory tract infection viral;Respiratory tract infection viral;Viral infections NEC;MILD;RECOVERED
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMILORIDE W/HYDROCHLOROTHIAZIDE|NULL;NULL;NULL
Concomitant Medication|AUXINA E|NULL;NULL;NULL
Concomitant Medication|CIPROTERONA + ETINILESTRADIOL|NULL;NULL;NULL
Concomitant Medication|KETOROLACO|NULL;NULL;NULL
Concomitant Medication|L CARNITINE|NULL;NULL;NULL
Concomitant Medication|NABUMETONA|NULL;NULL;NULL
Concomitant Medication|SUMATRIPTAN|NULL;NULL;NULL
Adverse Event|Vascular haemorrhagic disorders|Hematoma;Haematoma;Haemorrhages NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Inner ear infection;Labyrinthitis;Ear infections;MILD;RECOVERED
Adverse Event|Muscle disorders|Night cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Numbness lips;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Concomitant Medication|ASTELIN|NULL;NULL;NULL
Concomitant Medication|FLURBIPROFEN|NULL;NULL;NULL
Concomitant Medication|PROVENTIL HFA|NULL;NULL;NULL
Concomitant Medication|SODIUM BICARBONATE|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Resolved
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Resolved
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Severe;Resolved
Concomitant Medication|HYOSCYAMINE SULFATE|NULL;NULL;NULL
Adverse Event|Mood disorders and disturbances NEC|Affect lability;Affect lability;Affect alterations NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Digestion impaired;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|Dental and gingival conditions|Tooth discoloration;Tooth discolouration;Dental surface disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|GLANDOSANE|NULL;NULL;NULL
Concomitant Medication|NATRIUMPICOSULFAT|NULL;NULL;NULL
Concomitant Medication|PANZYTRAT|NULL;NULL;NULL
Concomitant Medication|PYRIDOSTIGMINE BROMIDE|NULL;NULL;NULL
Concomitant Medication|TEBONIN|NULL;NULL;NULL
Concomitant Medication|TROMCARDIN|NULL;NULL;NULL
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hypoglycemic episode;Hypoglycaemia;Hypoglycaemic conditions NEC;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine increased;Glucose urine present;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Generalized rash;Rash generalised;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Vaginal yeast infection;Vulvovaginal mycotic infection;Fungal infections NEC;MILD;RECOVERED
Concomitant Medication|AMOXICILLIN CLAVULANIC ACID|NULL;NULL;NULL
Concomitant Medication|INFLUENZA VIRUS VACCINE POLYVAL.|NULL;NULL;NULL
Concomitant Medication|MONISTAT|NULL;NULL;NULL
Concomitant Medication|OMEGA 3|NULL;NULL;NULL
Concomitant Medication|SOYA LECITHIN|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Camptocormia;Camptocormia;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Exhaustion;Fatigue;Asthenic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Vascular haemorrhagic disorders|Haematoma;Haematoma;Haemorrhages NEC;MODERATE;RECOVERED
Adverse Event|Lymphatic vessel disorders|Lymphedema;Lymphoedema;Lymphoedemas;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Aphagia;Aphagia;Gastrointestinal signs and symptoms NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory tract therapeutic procedures|Tracheostomy;Tracheostomy;Tracheal therapeutic procedures;SEVERE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|DICLOFENAC|75;PRN (as needed);Oral
Concomitant Medication|FLUOXETIN|20;QD (every day);Oral
Concomitant Medication|FLUOXETIN|40;BID (twice a day);Oral
Concomitant Medication|FLUOXETIN|60;BID (twice a day);Oral
Concomitant Medication|LEVOTHYROXINE|50;QD (every day);Oral
Concomitant Medication|TOLPERISONE|300;BID (twice a day);Oral
Concomitant Medication|AMITRIPTYLINE|125;TID (three times a day);Other (specify)
Concomitant Medication|CIPROFLOXACIN|500;BID (twice a day);Other (specify)
Concomitant Medication|CODEINE|30;TID (three times a day);Oral
Concomitant Medication|SORMODREN|12;TID (three times a day);Oral
Concomitant Medication|TOLPERISONE|150;QD (every day);Oral
Concomitant Medication|UNACID|UNK;BID (twice a day);Intravenous
Lab Test|Urine Protein|1+
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;Mild;NULL
Concomitant Medication|KERATIN|3;QD (every day);Oral
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Radius fracture;Radius fracture;Upper limb fractures and dislocations;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Arm fracture;Upper limb fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ALOE|NULL;NULL;NULL
Concomitant Medication|ARMOUR THYROID|NULL;NULL;NULL
Concomitant Medication|CALAMINE|NULL;NULL;NULL
Concomitant Medication|DMPS|NULL;NULL;NULL
Concomitant Medication|KAVA|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM TARTRATE|NULL;NULL;NULL
Concomitant Medication|ROXICET|NULL;NULL;NULL
Concomitant Medication|VITAPLEX|NULL;NULL;NULL
Concomitant Medication|WILD CHERRY BARK|NULL;NULL;NULL
Concomitant Medication|COENZYME Q10|120;QD (every day);Oral
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Flu symptoms;Influenza;Influenza viral infections;MILD;RECOVERED
Adverse Event|Lipid analyses|Triglycerides high;Blood triglycerides increased;Triglyceride analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Triglycerides high;Blood triglycerides increased;Triglyceride analyses;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Ankle injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Concomitant Medication|CHILDREN'S DIMETAPP COLD & ALLERGY|NULL;NULL;NULL
Concomitant Medication|DIMETAPP ALLERGY|NULL;NULL;NULL
Adverse Event|Muscle disorders|Weakness in extremity;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Neuropathy;Neuropathy peripheral;Peripheral neuropathies NEC;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Neuropathy;Neuropathy peripheral;Peripheral neuropathies NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Weakness in extremity;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Catheter site cellulitis;Catheter site cellulitis;Bacterial infections NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Drunkenness feeling of;Feeling drunk;Feelings and sensations NEC;SEVERE;RECOVERED
Adverse Event|White blood cell disorders|Eosinophilia;Eosinophilia;Eosinophilic disorders;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritus facial;Pruritus;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Folliculitis;Folliculitis;Bacterial infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal infection;Fungal infection;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;SEVERE;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flushes;Hot flush;Peripheral vascular disorders NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Concomitant Medication|APAP CODEINE|NULL;NULL;NULL
Concomitant Medication|CIPROHEPTADINA|NULL;NULL;NULL
Concomitant Medication|DANTROLENE|NULL;NULL;NULL
Concomitant Medication|LOBELINA|NULL;NULL;NULL
Adverse Event|Joint disorders|Knee arthritis;Arthritis;Arthropathies NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gallbladder disorders|Cholecystitis;Cholecystitis;Cholecystitis and cholelithiasis;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|PERCODAN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;Mild;NULL
Concomitant Medication|ACETAMINOPHEN|500;PRN (as needed);Oral
Concomitant Medication|COENZYME Q10|50;TID (three times a day);Oral
Concomitant Medication|DESOWEN|0.05;PRN (as needed);Topical
Concomitant Medication|DESOWEN|0.05;BID (twice a day);Topical
Concomitant Medication|EFFEXOR|225;QD (every day);Oral
Concomitant Medication|MELATONIN|15;PRN (as needed);Oral
Concomitant Medication|MELATONIN|6-12;QHS (at bedtime);Oral
Concomitant Medication|MYLANTA|2-4;PRN (as needed);Oral
Concomitant Medication|PSEUDOEPHEDRINE|30;PRN (as needed);Oral
Concomitant Medication|QUININE SULFATE|325;PRN (as needed);Oral
Concomitant Medication|ROLAIDS|2-4;PRN (as needed);Oral
Concomitant Medication|TYLENOL SINUS|1-2;PRN (as needed);Oral
Adverse Event|Vision disorders|Visual impairment;Visual impairment;Visual disorders NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|AVOMINE|NULL;NULL;NULL
Concomitant Medication|DAYQUIL|NULL;NULL;NULL
Concomitant Medication|OCCUFLOXIN|NULL;NULL;NULL
Concomitant Medication|VEXOL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff fingers;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Energy decreased;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergic reaction;Hypersensitivity;Allergic conditions NEC;MODERATE;RECOVERED
Concomitant Medication|ADVIL COLD & SINUS|NULL;NULL;NULL
Concomitant Medication|HERBAL PREPARATION|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chest ache;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Chest tightness;Chest discomfort;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Electric shock sensation;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Generalized joint pain;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Palpitations;Palpitations;Cardiac signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Presyncope;Presyncope;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruising;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Breathing difficult;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Shakiness;Tremor;Tremor (excl congenital);MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Skipped beats;Extrasystoles;Rate and rhythm disorders NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stools hard;Faeces hard;Faecal abnormalities NEC;MILD;RECOVERED
Concomitant Medication|FIORINAL WITH CODEINE|NULL;NULL;NULL
Adverse Event|Bone disorders (excl congenital and fractures)|Osteoporosis;Osteoporosis;Metabolic bone disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;MILD;RECOVERED
Concomitant Medication|ACETYLSALICYLIC ACID|1000;QD (every day);Oral
Concomitant Medication|ACETYLSALICYLIC ACID|250;QD (every day);Oral
Concomitant Medication|CLONAZEPAM|5;QD (every day);Oral
Concomitant Medication|CYCLO 3 FORT|2;QD (every day);Oral
Concomitant Medication|D-ALPHA TOCOPHEROL|1000;BID (twice a day);Oral
Concomitant Medication|ENOXAPARIN|0.4;QD (every day);Subcutaneous
Concomitant Medication|GLIMEPIRIDE|4;QD (every day);Oral
Concomitant Medication|GLIMEPIRIDE|6;QD (every day);Oral
Concomitant Medication|IDEOS|500;QD (every day);Oral
Concomitant Medication|METFORMIN EMBONATE|1400;BID (twice a day);Oral
Concomitant Medication|PARACETAMOL|3;TID (three times a day);Oral
Concomitant Medication|PHOLCODINE|3;TID (three times a day);Oral
Concomitant Medication|TROSPIUM CHLORIDE|40;QD (every day);Oral
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Severe;NULL
Adverse Event|Eye disorders NEC|Tearing decreased;Lacrimation decreased;Lacrimal disorders;Moderate;NULL
Concomitant Medication|SCOPODERM|NA;Other (specify);Transdermal
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Gastrointestinal therapeutic procedures|Inguinal hernia repair;Inguinal hernia repair;Hernia repairs;MODERATE;RECOVERED
Adverse Event|Joint disorders|Periarthritis scapulohumeralis;Periarthritis;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ARTOTEC|NULL;NULL;NULL
Concomitant Medication|DIAMICRON|NULL;NULL;NULL
Concomitant Medication|ELISOR|NULL;NULL;NULL
Concomitant Medication|GLUCOR|NULL;NULL;NULL
Concomitant Medication|LODALES|NULL;NULL;NULL
Concomitant Medication|TILCOTIL|NULL;NULL;NULL
Adverse Event|Lipid analyses|Cholesterol levels raised;Blood cholesterol increased;Cholesterol analyses;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Clonus of limbs;Clonus;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Tendon, ligament and cartilage disorders|Tendinous contracture;Tendinous contracture;Tendon disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Felt faint;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Flu-like symptoms;Influenza like illness;General signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);MILD;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Shingles;Herpes zoster;Herpes viral infections;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|CONJUGATED LINOLEIC ACID|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;MODERATE;RECOVERED
Adverse Event|Mental impairment disorders|Loss of memory;Amnesia;Memory loss (excl dementia);MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Benign shuddering attacks;Extrapyramidal disorder;Dyskinesias and movement disorders NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ACENOCUMAROL|NULL;NULL;NULL
Concomitant Medication|LOPERAMIDA|NULL;NULL;NULL
Concomitant Medication|NICERGOLINE|NULL;NULL;NULL
Concomitant Medication|PHENOBARBITAL|NULL;NULL;NULL
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;Moderate;NULL
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Adverse Event|Myocardial disorders|Left atrial enlargement;Left atrial dilatation;Myocardial disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Nightmares;Nightmare;Parasomnias;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Excess sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Anaemias nonhaemolytic and marrow depression|Normocytic anaemia;Normochromic normocytic anaemia;Anaemias NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Hips osteoarthritis;Osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Sensation of heat;Feeling hot;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Body temperature increased;Body temperature increased;Physical examination procedures;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhoea;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Viral infection;Viral infection;Viral infections NEC;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Viral upper respiratory tract infection;Viral upper respiratory tract infection;Viral infections NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Pins and needles;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Sodium increased;Blood sodium increased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in leg;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|FEMATRIX|NULL;NULL;NULL
Adverse Event|Vision disorders|Visual acuity decreased;Visual acuity reduced;Partial vision loss;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Creatinine decreased;Blood creatinine decreased;Renal function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Calcium increased;Blood calcium increased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;SEVERE;RECOVERED
Adverse Event|Viral infectious disorders|Herpes on lip;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Herpes on lip;Oral herpes;Herpes viral infections;MODERATE;RECOVERED
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eyes stinging;Eye pain;Ocular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezing expiratory;Wheezing;Bronchospasm and obstruction;MILD;RECOVERED
Adverse Event|Anal and rectal conditions NEC|Rectal prolapse;Rectal prolapse;Anal and rectal disorders NEC;MILD;RECOVERED
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|CEFPODOXIME|NULL;NULL;NULL
Concomitant Medication|CEPHALEX|NULL;NULL;NULL
Concomitant Medication|GUAIFEN-C|NULL;NULL;NULL
Concomitant Medication|HYDROCODEINE|NULL;NULL;NULL
Concomitant Medication|PHRENILIN|NULL;NULL;NULL
Concomitant Medication|BETACAROTENE|10000;TID (three times a day);Oral
Concomitant Medication|IMODIUM|2;PRN (as needed);Oral
Concomitant Medication|QUININE|260;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|1000;TID (three times a day);Oral
Concomitant Medication|XANAX|5;PRN (as needed);Oral
Concomitant Medication|ZESTRIL|10;QD (every day);Oral
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Cellulitis of leg;Cellulitis;Bacterial infections NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Bacterial infectious disorders|Staphylococcal infection;Staphylococcal infection;Staphylococcal infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff neck;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;MODERATE;RECOVERED
Concomitant Medication|CALCIUM GLUCONATE|NULL;NULL;NULL
Concomitant Medication|DEXTROSE W/POTASSIUM CHLORIDE|NULL;NULL;NULL
Concomitant Medication|ENEMAS|NULL;NULL;NULL
Concomitant Medication|ETOMIDATE|NULL;NULL;NULL
Concomitant Medication|NEUTRA-PHOS|NULL;NULL;NULL
Concomitant Medication|VECURONIUM|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ear buzzing;Tinnitus;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness in feet;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Suffocation feeling;Suffocation feeling;Respiratory signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal foot infection;Tinea pedis;Tinea infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary edema;Pulmonary oedema;Pulmonary oedemas;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CORICIDIN D|NULL;NULL;NULL
Concomitant Medication|K-DUR|NULL;NULL;NULL
Concomitant Medication|LOTRISONE|NULL;NULL;NULL
Concomitant Medication|NIZORAL|NULL;NULL;NULL
Concomitant Medication|ORGANIDIN NR|NULL;NULL;NULL
Concomitant Medication|RELIVE|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Candidiasis of mouth;Oral candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Type II diabetes mellitus;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Flank pain;Flank pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|ANALGESICS|NULL;NULL;NULL
Concomitant Medication|BELLADONNA EXTRACT|NULL;NULL;NULL
Concomitant Medication|FLUCONAZOL|NULL;NULL;NULL
Concomitant Medication|LEVOMEPROMAZINE|NULL;NULL;NULL
Concomitant Medication|SACCHAROMYCES BOULARDII|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;Mild;NULL
Adverse Event|Injuries NEC|Bruise of head;Contusion;Skin injuries NEC;Mild;NULL
Adverse Event|Eye disorders NEC|Eyes tearing;Lacrimation increased;Lacrimal disorders;Mild;NULL
Adverse Event|Respiratory disorders NEC|Itchy throat;Throat irritation;Upper respiratory tract signs and symptoms;Mild;NULL
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;Moderate;NULL
Adverse Event|Oral soft tissue conditions|Sores mouth;Stomatitis;Stomatitis and ulceration;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Skin appendage conditions|Sweating increased;Hyperhidrosis;Apocrine and eccrine gland disorders;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Skin colouring yellow;Yellow skin;Dermal and epidermal conditions NEC;Mild;NULL
Concomitant Medication|ATP|U;BID (twice a day);Oral
Concomitant Medication|AMBIEN|15;QHS (at bedtime);Oral
Concomitant Medication|AMBIEN|20;QHS (at bedtime);Oral
Concomitant Medication|AMBIEN|40-60;QHS (at bedtime);Oral
Concomitant Medication|AMBIEN|60;QHS (at bedtime);Oral
Concomitant Medication|B12|2;QD (every day);Oral
Concomitant Medication|B12|5;QD (every day);Sublingual
Concomitant Medication|BACLOFEN|20;TID (three times a day);Oral
Concomitant Medication|BENADRYL|25-50;PRN (as needed);Oral
Concomitant Medication|BIOTENE|150;BID (twice a day);Oral
Concomitant Medication|CHLORPROMAZINE|25;QHS (at bedtime);Oral
Concomitant Medication|COENZYME Q10|2000;QD (every day);Oral
Concomitant Medication|COENZYME Q10|2800;QD (every day);Oral
Concomitant Medication|COENZYME Q10|3200;QD (every day);Oral
Concomitant Medication|COENZYME Q10|1200;QD (every day);Oral
Concomitant Medication|NUEDEXTA|30/30;QD (every day);Oral
Concomitant Medication|FISH OIL|U;BID (twice a day);Oral
Concomitant Medication|FLAXSEED OIL|1000;BID (twice a day);Oral
Concomitant Medication|FLONASE|50;PRN (as needed);Intranasal
Concomitant Medication|GARLIC|650;QD (every day);Oral
Concomitant Medication|HYDROXYZINE|25;PRN (as needed);Oral
Concomitant Medication|LIDOCAINE HYDROCHLORIDE|20;QD (every day);Subcutaneous
Concomitant Medication|MAGNESIUM|250;QD (every day);Oral
Concomitant Medication|MELATONIN|400;QHS (at bedtime);Oral
Concomitant Medication|NADH|U;BID (twice a day);Oral
Concomitant Medication|NORTRIPTYLINE|10;QD (every day);Oral
Concomitant Medication|NORTRIPTYLINE|20;QD (every day);Oral
Concomitant Medication|GRAPE SEED|100;BID (twice a day);Oral
Concomitant Medication|PHENYLEPHRINE HYDROCHLORIDE|1;PRN (as needed);Intranasal
Concomitant Medication|PROPOXYPHENE N/APAP|100/650;PRN (as needed);Oral
Concomitant Medication|QUININE|200;QHS (at bedtime);Oral
Concomitant Medication|SAM-E|2;QD (every day);Oral
Concomitant Medication|SELENIUM|200;QD (every day);Oral
Concomitant Medication|SENNA|0-8.6;PRN (as needed);Oral
Concomitant Medication|SKELAXIN|400;PRN (as needed);Oral
Concomitant Medication|TRIAMCINOLONE|0.1;PRN (as needed);Topical
Concomitant Medication|TUMS|500;PRN (as needed);Oral
Concomitant Medication|TYLENOL PM|500;PRN (as needed);Oral
Concomitant Medication|VALTREX|1;BID (twice a day);Oral
Concomitant Medication|OLIVE LEAVES EXTRACT|1;BID (twice a day);Oral
Concomitant Medication|PSEUDOEPHEDRINE|30;;Oral
Adverse Event|Gastrointestinal signs and symptoms|Epigastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Rhinopharyngitis;Nasopharyngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Mild;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Moderate;Continuing
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids aggravated;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Moderate;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Mild;Continuing
Concomitant Medication|ACETAMINOPHEN W/OXYCODONE|NULL;NULL;NULL
Concomitant Medication|GINKO|NULL;NULL;NULL
Concomitant Medication|MEDROXYPROGESTERONE ACETATE|NULL;NULL;NULL
Concomitant Medication|PROPOXYPHENE AND ACETAMINOPHEN|NULL;NULL;NULL
Concomitant Medication|URIMAX|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|RBC urine;Red blood cells urine;Urinalysis NEC;MILD;RECOVERED
Concomitant Medication|DEXTROMETHORPHAN|NULL;NULL;NULL
Concomitant Medication|DICYCLOMINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|MYOFLEX|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in upper extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|Creatine kinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Tendon, ligament and cartilage disorders|Tendinitis;Tendonitis;Tendon disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CYCLO 3 FORT|NULL;NULL;NULL
Concomitant Medication|DUPHASTON|NULL;NULL;NULL
Concomitant Medication|EFFERALGAN CODEINE|NULL;NULL;NULL
Concomitant Medication|FELDENE|NULL;NULL;NULL
Concomitant Medication|PARALYOC|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Muscle spasticity aggravated;Muscle spasticity;Neuromuscular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|CYCLOBENZAPRINE|NULL;NULL;NULL
Concomitant Medication|MICONAZOLE NITRATE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervical pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;Severe;NULL
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;Mild;NULL
Concomitant Medication|DOLIPRANE|PRN;PRN (as needed);Oral
Concomitant Medication|FRAGMIN|2500;;Subcutaneous
Concomitant Medication|IXPRIM|1;;Oral
Concomitant Medication|IXPRIM|75/750;PRN (as needed);Oral
Concomitant Medication|IXPRIM|PRN;PRN (as needed);Oral
Concomitant Medication|TORENTAL|1;;Oral
Adverse Event|Gastrointestinal signs and symptoms|Epigastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands & feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramp of limb;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysaesthesia extremity;Dysaesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Laryngitis;Laryngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Hypaesthesia;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Raynaud's syndrome;Raynaud's phenomenon;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of limbs;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;SEVERE;RECOVERED
Adverse Event|Joint disorders|Jaw stiffness;Joint stiffness;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|LIMPTAR|NULL;NULL;NULL
Concomitant Medication|YPSILOHEEL|NULL;NULL;NULL
Adverse Event|Menopause and related conditions|Hot flushes menopausal;Menopausal symptoms;Menopausal effects NEC;MILD;RECOVERED
Adverse Event|Myocardial disorders|Left ventricular hypertrophy;Left ventricular hypertrophy;Myocardial disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Mouth ulcer;Mouth ulceration;Stomatitis and ulceration;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Mouth ulcer;Mouth ulceration;Stomatitis and ulceration;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Penicillin allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|AURUM|NULL;NULL;NULL
Concomitant Medication|GLONOINUM|NULL;NULL;NULL
Concomitant Medication|L-THREONINE|NULL;NULL;NULL
Concomitant Medication|MAGNESIOCARD|NULL;NULL;NULL
Concomitant Medication|SALVIA|NULL;NULL;NULL
Concomitant Medication|SULFUR|NULL;NULL;NULL
Lab Test|Urine Mucus|Trace
Adverse Event|Hepatobiliary investigations|Bilirubin elevated;Blood bilirubin increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Renal calculi;Nephrolithiasis;Renal lithiasis;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Ankle osteoarthritis;Osteoarthritis;Osteoarthropathies;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Exanthema facial;Rash;Rashes, eruptions and exanthems NEC;Mild;NULL
Adverse Event|Viral infectious disorders|Herpes labialis;Oral herpes;Herpes viral infections;Mild;NULL
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Allergic conditions|Pollinosis;Seasonal allergy;Atopic disorders;Moderate;NULL
Concomitant Medication|MAGNESIUM|NK;QD (every day);Oral
Adverse Event|Neurological disorders NEC|Taste garlic;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|THERAFLU|NULL;NULL;NULL
Concomitant Medication|BECLOVENT|NULL;NULL;NULL
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract;Cataract;Cataract conditions;Mild;NULL
Adverse Event|Renal disorders (excl nephropathies)|Renal insufficiency;Renal failure;Renal failure and impairment;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Moderate;NULL
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Moderate;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension worsened;Hypertension;Vascular hypertensive disorders NEC;Moderate;NULL
Concomitant Medication|LIORESAL|1;;Oral
Adverse Event|Skin appendage conditions|Night sweat;Night sweats;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Allergic skin reaction;Dermatitis allergic;Dermatitis and eczema;MILD;UNKNOWN
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|DEXAMETHASONE|NULL;NULL;NULL
Concomitant Medication|FLAVOXATE|NULL;NULL;NULL
Concomitant Medication|FLUTAMIDE|NULL;NULL;NULL
Concomitant Medication|METAMIZOL|NULL;NULL;NULL
Concomitant Medication|MORPHIN|NULL;NULL;NULL
Concomitant Medication|PIROXICAM|NULL;NULL;NULL
Concomitant Medication|PREDNISOLONE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Allergic skin reaction;Dermatitis allergic;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|AKATINOL|NULL;NULL;NULL
Concomitant Medication|CEFOTIAM|NULL;NULL;NULL
Concomitant Medication|COLESTID|7.5;QD (every day);Oral
Concomitant Medication|DRIXORAL|6;BID (twice a day);Oral
Concomitant Medication|FISH OIL|800;QD (every day);Oral
Concomitant Medication|QUININE|300;QD (every day);Oral
Concomitant Medication|ZOCOR|10;QD (every day);Oral
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|HISTINEX DM|NULL;NULL;NULL
Concomitant Medication|L-LYSINE|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Perspiration excessive;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse rate increased;Heart rate increased;Heart rate and pulse investigations;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Allergic respiratory symptom;Allergic respiratory symptom;Respiratory signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dermatitis herpetiformis;Dermatitis herpetiformis;Bullous conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Nocturnal diarrhea;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|DAPSONE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured metacarpal;Hand fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin discoloration;Skin discolouration;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Nerve pain;Neuralgia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Mild;NULL
Adverse Event|Joint disorders|Pain in joint involving shoulder region;Arthralgia;Joint related signs and symptoms;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Pyoderma;Pyoderma;Skin structures and soft tissue infections;Mild;NULL
Concomitant Medication|CEPHALEXIN|250;QID (four times a day);Oral
Concomitant Medication|CREATINE|700;QD (every day);Oral
Concomitant Medication|DHEA|25;QD (every day);Oral
Concomitant Medication|TYLENOL|1;QD (every day);Oral
Concomitant Medication|TYLENOL PM|2;PRN (as needed);Oral
Concomitant Medication|ZANTAC|75;PRN (as needed);Oral
Concomitant Medication|ARMOUR THYROID|90;QD (every day);Oral
Concomitant Medication|LOMOTIL|2;PRN (as needed);Oral
Concomitant Medication|LOMOTIL|2;QD (every day);Oral
Concomitant Medication|ULTRACET|2;PRN (as needed);Oral
Concomitant Medication|VICODIN|1;PRN (as needed);Oral
Concomitant Medication|WELLBUTRIN|150;BID (twice a day);Oral
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;Mild;NULL
Adverse Event|Headaches|Nocturnal headache;Headache;Headaches NEC;Mild;NULL
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;Moderate;NULL
Concomitant Medication|EQUANIL|400;;Oral
Concomitant Medication|HEXAQUINE|120;;Oral
Concomitant Medication|RILUZOLE|50;;Oral
Concomitant Medication|VITAMIN B1|32;;Oral
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;Moderate;NULL
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;Moderate;NULL
Adverse Event|Injuries NEC|Laceration of finger;Skin laceration;Skin injuries NEC;Moderate;NULL
Adverse Event|Injuries NEC|Contusion of hip;Contusion;Skin injuries NEC;Moderate;NULL
Concomitant Medication|COMTREX|1-2;PRN (as needed);Oral
Concomitant Medication|DURAGESIC|25;;Transdermal
Concomitant Medication|DURAGESIC|75;;Transdermal
Concomitant Medication|EX-LAX|2;PRN (as needed);Oral
Concomitant Medication|HYDROCODONE/APAP|500;PRN (as needed);Oral
Concomitant Medication|METHADONE|5;QD (every day);Oral
Concomitant Medication|ROBITUSSIN|1-2;PRN (as needed);Oral
Concomitant Medication|TETANUS VACCINE|one;1 time only;Intramuscular
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Neck cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Early morning awakening;Terminal insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Papule;Rash papular;Papulosquamous conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Taste metallic;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Viral gastroenteritis;Gastroenteritis viral;Viral infections NEC;MILD;RECOVERED
Adverse Event|Lipid analyses|Triglycerides high;Blood triglycerides increased;Triglyceride analyses;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ALKA-SELTZER PLUS COLD & SINUS|NULL;NULL;NULL
Concomitant Medication|COLLAGEN|NULL;NULL;NULL
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|NULL;NULL;NULL
Concomitant Medication|LOCAL ANESTHETICS|NULL;NULL;NULL
Concomitant Medication|LOMOTIL|NULL;NULL;NULL
Concomitant Medication|SKULLCAP|NULL;NULL;NULL
Concomitant Medication|VALRIAN|NULL;NULL;NULL
Concomitant Medication|ZINACEF|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal fullness;Abdominal distension;Flatulence, bloating and distension;Mild;NULL
Adverse Event|Respiratory disorders NEC|Hypoventilation;Hypoventilation;Breathing abnormalities;Mild;NULL
Adverse Event|Lymphatic vessel disorders|Lymphedema;Lymphoedema;Lymphoedemas;Moderate;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Mild;NULL
Adverse Event|General system disorders NEC|Oedema;Oedema;Oedema NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Hyperexcitation;Agitation;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Orthostatic hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PRAXILENE|NULL;NULL;NULL
Concomitant Medication|ZESTORETIC|NULL;NULL;NULL
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;Mild;NULL
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;Mild;NULL
Concomitant Medication|BISOLVON|8;;Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;Mild;NULL
Concomitant Medication|CALCIUM|1000;BID (twice a day);Oral
Concomitant Medication|HYDROCORTISONE|0.1;PRN (as needed);Topical
Concomitant Medication|MECLOZINE|25;QD (every day);Oral
Concomitant Medication|PRILOSEC|30;PRN (as needed);Oral
Concomitant Medication|VITAMIN D|1000;QD (every day);Oral
Concomitant Medication|VITAMIN E|500;BID (twice a day);Oral
Adverse Event|Epidermal and dermal conditions|Facial desquamation;Skin exfoliation;Exfoliative conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal therapeutic procedures|Colon polypectomy;Colon polypectomy;Large intestine therapeutic procedures;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal therapeutic procedures|Percutaneous endoscopic gastrostomy;Gastrostomy;Gastric therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Seborrheic eczema;Seborrhoeic dermatitis;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|HYDROCORTISONE ACETATE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Electric shock sensation;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Headaches|Headache aggravated;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain neck;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|NICOTINE|NULL;NULL;NULL
Concomitant Medication|PSYLLIUM HUSK|NULL;NULL;NULL
Adverse Event|Abdominal hernias and other abdominal wall conditions|Inguinal hernia;Inguinal hernia;Inguinal hernias;Mild;NULL
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;Mild;NULL
Concomitant Medication|INDOCID|1;;Oral
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heartbeats irregular;Heart rate irregular;Heart rate and pulse investigations;MILD;RECOVERED
Adverse Event|Hearing disorders|Hearing decreased;Hypoacusis;Hearing losses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Cervical disc degeneration;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dry throat;Dry throat;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heartbeats irregular;Heart rate irregular;Heart rate and pulse investigations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Myocardial disorders|Atrial hypertrophy;Atrial hypertrophy;Myocardial disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Liver function test abnormal;Liver function test abnormal;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal ulceration and perforation|Peptic ulcer;Peptic ulcer;Peptic ulcers and perforation;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|L-CARBOCYSTEINE|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram T wave inversion;Electrocardiogram T wave inversion;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Body temperature conditions|Slight fever;Pyrexia;Febrile disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ORAMORPH|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain lumbosacral;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Concomitant Medication|IMMUNOGLOBULIN|NULL;NULL;NULL
Lab Test|Urine Mucus|Large
Adverse Event|Epidermal and dermal conditions|Itchy rash;Rash pruritic;Pruritus NEC;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Itchy skin;Pruritus;Pruritus NEC;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;NULL;NULL
Concomitant Medication|TOTOLIN|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Epistaxis;Epistaxis;Nasal disorders NEC;Mild;Resolved
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);Mild;Resolved
Adverse Event|Breast disorders|Tenderness breast;Breast tenderness;Breast signs and symptoms;Mild;Resolved
Concomitant Medication|LEGATRIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Degenerative disc disease;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Coronary artery disorders|Anterior myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Lipid analyses|Triglycerides high;Blood triglycerides increased;Triglyceride analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin red;Erythema;Erythemas;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|EMPRACET|NULL;NULL;NULL
Concomitant Medication|INDOCID|NULL;NULL;NULL
Concomitant Medication|ROYAL JELLY|NULL;NULL;NULL
Adverse Event|Enzyme investigations NEC|CK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee osteoarthritis;Osteoarthritis;Osteoarthropathies;MODERATE;RECOVERED
Adverse Event|Ocular neuromuscular disorders|Ptosis of eyelid;Eyelid ptosis;Eyelid movement disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Swallowing disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALBURON|NULL;NULL;NULL
Concomitant Medication|ALMIDE|NULL;NULL;NULL
Concomitant Medication|ALVITYL|NULL;NULL;NULL
Concomitant Medication|AUXITRANS|NULL;NULL;NULL
Concomitant Medication|EDUCTYL|NULL;NULL;NULL
Concomitant Medication|MODOPAR|NULL;NULL;NULL
Concomitant Medication|PARAPSYLLIUM|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Liver function tests abnormal;Liver function test abnormal;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Aortic stenosis;Aortic stenosis;Aortic necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|Central nervous system vascular disorders|Transient ischemic attack;Transient ischaemic attack;Transient cerebrovascular events;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Myalgia of lower extremities;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Systolic ejection murmur;Cardiac murmur;Cardiac auscultatory investigations;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DIPROBASE|NULL;NULL;NULL
Concomitant Medication|TYLEX|NULL;NULL;NULL
Concomitant Medication|VOLTAROL|NULL;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Decreased white cell count;White blood cell count decreased;White blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Itchy rash;Rash pruritic;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|Bilirubin total abnormal;Blood bilirubin abnormal;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CALOMEL|NULL;NULL;NULL
Concomitant Medication|AMILORIDE|1;Three times per week;Oral
Concomitant Medication|QUAMATEL|1;PRN (as needed);Oral
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);Moderate;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;Mild;NULL
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Marked;NULL
Adverse Event|Breast disorders|Breast lump;Breast mass;Breast disorders NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Paresthesia;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Mild;NULL
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;Mild;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;Mild;NULL
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Moderate;NULL
Concomitant Medication|CITRICAL|NULL;NULL;NULL
Concomitant Medication|MIACALCIN|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngeal spasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;Moderate;NULL
Concomitant Medication|FORLAX|1;;Oral
Concomitant Medication|HEXAQUINE|1;;Oral
Concomitant Medication|LAROXYL|1;;Oral
Concomitant Medication|LIORESAL|2;;Oral
Adverse Event|Cardiac arrhythmias|Atrial flutter;Atrial flutter;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Cough increased;Cough;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|ECG abnormal;Electrocardiogram abnormal;ECG investigations;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|ECG abnormal;Electrocardiogram abnormal;ECG investigations;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;SEVERE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Anger;Anger;Emotional and mood disturbances NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;SEVERE;RECOVERED
Adverse Event|Cardiac arrhythmias|Left anterior fascicular block;Bundle branch block left;Cardiac conduction disorders;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Papular skin eruption;Rash papular;Papulosquamous conditions;MODERATE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Red blood cells urine positive;Red blood cells urine positive;Urinalysis NEC;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Speech slurred;Dysarthria;Speech and language abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CITRUS BIOFLAVONID|NULL;NULL;NULL
Concomitant Medication|L GLUTATHION|NULL;NULL;NULL
Concomitant Medication|L-CYSTEINE|NULL;NULL;NULL
Concomitant Medication|LUTEIN|NULL;NULL;NULL
Concomitant Medication|LYCOPENE|NULL;NULL;NULL
Concomitant Medication|ZEAXANTHIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;Mild;Resolved
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;Mild;Resolved
Adverse Event|Administration site reactions|Injection site reaction;Injection site reaction;Injection site reactions;Moderate;Resolved
Concomitant Medication|EMBELINE|NULL;NULL;NULL
Concomitant Medication|LO/OVRAL-28|NULL;NULL;NULL
Lab Test|Urine Renal Epithelial Cells|Few
Adverse Event|Administration site reactions|Injection site bruising;Injection site haematoma;Injection site reactions;NULL;NULL
Adverse Event|General system disorders NEC|Irritable;Irritability;General signs and symptoms NEC;NULL;NULL
Adverse Event|Viral infectious disorders|Cold sore mouth;Oral herpes;Herpes viral infections;NULL;NULL
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;NULL;NULL
Adverse Event|Pleural disorders|Pleurisy;Pleurisy;Pleural infections and inflammations;NULL;NULL
Adverse Event|Bacterial infectious disorders|Bacterial eye infection;Eye infection bacterial;Bacterial infections NEC;NULL;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;NULL;NULL
Adverse Event|Salivary gland conditions|Dry lips;Lip dry;Oral dryness and saliva altered;NULL;NULL
Adverse Event|Injuries NEC|Groin strain;Muscle strain;Muscle, tendon and ligament injuries;NULL;NULL
Adverse Event|Neurological disorders NEC|Near syncope;Presyncope;Neurological signs and symptoms NEC;NULL;NULL
Concomitant Medication|DILAZEP|NULL;NULL;NULL
Concomitant Medication|LACTOBACILLUS ACIDOPHILUS|NULL;NULL;NULL
Concomitant Medication|PARAFFIN SOFT|NULL;NULL;NULL
Concomitant Medication|VITAMINS NOS|NULL;NULL;NULL
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Dysuria;Dysuria;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ALFATIL|NULL;NULL;NULL
Concomitant Medication|BLOOD, WHOLE|NULL;NULL;NULL
Concomitant Medication|GLUCOSE|NULL;NULL;NULL
Concomitant Medication|PANTOPRAZOL|NULL;NULL;NULL
Concomitant Medication|PLASMA|NULL;NULL;NULL
Concomitant Medication|PREVISCAN|NULL;NULL;NULL
Concomitant Medication|SINTROM|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Localized tingling;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Tissue disorders NEC|Cyst;Cyst;Mass conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Collapse of lung;Collapse of lung;Chest and lung injuries NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urination difficulty;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Dry scalp;Dry skin;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limb discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sensation of heaviness;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|CYLERT|NULL;NULL;NULL
Concomitant Medication|DEXTROMETHORPHAN POLISTIREX|NULL;NULL;NULL
Concomitant Medication|QUINIDINE|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Vision disorders|Double vision;Diplopia;Visual disorders NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MODERATE;RECOVERED
Concomitant Medication|ALGOPYRIN|1;QD (every day);Oral
Concomitant Medication|FLUVAL|1;Other (specify);Intramuscular
Concomitant Medication|TEPERIN|0.5;QD (every day);Oral
Adverse Event|Allergic conditions|Environmental allergy;Hypersensitivity;Allergic conditions NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Athlete's foot;Tinea pedis;Tinea infections;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Burning foot;Burning sensation;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Congestion pulmonary;Pulmonary congestion;Pulmonary oedemas;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum excretion difficulty;Sputum retention;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Fear;Fear;Fear symptoms and phobic disorders (incl social phobia);MILD;RECOVERED
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle Weakness;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Back muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Complications associated with device|Injury associated with device;Injury associated with device;Complications associated with device NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Otitis externa;Otitis externa;Ear infections;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Skin red;Erythema;Erythemas;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Redness;Erythema;Erythemas;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sore back;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ASTRAGALUS PROPINQUUS ROOT|NULL;NULL;NULL
Concomitant Medication|CILAZAPRIL|NULL;NULL;NULL
Concomitant Medication|GINGER|NULL;NULL;NULL
Concomitant Medication|SOFRACORT|NULL;NULL;NULL
Concomitant Medication|TIGER BALM|NULL;NULL;NULL
Lab Test|Urine Bacteria|2+
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disturbance;Gastrointestinal disorder;Gastrointestinal disorders NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disturbance;Gastrointestinal disorder;Gastrointestinal disorders NEC;SEVERE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Red throat;Pharyngeal erythema;Pharyngeal disorders (excl infections and neoplasms);MILD;RECOVERED
Concomitant Medication|CLIDINIUM|NULL;NULL;NULL
Concomitant Medication|TRENTAL|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Bronchial disorders (excl neoplasms)|Asthmatic attack;Asthma;Bronchospasm and obstruction;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal investigations|Gastroscopy;Endoscopy upper gastrointestinal tract;Gastrointestinal and abdominal imaging procedures;MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATACAND|8;QD (every day);Oral
Concomitant Medication|BELOC|1;BID (twice a day);Oral
Concomitant Medication|CIPRAMIL|10;QD (every day);Oral
Concomitant Medication|COTRIM FORTE|1;QD (every day);Oral
Concomitant Medication|DIAZEPAM|5;QD (every day);Oral
Concomitant Medication|EMSER SALZ|2;BID (twice a day);Inhalation
Concomitant Medication|ENGYSTOL|1;QD (every day);Oral
Concomitant Medication|FLUOXETIN|10;QD (every day);Oral
Concomitant Medication|HORMEEL|20;BID (twice a day);Oral
Concomitant Medication|HYDROCHLOROTHIAZIDE|6.25;QD (every day);Oral
Concomitant Medication|MCP|90;TID (three times a day);Oral
Concomitant Medication|MESTINON|180;TID (three times a day);Oral
Concomitant Medication|MIRTAZAPINE|15;QD (every day);Oral
Concomitant Medication|OMEPRAZOL|20;QD (every day);Oral
Concomitant Medication|PULMICORT|2;BID (twice a day);Inhalation
Concomitant Medication|RAMIPRIL|7,5;BID (twice a day);Oral
Concomitant Medication|STILNOX|10;QD (every day);Oral
Concomitant Medication|TOGAL ASS|1200;TID (three times a day);Oral
Concomitant Medication|UVALYSAT|20;BID (twice a day);Oral
Concomitant Medication|VOLTAREN|75;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;Mild;NULL
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;Moderate;NULL
Adverse Event|Deliria (incl confusion)|Mental confusion;Confusional state;Confusion and disorientation;Mild;NULL
Adverse Event|Neurological disorders NEC|Paresthesia distal;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Respiratory disorders NEC|Increased bronchial secretion;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Cough ineffective;Cough;Coughing and associated symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Taste salty;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|ACETYLCYSTEIN|600;QID (four times a day);Oral
Concomitant Medication|AMITRIPTYLINE|5;QD (every day);Oral
Concomitant Medication|TAMSULOSIN|0,4;QD (every day);Oral
Adverse Event|Haematology investigations (incl blood groups)|Absolute neutrophil count increased;Neutrophil count increased;White blood cell analyses;MILD;RECOVERED
Concomitant Medication|BENYLIN FOUR FLU|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Boil;Furuncle;Skin structures and soft tissue infections;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Vascular disorders NEC|Flushing;Flushing;Peripheral vascular disorders NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Great toe fracture;Foot fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itchy;Pruritus;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Jock itch;Tinea cruris;Tinea infections;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash over arms;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Dental and gingival conditions|Loose tooth;Loose tooth;Dental disorders NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in lumbar spine;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Discomfort;Discomfort;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Bruising;Contusion;Skin injuries NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CECLOR CD|NULL;NULL;NULL
Concomitant Medication|TROVAFLOXACIN|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Renal colic;Renal colic;Urinary tract signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Urolithiases|Renal calculus;Nephrolithiasis;Renal lithiasis;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|B12|1000;QD (every day);Oral
Concomitant Medication|BACLOFEN|60;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|65;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|75;TID (three times a day);Oral
Concomitant Medication|BACLOFEN|85;TID (three times a day);Oral
Concomitant Medication|BUSCAPINE|30;TID (three times a day);Oral
Concomitant Medication|DIAZEPAM W/SULPIRIDE|1;QD (every day);Oral
Concomitant Medication|LITHIUM|100;QD (every day);Oral
Concomitant Medication|MAGNESIUM|809,70;BID (twice a day);Oral
Concomitant Medication|TIZANIDINE|2;QD (every day);Oral
Concomitant Medication|TIZANIDINE|4;QD (every day);Oral
Concomitant Medication|TIZANIDINE|8;TID (three times a day);Oral
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoidal bleeding;Haemorrhoidal haemorrhage;Haemorrhoids and gastrointestinal varices (excl oesophageal);Mild;NULL
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;Mild;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Calf pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Skin discoloration;Skin discolouration;Dermal and epidermal conditions NEC;Mild;NULL
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;Moderate;NULL
Concomitant Medication|ALBUTEROL SULFATE|4;BID (twice a day);Oral
Concomitant Medication|ALBUTEROL SULFATE|4;TID (three times a day);Oral
Concomitant Medication|BENEFIBER|4;QD (every day);Oral
Concomitant Medication|COLACE|0-200;PRN (as needed);Oral
Concomitant Medication|LIDOCAINE|2;QD (every day);Intramuscular
Concomitant Medication|MILK OF MAGNESIUM|400;PRN (as needed);Oral
Concomitant Medication|SUDAFED|30;BID (twice a day);Oral
Lab Test|Immunofixation|-
Adverse Event|Respiratory disorders NEC|Throat irritation;Throat irritation;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Bone pain;Bone pain;Bone related signs and symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heartbeats increased;Heart rate increased;Heart rate and pulse investigations;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Catheter infection;Catheter related infection;Infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Submandibular lymphadenopathy;Lymphadenopathy;Lymphatic system disorders NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle fatigue;Muscle fatigue;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Weakness of limbs;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Lung congestion;Pulmonary congestion;Pulmonary oedemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Postoperative nausea;Procedural nausea;Gastrointestinal and hepatobiliary procedural complications;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Submaxillary gland enlargement;Salivary gland enlargement;Salivary gland enlargements;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Breath sounds abnormal;Breath sounds abnormal;Physical examination procedures;MILD;RECOVERED
Concomitant Medication|BACTROBAN|NULL;NULL;NULL
Concomitant Medication|CYPROHEPTADINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysphasia;Aphasia;Cortical dysfunction NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine increased;Glucose urine present;Urinalysis NEC;MILD;UNKNOWN
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;MILD;UNKNOWN
Adverse Event|Neurological disorders NEC|Speech loss;Aphasia;Cortical dysfunction NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Dementia and amnestic conditions|Post concussive amnesia;Post-traumatic amnestic disorder;Amnestic disorders;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Eye contusion;Eye contusion;Eye injuries NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Urinary tract signs and symptoms|Urinary frequency aggravated;Pollakiuria;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nosebleed;Epistaxis;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CORTAID|NULL;NULL;NULL
Concomitant Medication|DOXIDAN|NULL;NULL;NULL
Concomitant Medication|FLUZONE|NULL;NULL;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Fractured toe;Foot fracture;Lower limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Sodium decreased;Blood sodium decreased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Raised triglycerides;Blood triglycerides increased;Triglyceride analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|LOZOL|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;Mild;Continuing
Adverse Event|External ear disorders (excl congenital)|Wax in ear;Cerumen impaction;External ear disorders NEC;Mild;Resolved
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;Mild;Continuing
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vaginal discharge;Vaginal discharge;Vulvovaginal signs and symptoms;Mild;Resolved
Concomitant Medication|BIOFLAVONOID|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;MILD;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;SEVERE;RECOVERED
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroparesis;Impaired gastric emptying;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;RECOVERED
Adverse Event|Disturbances in thinking and perception|Hallucinations;Hallucination;Perception disturbances;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Weakness of limbs;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Postoperative pain;Procedural pain;Non-site specific procedural complications;MILD;RECOVERED
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|FORTAZ|NULL;NULL;NULL
Concomitant Medication|HEPARITIN SULFATE|NULL;NULL;NULL
Concomitant Medication|INSULIN REGULAR|NULL;NULL;NULL
Concomitant Medication|MICRONASE|NULL;NULL;NULL
Concomitant Medication|NPH INSULIN|NULL;NULL;NULL
Concomitant Medication|PERIACTIN|NULL;NULL;NULL
Concomitant Medication|TESSALON PERLE|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Joint disorders|Contracture of hand joint;Joint contracture;Joint related disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Migraine;Migraine;Migraine headaches;MILD;RECOVERED
Concomitant Medication|CLEOCIN|NULL;NULL;NULL
Concomitant Medication|GINKO BILOBA|NULL;NULL;NULL
Concomitant Medication|MULTIPLE VITAMINS|NULL;NULL;NULL
Lab Test|Glucose|Moderate
Lab Test|Glucose|Trace
Lab Test|Glucose|Small
Lab Test|Glucose|Large
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;NULL;NULL
Adverse Event|Respiratory disorders NEC|Productive cough;Productive cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Cardiac arrhythmias|Left anterior hemiblock;Bundle branch block left;Cardiac conduction disorders;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine elevated;Glucose urine present;Urinalysis NEC;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);NULL;NULL
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Cardiac arrhythmias|Premature atrial contraction;Supraventricular extrasystoles;Supraventricular arrhythmias;NULL;NULL
Concomitant Medication|GLIBENCLAMIDE|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Removal of wisdom teeth;Wisdom teeth removal;Dental and gingival therapeutic procedures;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|CONCOR|5;BID (twice a day);Oral
Concomitant Medication|DYTIDE|1;QD (every day);Oral
Concomitant Medication|FEVARIN|100;BID (twice a day);Oral
Concomitant Medication|FEVARIN|50;QD (every day);Oral
Concomitant Medication|FLUVOXAMINE|100;BID (twice a day);Oral
Concomitant Medication|FLUVOXAMINE|50;QD (every day);Oral
Concomitant Medication|LINOLA-FETT|1;PRN (as needed);Oral
Concomitant Medication|MAGNESIUM|360;QD (every day);Oral
Concomitant Medication|MYKOSERT|1;PRN (as needed);Topical
Concomitant Medication|MYKOSERT|5;BID (twice a day);Topical
Concomitant Medication|PARACETAMOL|500;QD (every day);Oral
Concomitant Medication|POSTERISAN|5;PRN (as needed);
Concomitant Medication|ST. JOHN'S WORT|340;QD (every day);Oral
Concomitant Medication|ULTRACAIN|5;QD (every day);
Concomitant Medication|VIVINOX|144;QD (every day);Oral
Concomitant Medication|VIVINOX|7;QD (every day);Oral
Concomitant Medication|VIVINOX SLEEP|50;QD (every day);Oral
Concomitant Medication|VOLTAREN|5;PRN (as needed);Topical
Concomitant Medication|ZOPICLONE|7.5;QD (every day);Oral
Concomitant Medication|DYTIDE H|1;PRN (as needed);Oral
Concomitant Medication|LIMPTAR|400;BID (twice a day);Oral
Concomitant Medication|NOVALGIN|60;BID (twice a day);Oral
Concomitant Medication|SAROTEN|25;QD (every day);Oral
Concomitant Medication|SCOPODERM|1;Three times per week;Topical
Concomitant Medication|TRIAMTERENE|1;QD (every day);Oral
Adverse Event|Lipid analyses|Cholesterol high;Blood cholesterol increased;Cholesterol analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin breakdown;Skin disorder;Dermal and epidermal conditions NEC;MILD;RECOVERED
Concomitant Medication|ORTHO NOVUM|NULL;NULL;NULL
Concomitant Medication|PROPRANOLOL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Osteoarticular pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Digestion impaired;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscular pains;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|General system disorders NEC|Oedema;Oedema;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Face injury;Face injury;Site specific injuries NEC;MODERATE;RECOVERED
Concomitant Medication|BEDELIX|NULL;NULL;NULL
Concomitant Medication|MOBIC|NULL;NULL;NULL
Concomitant Medication|OESTROGEL|NULL;NULL;NULL
Concomitant Medication|SURGESTONE|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Creatinine decreased;Blood creatinine decreased;Renal function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Psychiatric disorders NEC|Encopresis;Encopresis;Psychiatric elimination disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Libido increased;Libido increased;Sexual desire disorders;MILD;RECOVERED
Adverse Event|Muscle disorders|Myalgia aggravated;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Tetanus;Tetanus;Clostridia infections;MILD;RECOVERED
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|MODANE|NULL;NULL;NULL
Concomitant Medication|SARGENOR|NULL;NULL;NULL
Concomitant Medication|SKENAN|NULL;NULL;NULL
Concomitant Medication|TRANSACALM|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Choked on food;Choking;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Residual urine;Residual urine;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DIKALIUMKLORAZEPAT|NULL;NULL;NULL
Concomitant Medication|METHIONINE|NULL;NULL;NULL
Concomitant Medication|MONO-EMBOLEX|NULL;NULL;NULL
Concomitant Medication|ORELOX|NULL;NULL;NULL
Concomitant Medication|PASPERTIN|NULL;NULL;NULL
Concomitant Medication|SUMMAVIT|NULL;NULL;NULL
Concomitant Medication|TILIDINE|NULL;NULL;NULL
Adverse Event|Lipid analyses|Cholesterol blood increased;Blood cholesterol increased;Cholesterol analyses;MODERATE;ONGOING (PERSISTENT)
Lab Test|Absolute Band Neutrophil Count|Normal
Adverse Event|Abdominal hernias and other abdominal wall conditions|Inguinal hernia;Inguinal hernia;Inguinal hernias;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Leg fracture;Lower limb fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Diverticular disorders|Zenker diverticulum;Pharyngoesophageal diverticulum;Diverticula;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ACIDOPHILUS|NULL;NULL;NULL
Concomitant Medication|CANDICIDIN|NULL;NULL;NULL
Concomitant Medication|NATRIUM|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|GLIPIZIDE|NULL;NULL;NULL
Adverse Event|Oral soft tissue conditions|Lip disorder;Lip disorder;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Tension headaches;Tension headache;Headaches NEC;MILD;RECOVERED
Concomitant Medication|GOODYS|NULL;NULL;NULL
Concomitant Medication|YOHIMBINE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Neck cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|BIOPLEX|NULL;NULL;NULL
Concomitant Medication|CHLOROPHYLL|NULL;NULL;NULL
Concomitant Medication|CHLORTAB|NULL;NULL;NULL
Concomitant Medication|ENTEX PSE|NULL;NULL;NULL
Concomitant Medication|KENALOG|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;NULL
Concomitant Medication|ATIVAN|0.5;PRN (as needed);Oral
Concomitant Medication|COENZYME Q10|800;QD (every day);Oral
Concomitant Medication|VITAMIN C|1000;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|1000;BID (twice a day);Oral
Adverse Event|Infections - pathogen unspecified|Bronchial infection;Bronchitis;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Numbness facial;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Numbness facial;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Eye redness;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Vascular disorders NEC|Facial flushing;Flushing;Peripheral vascular disorders NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;MILD;RECOVERED
Concomitant Medication|ADVIL CHILDRENS|NULL;NULL;NULL
Concomitant Medication|ARTIFICIAL TEARS|NULL;NULL;NULL
Concomitant Medication|GENTEAL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Lockjaw;Trismus;Muscle tone abnormalities;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Numbness in face;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Concomitant Medication|LO/OVRAL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;NULL
Concomitant Medication|ATROPINE|2-3;TID (three times a day);Oral
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Benign paroxysmal positional vertigo;Vertigo positional;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Jaw spasm;Trismus;Muscle tone abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED
Adverse Event|Urolithiases|Renal stone;Nephrolithiasis;Renal lithiasis;SEVERE;RECOVERED
Adverse Event|Cutaneous neoplasms benign|Sebaceous cyst;Dermal cyst;Skin cysts and polyps;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Seborrheic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Head pressure;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Stridor;Stridor;Laryngeal spasm, oedema and obstruction;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Muscle spasticity aggravated;Muscle spasticity;Neuromuscular disorders NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CHELATED ZINC|NULL;NULL;NULL
Concomitant Medication|FLUNISOLIDE|NULL;NULL;NULL
Concomitant Medication|HYDROCODONE/PSEUDOEPHEDRINE/GUAIFENESIN|NULL;NULL;NULL
Concomitant Medication|LIQUIBID|NULL;NULL;NULL
Concomitant Medication|MOTRIN IB SINUS|NULL;NULL;NULL
Concomitant Medication|NEOSPORINE|NULL;NULL;NULL
Concomitant Medication|OCEAN NASAL|NULL;NULL;NULL
Concomitant Medication|WATER|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Feeling sad;Depressed mood;Mood alterations with depressive symptoms;MILD;RECOVERED
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Vital capacity decreased;Vital capacity decreased;Respiratory and pulmonary function diagnostic procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|NIDDM;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Intestinal cramps;Gastrointestinal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;UNKNOWN
Concomitant Medication|DIAZEMULS|NULL;NULL;NULL
Concomitant Medication|MODULON|NULL;NULL;NULL
Concomitant Medication|TRUSOPT|NULL;NULL;NULL
Lab Test|Urine Calcium Oxalate Crystals|+
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Mild;Resolved with Residual
Concomitant Medication|DIGESTIVE ENZYMES|NULL;NULL;NULL
Concomitant Medication|IMMUNOCAL|NULL;NULL;NULL
Concomitant Medication|TRANSFER FACTOR|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Coronary artery disease;Coronary artery disease;Coronary artery disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Blood cholesterol increased;Blood cholesterol increased;Cholesterol analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Absolute neutrophil count increased;Neutrophil count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count increased;Neutrophil count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal ulceration and perforation|Ulcer stomach;Gastric ulcer;Gastric ulcers and perforation;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Emesis;Vomiting;Nausea and vomiting symptoms;MODERATE;RECOVERED
Concomitant Medication|JARSIN|NULL;NULL;NULL
Concomitant Medication|LEVOCARNITINE|NULL;NULL;NULL
Concomitant Medication|EUTHYROX|50;QD (every day);Oral
Concomitant Medication|GINKOBIL|60;TID (three times a day);Oral
Concomitant Medication|IBUPROFEN|1200;BID (twice a day);Oral
Concomitant Medication|LEFAX|1;QD (every day);Oral
Concomitant Medication|MIRTAZAPINE|30;QD (every day);Oral
Concomitant Medication|MIRTAZAPINE|45;QD (every day);Oral
Concomitant Medication|OMEPRAZOL|80;BID (twice a day);Oral
Concomitant Medication|SELEN|1;QD (every day);Oral
Concomitant Medication|VERTIGOHEEL|1;QD (every day);Oral
Concomitant Medication|VERTIGOHEEL|6;TID (three times a day);Oral
Concomitant Medication|ZOPICLONE|7.5;PRN (as needed);Oral
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;SEVERE;RECOVERED
Adverse Event|Psychiatric disorders NEC|Mental status changes;Mental status changes;Mental disorders NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Aches & pains in legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure systolic abnormal;Blood pressure systolic abnormal;Vascular tests NEC (incl blood pressure);MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Epigastric distress;Dyspepsia;Dyspeptic signs and symptoms;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Flatus;Flatulence;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Gastrointestinal ulceration and perforation|Peptic ulcer;Peptic ulcer;Peptic ulcers and perforation;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MILD;RECOVERED
Concomitant Medication|DIOVAN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Sleepy;Somnolence;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Increased libido;Libido increased;Sexual desire disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Otitis externa;Otitis externa;Ear infections;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Papular skin eruption;Rash papular;Papulosquamous conditions;MILD;RECOVERED
Adverse Event|Middle ear disorders (excl congenital)|Ear drum perforation;Tympanic membrane perforation;Tympanic membrane disorders (excl infections);SEVERE;RECOVERED
Adverse Event|General system disorders NEC|Swelling;Swelling;General signs and symptoms NEC;SEVERE;RECOVERED
Concomitant Medication|POLYMYCIN|NULL;NULL;NULL
Adverse Event|Joint disorders|Arthritic pains;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood in urine;Blood urine present;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Reproductive tract and breast disorders congenital|Hydrocele;Hydrocele;Male reproductive tract disorders congenital;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal stenosis and obstruction|Impaction of intestine;Intestinal obstruction;Gastrointestinal stenosis and obstruction NEC;MODERATE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Benign prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|STOOL SOFTENER|NULL;NULL;NULL
Concomitant Medication|CREATINE|3;QD (every day);Oral
Concomitant Medication|VITAMIN E|400;;Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Concomitant Medication|COENZYME Q10|240;TID (three times a day);Oral
Adverse Event|Cardiac arrhythmias|Atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose high;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED
Adverse Event|Coronary artery disorders|Inferior myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heart rate irregular;Heart rate irregular;Heart rate and pulse investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Premature ventricular contractions;Ventricular extrasystoles;Ventricular arrhythmias and cardiac arrest;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Abdominal distension;Abdominal distension;Flatulence, bloating and distension;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Bladder incontinence;Urinary incontinence;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;UNKNOWN
Adverse Event|Ancillary infectious topics|Nosocomial infection;Nosocomial infection;Infectious transmissions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BECLOMETHASONE DIPROPIONATE|NULL;NULL;NULL
Concomitant Medication|CEFUROXIME SODIUM|NULL;NULL;NULL
Concomitant Medication|CISAPRIDE MONOHYDRATE|NULL;NULL;NULL
Concomitant Medication|POTASSIUM IODIDE|NULL;NULL;NULL
Concomitant Medication|ENALAPRIL MALEATE|NULL;NULL;NULL
Adverse Event|Joint disorders|Hand osteoarthritis;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Platelet count decreased;Platelet count decreased;Platelet analyses;MILD;RECOVERED
Adverse Event|General system disorders NEC|Chest discomfort;Chest discomfort;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Esophageal discomfort;Oesophageal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Incomplete right bundle branch block;Bundle branch block right;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Loss of voice;Aphonia;Speech and language abnormalities;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Angioedema and urticaria|Hives;Urticaria;Urticarias;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Allergic reaction;Hypersensitivity;Allergic conditions NEC;SEVERE;RECOVERED
Adverse Event|Angioedema and urticaria|Hives;Urticaria;Urticarias;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Lip swelling;Lip swelling;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Concomitant Medication|CORRECTOL|NULL;NULL;NULL
Concomitant Medication|NOVOFLUPAM|NULL;NULL;NULL
Concomitant Medication|VITAMIN B3|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PAMINE|NULL;NULL;NULL
Adverse Event|Headaches|Cluster headache;Cluster headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Myocardial disorders|Ischemic cardiomyopathy;Ischaemic cardiomyopathy;Cardiomyopathies;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|AZITROMICIN|NULL;NULL;NULL
Concomitant Medication|CARVEDILOL|NULL;NULL;NULL
Concomitant Medication|CERIVASTATINE|NULL;NULL;NULL
Concomitant Medication|TRIMEBUTINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Percutaneous endoscopic gastrostomy;Gastrostomy;Gastric therapeutic procedures;MILD;RECOVERED
Adverse Event|Myocardial disorders|Right atrial enlargement;Right atrial dilatation;Myocardial disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness;Hypoaesthesia;Sensory abnormalities NEC;Mild;NULL
Adverse Event|Allergic conditions|Multiple allergies;Multiple allergies;Allergic conditions NEC;Moderate;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);Moderate;NULL
Concomitant Medication|BACLOFEN|40;QID (four times a day);Oral
Concomitant Medication|BACLOFEN|50;QID (four times a day);Oral
Concomitant Medication|BETACAROTENE|25000;TID (three times a day);Oral
Concomitant Medication|CLARINEX|5;QD (every day);Oral
Concomitant Medication|DANTRIUM|25;BID (twice a day);Oral
Concomitant Medication|DANTRIUM|25;QHS (at bedtime);Oral
Concomitant Medication|DANTRIUM|25;TID (three times a day);Oral
Concomitant Medication|ELIDEL|1;PRN (as needed);Topical
Concomitant Medication|LESCOL XL|80;QHS (at bedtime);Oral
Concomitant Medication|NASONEX|50;PRN (as needed);Inhalation
Concomitant Medication|OXYTROL|3.9;Twice per week;Transdermal
Concomitant Medication|PAXIL|12.5;QD (every day);Oral
Concomitant Medication|PAXIL|37.5;QD (every day);Oral
Concomitant Medication|PAXIL|50;QD (every day);PEG
Concomitant Medication|PAXIL|50;QD (every day);Oral
Concomitant Medication|PNEUMOVAX|0.5;QD (every day);Intramuscular
Concomitant Medication|PROVERA|5;;Oral
Concomitant Medication|PROVERA|5;QD (every day);Oral
Concomitant Medication|PROVERA|10;QD (every day);Oral
Concomitant Medication|TYLENOL EXTRA STRENGTH|500;PRN (as needed);Oral
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw bone pain;Pain in jaw;Bone related signs and symptoms;Mild;NULL
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Concomitant Medication|AMITRIPTYLINE|2.5;QHS (at bedtime);Oral
Concomitant Medication|NEURONTIN|300;QD (every day);Oral
Concomitant Medication|TYLENOL|1;PRN (as needed);Oral
Adverse Event|General system disorders NEC|Disease progression;Disease progression;General signs and symptoms NEC;Mild;NULL
Concomitant Medication|VITAMIN E|2000;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Fungal infectious disorders|Fungal foot infection;Tinea pedis;Tinea infections;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Incontinence urinary;Urinary incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Mood disorders and disturbances NEC|Mood swings;Mood swings;Fluctuating mood symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Nerve pain;Neuralgia;Sensory abnormalities NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder blade pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|ALCOHOL|NULL;NULL;NULL
Concomitant Medication|CORGARD|NULL;NULL;NULL
Concomitant Medication|MS CONTIN|NULL;NULL;NULL
Concomitant Medication|NEOSPORIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Osteoarticular pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Subluxation;Joint dislocation;Fractures and dislocations NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|SOLUCORT|NULL;NULL;NULL
Concomitant Medication|SURVECTOR|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;Mild;NULL
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;Marked;NULL
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;Moderate;NULL
Adverse Event|General system disorders NEC|Increased thirst;Thirst;Feelings and sensations NEC;Marked;NULL
Adverse Event|Respiratory disorders NEC|Throat irritation;Throat irritation;Upper respiratory tract signs and symptoms;Moderate;NULL
Lab Test|Creatinine|Normal
Lab Test|Sodium|Normal
Lab Test|Potassium|Normal
Lab Test|Blood Urea Nitrogen (BUN)|Normal
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Bronchoscopy;Bronchoscopy;Respiratory tract and thoracic imaging procedures;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum increased;Sputum increased;Coughing and associated symptoms;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Nycturia;Nocturia;Urinary tract signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|General system disorders NEC|Unable to walk;Abasia;Gait disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urge incontinence;Urge incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ATROPINE SULFATE|NULL;NULL;NULL
Concomitant Medication|CEFIXIM|NULL;NULL;NULL
Concomitant Medication|CEFUROXIME AXETIL|NULL;NULL;NULL
Concomitant Medication|DIPHENYLPYRALINE|NULL;NULL;NULL
Concomitant Medication|MODURETIK|NULL;NULL;NULL
Concomitant Medication|URION|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Eructation;Eructation;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Distended stomach;Gastric dilatation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED
Concomitant Medication|MYLANTA GAS|NULL;NULL;NULL
Concomitant Medication|SKELAXIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;Mild;NULL
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;Moderate;NULL
Concomitant Medication|DARVON|65;BID (twice a day);Oral
Concomitant Medication|DARVON|65;QID (four times a day);Oral
Concomitant Medication|RANITIDINE|75;PRN (as needed);Oral
Concomitant Medication|TYLENOL|2;PRN (as needed);Oral
Concomitant Medication|PNEUMOCOCCAL VACCINE|1;;Intramuscular
Adverse Event|Neurological disorders NEC|Head discomfort;Head discomfort;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Vision disorders|Double vision;Diplopia;Visual disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Inner ear disorder;Inner ear disorder;Inner ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscular weakness;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Numbness in fingers;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Restless legs;Restless legs syndrome;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Restless legs;Restless legs syndrome;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Stye;Hordeolum;Eye and eyelid infections;MODERATE;RECOVERED
Concomitant Medication|HURRICAINE|NULL;NULL;NULL
Concomitant Medication|TAGAMET HB|NULL;NULL;NULL
Concomitant Medication|THICK & EASY|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Unspecified laceration of eye;Eye penetration;Eye injuries NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Injury to finger NOS;Limb injury;Limb injuries NEC (incl traumatic amputation);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff neck;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|PRAVACOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Retention carbon dioxide;Hypercapnia;Conditions associated with abnormal gas exchange;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Feeling of fullness in abdomen;Abdominal distension;Flatulence, bloating and distension;MILD;RECOVERED
Concomitant Medication|FLUCTIN|NULL;NULL;NULL
Concomitant Medication|JOHANNISKRAUT-KAPSELN|NULL;NULL;NULL
Concomitant Medication|REGENERESEN|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Acne;Acne;Acnes;MILD;ONGOING (PERSISTENT)
Adverse Event|White blood cell disorders|Lymphopenia;Lymphopenia;Leukopenias NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Red blood cell disorders|Polycythaemia;Polycythaemia;Polycythaemia (excl rubra vera);MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Chronic obstructive pulmonary disease;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Plantar fasciitis;Plantar fasciitis;Musculoskeletal and connective tissue infections and inflammations NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Injury to shoulder NOS;Joint injury;Limb injuries NEC (incl traumatic amputation);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Bruise of head;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Papular rash;Rash papular;Papulosquamous conditions;MODERATE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;SEVERE;RECOVERED
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|Blood alkaline phosphatase high;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Ear congestion;Ear congestion;Ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Aural disorders NEC|Sensation of pressure in ear;Ear discomfort;Ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Scapula pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|D-ALPHA TOCOPHEROL|NULL;NULL;NULL
Concomitant Medication|MEGA MEN|NULL;NULL;NULL
Concomitant Medication|TETRACYCLINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Breathlessness;Dyspnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Depressed mood disorders and disturbances|Depressive disorder;Depression;Depressive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|Creatine kinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count increased;Lymphocyte count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Metrorrhagia;Metrorrhagia;Menstruation and uterine bleeding NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Mouth dry;Dry mouth;Oral dryness and saliva altered;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count decreased;Neutrophil count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Physical examination topics|Weight increase;Weight increased;Physical examination procedures;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|MAGNESPASMYL|NULL;NULL;NULL
Concomitant Medication|NOCTRAN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Generalized muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Generalized muscle weakness;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain neck;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anal and rectal conditions NEC|Perianal irritation;Anorectal discomfort;Anal and rectal signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|DUROGESIC|NULL;NULL;NULL
Concomitant Medication|FLEXERIL|NULL;NULL;NULL
Concomitant Medication|ZINC OXIDE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;Mild;Resolved with Residual
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;Severe;Resolved
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;Moderate;Resolved
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;Severe;Resolved with Residual
Concomitant Medication|LISINOPRIL|NULL;NULL;NULL
Adverse Event|Venous varices|Varicose veins of lower extremities;Varicose vein;Varicose veins non-site specific;MILD;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Partial hearing loss;Hypoacusis;Hearing losses;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|VOSOL HC|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Retention carbon dioxide;Hypercapnia;Conditions associated with abnormal gas exchange;SEVERE;RECOVERED
Adverse Event|Respiratory and mediastinal neoplasms malignant and unspecified|Small cell lung cancer;Small cell lung cancer stage unspecified;Respiratory tract small cell carcinomas;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CISPLATIN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Bone and joint injuries|Injury to shoulder NOS;Joint injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Concomitant Medication|AMITRIPTYLINE|15;QD (every day);Oral
Concomitant Medication|BISOPROLOL FUMARATE W/HYDROCHLOROTHIAZIDE|1;QD (every day);Oral
Concomitant Medication|BUSPIRONE HYDROCHLORIDE|1;QD (every day);Oral
Concomitant Medication|CORTIVAZOL|1;QD (every day);Other (specify)
Concomitant Medication|ERGOCALCIFEROL|4000;QD (every day);Oral
Concomitant Medication|IBUPROFEN|800;BID (twice a day);Oral
Concomitant Medication|LITHIUM ACETYLSALICYLATE|75;QD (every day);Oral
Concomitant Medication|MACROGOL|10;QD (every day);Oral
Concomitant Medication|OXOLAMINE CITRATE|UNK;PRN (as needed);Oral
Concomitant Medication|RISEDRONIC ACID|30;QD (every day);Oral
Concomitant Medication|SCOPOLAMINE|1;Other (specify);Oral
Concomitant Medication|SIMVASTATINE|40;QD (every day);Oral
Concomitant Medication|TIANEPTINE|150;BID (twice a day);Oral
Concomitant Medication|TOCOPHEROL|1;BID (twice a day);Oral
Concomitant Medication|TRAMADOL HYDROCHLORIDE|50;QD (every day);Oral
Adverse Event|Bone and joint injuries|Injury to shoulder NOS;Joint injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Concomitant Medication|PANMIST LA|NULL;NULL;NULL
Adverse Event|Body temperature conditions|Fever chills;Pyrexia;Febrile disorders;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tooth infection;Tooth infection;Dental and oral soft tissue infections;SEVERE;RECOVERED
Adverse Event|Headaches|Tension headache;Tension headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALKA SELTZER PLUS COLD|NULL;NULL;NULL
Concomitant Medication|IMPROVE|NULL;NULL;NULL
Concomitant Medication|LEDERCILLIN VK|NULL;NULL;NULL
Concomitant Medication|PROPRANOLOL HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|VITAMIN C + E|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Loss of consciousness;Loss of consciousness;Disturbances in consciousness NEC;MODERATE;RECOVERED
Concomitant Medication|URBANYL|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;Mild;Resolved
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;Mild;         .
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Dandruff;Dandruff;Scaly conditions;Mild;Continuing
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Continuing
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;Mild;Continuing
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;Mild;Continuing
Adverse Event|Injuries NEC|Pulled muscle;Muscle strain;Muscle, tendon and ligament injuries;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Joint disorders|Wrist pain;Arthralgia;Joint related signs and symptoms;Mild;Resolved
Adverse Event|Fungal infectious disorders|Yeast infection of the skin;Fungal skin infection;Fungal infections NEC;Mild;Continuing
Concomitant Medication|LOTRONEX|NULL;NULL;NULL
Concomitant Medication|VITAMIN A + D|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Tongue conditions|Tongue blistering;Tongue blistering;Tongue signs and symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal bloating;Abdominal distension;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Oedema limbs;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of limbs;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Lethargic;Lethargy;Disturbances in consciousness NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in foot;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|General system disorders NEC|Swelling of fingers;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Coronary artery disorders|Unstable angina;Angina unstable;Ischaemic coronary artery disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|AMLODIPINE BESYLATE|NULL;NULL;NULL
Concomitant Medication|XYLOMETAZOLINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Hepatobiliary investigations|Gamma GT increased;Gamma-glutamyltransferase increased;Liver function analyses;NA;UNDER TREATMENT/OBSERVATION
Adverse Event|Hepatobiliary investigations|Transaminases increased;Transaminases increased;Liver function analyses;NA;UNDER TREATMENT/OBSERVATION
Adverse Event|Uterine, pelvic and broad ligament disorders|Uterine bleeding;Uterine haemorrhage;Uterine disorders NEC;MILD;RECOVERED
Concomitant Medication|ACIDUM ARSENICOSUM ANHYDRICUM|3;QD (every day);Oral
Concomitant Medication|AURUM|60;TID (three times a day);Oral
Concomitant Medication|SEDATIF PC|3;TID (three times a day);Oral
Concomitant Medication|SEROPRAM|0.5;QD (every day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Gastric irritation;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Paresis;Paresis;Paralysis and paresis (excl cranial nerve);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Limb paresis;Monoparesis;Paralysis and paresis (excl cranial nerve);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Otitis media;Otitis media;Ear infections;MODERATE;RECOVERED
Concomitant Medication|PANOTILE|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Oral candida;Oral candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervical pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Urethral disorders (excl calculi)|Urethral false passage;Urethral disorder;Urethral disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|FUNGIZONE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Lower respiratory tract infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;         .;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;         .;Resolved
Adverse Event|Joint disorders|Contracture of hand joint;Joint contracture;Joint related disorders NEC;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;         .;Resolved
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Severe;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);         .;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;Continuing
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;         .;Resolved
Adverse Event|General system disorders NEC|General discomfort;Discomfort;Pain and discomfort NEC;         .;Resolved
Adverse Event|Headaches|Headache;Headache;Headaches NEC;         .;Resolved
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;Mild;Resolved
Adverse Event|Joint disorders|Joint stiffness;Joint stiffness;Joint related signs and symptoms;Moderate;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;         .;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;         .;Resolved
Concomitant Medication|CARDIZEM|NULL;NULL;NULL
Adverse Event|Joint disorders|Pain in ankle;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Injuries NEC|Wound;Wound;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Tendon strain;Tendon injury;Muscle, tendon and ligament injuries;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|COPD;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Wound;Wound;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Contusion of toe;Contusion;Skin injuries NEC;MILD;RECOVERED
Concomitant Medication|COMBIVENT|NULL;NULL;NULL
Concomitant Medication|COREG|NULL;NULL;NULL
Concomitant Medication|REFLEX|NULL;NULL;NULL
Lab Test|Urine Clarity|Normal
Lab Test|Urine Bilirubin|-
Lab Test|Urine Color|Normal
Adverse Event|Vision disorders|Blurry vision;Vision blurred;Visual disorders NEC;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);Mild;Resolved
Adverse Event|Administration site reactions|Injection site induration;Injection site induration;Injection site reactions;Mild;Continuing
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Severe;Resolved with Residual
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;Moderate;Resolved
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Resolved with Residual
Concomitant Medication|ESTRACE VAGINAL|NULL;NULL;NULL
Concomitant Medication|LANACANE|NULL;NULL;NULL
Concomitant Medication|LIDEX|NULL;NULL;NULL
Concomitant Medication|VAGIFEM|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Marked;NULL
Adverse Event|General system disorders NEC|Edema peripheral;Oedema peripheral;Oedema NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Infection upper respiratory;Upper respiratory tract infection;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Neurological disorders NEC|Nerve pain;Neuralgia;Sensory abnormalities NEC;Moderate;NULL
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;Moderate;NULL
Concomitant Medication|ALLEGRA|60;BID (twice a day);Oral
Concomitant Medication|ATARAX|10;PRN (as needed);Oral
Concomitant Medication|BIAXIN|1;QD (every day);Oral
Concomitant Medication|DARVOCET|100;PRN (as needed);Oral
Concomitant Medication|DEPO MEDROL|40;1 time only;Intramuscular
Concomitant Medication|DIGOXIN|.25;QD (every day);Oral
Concomitant Medication|HYDROXYZINE HCL|10;PRN (as needed);Oral
Concomitant Medication|MYSOLINE|25;PRN (as needed);Oral
Concomitant Medication|PREVACID|30;Other (specify);Oral
Concomitant Medication|QUINIDINE SULFATE|300;BID (twice a day);Oral
Concomitant Medication|ZITHROMAX|250;QD (every day);Oral
Adverse Event|Skin and subcutaneous tissue disorders NEC|Foot ulcer;Skin ulcer;Skin and subcutaneous tissue ulcerations;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Irritation skin;Skin irritation;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Reproductive organ and breast investigations (excl hormone analyses)|Breast biopsy;Biopsy breast;Reproductive organ and breast histopathology procedures;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Throat irritation;Throat irritation;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CARBIDOPA W/LEVODOPA|NULL;NULL;NULL
Adverse Event|Sexual function and fertility disorders|Ejaculation delayed;Ejaculation delayed;Erection and ejaculation conditions and disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DURAGESIC|NULL;NULL;NULL
Adverse Event|Injuries NEC|Accidental injury;Injury;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Acute respiratory failure;Acute respiratory failure;Respiratory failures (excl neonatal);SEVERE;DEATH
Concomitant Medication|METOPROLOL TARTRATE|25;QD (every day);Oral
Concomitant Medication|PERINDOPRIL|5;QD (every day);Oral
Adverse Event|Anxiety disorders and symptoms|Nervous;Nervousness;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NORDAZ|NULL;NULL;NULL
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Mild;NULL
Concomitant Medication|COENZYME Q10|150;QD (every day);Oral
Concomitant Medication|COLOSTRUM|1;QD (every day);Oral
Concomitant Medication|COLOSTRUM|U;QD (every day);Oral
Concomitant Medication|DOCUSATE|100;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE|500;BID (twice a day);Oral
Concomitant Medication|HYDROCORTISONE|U;PRN (as needed);Topical
Concomitant Medication|LACTULOSE|20;BID (twice a day);Oral
Concomitant Medication|MAGNESIUM|200;BID (twice a day);Oral
Concomitant Medication|PREPARATION H|U;PRN (as needed);Topical
Concomitant Medication|PROCTOSOL HC|2.5;PRN (as needed);Topical
Concomitant Medication|REMERON|30;QHS (at bedtime);Oral
Concomitant Medication|REMERON|15;QHS (at bedtime);Oral
Concomitant Medication|ALOE VERA|1;QD (every day);Oral
Concomitant Medication|ALOE VERA|2;QD (every day);Oral
Concomitant Medication|COD LIVER OIL|1;QD (every day);Oral
Concomitant Medication|CORAL CALCIUM|1000;BID (twice a day);Oral
Concomitant Medication|GRAPE SEED EXTRACT|100;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Otitis externa;Otitis externa;Ear infections;MODERATE;RECOVERED
Concomitant Medication|COLACE|100;PRN (as needed);Oral
Concomitant Medication|MORPHINE|10;PRN (as needed);Oral
Concomitant Medication|SENOKOT|1-2;PRN (as needed);Oral
Adverse Event|Urinary tract signs and symptoms|Bladder retention;Urinary retention;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Deliria (incl confusion)|Delirium;Delirium;Deliria;MODERATE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Atelectasis;Atelectasis;Parenchymal lung disorders NEC;MILD;RECOVERED
Concomitant Medication|BECLOMETHASONE|NULL;NULL;NULL
Concomitant Medication|BENZTROPINE|NULL;NULL;NULL
Concomitant Medication|PSYLLIUM|NULL;NULL;NULL
Concomitant Medication|SSKI|NULL;NULL;NULL
Concomitant Medication|SUCRALFATE|NULL;NULL;NULL
Concomitant Medication|THIORIDAZINE|NULL;NULL;NULL
Concomitant Medication|TIMENTIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Costal pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Chorioretinitis;Chorioretinitis;Retinal, choroid and vitreous infections and inflammations;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CEDROL|NULL;NULL;NULL
Concomitant Medication|CLEBOPRIDE|NULL;NULL;NULL
Concomitant Medication|PENTOXIFYLLINE|NULL;NULL;NULL
Concomitant Medication|SIMETICONE|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Clostridium difficile infection;Clostridial infection;Clostridia infections;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Chronic subdural hematoma;Subdural haematoma;Cerebral injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine output decreased;Urine output decreased;Urinary tract function analyses NEC;MILD;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Electrolyte imbalance;Electrolyte imbalance;Electrolyte imbalance NEC;MILD;RECOVERED
Adverse Event|Mental impairment disorders|Frontotemporal dementia;Frontotemporal dementia;Dementia (excl Alzheimer's type);MILD;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritic rash;Rash pruritic;Pruritus NEC;MILD;RECOVERED
Adverse Event|Bacterial infectious disorders|Pneumonia pseudomonal;Lung infection pseudomonal;Pseudomonal infections;MILD;RECOVERED
Adverse Event|Injuries NEC|Scalp laceration;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Ventilatory failure;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|HEPARIN SODIUM|NULL;NULL;NULL
Concomitant Medication|ORGANIDIN|NULL;NULL;NULL
Concomitant Medication|SUPREX|NULL;NULL;NULL
Concomitant Medication|THEODUR|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Eczema facial;Eczema;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone, calcium, magnesium and phosphorus metabolism disorders|Hypercalcaemia;Hypercalcaemia;Calcium metabolism disorders;MODERATE;RECOVERED
Adverse Event|Parathyroid gland disorders|Hyperparathyroidism;Hyperparathyroidism;Hyperparathyroid disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BRONCHODUAL|NULL;NULL;NULL
Concomitant Medication|CAPTOLANE|NULL;NULL;NULL
Concomitant Medication|DECONTRACTYL|NULL;NULL;NULL
Concomitant Medication|EURELIX|NULL;NULL;NULL
Concomitant Medication|HOMEOPLASMINE|NULL;NULL;NULL
Concomitant Medication|ICAZ|NULL;NULL;NULL
Concomitant Medication|SERESTA|NULL;NULL;NULL
Concomitant Medication|SYNALAR|NULL;NULL;NULL
Concomitant Medication|TERSIGAT|NULL;NULL;NULL
Concomitant Medication|TRIVASTAL|NULL;NULL;NULL
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff neck;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervicalgia;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Glucosuria;Glycosuria;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|COLTRAMYL|NULL;NULL;NULL
Concomitant Medication|DAFALGAN|NULL;NULL;NULL
Concomitant Medication|DAONIL|NULL;NULL;NULL
Concomitant Medication|PERMIXON|NULL;NULL;NULL
Concomitant Medication|SPASMINE|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Epistaxis;Epistaxis;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flushes;Hot flush;Peripheral vascular disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|Bilirubin increased;Blood bilirubin increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated haemoglobin increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|NYOLOL|NULL;NULL;NULL
Concomitant Medication|TANGANIL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Menstrual cycle and uterine bleeding disorders|Absence of menstruation;Amenorrhoea;Menstruation with decreased bleeding;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Chest aching;Chest pain;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Frustration;Frustration;Emotional and mood disturbances NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Frustration;Frustration;Emotional and mood disturbances NEC;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Chest cold;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Dental and gingival conditions|Tooth pain;Toothache;Dental pain and sensation disorders;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;SEVERE;RECOVERED
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Changes in physical activity|Teeth grinding;Bruxism;Stereotypies and automatisms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;SEVERE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchial mucus plug;Bronchial secretion retention;Bronchial conditions NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Irritable bowel;Irritable bowel syndrome;Gastrointestinal spastic and hypermotility disorders;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menstrual cramps;Dysmenorrhoea;Menstruation and uterine bleeding NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Mouth breathing;Mouth breathing;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff neck;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Palpitations;Palpitations;Cardiac signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Panic attacks;Panic attack;Panic attacks and disorders;SEVERE;RECOVERED
Adverse Event|Headaches|Sinus pain;Sinus headache;Headaches NEC;SEVERE;RECOVERED
Adverse Event|Oral soft tissue conditions|Sores lip;Cheilitis;Oral soft tissue disorders NEC;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Sore mouth;Oral pain;Oral soft tissue pain and paraesthesia;MODERATE;RECOVERED
Adverse Event|Tongue conditions|Sore tongue;Glossodynia;Tongue signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|ANUSOL PLUS|NULL;NULL;NULL
Concomitant Medication|DESIPRAMINE|NULL;NULL;NULL
Concomitant Medication|MIN-OVRAL|NULL;NULL;NULL
Concomitant Medication|NILSTAT|NULL;NULL;NULL
Concomitant Medication|OMNIPAQUE|NULL;NULL;NULL
Concomitant Medication|TUMS ULTRA|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Furuncle;Furuncle;Skin structures and soft tissue infections;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|Transaminases increased;Transaminases increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Ventricular extrasystoles;Ventricular extrasystoles;Ventricular arrhythmias and cardiac arrest;MILD;ONGOING (PERSISTENT)
Concomitant Medication|HEXOMEDINE|NULL;NULL;NULL
Concomitant Medication|ISOPTIN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramps calf;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Oxygen saturation decreased;Oxygen saturation decreased;Blood gas and acid base analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Abdominal abscess;Abdominal abscess;Abdominal and gastrointestinal infections;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|GENATROPINE|NULL;NULL;NULL
Concomitant Medication|PYOSTACINE|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood sugar increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Restless;Restlessness;Increased physical activity levels;MILD;ONGOING (PERSISTENT)
Concomitant Medication|GLUCOTROL|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;MILD;RECOVERED
Adverse Event|General system disorders NEC|Foot oedema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of lower extremities;Oedema peripheral;Oedema NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ATHYMIL|NULL;NULL;NULL
Concomitant Medication|TINSET|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Motor dysfunction;Motor dysfunction;Nervous system disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Walking difficulty;Gait disturbance;Gait disturbances;MILD;ONGOING (PERSISTENT)
Concomitant Medication|EPHYNAL|NULL;NULL;NULL
Adverse Event|Vision disorders|Abnormal vision;Visual impairment;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Bowel incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Watery diarrhea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Dysfunctional uterine bleeding;Dysfunctional uterine bleeding;Menstruation and uterine bleeding NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Menstrual cycle and uterine bleeding disorders|Dysfunctional uterine bleeding;Dysfunctional uterine bleeding;Menstruation and uterine bleeding NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Epigastric discomfort;Epigastric discomfort;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Irritable;Irritability;General signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Perspiration excessive;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|HALCION|NULL;NULL;NULL
Concomitant Medication|QUINTEX|NULL;NULL;NULL
Adverse Event|Mood disorders and disturbances NEC|Lack of feeling emotions;Emotional poverty;Emotional and mood disturbances NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Joint disorders|Periarthritis;Periarthritis;Joint related disorders NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Skin wound;Skin wound;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Torticollis;Torticollis;Muscle tone abnormalities;MODERATE;RECOVERED
Concomitant Medication|AGYRAX|NULL;NULL;NULL
Concomitant Medication|FENOFIBRATE|NULL;NULL;NULL
Concomitant Medication|FRAZOLINE|NULL;NULL;NULL
Concomitant Medication|MAXILASE|NULL;NULL;NULL
Concomitant Medication|MONURIL|NULL;NULL;NULL
Concomitant Medication|OROMEDINE|NULL;NULL;NULL
Concomitant Medication|PANOS|NULL;NULL;NULL
Concomitant Medication|SPASFON LYOC|NULL;NULL;NULL
Concomitant Medication|TRIAMINIC|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Acute dyspnea;Dyspnoea;Breathing abnormalities;Moderate;NULL
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Severe;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;Moderate;NULL
Concomitant Medication|DICODID|unknown;Unknown;Subcutaneous
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Concomitant Medication|SOMINEX|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Hand rash;Rash;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PROVENTOL|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Body odor;Skin odour abnormal;Dermal and epidermal conditions NEC;Mild;NULL
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Groin pain;Groin pain;Soft tissue disorders NEC;Mild;NULL
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Adverse Event|Neurological disorders NEC|Numbness in fingers;Hypoaesthesia;Sensory abnormalities NEC;Mild;NULL
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;Mild;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchospasm;Bronchospasm;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Dislocated shoulder;Joint dislocation;Fractures and dislocations NEC;MILD;RECOVERED
Adverse Event|Lipid analyses|Cholesterol total increased;Blood cholesterol increased;Cholesterol analyses;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Shingles;Herpes zoster;Herpes viral infections;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Gait disturbance;Gait disturbance;Gait disturbances;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MIRAPEX|NULL;NULL;NULL
Concomitant Medication|THERAGRAN|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);SEVERE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Anger;Anger;Emotional and mood disturbances NEC;MODERATE;RECOVERED
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Poison ivy rash;Dermatitis contact;Dermatitis and eczema;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Substernal pain;Chest pain;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Viral gastroenteritis;Gastroenteritis viral;Viral infections NEC;SEVERE;RECOVERED
Concomitant Medication|CENTURY SENIOR|NULL;NULL;NULL
Concomitant Medication|DICYCLOMINE|NULL;NULL;NULL
Concomitant Medication|ELOCON|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;Moderate;NULL
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;Mild;NULL
Concomitant Medication|NOLVADEX|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Chronic rhinitis;Rhinitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Chronic rhinitis;Rhinitis;Upper respiratory tract infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Femoral hernia;Femoral hernia;Femoral hernias;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Catheter related infection;Catheter related infection;Infections NEC;Moderate;Resolved
Adverse Event|Viral infectious disorders|Flu symptoms;Influenza;Influenza viral infections;Mild;Resolved
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Rash on face;Rash;Rashes, eruptions and exanthems NEC;Mild;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;Mild;Continuing
Concomitant Medication|ACETAMINOPHEN AND CODEINE|NULL;NULL;NULL
Concomitant Medication|BENAZEPRIL HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|CITALOPRAM HYDROBROMIDE|NULL;NULL;NULL
Concomitant Medication|SULFAMETHOXAZOLE|NULL;NULL;NULL
Concomitant Medication|SULPHAMETHOXAZOLE|NULL;NULL;NULL
Concomitant Medication|TRIAMINIC COUGH|NULL;NULL;NULL
Adverse Event|Joint disorders|Aching joints;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Pain menstrual;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MODERATE;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Dental fillings;Tooth repair;Dental and gingival therapeutic procedures;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|BENZHEXOL|NULL;NULL;NULL
Concomitant Medication|DMSA|NULL;NULL;NULL
Concomitant Medication|FLUVIRIN|NULL;NULL;NULL
Concomitant Medication|PNEUMOVAX II|NULL;NULL;NULL
Concomitant Medication|PREMPAK C|NULL;NULL;NULL
Concomitant Medication|VIBRAMYCIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Throat infection;Pharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Concomitant Medication|DIMETHYL SULFOXIDE|NULL;NULL;NULL
Concomitant Medication|LORACARBEF|NULL;NULL;NULL
Concomitant Medication|PSEUDOPHED|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;Moderate;Resolved
Concomitant Medication|ADVIL COLD|NULL;NULL;NULL
Concomitant Medication|CELECOXIB|NULL;NULL;NULL
Concomitant Medication|FEXOFENADINE HCL|NULL;NULL;NULL
Concomitant Medication|FLUOXETINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|GELONIDA|NULL;NULL;NULL
Concomitant Medication|METHYLPHENIDATE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|OXYCODONE HCL|NULL;NULL;NULL
Concomitant Medication|SUMATRIPTAN SUCCINATE|NULL;NULL;NULL
Lab Test|Red Blood Cells (RBC)|4750,000
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbar pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ALTIM|NULL;NULL;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;Marked;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Marked;NULL
Adverse Event|Cutaneous neoplasms benign|Warts;Skin papilloma;Skin neoplasms benign;Mild;NULL
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Hemoglobin A1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin and subcutaneous tissue disorders NEC|Ankle ulcer;Skin ulcer;Skin and subcutaneous tissue ulcerations;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urea blood elevated;Blood urea increased;Renal function analyses;MILD;RECOVERED
Concomitant Medication|AQUAPHOR|NULL;NULL;NULL
Concomitant Medication|FURORESE|NULL;NULL;NULL
Concomitant Medication|GLIBENHEXAL|NULL;NULL;NULL
Concomitant Medication|GLUCOBAY|NULL;NULL;NULL
Concomitant Medication|NEURIUM|NULL;NULL;NULL
Concomitant Medication|SAROTEN RETARD|NULL;NULL;NULL
Adverse Event|Muscle disorders|Back muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Infarction;Infarction;Non-site specific necrosis and vascular insufficiency NEC;MODERATE;RECOVERED
Concomitant Medication|OCUVITE|NULL;NULL;NULL
Concomitant Medication|VEETIDS|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Aching in limb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Irritant cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|General system disorders NEC|Facial pain;Facial pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Wrist sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Chest infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itchy;Pruritus;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anaemia;Anaemia;Anaemias NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Disease progression;Disease progression;General signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Extrapyramidal disorder;Extrapyramidal disorder;Dyskinesias and movement disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DIAMORPHINE|NULL;NULL;NULL
Adverse Event|Eye disorders congenital|Congenital ptosis of eyelid;Eyelid ptosis congenital;Eyelid disorders congenital;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Seborrheic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MILD;RECOVERED
Concomitant Medication|LACTULOSA|NULL;NULL;NULL
Adverse Event|Muscle disorders|Pain muscle;Myalgia;Muscle pains;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Wrist pain;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Joint disorders|Pain in joint involving shoulder region;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Movement disorders (incl parkinsonism)|Trembling;Tremor;Tremor (excl congenital);MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|NITROFURAL|NULL;NULL;NULL
Concomitant Medication|PREDNISOLON|NULL;NULL;NULL
Concomitant Medication|RIVANOL|NULL;NULL;NULL
Concomitant Medication|VITASPRINT|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Fungal infection of nail;Onychomycosis;Fungal infections NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lifestyle issues|Sight disability;Sight disability;Disability issues;MILD;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension aggravated;Hypertension;Vascular hypertensive disorders NEC;MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension aggravated;Hypertension;Vascular hypertensive disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal stuffiness;Nasal congestion;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CARDIZEM CD|NULL;NULL;NULL
Concomitant Medication|CHROMAGEN|NULL;NULL;NULL
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hair loss;Alopecia;Alopecias;MODERATE;RECOVERED
Adverse Event|Lipid metabolism disorders|Hypertriglyceridemia;Hypertriglyceridaemia;Elevated triglycerides;MODERATE;RECOVERED
Adverse Event|Gastrointestinal haemorrhages NEC|Melena;Melaena;Non-site specific gastrointestinal haemorrhages;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;RECOVERED
Concomitant Medication|CYSTEINE|NULL;NULL;NULL
Concomitant Medication|DEDROGYL|NULL;NULL;NULL
Concomitant Medication|OSTRAM|NULL;NULL;NULL
Concomitant Medication|XATRAL|NULL;NULL;NULL
Concomitant Medication|DUSPATALIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;Marked;NULL
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;Mild;NULL
Adverse Event|General system disorders NEC|Chest burning;Chest pain;Pain and discomfort NEC;Moderate;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety aggravated;Anxiety;Anxiety symptoms;Mild;NULL
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;Mild;NULL
Adverse Event|Neurological disorders NEC|Restless legs;Restless legs syndrome;Sensory abnormalities NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach ache;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;Moderate;NULL
Concomitant Medication|CHONDROITIN|NULL;NULL;NULL
Concomitant Medication|CITRACAL|NULL;NULL;NULL
Concomitant Medication|FIORINAL|NULL;NULL;NULL
Concomitant Medication|PLAQUENIL|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine elevated;Glucose urine present;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Contusion of elbow;Contusion;Skin injuries NEC;MILD;RECOVERED
Concomitant Medication|ORAL BALANCE|NULL;NULL;NULL
Adverse Event|Neuromuscular disorders|Serotonin syndrome;Serotonin syndrome;Muscle tone abnormal;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Neck rash;Rash;Rashes, eruptions and exanthems NEC;Mild;Continuing
Concomitant Medication|MYCOSTATIN|NULL;NULL;NULL
Concomitant Medication|PROBALANCE|NULL;NULL;NULL
Concomitant Medication|ALLEGRA|180;PRN (as needed);Oral
Concomitant Medication|CLARITIN|180;QD (every day);Oral
Adverse Event|Therapeutic and nontherapeutic effects (excl toxicity)|Drug interaction;Drug interaction;Interactions;MODERATE;RECOVERED
Adverse Event|Therapeutic and nontherapeutic effects (excl toxicity)|Adverse drug reaction;Adverse drug reaction;Therapeutic and nontherapeutic responses;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Ingrowing nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MILD;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Motion sickness;Motion sickness;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Photosensitivity;Photosensitivity reaction;Photosensitivity conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DEPO PROVERA|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Mild;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;Mild;NULL
Concomitant Medication|ATIVAN|2;PRN (as needed);Oral
Concomitant Medication|BEE POLLEN|4;QD (every day);Oral
Concomitant Medication|COLACE|100;QD (every day);PEG
Concomitant Medication|SENNA|364;QD (every day);PEG
Concomitant Medication|SIMETHICONE|80;PRN (as needed);Oral
Adverse Event|Vascular disorders NEC|Flushed face;Flushing;Peripheral vascular disorders NEC;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;Moderate;Resolved
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;Mild;Continuing
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menorrhagia;Menorrhagia;Menstruation with increased bleeding;Mild;Resolved
Adverse Event|Administration site reactions|Injection site swelling;Injection site swelling;Injection site reactions;Moderate;Resolved with Residual
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Snoring;Snoring;Upper respiratory tract signs and symptoms;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;Moderate;Continuing
Concomitant Medication|SMZ-TMP DS|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Ventricular extrasystoles;Ventricular extrasystoles;Ventricular arrhythmias and cardiac arrest;MODERATE;RECOVERED
Concomitant Medication|ZYLORIC|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Aches & pains in legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Carpal tunnel syndrome;Carpal tunnel syndrome;Mononeuropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Fibromyalgia;Fibromyalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Surgical scar;Scar;Skin injuries and mechanical dermatoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful hand;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle weakness trunk;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ELTROXIN|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood in urine;Blood urine present;Urinalysis NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Wound infection;Wound infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATACAND|16;BID (twice a day);Oral
Concomitant Medication|AZITROMAX|500;QD (every day);Oral
Concomitant Medication|BETA CAROTENE|6;QD (every day);Oral
Concomitant Medication|BETA GLUCAN|1.3/1.6;QD (every day);Oral
Concomitant Medication|CETIRIZIN|10;QD (every day);Oral
Concomitant Medication|COENZYME Q10|360;QD (every day);Oral
Concomitant Medication|CREATINE|2000;QD (every day);Oral
Concomitant Medication|DICLOCIL|1500;TID (three times a day);Oral
Concomitant Medication|TRIOBE|4,3;QD (every day);Oral
Concomitant Medication|VITAMIN C|1500;QD (every day);Oral
Concomitant Medication|VITAMIN E|300;QD (every day);Oral
Adverse Event|Purine and pyrimidine metabolism disorders|Gout;Gout;Purine metabolism disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|URTI (upper respiratory tract infection);Upper respiratory tract infection;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|URTI (upper respiratory tract infection);Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|CO AMOXICLAV|NULL;NULL;NULL
Concomitant Medication|CODEINE LINCTUS|NULL;NULL;NULL
Adverse Event|Joint disorders|Cervical spondylosis;Spinal osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Extrasystoles;Extrasystoles;Rate and rhythm disorders NEC;MODERATE;RECOVERED
Adverse Event|Sexual function and fertility disorders|Impotent;Erectile dysfunction;Erection and ejaculation conditions and disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Deafness left ear;Deafness unilateral;Hearing losses;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Muscle spasticity aggravated;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MILD;RECOVERED
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Nail growth increased;Nail growth abnormal;Nail and nail bed conditions (excl infections and infestations);MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigability;Fatigue;Asthenic conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLSALICYLIC ACID|75;QD (every day);Oral
Concomitant Medication|ATORVASTATIN|20;QD (every day);Oral
Concomitant Medication|CORENITEC|1;QD (every day);Oral
Concomitant Medication|VERAPAMIL HYDROCHLORIDE|240;QD (every day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Hyperactivity;Psychomotor hyperactivity;Dyskinesias and movement disorders NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Adverse Event|Mental impairment disorders|Difficulty thinking;Mental impairment;Mental impairment (excl dementia and memory loss);Mild;NULL
Concomitant Medication|VITAMIN E|300;;Oral
Adverse Event|General system disorders NEC|Edema peripheral;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ASPIRIN|81;PRN (as needed);Oral
Concomitant Medication|CLARITIN|1;QD (every day);Oral
Concomitant Medication|HYDROCHLOROTHIAZIDE|1;QD (every day);Oral
Concomitant Medication|LISINOPRIL|40;QD (every day);Oral
Concomitant Medication|METOPROLOL|50;QD (every day);Oral
Concomitant Medication|VACCINE, INFLUENZA|1;Other (specify);Intramuscular
Concomitant Medication|VITAMIN D|1200;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Paronychia;Paronychia;Skin structures and soft tissue infections;Mild;NULL
Concomitant Medication|BACLOFEN|10;;Oral
Concomitant Medication|KEFLEX|500;BID (twice a day);Oral
Concomitant Medication|QUININE|325;QD (every day);Oral
Adverse Event|Injuries NEC|Periorbital ecchymosis;Periorbital haemorrhage;Eye injuries NEC;MILD;RECOVERED
Adverse Event|Mental impairment disorders|Dementia;Dementia;Dementia (excl Alzheimer's type);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Echolalia;Echolalia;Stereotypies and automatisms;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fracture;Fracture;Fractures and dislocations NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;MILD;RECOVERED
Adverse Event|General system disorders NEC|Fatigability;Fatigue;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DIPROSTENE|NULL;NULL;NULL
Concomitant Medication|LACTEOL|NULL;NULL;NULL
Concomitant Medication|SAVARINE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Personality disorders and disturbances in behaviour|Personality change;Personality change;Behaviour and socialisation disturbances;Mild;NULL
Adverse Event|Disturbances in thinking and perception|Slowed thinking;Bradyphrenia;Thinking disturbances;Mild;NULL
Concomitant Medication|GUIATUSS AC|NULL;NULL;NULL
Concomitant Medication|VITAMIN C WITH ROSE HIPS|NULL;NULL;NULL
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;SEVERE;RECOVERED
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Muscle strain;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|CLORAD|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Digestion impaired;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Foot fracture;Foot fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Synovial and bursal disorders|Popliteal cyst;Synovial cyst;Synovial disorders;MODERATE;RECOVERED
Concomitant Medication|FURADANTINE|NULL;NULL;NULL
Concomitant Medication|HEXATRIONE|NULL;NULL;NULL
Concomitant Medication|LIPANOR|NULL;NULL;NULL
Concomitant Medication|MISOPROSTOL|NULL;NULL;NULL
Concomitant Medication|PHOSPHALUGEL|NULL;NULL;NULL
Concomitant Medication|PROPOFAN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Distress gastrointestinal;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tooth infection;Tooth infection;Dental and oral soft tissue infections;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Ragweed allergy;Seasonal allergy;Atopic disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|COMTREX|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Periorbital swelling;Eye swelling;Ocular disorders NEC;Mild;Resolved
Adverse Event|Muscle disorders|Cramps in legs;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Resolved
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);Mild;Resolved
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;Mild;Resolved
Adverse Event|Bone and joint injuries|Toe injury;Limb injury;Limb injuries NEC (incl traumatic amputation);Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;Resolved
Concomitant Medication|TONIC|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Numbness in hand;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Jaw spasm;Trismus;Muscle tone abnormalities;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BOTOX|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Cold intolerance;Temperature intolerance;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anal and rectal conditions NEC|Anal skin tags;Anal skin tags;Anal and rectal disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anaemias nonhaemolytic and marrow depression|Normocytic anaemia;Normochromic normocytic anaemia;Anaemias NEC;MILD;RECOVERED
Adverse Event|Cornification and dystrophic skin disorders|Callosities;Hyperkeratosis;Hyperkeratoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Immunology and allergy investigations|IgG increased;Blood immunoglobulin G increased;Immunoglobulin analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Foot injury;Limb injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Concomitant Medication|CO TENIDONE|NULL;NULL;NULL
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Hepatic enzyme increased;Hepatic enzyme increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Urinary infection;Urinary tract infection;Urinary tract infections;MILD;RECOVERED
Concomitant Medication|INOSINE|NULL;NULL;NULL
Concomitant Medication|KARDEGIC|NULL;NULL;NULL
Concomitant Medication|MIANSERINE|NULL;NULL;NULL
Concomitant Medication|MUCICLAR|NULL;NULL;NULL
Concomitant Medication|NICARDIPINE|NULL;NULL;NULL
Concomitant Medication|TRIMETAZIDINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DICLOFENAC COLESTYRAMINE|NULL;NULL;NULL
Concomitant Medication|DIMETINDENE MALEATE|NULL;NULL;NULL
Concomitant Medication|TELDANE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Burning esophagus;Oesophageal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal stuffiness;Nasal congestion;Nasal congestion and inflammations;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Concomitant Medication|NODOZ|NULL;NULL;NULL
Concomitant Medication|NOVAHISTINE DH|NULL;NULL;NULL
Lab Test|Urine Casts|1+
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;Moderate;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|RBC urine;Red blood cells urine;Urinalysis NEC;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Nightmares;Nightmare;Parasomnias;MILD;RECOVERED
Concomitant Medication|NAFTIDROFURYL|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Increased urinary frequency;Pollakiuria;Bladder and urethral symptoms;Mild;Resolved
Adverse Event|Gastrointestinal haemorrhages NEC|Blood in stool;Haematochezia;Non-site specific gastrointestinal haemorrhages;Mild;Resolved
Adverse Event|Breast disorders|Breast lump;Breast mass;Breast disorders NEC;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Poison ivy rash;Dermatitis contact;Dermatitis and eczema;Mild;Resolved
Adverse Event|Neurological disorders NEC|Dysesthesia;Dysaesthesia;Paraesthesias and dysaesthesias;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Runny nose;Rhinorrhoea;Upper respiratory tract signs and symptoms;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramps in legs;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Epigastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Delayed gastric emptying;Impaired gastric emptying;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Dry scalp;Dry skin;Dermal and epidermal conditions NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Fatigueability;Fatigue;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Increased muscle tone;Hypertonia;Muscle tone abnormal;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory and mediastinal neoplasms malignant and unspecified|Carcinoma of lung;Lung neoplasm malignant;Respiratory tract and pleural neoplasms malignant cell type unspecified NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Tracheostomy infection;Tracheostomy infection;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BUSPIRONE|NULL;NULL;NULL
Concomitant Medication|GLUCERNA|NULL;NULL;NULL
Concomitant Medication|GUAIFENEX|NULL;NULL;NULL
Concomitant Medication|METFORMIN HYDROCHLORIDE|NULL;NULL;NULL
Lab Test|Platelets|229,000
Adverse Event|Neurological disorders NEC|Algodystrophy;Complex regional pain syndrome;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Circulatory instability;Cardiovascular disorder;Cardiac disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain knee;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;SEVERE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disorder;Sleep disorder;Sleep disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ADEPAL|NULL;NULL;NULL
Concomitant Medication|BI-TILDIEM|NULL;NULL;NULL
Concomitant Medication|CALCITAR|NULL;NULL;NULL
Concomitant Medication|CALSYN|NULL;NULL;NULL
Concomitant Medication|CORVASAL|NULL;NULL;NULL
Concomitant Medication|GOMENOL|NULL;NULL;NULL
Concomitant Medication|IKOREL|NULL;NULL;NULL
Concomitant Medication|NALGESIC|NULL;NULL;NULL
Concomitant Medication|RHINATHIOL|NULL;NULL;NULL
Concomitant Medication|SEROPRAM|NULL;NULL;NULL
Concomitant Medication|SILOMAT|NULL;NULL;NULL
Adverse Event|Electrolyte and fluid balance conditions|Fluid intake reduced;Fluid intake reduced;Fluid intake decreased;NULL;NULL
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;NULL;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy;Gastrostomy;Gastric therapeutic procedures;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;NULL;NULL
Concomitant Medication|ROBITUSSIN-DAC|NULL;NULL;NULL
Adverse Event|Prostatic disorders (excl infections and inflammations)|Benign prostatic hyperplasia;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CIPROXIN|NULL;NULL;NULL
Concomitant Medication|OMNIC|NULL;NULL;NULL
Concomitant Medication|SANDOSTATINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Epigastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Traumatic fracture;Traumatic fracture;Fractures and dislocations NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ORNICETIL|NULL;NULL;NULL
Concomitant Medication|SEDATIF PC|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood in urine;Blood urine present;Urinalysis NEC;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Bilirubin total high;Blood bilirubin increased;Liver function analyses;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Yeast infection of the skin;Fungal skin infection;Fungal infections NEC;MILD;RECOVERED
Concomitant Medication|TAZORAC|NULL;NULL;NULL
Concomitant Medication|TRIMOX|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;Moderate;NULL
Adverse Event|Mental impairment disorders|Memory deficit;Memory impairment;Memory loss (excl dementia);Mild;NULL
Adverse Event|Neurological disorders NEC|Dizzy;Dizziness;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Mental impairment disorders|Cognitive impairment;Cognitive disorder;Mental impairment (excl dementia and memory loss);Mild;NULL
Adverse Event|Neurological disorders NEC|Paresthesia hand;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Neurological disorders NEC|Psychomotor skills impaired;Psychomotor skills impaired;Nervous system disorders NEC;Mild;NULL
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Mild;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure abnormal;Blood pressure abnormal;Vascular tests NEC (incl blood pressure);MILD;RECOVERED
Adverse Event|Injuries NEC|Open wound of fingers, without mention of complication;Open wound;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Lack of feeling emotions;Emotional poverty;Emotional and mood disturbances NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Light-headed feeling;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;Moderate;NULL
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Numbness in feet;Hypoaesthesia;Sensory abnormalities NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;Moderate;NULL
Concomitant Medication|OMEGA III|NULL;NULL;NULL
Concomitant Medication|VITAMIN B12|30;;Oral
Concomitant Medication|VITAMIN E|4000;;Oral
Adverse Event|Bone and joint injuries|Broken nose;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain (with radiation);Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Concomitant Medication|CALCIUM + VITAMIN D|600;BID (twice a day);Oral
Concomitant Medication|CREATINE|700;;Oral
Concomitant Medication|ACTOS|30;QD (every day);Oral
Concomitant Medication|DIOVAN|160;QD (every day);Oral
Concomitant Medication|GLYBURIDE|5;QD (every day);Oral
Concomitant Medication|TIAZAC|360;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Pharyngitis;Pharyngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;Mild;Continuing
Adverse Event|Mood disorders and disturbances NEC|Lability emotional;Affect lability;Affect alterations NEC;Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;Continuing
Adverse Event|Muscle disorders|Jaw spasm;Trismus;Muscle tone abnormalities;Moderate;Continuing
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Severe;Continuing
Concomitant Medication|CEFONICID|NULL;NULL;NULL
Concomitant Medication|PICOSULFATE DE SODIUM|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle cramps aggravated;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dizzy spells;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated haemoglobin increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Concomitant Medication|AVAFORTAN|NULL;NULL;NULL
Concomitant Medication|BECOTIDE|NULL;NULL;NULL
Concomitant Medication|CARBOSYLANE|NULL;NULL;NULL
Concomitant Medication|OSTEOGEL|NULL;NULL;NULL
Concomitant Medication|PRINCI B|NULL;NULL;NULL
Concomitant Medication|RELVENE|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Defecation urgency;Defaecation urgency;Gastrointestinal spastic and hypermotility disorders;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Contusion of shoulder region;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema fingers;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Irradiating pain;Pain;Pain and discomfort NEC;SEVERE;RECOVERED
Adverse Event|Injuries NEC|Excoriation;Excoriation;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Aphasia;Aphasia;Cortical dysfunction NEC;SEVERE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site inflammation;Procedural site reaction;Non-site specific procedural complications;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Diaphoresis;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of mouth;Mouth injury;Site specific injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;SEVERE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Eye redness;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;MODERATE;RECOVERED
Adverse Event|Joint disorders|Pain in elbow;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;MODERATE;RECOVERED
Concomitant Medication|SODIUM SULAMYD|NULL;NULL;NULL
Concomitant Medication|TRIAZIDE|NULL;NULL;NULL
Concomitant Medication|ZINCOFAX|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Cold sweat;Cold sweat;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|SNAKE VENOM ANTISERUM|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Shivering;Chills;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Sensation of warmth;Feeling hot;Feelings and sensations NEC;MODERATE;RECOVERED
Concomitant Medication|SEDARISTON|NULL;NULL;NULL
Concomitant Medication|SPONDYLONAL|NULL;NULL;NULL
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure diastolic abnormal;Blood pressure diastolic abnormal;Vascular tests NEC (incl blood pressure);MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrooesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Nightmares;Nightmare;Parasomnias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of legs;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;MODERATE;RECOVERED
Concomitant Medication|DETENSIEL|NULL;NULL;NULL
Concomitant Medication|CREATINE|10;QD (every day);Oral
Adverse Event|Headaches|Headache;Headache;Headaches NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Menstrual cycle and uterine bleeding disorders|Amenorrhea;Amenorrhoea;Menstruation with decreased bleeding;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Disorder speech;Speech disorder;Speech and language abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;SEVERE;RECOVERED
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezing;Wheezing;Bronchospasm and obstruction;MODERATE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezing inspiratory;Wheezing;Bronchospasm and obstruction;MILD;RECOVERED
Concomitant Medication|PROGESTERONE|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM|300;;Oral
Adverse Event|Anal and rectal conditions NEC|Anal fissure;Anal fissure;Anal and rectal disorders NEC;MILD;RECOVERED
Adverse Event|Mental impairment disorders|Forgetfulness;Memory impairment;Memory loss (excl dementia);MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Tooth infection;Tooth infection;Dental and oral soft tissue infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Dental and gingival conditions|Tooth pain;Toothache;Dental pain and sensation disorders;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|EQUATE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Leg injury;Limb injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Unsteadiness;Balance disorder;Cerebellar coordination and balance disturbances;MILD;RECOVERED
Concomitant Medication|ALENDRONATE|70;Once per week;Oral
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|1600;BID (twice a day);Other (specify)
Concomitant Medication|ATORVASTATIN|10;QD (every day);Oral
Concomitant Medication|ATROPINE|AS NEEDED;TID (three times a day);Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Vasovagal reaction;Presyncope;Neurological signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|CLAVUCID|NULL;NULL;NULL
Concomitant Medication|DYTENZIDE|NULL;NULL;NULL
Concomitant Medication|PENTAZOCINE|NULL;NULL;NULL
Concomitant Medication|PROPACETAMOL HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|SUCRALFAAT|NULL;NULL;NULL
Concomitant Medication|ZOLPIDEM HEMITARTRATE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Aural disorders NEC|Sensation of pressure in ear;Ear discomfort;Ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Watery diarrhea;Diarrhoea;Diarrhoea (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Glucosuria;Glycosuria;Urinary abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit increased;Haematocrit increased;Red blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|RBC count increased;Red blood cell count increased;Red blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine white blood cell increased;White blood cells urine positive;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Groin pain;Groin pain;Soft tissue disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cutaneous neoplasms benign|Sebaceous cyst;Dermal cyst;Skin cysts and polyps;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sneezing;Sneezing;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PILOCARPINE|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);Mild;         .
Adverse Event|Epidermal and dermal conditions|Allergic rash;Dermatitis allergic;Dermatitis and eczema;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Eye infection;Eye infection;Eye and eyelid infections;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Appetite and general nutritional disorders|Increased appetite;Increased appetite;Appetite disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Seborrhoeic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Throat infection;Pharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|BETAMETHASONE VALERATE|NULL;NULL;NULL
Concomitant Medication|CREATINE|2;BID (twice a day);Oral
Concomitant Medication|FLUCTIN|20;QD (every day);Oral
Concomitant Medication|VITAMIN E|2000;TID (three times a day);Oral
Lab Test|Urine RBCs|3+++
Adverse Event|Pulmonary vascular disorders|Pulmonary embolus;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;Severe;NULL
Concomitant Medication|ATROVENT|2;BID (twice a day);Inhalation
Adverse Event|Thyroid gland disorders|Enlarged thyroid;Goitre;Thyroid disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux disease;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness shoulder;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Arthritic pains;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety disorder;Anxiety disorder;Anxiety disorders NEC;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depressive disorder;Depression;Depressive disorders;MODERATE;RECOVERED
Adverse Event|Gastrointestinal conditions NEC|Food poisoning;Food poisoning;Gastrointestinal disorders NEC;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|MEGAMAG|NULL;NULL;NULL
Concomitant Medication|COENZYME Q10|150;BID (twice a day);Oral
Concomitant Medication|GINKGO BILOBA|60;QD (every day);Oral
Concomitant Medication|N ACETYL CYSTEIN|600;QD (every day);Oral
Concomitant Medication|PEPCID|U;;Intravenous
Concomitant Medication|PHENERGAN|25;QID (four times a day);Oral
Concomitant Medication|PHENERGAN|U;;Intravenous
Concomitant Medication|PHENERGAN|25;QID (four times a day);Rectal
Concomitant Medication|VITAMIN B12|1000;QD (every day);Oral
Concomitant Medication|VITAMIN E|1000;Every morning;Oral
Concomitant Medication|VITAMIN E|200;Every evening;Oral
Adverse Event|Gastrointestinal signs and symptoms|Acid indigestion;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Acute retention of urine;Urinary retention;Bladder and urethral symptoms;SEVERE;RECOVERED
Adverse Event|Bone and joint injuries|Fracture of clavicle;Clavicle fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Shoulder fracture;Upper limb fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Gastrointestinal haemorrhages NEC|GI bleed;Gastrointestinal haemorrhage;Non-site specific gastrointestinal haemorrhages;MILD;RECOVERED
Adverse Event|Bacterial infectious disorders|Helicobacter pylori infection;Helicobacter infection;Helicobacter infections;MODERATE;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Pain in spine;Bone pain;Bone related signs and symptoms;MILD;RECOVERED
Adverse Event|Mental impairment disorders|Short-term memory loss;Amnesia;Memory loss (excl dementia);MILD;ONGOING (PERSISTENT)
Concomitant Medication|IMITREX|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Nervousness;Nervousness;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Trismus;Trismus;Muscle tone abnormalities;MILD;RECOVERED
Concomitant Medication|KENACORT|NULL;NULL;NULL
Concomitant Medication|LACTITOL|NULL;NULL;NULL
Concomitant Medication|SIMVASTATIN|NULL;NULL;NULL
Concomitant Medication|VITAMIN D3|NULL;NULL;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menses delayed;Menstruation delayed;Menstruation with decreased bleeding;MILD;RECOVERED
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema lower limb;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|NOZINAN|NULL;NULL;NULL
Adverse Event|Lipid metabolism disorders|Hypercholesterolaemia;Hypercholesterolaemia;Elevated cholesterol;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Orthostatic dysregulation;Orthostatic intolerance;Autonomic nervous system disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Retching;Retching;Nausea and vomiting symptoms;MILD;RECOVERED
Concomitant Medication|OXYTETRACYCLIN|NULL;NULL;NULL
Concomitant Medication|ALPHA LIPOIC ACID|2;QD (every day);Oral
Concomitant Medication|CALCIUM & MAGNESIUM PLUS|4;QD (every day);Oral
Concomitant Medication|CARNOMAX|70;QD (every day);Oral
Concomitant Medication|COENZYME Q10|400;BID (twice a day);Oral
Concomitant Medication|CORTEF|5;TID (three times a day);Oral
Concomitant Medication|GLUTATHIONE|10;Three times per week;Intravenous
Concomitant Medication|KYO-DOPHILUS|330;BID (twice a day);Oral
Concomitant Medication|L-LYSINE|500;TID (three times a day);Oral
Concomitant Medication|LITHIUM|10;TID (three times a day);Oral
Concomitant Medication|MAG GLYCINATE|200;QD (every day);Oral
Concomitant Medication|MULTIVITAMIN|2;QD (every day);Oral
Concomitant Medication|DHA|500;BID (twice a day);Oral
Concomitant Medication|SELENIUM|130;BID (twice a day);Oral
Concomitant Medication|VITAMIN B|1;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|500;Three times per week;Intravenous
Concomitant Medication|ZINC|440;QD (every day);Oral
Adverse Event|Epidermal and dermal conditions|Erythema periorbital;Erythema;Erythemas;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful L arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Lip laceration;Mouth injury;Site specific injuries NEC;MILD;RECOVERED
Adverse Event|Eye disorders NEC|Periorbital swelling;Eye swelling;Ocular disorders NEC;MILD;RECOVERED
Lab Test|RBC Morphology: Macrocytosis|2+
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional incontinence;Affect lability;Affect alterations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hair growth abnormal;Hair growth abnormal;Pilar disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Increased appetite;Increased appetite;Appetite disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Fracture pain;Fracture pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Bone pain;Bone pain;Bone related signs and symptoms;MILD;ONGOING (PERSISTENT)
Lab Test|Urine Squamous Epithelial Cells|Large
Adverse Event|Oral soft tissue conditions|Sores mouth;Stomatitis;Stomatitis and ulceration;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Concomitant Medication|ROBITUSSIN AC|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscular weakness;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vulva disorder;Vulval disorder;Vulvovaginal disorders NEC;MILD;RECOVERED
Adverse Event|Urethral disorders (excl calculi)|Urethral irritation;Urethritis noninfective;Urethral infections and inflammations;MILD;RECOVERED
Lab Test|Urine Hemoglobin|-
Adverse Event|Tissue disorders NEC|Calcium deposits;Calcinosis;Trophic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint stiffness;Joint stiffness;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|NOVASEN|NULL;NULL;NULL
Concomitant Medication|SIALOR|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Bowel movement irregularity;Bowel movement irregularity;Gastrointestinal dyskinetic disorders;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash on face;Rash;Rashes, eruptions and exanthems NEC;MISSING DATA;UNKNOWN
Adverse Event|Respiratory disorders NEC|Voice alteration;Dysphonia;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle twitch;Muscle twitching;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|FLUVOXAMINE MALEATE|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Pulsatile tinnitus;Tinnitus;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DIFRAREL|NULL;NULL;NULL
Concomitant Medication|POLY-KARAYA|NULL;NULL;NULL
Concomitant Medication|VALPROMIDE|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Increased blood pressure;Blood pressure increased;Vascular tests NEC (incl blood pressure);Mild;NULL
Concomitant Medication|ELAVIL|10;QD (every day);Oral
Concomitant Medication|ELAVIL|5;QHS (at bedtime);Oral
Concomitant Medication|LECITHIN|1200;Every other day;Oral
Concomitant Medication|OMEGA 3|1000;BID (twice a day);Oral
Concomitant Medication|ROBITUSSIN DM|1;TID (three times a day);Oral
Concomitant Medication|SELENIUM|100;Once per week;Oral
Concomitant Medication|VITAMIN B6|50;Every other day;Oral
Concomitant Medication|VITAMIN C|500;Every other day;Oral
Concomitant Medication|VITAMIN E|400;Every other day;Oral
Concomitant Medication|FOLIC ACID|800;Every other day;Oral
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;Mild;NULL
Concomitant Medication|BACLOFEN|5/10;TID (three times a day);Oral
Concomitant Medication|BETACAROTENE|5000;QD (every day);Oral
Concomitant Medication|FOLIC ACID|1;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE|500;QD (every day);Oral
Concomitant Medication|MAGNESIUM|2;QD (every day);Oral
Concomitant Medication|PREMPRO|0.625/5;QD (every day);Oral
Concomitant Medication|TYLENOL W/CODEINE NO. 3|300/30;PRN (as needed);Oral
Concomitant Medication|TYLENOL|650;QHS (at bedtime);Oral
Concomitant Medication|TYLENOL PM|325/25;QHS (at bedtime);Oral
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;Mild;Continuing
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine output decreased;Urine output decreased;Urinary tract function analyses NEC;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Fecal impaction;Faecaloma;Faecal abnormalities NEC;Severe;Resolved
Adverse Event|Administration site reactions|Injection site irritation;Injection site irritation;Injection site reactions;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;         .
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Night sweat;Night sweats;Apocrine and eccrine gland disorders;Mild;NULL
Concomitant Medication|LIORESAL|5;TID (three times a day);Oral
Concomitant Medication|VITAMIN B COMPLEX|100;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|1000;;Oral
Adverse Event|Red blood cell disorders|RBC abnormal (NOS);Red blood cell abnormality;Red blood cell abnormal findings NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramp muscle;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Halitosis;Breath odour;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Calf pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|General system disorders NEC|Hernia;Hernia;Hernias NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Nephrolithiasis;Nephrolithiasis;Renal lithiasis;SEVERE;RECOVERED
Adverse Event|Cardiac arrhythmias|Defect conduction intraventricular;Conduction disorder;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Numbness in face;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Obesity;Obesity;General nutritional disorders NEC;SEVERE;RECOVERED
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Difficulty voiding;Dysuria;Bladder and urethral symptoms;SEVERE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary hesitancy;Urinary hesitation;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|CITRO-MAG|NULL;NULL;NULL
Concomitant Medication|CORTISPORIN|NULL;NULL;NULL
Concomitant Medication|DEXTROSE W/SODIUM CHLORIDE|NULL;NULL;NULL
Concomitant Medication|DIXARIT|NULL;NULL;NULL
Concomitant Medication|NITROFURANTOIN|NULL;NULL;NULL
Concomitant Medication|NORFLOXACIN|NULL;NULL;NULL
Concomitant Medication|PROVIODINE|NULL;NULL;NULL
Adverse Event|Skin vascular abnormalities|Increased tendency to bruise;Increased tendency to bruise;Purpura and related conditions;MILD;RECOVERED
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED
Concomitant Medication|DICLOFENAC SODIUM|NULL;NULL;NULL
Concomitant Medication|NOVO-SPIROZINE|NULL;NULL;NULL
Concomitant Medication|NOVOXAPAM|NULL;NULL;NULL
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;Mild;NULL
Adverse Event|Urinary tract signs and symptoms|Urination abnormal NOS;Micturition disorder;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Hiccups;Hiccups;Lower respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep problem;Sleep disorder;Sleep disorders NEC;MILD;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Reactive depression;Depression;Depressive disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Scratch;Scratch;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sore back;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|KETOPROFEN|NULL;NULL;NULL
Concomitant Medication|BETA CAROTENE|10000;TID (three times a day);Oral
Concomitant Medication|MINOCYCLINE|U;Unknown;Oral
Concomitant Medication|PREVACID|30;BID (twice a day);Oral
Concomitant Medication|RILUTEK|100;QHS (at bedtime);Oral
Concomitant Medication|TRIMOX|1000;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|1;TID (three times a day);Oral
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Laceration of finger;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Synovial and bursal disorders|Shoulder bursitis;Bursitis;Bursal disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Motion sickness;Motion sickness;Inner ear signs and symptoms;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Oral herpes;Oral herpes;Herpes viral infections;SEVERE;RECOVERED
Concomitant Medication|DRAMAMINE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;Moderate;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;Severe;Resolved
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Continuing
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;Mild;Continuing
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);Severe;Resolved
Adverse Event|Neuromuscular disorders|Muscle spasticity aggravated;Muscle spasticity;Neuromuscular disorders NEC;Moderate;Continuing
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;Severe;Continuing
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;Moderate;Continuing
Concomitant Medication|CENTRUM SILVER|1;QD (every day);Oral
Concomitant Medication|VITAMIN B|1;QD (every day);Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|AMITRIPTYLINE|20;BID (twice a day);Oral
Concomitant Medication|AMITRIPTYLINE|30;TID (three times a day);Oral
Concomitant Medication|AMITRIPTYLINE|75;TID (three times a day);Oral
Concomitant Medication|CARBOCISTEINE|30;PRN (as needed);Oral
Concomitant Medication|DICLOFENAC|139.5;TID (three times a day);Oral
Concomitant Medication|ESTRADIOL VALERATE|1;QD (every day);Oral
Concomitant Medication|FLUOXETINE|20;QD (every day);Oral
Concomitant Medication|LORAZEPAM|2.5;QHS (at bedtime);Sublingual
Concomitant Medication|NATRIUMPICOSULFAT|7;PRN (as needed);Oral
Concomitant Medication|PARACETAMOL|1000;PRN (as needed);Intravenous
Concomitant Medication|PARACETAMOL|500;PRN (as needed);Oral
Concomitant Medication|TRAMADOL HYDROCHLORIDE|30;TID (three times a day);Other (specify)
Concomitant Medication|AMOXICILLIN|1750;BID (twice a day);Other (specify)
Concomitant Medication|CLAVULANIC ACID|250;BID (twice a day);Other (specify)
Concomitant Medication|PARACETAMOL|500;PRN (as needed);Other (specify)
Adverse Event|Bone and joint injuries|Malleolar fracture;Ankle fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Thoracic vertebral fracture T12;Thoracic vertebral fracture;Spinal fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tracheitis;Tracheitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Mood disorder NOS;Affective disorder;Mood disorders NEC;MODERATE;RECOVERED
Concomitant Medication|AMOXICILLIN|3;TID (three times a day);Oral
Concomitant Medication|BROMAZEPAM|1.5;QD (every day);Oral
Concomitant Medication|ENOXAPARIN|UNK;QD (every day);Subcutaneous
Concomitant Medication|FONDAPARINUX SODIUM|2.5;QD (every day);Subcutaneous
Concomitant Medication|HYDROCHLOROTHIAZIDE|80;QD (every day);Oral
Concomitant Medication|NEBIVOLOL|2.5;QD (every day);Oral
Concomitant Medication|POTASSIUM CHLORIDE|600;QD (every day);Oral
Concomitant Medication|ZOPICLONE|3.75;QD (every day);Oral
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Abnormal ECG;Electrocardiogram abnormal;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Abnormal ECG;Electrocardiogram abnormal;ECG investigations;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Aphasia;Aphasia;Cortical dysfunction NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Middle ear disorders (excl congenital)|Tympanic membrane disorder;Tympanic membrane disorder;Tympanic membrane disorders (excl infections);MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Eye irritation;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Adverse Event|Ocular neuromuscular disorders|Lid lag;Lid lag;Eyelid movement disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Ear and labyrinthine disorders congenital|Congenital deafness;Deafness congenital;Hearing disorders congenital;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Vision disorders|Farsighted;Hypermetropia;Refractive and accommodative disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Papular skin eruption;Rash papular;Papulosquamous conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Frontotemporal dementia;Frontotemporal dementia;Dementia (excl Alzheimer's type);MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|General discomfort;Discomfort;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Gamma-GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Enzyme investigations NEC|Blood alkaline phosphatase high;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Chloride low;Blood chloride decreased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Calcium low;Blood calcium decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Enlarged prostate;Prostatomegaly;Prostatic signs, symptoms and disorders NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Stupor;Stupor;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Stupor;Stupor;Disturbances in consciousness NEC;SEVERE;RECOVERED
Concomitant Medication|CEFOTAN|NULL;NULL;NULL
Concomitant Medication|DURACT|NULL;NULL;NULL
Concomitant Medication|GINSANA|NULL;NULL;NULL
Concomitant Medication|NAPHCON A|NULL;NULL;NULL
Adverse Event|Joint disorders|Capsulitis;Periarthritis;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Deliria (incl confusion)|Confusional state;Confusional state;Confusion and disorientation;MODERATE;RECOVERED
Concomitant Medication|CYTOTEC|NULL;NULL;NULL
Concomitant Medication|SPECIAFOLDINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Decubitus ulcer;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|CYCLOBENZAPRINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|GEMFIBROZIL|600;BID (twice a day);Oral
Concomitant Medication|GLUCOPHAGE|500;QD (every day);Oral
Concomitant Medication|LIDOCAINE|2;1 time only;Subcutaneous
Concomitant Medication|MULTIVITAMIN|1/1;QD (every day);Oral
Concomitant Medication|PRANDIN|0.5;TID (three times a day);Oral
Concomitant Medication|VITAMIN B|1/1;QD (every day);Oral
Concomitant Medication|ZETIA|10;QHS (at bedtime);Oral
Adverse Event|General system disorders NEC|Feeling of warmth;Feeling hot;Feelings and sensations NEC;Mild;NULL
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Postural hypotension;Orthostatic hypotension;Vascular hypotensive disorders;Mild;NULL
Concomitant Medication|DEXTROMETHORPHAN|25;BID (twice a day);Oral
Concomitant Medication|QUINIDINE|25;BID (twice a day);Oral
Adverse Event|Headaches|Chronic migraine;Migraine;Migraine headaches;SEVERE;UNKNOWN
Adverse Event|Skin appendage conditions|Cold sweat;Cold sweat;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Hearing disorders|Hard of hearing;Hypoacusis;Hearing losses;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Swelling of elbows;Joint swelling;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Migraine;Migraine;Migraine headaches;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Fungal foot infection;Tinea pedis;Tinea infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ANAPROX|NULL;NULL;NULL
Concomitant Medication|DIOCTO-C|NULL;NULL;NULL
Concomitant Medication|ENEMA|NULL;NULL;NULL
Concomitant Medication|FLUOCINONIDE|NULL;NULL;NULL
Concomitant Medication|NP-27|NULL;NULL;NULL
Concomitant Medication|ORUDIS|NULL;NULL;NULL
Lab Test|Polychromasia|2+
Lab Test|RBC Morphology: Microcytosis|3+
Lab Test|RBC Morphology: Schistocytes|+
Lab Test|RBC Morphology: Elliptocytes|1+
Lab Test|RBC Morphology: Tear drop cells|1+
Lab Test|RBC Morphology: Microcytosis|2+
Lab Test|RBC Morphology: Anisocytosis|3+
Lab Test|RBC Morphology: Anisocytosis|2+
Lab Test|RBC Morphology: Target Cells|1+
Lab Test|RBC Morphology: Target Cells|2+
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|ECG abnormal;Electrocardiogram abnormal;ECG investigations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Coronary artery disorders|Septal myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MEGACE|NULL;NULL;NULL
Concomitant Medication|AFRIN|2;PRN (as needed);Intranasal
Concomitant Medication|ALLEREX|1;BID (twice a day);Oral
Concomitant Medication|ALPHA LIPOIC ACID|1;QD (every day);Oral
Concomitant Medication|ASTELIN|2;QD (every day);Inhalation
Concomitant Medication|AZITHROMAX|500;QD (every day);Oral
Concomitant Medication|ELECTROLYTE|2400;BID (twice a day);Oral
Concomitant Medication|FISH OIL|2;BID (twice a day);Oral
Concomitant Medication|FOLIC ACID|0.8;QD (every day);Oral
Concomitant Medication|GLUTAMATE|1;QD (every day);Oral
Concomitant Medication|L-THREONINE|200;QD (every day);Oral
Concomitant Medication|MUCINEX|1350;BID (twice a day);Oral
Concomitant Medication|PROBIOTIC|1;QD (every day);Oral
Concomitant Medication|VITAMIN B COMPLEX|2;BID (twice a day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;Resolved with Residual
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Mild;Resolved
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;Resolved with Residual
Concomitant Medication|FENTANYL TRANSDERMAL SYSTEM|NULL;NULL;NULL
Concomitant Medication|SECONAL|NULL;NULL;NULL
Concomitant Medication|TRAMADOL HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dizzy spells;Dizziness;Neurological signs and symptoms NEC;Mild;Continuing
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Moderate;Resolved with Residual
Adverse Event|Epidermal and dermal conditions|Itch;Pruritus;Pruritus NEC;Mild;Resolved
Adverse Event|Bone and joint injuries|Leg fracture;Lower limb fracture;Lower limb fractures and dislocations;Moderate;Resolved
Concomitant Medication|DROPERIDOL|NULL;NULL;NULL
Concomitant Medication|HALOBETASOL|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Coronary artery disease;Coronary artery disease;Coronary artery disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Infection ingrowing toenail;Paronychia;Skin structures and soft tissue infections;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;Marked;NULL
Adverse Event|Injuries NEC|Lip laceration;Mouth injury;Site specific injuries NEC;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;Marked;NULL
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;Moderate;NULL
Adverse Event|Oral soft tissue conditions|Tingling tongue;Paraesthesia oral;Oral soft tissue pain and paraesthesia;Mild;NULL
Concomitant Medication|DIPROLENE AF|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Halitosis;Breath odour;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Rhinitis allergic;Rhinitis allergic;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ACETIC ACID|NULL;NULL;NULL
Concomitant Medication|ANADIN|NULL;NULL;NULL
Concomitant Medication|PHOLCODINE LINCTUS|NULL;NULL;NULL
Concomitant Medication|ACEDICONE|NULL;NULL;NULL
Concomitant Medication|BEROTEC|NULL;NULL;NULL
Concomitant Medication|CIPROFIBRATE|NULL;NULL;NULL
Concomitant Medication|PNEUMOVAX 23|NULL;NULL;NULL
Concomitant Medication|TUSSINOL|NULL;NULL;NULL
Adverse Event|Platelet disorders|Thrombopenia;Thrombocytopenia;Thrombocytopenias;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruise;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Bad dreams;Abnormal dreams;Parasomnias;MILD;RECOVERED
Adverse Event|Injuries NEC|Falling;Fall;Non-site specific injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urine incontinence;Urinary incontinence;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash on face;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Aural disorders NEC|Ear congestion;Ear congestion;Ear disorders NEC;Mild;Resolved
Concomitant Medication|FLECAINIDE ACETATE|NULL;NULL;NULL
Concomitant Medication|MAVIK|NULL;NULL;NULL
Concomitant Medication|NYSTATIN W/TRIAMCINOLONE|NULL;NULL;NULL
Concomitant Medication|PEPPERMINT OIL|NULL;NULL;NULL
Adverse Event|Spinal cord and nerve root disorders|Radiculitis;Radiculitis;Spinal cord and nerve root disorders NEC;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Clonus;Clonus;Neurological signs and symptoms NEC;Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Dandruff;Dandruff;Scaly conditions;Mild;Resolved
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Moderate;Continuing
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Erythematous rash;Rash erythematous;Erythemas;Mild;Resolved
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngospasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;Moderate;Continuing
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;Moderate;Continuing
Adverse Event|Joint disorders|Adhesive capsulitis;Periarthritis;Joint related disorders NEC;Moderate;Continuing
Adverse Event|Middle ear disorders (excl congenital)|Tympanic membrane perforation;Tympanic membrane perforation;Tympanic membrane disorders (excl infections);Mild;Resolved
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;Mild;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Mild;Resolved
Concomitant Medication|BENADRYL LOTION N|NULL;NULL;NULL
Concomitant Medication|NATURAL TEARS|NULL;NULL;NULL
Concomitant Medication|SOY ISOFLAVONE|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrointestinal hypomotility;Gastrointestinal hypomotility;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Potassium decreased;Blood potassium decreased;Mineral and electrolyte analyses;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|BELLADONNA HERB|NULL;NULL;NULL
Concomitant Medication|BELLADONNA TINCTURE|NULL;NULL;NULL
Concomitant Medication|CHILDRENS CHEWABLE VITAMINS|NULL;NULL;NULL
Concomitant Medication|ENULOSE|NULL;NULL;NULL
Concomitant Medication|ESTAZOLAM|NULL;NULL;NULL
Adverse Event|Headaches|Nocturnal headache;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;MILD;RECOVERED
Concomitant Medication|CLOZAPINE|NULL;NULL;NULL
Concomitant Medication|CREATININE|NULL;NULL;NULL
Concomitant Medication|LEVOTHROID|NULL;NULL;NULL
Concomitant Medication|PANTOTHENIC ACID|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Burning micturition;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|GGT increased;Gamma-glutamyltransferase increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash on face;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Rotator cuff injury;Rotator cuff syndrome;Joint related disorders NEC;MODERATE;RECOVERED
Concomitant Medication|CALMAG|NULL;NULL;NULL
Concomitant Medication|PROFLAVANOL C 100|NULL;NULL;NULL
Lab Test|RBC Morphology: Spherocytes|+
Adverse Event|Injuries NEC|Skin laceration;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED
Lab Test|Urine blood|Small
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Weakness in extremity;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Generalized muscle aches;Myalgia;Muscle pains;MILD;RECOVERED
Adverse Event|Muscle disorders|Generalized muscle aches;Myalgia;Muscle pains;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Water, electrolyte and mineral investigations|Potassium low;Blood potassium decreased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle fatigue;Muscle fatigue;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Abrasions;Excoriation;Skin injuries NEC;MODERATE;RECOVERED
Concomitant Medication|PROPANTHELINE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Blister;Blister;Bullous conditions;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Wrist pain;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|ORTHO-NOVUM 7/7/7|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;NULL;NULL
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Vital capacity decreased;Vital capacity decreased;Respiratory and pulmonary function diagnostic procedures;NULL;NULL
Concomitant Medication|HYDRALAZINE|NULL;NULL;NULL
Adverse Event|Dental and gingival conditions|Inflammation gum;Gingivitis;Gingival disorders NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Nocturnal agitation;Agitation;Anxiety symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Hepatic and hepatobiliary disorders|Liver damage;Liver injury;Hepatic and hepatobiliary disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Cloudy vision;Vision blurred;Visual disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CETIRIZIN|NULL;NULL;NULL
Concomitant Medication|THIAMINE CHLORIDE|NULL;NULL;NULL
Concomitant Medication|XIPAMIDE|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy aggravated;Hypersensitivity;Allergic conditions NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Neck rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Type I diabetes mellitus;Type 1 diabetes mellitus;Diabetes mellitus (incl subtypes);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;SEVERE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Reactive depression;Depression;Depressive disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Tachycardia nervous;Tachycardia;Rate and rhythm disorders NEC;MILD;RECOVERED
Concomitant Medication|METAMIZOLE|NULL;NULL;NULL
Concomitant Medication|PAROXETIN|NULL;NULL;NULL
Concomitant Medication|TAFIL|NULL;NULL;NULL
Concomitant Medication|TRIMIPRAMINE MESILATE|NULL;NULL;NULL
Adverse Event|Tongue conditions|Tongue disorder;Tongue disorder;Tongue disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Feeling hot;Feeling hot;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cranial nerve disorders (excl neoplasms)|Altered smell sensation;Parosmia;Olfactory nerve disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Pulled hamstring;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED
Concomitant Medication|FLUMADINE|NULL;NULL;NULL
Concomitant Medication|WHEAT GERM|NULL;NULL;NULL
Concomitant Medication|ZINC CHELATE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Lump feeling in throat;Sensation of foreign body;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Bee sting;Arthropod sting;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|COLOSTRUM|NULL;NULL;NULL
Concomitant Medication|MYOTONINE|NULL;NULL;NULL
Concomitant Medication|NAPHAZOLINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|SULFATRIM|NULL;NULL;NULL
Lab Test|Urine Protein|2++
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;Mild;NULL
Adverse Event|Iron and trace metal metabolism disorders|Iron deficiency;Iron deficiency;Iron deficiencies;Mild;NULL
Adverse Event|Respiratory disorders NEC|Hoarseness;Dysphonia;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CITRACAL + D|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;NULL
Concomitant Medication|CIPRAMIL|20;BID (twice a day);Oral
Adverse Event|General system disorders NEC|Sickness;Malaise;Asthenic conditions;MILD;RECOVERED
Adverse Event|Dental and gingival conditions|Tooth abnormal;Tooth disorder;Dental disorders NEC;MILD;RECOVERED
Concomitant Medication|ACETYLCYSTEIN|1200;BID (twice a day);Oral
Concomitant Medication|IBUPROFEN|400;QD (every day);Oral
Concomitant Medication|MCP|60;TID (three times a day);Oral
Concomitant Medication|PANDEMRIX|0.5;QD (every day);Oral
Concomitant Medication|STANGYL|100;QD (every day);Oral
Concomitant Medication|ZOP|7.5;QD (every day);Oral
Adverse Event|Ocular haemorrhages and vascular disorders NEC|Conjunctival hemorrhage;Conjunctival haemorrhage;Conjunctival and corneal bleeding and vascular disorders;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pityriasis rosea;Pityriasis rosea;Papulosquamous conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ERCEFURYL|NULL;NULL;NULL
Concomitant Medication|FLUIMUCIL|NULL;NULL;NULL
Concomitant Medication|FLUVIRINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysesthesia;Dysaesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Psychiatric disorders NEC|Psychic disturbance;Mental disorder;Mental disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urinary protein increased;Protein urine present;Urinalysis NEC;MILD;RECOVERED
Concomitant Medication|LITHIUM|NULL;NULL;NULL
Concomitant Medication|LITHOBID|NULL;NULL;NULL
Concomitant Medication|METOCLOPRAMIDE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|NASAL DECONGESTANT|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Costal pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Respiratory dyskinesia;Respiratory dyskinesia;Dyskinesias and movement disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Secretion discharge;Secretion discharge;General signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Swallowing impaired;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Meteorism;Flatulence;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Blood phosphorus increased;Blood phosphorus increased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Swallowing impaired;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|AVLOCARDYL|NULL;NULL;NULL
Concomitant Medication|PROTHIADEN|NULL;NULL;NULL
Concomitant Medication|QUOTANE|NULL;NULL;NULL
Concomitant Medication|SONDALIS HP|NULL;NULL;NULL
Concomitant Medication|VASTEN|NULL;NULL;NULL
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;Moderate;NULL
Adverse Event|Appetite and general nutritional disorders|Appetite absent;Decreased appetite;Appetite disorders;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Pyrosis;Dyspepsia;Dyspeptic signs and symptoms;Moderate;NULL
Concomitant Medication|GAVISCON|1;;Oral
Concomitant Medication|MOPRAL|1;;Oral
Adverse Event|Haematology investigations (incl blood groups)|APTT increased;Activated partial thromboplastin time prolonged;Coagulation and bleeding analyses;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|APTT;Activated partial thromboplastin time;Coagulation and bleeding analyses;NULL;NULL
Adverse Event|Aural disorders NEC|Earache;Ear pain;Ear disorders NEC;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;NULL;NULL
Adverse Event|Oral soft tissue conditions|Chapped lips;Chapped lips;Oral soft tissue disorders NEC;NULL;NULL
Adverse Event|Salivary gland conditions|Increased salivation;Salivary hypersecretion;Salivary gland disorders NEC;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;NULL;NULL
Concomitant Medication|FOSINOPRIL|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;Moderate;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Metrorrhagia;Metrorrhagia;Menstruation and uterine bleeding NEC;Mild;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;Mild;NULL
Concomitant Medication|DEROXAT|0,5;;Oral
Concomitant Medication|JAMYLENE|1;;Oral
Concomitant Medication|LAROXYL|10;;Oral
Concomitant Medication|LAROXYL|25;;Oral
Concomitant Medication|TRANSILANE|1;;Oral
FVC|fvc|
FVC|fvc_percent|
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Marked;NULL
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Adverse Event|Vision disorders|Double vision;Diplopia;Visual disorders NEC;Mild;NULL
Concomitant Medication|MIRALAX|NULL;NULL;NULL
Concomitant Medication|SUMYCIN|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Moderate;Continuing
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Elevated BP;Blood pressure increased;Vascular tests NEC (incl blood pressure);Moderate;Resolved
Adverse Event|Vascular disorders NEC|Flushing;Flushing;Peripheral vascular disorders NEC;Moderate;Resolved
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;Moderate;Resolved
Concomitant Medication|LOW-OGESTREL|NULL;NULL;NULL
Adverse Event|Joint disorders|Stiff knees;Joint stiffness;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Platelet count decreased;Platelet count decreased;Platelet analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Disturbances in thinking and perception|Hallucinations;Hallucination;Perception disturbances;SEVERE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Venostasis;Venous insufficiency;Non-site specific necrosis and vascular insufficiency NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Shallow breathing;Hypoventilation;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood in urine;Blood urine present;Urinalysis NEC;MILD;UNKNOWN
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pitting edema;Oedema;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine;White blood cells urine;Urinalysis NEC;MILD;UNKNOWN
Concomitant Medication|OGEN|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Dysgeusia;Dysgeusia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Hair loss;Alopecia;Alopecias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Nail growth abnormal;Nail growth abnormal;Nail and nail bed conditions (excl infections and infestations);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Viral syndrome;Viral infection;Viral infections NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anguish;Anxiety;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Dental abscess;Tooth abscess;Dental and oral soft tissue infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension aggravated;Hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Swallowing disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Wound NOS;Wound;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal spasm;Abdominal rigidity;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Bone and joint injuries|Great toe fracture;Foot fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paraesthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Sprained ankle;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Blood phosphorus decreased;Blood phosphorus decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menses painful;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MODERATE;RECOVERED
Concomitant Medication|FERUS|NULL;NULL;NULL
Concomitant Medication|TACHIPIRINA|NULL;NULL;NULL
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;NULL;NULL
Adverse Event|Physical examination topics|Wt loss;Weight decreased;Physical examination procedures;NULL;NULL
Adverse Event|Injuries NEC|Bruising of face;Contusion;Skin injuries NEC;NULL;NULL
Adverse Event|Physical examination topics|Weight;Weight;Physical examination procedures;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Frequency urinary;Pollakiuria;Bladder and urethral symptoms;NULL;NULL
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;NULL;NULL
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Mild;Continuing
Adverse Event|General system disorders NEC|Feeling of warmth;Feeling hot;Feelings and sensations NEC;Mild;Continuing
Adverse Event|Joint disorders|Effusion of elbow;Joint effusion;Joint related signs and symptoms;Moderate;Continuing
Concomitant Medication|CURAD SCAR THERAPY|NULL;NULL;NULL
Concomitant Medication|ETODOLAC|NULL;NULL;NULL
Concomitant Medication|HYDROXYCHLOROQUINE SULFATE|NULL;NULL;NULL
Concomitant Medication|PAROXETINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ZOLPIDEM TARTRATE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Heaviness in limbs;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Insomnia exacerbated;Insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest pressure;Chest discomfort;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Sexual function and fertility disorders|Sexual dysfunction;Sexual dysfunction;Sexual function and fertility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Taste abnormality;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Suffocation;Asphyxia;Conditions associated with abnormal gas exchange;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BROMAZEPAN|NULL;NULL;NULL
Concomitant Medication|TIBOLENE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Paraesthesia of fingers;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum expectoration difficult;Sputum retention;Coughing and associated symptoms;MILD;RECOVERED
Concomitant Medication|CALCIUM BETA-HYDROXY BETA-METHYLBUTYRATE|NULL;NULL;NULL
Concomitant Medication|PROPRANOLOL INDERAL LA|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Itchy legs;Pruritus;Pruritus NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Nystagmus;Nystagmus;Cerebellar coordination and balance disturbances;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Neck rash;Rash;Rashes, eruptions and exanthems NEC;Mild;NULL
Adverse Event|Appetite and general nutritional disorders|Cachexia;Cachexia;General nutritional disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit low;Haematocrit decreased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Shallow breathing;Hypoventilation;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezes;Wheezing;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DESONIDE|NULL;NULL;NULL
Concomitant Medication|SUDAFED COLD AND COUGH|NULL;NULL;NULL
Concomitant Medication|TRIMEDIL|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urethral disorders (excl calculi)|Urethral false passage;Urethral disorder;Urethral disorders NEC;SEVERE;RECOVERED
Adverse Event|Lipid metabolism disorders|Hypercholesterolaemia;Hypercholesterolaemia;Elevated cholesterol;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;MODERATE;RECOVERED
Concomitant Medication|CLAVENTIN|NULL;NULL;NULL
Concomitant Medication|NETROMICINE|NULL;NULL;NULL
Concomitant Medication|NOCTAMIDE|NULL;NULL;NULL
Concomitant Medication|TRIDESONIT|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle cramp;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Allergic conditions|House dust allergy;House dust allergy;Atopic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ALPRAZOLAM|0.5;PRN (as needed);Oral
Concomitant Medication|AZITHROMYCINE|500;QD (every day);Oral
Concomitant Medication|CARBOMERE|2 MG/G;BID (twice a day);
Concomitant Medication|DIMETHOXANATE HYDROCHLORIDE|30;TID (three times a day);Oral
Concomitant Medication|GABAPENTIN|300;QD (every day);Oral
Concomitant Medication|IBUPROFEN|400;BID (twice a day);Oral
Concomitant Medication|INFLUVAC|0.5;QD (every day);Intramuscular
Concomitant Medication|PANDEMRIX|0.5;QD (every day);Intramuscular
Concomitant Medication|PARACETAMOL|325;PRN (as needed);Oral
Concomitant Medication|PYRIDOSTIGMINE BROMIDE|60;TID (three times a day);Oral
Concomitant Medication|TRAMADOL HYDROCHLORIDE|37.5;PRN (as needed);Oral
Adverse Event|Disturbances in thinking and perception|Auditory and visual hallucinations;Hallucinations, mixed;Perception disturbances;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Positional dizziness;Dizziness postural;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Peripheral swelling;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Electric shock sensation;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Fracture of neck of femur;Femoral neck fracture;Lower limb fractures and dislocations;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Inflammation lips;Cheilitis;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Sensation of warmth;Feeling hot;Feelings and sensations NEC;MILD;RECOVERED
Concomitant Medication|NEOSYNEPHRINE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;Moderate;Resolved
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ear ringing;Tinnitus;Inner ear signs and symptoms;Mild;Resolved
Adverse Event|General system disorders NEC|Flu-like symptoms;Influenza like illness;General signs and symptoms NEC;Mild;Resolved
Adverse Event|Skin appendage conditions|Heat rash;Heat rash;Apocrine and eccrine gland disorders;Mild;Resolved
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Mild;Continuing
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Mild;Resolved
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Moderate;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose bleed;Epistaxis;Nasal disorders NEC;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Pustules on hand;Rash pustular;Skin structures and soft tissue infections;Mild;Resolved
Adverse Event|Sleep disturbances (incl subtypes)|Sleep restless;Poor quality sleep;Sleep disturbances NEC;Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Skin rough;Dry skin;Dermal and epidermal conditions NEC;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;Mild;Resolved
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;Moderate;Resolved
Concomitant Medication|ANTIBIOTIC|NULL;NULL;NULL
Concomitant Medication|LIQUID B|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dizzy spells;Dizziness;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vaginal itching;Vulvovaginal pruritus;Vulvovaginal signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Fungal infectious disorders|Vaginal candida;Vulvovaginal candidiasis;Candida infections;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BENCIDAMINA|500;QD (every day);Topical
Concomitant Medication|BOTOX|UNK;Other (specify);Intramuscular
Concomitant Medication|HYDROCORTISONE MICONAZOLE|2;BID (twice a day);Topical
Adverse Event|Disturbances in thinking and perception|Auditory hallucinations;Hallucination, auditory;Perception disturbances;MODERATE;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Non-insulin-dependent diabetes mellitus;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);NULL;NULL
Adverse Event|Neurological disorders NEC|Dizzy;Dizziness;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|Administration site reactions|Injection site induration;Injection site induration;Injection site reactions;NULL;NULL
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Tingling;Paraesthesia;Paraesthesias and dysaesthesias;NULL;NULL
Adverse Event|Administration site reactions|Pain injection site;Injection site pain;Injection site reactions;NULL;NULL
Adverse Event|Skin appendage conditions|Cold sweat;Cold sweat;Apocrine and eccrine gland disorders;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Aching in limb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Skin appendage conditions|Clammy;Cold sweat;Apocrine and eccrine gland disorders;NULL;NULL
Adverse Event|Respiratory disorders NEC|Hoarseness;Dysphonia;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Head cold;Nasopharyngitis;Upper respiratory tract infections;NULL;NULL
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Respiratory disorders NEC|Sniffles;Rhinorrhoea;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;NULL;NULL
Concomitant Medication|COTYLENOL|NULL;NULL;NULL
Concomitant Medication|DI-GESIC|NULL;NULL;NULL
Concomitant Medication|PERDIEM|NULL;NULL;NULL
Concomitant Medication|PHILLIPS LAXCAPS|NULL;NULL;NULL
Concomitant Medication|THERAGRAN-M|NULL;NULL;NULL
Adverse Event|Injuries NEC|Rib injury;Skeletal injury;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Explosive diarrhea;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Concomitant Medication|ANTIHISTAMINES|NULL;NULL;NULL
Adverse Event|Injuries NEC|Bruise;Contusion;Skin injuries NEC;Mild;Resolved
Adverse Event|Injuries NEC|Contusion of back;Contusion;Skin injuries NEC;Moderate;Resolved
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Moderate;Resolved
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;Moderate;Resolved
Adverse Event|Vascular haemorrhagic disorders|Hemorrhage;Haemorrhage;Haemorrhages NEC;Severe;Resolved
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Resolved
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;Moderate;Resolved
Concomitant Medication|L-CARNITINE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnoea at rest;Dyspnoea at rest;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stools hard;Faeces hard;Faecal abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Lung congestion;Pulmonary congestion;Pulmonary oedemas;MODERATE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Decreased exercise endurance;Exercise tolerance decreased;General signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Decreased exercise endurance;Exercise tolerance decreased;General signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;MILD;RECOVERED
Adverse Event|Miscellaneous and site unspecified neoplasms malignant and unspecified|Squamous cell carcinoma;Squamous cell carcinoma;Neoplasms malignant site unspecified NEC;MILD;RECOVERED
Concomitant Medication|NITROLINGUAL|NULL;NULL;NULL
Concomitant Medication|ATIVAN|1;PRN (as needed);Oral
Concomitant Medication|COENZYME Q10|300;BID (twice a day);Oral
Concomitant Medication|NUEDEXTA|30/75;QD (every day);Oral
Concomitant Medication|L-LYSINE|500;QID (four times a day);Oral
Concomitant Medication|LIDOCAINE|100;1 time only;Subcutaneous
Concomitant Medication|METHYLSULFONYLMETHANE|1000;BID (twice a day);Oral
Concomitant Medication|PERCOCET|5;PRN (as needed);Oral
Concomitant Medication|TETRACYCLINE|500;TID (three times a day);Oral
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;Mild;Resolved
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;Moderate;Continuing
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;Moderate;Continuing
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;Moderate;Resolved
Concomitant Medication|B 12|NULL;NULL;NULL
Concomitant Medication|DIRAHIST|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Queasy;Nausea;Nausea and vomiting symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Coronary artery disorders|Myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|BELOC|NULL;NULL;NULL
Concomitant Medication|BISOPROLOL FUMARATE|NULL;NULL;NULL
Concomitant Medication|CHININE SULFATE|NULL;NULL;NULL
Concomitant Medication|ELANTAN|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;Mild;NULL
Adverse Event|Vascular disorders NEC|Flushed face;Flushing;Peripheral vascular disorders NEC;MILD;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Radicular pain;Radicular pain;Spinal cord and nerve root disorders NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;MODERATE;RECOVERED
Concomitant Medication|DELTASONE|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis;Cellulitis;Bacterial infections NEC;MODERATE;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Pain in spine;Bone pain;Bone related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site irritation;Procedural site reaction;Non-site specific procedural complications;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|TMJ syndrome;Temporomandibular joint syndrome;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CEPACOL|NULL;NULL;NULL
Concomitant Medication|NEOSPORIN OPHTHALMIC|NULL;NULL;NULL
Lab Test|Urine Color|RED
Lab Test|Red Blood Cells (RBC)|Very Large
Lab Test|Protein|2+
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Rash over arms;Rash;Rashes, eruptions and exanthems NEC;NULL;NULL
Adverse Event|Eye disorders NEC|Eye edema;Eye oedema;Ocular disorders NEC;NULL;NULL
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;NULL;NULL
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;NULL;NULL
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Skin appendage conditions|Diaphoresis;Hyperhidrosis;Apocrine and eccrine gland disorders;NULL;NULL
Concomitant Medication|FIBRE, DIETARY|NULL;NULL;NULL
Concomitant Medication|LANOLIN|NULL;NULL;NULL
Concomitant Medication|PHENOLPHTHALEIN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Acute chest pain;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Acute chest pain;Chest pain;Pain and discomfort NEC;MODERATE;RECOVERED
Concomitant Medication|BISCODYL|NULL;NULL;NULL
Concomitant Medication|MICROLAX|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;Mild;Continuing
Adverse Event|Skin appendage conditions|Acne rosacea;Rosacea;Rosaceas;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;SEVERE;RECOVERED
Adverse Event|Deliria (incl confusion)|Disorientation;Disorientation;Confusion and disorientation;MILD;RECOVERED
Adverse Event|Immunology and allergy investigations|Elevated prostate specific antigen [PSA];Prostatic specific antigen increased;Cell marker procedures;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ACCOLATE|NULL;NULL;NULL
Concomitant Medication|CHONDROITIN COMPLEX|NULL;NULL;NULL
Concomitant Medication|ZYFLO|NULL;NULL;NULL
Lab Test|RBC Morphology: Microcytosis|1+
Adverse Event|Gastrointestinal signs and symptoms|Epigastric burning;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Post procedural infection;Post procedural infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Breast disorders|Breast cyst;Breast cyst;Benign and malignant breast neoplasms;MODERATE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Pain post biopsy;Procedural pain;Non-site specific procedural complications;MODERATE;RECOVERED
Adverse Event|Skin vascular abnormalities|Petechiae;Petechiae;Purpura and related conditions;MODERATE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine;White blood cells urine;Urinalysis NEC;MILD;RECOVERED
Concomitant Medication|CALTRATE|NULL;NULL;NULL
Concomitant Medication|FLEXICAL|NULL;NULL;NULL
Concomitant Medication|MONISTAT-7|NULL;NULL;NULL
Concomitant Medication|OSCAL D|NULL;NULL;NULL
Concomitant Medication|PRINCIPEN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Pain throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|NIVAQUINE|NULL;NULL;NULL
Concomitant Medication|PALUDRINE|NULL;NULL;NULL
Concomitant Medication|RINUTAN|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Foot fracture;Foot fracture;Lower limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Hepatic and hepatobiliary disorders|Hepatitis;Hepatitis;Hepatocellular damage and hepatitis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy legs;Pruritus;Pruritus NEC;MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Panic attacks;Panic attack;Panic attacks and disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|LACTAID|NULL;NULL;NULL
Adverse Event|Eye therapeutic procedures|Eye laser surgery;Eye laser surgery;Eye therapeutic procedures NEC;MODERATE;RECOVERED
Concomitant Medication|CYPROTERONE ACETATE|NULL;NULL;NULL
Concomitant Medication|ETHINYLOESTRADIOL|NULL;NULL;NULL
Concomitant Medication|FLUOROMETHOLONE|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;MODERATE;RECOVERED
Concomitant Medication|CHIBRO-CADRON|NULL;NULL;NULL
Concomitant Medication|RIFAMYCINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Common cold syndrome;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Purine and pyrimidine metabolism disorders|Gout;Gout;Purine metabolism disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;MODERATE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Malignant and unspecified neoplasms gastrointestinal NEC|Pancreatic cyst;Pancreatic cyst;Pancreatic neoplasms;MILD;RECOVERED
Adverse Event|Personality disorders and disturbances in behaviour|Paranoia;Paranoia;Behaviour and socialisation disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ASACOL|NULL;NULL;NULL
Concomitant Medication|DYNACIRC|NULL;NULL;NULL
Concomitant Medication|LESCOL|NULL;NULL;NULL
Concomitant Medication|PROMETHAZINE W/CODEINE|NULL;NULL;NULL
Concomitant Medication|TOLECTIN|NULL;NULL;NULL
Concomitant Medication|CREATINE|3;;Oral
Adverse Event|Salivary gland conditions|Increased salivation;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;Marked;NULL
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;Moderate;NULL
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Sneezing;Sneezing;Upper respiratory tract signs and symptoms;Mild;NULL
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sleep apnea;Sleep apnoea syndrome;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Hypercarbia;Hypercapnia;Conditions associated with abnormal gas exchange;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Headaches|Ophthalmic migraine;Migraine with aura;Migraine headaches;MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Oxygen saturation decreased;Oxygen saturation decreased;Blood gas and acid base analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Embolism and thrombosis|Thrombophlebitis leg;Thrombophlebitis;Peripheral embolism and thrombosis;MODERATE;RECOVERED
Concomitant Medication|CALVEPEN|NULL;NULL;NULL
Concomitant Medication|FLUCLON|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Albuminuria;Albuminuria;Urinary abnormalities;Mild;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Moderate;NULL
Adverse Event|Ocular infections, irritations and inflammations|Itchy eyes;Eye pruritus;Ocular infections, inflammations and associated manifestations;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck mass;Neck mass;Soft tissue disorders NEC;Mild;NULL
Adverse Event|General system disorders NEC|Thirst excessive;Thirst;Feelings and sensations NEC;Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Moderate;NULL
Concomitant Medication|ASTRAGALUS PROPINQUUS ROOT|2000;QD (every day);Oral
Concomitant Medication|CHLORTAB|4;PRN (as needed);Oral
Concomitant Medication|EFFEXOR|75;QD (every day);Oral
Concomitant Medication|EQUATE|1000;PRN (as needed);Oral
Concomitant Medication|HC TUSSIVE|5;PRN (as needed);Oral
Concomitant Medication|LORATADINE|10;PRN (as needed);Oral
Concomitant Medication|ROBITUSSIN|0-200;PRN (as needed);Oral
Concomitant Medication|TYLENOL MAXIMUM STRENGTH SINUS|1000;PRN (as needed);Oral
Concomitant Medication|VICKS DAYQUIL|2;PRN (as needed);Oral
Concomitant Medication|VICKS NYQUIL|500;PRN (as needed);Oral
Concomitant Medication|Z-PAK|250/500;QD (every day);Oral
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;Moderate;NULL
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;Marked;NULL
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Moderate;NULL
Concomitant Medication|DEXTROMETHORPHAN|30;BID (twice a day);Oral
Concomitant Medication|FLEET PHOSPHO SODA|45/24;QD (every day);Oral
Concomitant Medication|FLONASE|50;QD (every day);Inhalation
Concomitant Medication|MECLIZINE|25;PRN (as needed);Oral
Concomitant Medication|NASONEX|50;QHS (at bedtime);Inhalation
Concomitant Medication|PAXIL|60;QD (every day);Oral
Concomitant Medication|QUINIDINE SULFATE|200;BID (twice a day);Oral
Concomitant Medication|RESTORIL|15;PRN (as needed);Oral
Concomitant Medication|SURFAK|240;PRN (as needed);Oral
Concomitant Medication|TRAZODONE|50;QHS (at bedtime);Oral
Concomitant Medication|TRAZODONE|100;QHS (at bedtime);Oral
Adverse Event|Neurological disorders NEC|Clonus;Clonus;Neurological signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BACLOFEN|87.5;TID (three times a day);Oral
Concomitant Medication|CITALOPRAM|10;QD (every day);Oral
Concomitant Medication|DIAZEPAM|15;TID (three times a day);Oral
Concomitant Medication|ESCITALOPRAM|15;Every morning;Oral
Concomitant Medication|PRAMIPEXOLE|0.175;QD (every day);Oral
Concomitant Medication|PRAMIPEXOLE|0.525;BID (twice a day);Oral
Adverse Event|Neurological disorders NEC|Numbness in feet;Hypoaesthesia;Sensory abnormalities NEC;Mild;NULL
Concomitant Medication|CLONIDINE|0.1;QID (four times a day);Oral
Concomitant Medication|CLONIDINE|0.1;TID (three times a day);Oral
Concomitant Medication|CLONIDINE|2.5;Once per week;Transdermal
Concomitant Medication|NEUROTIN|100;QID (four times a day);Oral
Concomitant Medication|PROVIGIL|100;QD (every day);Oral
Concomitant Medication|VITAMIN C|2000;BID (twice a day);Oral
Concomitant Medication|ZANAFLEX|50;BID (twice a day);Oral
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;Mild;NULL
Concomitant Medication|BACLOFEN|7,5;BID (twice a day);Oral
Concomitant Medication|VERTIGOHEEL|210;QD (every day);Oral
Concomitant Medication|ATROPINE SULFATE|1 DROP;PRN (as needed);Other (specify)
Adverse Event|Infections - pathogen unspecified|Abscess on buttock;Subcutaneous abscess;Skin structures and soft tissue infections;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbar pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vascular haemorrhagic disorders|Hematoma;Haematoma;Haemorrhages NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|HYDROCHLOROTHIAZIDE W/VALSARTAN|80;QD (every day);Oral
Concomitant Medication|MACROGOL|4;QD (every day);Oral
Concomitant Medication|MUPIROCINE|2;BID (twice a day);Topical
Adverse Event|Oral soft tissue conditions|Oral lesion;Oral disorder;Oral soft tissue disorders NEC;NULL;NULL
Adverse Event|General system disorders NEC|Flu-like symptoms;Influenza like illness;General signs and symptoms NEC;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Esophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;NULL;NULL
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Light-headed;Dizziness;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Light headedness;Dizziness;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;NULL;NULL
Concomitant Medication|ANCOVERT|NULL;NULL;NULL
Concomitant Medication|DILTIAZEM|NULL;NULL;NULL
Adverse Event|Body temperature conditions|Hypothermia;Hypothermia;Body temperature altered;MILD;ONGOING (PERSISTENT)
Adverse Event|Coronary artery disorders|Anterolateral myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;SEVERE;UNKNOWN
Adverse Event|Metabolic, nutritional and blood gas investigations|Hemoglobin A1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycaemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ASS-RATIOPHARM|NULL;NULL;NULL
Adverse Event|Injuries NEC|Traumatic injury;Injury;Non-site specific injuries NEC;Mild;NULL
Concomitant Medication|BROMFED|12/120;BID (twice a day);Oral
Concomitant Medication|CEPHALEXIN|500;TID (three times a day);Oral
Concomitant Medication|MESTINON|60;PRN (as needed);Oral
Concomitant Medication|HYDROCODONE|5;PRN (as needed);Oral
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;Moderate;NULL
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;Moderate;NULL
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;Marked;NULL
Adverse Event|Neurological disorders NEC|Facial paresthesia;Paraesthesia;Paraesthesias and dysaesthesias;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Marked;NULL
Concomitant Medication|DEPO-MEDROL + LIDOCAINE|NULL;NULL;NULL
Concomitant Medication|DEXAMETHASONE SODIUM PHOSPHATE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Algodystrophy;Complex regional pain syndrome;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Superinfection lung;Lung infection;Lower respiratory tract and lung infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Difficult digestion;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Neutrophils increased;Neutrophil count increased;White blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in heel;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Scapula pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Circulatory insufficiency;Cardiovascular insufficiency;Cardiac disorders NEC;MILD;RECOVERED
Concomitant Medication|FONZYLANE|NULL;NULL;NULL
Concomitant Medication|MIACALCIC|NULL;NULL;NULL
Concomitant Medication|ROHYPNOL|NULL;NULL;NULL
Concomitant Medication|VELITEN|NULL;NULL;NULL
Adverse Event|Oral soft tissue conditions|Mouth paresthesia;Paraesthesia oral;Oral soft tissue pain and paraesthesia;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DIOVAN HCT|NULL;NULL;NULL
Concomitant Medication|FIBERSOURCE|NULL;NULL;NULL
Concomitant Medication|MICROZIDE|NULL;NULL;NULL
Concomitant Medication|VERELAN|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;Mild;NULL
Adverse Event|Skin neoplasms malignant and unspecified|Melanoma;Malignant melanoma;Skin melanomas (excl ocular);Moderate;NULL
Adverse Event|Mental impairment disorders|Memory loss;Amnesia;Memory loss (excl dementia);Mild;NULL
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Swollen glands;Lymphadenopathy;Lymphatic system disorders NEC;Mild;NULL
Adverse Event|Gastrointestinal haemorrhages NEC|Blood in stool;Haematochezia;Non-site specific gastrointestinal haemorrhages;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Breathing difficult;Dyspnoea;Breathing abnormalities;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|PHYTOBRONCHIN|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Dreaming excessive;Abnormal dreams;Parasomnias;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Loss of energy;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin erythema;Erythema;Erythemas;MODERATE;RECOVERED
Adverse Event|Eye disorders NEC|Eye pain;Eye pain;Ocular disorders NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DF118|NULL;NULL;NULL
Concomitant Medication|MAXOLON|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine RBC increased;Red blood cells urine positive;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|White blood cell disorders|Eosinophilia;Eosinophilia;Eosinophilic disorders;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Herniated disc;Intervertebral disc protrusion;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hypercholesteremia;Hypercholesterolaemia;Elevated cholesterol;MILD;RECOVERED
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Renal stone;Nephrolithiasis;Renal lithiasis;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Upper respiratory tract inflammation;Upper respiratory tract inflammation;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Concomitant Medication|TYLENOL W/CODEINE NO. 4|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;Mild;NULL
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Chapped lips;Chapped lips;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Chapped lips;Chapped lips;Oral soft tissue disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Chapped lips;Chapped lips;Oral soft tissue disorders NEC;SEVERE;RECOVERED
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Burning sensation skin;Skin burning sensation;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Periorbital pain;Eye pain;Ocular disorders NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Throat pain;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Near syncope;Presyncope;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Eye disorders NEC|Periorbital pain;Eye pain;Ocular disorders NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Rosacea;Rosacea;Rosaceas;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Throat pain;Oropharyngeal pain;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Pain urethral;Urethral pain;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vaginal bleeding;Vaginal haemorrhage;Vulvovaginal disorders NEC;MILD;RECOVERED
Concomitant Medication|AURALGAN|NULL;NULL;NULL
Concomitant Medication|BILBERRY|NULL;NULL;NULL
Concomitant Medication|BIOZYME|NULL;NULL;NULL
Concomitant Medication|METEX|NULL;NULL;NULL
Concomitant Medication|SALMON OIL|NULL;NULL;NULL
Adverse Event|Injuries NEC|Back strain;Muscle strain;Muscle, tendon and ligament injuries;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscular weakness;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;NULL;NULL
Concomitant Medication|CLOBAZAM|NULL;NULL;NULL
Concomitant Medication|CLOBUTINOL|NULL;NULL;NULL
Concomitant Medication|CLORAZEPIC ACID|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Mild;Resolved
Adverse Event|Angioedema and urticaria|Hives;Urticaria;Urticarias;Moderate;Resolved
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;Moderate;Continuing
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Nauseated;Nausea;Nausea and vomiting symptoms;Moderate;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;Continuing
Concomitant Medication|BETAXOLOL|NULL;NULL;NULL
Concomitant Medication|KERLONE|NULL;NULL;NULL
Concomitant Medication|METHADONE|NULL;NULL;NULL
Concomitant Medication|SAM-E|NULL;NULL;NULL
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Severe;Resolved
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;Severe;Resolved
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;Mild;         .
Adverse Event|Urinary tract signs and symptoms|Increased urinary frequency;Pollakiuria;Bladder and urethral symptoms;Mild;Continuing
Adverse Event|Viral infectious disorders|Herpes ophthalmic;Herpes ophthalmic;Herpes viral infections;Mild;Continuing
Adverse Event|Administration site reactions|Injection site rash;Injection site rash;Injection site reactions;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Urine odor foul;Urine odour abnormal;Urinary abnormalities;Mild;Resolved
Concomitant Medication|AMINO ACID COMPLEX|NULL;NULL;NULL
Concomitant Medication|L-ASPARTIC ACID|NULL;NULL;NULL
Concomitant Medication|VIROPTIC|NULL;NULL;NULL
Adverse Event|Administration site reactions|Injection site bruising;Injection site haematoma;Injection site reactions;Mild;Resolved
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Choked on food;Choking;Upper respiratory tract signs and symptoms;Moderate;Continuing
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;Severe;Continuing
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;Moderate;Continuing
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Elevated BP;Blood pressure increased;Vascular tests NEC (incl blood pressure);Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;Mild;Resolved
Adverse Event|Body temperature conditions|Feverish;Pyrexia;Febrile disorders;Mild;Resolved
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;Continuing
Adverse Event|General system disorders NEC|Pain aggravated;Pain;Pain and discomfort NEC;Moderate;Continuing
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;Moderate;Continuing
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Mild;Resolved
Adverse Event|General system disorders NEC|Unable to walk;Abasia;Gait disturbances;Severe;Continuing
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Moderate;Continuing
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Severe;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal ulcer;Nasal ulcer;Nasal disorders NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Breathlessness;Dyspnoea;Breathing abnormalities;Severe;Resolved
Concomitant Medication|A & D OINTMENT|NULL;NULL;NULL
Concomitant Medication|CODAL-DH|NULL;NULL;NULL
Concomitant Medication|GUAIFENEX PSE|NULL;NULL;NULL
Concomitant Medication|HEPAVIT|NULL;NULL;NULL
Concomitant Medication|SOLU MEDROL|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchopneumonia;Bronchopneumonia;Lower respiratory tract and lung infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine present;Glucose urine present;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Pleural disorders|Pleural effusion;Pleural effusion;Pneumothorax and pleural effusions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Cyanosis of lip;Cyanosis;Cardiac signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Stools watery;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Erythematous rash;Rash erythematous;Erythemas;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|BALMINIL|NULL;NULL;NULL
Concomitant Medication|BALMINIL DM|NULL;NULL;NULL
Concomitant Medication|CANESTEN|NULL;NULL;NULL
Concomitant Medication|CELESTODERM GARAMYCIN|NULL;NULL;NULL
Concomitant Medication|HUMULIN R|NULL;NULL;NULL
Concomitant Medication|NITRODUR|NULL;NULL;NULL
Concomitant Medication|NITRONG|NULL;NULL;NULL
Adverse Event|Gallbladder disorders|Cholelithiasis;Cholelithiasis;Cholecystitis and cholelithiasis;MILD;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Hiatus hernia;Hiatus hernia;Diaphragmatic hernias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral moniliasis;Oral candidiasis;Candida infections;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling of extremity;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|RILUTEK|1;;Oral
Adverse Event|Gastrointestinal ulceration and perforation|Gastrointestinal ulcer;Gastrointestinal ulcer;Gastrointestinal ulcers and perforation, site unspecified;MILD;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic disorder;Prostatic disorder;Prostatic signs, symptoms and disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MEBEVERINE|NULL;NULL;NULL
Concomitant Medication|SERENOA REPENS|NULL;NULL;NULL
Concomitant Medication|TERAZOSINE|NULL;NULL;NULL
Concomitant Medication|QUININE|260;QHS (at bedtime);Oral
Adverse Event|Infections - pathogen unspecified|Postoperative wound infection;Postoperative wound infection;Infections NEC;MILD;RECOVERED
Adverse Event|Coronary artery disorders|Anterior myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Ataxia;Ataxia;Cerebellar coordination and balance disturbances;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Ataxia;Ataxia;Cerebellar coordination and balance disturbances;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory dysfunction NOS;Respiratory disorder;Respiratory tract disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site irritation;Procedural site reaction;Non-site specific procedural complications;MILD;RECOVERED
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Postoperative wound infection;Postoperative wound infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;SEVERE;RECOVERED
Adverse Event|Fungal infectious disorders|Vaginal candidiasis;Vulvovaginal candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Taste metallic;Dysgeusia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Nonspecific chest pain;Chest pain;Pain and discomfort NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ASPIRIN BUFFERED|NULL;NULL;NULL
Concomitant Medication|EQUALACTIN|NULL;NULL;NULL
Lab Test|White Blood Cell (WBC)|Very Large
Lab Test|Urine Renal Epithelial Cells|Moderate
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;NULL;NULL
Adverse Event|Viral infectious disorders|Shingles;Herpes zoster;Herpes viral infections;NULL;NULL
Lab Test|Polychromasia|+
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Concomitant Medication|ALFALFA|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|INDOCIN|NULL;NULL;NULL
Concomitant Medication|MYCELEX TROCHE|NULL;NULL;NULL
Concomitant Medication|VISTARIL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Loss of consciousness;Loss of consciousness;Disturbances in consciousness NEC;SEVERE;DEATH
Adverse Event|Electrolyte and fluid balance conditions|Electrolyte disturbance;Electrolyte imbalance;Electrolyte imbalance NEC;SEVERE;DEATH
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;SEVERE;DEATH
Adverse Event|Electrolyte and fluid balance conditions|Hyponatremia;Hyponatraemia;Sodium imbalance;SEVERE;DEATH
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;SEVERE;DEATH
Concomitant Medication|ASCORBIC ACID|1000;QD (every day);Oral
Concomitant Medication|BACLOFEN|50;TID (three times a day);Oral
Concomitant Medication|CEFTRIAXONE|2;BID (twice a day);Intramuscular
Concomitant Medication|CLONAZEPAM|7;QD (every day);Oral
Concomitant Medication|DANTROLENE|50;BID (twice a day);Oral
Concomitant Medication|LITHIUM|300;BID (twice a day);Oral
Concomitant Medication|MAGNESIUM|12;BID (twice a day);Oral
Concomitant Medication|PAROXETINE|30;QD (every day);Oral
Concomitant Medication|TOCOPHEROL|300;QD (every day);Oral
Adverse Event|Cardiac disorder signs and symptoms|Acrocyanosis;Cyanosis;Cardiac signs and symptoms NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;Moderate;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in extremity;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Flatus;Flatulence;Flatulence, bloating and distension;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Flatus;Flatulence;Flatulence, bloating and distension;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased stool frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Soft stools;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;Mild;Continuing
Adverse Event|Lipid metabolism disorders|Hypercholesteremia;Hypercholesterolaemia;Elevated cholesterol;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Moderate;Continuing
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;Mild;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary hesitancy;Urinary hesitation;Bladder and urethral symptoms;Mild;Continuing
Lab Test|Urine Glucose|Normal
Adverse Event|Ocular neuromuscular disorders|Anisocoria;Pupils unequal;Pupil disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Bloodshot eye;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Adverse Event|Hearing disorders|Hearing decreased;Hypoacusis;Hearing losses;MILD;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hypoglycemia;Hypoglycaemia;Hypoglycaemic conditions NEC;MODERATE;RECOVERED
Adverse Event|Thyroid gland disorders|Hypothyroidism;Hypothyroidism;Thyroid hypofunction disorders;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Macular rash;Rash macular;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Precordial pain;Chest pain;Pain and discomfort NEC;MODERATE;RECOVERED
Concomitant Medication|METOPROLOL TARTRATE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Amblyopia unilateral;Amblyopia;Amblyopic vision impairment;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint range of motion decreased;Joint range of motion decreased;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Reproductive neoplasms female benign|Uterine fibroids;Uterine leiomyoma;Uterine neoplasms benign;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Leg infection;Localised infection;Infections NEC;MILD;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Itchy eyes;Eye pruritus;Ocular infections, inflammations and associated manifestations;Mild;NULL
Adverse Event|Therapeutic procedures and supportive care NEC|Nutritional supplement;Medical diet;Dietary and nutritional therapies;Moderate;NULL
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;Mild;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;Moderate;NULL
Concomitant Medication|FLAXSEED OIL|4;QD (every day);Oral
Concomitant Medication|GRAPE SEED EXTRACT|100;BID (twice a day);Oral
Adverse Event|Cardiac arrhythmias|Left bundle branch block;Bundle branch block left;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Heart failures|Right ventricular failure;Right ventricular failure;Right ventricular failures;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AQUEOUS|NULL;NULL;NULL
Concomitant Medication|BENDROFLUAZIDE|NULL;NULL;NULL
Concomitant Medication|LOSARTAN POTASSIUM|NULL;NULL;NULL
Adverse Event|Headaches|Nocturnal headache;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CHLORPROMAZINE|NULL;NULL;NULL
Concomitant Medication|LODINE XL|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|C.difficile colitis;Clostridium difficile colitis;Clostridia infections;Mild;Resolved
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;Moderate;Resolved
Adverse Event|Bacterial infectious disorders|Cellulitis of arm;Cellulitis;Bacterial infections NEC;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;Resolved
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Severe;Continuing
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Mild;Continuing
Concomitant Medication|CEFAZOLIN SODIUM|NULL;NULL;NULL
Concomitant Medication|PULMOCARE|NULL;NULL;NULL
Adverse Event|Bladder and bladder neck disorders (excl calculi)|Hypotonic urinary bladder;Hypotonic urinary bladder;Myoneurogenic bladder disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Blister;Blister;Bullous conditions;MILD;RECOVERED
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Dermatitic reaction of face;Dermatitis;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gagging;Retching;Nausea and vomiting symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Vascular disorders NEC|Hot flushes;Hot flush;Peripheral vascular disorders NEC;MILD;RECOVERED
Adverse Event|Microbiology and serology investigations|Tuberculosis test positive;Tuberculosis test positive;Mycobacteria identification and serology;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Aphthous stomatitis;Aphthous stomatitis;Stomatitis and ulceration;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Scoliosis;Scoliosis;Spine and neck deformities;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM CITRATE W/MAGNESIUM|NULL;NULL;NULL
Concomitant Medication|CHEMIX|NULL;NULL;NULL
Concomitant Medication|DIPROLENE|NULL;NULL;NULL
Concomitant Medication|ISONIAZID|NULL;NULL;NULL
Concomitant Medication|ROSCAL|NULL;NULL;NULL
Concomitant Medication|VITAMIN B5|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chest pain precordial;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Lab Test|Thyroid Stimulating Hormone|Normal
Adverse Event|Respiratory disorders NEC|Choking sensation;Choking sensation;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Foot cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Supine dyspnea;Orthopnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional incontinence;Affect lability;Affect alterations NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Flatus;Flatulence;Flatulence, bloating and distension;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stools hard;Faeces hard;Faecal abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Postprandial nausea;Nausea;Nausea and vomiting symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Gastrointestinal haemorrhages NEC|Rectal bleeding;Rectal haemorrhage;Intestinal haemorrhages;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Seborrheic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MODERATE;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Type II diabetes mellitus;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;SEVERE;RECOVERED
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;MODERATE;RECOVERED
Concomitant Medication|BEANO|NULL;NULL;NULL
Concomitant Medication|PATANOL|NULL;NULL;NULL
Concomitant Medication|PROTUSS|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Hoarse voice;Dysphonia;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Peripheral neuropathies|Meralgia paraesthetica;Meralgia paraesthetica;Mononeuropathies;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;SEVERE;RECOVERED
Adverse Event|Bone and joint injuries|Knee sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Ankle injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Incontinence;Incontinence;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Viral gastroenteritis;Gastroenteritis viral;Viral infections NEC;MODERATE;RECOVERED
Concomitant Medication|DECOHISTINE DH|NULL;NULL;NULL
Concomitant Medication|GYNE-LOTRIMIN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;Moderate;NULL
Concomitant Medication|ALLEGRA-D|60;QD (every day);Oral
Concomitant Medication|CLARITIN-D|5;BID (twice a day);Oral
Concomitant Medication|FLONASE|1;QD (every day);Inhalation
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Halitosis;Breath odour;Gastrointestinal signs and symptoms NEC;Mild;NULL
Concomitant Medication|COENZYME Q10|1;BID (twice a day);Oral
Concomitant Medication|NUEDEXTA|25/25;BID (twice a day);Oral
Concomitant Medication|NORVASC|10;QD (every day);Oral
Concomitant Medication|PREVPAC|1;BID (twice a day);Oral
Concomitant Medication|BETACAROTENE|25000;BID (twice a day);Oral
Concomitant Medication|FAMOTIDINE|25;BID (twice a day);Oral
Concomitant Medication|MAGNESIUM CITRATE|15;PRN (as needed);Oral
Concomitant Medication|PEPCID|20;QD (every day);Oral
Concomitant Medication|STOOL SOFTENER|1;BID (twice a day);Oral
Concomitant Medication|RULID|NULL;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site discomfort;Post procedural discomfort;Non-site specific procedural complications;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Moderate;NULL
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;Moderate;NULL
Concomitant Medication|BACLOFEN|10;BID (twice a day);PEG
Concomitant Medication|BACLOFEN|10;QID (four times a day);PEG
Concomitant Medication|BACLOFEN|20;TID (three times a day);PEG
Concomitant Medication|DEPO PROVERA|150;;Intramuscular
Concomitant Medication|GUAIFENESIN|200;TID (three times a day);PEG
Concomitant Medication|GUAIFENEX|1;QD (every day);Oral
Concomitant Medication|GUAIFENEX|1;QD (every day);PEG
Concomitant Medication|LIPITOR|20;QD (every day);PEG
Concomitant Medication|MORPHINE SULFATE|2;PRN (as needed);Intravenous
Concomitant Medication|NASACORT AQ|4;QD (every day);Inhalation
Concomitant Medication|PROZAC|40;QD (every day);Oral
Concomitant Medication|PROZAC|40;QD (every day);PEG
Concomitant Medication|PROZAC|20;TID (three times a day);PEG
Concomitant Medication|QUININE|260;BID (twice a day);PEG
Concomitant Medication|TYLENOL|500-1000;PRN (as needed);PEG
Concomitant Medication|TYLENOL|500-1000;PRN (as needed);Oral
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Degeneration of lumbar or lumbosacral intervertebral disc;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Generalized rash;Rash generalised;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose high;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;ONGOING (PERSISTENT)
Adverse Event|Synovial and bursal disorders|Shoulder bursitis;Bursitis;Bursal disorders;MILD;RECOVERED
Adverse Event|Joint disorders|Effusion of knee;Joint effusion;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PHYTOBEC #1|NULL;NULL;NULL
Concomitant Medication|TOPICORT|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Coronary atherosclerosis;Arteriosclerosis coronary artery;Coronary artery disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Bed sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Nocturnal enuresis;Enuresis;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Upper back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in hand;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Rage;Anger;Emotional and mood disturbances NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;Marked;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;Marked;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Concomitant Medication|DHEA|50;QD (every day);Oral
Concomitant Medication|DULCOLAX|1;QHS (at bedtime);Oral
Concomitant Medication|HYDROCHLOROTHIAZIDE|50;QD (every day);Oral
Concomitant Medication|MAGNESIUM|400;QD (every day);Oral
Concomitant Medication|ONE A DAY MULTI VITAMIN & MINERALS|1/2;QD (every day);Oral
Concomitant Medication|POTASSIUM CHLORIDE|10;QD (every day);Oral
Concomitant Medication|POTASSIUM CHLORIDE|20;QD (every day);Oral
Concomitant Medication|ROBITUSSIN DM|1/2;BID (twice a day);Oral
Concomitant Medication|TRICOR|160;QD (every day);Oral
Concomitant Medication|TYLENOL|325;PRN (as needed);Oral
Concomitant Medication|XANAX|0.25;BID (twice a day);Oral
Concomitant Medication|ZITHROMAX|500;QD (every day);Oral
Concomitant Medication|ZYPREXA|2.5;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Arm discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Toe osteoarthritis;Osteoarthritis;Osteoarthropathies;MILD;RECOVERED
Adverse Event|General system disorders NEC|Chest tightness;Chest discomfort;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Flu symptoms;Influenza;Influenza viral infections;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Chest tightness;Chest discomfort;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|RAXAR|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Nocturnal agitation;Agitation;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Endocrine neoplasms malignant and unspecified|Thyroid nodule;Thyroid neoplasm;Endocrine neoplasms malignant and unspecified NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Miscellaneous and site unspecified neoplasms malignant and unspecified|Squamous cell carcinoma of head and neck;Head and neck cancer;Neoplasms malignant site unspecified NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|TETANOL|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo positional;Vertigo positional;Inner ear signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|SELECTOL|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum increased;Sputum increased;Coughing and associated symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|ALS;Amyotrophic lateral sclerosis;Motor neurone diseases;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|KELTICAN|NULL;NULL;NULL
Concomitant Medication|PARACODIN|NULL;NULL;NULL
Lab Test|Urine Uric Acid Crystals|Large
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);NULL;NULL
Adverse Event|Epidermal and dermal conditions|Burning sensation skin;Skin burning sensation;Dermal and epidermal conditions NEC;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gagging;Retching;Nausea and vomiting symptoms;NULL;NULL
Adverse Event|Salivary gland conditions|Lip dry;Lip dry;Oral dryness and saliva altered;NULL;NULL
Adverse Event|Skin appendage conditions|Hair loss;Alopecia;Alopecias;NULL;NULL
Adverse Event|Neurological disorders NEC|Clonus of limbs;Clonus;Neurological signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Numbness in face;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MODERATE;RECOVERED
Concomitant Medication|ESTREVA|NULL;NULL;NULL
Concomitant Medication|ORGAMETRIL|NULL;NULL;NULL
Concomitant Medication|SELEXID|NULL;NULL;NULL
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anemia;Anaemia;Anaemias NEC;Mild;NULL
Adverse Event|Reproductive neoplasms female benign|Fibroids;Uterine leiomyoma;Uterine neoplasms benign;Mild;NULL
Adverse Event|Reproductive neoplasms female benign|Uterine fibroids;Uterine leiomyoma;Uterine neoplasms benign;Moderate;NULL
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;Mild;NULL
Concomitant Medication|ALLEGRA D|1;BID (twice a day);Oral
Concomitant Medication|COLACE|100;TID (three times a day);Oral
Concomitant Medication|DIFLUCAN|1;QD (every day);Oral
Concomitant Medication|DOXEPIN|10;PRN (as needed);Oral
Concomitant Medication|IRON|2;QD (every day);Oral
Concomitant Medication|KLONOPIN|1;PRN (as needed);Oral
Concomitant Medication|LORAZEPAM|1;TID (three times a day);Oral
Concomitant Medication|MORPHINE SULFATE|1;PRN (as needed);Intravenous
Concomitant Medication|MORPHINE|2;PRN (as needed);Intravenous
Concomitant Medication|NYQUIL|2;PRN (as needed);Oral
Concomitant Medication|PERCOCET|325/5;PRN (as needed);Oral
Concomitant Medication|GUAIFENESIN|1200;BID (twice a day);Oral
Concomitant Medication|ROXICET|1;PRN (as needed);Oral
Concomitant Medication|TORADOL|15;PRN (as needed);Intravenous
Concomitant Medication|TYLENOL WITH CODEINE|1;PRN (as needed);Oral
Concomitant Medication|VERSED|0.5;QD (every day);Intravenous
Concomitant Medication|VICKS|2;PRN (as needed);Oral
Concomitant Medication|ALBUTEROL|2;QD (every day);Inhalation
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Congestion nasal;Nasal congestion;Nasal congestion and inflammations;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Lockjaw;Trismus;Muscle tone abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Myopia;Myopia;Refractive and accommodative disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;Moderate;Resolved
Adverse Event|Injuries by physical agents|Burn;Thermal burn;Thermal burns;Moderate;Resolved
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;Moderate;Continuing
Adverse Event|General system disorders NEC|Secretion discharge;Secretion discharge;General signs and symptoms NEC;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Infected insect bite;Infected bites;Infections NEC;Severe;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Severe;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved with Residual
Adverse Event|Bone and joint injuries|Foot sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);Moderate;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Severe;Continuing
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine abnormal;Urine analysis abnormal;Urinalysis NEC;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Respiratory dysfunction NOS;Respiratory disorder;Respiratory tract disorders NEC;Moderate;Continuing
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;Moderate;Resolved
Adverse Event|Epidermal and dermal conditions|Dry rash face;Rash;Rashes, eruptions and exanthems NEC;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;Moderate;Resolved
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;Mild;Resolved
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;Moderate;Continuing
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;Moderate;Continuing
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Erythema;Erythema;Erythemas;Mild;Continuing
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;Severe;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Respiratory depression;Respiratory depression;Breathing abnormalities;Moderate;Resolved with Residual
Adverse Event|Epidermal and dermal conditions|Seborrheic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|Superinfection lung;Lung infection;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Non-insulin-dependent diabetes mellitus;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hair growth abnormal;Hair growth abnormal;Pilar disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Rhinorrhea;Rhinorrhoea;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);MODERATE;RECOVERED
Concomitant Medication|JOSACINE|NULL;NULL;NULL
Concomitant Medication|PIVALONE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;Mild;Continuing
Adverse Event|Injuries NEC|Eye contusion;Eye contusion;Eye injuries NEC;Moderate;Resolved
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Moderate;Resolved with Residual
Adverse Event|Enzyme investigations NEC|Creatine kinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;Severe;Resolved with Residual
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;Continuing
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;Moderate;Resolved
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Resolved
Adverse Event|General system disorders NEC|General discomfort;Discomfort;Pain and discomfort NEC;Moderate;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Seborrheic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;Mild;Continuing
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;Moderate;Continuing
Concomitant Medication|DIMETAPP DM|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;Moderate;NULL
Adverse Event|Cranial nerve disorders (excl neoplasms)|Bell's palsy;Facial palsy;Facial cranial nerve disorders;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Gait disturbance;Gait disturbance;Gait disturbances;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Stupor;Stupor;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Subdural hematoma;Subdural haematoma;Cerebral injuries NEC;MILD;RECOVERED
Concomitant Medication|B-12|NULL;NULL;NULL
Concomitant Medication|SINEQUAN|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Lacrimal gland disorder;Lacrimal disorder;Lacrimal disorders;MILD;RECOVERED
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Orthostatic hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MODERATE;RECOVERED
Concomitant Medication|KERATYL|NULL;NULL;NULL
Concomitant Medication|SEGLOR|NULL;NULL;NULL
Concomitant Medication|TORENTAL|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Persistent dry cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Aural disorders NEC|Earache;Ear pain;Ear disorders NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Swelling of knees;Joint swelling;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|AMBROLOS|NULL;NULL;NULL
Concomitant Medication|NIACINAMIDE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness shoulder;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Frustration;Frustration;Emotional and mood disturbances NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Thyroid gland disorders|Hypothyroidism;Hypothyroidism;Thyroid hypofunction disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular disorders NEC|Pallor;Pallor;Site specific vascular disorders NEC;MODERATE;RECOVERED
Adverse Event|Vision disorders|Low visual acuity;Visual acuity reduced;Partial vision loss;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Red neck;Erythema;Erythemas;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Redness;Erythema;Erythemas;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff neck;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|GARASONE|NULL;NULL;NULL
Concomitant Medication|LIDOCAINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|MEPIVACAINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ROBIDRINE|NULL;NULL;NULL
Concomitant Medication|TANTUM|NULL;NULL;NULL
Adverse Event|Joint disorders|Degenerative joint disease;Osteoarthritis;Osteoarthropathies;MODERATE;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Bone spur;Exostosis;Bone disorders NEC;MODERATE;RECOVERED
Concomitant Medication|OXAPROZIN|NULL;NULL;NULL
Concomitant Medication|PROSOM|NULL;NULL;NULL
Concomitant Medication|PROTECTOR|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids aggravated;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Mild;NULL
Concomitant Medication|ATEPADENE|1;;Oral
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Coronary artery disorders|Acute coronary syndrome;Acute coronary syndrome;Ischaemic coronary artery disorders;MILD;RECOVERED
Adverse Event|Male reproductive tract infections and inflammations|Acute prostatitis;Prostatitis;Prostate and seminal vesicles infections and inflammations;MILD;RECOVERED
Concomitant Medication|ALLOPURINOL|200;QD (every day);Oral
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|3;TID (three times a day);Oral
Concomitant Medication|BETAMETHASONE|2;QD (every day);Oral
Concomitant Medication|COTAREG|160/25;QD (every day);Oral
Concomitant Medication|DIANTALVIC|2;PRN (as needed);Oral
Concomitant Medication|FLECAINIDE|200;QD (every day);Oral
Concomitant Medication|FUNGIZONE|2;BID (twice a day);Topical
Concomitant Medication|OMEPRAZOLE|10;QD (every day);Oral
Concomitant Medication|TETRAZEPAM|25;QHS (at bedtime);Oral
Concomitant Medication|TETRAZEPAM|50;QHS (at bedtime);Oral
Concomitant Medication|ZOPIDEM|20;PRN (as needed);Oral
Concomitant Medication|ALLOPURINOL|100;QD (every day);Oral
Concomitant Medication|AUGMENTIN|3;TID (three times a day);Oral
Concomitant Medication|CIPROFLOXACINE|1;BID (twice a day);Oral
Concomitant Medication|CLOPIDOGREL|75;QD (every day);Oral
Concomitant Medication|ENOXAPARIN|1;QD (every day);Subcutaneous
Concomitant Medication|ENOXAPARIN|2;BID (twice a day);Subcutaneous
Concomitant Medication|ESCITALOPRAM|20;QD (every day);Oral
Concomitant Medication|HYDROXYZINE|25;QD (every day);Oral
Concomitant Medication|PRISTINAMYCINE|6;TID (three times a day);Oral
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;SEVERE;RECOVERED
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract;Cataract;Cataract conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paresthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Vascular inflammations|Phlebitis lower limb;Phlebitis;Phlebitis NEC;SEVERE;RECOVERED
Adverse Event|General system disorders NEC|Thoracic pain;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;MODERATE;RECOVERED
Concomitant Medication|OROCAL D3|NULL;NULL;NULL
Concomitant Medication|PRESTOLE|NULL;NULL;NULL
Concomitant Medication|TRIFLUCAN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Inner ear disorder;Inner ear disorder;Inner ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness of limbs;Muscular weakness;Muscle weakness conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;Mild;NULL
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Concomitant Medication|ALPHAGAN|NULL;NULL;NULL
Concomitant Medication|LEVOBUNOLOL|NULL;NULL;NULL
Concomitant Medication|XALATAN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Breathlessness;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Meteorism;Flatulence;Flatulence, bloating and distension;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Itchy throat;Throat irritation;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Congestion pulmonary;Pulmonary congestion;Pulmonary oedemas;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;NULL;NULL
Adverse Event|Neurological disorders NEC|Unsteadiness;Balance disorder;Cerebellar coordination and balance disturbances;NULL;NULL
Adverse Event|Endocrine investigations (incl sex hormones)|Thyroxine low;Thyroxine decreased;Thyroid analyses;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Urine incontinence;Urinary incontinence;Bladder and urethral symptoms;NULL;NULL
Concomitant Medication|ALLEREST|NULL;NULL;NULL
Adverse Event|Physical examination topics|Weight increased;Weight increased;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated hemoglobin increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PRACTAZIN|NULL;NULL;NULL
Concomitant Medication|VIVALAN|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Change in ECG;Electrocardiogram change;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Gritty feeling in eyes;Foreign body sensation in eyes;Ocular sensation disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|FRUMIL|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Urinary tract signs and symptoms|Urge incontinence;Urge incontinence;Bladder and urethral symptoms;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|DIOSMECTITE|3;PRN (as needed);Oral
Concomitant Medication|IBUPROFEN|1;PRN (as needed);Oral
Concomitant Medication|OXYBUTYNIN|2.5;QD (every day);Oral
Concomitant Medication|PARACETAMOL|1;PRN (as needed);Oral
Adverse Event|Viral infectious disorders|Oral herpes;Oral herpes;Herpes viral infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fractured metatarsal;Foot fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Scalp laceration;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Ocular neuromuscular disorders|Divergent concomitant strabismus;Strabismus;Ocular nerve and muscle disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Dental and gingival conditions|Inflammation gum;Gingivitis;Gingival disorders NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Lower respiratory tract infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Awakening early;Terminal insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Adverse Event|Physical examination topics|Weight decrease;Weight decreased;Physical examination procedures;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|CALCIPARINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Epigastric burning;Dyspepsia;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Throat pain;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Pyrosis;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Runny nose;Rhinorrhoea;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|RENNIE|NULL;NULL;NULL
Concomitant Medication|TOCOPHERYL ACETATE|NULL;NULL;NULL
Concomitant Medication|TOCOPHERYL ACETATE-D-ALPHA|NULL;NULL;NULL
Concomitant Medication|BEECHAM'S|NULL;NULL;NULL
Concomitant Medication|CALCITE D|NULL;NULL;NULL
Concomitant Medication|NEOCITRAN|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy to cow's milk;Milk allergy;Allergies to foods, food additives, drugs and other chemicals;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Ocular neuromuscular disorders|Blepharoptosis;Eyelid ptosis;Eyelid movement disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Herpes simplex;Herpes simplex;Herpes viral infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Hot feeling in feet;Feeling hot;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety aggravated;Anxiety;Anxiety symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Water, electrolyte and mineral investigations|Serum sodium decreased;Blood sodium decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|B-100 COMPLEX|NULL;NULL;NULL
Concomitant Medication|FAMCICLOVIR|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Herpes on lip;Oral herpes;Herpes viral infections;NULL;NULL
Adverse Event|Vascular disorders NEC|Facial flushing;Flushing;Peripheral vascular disorders NEC;NULL;NULL
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;NULL;NULL
Concomitant Medication|CAMPHO-PHENIQUE|NULL;NULL;NULL
Concomitant Medication|ERGOCALCIFEROL|NULL;NULL;NULL
Concomitant Medication|ONE A DAY|NULL;NULL;NULL
Concomitant Medication|RETINOL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste diminished;Hypogeusia;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|CALCIUM CARBONATE|NULL;NULL;NULL
Concomitant Medication|CELL WISE|NULL;NULL;NULL
Concomitant Medication|MEL-VITA|NULL;NULL;NULL
Concomitant Medication|MELA-CAL|NULL;NULL;NULL
Concomitant Medication|NURASIC|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal colic;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;MILD;RECOVERED
Concomitant Medication|COLOFAC|NULL;NULL;NULL
Concomitant Medication|MERBENTYL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Polypnea;Tachypnoea;Breathing abnormalities;MODERATE;RECOVERED
Concomitant Medication|DILANTIN|100;BID (twice a day);Oral
Concomitant Medication|DILANTIN|100;QD (every day);Oral
Concomitant Medication|ROBITUSSIN DM|100/30;PRN (as needed);Oral
Concomitant Medication|SUPER B COMPLEX|1;QD (every day);Oral
Concomitant Medication|XANAX|.25;PRN (as needed);Oral
Adverse Event|Viral infectious disorders|Cold sore mouth;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Eye disorders NEC|Eyes stinging;Eye pain;Ocular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal ulceration and perforation|Peptic ulcer disease;Peptic ulcer;Peptic ulcers and perforation;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ANBESOL|NULL;NULL;NULL
Concomitant Medication|BROMTAPP|NULL;NULL;NULL
Concomitant Medication|EXPECTORANT|NULL;NULL;NULL
Concomitant Medication|ZILACTIN|NULL;NULL;NULL
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin low;Haemoglobin decreased;Red blood cell analyses;MILD;RECOVERED
Concomitant Medication|COENZYME Q10|100;TID (three times a day);Oral
Concomitant Medication|DARVOCET-N|100;BID (twice a day);Oral
Concomitant Medication|LISINOPRIL|2.5;QD (every day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Neck cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vaginal bleeding;Vaginal haemorrhage;Vulvovaginal disorders NEC;MODERATE;RECOVERED
Concomitant Medication|CALCITONIN|NULL;NULL;NULL
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Pulmonary vascular disorders|Pulmonary embolus;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Bone and joint injuries|Femur fracture;Femur fracture;Lower limb fractures and dislocations;SEVERE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|CIPRALEX|10;QD (every day);Oral
Concomitant Medication|FOLIC ACID|5;QD (every day);Oral
Concomitant Medication|IMMUNOGLOBULINS|30;Other (specify);Intravenous
Concomitant Medication|CLEXANE|140;BID (twice a day);Oral
Concomitant Medication|RAMIPRIL|5;QD (every day);Oral
Concomitant Medication|SLOW K|0.6;BID (twice a day);Oral
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Mild;NULL
Adverse Event|Protozoal infectious disorders|Babesiosis;Babesiosis;Babesia infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Pulled muscle;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED
Concomitant Medication|DOXYCLINE|NULL;NULL;NULL
Concomitant Medication|QUININE SULF|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gallbladder disorders|Gallstones;Cholelithiasis;Cholecystitis and cholelithiasis;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Lumbar disc herniation;Intervertebral disc protrusion;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in ankle;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in foot;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Pressure sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;RECOVERED
Adverse Event|Hepatic and hepatobiliary disorders|Hepatic lesion;Hepatic lesion;Hepatic and hepatobiliary disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac and vascular disorders congenital|Hemangioma congenital;Haemangioma congenital;Vascular anomalies congenital NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Unsteady gait;Gait disturbance;Gait disturbances;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BENGAY|NULL;NULL;NULL
Concomitant Medication|ESTRAGEST|NULL;NULL;NULL
Concomitant Medication|ESTRATAB|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle fatigue;Muscle fatigue;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;RECOVERED
Concomitant Medication|ACETAMINOPHEN W/PSEUDOEPHEDRINE|NULL;NULL;NULL
Concomitant Medication|ENZYMES NOS|NULL;NULL;NULL
Concomitant Medication|Z BEC|NULL;NULL;NULL
Lab Test|Absolute Basophil Count|Trace
Adverse Event|Joint disorders|Pain in joint involving shoulder region;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Joint disorders|Pain in elbow;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Concomitant Medication|ANSAID|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchopathy;Bronchial disorder;Bronchial conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;SEVERE;RECOVERED
Adverse Event|Genitourinary tract disorders NEC|Urinary tract disorder;Urinary tract disorder;Genital and urinary tract disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;MILD;RECOVERED
Concomitant Medication|BRICANYL|NULL;NULL;NULL
Concomitant Medication|KALEORID|NULL;NULL;NULL
Concomitant Medication|OROKEN|NULL;NULL;NULL
Concomitant Medication|TADENAN|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;MODERATE;UNKNOWN
Adverse Event|Administration site reactions|Injection site paresthesia;Injection site paraesthesia;Injection site reactions;MILD;UNKNOWN
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MILD;UNKNOWN
Concomitant Medication|DARVON-N COMPOUND|NULL;NULL;NULL
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Chemical diabetes;Glucose tolerance impaired;Hyperglycaemic conditions NEC;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Increased blood pressure;Blood pressure increased;Vascular tests NEC (incl blood pressure);MILD;RECOVERED
Adverse Event|Abdominal hernias and other abdominal wall conditions|Abdominal hernia;Abdominal hernia;Abdominal hernias, site unspecified;MILD;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Chemical diabetes;Glucose tolerance impaired;Hyperglycaemic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|APROTAN|NULL;NULL;NULL
Concomitant Medication|ELIMITE|NULL;NULL;NULL
Concomitant Medication|GALIUM|NULL;NULL;NULL
Concomitant Medication|GOLD BOND|NULL;NULL;NULL
Concomitant Medication|VITA-LEA|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Deglutition disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Inhalation pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;SEVERE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disorder;Sleep disorder;Sleep disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|LAMALINE|NULL;NULL;NULL
Adverse Event|Water, electrolyte and mineral investigations|Potassium low;Blood potassium decreased;Mineral and electrolyte analyses;Mild;NULL
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;Marked;NULL
Concomitant Medication|COZAAR|100;QD (every day);Oral
Concomitant Medication|IMODIUM|4;PRN (as needed);Oral
Concomitant Medication|PERCOCET|5/325;PRN (as needed);Oral
Concomitant Medication|POTASSIUM|99;QD (every day);Oral
Concomitant Medication|TRAZODONE|50;PRN (as needed);Oral
Concomitant Medication|XANAX|0.5;QD (every day);Oral
Adverse Event|Fungal infectious disorders|Athlete's foot;Tinea pedis;Tinea infections;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Facial paresthesia;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gas pain;Flatulence;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal conditions NEC|Sour stomach;Hyperchlorhydria;Gastrointestinal mucosal dystrophies and secretion disorders;MILD;RECOVERED
Adverse Event|Gastrointestinal conditions NEC|Sour stomach;Hyperchlorhydria;Gastrointestinal mucosal dystrophies and secretion disorders;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Increased upper airway secretion;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|DRISDOL|NULL;NULL;NULL
Concomitant Medication|MEDROL|NULL;NULL;NULL
Concomitant Medication|MICATIN|NULL;NULL;NULL
Concomitant Medication|NAPRELAN|NULL;NULL;NULL
Concomitant Medication|ROBITUSSIN COLD|NULL;NULL;NULL
Concomitant Medication|SALIVART|NULL;NULL;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Bleeding menstrual heavy;Menorrhagia;Menstruation with increased bleeding;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression aggravated;Depression;Depressive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Anxiety depression;Depression;Depressive disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Medication errors|Drug overdose;Overdose;Overdoses;MODERATE;RECOVERED
Adverse Event|Ocular neuromuscular disorders|Mydriasis;Mydriasis;Pupil disorders;MODERATE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Venous insufficiency;Venous insufficiency;Non-site specific necrosis and vascular insufficiency NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ADRONAT|NULL;NULL;NULL
Concomitant Medication|FOLINA|NULL;NULL;NULL
Concomitant Medication|GINODEN|NULL;NULL;NULL
Concomitant Medication|LUTENYL|NULL;NULL;NULL
Concomitant Medication|SEREUPIN|NULL;NULL;NULL
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Burning in throat;Throat irritation;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Vision disorders|Diplopia;Diplopia;Visual disorders NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Depressed mood disorders and disturbances|Dysthymia;Dysthymic disorder;Depressive disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Physical examination topics|Lost weight;Weight decreased;Physical examination procedures;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Thyroid gland disorders|Hyperthyroidism;Hyperthyroidism;Thyroid hyperfunction disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anaemia aggravated;Anaemia;Anaemias NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALGOPYRIN|UNK;Unknown;Oral
Concomitant Medication|ALPRAZOLAM|0,25;QD (every day);Oral
Concomitant Medication|CAVINTON|HALF;QD (every day);Oral
Concomitant Medication|CIPROBAY|500;BID (twice a day);Oral
Concomitant Medication|FAMOTIDINE|40;BID (twice a day);Oral
Concomitant Medication|METHYLPREDNISOLONE|32;QD (every day);Oral
Concomitant Medication|METHYLPREDNISOLONE|UNK;Unknown;Intravenous
Concomitant Medication|METOPROLOL|50;BID (twice a day);Oral
Concomitant Medication|METOTHYRIN|1,5;QD (every day);Oral
Concomitant Medication|METOTHYRIN|2;BID (twice a day);Oral
Concomitant Medication|METOTHYRIN|3;BID (twice a day);Oral
Concomitant Medication|METOTHYRIN|3;TID (three times a day);Oral
Concomitant Medication|NOOTROPIL|600;QD (every day);Oral
Concomitant Medication|PENTOXIFYLLINE|UNK;Unknown;Intravenous
Concomitant Medication|POTASSIUM CHLORIDE|3;TID (three times a day);Oral
Concomitant Medication|PROPRANOLOL|1,5;TID (three times a day);Oral
Concomitant Medication|PROPRANOLOL|50;BID (twice a day);Oral
Concomitant Medication|STILNOX|UNK;Unknown;Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Acute lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Anal and rectal conditions NEC|Anal sphincter atony;Anal sphincter atony;Anal and rectal disorders NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Atlantoaxial instability;Atlantoaxial instability;Joint related disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disorders and disturbances|Sleep disturbance;Sleep disorder;Sleep disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Hypoventilation;Hypoventilation;Breathing abnormalities;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Acute dyspnea;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Reactive depression;Depression;Depressive disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|DICLOFENAC|100;BID (twice a day);Oral
Concomitant Medication|LIORESAL|15;TID (three times a day);Oral
Concomitant Medication|LIORESAL|5;QD (every day);Oral
Concomitant Medication|OPIPRAMOL|100;QD (every day);Oral
Concomitant Medication|OPIPRAMOL|150;BID (twice a day);Oral
Concomitant Medication|PANTOZOL|20;QD (every day);Oral
Concomitant Medication|AMITRIPTYLINE|50;BID (twice a day);Oral
Concomitant Medication|IBUPROFEN|1200;TID (three times a day);Oral
Concomitant Medication|SEVREDOL|10;QD (every day);Oral
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;NULL
Adverse Event|Platelet disorders|Thrombocytopenia;Thrombocytopenia;Thrombocytopenias;Mild;NULL
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;Moderate;NULL
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;Mild;NULL
Concomitant Medication|COUMADIN|5;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|300;QD (every day);Oral
Concomitant Medication|HEPARIN|1000;Continuous IV;Intravenous
Concomitant Medication|HYDROXYUREA|500;QD (every day);Oral
Concomitant Medication|PROCARDIA|30;QD (every day);Oral
Concomitant Medication|TUMS|2;QD (every day);Oral
Concomitant Medication|TYLENOL|650;TID (three times a day);Oral
Concomitant Medication|ZITHROMAX|500;Continuous IV;Intravenous
Concomitant Medication|SENOKOT|8.6;BID (twice a day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Epigastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Purine and pyrimidine metabolism disorders|Hyperuricemia;Hyperuricaemia;Purine metabolism disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Pollakiuria;Pollakiuria;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Contusion of thigh;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Concomitant Medication|HEMOCLAR|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured ribs;Rib fracture;Thoracic cage fractures and dislocations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal conditions NEC|Hyperacidity;Hyperchlorhydria;Gastrointestinal mucosal dystrophies and secretion disorders;MODERATE;RECOVERED
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness of upper extremities;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Numbness lips;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Wt loss;Weight decreased;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CARDIOLITE|NULL;NULL;NULL
Concomitant Medication|PINK BISMUTH|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;NULL;NULL
Adverse Event|Vascular disorders NEC|Flushed;Flushing;Peripheral vascular disorders NEC;NULL;NULL
Adverse Event|Joint disorders|Pain in knee;Arthralgia;Joint related signs and symptoms;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Rash both legs;Rash;Rashes, eruptions and exanthems NEC;NULL;NULL
Adverse Event|Administration site reactions|Rash injection site;Injection site rash;Injection site reactions;NULL;NULL
Adverse Event|Skin appendage conditions|Hair growth abnormal;Hair growth abnormal;Pilar disorders NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Foot abscess;Abscess limb;Infections NEC;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Kidney pain;Renal pain;Urinary tract signs and symptoms NEC;NULL;NULL
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;NULL;NULL
Adverse Event|Administration site reactions|Injection site rash;Injection site rash;Injection site reactions;NULL;NULL
Concomitant Medication|ISOSORBIDE DINITRATE|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Oral candida;Oral candidiasis;Candida infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|MYCOSTATINE|NULL;NULL;NULL
Concomitant Medication|SUPRADYNE|NULL;NULL;NULL
Concomitant Medication|MINOXIDIL|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Kyphosis;Kyphosis;Spine and neck deformities;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;MILD;UNKNOWN
Adverse Event|Hepatic and hepatobiliary disorders|Liver enlargement;Hepatomegaly;Hepatobiliary signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Parotid gland enlargement;Parotid gland enlargement;Salivary gland enlargements;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;Mild;NULL
Adverse Event|Glaucoma and ocular hypertension|Glaucoma;Glaucoma;Glaucomas (excl congenital);Mild;NULL
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Mild;NULL
Concomitant Medication|ALBUTEROL|2.5;BID (twice a day);Inhalation
Concomitant Medication|BACLOFEN|10;BID (twice a day);Inhalation
Concomitant Medication|MUCOMYST|1;BID (twice a day);Inhalation
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal fullness;Abdominal distension;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|KETOCONAZOLE|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Bladder spasm;Bladder spasm;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Spasms;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Breathing difficult;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit increased;Haematocrit increased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin increased;Haemoglobin increased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine;Protein urine;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Falling;Fall;Non-site specific injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;RECOVERED
Adverse Event|Embolism and thrombosis|DVT of legs;Deep vein thrombosis;Peripheral embolism and thrombosis;SEVERE;RECOVERED
Adverse Event|Bladder and bladder neck disorders (excl calculi)|Overactive bladder;Hypertonic bladder;Myoneurogenic bladder disorders;MODERATE;RECOVERED
Concomitant Medication|APO-OXYBUTYNIN|NULL;NULL;NULL
Concomitant Medication|CES|NULL;NULL;NULL
Concomitant Medication|NOVO-MEDRONE|NULL;NULL;NULL
Concomitant Medication|NOVO-TRIPRAMINE|NULL;NULL;NULL
Concomitant Medication|RHOVANE|NULL;NULL;NULL
Concomitant Medication|VITAMIN C AND E|NULL;NULL;NULL
Adverse Event|Renal disorders (excl nephropathies)|Anuria;Anuria;Renal failure and impairment;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit low;Haematocrit decreased;Red blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin low;Haemoglobin decreased;Red blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|RBC decreased;Red blood cell count decreased;Red blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hypertriglyceridemia;Hypertriglyceridaemia;Elevated triglycerides;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sexual function and fertility disorders|Impotent;Erectile dysfunction;Erection and ejaculation conditions and disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Myalgia of lower extremities;Myalgia;Muscle pains;SEVERE;RECOVERED
Concomitant Medication|CEFTIZOXIME SODIUM|NULL;NULL;NULL
Concomitant Medication|HEPRIN|NULL;NULL;NULL
Concomitant Medication|ISOSORBIDE MONONITRATE|NULL;NULL;NULL
Concomitant Medication|SUPHEDRINE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Enlarged tonsils;Tonsillar hypertrophy;Pharyngeal disorders (excl infections and neoplasms);MILD;RECOVERED
Concomitant Medication|FATTY ACIDS NOS|NULL;NULL;NULL
Concomitant Medication|MULTI MINERAL|NULL;NULL;NULL
Concomitant Medication|ORTHO TRI-CYCLEN|NULL;NULL;NULL
Concomitant Medication|PAPAYA ENZYME|NULL;NULL;NULL
Concomitant Medication|RELAX|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Night sweat;Night sweats;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Tendon, ligament and cartilage disorders|Scheuermann's disease;Osteochondrosis;Cartilage disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;Moderate;NULL
Concomitant Medication|BACLOFEN|20;PRN (as needed);Oral
Concomitant Medication|BACTRIM|160/800;BID (twice a day);Oral
Concomitant Medication|JUICE PLUS|3;BID (twice a day);Oral
Concomitant Medication|ORTHO TRI-CYCLEN|U;QD (every day);Oral
Adverse Event|General system disorders NEC|Gait disorder;Gait disturbance;Gait disturbances;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Reproductive neoplasms male benign|Prostatic adenoma;Prostatic adenoma;Prostatic neoplasms benign;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Hepatic enzyme increased;Hepatic enzyme increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|TROLOVOL|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Premature atrial contraction;Supraventricular extrasystoles;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|COPD;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fractured ribs;Rib fracture;Thoracic cage fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Joint disorders|Stiff joint;Joint stiffness;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Bilirubin indirect increased;Blood bilirubin unconjugated increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Bilirubin increased;Blood bilirubin increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Scar;Scar;Skin injuries and mechanical dermatoses;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heartbeats irregular;Heart rate irregular;Heart rate and pulse investigations;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CYTOKINES AND IMMUNOMODULATORS|NULL;NULL;NULL
Adverse Event|Seizures (incl subtypes)|Seizure;Convulsion;Seizures and seizure disorders NEC;Moderate;NULL
Concomitant Medication|CLONAZEPAM|1;BID (twice a day);Oral
Concomitant Medication|METHADONE|5;BID (twice a day);Oral
Concomitant Medication|PHENERGAN|25;PRN (as needed);Oral
Concomitant Medication|XANAX|0.5;TID (three times a day);Oral
Concomitant Medication|XANAX|1;TID (three times a day);Oral
Concomitant Medication|NEURONTIN|600;QID (four times a day);Oral
Adverse Event|Gastrointestinal conditions NEC|Colovesical fistula;Enterovesical fistula;Gastrointestinal fistulae;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Upper respiratory tract disorders (excl infections)|Congestion nasal;Nasal congestion;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;MILD;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Facial weakness;Facial paresis;Facial cranial nerve disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Arm fracture;Upper limb fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Muscle disorders|Twitching;Muscle twitching;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruising;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Concomitant Medication|SILYBUM MARIANUM|NULL;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site bleeding;Post procedural haemorrhage;Non-site specific procedural complications;Mild;NULL
Adverse Event|Physical examination and organ system status topics|Coarse breath sounds;Breath sounds abnormal;Physical examination procedures and organ system status;Mild;NULL
Adverse Event|Urinary tract signs and symptoms|Frequency urinary;Pollakiuria;Bladder and urethral symptoms;Mild;NULL
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;Mild;NULL
Adverse Event|Tendon, ligament and cartilage disorders|Ligament pain;Ligament pain;Ligament disorders;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;Moderate;NULL
Adverse Event|General system disorders NEC|Tenderness;Tenderness;Pain and discomfort NEC;Mild;NULL
Concomitant Medication|BEXTRA|1;PRN (as needed);Other (specify)
Concomitant Medication|OXYGEN|1-2;PRN (as needed);Intranasal
Concomitant Medication|ROBINUL|2;TID (three times a day);Other (specify)
Concomitant Medication|ROXANOL|0.5-1;PRN (as needed);Other (specify)
Concomitant Medication|SCOPOLAMINE|1.5;Other (specify);Transdermal
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;Mild;NULL
Concomitant Medication|CAPTOMER|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal bloating;Abdominal distension;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Throat secretion increased;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DEQUALINIUM CHLORIDE|NULL;NULL;NULL
Concomitant Medication|FLUTICASONE PROPIONATE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BACLOFEN|200;BID (twice a day);Oral
Concomitant Medication|DRIDASE|15;TID (three times a day);Oral
Concomitant Medication|MARCUMAR|1;;Oral
Concomitant Medication|MARCUMAR|1;QD (every day);Oral
Concomitant Medication|MIRTAZAPINE|7.5;QD (every day);Oral
Concomitant Medication|OMEP|1;QD (every day);Oral
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Hypotension;Hypotension;Vascular hypotensive disorders;MILD;RECOVERED
Adverse Event|Anterior eye structural change, deposit and degeneration|Arcus senilis;Arcus lipoides;Corneal structural change, deposit and degeneration;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Soft stools;Diarrhoea;Diarrhoea (excl infective);SEVERE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram T wave abnormal;Electrocardiogram T wave abnormal;ECG investigations;MILD;RECOVERED
Adverse Event|General system disorders NEC|Chest burning;Chest pain;Pain and discomfort NEC;NULL;NULL
Adverse Event|Body temperature conditions|Intermittent fever;Pyrexia;Febrile disorders;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;NULL;NULL
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Physical examination topics|Lost weight;Weight decreased;Physical examination procedures;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BREXINE|NULL;NULL;NULL
Concomitant Medication|CYCLO 3|NULL;NULL;NULL
Concomitant Medication|PRORHINEL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Feeling of gastrointestinal fullness;Abdominal distension;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Common cold;Nasopharyngitis;Upper respiratory tract infections;SEVERE;RECOVERED
Concomitant Medication|TUSSIONEX|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Foot tinea;Tinea pedis;Tinea infections;MODERATE;RECOVERED
Concomitant Medication|MICONAZOLNITRAAT/HYDROCORTISON|NULL;NULL;NULL
Concomitant Medication|AMITRIPTYLINE|25;;Oral
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoidal bleeding;Haemorrhoidal haemorrhage;Haemorrhoids and gastrointestinal varices (excl oesophageal);MODERATE;RECOVERED
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoidal bleeding;Haemorrhoidal haemorrhage;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Fungal skin infection;Fungal skin infection;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Pleuritic pain;Pleuritic pain;Lower respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal vascular conditions|Haemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|AULIN|NULL;NULL;NULL
Concomitant Medication|CALCIA|NULL;NULL;NULL
Concomitant Medication|CENTYL K|NULL;NULL;NULL
Concomitant Medication|CODOLAX|NULL;NULL;NULL
Concomitant Medication|CYCLIZINE|NULL;NULL;NULL
Concomitant Medication|DESMOPRESSIN|NULL;NULL;NULL
Concomitant Medication|DYDROGESTERONE|NULL;NULL;NULL
Concomitant Medication|ISTIN|NULL;NULL;NULL
Concomitant Medication|MEFENAMIC ACID|NULL;NULL;NULL
Concomitant Medication|MST|NULL;NULL;NULL
Concomitant Medication|PRIMOLUT N|NULL;NULL;NULL
Concomitant Medication|SEVREDOL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Giddiness;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Giddiness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Menopause and related conditions|Hot flushes menopausal;Menopausal symptoms;Menopausal effects NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Post coital bleeding;Coital bleeding;Vulvovaginal signs and symptoms;MILD;RECOVERED
Adverse Event|Ovarian and fallopian tube disorders|Primary ovarian failure;Ovarian failure;Ovarian and fallopian tube disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergic reaction to bee sting;Allergy to arthropod sting;Allergic conditions NEC;MODERATE;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ear buzzing;Tinnitus;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Neuralgia;Neuralgia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Orthostatic hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Orthostatic hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MILD;RECOVERED
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in heel;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Mycosis;Fungal infection;Fungal infections NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|DESURIC|NULL;NULL;NULL
Concomitant Medication|TENORDATE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Viral infectious disorders|Viral upper respiratory tract infection;Viral upper respiratory tract infection;Viral infections NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;NULL
Adverse Event|Infections - pathogen unspecified|Skin infection;Skin infection;Skin structures and soft tissue infections;Moderate;NULL
Concomitant Medication|MINOCYCLINE|100;QD (every day);Oral
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;Moderate;Continuing
Lab Test|Urine blood|+
Adverse Event|Epidermal and dermal conditions|Sloughing;Skin exfoliation;Exfoliative conditions;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BUFLOMEDIL|NULL;NULL;NULL
Concomitant Medication|CHLORAZEPATE|NULL;NULL;NULL
Concomitant Medication|CLARAMID|NULL;NULL;NULL
Concomitant Medication|DUODERM|NULL;NULL;NULL
Concomitant Medication|ALGINIC ACID|1;QD (every day);Oral
Concomitant Medication|BROMAZEPAM|3;QHS (at bedtime);Oral
Concomitant Medication|ESOMEPRAZOLE|20;QD (every day);Oral
Concomitant Medication|GAVISCON|1;PRN (as needed);Oral
Concomitant Medication|VITAMIN E|1;BID (twice a day);Oral
Concomitant Medication|ALGINIC ACID|3;TID (three times a day);Oral
Adverse Event|General system disorders NEC|Gait disorder;Gait disturbance;Gait disturbances;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Oral soft tissue conditions|Numbness oral;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Numbness oral;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|RILUZOLE|100;TID (three times a day);Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;UNKNOWN
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MILD;UNKNOWN
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count increased;Lymphocyte count increased;White blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine RBC increased;Red blood cells urine positive;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|WBC increased;White blood cell count increased;White blood cell analyses;MILD;UNKNOWN
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Spinal stenosis NOS;Spinal column stenosis;Spine and neck deformities;MILD;UNKNOWN
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Syrinx;Syringomyelia;Spinal cord and nerve root disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CASODEX|NULL;NULL;NULL
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anaemia;Anaemia;Anaemias NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urine incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Bizarre dreams;Abnormal dreams;Parasomnias;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Discomfort in joints;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Dreams abnormal;Abnormal dreams;Parasomnias;Mild;NULL
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;Mild;NULL
Adverse Event|Joint disorders|Pain in joint involving hand;Arthralgia;Joint related signs and symptoms;Mild;NULL
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck stiff;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|Skin appendage conditions|Night sweat;Night sweats;Apocrine and eccrine gland disorders;Moderate;NULL
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;Mild;NULL
Adverse Event|Neurological disorders NEC|Numbness localized;Hypoaesthesia;Sensory abnormalities NEC;Mild;NULL
Concomitant Medication|SULFAMETHOXAZOLE|800;BID (twice a day);Oral
Concomitant Medication|TRIMETHOPRIM|160;BID (twice a day);Oral
Concomitant Medication|TYLENOL|1000;QD (every day);Oral
Concomitant Medication|TYLENOL|1000;BID (twice a day);Oral
Concomitant Medication|TYLENOL EXTRA STRENGTH|1000;QD (every day);Oral
Concomitant Medication|TYLENOL EXTRA STRENGTH|1000;BID (twice a day);Oral
Concomitant Medication|ZIAC|5/6.25;QD (every day);Oral
Adverse Event|General system disorders NEC|Edema legs;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|NATURE'S WAY MULTIVITAMIN|NULL;NULL;NULL
Concomitant Medication|TIAZAC|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema arms;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Colitis;Colitis;Colitis (excl infective);MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pharyngitis;Pharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Angioedema and urticaria|Urticaria;Urticaria;Urticarias;MILD;RECOVERED
Concomitant Medication|EXOCIN|NULL;NULL;NULL
Concomitant Medication|TOBREX|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CELIPROLOL|NULL;NULL;NULL
Concomitant Medication|METILDIGOXIN|NULL;NULL;NULL
Concomitant Medication|PIRACETAM|NULL;NULL;NULL
Concomitant Medication|PROMETHAZIN|NULL;NULL;NULL
Concomitant Medication|XYLOMETAZOLIN|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Acute bronchitis;Bronchitis;Lower respiratory tract and lung infections;Moderate;NULL
Adverse Event|Skin appendage conditions|Alopecia;Alopecia;Alopecias;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Initial insomnia;Initial insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Concomitant Medication|KERATIN|3.5;;Oral
Concomitant Medication|LIMPTAR|200;;Oral
Concomitant Medication|SCOPODERM|1;Other (specify);Topical
Concomitant Medication|VITAMIN E|2000;;Oral
Adverse Event|Gastrointestinal signs and symptoms|Nauseated;Nausea;Nausea and vomiting symptoms;MILD;RECOVERED
Concomitant Medication|NYTOL|NULL;NULL;NULL
Concomitant Medication|PRILOSEC|20;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|10000;QD (every day);Oral
Adverse Event|Bone and joint injuries|Fractured thumb;Hand fracture;Upper limb fractures and dislocations;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Fractured thumb;Hand fracture;Upper limb fractures and dislocations;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Gingival disease;Gingival disorder;Gingival disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Generalized muscle aches;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|DIPHEDRYL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema extremities;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Fluid retention in tissues;Fluid retention;Total fluid volume increased;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Abdominal infection;Abdominal infection;Abdominal and gastrointestinal infections;MILD;RECOVERED
Adverse Event|Joint disorders|Pain in knee;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema knees;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Concomitant Medication|VICKS 44|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated hemoglobin decreased;Glycosylated haemoglobin decreased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|Hepatic enzyme increased;Hepatic enzyme increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Nocturnal cough;Cough;Coughing and associated symptoms;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritus;Pruritus;Pruritus NEC;MILD;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|BETNESOL|NULL;NULL;NULL
Concomitant Medication|PENGLOBE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Gait instability;Gait disturbance;Gait disturbances;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Gait spastic;Gait spastic;Paralysis and paresis (excl cranial nerve);MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp of limb;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Heat intolerance;Temperature intolerance;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Obesity;Obesity;General nutritional disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Stools watery;Diarrhoea;Diarrhoea (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular neuromuscular disorders|Eyelid twitching;Blepharospasm;Eyelid movement disorders;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|CALTRATE|1;QD (every day);Oral
Concomitant Medication|COENZYME Q10|300;TID (three times a day);Oral
Concomitant Medication|DIPHENHYDRAMINE|50;BID (twice a day);Oral
Concomitant Medication|HYDROCORTISONE|1;QD (every day);Topical
Concomitant Medication|IBUPROFEN|200;PRN (as needed);Oral
Concomitant Medication|METHYLPREDNISOLONE|40;QD (every day);Oral
Concomitant Medication|NUEDEXTA|60/20;BID (twice a day);Oral
Concomitant Medication|ORTHO-NOVUM 7/7/7|1;QD (every day);Oral
Concomitant Medication|PSEUDOEPHEDRINE HYDROCHLORIDE|60;PRN (as needed);Oral
Concomitant Medication|VITAMIN B COMPLEX|50;QD (every day);Oral
Concomitant Medication|LOTRIMIN|1;QD (every day);Topical
Adverse Event|Joint disorders|Joint range of motion decreased;Joint range of motion decreased;Joint related signs and symptoms;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;Mild;NULL
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Feeling drunk;Feeling drunk;Feelings and sensations NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Water, electrolyte and mineral investigations|Potassium increased;Blood potassium increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Metabolic, nutritional and blood gas investigations|Urine ketone body;Urine ketone body;Metabolism tests NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Feeling drunk;Feeling drunk;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Potassium high;Blood potassium increased;Mineral and electrolyte analyses;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Movement disorders (incl parkinsonism)|Shaking of hands;Tremor;Tremor (excl congenital);MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Nystagmus;Nystagmus;Cerebellar coordination and balance disturbances;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Metabolic, nutritional and blood gas investigations|Oxygen saturation low;Oxygen saturation decreased;Blood gas and acid base analyses;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Movement disorders (incl parkinsonism)|Shaking of hands;Tremor;Tremor (excl congenital);MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;MILD;RECOVERED
Adverse Event|Vision disorders|Flashing lights;Photopsia;Visual disorders NEC;MODERATE;RECOVERED
Concomitant Medication|CALCIUM MAGNESIUM|333;QD (every day);Oral
Concomitant Medication|ESTROGEN|50;Other (specify);Topical
Concomitant Medication|GINSENG|1;QD (every day);Oral
Concomitant Medication|NOVO-MEDRONE|2.5;QD (every day);Oral
Concomitant Medication|AERIUS|5;QD (every day);Oral
Concomitant Medication|TAMIFLU|30;QD (every day);Oral
Lab Test|Urine blood|Normal
Lab Test|Urine Protein|Normal
Adverse Event|General system disorders NEC|Chest tightness of;Chest discomfort;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;SEVERE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep maintenance insomnia;Middle insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Scoliosis;Scoliosis;Spine and neck deformities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Blood and lymphatic system disorders congenital|Thalassemia minor;Thalassaemia beta;Haemoglobinopathies congenital;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMIODARONE|100;QD (every day);Oral
Concomitant Medication|AMIODARONE|200;QD (every day);Oral
Concomitant Medication|BENADRYL|25;QD (every day);Oral
Concomitant Medication|CHOLESTYRAMINE|86;BID (twice a day);Oral
Concomitant Medication|HYDROCHLOROTHIAZIDE|25;BID (twice a day);Oral
Concomitant Medication|LEVOXYL|.75;QD (every day);Oral
Concomitant Medication|ZESTRIL|30;QD (every day);Oral
Concomitant Medication|COUMADIN|2;Twice per week;Oral
Concomitant Medication|COUMADIN|4;Four times per week;Oral
Concomitant Medication|METOPROLOL|25;BID (twice a day);Oral
Adverse Event|General system disorders NEC|Edema of legs;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|Gastrointestinal haemorrhages NEC|Blood stool;Haematochezia;Non-site specific gastrointestinal haemorrhages;Mild;NULL
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Kyphosis;Kyphosis;Spine and neck deformities;Mild;NULL
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;Mild;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Moderate;NULL
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Embolism and thrombosis|Thrombosis leg;Thrombosis;Non-site specific embolism and thrombosis;Moderate;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal ulcer;Nasal ulcer;Nasal disorders NEC;Mild;NULL
Adverse Event|Synovial and bursal disorders|Olecranon bursitis;Bursitis;Bursal disorders;Moderate;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis of arm;Cellulitis;Bacterial infections NEC;Marked;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis of arm;Cellulitis;Bacterial infections NEC;Moderate;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);Mild;NULL
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;Moderate;NULL
Concomitant Medication|ANCEF|1;TID (three times a day);Intravenous
Concomitant Medication|BACTROBAN|2;PRN (as needed);Topical
Concomitant Medication|CREATINE|4.5;TID (three times a day);Oral
Concomitant Medication|CREATINE|6.3;QD (every day);Oral
Concomitant Medication|LEVAQUIN|750;QD (every day);Oral
Concomitant Medication|MORPHINE SULFATE|0-2;PRN (as needed);Intravenous
Concomitant Medication|ROCEPHINE|1;QD (every day);Intravenous
Concomitant Medication|TRIMOX|500;TID (three times a day);Oral
Concomitant Medication|TYLENOL PM|500/25;QHS (at bedtime);Oral
Concomitant Medication|VICODIN|5/500;PRN (as needed);Oral
Concomitant Medication|PNEUMOCOCCAL VACCINE|.5;QD (every day);Intramuscular
Adverse Event|Coronary artery disorders|Angina pectoris;Angina pectoris;Ischaemic coronary artery disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Supine dyspnea;Orthopnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Peripheral neuropathies|Sensory neuropathy;Peripheral sensory neuropathy;Peripheral neuropathies NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular haemorrhages and vascular disorders NEC|Eye hemorrhage;Eye haemorrhage;Ocular bleeding and vascular disorders NEC;MILD;RECOVERED
Concomitant Medication|LIDOCAINE AND PRILOCAINE|NULL;NULL;NULL
Adverse Event|Joint disorders|Joint ache;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Tingling lips;Paraesthesia oral;Oral soft tissue pain and paraesthesia;MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Agitation;Agitation;Anxiety symptoms;SEVERE;RECOVERED
Adverse Event|Skin appendage conditions|Cold sweat;Cold sweat;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Dysesthesia thigh;Dysaesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Numbness facial;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor aggravated;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Acrocyanosis;Cyanosis;Cardiac signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Nervousness;Nervousness;Anxiety symptoms;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in leg;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Vestibular neuronitis;Vestibular neuronitis;Viral infections NEC;MILD;RECOVERED
Adverse Event|Hepatobiliary investigations|Raised LFTs;Liver function test abnormal;Liver function analyses;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Fungal infection of nail;Onychomycosis;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Degenerative joint disease;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|FERROUS GLUCONATE|NULL;NULL;NULL
Concomitant Medication|PHENERGAN DM|NULL;NULL;NULL
Adverse Event|Injuries NEC|Lip laceration;Mouth injury;Site specific injuries NEC;MODERATE;RECOVERED
Concomitant Medication|CHROMIUM|NULL;NULL;NULL
Concomitant Medication|GAMMA-LINOLENIC ACID|NULL;NULL;NULL
Concomitant Medication|INOSITOL|NULL;NULL;NULL
Concomitant Medication|VANADYL SULFATE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervicalgia;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tracheitis;Tracheitis;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vaginal bleeding;Vaginal haemorrhage;Vulvovaginal disorders NEC;SEVERE;RECOVERED
Concomitant Medication|ANETHOLE TRITHIONE|NULL;NULL;NULL
Concomitant Medication|INFLUVAC|NULL;NULL;NULL
Concomitant Medication|METHYLERGOMETRINE MALEATE|NULL;NULL;NULL
Concomitant Medication|SULFAMETHOXAZOL W/TRIMETOPRIM|NULL;NULL;NULL
Concomitant Medication|TENOXICAM|NULL;NULL;NULL
Concomitant Medication|TRANEXAMIC ACID|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Abnormal arterial blood gases;Blood gases abnormal;Blood gas and acid base analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor of hands;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Concomitant Medication|CITIOLONE|NULL;NULL;NULL
Concomitant Medication|PINAZEPAM|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Abnormal ECG;Electrocardiogram abnormal;ECG investigations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Astigmatism;Astigmatism;Refractive and accommodative disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Heart failures|Congestive heart failure;Cardiac failure congestive;Heart failures NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Head and neck therapeutic procedures|Dental treatment;Dental care;Dental and gingival therapeutic procedures;MILD;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Dental treatment;Dental care;Dental and gingival therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Cervical disc herniation;Intervertebral disc protrusion;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Nasal irritation;Nasal discomfort;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Sulfonamide allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PNEUMOCOCCAL VACCINE POLYVALENT|NULL;NULL;NULL
Adverse Event|Oral soft tissue conditions|Burning oral sensation;Oral discomfort;Oral soft tissue signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Meniere's disease;Meniere's disease;Inner ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema fingers;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Disturbances in thinking and perception|Hallucinations;Hallucination;Perception disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Haematology investigations (incl blood groups)|Monocyte count high;Monocyte count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional disturbance NOS;Emotional disorder;Emotional and mood disturbances NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count low;Lymphocyte count decreased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count low;Lymphocyte count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Salivation;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Acute lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in heel;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder blade pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Injuries NEC|Tick bite;Arthropod bite;Non-site specific injuries NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NUTILIS AQUA|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy to nuts;Food allergy;Allergies to foods, food additives, drugs and other chemicals;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest pressure;Chest discomfort;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Flaking skin;Skin exfoliation;Exfoliative conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Flaking skin;Skin exfoliation;Exfoliative conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Neuromuscular disorders|Muscle fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Oily skin;Seborrhoea;Sebaceous gland disorders;MILD;RECOVERED
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Breast disorders|Breast enlargement male;Gynaecomastia;Breast disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Kidney stones;Nephrolithiasis;Renal lithiasis;MODERATE;RECOVERED
Concomitant Medication|CLONIDINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|FOSINOPRIL SODIUM|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervicodynia;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Periarthritis;Periarthritis;Joint related disorders NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ATEPADENE|NULL;NULL;NULL
Concomitant Medication|DOXIUM|NULL;NULL;NULL
Concomitant Medication|IMOVAN|NULL;NULL;NULL
Concomitant Medication|MYOVITON|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|General system disorders NEC|Feeling of warmth;Feeling hot;Feelings and sensations NEC;Moderate;Resolved
Adverse Event|Muscle disorders|Generalised muscle aches;Myalgia;Muscle pains;Moderate;Continuing
Adverse Event|Allergic conditions|Allergic reaction to analgesics;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ear noises;Tinnitus;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal ulcer;Nasal ulcer;Nasal disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Blood bicarbonate increased;Blood bicarbonate increased;Mineral and electrolyte analyses;MILD;RECOVERED
Concomitant Medication|CO-DANTHRAMER|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Groin pain;Groin pain;Soft tissue disorders NEC;MODERATE;RECOVERED
Concomitant Medication|POLYVIDONE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Brain lesion;Central nervous system lesion;Nervous system disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Crying;Crying;Neurological signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Incomplete right bundle branch block;Bundle branch block right;Cardiac conduction disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Throat constriction;Throat tightness;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Forehead swelling;Swelling face;Dermal and epidermal conditions NEC;MODERATE;RECOVERED
Concomitant Medication|BIOFLAVONOIDS|NULL;NULL;NULL
Concomitant Medication|BIOTIN|NULL;NULL;NULL
Concomitant Medication|BORON|NULL;NULL;NULL
Concomitant Medication|CAFFEINE|NULL;NULL;NULL
Concomitant Medication|CHOLINE|NULL;NULL;NULL
Concomitant Medication|DICLOXACILLIN|NULL;NULL;NULL
Concomitant Medication|IODINE|NULL;NULL;NULL
Concomitant Medication|MOLYBDENUM|NULL;NULL;NULL
Concomitant Medication|PABA|NULL;NULL;NULL
Concomitant Medication|SALICYLAMIDE|NULL;NULL;NULL
Concomitant Medication|SILICON|NULL;NULL;NULL
Concomitant Medication|VANADIUM|NULL;NULL;NULL
Concomitant Medication|VITAMIN B2|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;MILD;UNKNOWN
Adverse Event|Allergic conditions|Pollen allergy;Seasonal allergy;Atopic disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALLERGOSPASMIN|NULL;NULL;NULL
Concomitant Medication|CEFETAMET|NULL;NULL;NULL
Concomitant Medication|SOLOSIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Ankle oedema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Microscopic haematuria;Haematuria;Urinary abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Headache aggravated;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Twitching;Muscle twitching;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|CODEINE PHOSPHATE W/PARACETAMOL|NULL;NULL;NULL
Concomitant Medication|DOXAPRAM|NULL;NULL;NULL
Concomitant Medication|GLYCERYL TRINITRATE|NULL;NULL;NULL
Concomitant Medication|KAPAKE|NULL;NULL;NULL
Concomitant Medication|PARACETAMOL CODEINE|NULL;NULL;NULL
Concomitant Medication|SUSCARD|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Infection upper respiratory;Upper respiratory tract infection;Upper respiratory tract infections;Mild;NULL
Concomitant Medication|COUMADIN|2.5/5.0;QD (every day);Oral
Concomitant Medication|NUEDEXTA|30/75;BID (twice a day);Oral
Concomitant Medication|ROBITUSSIN AC|1;PRN (as needed);Oral
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Pyrosis;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Rosacea;Rosacea;Rosaceas;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Depressed mood disorders and disturbances|Dysthymia;Dysthymic disorder;Depressive disorders;Mild;NULL
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|QUININE SULFATE|260;QHS (at bedtime);Oral
Adverse Event|Injuries NEC|Trauma;Injury;Non-site specific injuries NEC;SEVERE;RECOVERED
Concomitant Medication|MOTIVAL|NULL;NULL;NULL
Concomitant Medication|NOOTROPIL|NULL;NULL;NULL
Concomitant Medication|NOOTROPYL|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Nightmares;Nightmare;Parasomnias;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|LANSOYL|NULL;NULL;NULL
Concomitant Medication|MAGNE B6|NULL;NULL;NULL
Adverse Event|Lipid analyses|Cholesterol total increased;Blood cholesterol increased;Cholesterol analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Oral aphthae;Aphthous stomatitis;Stomatitis and ulceration;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Foot sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|STERIMAR|NULL;NULL;NULL
Concomitant Medication|VISCERALGINE FORTE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured ribs;Rib fracture;Thoracic cage fractures and dislocations;Moderate;NULL
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;Mild;NULL
Concomitant Medication|MV|1;QD (every day);Oral
Concomitant Medication|PERCOCET|U;PRN (as needed);Oral
Adverse Event|Epidermal and dermal conditions|Swollen of face feeling;Swelling face;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flushes facial;Hot flush;Peripheral vascular disorders NEC;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Seborrhea;Seborrhoea;Sebaceous gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Tongue conditions|Swelling of tongue;Swollen tongue;Tongue signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Nycturia;Nocturia;Urinary tract signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|RHINOPRONT|NULL;NULL;NULL
Lab Test|Hepatitis C Antibody|-
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Administration site reactions|Instillation site rash;Instillation site rash;Application and instillation site reactions;MODERATE;RECOVERED
Concomitant Medication|POLYSPORIN|NULL;NULL;NULL
Concomitant Medication|ADVAIR|250/50;PRN (as needed);Inhalation
Concomitant Medication|ATROVENT|21;QHS (at bedtime);Inhalation
Concomitant Medication|DEXTROMETHORPHAN|30;QD (every day);Oral
Concomitant Medication|QUINIDINE|75;QD (every day);Oral
Concomitant Medication|SUDAFED|2;TID (three times a day);Oral
Concomitant Medication|ZITHROMAX|1-2;QD (every day);Oral
Concomitant Medication|MULTI VITAMIN & MINERAL|2;QD (every day);Oral
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Ischemia;Ischaemia;Non-site specific necrosis and vascular insufficiency NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Libido decreased;Libido decreased;Sexual desire disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Loss of energy;Asthenia;Asthenic conditions;MILD;RECOVERED
Adverse Event|Vision disorders|Presbyopia;Presbyopia;Refractive and accommodative disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Viral infection;Viral infection;Viral infections NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Intertrigo;Intertrigo;Dermatitis and eczema;MILD;RECOVERED
Concomitant Medication|CHLORHEXIDINE|NULL;NULL;NULL
Concomitant Medication|DIMETHOXANATE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|DUOVENT|NULL;NULL;NULL
Concomitant Medication|MARVELON|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Erythrosis;Erythrosis;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Platelet disorders|Thrombopenia;Thrombocytopenia;Thrombocytopenias;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Body hair increased;Hypertrichosis;Hypertrichoses;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Feeling unwell;Malaise;Asthenic conditions;MILD;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);MILD;RECOVERED
Concomitant Medication|TETANUS AND DIPHTHERIA TOXOIDS ADSORBED|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Sensory disturbance;Sensory disturbance;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Hip injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Synovial and bursal disorders|Bursitis of knee;Bursitis;Bursal disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|TYLENOL ALLERGY-D|NULL;NULL;NULL
Concomitant Medication|ZINC GLUCONATE|NULL;NULL;NULL
Adverse Event|Headaches|Headache aggravated;Headache;Headaches NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;Mild;NULL
Concomitant Medication|COENZYME Q10|80;BID (twice a day);Oral
Concomitant Medication|SELENIUM|100;QD (every day);Oral
Concomitant Medication|VITAMIN A|10000;QD (every day);Oral
Concomitant Medication|VITAMIN C|1;BID (twice a day);Oral
Adverse Event|Cardiac arrhythmias|Bradycardia;Bradycardia;Rate and rhythm disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Diaphoresis;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Felt faint;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema of extremities;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Peripheral neuropathies|Foot drop;Peroneal nerve palsy;Mononeuropathies;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Splenomegaly;Splenomegaly;Spleen disorders;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Difficulty in standing;Dysstasia;Cerebellar coordination and balance disturbances;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|AMPHOJEL|NULL;NULL;NULL
Concomitant Medication|HYDERM|NULL;NULL;NULL
Concomitant Medication|SIBERIAN GINSENG|NULL;NULL;NULL
Concomitant Medication|TYLOX|NULL;NULL;NULL
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;Mild;NULL
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Adverse Event|Joint disorders|Joint inflammation;Arthritis;Arthropathies NEC;Mild;NULL
Adverse Event|Allergic conditions|Allergy to vaccine;Allergy to vaccine;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness lower limb;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Visual acuity decreased;Visual acuity reduced;Partial vision loss;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hoarse voice;Dysphonia;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Redness;Erythema;Erythemas;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;MODERATE;RECOVERED
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;MODERATE;RECOVERED
Concomitant Medication|B COMPLEX WITH VITAMIN C|NULL;NULL;NULL
Concomitant Medication|EDTA|NULL;NULL;NULL
Concomitant Medication|SANUVIS|NULL;NULL;NULL
Concomitant Medication|UTILIN D6|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Athlete's foot;Tinea pedis;Tinea infections;Mild;NULL
Adverse Event|Neurological disorders NEC|Faint;Syncope;Disturbances in consciousness NEC;Moderate;NULL
Adverse Event|Sleep disorders and disturbances|Sleep disorder;Sleep disorder;Sleep disorders NEC;Mild;NULL
Concomitant Medication|QUININE|324;TID (three times a day);Oral
Concomitant Medication|VITAMIN D|400;QD (every day);Oral
Adverse Event|Angioedema and urticaria|Urticarial rash;Urticaria;Urticarias;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Flaking skin;Skin exfoliation;Exfoliative conditions;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Reflex sympathetic dystrophy;Complex regional pain syndrome;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Foot sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Tension headache;Tension headache;Headaches NEC;MODERATE;RECOVERED
Concomitant Medication|NASAREL|NULL;NULL;NULL
Adverse Event|Hepatic and hepatobiliary disorders|Hyperbilirubinemia;Hyperbilirubinaemia;Cholestasis and jaundice;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in limb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Sputum bloody;Haemoptysis;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Psoriasis;Psoriasis;Psoriatic conditions;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Psoriasis;Psoriasis;Psoriatic conditions;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|Transaminases increased;Transaminases increased;Liver function analyses;MODERATE;RECOVERED
Concomitant Medication|ACTISOUFRE|NULL;NULL;NULL
Concomitant Medication|HYPOSTAMINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;NULL;NULL
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Administration site reactions|Injection site itching;Injection site pruritus;Injection site reactions;NULL;NULL
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;NULL;NULL
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;NULL;NULL
Adverse Event|Muscle disorders|Cramp of limb;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dry throat;Dry throat;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Concomitant Medication|CLEMASTINE|NULL;NULL;NULL
Concomitant Medication|ESTROGENS CONJUGATED|NULL;NULL;NULL
Concomitant Medication|IPRINDOLE|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine glucose;Glucose urine;Urinalysis NEC;SEVERE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count high;Eosinophil count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|Blood alkaline phosphatase high;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Blood bicarbonate increased;Blood bicarbonate increased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of leg;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Concomitant Medication|NEUROPLEX|NULL;NULL;NULL
Concomitant Medication|PANCREATIC ENZYMES|NULL;NULL;NULL
Concomitant Medication|PEPSIN|NULL;NULL;NULL
Concomitant Medication|RIBONUCLEIC ACID|NULL;NULL;NULL
Concomitant Medication|VASCULIN|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo positional;Vertigo positional;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood sugar increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Infected cyst;Infected cyst;Infections NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Heartburn aggravated;Dyspepsia;Dyspeptic signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Atelectasis;Atelectasis;Parenchymal lung disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Embolism and thrombosis|DVT;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ASPIRIN|650;PRN (as needed);Oral
Concomitant Medication|AUGMENTIN|250;BID (twice a day);Oral
Concomitant Medication|CLARITIN|10;QD (every day);Oral
Concomitant Medication|CODEINE|2;PRN (as needed);Oral
Concomitant Medication|DIPHENHYDRAMINE|50;PRN (as needed);Oral
Concomitant Medication|MECLIZINE|25;BID (twice a day);Oral
Concomitant Medication|METFORMIN|1000;BID (twice a day);Oral
Concomitant Medication|MOTRIN|600;TID (three times a day);Oral
Concomitant Medication|ZANTAC|150;PRN (as needed);Oral
Concomitant Medication|CEFTIN|1000;BID (twice a day);Oral
Concomitant Medication|COUMADIN|3;QD (every day);Oral
Concomitant Medication|DEXTROSE SALINE|3000;QD (every day);Intravenous
Concomitant Medication|LOVENOX|180;BID (twice a day);Subcutaneous
Concomitant Medication|ROCEPHINE|2;QD (every day);Intramuscular
Adverse Event|Muscle disorders|Muscle cramps aggravated;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Calcium high;Blood calcium increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CO-PROXAMOL|NULL;NULL;NULL
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataracts;Cataract;Cataract conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Blood chloride increased;Blood chloride increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram QT prolonged;Electrocardiogram QT prolonged;ECG investigations;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema upper extremities;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Gamma GT raised;Gamma-glutamyltransferase increased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Stiff joint;Joint stiffness;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic, nutritional and blood gas investigations|HbA1C decreased;Glycosylated haemoglobin decreased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Itching all over;Pruritus generalised;Pruritus NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;SEVERE;RECOVERED
Adverse Event|Myocardial disorders|Left ventricular hypertrophy;Left ventricular hypertrophy;Myocardial disorders NEC;MILD;RECOVERED
Adverse Event|Anaemias nonhaemolytic and marrow depression|Pernicious anemia;Pernicious anaemia;Anaemia deficiencies;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;MODERATE;RECOVERED
Adverse Event|Ectoparasitic disorders|Scabies;Acarodermatitis;Ectoparasitic infestations;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|BACITRACIN ZINC|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Pharyngitis;Pharyngitis;Upper respiratory tract infections;MILD;UNKNOWN
Concomitant Medication|FEVARIN|NULL;NULL;NULL
Concomitant Medication|LARYLIN|NULL;NULL;NULL
Concomitant Medication|METAPLEXAN|NULL;NULL;NULL
Concomitant Medication|MICROKLIST|NULL;NULL;NULL
Concomitant Medication|REPELTIN|NULL;NULL;NULL
Concomitant Medication|XIMOVAN|NULL;NULL;NULL
Adverse Event|Allergic conditions|House dust allergy;House dust allergy;Atopic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract (right);Cataract;Cataract conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Mental impairment disorders|Short-term memory impairment;Memory impairment;Memory loss (excl dementia);MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine output decreased;Urine output decreased;Urinary tract function analyses NEC;MODERATE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Dumping syndrome;Post gastric surgery syndrome;Gastrointestinal and hepatobiliary procedural complications;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in hand;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Gastrointestinal stoma complication;Gastrointestinal stoma complication;Gastrointestinal and hepatobiliary procedural complications;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Back muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Prolonged expiration;Prolonged expiration;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Distention;Abdominal distension;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;MILD;RECOVERED
Adverse Event|Tongue conditions|Tongue white;Tongue discolouration;Tongue signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ATASOL|NULL;NULL;NULL
Concomitant Medication|BECLOFORT|NULL;NULL;NULL
Concomitant Medication|EPIMORPH|NULL;NULL;NULL
Concomitant Medication|PHYLLOCONTIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Equilibrium loss;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Spinal cord degeneration;Myelopathy;Spinal cord and nerve root disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Femur head fracture;Femur fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Adverse Event|General system disorders NEC|Fatigability generalized;Fatigue;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Trembling;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Red face;Erythema;Erythemas;MILD;RECOVERED
Concomitant Medication|VALIUM|1/2;;Oral
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;Moderate;NULL
Concomitant Medication|IBUPROFEN|1800;QID (four times a day);Oral
Adverse Event|Vascular disorders NEC|Flushed;Flushing;Peripheral vascular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|Creatine phosphokinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BETASELEN|NULL;NULL;NULL
Concomitant Medication|HEPTAMYL|NULL;NULL;NULL
Concomitant Medication|NUTRIDORAL|NULL;NULL;NULL
Concomitant Medication|NUTRIDRINK|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured toe;Foot fracture;Lower limb fractures and dislocations;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Bone and joint injuries|Fractured nose;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;Moderate;NULL
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Adverse Event|Bone and joint injuries|Sprained ankle;Joint sprain;Limb injuries NEC (incl traumatic amputation);Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Urine odor foul;Urine odour abnormal;Urinary abnormalities;Mild;NULL
Concomitant Medication|ENDOCET|NULL;NULL;NULL
Concomitant Medication|NECON|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Choked on food;Choking;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Fungal infectious disorders|Thrush oral;Oral candidiasis;Candida infections;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATROPINE|1;PRN (as needed);Sublingual
Concomitant Medication|CALCIUM VITAMIN D|650;QD (every day);Oral
Concomitant Medication|COLACE|200;BID (twice a day);Other (specify)
Concomitant Medication|FLUCONAZOLE|100;QD (every day);Other (specify)
Concomitant Medication|FLUTICASONE PROPIONATE|2;BID (twice a day);Intranasal
Concomitant Medication|FLUTICASONE PROPIONATE|2;PRN (as needed);Intranasal
Concomitant Medication|GARLIC|500;QD (every day);Oral
Concomitant Medication|GLYCOPYRROLATE|0.05;PRN (as needed);Subcutaneous
Concomitant Medication|LORAZEPAM|0.5;PRN (as needed);Sublingual
Concomitant Medication|LORAZEPAM|1;PRN (as needed);Sublingual
Concomitant Medication|MIDAZOLAM|2.5;PRN (as needed);Subcutaneous
Concomitant Medication|MORPHINE|2.5;PRN (as needed);Subcutaneous
Concomitant Medication|MORPHINE|2.5;QHS (at bedtime);Other (specify)
Concomitant Medication|MULTIVITAMIN|1;Every morning;Oral
Concomitant Medication|MULTIVITAMIN|1;PRN (as needed);Oral
Concomitant Medication|NYSTATIN|400,000;QID (four times a day);Other (specify)
Concomitant Medication|NYSTATIN|800,000;QID (four times a day);Other (specify)
Concomitant Medication|PHENYLEPHRINE|2;BID (twice a day);Oral
Concomitant Medication|PHENYLEPHRINE HYDROCHLORIDE|1;PRN (as needed);Oral
Concomitant Medication|RILUZOLE|100;BID (twice a day);Other (specify)
Concomitant Medication|SALMON OIL|1000;QD (every day);Oral
Concomitant Medication|SIMETHICONE|320;QID (four times a day);Other (specify)
Concomitant Medication|ZINC OXIDE|1;PRN (as needed);Topical
Adverse Event|Bone and joint injuries|Fractured finger;Hand fracture;Upper limb fractures and dislocations;Moderate;Resolved
Concomitant Medication|DESOWEN|NULL;NULL;NULL
Concomitant Medication|HERBOLAX|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Dermatomycosis, unspecified;Fungal skin infection;Fungal infections NEC;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Limb paresis;Monoparesis;Paralysis and paresis (excl cranial nerve);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness in toes;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw cyst;Jaw cyst;Bone disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BRONCHIPRET|NULL;NULL;NULL
Concomitant Medication|THYME|NULL;NULL;NULL
Concomitant Medication|UMCKALOABO|NULL;NULL;NULL
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disorder;Gastrointestinal disorder;Gastrointestinal disorders NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;Moderate;NULL
Adverse Event|General system disorders NEC|Edema peripheral;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Clonus;Clonus;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Burning skin;Skin burning sensation;Dermal and epidermal conditions NEC;Moderate;NULL
Concomitant Medication|ACIPHEX|30;QD (every day);Oral
Concomitant Medication|BOTOX|30;1 time only;Intramuscular
Concomitant Medication|COPPER|1;QD (every day);Oral
Concomitant Medication|IRBESARTAN|300;QD (every day);Oral
Concomitant Medication|KLONOPIN|2;QD (every day);Oral
Concomitant Medication|LASIX|20;QD (every day);Oral
Concomitant Medication|NEURONTIN|300;BID (twice a day);Oral
Concomitant Medication|NITRO-MACK|100;BID (twice a day);Oral
Concomitant Medication|NORTRIPTYLINE|75;QHS (at bedtime);Oral
Concomitant Medication|POTASSIUM|20;QD (every day);Oral
Concomitant Medication|TERAZOSIN HYDROCHLORIDE|5;QD (every day);Oral
Adverse Event|Muscle disorders|Spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|SINUS|NULL;NULL;NULL
Concomitant Medication|TYLENOL COLD & FLU|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Greenish stool;Faeces discoloured;Faecal abnormalities NEC;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;Moderate;NULL
Adverse Event|Injuries NEC|Rib injury;Skeletal injury;Non-site specific injuries NEC;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Marked;NULL
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;Moderate;NULL
Adverse Event|Bone and joint injuries|Fracture of ankle;Ankle fracture;Lower limb fractures and dislocations;Marked;NULL
Adverse Event|Bone and joint injuries|Fractured toe;Foot fracture;Lower limb fractures and dislocations;Marked;NULL
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Marked;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Spinal pain;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;Moderate;NULL
Adverse Event|Fungal infectious disorders|Thrush;Candidiasis;Candida infections;Moderate;NULL
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Marked;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Motion sickness;Motion sickness;Inner ear signs and symptoms;Mild;NULL
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;Moderate;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;Severe;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Allergic asthma;Asthma;Bronchospasm and obstruction;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Urinary infection;Urinary tract infection;Urinary tract infections;Mild;NULL
Concomitant Medication|ARTANE|1;;Oral
Concomitant Medication|ASPEGIC|1000;;Oral
Concomitant Medication|DOLIPRANE|1;;Oral
Concomitant Medication|DOLIPRANE|2;;Oral
Concomitant Medication|LEXOMIL|1/2;;Oral
Concomitant Medication|LIORESAL|0.5;;Oral
Concomitant Medication|PROZAC|1;;Oral
Concomitant Medication|VALIUM|0,5;;Oral
Concomitant Medication|VALIUM|1;;Oral
Adverse Event|Bacterial infectious disorders|Bacteriuria;Bacteriuria;Bacterial infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ADALAT CC|NULL;NULL;NULL
Concomitant Medication|LIBRIUM|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw pain;Pain in jaw;Bone related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Productive cough;Productive cough;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Idiopathic edema;Oedema;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|MULTIVITAMIN MULTIMINERAL|NULL;NULL;NULL
Adverse Event|Disturbances in thinking and perception|Hallucination;Hallucination;Perception disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Grip strength decreased;Grip strength decreased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CAPISTEN|NULL;NULL;NULL
Concomitant Medication|NORFLEX|NULL;NULL;NULL
Adverse Event|Joint disorders|Arthrosis;Osteoarthritis;Osteoarthropathies;MILD;RECOVERED
Concomitant Medication|ART|NULL;NULL;NULL
Concomitant Medication|DORZOLAMIDE|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Eye pruritus;Eye pruritus;Ocular infections, inflammations and associated manifestations;Mild;NULL
Concomitant Medication|LIORESAL|4;;Oral
Adverse Event|Joint disorders|Arthrosis;Osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in elbow;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin vascular abnormalities|Hemorrhage subcutaneous;Haemorrhage subcutaneous;Skin haemorrhages;MILD;RECOVERED
Concomitant Medication|CAPSAICIN|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Shoulder fracture;Upper limb fracture;Upper limb fractures and dislocations;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Lower abdominal pain;Abdominal pain lower;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Lichenification;Lichenification;Papulosquamous conditions;MILD;RECOVERED
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Skin and subcutaneous tissue therapeutic procedures|Toe nail removal;Nail operation;Nail therapeutic procedures;MILD;RECOVERED
Concomitant Medication|BUTYLSCOPOLAMIN|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anguish;Anxiety;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Excitability;Agitation;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Joint disorders|Hip arthrosis;Osteoarthritis;Osteoarthropathies;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Nightmare;Nightmare;Parasomnias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Resonance disorder;Dysphonia;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Swallowing disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ACTAPULGITE|NULL;NULL;NULL
Concomitant Medication|CIBLOR|NULL;NULL;NULL
Concomitant Medication|FEBRECTOL|NULL;NULL;NULL
Concomitant Medication|GLOSSITHIASE|NULL;NULL;NULL
Concomitant Medication|NEGRAM|NULL;NULL;NULL
Concomitant Medication|NEUTRAGEL|NULL;NULL;NULL
Concomitant Medication|OROPIVALONE|NULL;NULL;NULL
Concomitant Medication|RILMENIDINE|NULL;NULL;NULL
Concomitant Medication|SPASFON-LYOC|NULL;NULL;NULL
Concomitant Medication|COENZYME Q10|300;QD (every day);Oral
Concomitant Medication|DIGESTIVE ENZYMES|U;QD (every day);Oral
Concomitant Medication|QUININE SULFATE|250;QD (every day);Oral
Concomitant Medication|QUININE SULFATE|250;BID (twice a day);Oral
Concomitant Medication|TYLENOL|1000;TID (three times a day);Oral
Concomitant Medication|ZIAC|25;QD (every day);Oral
Adverse Event|Breast disorders|Breast tension;Breast discomfort;Breast signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|OESTROGEN|NULL;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Absolute lymphocyte count decreased;Lymphocyte count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Breast neoplasms benign (incl nipple)|Fibroadenoma of breast;Fibroadenoma of breast;Breast and nipple neoplasms benign;MILD;RECOVERED
Adverse Event|Hearing disorders|Deafness both ears;Deafness bilateral;Hearing losses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophils increased;Neutrophil count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Persistent cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Cyanosis peripheral;Cyanosis;Cardiac signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Infected ingrowing toe nail;Paronychia;Skin structures and soft tissue infections;MILD;RECOVERED
Adverse Event|Injuries NEC|Contusion of elbow;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Seborrhea;Seborrhoea;Sebaceous gland disorders;MILD;RECOVERED
Concomitant Medication|CHLORPHENIRAMINE MALEATE|NULL;NULL;NULL
Concomitant Medication|VALISONE|NULL;NULL;NULL
Adverse Event|Injuries NEC|Laceration of face;Skin laceration;Skin injuries NEC;Mild;NULL
Adverse Event|Sleep disturbances (incl subtypes)|Sleep excessive;Hypersomnia;Narcolepsy and hypersomnia;Mild;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Dyspnea exacerbated;Dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|BETAHISTINE|NULL;NULL;NULL
Adverse Event|Heart failures|Cardiac insufficiency;Cardiac failure;Heart failures NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hypertriglyceridemia;Hypertriglyceridaemia;Elevated triglycerides;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Vaginal mycosis;Vulvovaginal mycotic infection;Fungal infections NEC;MODERATE;RECOVERED
Concomitant Medication|ACTRAPID|NULL;NULL;NULL
Concomitant Medication|ALDALIX|NULL;NULL;NULL
Concomitant Medication|CAPTEA|NULL;NULL;NULL
Concomitant Medication|DIFFU K|NULL;NULL;NULL
Concomitant Medication|LENITRAL|NULL;NULL;NULL
Concomitant Medication|LIQUID PARAFFIN|NULL;NULL;NULL
Concomitant Medication|MONOTILDIEM|NULL;NULL;NULL
Concomitant Medication|NITRIDERM|NULL;NULL;NULL
Concomitant Medication|ORGASULINE NPH|NULL;NULL;NULL
Concomitant Medication|PARKINANE|NULL;NULL;NULL
Concomitant Medication|POLYGYNAX|NULL;NULL;NULL
Concomitant Medication|TAMARINE|NULL;NULL;NULL
Concomitant Medication|UMULINE NPH|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Suicidal depression;Depression suicidal;Depressive disorders;MILD;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Inappetence;Decreased appetite;Appetite disorders;MODERATE;RECOVERED
Concomitant Medication|COLCHIMAX|NULL;NULL;NULL
Concomitant Medication|PANFUREX|NULL;NULL;NULL
Concomitant Medication|VAGOSTABYL|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Ophthalmic herpes zoster;Herpes zoster ophthalmic;Herpes viral infections;MODERATE;RECOVERED
Adverse Event|Gastrointestinal stenosis and obstruction|Subocclusive syndrome;Subileus;Gastrointestinal stenosis and obstruction NEC;MODERATE;RECOVERED
Concomitant Medication|COLOPEG|NULL;NULL;NULL
Concomitant Medication|FLUDEX|NULL;NULL;NULL
Concomitant Medication|PHYSIOTENS|NULL;NULL;NULL
Adverse Event|Angioedema and urticaria|Urticaria;Urticaria;Urticarias;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;Moderate;NULL
Concomitant Medication|BETA-VAL|NULL;NULL;NULL
Concomitant Medication|POLBAX|NULL;NULL;NULL
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;Mild;NULL
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;Moderate;NULL
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Mild;NULL
Concomitant Medication|ATROPINE SULFATE|1;PRN (as needed);Other (specify)
Adverse Event|Epidermal and dermal conditions|Erythema periorbital;Erythema;Erythemas;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BETAMETHASONE DIPROPIONATE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Acid indigestion;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Monocyte percentage decreased;Monocyte percentage decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Tenderness epigastric;Abdominal tenderness;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Bone and joint injuries|Hand fracture;Hand fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Ocular sensory symptoms NEC|Gritty eyes;Foreign body sensation in eyes;Ocular sensation disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|FAVERIN|NULL;NULL;NULL
Concomitant Medication|SODIUM CROMOGLYCATE|NULL;NULL;NULL
Concomitant Medication|ZINC AND CASTOR OIL|NULL;NULL;NULL
Adverse Event|Oral soft tissue conditions|Tongue sensation loss of;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomachache;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Cracked lips;Chapped lips;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Concomitant Medication|ADVIL COLD AND FLU|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Broken nose;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|DOLOMITE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chills;Chills;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Phosphate increased;Blood phosphorus increased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Lyme disease;Lyme disease;Borrelial infections;MILD;RECOVERED
Adverse Event|Gastrointestinal ulceration and perforation|Peptic ulcer disease;Peptic ulcer;Peptic ulcers and perforation;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Migraine headache;Migraine;Migraine headaches;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Sick sinus syndrome;Sick sinus syndrome;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALLEGRA D|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|DVT;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;NULL
Adverse Event|Appetite and general nutritional disorders|Oral intake reduced;Hypophagia;Appetite disorders;Moderate;NULL
Adverse Event|Medication errors|Drug administration error;Drug administration error;Maladministrations;Moderate;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|BUN increased;Blood urea increased;Renal function analyses;Mild;NULL
Concomitant Medication|TOPAMAX|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;Mild;NULL
Adverse Event|Joint disorders|Adhesive capsulitis;Periarthritis;Joint related disorders NEC;Mild;NULL
Adverse Event|Peritoneal and retroperitoneal conditions|Peritonitis;Peritonitis;Peritoneal and retroperitoneal disorders;Moderate;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Soft stools;Diarrhoea;Diarrhoea (excl infective);Mild;NULL
Adverse Event|Physical examination topics|Wt loss;Weight decreased;Physical examination procedures;Mild;NULL
Concomitant Medication|B-VITAMINS|NULL;NULL;NULL
Concomitant Medication|MEFOXIN|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Bouveret-Hoffmann syndrome;Supraventricular tachycardia;Supraventricular arrhythmias;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;NULL;NULL
Adverse Event|Viral infectious disorders|Fever blister;Oral herpes;Herpes viral infections;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);NULL;NULL
Adverse Event|Respiratory disorders NEC|Sneezing;Sneezing;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Itchy eyes;Eye pruritus;Ocular infections, inflammations and associated manifestations;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Flank pain;Flank pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Injuries NEC|Bruising of foot;Contusion;Skin injuries NEC;NULL;NULL
Adverse Event|Pigmentation disorders|Skin hyperpigmentation;Skin hyperpigmentation;Hyperpigmentation disorders;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;NULL;NULL
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;NULL;NULL
Concomitant Medication|MULTIVITAMIN AND MINERAL SUPPLEMENT|NULL;NULL;NULL
Concomitant Medication|MUPIROCIN|NULL;NULL;NULL
Concomitant Medication|TRIOMINIC|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal chest pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Presbyopia;Presbyopia;Refractive and accommodative disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Seizures (incl subtypes)|Seizures;Convulsion;Seizures and seizure disorders NEC;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchial mucus plug;Bronchial secretion retention;Bronchial conditions NEC;MODERATE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Lung infiltration;Lung infiltration;Parenchymal lung disorders NEC;MILD;RECOVERED
Concomitant Medication|ALLANTOIN|NULL;NULL;NULL
Concomitant Medication|DIMETHICONE|NULL;NULL;NULL
Concomitant Medication|DIOCTO|NULL;NULL;NULL
Concomitant Medication|JOINT FUEL|NULL;NULL;NULL
Concomitant Medication|MUCOSIL|NULL;NULL;NULL
Concomitant Medication|VASELINE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Concomitant Medication|MESTINON|60;TID (three times a day);Oral
Adverse Event|Synovial and bursal disorders|Bursitis;Bursitis;Bursal disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Fluid retention;Fluid retention;Total fluid volume increased;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Foot sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Knee sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Tongue conditions|Tongue ulceration;Tongue ulceration;Tongue disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PAMIDRONATE DISODIUM|NULL;NULL;NULL
Concomitant Medication|PERIDEX|NULL;NULL;NULL
Concomitant Medication|ROBAXIN|NULL;NULL;NULL
Concomitant Medication|SUPER E COMPLEX|NULL;NULL;NULL
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pressure sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Belching;Eructation;Dyspeptic signs and symptoms;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dry heaves;Retching;Nausea and vomiting symptoms;SEVERE;RECOVERED
Adverse Event|Bacterial infectious disorders|Folliculitis;Folliculitis;Bacterial infections NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dry heaves;Retching;Nausea and vomiting symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose congestion;Nasal congestion;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pustule;Rash pustular;Skin structures and soft tissue infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Pustule;Rash pustular;Skin structures and soft tissue infections;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ATHLETES FOOT|NULL;NULL;NULL
Concomitant Medication|TUSSIGON|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Anorexia;Decreased appetite;Appetite disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Thyroid gland disorders|Goiter;Goitre;Thyroid disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Skin vascular abnormalities|Petechiae;Petechiae;Purpura and related conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Skin and subcutaneous tissue disorders NEC|Multiple skin ulcers;Skin ulcer;Skin and subcutaneous tissue ulcerations;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CLOPERASTINE|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Heaviness in limbs;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;NULL;NULL
Concomitant Medication|VITAMIDYNE A AND D|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Severe;Resolved
Adverse Event|Bone disorders (excl congenital and fractures)|Coccyalgia;Coccydynia;Bone related signs and symptoms;Mild;Continuing
Adverse Event|Neurological disorders NEC|Dizzy spells;Dizziness;Neurological signs and symptoms NEC;Mild;         .
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Mild;Resolved with Residual
Adverse Event|Urolithiases|Kidney stones;Nephrolithiasis;Renal lithiasis;Moderate;Resolved
Adverse Event|Gastrointestinal stenosis and obstruction|Small bowel obstruction;Small intestinal obstruction;Duodenal and small intestinal stenosis and obstruction;Severe;Resolved
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;Mild;Continuing
Concomitant Medication|PROPOXYPHENE|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Dorsalgia;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrooesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED
Adverse Event|White blood cell disorders|Leucopenia;Leukopenia;Leukopenias NEC;MODERATE;RECOVERED
Concomitant Medication|CIBADREX|NULL;NULL;NULL
Concomitant Medication|TELFAST|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure increased;Blood pressure increased;Vascular tests NEC (incl blood pressure);MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ACETYL L CARNITINE|NULL;NULL;NULL
Concomitant Medication|ADENINE|NULL;NULL;NULL
Concomitant Medication|NADH|NULL;NULL;NULL
Concomitant Medication|SILYMARIN|NULL;NULL;NULL
Concomitant Medication|SODIUM ASCORBATE|NULL;NULL;NULL
Concomitant Medication|WOBENZYM N|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Wound infection;Wound infection;Infections NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Appendicitis;Appendicitis;Abdominal and gastrointestinal infections;Moderate;Resolved with Residual
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Vital capacity decreased;Vital capacity decreased;Respiratory and pulmonary function diagnostic procedures;Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Decubitus;Decubitus ulcer;Skin injuries and mechanical dermatoses;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|Infection;Infection;Infections NEC;Mild;Resolved
Adverse Event|Procedural and device related injuries and complications NEC|Postoperative pain;Procedural pain;Non-site specific procedural complications;Mild;Resolved
Concomitant Medication|NUTREN 1.5|NULL;NULL;NULL
Concomitant Medication|OSMOLITE HN|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Cardio-respiratory arrest;Cardio-respiratory arrest;Ventricular arrhythmias and cardiac arrest;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy;Gastrostomy;Gastric therapeutic procedures;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Spinal pain;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Periarthritis scapulohumeralis;Periarthritis;Joint related disorders NEC;MODERATE;RECOVERED
Concomitant Medication|DUVADILAN|NULL;NULL;NULL
Concomitant Medication|DUXIL|NULL;NULL;NULL
Concomitant Medication|ELUDRIL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Dysmenorrhea;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Raised triglycerides;Blood triglycerides increased;Triglyceride analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menstrual cramps;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Uterine, pelvic and broad ligament disorders|Pelvic cyst;Pelvic cyst;Pelvis and broad ligament disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anterior eye structural change, deposit and degeneration|Corneal lesion;Corneal lesion;Corneal structural change, deposit and degeneration;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Crackles lung;Rales;Lower respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp of limb;Muscle spasms;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Herpes ocular;Herpes ophthalmic;Herpes viral infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Endocrine disorders of gonadal function|Estrogen deficiency;Oestrogen deficiency;Endocrine abnormalities of gonadal function NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological, special senses and psychiatric investigations|Increased intraocular pressure;Intraocular pressure increased;Ophthalmic function diagnostic procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Headaches|Migraine;Migraine;Migraine headaches;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Motion sickness;Motion sickness;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Unsteady gait;Gait disturbance;Gait disturbances;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|APO-TIMOP|NULL;NULL;NULL
Concomitant Medication|CYCLOSPORIN|NULL;NULL;NULL
Concomitant Medication|LIPIDIL|NULL;NULL;NULL
Adverse Event|Joint disorders|Knee arthritis;Arthritis;Arthropathies NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Back muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Burning foot;Burning sensation;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Environmental allergy;Hypersensitivity;Allergic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cranial nerve disorders (excl neoplasms)|Smelly sensation;Parosmia;Olfactory nerve disorders;MODERATE;RECOVERED
Adverse Event|Vascular disorders NEC|Facial flushing;Flushing;Peripheral vascular disorders NEC;MODERATE;RECOVERED
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;SEVERE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Bloodshot eye;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;MODERATE;RECOVERED
Adverse Event|Suicidal and self-injurious behaviours NEC|Suicidal ideation;Suicidal ideation;Suicidal and self-injurious behaviour;MODERATE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Overweight;Overweight;General nutritional disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Investigations, imaging and histopathology procedures NEC|MRI abnormal;Nuclear magnetic resonance imaging abnormal;Imaging procedures NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Nocturia;Nocturia;Urinary tract signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Nervous system neoplasms benign|Perineurial cyst;Perineurial cyst;Nervous system cysts and polyps;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Eye redness;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;SEVERE;RECOVERED
Adverse Event|Eye disorders NEC|Swollen eyes;Eye swelling;Ocular disorders NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Lumbar disc disease;Intervertebral disc disorder;Intervertebral disc disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DEQUADIN|NULL;NULL;NULL
Concomitant Medication|FIBYRAX|NULL;NULL;NULL
Concomitant Medication|PROTEGRA|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Purulent discharge;Purulent discharge;Infections NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Rotator cuff tendinitis;Rotator cuff syndrome;Joint related disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;Continuing
Adverse Event|Bone and joint injuries|Fibula fracture;Fibula fracture;Lower limb fractures and dislocations;Moderate;Resolved
Adverse Event|Urinary tract signs and symptoms|Painful urination;Dysuria;Bladder and urethral symptoms;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;Moderate;Continuing
Adverse Event|Bone and joint injuries|Broken ankle;Ankle fracture;Lower limb fractures and dislocations;Moderate;Resolved
Concomitant Medication|TOFRANIL|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Mild;Resolved
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Mild;Continuing
Adverse Event|Urinary tract signs and symptoms|Urge incontinence;Urge incontinence;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PROSTA FINK|NULL;NULL;NULL
Concomitant Medication|SELEN|NULL;NULL;NULL
Concomitant Medication|ZINKOROTAT|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Emphysema pulmonary;Emphysema;Parenchymal lung disorders NEC;Marked;NULL
Adverse Event|Muscle disorders|Spasms;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Adverse Event|General system disorders NEC|Swelling of fingers;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;Moderate;NULL
Concomitant Medication|BETAMETHASONE DIPROPIONATE|.05;QD (every day);Topical
Concomitant Medication|CYCLOBENZAPRINE|10;PRN (as needed);Oral
Concomitant Medication|DETROL|4;QD (every day);Oral
Concomitant Medication|DETROL|2;QD (every day);Oral
Concomitant Medication|DUONEB|3;QID (four times a day);Inhalation
Concomitant Medication|ENALAPRIL|2.5;QD (every day);Oral
Concomitant Medication|FUROSEMIDE|40;QD (every day);Oral
Concomitant Medication|MUCOMYST|10;QD (every day);Inhalation
Concomitant Medication|MUCOMYST|3;BID (twice a day);Inhalation
Concomitant Medication|ROBITUSSIN|1/2;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1;TID (three times a day);PEG
Concomitant Medication|TYLENOL|1500;PRN (as needed);Oral
Concomitant Medication|VITAMIN C WITH ROSE HIPS|1000;QD (every day);Oral
Concomitant Medication|VITAMIN E|1400;QD (every day);Oral
Lab Test|Urine Glucose|3+++
Adverse Event|Neurological disorders NEC|Taste sweet;Dysgeusia;Sensory abnormalities NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Nocturnal cough;Cough;Coughing and associated symptoms;Mild;Continuing
Adverse Event|Muscle disorders|Cramps in legs;Muscle spasms;Muscle related signs and symptoms NEC;Severe;Continuing
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);Moderate;Resolved
Adverse Event|Hepatobiliary investigations|SGPT increased;Alanine aminotransferase increased;Liver function analyses;Moderate;Resolved
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;Severe;Continuing
Adverse Event|Skin vascular abnormalities|Telangiectasia;Telangiectasia;Telangiectasia and related conditions;Mild;Continuing
Concomitant Medication|CITALOPRAM|NULL;NULL;NULL
Concomitant Medication|ETOLAC XL|NULL;NULL;NULL
Concomitant Medication|METFORMIN|NULL;NULL;NULL
Concomitant Medication|TROGLITAZONE|NULL;NULL;NULL
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Hypotension;Hypotension;Vascular hypotensive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhoea recurrent;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Swollen glands;Lymphadenopathy;Lymphatic system disorders NEC;MILD;RECOVERED
Concomitant Medication|FLUDROCORTISONE|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM PHOSPHATE|NULL;NULL;NULL
Concomitant Medication|NUROFEN|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Hemoglobin A1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Ankle fracture;Ankle fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Hoarseness of voice;Dysphonia;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in ankle;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|CASANTHRANOL|NULL;NULL;NULL
Concomitant Medication|SALAGEN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Fecaloma;Faecaloma;Faecal abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal inflammatory conditions|Hemorrhagic gastritis;Gastritis haemorrhagic;Gastritis (excl infective);MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Oesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|TAKETIAM|NULL;NULL;NULL
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Lymphadenopathy;Lymphadenopathy;Lymphatic system disorders NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Crackles lung;Rales;Lower respiratory tract signs and symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BUPIVACAINE|4;QD (every day);Other (specify)
Concomitant Medication|CEFDINIR|600;BID (twice a day);Oral
Concomitant Medication|CHERATUSSIN AC|2;PRN (as needed);Oral
Concomitant Medication|COD LIVER OIL|3;QD (every day);Oral
Concomitant Medication|CREATINE|200;QD (every day);Oral
Concomitant Medication|DEPO MEDROL|40;QD (every day);Other (specify)
Concomitant Medication|FLAXSEED OIL|2;QD (every day);Oral
Concomitant Medication|FLUTICASONE PROPIONATE|4;BID (twice a day);Inhalation
Concomitant Medication|JUICE PLUS|400;BID (twice a day);Oral
Concomitant Medication|LORAZEPAM|ONE;QHS (at bedtime);Oral
Concomitant Medication|MSM|2000;QD (every day);Oral
Concomitant Medication|MUCINEX|1;QD (every day);Oral
Concomitant Medication|MULTIVITAMIN|TWO;QD (every day);Oral
Concomitant Medication|OXYMETAZOLINE|6;TID (three times a day);Intranasal
Concomitant Medication|SALINE|6;TID (three times a day);Intranasal
Concomitant Medication|SULFAMETHOXAZOLE|2;BID (twice a day);Oral
Concomitant Medication|VITAMIN B12|5000;QD (every day);Oral
Concomitant Medication|VITAMIN E|50;QD (every day);Oral
Concomitant Medication|DIPHENHYDRAMINE HYDROCHLORIDE|50;QHS (at bedtime);Oral
Concomitant Medication|TYLENOL PM|650;QHS (at bedtime);Oral
Adverse Event|Respiratory disorders NEC|Oral mucosa blister;Oropharyngeal blistering;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Concomitant Medication|HYDROCHLOROTHIAZIDE W/SPIRONOLACTONE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;Mild;NULL
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;Mild;NULL
Concomitant Medication|HYDROCHLOROTHIAZIDE|20;QD (every day);Oral
Concomitant Medication|PENICILLIN|500;QID (four times a day);Oral
Concomitant Medication|PRILOSEC|20;PRN (as needed);
Concomitant Medication|CHLOR-TRIMETON|1;PRN (as needed);Oral
Concomitant Medication|GLUCOSAMINE SULFATE|1;QD (every day);Oral
Concomitant Medication|METAMUCIL|1;QD (every day);Oral
Adverse Event|Respiratory disorders NEC|Throat burning sensation of;Throat irritation;Upper respiratory tract signs and symptoms;Mild;Resolved
Adverse Event|Tongue conditions|Burning tongue;Glossodynia;Tongue signs and symptoms;Mild;Resolved
Adverse Event|Aural disorders NEC|Earache;Ear pain;Ear disorders NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Mild;Continuing
Concomitant Medication|IBUPROFEN W/PSEUDOEPHEDRINE|NULL;NULL;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Paralysis;Paralysis;Paralysis and paresis (excl cranial nerve);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal infection of nail;Onychomycosis;Fungal infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in extremity;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|VICKS COLDCARE|NULL;NULL;NULL
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|2625;QID (four times a day);Oral
Concomitant Medication|BUPRENORPHINE|10;Other (specify);Other (specify)
Concomitant Medication|CEFDITORENE|200;BID (twice a day);Oral
Concomitant Medication|DEXTROPROPOXIFEN|300;BID (twice a day);Oral
Concomitant Medication|GABAPENTIN|400;QD (every day);Oral
Concomitant Medication|METAMIZOL|1725;QID (four times a day);Oral
Concomitant Medication|TRAMADOL|150;QID (four times a day);Oral
Adverse Event|Vision disorders|Blurry vision;Vision blurred;Visual disorders NEC;MILD;RECOVERED
Concomitant Medication|ESCITALOPRAM OXALATE|20;QD (every day);Oral
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|1;Unknown;Unknown
Concomitant Medication|IPRATROPIUM|0.5;Unknown;Inhalation
Concomitant Medication|PARACETAMOL|UNK;Unknown;Intravenous
Concomitant Medication|SALBUTAMOL|400;BID (twice a day);Inhalation
Concomitant Medication|TERBUTALINE|5;Unknown;Inhalation
Adverse Event|Skin appendage conditions|Hyperhidrosis;Hyperhidrosis;Apocrine and eccrine gland disorders;SEVERE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;SEVERE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|SCOPOLAMINE|1,5;Other (specify);Topical
Concomitant Medication|TRAMADOL|200;BID (twice a day);Oral
Concomitant Medication|TRAMADOL|75;QD (every day);Oral
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Acute respiratory distress syndrome;Acute respiratory distress syndrome;Pulmonary oedemas;SEVERE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Acute diarrhoea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Concomitant Medication|EXPUTEX|NULL;NULL;NULL
Concomitant Medication|NORMISON|NULL;NULL;NULL
Concomitant Medication|PULMOZYME|NULL;NULL;NULL
Adverse Event|Allergic conditions|Drug allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Claustrophobia;Claustrophobia;Fear symptoms and phobic disorders (incl social phobia);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Exhaustion;Fatigue;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal infection;Fungal infection;Fungal infections NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Pulled muscle;Muscle strain;Muscle, tendon and ligament injuries;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Shakiness;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Adverse Event|Cornification and dystrophic skin disorders|Actinic keratosis;Actinic keratosis;Skin preneoplastic conditions NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Pain in elbow;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|THYROLAR|NULL;NULL;NULL
Adverse Event|Hepatic and hepatobiliary disorders|Liver enlargement;Hepatomegaly;Hepatobiliary signs and symptoms;MILD;RECOVERED
Adverse Event|Ocular neuromuscular disorders|Pupil fixed;Pupil fixed;Pupil disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal ulceration and perforation|Ulcer stomach;Gastric ulcer;Gastric ulcers and perforation;MILD;RECOVERED
Concomitant Medication|CEFTIZOXIME|NULL;NULL;NULL
Concomitant Medication|PRO BANTHINE|NULL;NULL;NULL
Concomitant Medication|BUERLECITHIN|3;BID (twice a day);Oral
Concomitant Medication|CREATINE|2;TID (three times a day);Oral
Concomitant Medication|VITASPRINT|1;QD (every day);Oral
Adverse Event|Neurological disorders NEC|Faint;Syncope;Disturbances in consciousness NEC;MILD;RECOVERED
Concomitant Medication|NAPHAZOLINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MODERATE;RECOVERED
Adverse Event|Neuromuscular disorders|Hypertonus;Hypertonia;Muscle tone abnormal;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Increased urea;Blood urea increased;Renal function analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Gastrointestinal infection;Gastrointestinal infection;Abdominal and gastrointestinal infections;SEVERE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Kidney pain;Renal pain;Urinary tract signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Throat sore;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|SAB SIMPLEX|NULL;NULL;NULL
Concomitant Medication|URIDINE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiff neck;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|AVAPRO|NULL;NULL;NULL
Concomitant Medication|METATONE|NULL;NULL;NULL
Concomitant Medication|GOTU KOLA|NULL;NULL;NULL
Concomitant Medication|PREGNENOLONE|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Arthritis;Arthritis;Arthropathies NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertension exacerbated;Hypertension;Vascular hypertensive disorders NEC;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MODERATE;UNKNOWN
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation aggravated;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|T wave flattening of;Electrocardiogram T wave amplitude decreased;ECG investigations;Mild;NULL
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal ulceration and perforation|Duodenal ulcer;Duodenal ulcer;Duodenal ulcers and perforation;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Food intolerance syndromes|Cow's milk intolerance;Cow's milk intolerance;Food malabsorption and intolerance syndromes (excl sugar intolerance);MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Mood elevated;Elevated mood;Emotional and mood disturbances NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;SEVERE;RECOVERED
Concomitant Medication|BROMPHENIRAMINE|NULL;NULL;NULL
Concomitant Medication|CROMOLYN|NULL;NULL;NULL
Concomitant Medication|DEXTROSE SALINE|NULL;NULL;NULL
Concomitant Medication|FAT EMULSIONS|NULL;NULL;NULL
Concomitant Medication|NIFEREX|NULL;NULL;NULL
Concomitant Medication|RIFAMPIN|NULL;NULL;NULL
Concomitant Medication|STADOL|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Concomitant Medication|TEDIVAX|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Allergic conjunctivitis;Conjunctivitis allergic;Conjunctival infections, irritations and inflammations;MILD;RECOVERED
Adverse Event|Joint disorders|Joint hyperextension;Joint hyperextension;Joint related disorders NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Rib injury;Skeletal injury;Non-site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Wrist sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|WEIGHT GAINER|NULL;NULL;NULL
Concomitant Medication|OXYCODONE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|VICODIN ES|NULL;NULL;NULL
Concomitant Medication|OROCAL|NULL;NULL;NULL
Concomitant Medication|RENITEC|NULL;NULL;NULL
Concomitant Medication|SIBELIUM|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;Mild;         .
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;Mild;         .
Concomitant Medication|OMEGA-3 FATTY ACIDS|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp of limb;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Finger cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Hay fever;Seasonal allergy;Atopic disorders;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count high;Neutrophil count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count low;Lymphocyte count decreased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness in fingers;Hypoaesthesia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful R arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram QRS complex abnormal;Electrocardiogram QRS complex abnormal;ECG investigations;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Restless leg syndrome;Restless legs syndrome;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Pain head;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Unconsciousness;Loss of consciousness;Disturbances in consciousness NEC;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|ANTACID|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Lyme disease;Lyme disease;Borrelial infections;Moderate;Resolved
Adverse Event|Bacterial infectious disorders|Staphylococcal infection;Staphylococcal infection;Staphylococcal infections;Mild;Resolved
Concomitant Medication|CEFALEXIN MONOHYDRATE|NULL;NULL;NULL
Concomitant Medication|OLIVE LEAVES EXTRACT|NULL;NULL;NULL
Adverse Event|Sexual function and fertility disorders|Erectile dysfunction;Erectile dysfunction;Erection and ejaculation conditions and disorders;MILD;RECOVERED
Concomitant Medication|ALFA-TOCOPHEROL ACETATE|1000;BID (twice a day);Oral
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Concomitant Medication|RILUTEK|50 mg;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|600;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain aggravated;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Muscle wasting;Muscle atrophy;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Strength loss of;Asthenia;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Strength loss of;Asthenia;Asthenic conditions;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|GAMMA GLOBULIN|NULL;NULL;NULL
Concomitant Medication|GAMMAGLOBULIN|NULL;NULL;NULL
Concomitant Medication|HEPATITIS A VACCINE|NULL;NULL;NULL
Concomitant Medication|HMS 90|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Heat rash;Heat rash;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Oropharyngeal spasm;Oropharyngeal spasm;Pharyngeal disorders (excl infections and neoplasms);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|TYLENOL ALL/SINUS|NULL;NULL;NULL
Concomitant Medication|ZEPHREX|NULL;NULL;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);MILD;RECOVERED
Adverse Event|Injuries NEC|Eye injury;Eye injury;Eye injuries NEC;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;SEVERE;RECOVERED
Adverse Event|Manic and bipolar mood disorders and disturbances|Bipolar disorder;Bipolar disorder;Bipolar disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Metabolic and nutritional disorders congenital|Gilbert's syndrome;Gilbert's syndrome;Inborn errors of bilirubin metabolism;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Difficulty voiding;Dysuria;Bladder and urethral symptoms;Mild;Continuing
Adverse Event|Purine and pyrimidine metabolism disorders|Gout;Gout;Purine metabolism disorders NEC;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;Severe;Continuing
Adverse Event|Testicular and epididymal disorders|Pain in testis;Testicular pain;Testicular and epididymal disorders NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Prostate infection;Prostate infection;Male reproductive tract infections;Moderate;Resolved
Concomitant Medication|TRIMEX|NULL;NULL;NULL
Adverse Event|Gastrointestinal haemorrhages NEC|Blood in stool;Haematochezia;Non-site specific gastrointestinal haemorrhages;MILD;RECOVERED
Concomitant Medication|CLIMAVAL|NULL;NULL;NULL
Concomitant Medication|ISOPROPAMIDE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;SEVERE;RECOVERED
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;MODERATE;RECOVERED
Concomitant Medication|CARMEX|NULL;NULL;NULL
Concomitant Medication|NUTRIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Drooling;Drooling;Neurological signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Aural disorders NEC|Ear ache;Ear pain;Ear disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Menopause and related conditions|Menopausal symptoms;Menopausal symptoms;Menopausal effects NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory distress;Respiratory distress;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin irritation;Skin irritation;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Thoracic pain;Chest pain;Pain and discomfort NEC;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|URTI;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|BENZYLPENICILLIN|NULL;NULL;NULL
Concomitant Medication|DIFENE|NULL;NULL;NULL
Concomitant Medication|ESTRACOMBI|NULL;NULL;NULL
Concomitant Medication|PONSTAN|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Feeling hot and cold;Feeling of body temperature change;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Meteorism;Flatulence;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Renal colic;Renal colic;Urinary tract signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;SEVERE;RECOVERED
Adverse Event|Viral infectious disorders|Viral pharyngitis;Viral pharyngitis;Viral infections NEC;MODERATE;RECOVERED
Concomitant Medication|BAMBUTEROL|NULL;NULL;NULL
Concomitant Medication|CEPHALOSPORIN NOS|NULL;NULL;NULL
Concomitant Medication|DIMETICONE|NULL;NULL;NULL
Concomitant Medication|MEPIPHYLLINE|NULL;NULL;NULL
Concomitant Medication|METAMIDOL|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heart murmur;Cardiac murmur;Cardiac auscultatory investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anaemia;Anaemia;Anaemias NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;NULL;NULL
Adverse Event|Injuries by physical agents|Sunburn;Sunburn;Radiation injuries;NULL;NULL
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;NULL;NULL
Adverse Event|Injuries NEC|Contusion of knee;Contusion;Skin injuries NEC;NULL;NULL
Adverse Event|Joint disorders|Swelling of L knee;Joint swelling;Joint related signs and symptoms;NULL;NULL
Adverse Event|Respiratory disorders NEC|Increased upper airway secretion;Increased upper airway secretion;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in toe;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Spinal cord and nerve root disorders|Sciatic neuralgia;Sciatica;Lumbar spinal cord and nerve root disorders;NULL;NULL
Concomitant Medication|AXOTAL|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|PCO2 increased;PCO2 increased;Blood gas and acid base analyses;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Epigastric discomfort;Epigastric discomfort;Dyspeptic signs and symptoms;MILD;RECOVERED
Concomitant Medication|CYSTOSPAZ|NULL;NULL;NULL
Concomitant Medication|MINITRAN|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Increased appetite;Increased appetite;Appetite disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Contracture;Muscle contracture;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|IBUPROFEN|2;PRN (as needed);Oral
Concomitant Medication|IBUPROFEN|3600;TID (three times a day);Oral
Concomitant Medication|TYLENOL EXTRA STRENGTH|2;PRN (as needed);Oral
Concomitant Medication|DHA|400;QD (every day);Oral
Concomitant Medication|EPA|630;QD (every day);Oral
Concomitant Medication|INOSITOL NICOTINATE|200;QD (every day);Oral
Concomitant Medication|NASONEX|4;QD (every day);Intranasal
Concomitant Medication|OMEGA 3|400;QD (every day);Oral
Concomitant Medication|PNEUMOCOCCAL VACCINE|1;Other (specify);Intramuscular
Concomitant Medication|RESVERATROL|100;QD (every day);Oral
Adverse Event|Personality disorders and disturbances in behaviour|Aggressiveness;Aggression;Behaviour and socialisation disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Sialorrhoea;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Disease progression;Disease progression;General signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|KOREC|NULL;NULL;NULL
Concomitant Medication|NATISEDINE|NULL;NULL;NULL
Concomitant Medication|NORMACOL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in lumbar spine;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Continuing
Concomitant Medication|METHSCOPOLAMINE BROMIDE|NULL;NULL;NULL
Concomitant Medication|SYNTHYROID|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Osteoarticular pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;SEVERE;RECOVERED
Concomitant Medication|ATROPINUM SULFURICUM|NULL;NULL;NULL
Concomitant Medication|CYSTINOL AKUT|NULL;NULL;NULL
Concomitant Medication|EMBIAL|NULL;NULL;NULL
Concomitant Medication|KEPINOL|NULL;NULL;NULL
Concomitant Medication|REMESTAN|NULL;NULL;NULL
Adverse Event|Lipid metabolism disorders|Hyperlipidemia;Hyperlipidaemia;Hyperlipidaemias NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NICOLAN|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo positional;Vertigo positional;Inner ear signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic hyperplasia;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Enzyme investigations NEC|CK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;RECOVERED
Concomitant Medication|DEXCHLORPHENIRAMINE|NULL;NULL;NULL
Concomitant Medication|HALAZEPAM|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal inflammation;Nasal inflammation;Nasal congestion and inflammations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Physical examination topics|Loss of weight;Weight decreased;Physical examination procedures;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Irritative cough;Cough;Coughing and associated symptoms;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ASPECTON N|NULL;NULL;NULL
Concomitant Medication|BROTIZOLAM|NULL;NULL;NULL
Concomitant Medication|GELSEMIUM|NULL;NULL;NULL
Concomitant Medication|MELPERON|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Emesis;Vomiting;Nausea and vomiting symptoms;MILD;RECOVERED
Adverse Event|Injuries by physical agents|Burns first degree;Burns first degree;Thermal burns;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Groggy;Somnolence;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Daytime sleepiness;Somnolence;Disturbances in consciousness NEC;Moderate;NULL
Adverse Event|General system disorders NEC|Energy decreased;Asthenia;Asthenic conditions;Moderate;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menstrual irregularity;Menstruation irregular;Menstruation and uterine bleeding NEC;Mild;NULL
Adverse Event|General system disorders NEC|General symptom;General symptom;General signs and symptoms NEC;Mild;NULL
Adverse Event|Viral infectious disorders|Viral upper respiratory tract infection;Viral upper respiratory tract infection;Viral infections NEC;Mild;NULL
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;Mild;NULL
Concomitant Medication|DHA|NULL;NULL;NULL
Concomitant Medication|NICOTROL|NULL;NULL;NULL
Concomitant Medication|PROVIGIL|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Anxiodepressive syndrome;Depression;Depressive disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Thorax pain;Chest pain;Pain and discomfort NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALPRAZOLAM|0.5;QD (every day);Oral
Concomitant Medication|ALPRAZOLAM|1;PRN (as needed);Oral
Concomitant Medication|ALPRAZOLAM|1;QD (every day);Oral
Concomitant Medication|BROMAZEPAM|3;BID (twice a day);Oral
Concomitant Medication|DEXKETOPROFEN|50;BID (twice a day);Oral
Concomitant Medication|GABAPENTIN|1200;TID (three times a day);Oral
Concomitant Medication|GABAPENTIN|900;QD (every day);Oral
Concomitant Medication|GABAPENTIN|900;QID (four times a day);Oral
Concomitant Medication|KETAZOLAM|30;QD (every day);Oral
Concomitant Medication|PREGABALINE|75;QD (every day);Oral
Concomitant Medication|RANITIDINE|1;QD (every day);Intravenous
Concomitant Medication|ZOLPIDEM|10;QD (every day);Oral
Concomitant Medication|ZOLPIDEM|5;QD (every day);Oral
Concomitant Medication|BACLOFEN|25;TID (three times a day);Oral
Concomitant Medication|MELATONIN|3;QD (every day);Oral
Concomitant Medication|PREGABALINE|50;QD (every day);Oral
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;Mild;NULL
Adverse Event|Synovial and bursal disorders|Bursitis;Bursitis;Bursal disorders;Marked;NULL
Concomitant Medication|BETACAROTENE|2500;QD (every day);Oral
Concomitant Medication|BUSPAR|10;BID (twice a day);Oral
Concomitant Medication|GARLIC|1;TID (three times a day);Oral
Concomitant Medication|GARLIC|1;BID (twice a day);Oral
Concomitant Medication|IMITREX|50;PRN (as needed);Oral
Concomitant Medication|NEURONTIN|2000;QD (every day);Oral
Concomitant Medication|NEURONTIN|3000;QD (every day);Oral
Concomitant Medication|NEURONTIN|3300;QD (every day);Oral
Concomitant Medication|NEURONTIN|400;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|1200;BID (twice a day);Oral
Concomitant Medication|NUTRIENT 950|1;TID (three times a day);Oral
Adverse Event|Injuries NEC|Kidney contusion;Renal injury;Renal and urinary tract injuries NEC;MODERATE;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Altered smell sensation;Parosmia;Olfactory nerve disorders;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Systolic murmur;Cardiac murmur;Cardiac auscultatory investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Cellulitis of leg;Cellulitis;Bacterial infections NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Noises in head;Tinnitus;Inner ear signs and symptoms;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Psoriasis;Psoriasis;Psoriatic conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Rheumatoid arthritis;Rheumatoid arthritis;Rheumatoid arthropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Distress gastrointestinal;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|SULFACETAMIDE SODIUM|NULL;NULL;NULL
Concomitant Medication|CLAVULIN|875;BID (twice a day);Oral
Concomitant Medication|PRILOSEC|40;QD (every day);Oral
Adverse Event|Viral infectious disorders|Flu syndrome;Influenza;Influenza viral infections;Moderate;NULL
Concomitant Medication|FOLIC ACID|1;BID (twice a day);Oral
Concomitant Medication|NEURONTIN|100;TID (three times a day);Oral
Concomitant Medication|NEURONTIN|100;PRN (as needed);Oral
Concomitant Medication|PSEUDOPHED|2;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1000;1 time only;Oral
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Bruising;Contusion;Skin injuries NEC;Mild;NULL
Concomitant Medication|BETA CAROTENE|25000;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|1;QD (every day);Oral
Concomitant Medication|SYNTHROID|0.15;QD (every day);Oral
Concomitant Medication|ZESTRIL|5;QD (every day);Oral
Concomitant Medication|HYPROMELLOSE|NULL;NULL;NULL
Adverse Event|Cranial nerve disorders (excl neoplasms)|Bell's palsy;Facial palsy;Facial cranial nerve disorders;Mild;NULL
Concomitant Medication|LIQUID TEARS|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Chest infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Dental and gingival conditions|Tooth decay;Dental caries;Dental and periodontal infections and inflammations;MILD;RECOVERED
Concomitant Medication|ADRENALINE|NULL;NULL;NULL
Concomitant Medication|CALCIUM HYDROXIDE|NULL;NULL;NULL
Concomitant Medication|EUGENOL|NULL;NULL;NULL
Concomitant Medication|FELYPRESSIN|NULL;NULL;NULL
Concomitant Medication|MERCURY|NULL;NULL;NULL
Concomitant Medication|PRILOCAINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|SILVER|NULL;NULL;NULL
Adverse Event|Neuromuscular disorders|Hypertonia;Hypertonia;Muscle tone abnormal;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Seborrhoeic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Chest injury;Chest injury;Chest and lung injuries NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal vascular conditions|Haemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYL L CARNITINE|3;TID (three times a day);Oral
Concomitant Medication|CARBOLITHIUM|600;QID (four times a day);Oral
Concomitant Medication|LOPERAMIDE|2;QD (every day);Oral
Concomitant Medication|MESALAZINE|500;QD (every day);Oral
Concomitant Medication|PARACETAMOL|1000;PRN (as needed);Oral
Adverse Event|Appetite and general nutritional disorders|Appetite absent;Decreased appetite;Appetite disorders;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscular pain;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Circulatory insufficiency;Cardiovascular insufficiency;Cardiac disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM COMPLEX|NULL;NULL;NULL
Concomitant Medication|FISH LIVER OIL|NULL;NULL;NULL
Adverse Event|Gastrointestinal stenosis and obstruction|Impaction of intestine;Intestinal obstruction;Gastrointestinal stenosis and obstruction NEC;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Chronic rhinitis;Rhinitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Generalised muscle weakness;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;SEVERE;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Oxygen saturation decreased;Oxygen saturation decreased;Blood gas and acid base analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Mild;Resolved with Residual
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Severe;Continuing
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;Moderate;Resolved with Residual
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Moderate;Resolved with Residual
Adverse Event|General system disorders NEC|Secretion discharge;Secretion discharge;General signs and symptoms NEC;Severe;Continuing
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;Moderate;Resolved with Residual
Adverse Event|Water, electrolyte and mineral investigations|Potassium low;Blood potassium decreased;Mineral and electrolyte analyses;Mild;Resolved
Adverse Event|Changes in physical activity|Restless;Restlessness;Increased physical activity levels;Moderate;Continuing
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;Moderate;Resolved with Residual
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Moderate;Resolved with Residual
Adverse Event|Dental and gingival conditions|Toothache;Toothache;Dental pain and sensation disorders;Mild;Resolved
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;Severe;Continuing
Concomitant Medication|D5LRS|NULL;NULL;NULL
Concomitant Medication|SAFE CLEANSE|NULL;NULL;NULL
Adverse Event|Purine and pyrimidine metabolism disorders|Gout attack;Gout;Disorders of purine metabolism;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Walking difficulty;Gait disturbance;Gait disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Purine and pyrimidine metabolism disorders|Gout attack;Gout;Disorders of purine metabolism;MODERATE;RECOVERED
Concomitant Medication|HYDROXYETHYLCELLULOSE|NULL;NULL;NULL
Concomitant Medication|PHENPROCOUMON|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Concomitant Medication|LIPANTHYL|1;;Oral
Concomitant Medication|MAGNE B6|2;;Oral
Adverse Event|General system disorders NEC|Flu-like illness;Influenza like illness;General signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Sinus bradycardia;Sinus bradycardia;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Lymph node disorder;Lymphadenopathy;Lymphatic system disorders NEC;MILD;ONGOING (PERSISTENT)
Lab Test|Urine Color|AMBER
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw pain;Pain in jaw;Bone related signs and symptoms;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Itchy;Pruritus;Pruritus NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain foot;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Central nervous system vascular disorders|Cerebrovascular accident;Cerebrovascular accident;Central nervous system haemorrhages and cerebrovascular accidents;MILD;RECOVERED
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Acute hypotension;Hypotension;Vascular hypotensive disorders;Mild;NULL
Adverse Event|Cardiac arrhythmias|Arrhythmia;Arrhythmia;Rate and rhythm disorders NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Decubitus ulcer;Decubitus ulcer;Skin injuries and mechanical dermatoses;Moderate;NULL
Adverse Event|General system disorders NEC|Face oedema;Face oedema;Oedema NEC;Mild;NULL
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;Mild;NULL
Adverse Event|Electrolyte and fluid balance conditions|Hyponatraemia;Hyponatraemia;Sodium imbalance;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Pyelonephritis;Pyelonephritis;Urinary tract infections;Moderate;NULL
Concomitant Medication|FRESUBIN|500;TID (three times a day);Oral
Concomitant Medication|VITAMINS NOS|500;BID (twice a day);Oral
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Emphysema;Emphysema;Parenchymal lung disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PROCAN|NULL;NULL;NULL
Concomitant Medication|SULINDAC|NULL;NULL;NULL
Concomitant Medication|CLONAZEPAM|0.5;QD (every day);Oral
Concomitant Medication|LUPRON|7.5;Monthly or once a month;Intramuscular
Concomitant Medication|IMITREX|5;PRN (as needed);Inhalation
Concomitant Medication|INDERAL|60;QD (every day);Oral
Concomitant Medication|PREMARIN|0.3;QD (every day);Oral
Concomitant Medication|ULTRAM|50;PRN (as needed);Oral
Concomitant Medication|VITAMIN C|3000;QD (every day);Oral
Adverse Event|Neurological disorders NEC|Dizzy;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Solar rash;Solar dermatitis;Photosensitivity and photodermatosis conditions;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Anal infection;Anal infection;Abdominal and gastrointestinal infections;MILD;RECOVERED
Adverse Event|Injuries NEC|Laceration of hand;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stools abnormal;Abnormal faeces;Faecal abnormalities NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruise of head;Contusion;Skin injuries NEC;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Severe;Resolved
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;Mild;Continuing
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;Moderate;Continuing
Adverse Event|Enzyme investigations NEC|Alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;Mild;Resolved
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;Severe;Continuing
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;Mild;Resolved
Adverse Event|Neurological disorders NEC|Lethargic;Lethargy;Disturbances in consciousness NEC;Moderate;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;Moderate;Continuing
Adverse Event|Fungal infectious disorders|Yeast infection of the mouth;Oral fungal infection;Fungal infections NEC;Mild;Continuing
Adverse Event|Fungal infectious disorders|Yeast infection of the mouth;Oral fungal infection;Fungal infections NEC;Moderate;Resolved with Residual
Concomitant Medication|MG-PLUS-PROTEIN|NULL;NULL;NULL
Adverse Event|Eye disorders congenital|Colour blindness;Colour blindness;Ocular disorders congenital NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Middle ear disorders (excl congenital)|Ear drum perforation;Tympanic membrane perforation;Tympanic membrane disorders (excl infections);MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Lower respiratory tract infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Thoracic pain;Chest pain;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BENZAFIBRATO|NULL;NULL;NULL
Concomitant Medication|BEZAFIBRAT|NULL;NULL;NULL
Concomitant Medication|CALCIUM VERLA|NULL;NULL;NULL
Concomitant Medication|CEFETAMET PIVOXIL|NULL;NULL;NULL
Concomitant Medication|CHININ|NULL;NULL;NULL
Concomitant Medication|JODTHYROX|NULL;NULL;NULL
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;Severe;NULL
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;Moderate;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Severe;NULL
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Severe;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;Severe;NULL
Adverse Event|General system disorders NEC|Flu like symptoms;Influenza like illness;General signs and symptoms NEC;Moderate;NULL
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;Severe;NULL
Adverse Event|Injuries NEC|Bee sting;Arthropod sting;Non-site specific injuries NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLCYSTEIN|1800;TID (three times a day);Oral
Concomitant Medication|BRONCHIPRET|80;BID (twice a day);Oral
Concomitant Medication|DEXCHLORPHENIRAMINE|UNK;TID (three times a day);Oral
Concomitant Medication|FLUOCID|UNK;PRN (as needed);Other (specify)
Concomitant Medication|GELOMYRTOL|360;TID (three times a day);Oral
Concomitant Medication|IBUPROFEN|PRN;PRN (as needed);Oral
Concomitant Medication|MCP|10;PRN (as needed);Oral
Concomitant Medication|MCP|UNK;PRN (as needed);Oral
Concomitant Medication|RILUTEK|50;QHS (at bedtime);Oral
Concomitant Medication|SIRDALUD|2;PRN (as needed);Oral
Concomitant Medication|TOLPERISONE|150;PRN (as needed);Oral
Concomitant Medication|WICK DAYMED|337.5;QD (every day);Oral
Concomitant Medication|WICK DAYMED|UNK;QHS (at bedtime);Oral
Concomitant Medication|BETAINE HCL|NULL;NULL;NULL
Concomitant Medication|KOREAN GINSENG|NULL;NULL;NULL
Concomitant Medication|LIPASE|NULL;NULL;NULL
Concomitant Medication|PAPAIN|NULL;NULL;NULL
Concomitant Medication|PHOSPHORUS|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnoea;Dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Deafness;Deafness;Hearing losses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Speech slurred;Dysarthria;Speech and language abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Tooth caries;Dental caries;Dental and periodontal infections and inflammations;MILD;RECOVERED
Concomitant Medication|DIHYDROCODEINE|NULL;NULL;NULL
Concomitant Medication|VICKS COUGH|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Buttock pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;Moderate;NULL
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;Moderate;NULL
Adverse Event|Viral infectious disorders|Flu symptoms;Influenza;Influenza viral infections;Moderate;NULL
Adverse Event|Bone and joint injuries|Cervical vertebral fracture C2;Cervical vertebral fracture;Spinal fractures and dislocations;Marked;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Oral soft tissue conditions|Mouth paresthesia;Paraesthesia oral;Oral soft tissue pain and paraesthesia;Moderate;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ringing in ears;Tinnitus;Inner ear signs and symptoms;Moderate;NULL
Adverse Event|Injuries NEC|Subdural hematoma;Subdural haematoma;Cerebral injuries NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;Marked;NULL
Concomitant Medication|CALCITRATE|NULL;NULL;NULL
Concomitant Medication|CHOLESTYRAMINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Common cold;Nasopharyngitis;Upper respiratory tract infections;Mild;Resolved
Adverse Event|Body temperature conditions|Fever;Pyrexia;Febrile disorders;Mild;Resolved
Adverse Event|General system disorders NEC|General discomfort;Discomfort;Pain and discomfort NEC;Mild;Resolved
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;Mild;Resolved
Adverse Event|Neurological disorders NEC|Taste changed;Dysgeusia;Sensory abnormalities NEC;Mild;Resolved
Adverse Event|Injuries NEC|Ear abrasion;Ear abrasion;Ear injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal dryness;Nasal dryness;Nasal disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal bleeding;Epistaxis;Nasal disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Pressure sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Conjunctival redness;Conjunctival hyperaemia;Conjunctival infections, irritations and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Subluxation shoulder;Joint dislocation;Fractures and dislocations NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|SALINEX|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Dental abscess;Tooth abscess;Dental and oral soft tissue infections;Mild;NULL
Adverse Event|Joint disorders|Wrist pain;Arthralgia;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|CREATINE PHOSPHATE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness shoulder;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Moderate;Continuing
Adverse Event|Vascular disorders NEC|Facial flushing;Flushing;Peripheral vascular disorders NEC;Moderate;Resolved
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;Mild;Resolved
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;Mild;Continuing
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Moderate;Resolved
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;Mild;Continuing
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;Moderate;Resolved with Residual
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Continuing
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;Mild;Resolved with Residual
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Aches & pains in legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Skin neoplasms malignant and unspecified|Lentigo maligna;Lentigo maligna stage unspecified;Skin melanomas (excl ocular);Moderate;Resolved with Residual
Adverse Event|Injuries NEC|Mosquito bite;Arthropod bite;Non-site specific injuries NEC;Moderate;Resolved
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;Moderate;Resolved with Residual
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;Severe;Continuing
Adverse Event|Bone and joint injuries|Wrist fracture;Wrist fracture;Upper limb fractures and dislocations;Moderate;Resolved with Residual
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Throat constriction;Throat tightness;Upper respiratory tract signs and symptoms;Moderate;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;Mild;Continuing
Adverse Event|Viral infectious disorders|Eye infection viral;Eye infection viral;Viral infections NEC;Mild;Resolved
Adverse Event|Muscle disorders|Wry neck;Torticollis;Muscle tone abnormalities;Moderate;Resolved
Concomitant Medication|CHLORPHENAMINE MALEATE|NULL;NULL;NULL
Concomitant Medication|EUCERIN|NULL;NULL;NULL
Concomitant Medication|RESVERATROL|NULL;NULL;NULL
Lab Test|Bicarbonate|-
Adverse Event|Gastrointestinal signs and symptoms|Swallowing impaired;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMBROHEXAL|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Glucosuria;Glycosuria;Urinary abnormalities;MILD;RECOVERED
Concomitant Medication|PECTORHINYL|NULL;NULL;NULL
Concomitant Medication|TONICUM|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy to molds;Mycotic allergy;Allergic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Grass allergy;Seasonal allergy;Atopic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Bone inflammation;Osteitis;Bone disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Coccyalgia;Coccydynia;Bone related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Sweaty;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Fluid retention;Fluid retention;Total fluid volume increased;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Fungal infection;Fungal infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Gingival disease;Gingival disorder;Gingival disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Lower respiratory tract infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Rigors;Chills;Feelings and sensations NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Gastrointestinal ulceration and perforation|Stomach ulcer;Gastric ulcer;Gastric ulcers and perforation;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Disturbances in thinking and perception|Visual hallucinations;Hallucination, visual;Perception disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Yeast infection of the skin;Fungal skin infection;Fungal infections NEC;MODERATE;RECOVERED
Concomitant Medication|CHLORPHENIRAMINE W/HYDROCODONE|NULL;NULL;NULL
Concomitant Medication|DURATUSS G|NULL;NULL;NULL
Concomitant Medication|GOLYTELY|NULL;NULL;NULL
Concomitant Medication|LABETALOL|NULL;NULL;NULL
Concomitant Medication|MEXILETINE|NULL;NULL;NULL
Concomitant Medication|MOISTURIZER|NULL;NULL;NULL
Concomitant Medication|NITROPASTE|NULL;NULL;NULL
Concomitant Medication|RISPID|NULL;NULL;NULL
Concomitant Medication|THEO 24|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Extrasystoles;Extrasystoles;Rate and rhythm disorders NEC;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Cardiac arrhythmia;Arrhythmia;Rate and rhythm disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Knee injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|FONLIPOL|NULL;NULL;NULL
Concomitant Medication|QUESTRAN|NULL;NULL;NULL
Concomitant Medication|SOLUPSAN|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Shoulder fracture;Upper limb fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Hypochondrial pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Dysphasia;Aphasia;Cortical dysfunction NEC;Severe;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Flank pain;Flank pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Common cold;Nasopharyngitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;Moderate;NULL
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;Moderate;NULL
Adverse Event|Muscle disorders|Jaw spasm;Trismus;Muscle tone abnormalities;Moderate;NULL
Concomitant Medication|AMITRIPTYLINE|25;Every morning;Oral
Concomitant Medication|AMITRIPTYLINE|50;QHS (at bedtime);Oral
Concomitant Medication|AMITRIPTYLINE|75;QHS (at bedtime);Oral
Concomitant Medication|LEXAPRO|10;;Oral
Concomitant Medication|LEXAPRO|5;;Oral
Concomitant Medication|LEXAPRO|5;QD (every day);Oral
Concomitant Medication|LIDOCAINE|1.5;QD (every day);Subcutaneous
Concomitant Medication|LIDOCAINE|U;QD (every day);Subcutaneous
Concomitant Medication|ROBITUSSIN CF|2;QHS (at bedtime);Oral
Concomitant Medication|ULTRAM|50;Once per week;Oral
Concomitant Medication|VITAMIN A|16000;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Cystitis;Cystitis;Urinary tract infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal vascular conditions|Haemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Hoarseness;Dysphonia;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Urinary infection;Urinary tract infection;Urinary tract infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ALDOMET|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Nervousness;Nervousness;Anxiety symptoms;Mild;NULL
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;Mild;NULL
Adverse Event|Vascular disorders NEC|Pale skin;Pallor;Site specific vascular disorders NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;NULL
Concomitant Medication|CLINUTREN HP ENERGY|PRN;PRN (as needed);Oral
Concomitant Medication|DIANTALVIC|1;PRN (as needed);Oral
Concomitant Medication|FORTIMEL|PRN;PRN (as needed);Oral
Concomitant Medication|IMOVANE|7,5;;Oral
Concomitant Medication|LIORESAL|20;;Oral
Concomitant Medication|LIORESAL|3;;Oral
Concomitant Medication|RIVOTRIL|PRN;PRN (as needed);Oral
Adverse Event|Epidermal and dermal conditions|Itching both hands;Pruritus;Pruritus NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Difficulty in walking;Gait disturbance;Gait disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Fear;Fear;Fear symptoms and phobic disorders (incl social phobia);NULL;NULL
Adverse Event|Respiratory disorders NEC|Runny nose;Rhinorrhoea;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Bad breath;Breath odour;Gastrointestinal signs and symptoms NEC;NULL;NULL
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;NULL;NULL
Adverse Event|Cardiac arrhythmias|Left anterior fascicular block;Bundle branch block left;Cardiac conduction disorders;NULL;NULL
Adverse Event|Myocardial disorders|Left ventricular hypertrophy;Left ventricular hypertrophy;Myocardial disorders NEC;NULL;NULL
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;NULL;NULL
Adverse Event|Allergic conditions|Allergy to nuts;Food allergy;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Coronary artery disorders|Ischemic heart disease;Myocardial ischaemia;Ischaemic coronary artery disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Bacterial eye infection;Eye infection bacterial;Bacterial infections NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Vertebral osteophyte;Exostosis;Bone disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Snoring;Snoring;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hypoglycemia;Hypoglycaemia;Hypoglycaemic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Sensation of pressure in eye;Abnormal sensation in eye;Ocular sensation disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Swollen lips;Lip swelling;Oral soft tissue disorders NEC;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Swollen lips;Lip swelling;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Swollen lips;Lip swelling;Oral soft tissue disorders NEC;SEVERE;RECOVERED
Adverse Event|Cardiac arrhythmias|Left anterior fascicular block;Bundle branch block left;Cardiac conduction disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Facial pain;Facial pain;Pain and discomfort NEC;MODERATE;RECOVERED
Concomitant Medication|APO-DESIPRAMINE|NULL;NULL;NULL
Concomitant Medication|FRAMYCETIN SULFATE|NULL;NULL;NULL
Concomitant Medication|NITRO-SPRAY|NULL;NULL;NULL
Concomitant Medication|NITROSPRAY|NULL;NULL;NULL
Concomitant Medication|TOPSYM|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BIOTIN|300;QD (every day);Oral
Concomitant Medication|CHLORELLA VULGARIS|6;TID (three times a day);Oral
Concomitant Medication|DMSA|1500;TID (three times a day);Oral
Concomitant Medication|FISH OIL|2000;BID (twice a day);Oral
Concomitant Medication|GARLIC|6000;QD (every day);Oral
Concomitant Medication|LYCOPENE|15;QD (every day);Oral
Concomitant Medication|MULTIVITAMIN|4;TID (three times a day);Oral
Concomitant Medication|OMEGA 3-6-9|2;BID (twice a day);Oral
Concomitant Medication|SOLIDAGO|120;TID (three times a day);Oral
Concomitant Medication|SOY ISOFLAVONES|400;QD (every day);Oral
Concomitant Medication|VITAMIN D|800;BID (twice a day);Oral
Concomitant Medication|CALCIUM|225;TID (three times a day);Oral
Concomitant Medication|MAGNESIUM|225;TID (three times a day);Oral
Adverse Event|Respiratory disorders NEC|Use of accessory respiratory muscles;Use of accessory respiratory muscles;Respiratory signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash on face;Rash;Rashes, eruptions and exanthems NEC;Mild;NULL
Concomitant Medication|MSM|1;QD (every day);Oral
Concomitant Medication|QUININE|32;BID (twice a day);Oral
Adverse Event|Urinary tract signs and symptoms|Frequency urinary;Pollakiuria;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy rash;Rash pruritic;Pruritus NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MAGNESIUM GLUCONATE|NULL;NULL;NULL
Concomitant Medication|TALC POWDER|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Foot oedema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose bowel;Diarrhoea;Diarrhoea (excl infective);MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Menopause and related conditions|Postmenopausal syndrome;Menopausal symptoms;Menopausal effects NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Hair growth decreased;Hair growth abnormal;Pilar disorders NEC;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Thrush vaginal;Vulvovaginal candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Reduced dexterity;Motor dysfunction;Nervous system disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Hot feeling generalized;Feeling hot;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;MODERATE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma aggravated;Asthma;Bronchospasm and obstruction;MODERATE;RECOVERED
Concomitant Medication|TRINORDIAL|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Serum bilirubin increased;Blood bilirubin increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Serum calcium increased;Blood calcium increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;Mild;Continuing
Adverse Event|Upper respiratory tract disorders (excl infections)|Dry nose;Nasal dryness;Nasal disorders NEC;Mild;Continuing
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;Mild;Resolved
Adverse Event|Joint disorders|Gouty arthritis;Gouty arthritis;Crystal arthropathic disorders;Moderate;Continuing
Adverse Event|Injuries NEC|Fall;Fall;Non-site specific injuries NEC;Mild;Continuing
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Moderate;Continuing
Adverse Event|Bladder and bladder neck disorders (excl calculi)|Overactive bladder;Hypertonic bladder;Myoneurogenic bladder disorders;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Urine incontinence;Urinary incontinence;Bladder and urethral symptoms;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal pain;Gastrointestinal pain;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;Mild;Continuing
Adverse Event|Bone and joint injuries|Fracture of upper end or unspecified part of tibia and fibula, closed;Lower limb fracture;Lower limb fractures and dislocations;Moderate;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in leg;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;Moderate;Continuing
Adverse Event|Physical examination topics|Wt loss;Weight decreased;Physical examination procedures;Mild;Continuing
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLCYSTEIN|600;BID (twice a day);Oral
Concomitant Medication|BACLOFEN|45;TID (three times a day);Oral
Concomitant Medication|MIDAZOLAM|3;QD (every day);Oral
Concomitant Medication|PANTOZOL|40;QD (every day);Oral
Concomitant Medication|PROPOFOL|120;QD (every day);Intravenous
Concomitant Medication|TOLPERISONE|150;BID (twice a day);Oral
Concomitant Medication|TOLPERISONE|600;QD (every day);Oral
Concomitant Medication|ZOP|15;BID (twice a day);Oral
Adverse Event|Vision disorders|Blurry vision;Vision blurred;Visual disorders NEC;Mild;Continuing
Adverse Event|Administration site reactions|Injection site mass;Injection site mass;Injection site reactions;Mild;Resolved
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;Mild;Resolved with Residual
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;Mild;Resolved
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;Mild;Resolved
Adverse Event|Physical examination topics|Weight gain;Weight increased;Physical examination procedures;Mild;Continuing
Concomitant Medication|GENASAL|NULL;NULL;NULL
Concomitant Medication|MARIJUANA|NULL;NULL;NULL
Concomitant Medication|POTASSIUM CHLORATE|NULL;NULL;NULL
Concomitant Medication|TERAZOSIN HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ZYLOPRIM|NULL;NULL;NULL
Concomitant Medication|ATENOLOL|20;Every morning;Oral
Concomitant Medication|OMEPRAZOL|40;Every morning;Oral
Concomitant Medication|SIMVASTATIN|20;QHS (at bedtime);Oral
Adverse Event|Movement disorders (incl parkinsonism)|Trembling;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Degenerative disc disease;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Dry scalp;Dry skin;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Eruption facial;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Foot infection;Localised infection;Infections NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Left upper quadrant pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Breast disorders|Breast pain;Breast pain;Breast signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Percussion test abnormal;Percussion test abnormal;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Shooting pain;Pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Subluxation shoulder;Joint dislocation;Fractures and dislocations NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|COLPRONE|NULL;NULL;NULL
Concomitant Medication|DEPURATUM|NULL;NULL;NULL
Concomitant Medication|LECITHINE|NULL;NULL;NULL
Concomitant Medication|LIVOSTIN|NULL;NULL;NULL
Concomitant Medication|LOPROX|NULL;NULL;NULL
Concomitant Medication|ROBAXISAL|NULL;NULL;NULL
Adverse Event|Gastrointestinal ulceration and perforation|Duodenal ulcer;Duodenal ulcer;Duodenal ulcers and perforation;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal foot infection;Tinea pedis;Tinea infections;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Enzyme investigations NEC|CPK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;RECOVERED
Adverse Event|Injuries NEC|Bruising of leg;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Connective tissue disorders (excl congenital)|Polymyalgia rheumatica;Polymyalgia rheumatica;Connective tissue disorders (excl LE);MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Forehead swelling;Swelling face;Dermal and epidermal conditions NEC;MILD;RECOVERED
Concomitant Medication|GENASOFT PLUS|NULL;NULL;NULL
Concomitant Medication|HUMALOG|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Hemoglobinuria;Haemoglobinuria;Urinary abnormalities;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urinary frequency aggravated;Pollakiuria;Bladder and urethral symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Pain in joint involving hand;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Nerve pain;Neuralgia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Headache recurrent;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Xanthelasma;Xanthelasma;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|GLUCOSAMINE SULFATE|NULL;NULL;NULL
Adverse Event|Water, electrolyte and mineral investigations|Serum bicarbonate increased;Blood bicarbonate increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Calcium increased;Blood calcium increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Lethargic;Lethargy;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Chloride low;Blood chloride decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Sodium low;Blood sodium decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Chloride decreased;Blood chloride decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Cardiac arrhythmias|Supraventricular arrhythmia NOS;Arrhythmia supraventricular;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Supraventricular arrhythmia NOS;Arrhythmia supraventricular;Supraventricular arrhythmias;MILD;RECOVERED
Adverse Event|Joint disorders|Pain in joint;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Deafness bilateral;Deafness bilateral;Hearing losses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neuromuscular disorders|Muscle fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Speech impairment NOS;Speech disorder;Speech and language abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Administration site reactions|Injection site blisters;Injection site vesicles;Injection site reactions;Mild;Resolved
Adverse Event|Neurological disorders NEC|Extremities burning sensation of;Burning sensation;Paraesthesias and dysaesthesias;Moderate;Resolved
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;Moderate;Resolved
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Mild;Resolved with Residual
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disorder;Gastrointestinal disorder;Gastrointestinal disorders NEC;Moderate;Resolved
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Moderate;Resolved
Adverse Event|Administration site reactions|Injection site induration;Injection site induration;Injection site reactions;Moderate;Resolved
Adverse Event|Anxiety disorders and symptoms|Nervousness;Nervousness;Anxiety symptoms;Mild;Continuing
Adverse Event|Administration site reactions|Pain injection site;Injection site pain;Injection site reactions;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Upper abdominal pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Erythromacular rash;Rash macular;Rashes, eruptions and exanthems NEC;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;Mild;Resolved
Adverse Event|General system disorders NEC|Sensation of warmth;Feeling hot;Feelings and sensations NEC;Mild;Resolved
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;MILD;RECOVERED
Adverse Event|Haematological disorders NEC|Hyperglobulinemia;Hyperglobulinaemia;Haematological disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Wound NOS;Wound;Non-site specific injuries NEC;MILD;RECOVERED
Concomitant Medication|TENSTATEN|NULL;NULL;NULL
Concomitant Medication|HYDROXYCHLOROQUINE|200;BID (twice a day);Oral
Concomitant Medication|METHOTREXATE|2.5;Once per week;Oral
Concomitant Medication|PREVACID|30;Once per week;Oral
Adverse Event|Neurological disorders NEC|Dizzy spells;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Reduced dexterity;Motor dysfunction;Nervous system disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Alertness decreased;Depressed level of consciousness;Disturbances in consciousness NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Writing impaired;Dysgraphia;Cortical dysfunction NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Dizziness aggravated;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Spasm temporomandibular;Trismus;Muscle tone abnormalities;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Spasm temporomandibular;Trismus;Muscle tone abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Vision disorders|Transient visual loss;Blindness transient;Blindness (excl colour blindness);MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Jaw spasm;Trismus;Muscle tone abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|AMITRIPTYLINE|60;Other (specify);Oral
Concomitant Medication|AMITRIPTYLINE|90;Other (specify);Oral
Concomitant Medication|BOTOX|10;Other (specify);Other (specify)
Concomitant Medication|BOTOX|100;Other (specify);Other (specify)
Concomitant Medication|BOTOX|30;Other (specify);Other (specify)
Concomitant Medication|BOTOX|90;Other (specify);Other (specify)
Concomitant Medication|ESCITALOPRAM OXALATE|10;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE|2;BID (twice a day);Oral
Concomitant Medication|SCOPOLAMINE|1;;Other (specify)
Concomitant Medication|SCOPOLAMINE|1;Other (specify);Other (specify)
Concomitant Medication|VACCINE, INFLUENZA|0.5;Other (specify);Intramuscular
Concomitant Medication|AMITRIPTYLINE|120;Other (specify);Oral
Concomitant Medication|AMITRIPTYLINE|150;Other (specify);Oral
Concomitant Medication|BOTOX|50;Other (specify);Other (specify)
Concomitant Medication|BOTOX|80;Other (specify);Other (specify)
Concomitant Medication|BOTOX|UNK;Other (specify);Other (specify)
Concomitant Medication|GATIFLOXACIN|4;QD (every day);
Concomitant Medication|METAMUCIL|1;PRN (as needed);Oral
Concomitant Medication|SENNA|2;QD (every day);Oral
Concomitant Medication|SENNA|3;QD (every day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Rhinosinusitis;Sinusitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;Moderate;NULL
Concomitant Medication|CELEBREX|100;;Oral
Concomitant Medication|LEXOMIL|PRN;PRN (as needed);Oral
Concomitant Medication|SEROPRAM|1;;Oral
Adverse Event|Vision disorders|Optic neuropathy;Optic neuropathy;Visual pathway disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Supraventricular tachycardia;Supraventricular tachycardia;Supraventricular arrhythmias;MILD;RECOVERED
Concomitant Medication|LATANOPROST|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Cranial nerve disorders (excl neoplasms)|Tongue weak;Tongue paralysis;Hypoglossal nerve disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Cognitive disorders;Cognitive disorder;Mental impairment (excl dementia and memory loss);MILD;ONGOING (PERSISTENT)
Concomitant Medication|QUININE SULFATE|325;BID (twice a day);Oral
Adverse Event|Vascular disorders NEC|Flushed face;Flushing;Peripheral vascular disorders NEC;NULL;NULL
Adverse Event|Gastrointestinal haemorrhages NEC|Rectal bleeding;Rectal haemorrhage;Intestinal haemorrhages;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Infected ingrowing toe nail;Paronychia;Skin structures and soft tissue infections;NULL;NULL
Adverse Event|Microbiology and serology investigations|Tuberculosis test positive;Tuberculosis test positive;Mycobacteria identification and serology;NULL;NULL
Adverse Event|Joint disorders|Pseudogout;Chondrocalcinosis pyrophosphate;Crystal arthropathic disorders;NULL;NULL
Adverse Event|Pleural disorders|Pleural effusion;Pleural effusion;Pneumothorax and pleural effusions NEC;NULL;NULL
Adverse Event|Joint disorders|Degenerative joint disease;Osteoarthritis;Osteoarthropathies;NULL;NULL
Adverse Event|Oral soft tissue conditions|Lip ulcer;Lip ulceration;Oral soft tissue disorders NEC;NULL;NULL
Concomitant Medication|CAMPHOR|NULL;NULL;NULL
Concomitant Medication|CEFRADINE|NULL;NULL;NULL
Concomitant Medication|CHERACOL|NULL;NULL;NULL
Concomitant Medication|INDOMETACIN|NULL;NULL;NULL
Concomitant Medication|ISOCAL|NULL;NULL;NULL
Adverse Event|Respiratory and mediastinal neoplasms malignant and unspecified|Lung nodule;Lung neoplasm;Respiratory tract and pleural neoplasms malignancy unspecified NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema of legs;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Embolism and thrombosis|Thrombosis leg;Thrombosis;Non-site specific embolism and thrombosis;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;Moderate;Continuing
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heart rate irregular;Heart rate irregular;Heart rate and pulse investigations;Mild;Continuing
Concomitant Medication|ROSIGLITAZONE MALEATE|NULL;NULL;NULL
Adverse Event|Hepatobiliary therapeutic procedures|Cholecystectomy;Cholecystectomy;Biliary tract and gallbladder therapeutic procedures;Marked;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;Marked;NULL
Adverse Event|Neurological disorders NEC|Sleepiness;Somnolence;Disturbances in consciousness NEC;Marked;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;SEVERE;RECOVERED
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Thyroid gland disorders|Hashimoto's disease;Autoimmune thyroiditis;Acute and chronic thyroiditis;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in upper extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thumb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Swelling of hands;Oedema peripheral;Oedema NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Headaches|Headache;Headache;Headaches NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Appetite and general nutritional disorders|Appetite absent;Decreased appetite;Appetite disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Oral soft tissue conditions|Swollen lips;Lip swelling;Oral soft tissue disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ASPIRIN|1500;BID (twice a day);Oral
Concomitant Medication|ASPIRIN|762;BID (twice a day);Oral
Concomitant Medication|ASPIRIN|81;QD (every day);Oral
Concomitant Medication|BACLOFEN|20;QHS (at bedtime);Oral
Concomitant Medication|CLONAZEPAM|.5;QD (every day);Oral
Concomitant Medication|COLACE|150;TID (three times a day);Oral
Concomitant Medication|FIORINAL|1;PRN (as needed);Oral
Concomitant Medication|FISH OIL|2;QD (every day);Oral
Concomitant Medication|GABAPENTIN|100;QHS (at bedtime);Oral
Concomitant Medication|IBUPROFEN|2400;PRN (as needed);Oral
Concomitant Medication|LYRICA|100;BID (twice a day);Oral
Concomitant Medication|LYRICA|300;TID (three times a day);Oral
Concomitant Medication|MORPHINE SULFATE|20;PRN (as needed);Oral
Concomitant Medication|TYLENOL W/CODEINE NO. 3|4;QID (four times a day);Oral
Concomitant Medication|VACCINE, INFLUENZA|UNK;Other (specify);Intramuscular
Adverse Event|Mental impairment disorders|Cognitive impairment;Cognitive disorder;Mental impairment (excl dementia and memory loss);Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Moderate;Continuing
Concomitant Medication|METHYLPHENIDATE|NULL;NULL;NULL
Concomitant Medication|RISPERIDONE|NULL;NULL;NULL
Concomitant Medication|RIVASTIGMINE TARTRATE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Oral infection;Oral infection;Dental and oral soft tissue infections;Moderate;NULL
Concomitant Medication|ACETAMINOPHEN|1000;BID (twice a day);Oral
Concomitant Medication|ACETAMINOPHEN|1000;QD (every day);Oral
Concomitant Medication|ALPHA LIPOIC ACID|1;BID (twice a day);Oral
Concomitant Medication|CIPROFLOXACIN|250;TID (three times a day);Oral
Concomitant Medication|CIPROFLOXACIN|500;BID (twice a day);Oral
Concomitant Medication|EFFEXOR|37.5;QD (every day);Oral
Concomitant Medication|GAS X|400;QD (every day);Oral
Concomitant Medication|METRONIDAZOLE|500;BID (twice a day);Oral
Concomitant Medication|N ACETYL CYSTEIN|100;TID (three times a day);Oral
Concomitant Medication|NOVOCAINE|U;QD (every day);Intramuscular
Concomitant Medication|PYCNOGENOL|50;QD (every day);Oral
Concomitant Medication|SELENIUM|1;QD (every day);Oral
Concomitant Medication|SILYMARIN|1;QD (every day);Oral
Concomitant Medication|VITAMIN B12|9000;QD (every day);Oral
Concomitant Medication|XANAX|2.5;TID (three times a day);Oral
Adverse Event|Infections - pathogen unspecified|Vaginitis;Vaginal infection;Female reproductive tract infections;MILD;RECOVERED
Concomitant Medication|CALTRATE 600+D3 PLUS MINERALS|NULL;NULL;NULL
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;Moderate;NULL
Adverse Event|Physical examination topics|Neurological reaction time decreased;Neurological examination abnormal;Physical examination procedures;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neuromuscular disorders|Fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vitamin related disorders|Vitamin D deficiency;Vitamin D deficiency;Fat soluble vitamin deficiencies and disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Urinary tract signs and symptoms|Renal pain;Renal pain;Urinary tract signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Facial pain;Facial pain;Pain and discomfort NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Testicular and epididymal disorders|Testicular pain;Testicular pain;Testicular and epididymal disorders NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Testicular and epididymal disorders|Testicular cyst;Testicular cyst;Testicular and epididymal neoplasms;MILD;RECOVERED
Adverse Event|Suicidal and self-injurious behaviours NEC|Attempted suicide;Suicide attempt;Suicidal and self-injurious behaviour;MODERATE;RECOVERED
Concomitant Medication|BRINZOLAMIDE|2;BID (twice a day);
Concomitant Medication|COLECALCIFEROL|1;Once per week;Oral
Concomitant Medication|DICLOFENAC|75;QD (every day);Oral
Concomitant Medication|CASSADAN|0.25;Unknown;Oral
Adverse Event|Renal and urinary tract investigations and urinalyses|pH urine increased;pH urine increased;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Genital infection fungal;Genital infection fungal;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Worsening of tinnitus;Tinnitus;Inner ear signs and symptoms;MILD;RECOVERED
Concomitant Medication|JEVITY PLUS|NULL;NULL;NULL
Concomitant Medication|TRAUMACAL|NULL;NULL;NULL
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MILD;RECOVERED
Adverse Event|Bone, calcium, magnesium and phosphorus metabolism disorders|Hypercalcemia;Hypercalcaemia;Calcium metabolism disorders;MILD;RECOVERED
Adverse Event|Injuries NEC|Eye burns;Eye burns;Eye injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Eye scratch;Superficial injury of eye;Eye injuries NEC;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Eye infection;Eye infection;Eye and eyelid infections;SEVERE;RECOVERED
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Erythema facial;Erythema;Erythemas;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Unsteady gait;Gait disturbance;Gait disturbances;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ACTIFED PLUS|NULL;NULL;NULL
Concomitant Medication|ISOPTO HOMATROPINE|NULL;NULL;NULL
Concomitant Medication|SULFACETAMIDE|NULL;NULL;NULL
Concomitant Medication|TOBRADEX|NULL;NULL;NULL
Concomitant Medication|TRIAMINIC EXPECTORANT|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;Mild;NULL
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|AGREAL|NULL;NULL;NULL
Concomitant Medication|DOSULEPIN|NULL;NULL;NULL
Concomitant Medication|MONTMORILLONITE|NULL;NULL;NULL
Concomitant Medication|SYMPAVAGOL|NULL;NULL;NULL
Concomitant Medication|TRINITRINE|NULL;NULL;NULL
Concomitant Medication|VERALIPRIDE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured wrist;Wrist fracture;Upper limb fractures and dislocations;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;NULL
Adverse Event|Fungal infectious disorders|Thrush;Candidiasis;Candida infections;Mild;NULL
Concomitant Medication|BIAXIN XL|500;BID (twice a day);Oral
Concomitant Medication|MACRODANTIN|50;QID (four times a day);Oral
Concomitant Medication|MYTUSSIN AC|5;PRN (as needed);Oral
Concomitant Medication|PRILOSEC|1;QD (every day);Oral
Concomitant Medication|TAGAMET|400;QD (every day);Oral
Concomitant Medication|TOPROL|25;QD (every day);Oral
Concomitant Medication|ADVAIR|100/50;QD (every day);Oral
Concomitant Medication|BENZONATATE|100;TID (three times a day);Oral
Concomitant Medication|MYCELEX|10;;Oral
Concomitant Medication|CHONDROITIN|600;QD (every day);Oral
Concomitant Medication|CREATINE|4.8;QD (every day);Oral
Concomitant Medication|CREATINE MONOHYDRATE|1200;QD (every day);Oral
Concomitant Medication|FLONASE|50;QID (four times a day);Intranasal
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|750 and 600;QD (every day);Oral
Concomitant Medication|GLUCOSAMINE|750;QD (every day);Oral
Concomitant Medication|PREVACID|30;QD (every day);Oral
Concomitant Medication|TERAGRAN M|1;QD (every day);Oral
Adverse Event|Injuries NEC|Bone contusion;Skeletal injury;Non-site specific injuries NEC;Moderate;NULL
Adverse Event|Joint disorders|Pain knee;Arthralgia;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|VITAMIN E|200;QID (four times a day);Oral
Adverse Event|Administration site reactions|Catheter site related reaction;Catheter site related reaction;Implant and catheter site reactions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Skin infection;Skin infection;Skin structures and soft tissue infections;MILD;RECOVERED
Concomitant Medication|FUCIDINE|NULL;NULL;NULL
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Breast disorders|Breast tenderness;Breast tenderness;Breast signs and symptoms;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Abnormal physical sensation;Sensory disturbance;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Unsteady gait;Gait disturbance;Gait disturbances;MODERATE;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Clonus;Clonus;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Dizzy on standing;Dizziness postural;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Cutaneous neoplasms benign|Sebaceous cyst;Dermal cyst;Skin cysts and polyps;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Bizarre dreams;Abnormal dreams;Parasomnias;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin discoloration;Skin discolouration;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Swelling of fingers;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Concomitant Medication|BELLERGAL|NULL;NULL;NULL
Concomitant Medication|GUIATEX|NULL;NULL;NULL
Concomitant Medication|THERAFLU SINUS & COLD|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo positional;Vertigo positional;Inner ear signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Cardiac arrhythmias|Sinus bradycardia;Sinus bradycardia;Supraventricular arrhythmias;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Male reproductive tract infections and inflammations|Prostatitis;Prostatitis;Prostate and seminal vesicles infections and inflammations;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ASPIRIN|325;PRN (as needed);Oral
Concomitant Medication|VITAMIN D|1;QD (every day);Oral
Concomitant Medication|CIPRO|1000;BID (twice a day);Oral
Lab Test|Urine Triple Phosphate Crystals|Large
Adverse Event|Neurological disorders NEC|Dysgeusia;Dysgeusia;Sensory abnormalities NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysesthesia;Dysaesthesia;Paraesthesias and dysaesthesias;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Vesicles;Blister;Bullous conditions;NULL;NULL
Concomitant Medication|BENZYDAMINE|NULL;NULL;NULL
Adverse Event|Joint disorders|Arthritis of neck;Spondylitis;Spondyloarthropathies;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal vascular conditions|Haemorrhoidal crisis;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Early morning stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|BREXIN|NULL;NULL;NULL
Concomitant Medication|LOPRIL|NULL;NULL;NULL
Concomitant Medication|GENISTEIN|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Frequency urinary;Pollakiuria;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Neuromuscular weakness;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|TIGAN|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Oral dryness;Dry mouth;Oral dryness and saliva altered;Mild;NULL
Concomitant Medication|TOPALGIC|1;;Oral
Adverse Event|Vision disorders|Blurry vision;Vision blurred;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Cholesterol high;Blood cholesterol increased;Cholesterol analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Lipid metabolism disorders|Hypertriglyceridemia;Hypertriglyceridaemia;Elevated triglycerides;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Numbness of upper extremities;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Investigations, imaging and histopathology procedures NEC|Hospitalisation for further diagnosis;Investigation;Investigations NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in fingers;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|KELTICAN N|NULL;NULL;NULL
Concomitant Medication|NEUROTRAT|NULL;NULL;NULL
Concomitant Medication|UNACID|NULL;NULL;NULL
Concomitant Medication|URACID|NULL;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Atypical lymphocytes;Lymphocyte morphology abnormal;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Lymphocytes raised;Lymphocyte count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Diverticular disorders|Diverticulosis;Diverticulum;Diverticula;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Urinary tract signs and symptoms|Glucosuria;Glycosuria;Urinary abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|EXCEDRIN|2;Other (specify);Oral
Concomitant Medication|MEPERIDINE|75;;Intravenous
Concomitant Medication|METFORM|2;BID (twice a day);Oral
Concomitant Medication|MIDAZOLAM|4;;Intravenous
Concomitant Medication|MOTRIN|2;QD (every day);Oral
Concomitant Medication|VIAGRA|10;PRN (as needed);Oral
Concomitant Medication|IBUPROFEN|2;Other (specify);Oral
Adverse Event|Allergic conditions|Allergic reaction to antibiotics;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Lower respiratory tract infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|NIFEDIPIN|NULL;NULL;NULL
Concomitant Medication|TRISEQUENS|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal distension;Abdominal distension;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Bowel incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Vaginal candida;Vulvovaginal candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Clostridium difficile colitis;Clostridium difficile colitis;Clostridia infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Clostridium difficile infection;Clostridial infection;Clostridia infections;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional incontinence;Affect lability;Affect alterations NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Heat sensitivity;Temperature intolerance;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;MILD;RECOVERED
Adverse Event|Anal and rectal conditions NEC|Discomfort rectal;Anorectal discomfort;Anal and rectal signs and symptoms;MODERATE;RECOVERED
Adverse Event|Embolism and thrombosis|Thrombophlebitis leg;Thrombophlebitis;Peripheral embolism and thrombosis;SEVERE;RECOVERED
Adverse Event|Embolism and thrombosis|Thrombophlebitis leg;Thrombophlebitis;Peripheral embolism and thrombosis;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Mental impairment disorders|Memory loss;Amnesia;Memory loss (excl dementia);MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Flank pain;Flank pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Concomitant Medication|ACAPRIL|20;QD (every day);Oral
Concomitant Medication|K-LYTE|30;QD (every day);Oral
Concomitant Medication|POTASSIUM CHLORIDE|40;BID (twice a day);Oral
Concomitant Medication|HYDROCHLOROTHIAZIDE W/TRIAMTERENE|1;QD (every day);Oral
Adverse Event|Gastrointestinal inflammatory conditions|Colitis;Colitis;Colitis (excl infective);MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal inflammatory conditions|Oesophagitis;Oesophagitis;Oesophagitis (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Tendon, ligament and cartilage disorders|Tendinitis;Tendonitis;Tendon disorders;MILD;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Disorder circulatory system;Cardiovascular disorder;Cardiac disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal conditions NEC|Gastrointestinal disorder;Gastrointestinal disorder;Gastrointestinal disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|BETNEVAL|NULL;NULL;NULL
Concomitant Medication|CALCIDOSE|NULL;NULL;NULL
Concomitant Medication|COLOPRIV|NULL;NULL;NULL
Concomitant Medication|DERINOX|NULL;NULL;NULL
Concomitant Medication|EUPAN|NULL;NULL;NULL
Concomitant Medication|HEXASPRAY|NULL;NULL;NULL
Concomitant Medication|OGAST|NULL;NULL;NULL
Concomitant Medication|POLARAMINE|NULL;NULL;NULL
Concomitant Medication|POLERY|NULL;NULL;NULL
Concomitant Medication|TOPLEXIL|NULL;NULL;NULL
Concomitant Medication|TROPHIRES|NULL;NULL;NULL
Concomitant Medication|ULTRA LEVURE|NULL;NULL;NULL
Concomitant Medication|VIRLIX|NULL;NULL;NULL
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract (right);Cataract;Cataract conditions;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful feet;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;Mild;Continuing
Concomitant Medication|RIZATRIPTAN BENZOATE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Boil on buttock;Furuncle;Skin structures and soft tissue infections;Moderate;NULL
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;Moderate;NULL
Concomitant Medication|BALANCED B-150|1;QD (every day);Oral
Concomitant Medication|CEPHALEXIN|500;BID (twice a day);Oral
Concomitant Medication|KLONOPIN|1;QHS (at bedtime);Oral
Concomitant Medication|NEURONTIN|600;QHS (at bedtime);Oral
Concomitant Medication|TRAMADOL HYDROCHLORIDE|50;PRN (as needed);Oral
Concomitant Medication|VITAMIN A AND D|1;QD (every day);Oral
Concomitant Medication|CORAL CALCIUM|1000;QD (every day);Oral
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;Mild;Resolved
Adverse Event|Water, electrolyte and mineral investigations|Potassium increased;Blood potassium increased;Mineral and electrolyte analyses;Mild;Resolved
Adverse Event|Mood disorders and disturbances NEC|Emotional lability;Affect lability;Affect alterations NEC;Moderate;Continuing
Adverse Event|Injuries NEC|Face injury;Face injury;Site specific injuries NEC;Mild;Resolved
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Inability to orgasm;Anorgasmia;Orgasmic disorders and disturbances;Moderate;Continuing
Concomitant Medication|FLUVASTATIN|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Circulatory insufficiency;Cardiovascular insufficiency;Cardiac disorders NEC;MODERATE;RECOVERED
Concomitant Medication|BENTELAN|NULL;NULL;NULL
Concomitant Medication|BRONCHOKOD|NULL;NULL;NULL
Concomitant Medication|KLIPAL|NULL;NULL;NULL
Concomitant Medication|SINTOCEF|NULL;NULL;NULL
Concomitant Medication|VERATRAN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum excretion difficulty;Sputum retention;Coughing and associated symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Gastrointestinal stoma complication;Gastrointestinal stoma complication;Gastrointestinal and hepatobiliary procedural complications;MILD;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site rash;Procedural site reaction;Non-site specific procedural complications;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Vesicular rash;Rash vesicular;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Enzyme investigations NEC|CK increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Lipid metabolism disorders|Hypercholesteremia;Hypercholesterolaemia;Elevated cholesterol;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Yawning;Yawning;Upper respiratory tract signs and symptoms;MILD;UNKNOWN
Adverse Event|Urinary tract signs and symptoms|Urge incontinence;Urge incontinence;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|DELIX|NULL;NULL;NULL
Concomitant Medication|KLACID|NULL;NULL;NULL
Concomitant Medication|NIMOTOP S|NULL;NULL;NULL
Concomitant Medication|SIOFOR|NULL;NULL;NULL
Concomitant Medication|SPASURET|NULL;NULL;NULL
Adverse Event|Gastrointestinal haemorrhages NEC|Blood in stool;Haematochezia;Non-site specific gastrointestinal haemorrhages;Moderate;NULL
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;Moderate;NULL
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;Moderate;NULL
Concomitant Medication|ALACERIL|NULL;NULL;NULL
Concomitant Medication|DIPHENOXYLATE/ATROPINE|NULL;NULL;NULL
Concomitant Medication|ASPIRIN|400;QD (every day);Oral
Concomitant Medication|ORTHOMOL|NK;BID (twice a day);Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Bowel movement irregularity;Bowel movement irregularity;Gastrointestinal dyskinetic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;MILD;RECOVERED
Concomitant Medication|K-LYTE|NULL;NULL;NULL
Concomitant Medication|PROCALAMINE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Blood blister;Blood blister;Bullous conditions;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Ankle fracture;Ankle fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in heel;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|DEOXYRIBONUCLEIC ACID|NULL;NULL;NULL
Concomitant Medication|DPA|NULL;NULL;NULL
Concomitant Medication|FIBROPLEX|NULL;NULL;NULL
Concomitant Medication|L-ARGININE|NULL;NULL;NULL
Concomitant Medication|MEGA-VITA|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo aggravated;Vertigo;Inner ear signs and symptoms;Mild;NULL
Concomitant Medication|SONATA|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle fatigue;Muscle fatigue;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Stomach flu;Gastroenteritis viral;Viral infections NEC;SEVERE;RECOVERED
Concomitant Medication|PEPCID|20;PRN (as needed);Oral
Concomitant Medication|PREVPAC|4;BID (twice a day);Oral
Concomitant Medication|ULTRACET|37.5;BID (twice a day);Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Esophageal spasm;Oesophageal spasm;Gastrointestinal spastic and hypermotility disorders;Mild;Continuing
Concomitant Medication|NTG|NULL;NULL;NULL
Concomitant Medication|RABEPRAZOLE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Flaking skin;Skin exfoliation;Exfoliative conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Itchy eyes;Eye pruritus;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngeal spasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Bronchial disorders (excl neoplasms)|Asthmatic attack;Asthma;Bronchospasm and obstruction;SEVERE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anguish;Anxiety;Anxiety symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Taste bitter;Dysgeusia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Fatigability;Fatigue;Asthenic conditions;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|CHLORAMMONIC|NULL;NULL;NULL
Adverse Event|Injuries NEC|Closed head injury;Traumatic brain injury;Cerebral injuries NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Aphagia;Aphagia;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Inguinal hernia;Inguinal hernia;Inguinal hernias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|White blood cell disorders|Neutropenia;Neutropenia;Neutropenias;MODERATE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine;White blood cells urine;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CEFPROZIL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Decreased vibratory sense;Decreased vibratory sense;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Nocturnal headache;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose bowels;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose bowels;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Panic attack;Panic attack;Panic attacks and disorders;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Pulled muscle;Muscle strain;Muscle, tendon and ligament injuries;SEVERE;RECOVERED
Adverse Event|Ocular haemorrhages and vascular disorders NEC|Broken blood vessel in eye;Eye haemorrhage;Ocular bleeding and vascular disorders NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Ankle oedema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Concomitant Medication|FORT-E-VITE|NULL;NULL;NULL
Concomitant Medication|FYBOGEL|NULL;NULL;NULL
Concomitant Medication|OXYTETRACYLINE|NULL;NULL;NULL
Adverse Event|Joint disorders|Stiff knees;Joint stiffness;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ACECLOFENAC|NULL;NULL;NULL
Concomitant Medication|CARBOCYSTEINE|NULL;NULL;NULL
Concomitant Medication|CLOPERASTINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|SALMETEROL|NULL;NULL;NULL
Concomitant Medication|TICLOPIDIN|NULL;NULL;NULL
Adverse Event|Tongue conditions|Tongue spasm;Tongue spasm;Tongue signs and symptoms;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Soft tissue neoplasms benign|Lipoma;Lipoma;Soft tissue neoplasms benign NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|VITAMIN D2|NULL;NULL;NULL
Adverse Event|Injuries NEC|Bruising of face;Contusion;Skin injuries NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Injuries NEC|Muscle strain;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Root canal procedure;Endodontic procedure;Dental and gingival therapeutic procedures;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|DETROL LA|4;QD (every day);Oral
Concomitant Medication|LASIX|1/2;QD (every day);Oral
Concomitant Medication|XANAX|0.25;QHS (at bedtime);Oral
Concomitant Medication|MUCINEX|2;BID (twice a day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Abdominal bloating;Abdominal distension;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Choked on food;Choking;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Hyperreflexia;Hyperreflexia;Abnormal reflexes;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Oral infection;Oral infection;Dental and oral soft tissue infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle contracture;Muscle contracture;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral candidiasis;Oral candidiasis;Candida infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle tightness;Muscle tightness;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ANUSOL-HC|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Generalised muscle aches;Myalgia;Muscle pains;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Macular rash;Rash macular;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Hand osteoarthritis;Osteoarthritis;Osteoarthropathies;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Papular skin eruption;Rash papular;Papulosquamous conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;SEVERE;RECOVERED
Adverse Event|Joint disorders|Ankle stiffness;Joint stiffness;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergy to grains;Food allergy;Allergies to foods, food additives, drugs and other chemicals;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Flashing vision;Photopsia;Visual disorders NEC;MODERATE;RECOVERED
Adverse Event|Headaches|Pounding in head;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Flashing vision;Photopsia;Visual disorders NEC;MILD;RECOVERED
Concomitant Medication|CARISOPRODOL|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;Mild;Resolved
Adverse Event|Oral soft tissue conditions|Canker sores oral;Aphthous stomatitis;Stomatitis and ulceration;Mild;Resolved
Adverse Event|Neurological disorders NEC|Light headedness;Dizziness;Neurological signs and symptoms NEC;Mild;Resolved
Adverse Event|Sleep disorders and disturbances|Sleep problem;Sleep disorder;Sleep disorders NEC;Mild;Resolved
Concomitant Medication|THERAFLU DAYTIME|NULL;NULL;NULL
Concomitant Medication|THERAFLU NIGHT TIME|NULL;NULL;NULL
Lab Test|White Blood Cell (WBC)|6,900
Lab Test|Platelets|303,000
Lab Test|Red Blood Cells (RBC)|4820,000
Adverse Event|Gastrointestinal ulceration and perforation|Ulcer gastric;Gastric ulcer;Gastric ulcers and perforation;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DYNABAC|NULL;NULL;NULL
Concomitant Medication|FLUISEDAL|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Atelectasis;Atelectasis;Parenchymal lung disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchial spasm;Bronchospasm;Bronchospasm and obstruction;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Bacterial infectious disorders|Staphylococcal infection;Staphylococcal infection;Staphylococcal infections;MILD;RECOVERED
Concomitant Medication|CALCIUM CARBONATE W/VITAMIN D|NULL;NULL;NULL
Concomitant Medication|LACHYDRIN|NULL;NULL;NULL
Concomitant Medication|MENTHACIN|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Rhinitis allergic;Rhinitis allergic;Nasal congestion and inflammations;Mild;NULL
Concomitant Medication|VITAMIN B12|1;QD (every day);Oral
Concomitant Medication|ZYRTEC|5;QD (every day);Oral
Adverse Event|Neurological disorders NEC|Apraxia;Apraxia;Cortical dysfunction NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin lesion;Skin lesion;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Laryngitis;Laryngitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin and subcutaneous tissue therapeutic procedures|Mole excision;Mole excision;Skin lesion excisions;MILD;RECOVERED
Adverse Event|Vascular inflammations|Phlebitis lower limb;Phlebitis;Phlebitis NEC;MODERATE;RECOVERED
Concomitant Medication|FLUNIR|NULL;NULL;NULL
Adverse Event|Muscle disorders|Twitching;Muscle twitching;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Urolithiases|Kidney stones;Nephrolithiasis;Renal lithiasis;Moderate;NULL
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|Respiratory and mediastinal neoplasms benign (excl mesotheliomas)|Pulmonary hamartoma;Benign lung neoplasm;Respiratory tract and pleural neoplasms benign NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Increased urea;Blood urea increased;Renal function analyses;MILD;RECOVERED
Concomitant Medication|COLLAGEN COMPLEX|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Facial swelling;Swelling face;Dermal and epidermal conditions NEC;Mild;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);Mild;NULL
Concomitant Medication|PHEMEROL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Foot oedema;Oedema peripheral;Oedema NEC;Moderate;NULL
Concomitant Medication|VALIUM|1,5;;Oral
Adverse Event|Gastrointestinal signs and symptoms|Aphagia;Aphagia;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Blood potassium increased;Blood potassium increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Protein and chemistry analyses NEC|Serum total protein increased;Protein total increased;Protein analyses NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Nasal discharge;Rhinorrhoea;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Shallow breathing;Hypoventilation;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Bad breath;Breath odour;Gastrointestinal signs and symptoms NEC;Mild;NULL
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;Mild;NULL
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;Mild;NULL
Adverse Event|Joint disorders|Swelling of knees;Joint swelling;Joint related signs and symptoms;Moderate;NULL
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Vaginal discharge;Vaginal discharge;Vulvovaginal signs and symptoms;Mild;NULL
Concomitant Medication|OMEGA-EFA|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste bitter;Dysgeusia;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Taste bitter;Dysgeusia;Sensory abnormalities NEC;Moderate;Resolved with Residual
Adverse Event|Neurological disorders NEC|Taste bitter;Dysgeusia;Sensory abnormalities NEC;Severe;Resolved with Residual
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Moderate;Continuing
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved with Residual
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);Severe;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Mild;Resolved with Residual
Adverse Event|Infections - pathogen unspecified|Maxillary sinusitis;Sinusitis;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Mucous stools;Mucous stools;Faecal abnormalities NEC;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Mucous stool;Mucous stools;Faecal abnormalities NEC;Mild;Resolved with Residual
Adverse Event|Gastrointestinal signs and symptoms|Mucous stool;Mucous stools;Faecal abnormalities NEC;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Postprandial nausea;Nausea;Nausea and vomiting symptoms;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Postprandial nausea;Nausea;Nausea and vomiting symptoms;Moderate;Resolved with Residual
Adverse Event|Gastrointestinal signs and symptoms|Postprandial nausea;Nausea;Nausea and vomiting symptoms;Severe;Resolved
Adverse Event|Neurological disorders NEC|Presyncope;Presyncope;Neurological signs and symptoms NEC;Moderate;Resolved
Adverse Event|Vision disorders|Photopsia;Photopsia;Visual disorders NEC;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Mild;Resolved
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;Moderate;Resolved with Residual
Concomitant Medication|FORMULA 44-D|NULL;NULL;NULL
Concomitant Medication|SCANDISHAKE MIX|NULL;NULL;NULL
Concomitant Medication|SINUS RELIEF|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Liver function tests abnormal;Liver function test abnormal;Liver function analyses;Mild;NULL
Adverse Event|Neurological disorders NEC|Unsteadiness;Balance disorder;Cerebellar coordination and balance disturbances;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CEDAX|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Heartburn;Dyspepsia;Dyspeptic signs and symptoms;MILD;UNKNOWN
Adverse Event|Myocardial disorders|Left atrial enlargement;Left atrial dilatation;Myocardial disorders NEC;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Chloride increased;Blood chloride increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Sodium increased;Blood sodium increased;Mineral and electrolyte analyses;MILD;RECOVERED
Concomitant Medication|OXYBUTIN|NULL;NULL;NULL
Concomitant Medication|ZINAXIN|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;Mild;NULL
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Queasy;Nausea;Nausea and vomiting symptoms;Mild;NULL
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;Mild;NULL
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Epigastric distress;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Concomitant Medication|ALPRAZOLAM|0.25;QD (every day);Oral
Concomitant Medication|AMOXICILLIN|875;TID (three times a day);Oral
Concomitant Medication|CLAVULANIC ACID|125;TID (three times a day);Oral
Concomitant Medication|DOMPERIDONE|10;PRN (as needed);Oral
Concomitant Medication|TETRAZEPAM|75;TID (three times a day);Oral
Concomitant Medication|TRAZODONE HYDROCHLORIDE|100;QD (every day);Oral
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract (left);Cataract;Cataract conditions;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Cellulitis of leg;Cellulitis;Bacterial infections NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Swelling of knees;Joint swelling;Joint related signs and symptoms;SEVERE;RECOVERED
Adverse Event|Oral soft tissue conditions|Sores mouth;Stomatitis;Stomatitis and ulceration;MILD;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Sores mouth;Stomatitis;Stomatitis and ulceration;MILD;RECOVERED
Concomitant Medication|CAFERGOT|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion;Contusion;Skin injuries NEC;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);Fatal;         .
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Urination difficulty;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|ASTEMIZOLE|NULL;NULL;NULL
Concomitant Medication|ADVAIR|2;BID (twice a day);Inhalation
Concomitant Medication|ALPHA LIPOIC ACID|200;QD (every day);Oral
Concomitant Medication|FLOVENT|2;BID (twice a day);Inhalation
Concomitant Medication|VENTOLIN|2;PRN (as needed);Inhalation
Concomitant Medication|ZITHROMAX|500;1 time only;Oral
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine increased;Glucose urine present;Urinalysis NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Hair growth increased;Hair growth abnormal;Pilar disorders NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Spasms;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PRAVASTATIN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Shooting pain;Pain;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|SLOW K|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervical pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Bladder incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Carbuncle;Carbuncle;Skin structures and soft tissue infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED
Adverse Event|Allergic conditions|Allergic edema;Allergic oedema;Allergic conditions NEC;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Rash mouth;Rash;Rashes, eruptions and exanthems NEC;SEVERE;RECOVERED
Concomitant Medication|GUAITEX|NULL;NULL;NULL
Concomitant Medication|HYDROXYCHLOROQUINE|NULL;NULL;NULL
Concomitant Medication|ICHTHAMMOL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders congenital|Congenital nystagmus;Congenital nystagmus;Neurological disorders congenital NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eye swelling;Eye swelling;Ocular disorders NEC;MILD;RECOVERED
Adverse Event|Eye disorders NEC|Tearing eyes;Lacrimation increased;Lacrimal disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Edema knees;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in upper extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|COLLUNOVAR|NULL;NULL;NULL
Concomitant Medication|LEVOPHED|NULL;NULL;NULL
Concomitant Medication|MAXILASE 3000|NULL;NULL;NULL
Concomitant Medication|RHINOTROPHYL|NULL;NULL;NULL
Concomitant Medication|RIBATRAN|NULL;NULL;NULL
Concomitant Medication|TICARPEN|NULL;NULL;NULL
Concomitant Medication|TUSSILENE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Hiccups;Hiccups;Lower respiratory tract signs and symptoms;NULL;NULL
Concomitant Medication|ROBITUSSIN-DM|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Expectoration;Productive cough;Coughing and associated symptoms;Mild;NULL
Concomitant Medication|ACETYLCYSTEIN|600;;Oral
Concomitant Medication|COENZYME Q10|not known;;Oral
Concomitant Medication|LIMPTAR N|200;;Oral
Concomitant Medication|PENTOXIFYLLINE|300;;Oral
Concomitant Medication|SELEN|5;;Oral
Concomitant Medication|VITAMIN E|1200;;Oral
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Chest tenderness;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|PENICILLIN V|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Pyrosis;Dyspepsia;Dyspeptic signs and symptoms;Mild;NULL
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Hepatobiliary investigations|GGT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin low;Haemoglobin decreased;Red blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pitting edema;Oedema;Oedema NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BEECHAMS FLU-PLUS|NULL;NULL;NULL
Concomitant Medication|DIFFLAM|NULL;NULL;NULL
Concomitant Medication|E 45 ITCH RELIEF|NULL;NULL;NULL
Concomitant Medication|VENOS COUGH|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Tracheobronchitis;Tracheobronchitis;Upper respiratory tract infections;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|FLUVASTATINE|10;QD (every day);Oral
Concomitant Medication|FLUVASTATINE|20;QD (every day);Oral
Concomitant Medication|LEVOFLOXACIN|500;QD (every day);Intravenous
Concomitant Medication|OMEPRAZOL|20;QD (every day);Other (specify)
Concomitant Medication|PARACETAMOL|1;TID (three times a day);Intravenous
Concomitant Medication|SALBUTAMOL|300;TID (three times a day);Inhalation
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;NULL;NULL
Adverse Event|Allergic conditions|Insect sting allergy;Allergy to arthropod sting;Allergic conditions NEC;NULL;NULL
Concomitant Medication|DECOLD|NULL;NULL;NULL
Concomitant Medication|PERCOGESIC|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure diastolic increased;Blood pressure diastolic increased;Vascular tests NEC (incl blood pressure);MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Increased platelets;Platelet count increased;Platelet analyses;MILD;RECOVERED
Concomitant Medication|MINOVITAL|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnoea;Dyspnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Thyroid gland disorders|Graves-Basedow disease;Basedow's disease;Thyroid hyperfunction disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|MINERAL SUPPLEMENTS|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;         .
Adverse Event|Gastrointestinal inflammatory conditions|Colitis;Colitis;Colitis (excl infective);Moderate;Resolved
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;Moderate;Resolved
Concomitant Medication|SULFASALAZINE|NULL;NULL;NULL
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;SEVERE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Appetite absent;Decreased appetite;Appetite disorders;NULL;NULL
Adverse Event|General system disorders NEC|Swelling of fingers;Oedema peripheral;Oedema NEC;NULL;NULL
Adverse Event|General system disorders NEC|Swollen thumb;Oedema peripheral;Oedema NEC;NULL;NULL
Adverse Event|Tendon, ligament and cartilage disorders|Tendonitis;Tendonitis;Tendon disorders;NULL;NULL
Lab Test|Immunofixation|+
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;SEVERE;RECOVERED
Adverse Event|Tongue conditions|Tongue blistering;Tongue blistering;Tongue signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Headaches|Nocturnal headache;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension exacerbated;Hypertension;Vascular hypertensive disorders NEC;SEVERE;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;MILD;ONGOING (PERSISTENT)
Adverse Event|Tongue conditions|Tongue sore;Glossodynia;Tongue signs and symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema upper extremities;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Increased bronchial secretion;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ECHINACIN|NULL;NULL;NULL
Concomitant Medication|GLIBENCLAMID|NULL;NULL;NULL
Concomitant Medication|IS 5 MONO|NULL;NULL;NULL
Concomitant Medication|LYOGEN|NULL;NULL;NULL
Concomitant Medication|SINUPRET|NULL;NULL;NULL
Concomitant Medication|VITAMIN B KOMPLEX|NULL;NULL;NULL
Lab Test|Urine Triple Phosphate Crystals|Moderate
Adverse Event|Administration site reactions|Pain during injection;Injection site pain;Injection site reactions;NULL;NULL
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose congestion;Nasal congestion;Nasal congestion and inflammations;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|General system disorders NEC|Discomfort;Discomfort;Pain and discomfort NEC;NULL;NULL
Adverse Event|Skin appendage conditions|Hair thinning;Alopecia;Alopecias;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Buttock pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Fungal infectious disorders|Thrush;Candidiasis;Candida infections;NULL;NULL
Adverse Event|Vision disorders|Blurred vision;Vision blurred;Visual disorders NEC;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;NULL;NULL
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;NULL;NULL
Concomitant Medication|OTOSPORIN|NULL;NULL;NULL
Concomitant Medication|TOLMETIN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cervical dystonia;Torticollis;Muscle tone abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cervical dystonia;Torticollis;Muscle tone abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|B6|NULL;NULL;NULL
Adverse Event|Protein and amino acid metabolism disorders NEC|Hypoalbuminemia;Hypoalbuminaemia;Protein metabolism disorders NEC;MODERATE;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Hypokalaemia;Hypokalaemia;Potassium imbalance;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;MILD;UNKNOWN
Adverse Event|Fungal infectious disorders|Oral candida;Oral candidiasis;Candida infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|WBC decreased;White blood cell count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Wound infection;Wound infection;Infections NEC;MILD;RECOVERED
Concomitant Medication|ATRACURIUM|NULL;NULL;NULL
Concomitant Medication|BUPIVACAINE|NULL;NULL;NULL
Concomitant Medication|DEXTROSE|NULL;NULL;NULL
Concomitant Medication|DEXTROSE IN WATER|NULL;NULL;NULL
Concomitant Medication|GLYCOPYRRONIUM BROMIDE|NULL;NULL;NULL
Concomitant Medication|HARTMANS|NULL;NULL;NULL
Concomitant Medication|LIVIAL|NULL;NULL;NULL
Concomitant Medication|NEOSTIGMINE|NULL;NULL;NULL
Concomitant Medication|PICOLAX|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;SEVERE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|WBC decreased;White blood cell count decreased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BRISERIN|NULL;NULL;NULL
Concomitant Medication|PEPDUL|NULL;NULL;NULL
Concomitant Medication|TARIVID|NULL;NULL;NULL
Concomitant Medication|ACETYLCYSTEIN|600;TID (three times a day);Oral
Concomitant Medication|ATORVASTATIN|80;QD (every day);Oral
Concomitant Medication|IBUPROFEN|600;QD (every day);Oral
Concomitant Medication|SERTRALINE HYDROCHLORIDE|50;QD (every day);Oral
Concomitant Medication|VITAMIN E|200;QD (every day);Oral
Adverse Event|Bronchial disorders (excl neoplasms)|Allergic asthma;Asthma;Bronchospasm and obstruction;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Bronchial disorders (excl neoplasms)|Allergic asthma;Asthma;Bronchospasm and obstruction;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Chronic pain;Pain;Pain and discomfort NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Elevated mood;Elevated mood;Emotional and mood disturbances NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Energy increased;Energy increased;General signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Anaemias nonhaemolytic and marrow depression|Iron deficiency anemia;Iron deficiency anaemia;Anaemia deficiencies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezes;Wheezing;Bronchospasm and obstruction;MODERATE;RECOVERED
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;MODERATE;RECOVERED
Adverse Event|Bacterial infectious disorders|Streptococcal sore throat;Pharyngitis streptococcal;Streptococcal infections;SEVERE;RECOVERED
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|CHLORZOXAZONE|NULL;NULL;NULL
Concomitant Medication|FEOSOL|NULL;NULL;NULL
Concomitant Medication|KINESED|NULL;NULL;NULL
Concomitant Medication|LEVSINEX|NULL;NULL;NULL
Concomitant Medication|ONE A DAY WOMEN'S|NULL;NULL;NULL
Concomitant Medication|PRELONE|NULL;NULL;NULL
Concomitant Medication|TERAGRAN M|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis of arm;Cellulitis;Bacterial infections NEC;NULL;NULL
Adverse Event|Joint disorders|Aching in knees;Arthralgia;Joint related signs and symptoms;NULL;NULL
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;NULL;NULL
Adverse Event|Dental and gingival conditions|Tooth ache;Toothache;Dental pain and sensation disorders;NULL;NULL
Adverse Event|Respiratory disorders NEC|Sleep apnea;Sleep apnoea syndrome;Breathing abnormalities;Moderate;NULL
Concomitant Medication|ATENOLOL|50;QD (every day);Oral
Concomitant Medication|CARMOL 20|1/1;PRN (as needed);Topical
Concomitant Medication|CLOBETASOL PROPIONATE|1/1;PRN (as needed);Topical
Concomitant Medication|HYDROCORTISONE|1/1;PRN (as needed);Topical
Adverse Event|Injuries NEC|Laceration;Laceration;Non-site specific injuries NEC;Mild;NULL
Adverse Event|Ocular infections, irritations and inflammations|Eye redness;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;Mild;NULL
Concomitant Medication|ALLEGRA|1;QD (every day);Oral
Concomitant Medication|GENTAMICIN|1;QID (four times a day);Topical
Concomitant Medication|VITAMIN B12|1;Monthly or once a month;Intramuscular
Concomitant Medication|MULTIVITAMIN|1;BID (twice a day);Oral
Concomitant Medication|TETANUS VACCINE|0.5;QD (every day);Intramuscular
Concomitant Medication|VITAMIN B|100;BID (twice a day);Oral
Concomitant Medication|AEROBID|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;RECOVERED
Adverse Event|Embolism and thrombosis|DVT of calf;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Calf pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Chronic sinusitis;Chronic sinusitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Skin and subcutaneous tissue disorders congenital|Ichthyosis;Ichthyosis;Skin and subcutaneous tissue disorders congenital NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Rheumatoid arthritis;Rheumatoid arthritis;Rheumatoid arthropathies;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|METHOTREXATE|NULL;NULL;NULL
Concomitant Medication|TUMS ANTACID|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Q axis, left axis deviation;QRS axis abnormal;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Water, electrolyte and mineral investigations|Blood chloride decreased;Blood chloride decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Sodium decreased;Blood sodium decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Sodium low;Blood sodium decreased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Intraventricular block;Conduction disorder;Cardiac conduction disorders;MILD;RECOVERED
Adverse Event|Muscle disorders|Cramps legs;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Adverse Event|Haematology investigations (incl blood groups)|Increased white cell count;White blood cell count increased;White blood cell analyses;Moderate;NULL
Adverse Event|Purine and pyrimidine metabolism disorders|Gout;Gout;Purine metabolism disorders NEC;Mild;NULL
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;Marked;NULL
Concomitant Medication|COLCHICINE|0.6;QID (four times a day);Oral
Concomitant Medication|COUMADIN|7.5;QD (every day);Inhalation
Concomitant Medication|DIOVAN HCT|160;QD (every day);Oral
Concomitant Medication|ECHINACEA|1;PRN (as needed);Oral
Concomitant Medication|HEPARIN|U;Continuous IV;Transdermal
Concomitant Medication|INSULINA HUMALOG|30;BID (twice a day);Subcutaneous
Concomitant Medication|INSULINA HUMALOG|50;TID (three times a day);Subcutaneous
Concomitant Medication|INSULIN NPH|145;BID (twice a day);Subcutaneous
Concomitant Medication|LIPOIC ACID|2;BID (twice a day);Oral
Concomitant Medication|LANTUS|100;QD (every day);Subcutaneous
Concomitant Medication|NEUROPLUS|3;BID (twice a day);Oral
Concomitant Medication|PLAVEX|75;QD (every day);Oral
Concomitant Medication|QUININE SULFATE|324;QHS (at bedtime);Oral
Concomitant Medication|SILYMARIN|2;BID (twice a day);Oral
Adverse Event|Infections - pathogen unspecified|Dental abscess;Tooth abscess;Dental and oral soft tissue infections;SEVERE;RECOVERED
Concomitant Medication|ALPRESS|NULL;NULL;NULL
Concomitant Medication|BI-PROFENID|NULL;NULL;NULL
Concomitant Medication|CATAPRESSAN|NULL;NULL;NULL
Adverse Event|Injuries NEC|Laceration of thumb;Skin laceration;Skin injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|OSPEN|NULL;NULL;NULL
Adverse Event|Cervix disorders (excl infections and inflammations)|Cervical dysplasia;Cervical dysplasia;Cervix disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Genital herpes;Genital herpes;Herpes viral infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hyperventilation;Hyperventilation;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Tremor muscle;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Listlessness;Listless;Mood disorders NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Throat tightness;Throat tightness;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Neuromuscular disorders|ALS;Amyotrophic lateral sclerosis;Motor neurone diseases;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BECONASE AQ|NULL;NULL;NULL
Concomitant Medication|ESGIC|NULL;NULL;NULL
Concomitant Medication|LOESTRIN|NULL;NULL;NULL
Concomitant Medication|TALWIN|NULL;NULL;NULL
Adverse Event|Headaches|Cephalgia;Headache;Headaches NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach heaviness;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BIFONAZOLE|NULL;NULL;NULL
Concomitant Medication|PRISTINAMYCINE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Dorsalgia;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Dorsalgia;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Cognitive impairment;Cognitive disorder;Mental impairment (excl dementia and memory loss);Moderate;NULL
Adverse Event|Fungal infectious disorders|Onychomycosis;Onychomycosis;Fungal infections NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Infection;Infection;Infections NEC;Moderate;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Weakness left or right side;Hemiparesis;Paralysis and paresis (excl cranial nerve);Moderate;NULL
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;Mild;NULL
Adverse Event|Vascular disorders NEC|Pallor;Pallor;Site specific vascular disorders NEC;Mild;NULL
Concomitant Medication|COLACE|1;BID (twice a day);PEG
Concomitant Medication|EFFEXOR|37.5;BID (twice a day);Oral
Concomitant Medication|EFFEXOR|37.5;BID (twice a day);PEG
Concomitant Medication|FISH OIL|1000;BID (twice a day);Oral
Concomitant Medication|LEVAQUIN|500;QD (every day);Intravenous
Concomitant Medication|LEVAQUIN|500;QD (every day);PEG
Concomitant Medication|CENTRUM|1;QD (every day);PEG
Concomitant Medication|TYLENOL|650;PRN (as needed);PEG
Concomitant Medication|MIRALAX|1;PRN (as needed);PEG
Concomitant Medication|PREVACID|30;QD (every day);PEG
Concomitant Medication|PRILOSEC|20;PRN (as needed);Oral
Concomitant Medication|VALIUM|2;PRN (as needed);PEG
Adverse Event|Nervous system, skull and spine therapeutic procedures|Craniotomy;Craniotomy;Skull and brain therapeutic procedures;SEVERE;RECOVERED
Concomitant Medication|HISMANAL|NULL;NULL;NULL
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Infection respiratory;Respiratory tract infection;Infections NEC;Moderate;NULL
Concomitant Medication|ALKA SELTZER|2;PRN (as needed);Oral
Concomitant Medication|ALLEGRA D|180;1 time only;Oral
Concomitant Medication|AMITRIPTYLINE|25;BID (twice a day);Oral
Concomitant Medication|AUGMENTIN|500;BID (twice a day);Oral
Concomitant Medication|SUDAFED|60;PRN (as needed);Oral
Concomitant Medication|TUSSIONEX PENNKINETIC|1;BID (twice a day);Oral
Concomitant Medication|ZITHROMAX|500;BID (twice a day);Oral
Lab Test|Urine HCG|-
Concomitant Medication|POLYFAX|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Respiratory disorder;Respiratory disorder;Respiratory tract disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CYCLO-MENORETTE|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;Severe;Resolved
Adverse Event|Respiratory disorders NEC|Voice alteration;Dysphonia;Upper respiratory tract signs and symptoms;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Skin irritation;Skin irritation;Dermatitis and eczema;Mild;Resolved
Concomitant Medication|DEPO TESTOSTERONE|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;NULL
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Severe;NULL
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;Moderate;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis leg;Deep vein thrombosis;Peripheral embolism and thrombosis;Severe;NULL
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;Severe;NULL
Adverse Event|Infections - pathogen unspecified|Throat infection;Pharyngitis;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Food intolerance syndromes|Alcohol tolerance lowered;Alcohol intolerance;Food malabsorption and intolerance syndromes (excl sugar intolerance);MODERATE;RECOVERED
Adverse Event|Skin investigations|Skin biopsy;Biopsy skin;Skin histopathology procedures;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Tinea pedis;Tinea pedis;Tinea infections;MILD;RECOVERED
Concomitant Medication|BENZYLPENICILLINE|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depressive reaction;Depression;Depressive disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Sinus arrhythmia;Sinus arrhythmia;Supraventricular arrhythmias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Cardiac murmur;Cardiac murmur;Cardiac auscultatory investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Stress incontinence;Stress urinary incontinence;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|CEBION|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depressive episode;Depression;Depressive disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Bacterial infectious disorders|Erythema migrans;Erythema migrans;Borrelial infections;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Bacterial infectious disorders|Lyme disease;Lyme disease;Borrelial infections;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Skin appendage conditions|Seborrhea;Seborrhoea;Sebaceous gland disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Numbness facial;Hypoaesthesia facial;Dermal and epidermal conditions NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness of extremities;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Unsteady gait;Gait disturbance;Gait disturbances;SEVERE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|AMOXICILLIN|3000;TID (three times a day);Oral
Concomitant Medication|DOXYCYCLINE|200;QD (every day);Oral
Concomitant Medication|ESTRADIOL|25;Other (specify);Topical
Adverse Event|Injuries NEC|Contusion of toe;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbar pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Red blood cell disorders|Macrocytosis;Macrocytosis;Red blood cell abnormal findings NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Capsulitis;Periarthritis;Joint related disorders NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Eye disorders NEC|Tearing eyes;Lacrimation increased;Lacrimal disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Epigastric fullness;Abdominal distension;Flatulence, bloating and distension;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Anxiety disorders and symptoms|Panic attacks;Panic attack;Panic attacks and disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);SEVERE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ANTIBIOTIC|0.5;QD (every day);Oral
Concomitant Medication|INSIDON|50;PRN (as needed);Oral
Concomitant Medication|TAVANIC|2;TID (three times a day);Oral
Concomitant Medication|TRAMADOLOR|50;PRN (as needed);Oral
Concomitant Medication|OPIPRAMOL|100;BID (twice a day);Oral
Concomitant Medication|TAVANIC|1;QD (every day);Oral
Concomitant Medication|TAVOR|1;PRN (as needed);Oral
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;RECOVERED
Concomitant Medication|BROMAZEPAM|1;PRN (as needed);Oral
Concomitant Medication|QUININE SULFATE|500;BID (twice a day);Oral
Concomitant Medication|TOCOPHEROL|400;QD (every day);Oral
Concomitant Medication|ALUTAB|NULL;NULL;NULL
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|AMLODIPINE|10;QD (every day);Oral
Concomitant Medication|NORETISTERONE|10;QD (every day);Oral
Concomitant Medication|PARACETAMOL|1;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;Moderate;NULL
Concomitant Medication|CALCIUM|1;QD (every day);Oral
Concomitant Medication|CEFEPIME|1;BID (twice a day);Transdermal
Concomitant Medication|EVISTA|60;QD (every day);Oral
Concomitant Medication|LEVOXYL|0.1;QD (every day);Oral
Concomitant Medication|TENORETIC|25;QD (every day);Oral
Adverse Event|General system disorders NEC|Feeling dazed;Feeling abnormal;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Feeling dazed;Feeling abnormal;Feelings and sensations NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal ulceration and perforation|Erosive esophagitis;Erosive oesophagitis;Oesophageal ulcers and perforation;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Abnormal dreams;Abnormal dreams;Parasomnias;MILD;RECOVERED
Adverse Event|Prostatic disorders (excl infections and inflammations)|Benign prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Visual acuity decreased;Visual acuity reduced;Partial vision loss;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|ASPIRIN CHILDREN|NULL;NULL;NULL
Concomitant Medication|CODIMAL DH|NULL;NULL;NULL
Concomitant Medication|MYSOLINE|NULL;NULL;NULL
Adverse Event|Head and neck therapeutic procedures|Periodontal operation;Periodontal operation;Dental and gingival therapeutic procedures;MILD;RECOVERED
Adverse Event|Eye therapeutic procedures|Keratotomy;Keratotomy;Corneal and scleral therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Ankle fracture;Ankle fracture;Lower limb fractures and dislocations;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|V-CILLIN K|NULL;NULL;NULL
Concomitant Medication|PECTOSAN|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Dental abscess;Tooth abscess;Dental and oral soft tissue infections;MILD;RECOVERED
Concomitant Medication|AROVENT|NULL;NULL;NULL
Concomitant Medication|DAFALGAN CODEINE|NULL;NULL;NULL
Adverse Event|Injuries NEC|Lumbosacral strain;Muscle strain;Muscle, tendon and ligament injuries;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Moderate;Resolved
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Flaking skin;Skin exfoliation;Exfoliative conditions;Mild;Resolved
Adverse Event|Hepatobiliary investigations|Raised LFTs;Liver function test abnormal;Liver function analyses;Mild;Resolved
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;Mild;Continuing
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Mild;Resolved with Residual
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Nocturia;Nocturia;Urinary tract signs and symptoms NEC;Moderate;Continuing
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;Mild;Resolved
Adverse Event|Joint disorders|Joint hyperextension;Joint hyperextension;Joint related disorders NEC;Moderate;Continuing
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Continuing
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;Moderate;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;Moderate;Continuing
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Moderate;Continuing
Concomitant Medication|UREX|NULL;NULL;NULL
Adverse Event|Procedural related injuries and complications NEC|Stoma site redness;Procedural site reaction;Non-site specific procedural complications;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;MILD;UNKNOWN
Concomitant Medication|TERBUTALINE SULFATE|NULL;NULL;NULL
Lab Test|Urine Ammonia Urate Crystals|Moderate
Adverse Event|Oral soft tissue conditions|Lip pigmental spot;Pigmentation lip;Oral soft tissue disorders NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste abnormality;Dysgeusia;Sensory abnormalities NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;NULL;NULL
Adverse Event|Water, electrolyte and mineral investigations|Blood bicarbonate increased;Blood bicarbonate increased;Mineral and electrolyte analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|DOXYLAMINE SUCCINATE|NULL;NULL;NULL
Concomitant Medication|ESGIC-PLUS|NULL;NULL;NULL
Concomitant Medication|LIQUID OXYGEN|NULL;NULL;NULL
Concomitant Medication|TRANSDERM-NITRO|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Flu-like symptoms;Influenza like illness;General signs and symptoms NEC;Mild;NULL
Adverse Event|General system disorders NEC|Flu-like symptoms;Influenza like illness;General signs and symptoms NEC;Moderate;NULL
Concomitant Medication|ACETYL L CARNITINE|500;BID (twice a day);Oral
Concomitant Medication|ADVAIR|50/250;BID (twice a day);Inhalation
Concomitant Medication|ALBUTEROL|17;PRN (as needed);Inhalation
Concomitant Medication|ALPHA LIPOIC ACID|250;BID (twice a day);Oral
Concomitant Medication|ALTACE|2.5;QD (every day);Oral
Concomitant Medication|B COMPLEX|1;BID (twice a day);Oral
Concomitant Medication|CALCIUM D GLUCARATE|200;BID (twice a day);Oral
Concomitant Medication|CARNOSINE|500;BID (twice a day);Oral
Concomitant Medication|CORAL CALCIUM|1500;BID (twice a day);Oral
Concomitant Medication|CREATINE|2500;BID (twice a day);Oral
Concomitant Medication|FLAXSEED OIL|1;BID (twice a day);Oral
Concomitant Medication|GAMMA|340;BID (twice a day);Oral
Concomitant Medication|GARLIC|73.5;BID (twice a day);Oral
Concomitant Medication|GINKO|60;BID (twice a day);Oral
Concomitant Medication|KLONOPIN|0.5;QHS (at bedtime);Oral
Concomitant Medication|L-THREONINE|100;BID (twice a day);Oral
Concomitant Medication|MELATONIN|10;QD (every day);Oral
Concomitant Medication|METHYLCOBALAMIN|5;BID (twice a day);Oral
Concomitant Medication|MULTIVITAMIN|3;TID (three times a day);Oral
Concomitant Medication|N ACETYL CYSTEIN|600;BID (twice a day);Oral
Concomitant Medication|NEUROMINS|100;BID (twice a day);Oral
Concomitant Medication|POTASSIUM|99;BID (twice a day);Oral
Concomitant Medication|SAME|200;BID (twice a day);Oral
Concomitant Medication|SELENIUM|200;BID (twice a day);Oral
Concomitant Medication|SILIBININ|266;BID (twice a day);Oral
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Mild;Continuing
Adverse Event|Injuries NEC|Concussion;Concussion;Cerebral injuries NEC;Moderate;Resolved with Residual
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Elevated BP;Blood pressure increased;Vascular tests NEC (incl blood pressure);Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Joint infection;Arthritis infective;Bone and joint infections;Mild;Resolved
Adverse Event|Bacterial infectious disorders|Streptococcal sore throat;Pharyngitis streptococcal;Streptococcal infections;Mild;Resolved
Concomitant Medication|ALESSE-28|NULL;NULL;NULL
Concomitant Medication|DIMETABS|NULL;NULL;NULL
Concomitant Medication|ORTHO-NOVUM|NULL;NULL;NULL
Concomitant Medication|ROBITUSSIN EXPECTORANT|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal bloating;Abdominal distension;Flatulence, bloating and distension;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Muscle disorders|Generalized muscle aches;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal stenosis and obstruction|Esophageal stricture;Oesophageal stenosis;Oesophageal stenosis and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Esophagitis;Oesophagitis;Oesophagitis (excl infective);MILD;RECOVERED
Adverse Event|Male reproductive tract infections and inflammations|Prostatitis;Prostatitis;Prostate and seminal vesicles infections and inflammations;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Energy decreased;Asthenia;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Flu like symptoms;Influenza like illness;General signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Nocturia;Nocturia;Urinary tract signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Concomitant Medication|CENTRUM FORTE|NULL;NULL;NULL
Concomitant Medication|DEFENDOL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Acid indigestion;Dyspepsia;Dyspeptic signs and symptoms;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|Haematology investigations (incl blood groups)|WBC count;White blood cell count;White blood cell analyses;Mild;NULL
Adverse Event|Bone and joint injuries|Great toe fracture;Foot fracture;Lower limb fractures and dislocations;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|Dental and gingival conditions|Tooth ache;Toothache;Dental pain and sensation disorders;Mild;NULL
Concomitant Medication|BACLOFEN|10;Continuous IV;Oral
Concomitant Medication|BACLOFEN|5;QID (four times a day);Oral
Concomitant Medication|RANITIDINE|20;BID (twice a day);Oral
Concomitant Medication|TIZANIDINE|12;QD (every day);Oral
Concomitant Medication|TIZANIDINE|20;QD (every day);Oral
Concomitant Medication|TIZANIDINE|8;;Oral
Concomitant Medication|TIZANIDINE|8;QD (every day);Oral
Concomitant Medication|TRAZODONE|50;QD (every day);Oral
Concomitant Medication|TUMS|1;QID (four times a day);Oral
Adverse Event|Muscle disorders|Cramps calf;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Finger cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Localized itching;Pruritus;Pruritus NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Nerve pain;Neuralgia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle cramps aggravated;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLSALICYLIC ACID|81;;Oral
Concomitant Medication|ACETYLSALICYLIC ACID|81;QD (every day);Oral
Concomitant Medication|BISOPROLOL|2.5;Every morning;Oral
Concomitant Medication|CALCITE D|2;BID (twice a day);Oral
Concomitant Medication|CHLORPHENIRAMINE|4;PRN (as needed);Oral
Concomitant Medication|DIPROSALIC|1;QD (every day);Topical
Concomitant Medication|LEVOTHYROXINE SODIUM|0.1;Every morning;Oral
Concomitant Medication|LEVOTHYROXINE SODIUM|0.125;Other (specify);Oral
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Microbiology and serology investigations|Helicobacter pylori test positive;Helicobacter test positive;Bacteria identification and serology (excl mycobacteria);Mild;NULL
Concomitant Medication|SYNTHROID|1;QD (every day);Oral
Lab Test|RBC Morphology: Anisocytosis|Trace
Lab Test|Polychromasia|Moderate
Lab Test|Antinuclear Antibody|-
Lab Test|CK|Normal
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Platelets increased;Platelet count increased;Platelet analyses;MISSING DATA;ONGOING (PERSISTENT)
Adverse Event|Protozoal infectious disorders|Giardiasis;Giardiasis;Giardia infections;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory dysfunction NOS;Respiratory disorder;Respiratory tract disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Eosinophil count increased;Eosinophil count increased;White blood cell analyses;MISSING DATA;RECOVERED
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Increased platelets;Platelet count increased;Platelet analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;SEVERE;RECOVERED
Adverse Event|Gastrointestinal neoplasms malignant and unspecified|Colon cancer;Colon cancer;Colonic neoplasms malignant;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hematology test abnormal;Haematology test abnormal;Haematological analyses NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;MISSING DATA;MISSING DATA
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine present;Protein urine present;Urinalysis NEC;MISSING DATA;RECOVERED
Adverse Event|General system disorders NEC|Thirst;Thirst;Feelings and sensations NEC;MODERATE;RECOVERED
Concomitant Medication|ACILAC|NULL;NULL;NULL
Concomitant Medication|DIOVOL|NULL;NULL;NULL
Concomitant Medication|FERINSOL|NULL;NULL;NULL
Concomitant Medication|MAALOX H2|NULL;NULL;NULL
Concomitant Medication|OVOL|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Sulfonamide allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MILD;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|BPH;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MILD;UNKNOWN
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Physical examination topics|Weight increase;Weight increased;Physical examination procedures;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urine flow decreased;Urine flow decreased;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;MILD;RECOVERED
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Premature ejaculation;Premature ejaculation;Orgasmic disorders and disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Suicidal and self-injurious behaviours NEC|Suicidal ideation;Suicidal ideation;Suicidal and self-injurious behaviour;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;Marked;NULL
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;Marked;NULL
Adverse Event|Coronary artery disorders|Myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;Marked;NULL
Concomitant Medication|CLARINEX|5;PRN (as needed);Oral
Concomitant Medication|DYAZIDE|37.5;QD (every day);Oral
Concomitant Medication|KLONOPIN|0.5;TID (three times a day);Oral
Concomitant Medication|LASIX|20;PRN (as needed);Oral
Concomitant Medication|LORAZEPAM|1.0;BID (twice a day);Oral
Concomitant Medication|PAXIL|30;QHS (at bedtime);Oral
Concomitant Medication|PHAZYME|180;PRN (as needed);Oral
Concomitant Medication|TAMOXIFEN|10;BID (twice a day);Oral
Concomitant Medication|TEMAZEPAM|30;QHS (at bedtime);Oral
Concomitant Medication|TOPROL|50;QD (every day);Oral
Concomitant Medication|XANAX|1.0;QHS (at bedtime);Oral
Adverse Event|Injuries NEC|Traumatic injury;Injury;Non-site specific injuries NEC;Moderate;NULL
Concomitant Medication|NATURE'S OWN ANTIOXIDANT FORMULA|1;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|250;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|200;BID (twice a day);Oral
Concomitant Medication|NEURONTIN|800;TID (three times a day);Oral
Concomitant Medication|ZOVIRAX|200;PRN (as needed);Oral
Adverse Event|Synovial and bursal disorders|Shoulder bursitis;Bursitis;Bursal disorders;Moderate;Resolved
Adverse Event|Synovial and bursal disorders|Shoulder bursitis;Bursitis;Bursal disorders;Severe;Resolved
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Resolved with Residual
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Severe;Resolved
Concomitant Medication|OMEGA|NULL;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Low platelets;Platelet count decreased;Platelet analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|ANALPRAM HC|NULL;NULL;NULL
Adverse Event|Cardiac valve disorders|Aortic valve incompetence;Aortic valve incompetence;Aortic valvular disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal therapeutic procedures|Rectal prolapse repair;Rectal prolapse repair;Anorectal therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Palpitations;Palpitations;Cardiac signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anal and rectal conditions NEC|Rectal prolapse;Rectal prolapse;Anal and rectal disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anal and rectal conditions NEC|Rectal prolapse;Rectal prolapse;Anal and rectal disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal therapeutic procedures|Repair rectal prolapse;Rectal prolapse repair;Anorectal therapeutic procedures;MODERATE;RECOVERED
Concomitant Medication|NU-SEALS ASPIRIN|NULL;NULL;NULL
Adverse Event|Physical examination topics|Breath sounds decreased;Breath sounds abnormal;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Generalized itching;Pruritus generalised;Pruritus NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Pigmentation disorders|Hyperpigmentation skin;Skin hyperpigmentation;Hyperpigmentation disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Abdominal distension;Abdominal distension;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Gastric infection;Gastric infection;Abdominal and gastrointestinal infections;MODERATE;RECOVERED
Concomitant Medication|CALAN|NULL;NULL;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Dystonia;Dystonia;Dystonias;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Flushed;Flushing;Peripheral vascular disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ALENDRONATE SODIUM|NULL;NULL;NULL
Concomitant Medication|ETIDRONATE|NULL;NULL;NULL
Concomitant Medication|PROMEGESTONE|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Ringworm NOS;Tinea infection;Tinea infections;Mild;NULL
Concomitant Medication|SPORINEX|100;BID (twice a day);Oral
Concomitant Medication|ZOLOFT|50;QHS (at bedtime);Oral
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Arm discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest discomfort;Chest discomfort;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Choked on food;Choking;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PROMETHAZINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ROXICODONE|NULL;NULL;NULL
Adverse Event|Gallbladder disorders|Cholelithiasis;Cholelithiasis;Cholecystitis and cholelithiasis;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Laryngitis;Laryngitis;Upper respiratory tract infections;MODERATE;RECOVERED
Adverse Event|Cardiac disorder signs and symptoms|Palpitation;Palpitations;Cardiac signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Paralysis;Paralysis;Paralysis and paresis (excl cranial nerve);MILD;RECOVERED
Adverse Event|Seizures (incl subtypes)|Seizure;Convulsion;Seizures and seizure disorders NEC;MILD;RECOVERED
Adverse Event|Sleep disturbances (incl subtypes)|Sleep paralysis;Sleep paralysis;Abnormal sleep-related events;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disturbances (incl subtypes)|Sleep paralysis;Sleep paralysis;Abnormal sleep-related events;MILD;RECOVERED
Adverse Event|Sleep disturbances (incl subtypes)|Sleep paralysis;Sleep paralysis;Abnormal sleep-related events;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Bladder cramps;Bladder pain;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Skeletal pain;Bone pain;Bone related signs and symptoms;MILD;RECOVERED
Concomitant Medication|BETAINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|DURALEX|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Knee injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|General system disorders NEC|Pedal oedema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Mouth bleeding;Mouth haemorrhage;Oral soft tissue haemorrhages;MILD;RECOVERED
Concomitant Medication|TAMBOCOR|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Fear of falling;Fear of falling;Fear symptoms and phobic disorders (incl social phobia);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|EOSINE ALCOOL|NULL;NULL;NULL
Adverse Event|Thoracic disorders (excl lung and pleura)|Diaphragm muscle weakness;Diaphragm muscle weakness;Diaphragmatic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;MODERATE;RECOVERED
Concomitant Medication|VITAMIN B PLUS C|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Sweating increased;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Mood swings;Mood swings;Fluctuating mood symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sleep apnea;Sleep apnoea syndrome;Breathing abnormalities;MILD;RECOVERED
Concomitant Medication|HEPATITIS B VACCINE|NULL;NULL;NULL
Concomitant Medication|TUBERCULOSIS VACCINES|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal fullness;Abdominal distension;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MAGALDRATE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Upper respiratory tract congestion;Upper respiratory tract congestion;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Microbiology and serology investigations|Hepatitis viral test positive;Hepatitis viral test positive;Virus identification and serology;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ESTRATEST HS|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Nasal mucus increased;Rhinorrhoea;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|QUERCETIN|NULL;NULL;NULL
Concomitant Medication|TURMERIC|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Gait instability;Gait disturbance;Gait disturbances;MILD;RECOVERED
Concomitant Medication|ACETYL L CARNITINE|1;BID (twice a day);Oral
Concomitant Medication|GLUTATHIONE|250;QD (every day);Oral
Concomitant Medication|OMEGA 3|500;QD (every day);Oral
Adverse Event|Injuries NEC|Black eye;Periorbital haematoma;Eye injuries NEC;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Hemorrhage oral;Mouth haemorrhage;Oral soft tissue haemorrhages;MODERATE;RECOVERED
Concomitant Medication|CAL/MAG CITRATE|NULL;NULL;NULL
Concomitant Medication|AZO STANDARD|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Transaminases increased;Transaminases increased;Liver function analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Genital labial cyst;Vulva cyst;Vulvovaginal cysts and neoplasms;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Nocturnal agitation;Agitation;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BISOPROLOL|5;QD (every day);Oral
Concomitant Medication|SERTRALINE|UNK;QD (every day);Oral
Concomitant Medication|ZOPICLONE|7.5;QHS (at bedtime);Oral
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;Mild;Continuing
Adverse Event|Neuromuscular disorders|ALS;Amyotrophic lateral sclerosis;Motor neurone diseases;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Light headedness;Dizziness;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NIQUIL|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|COPD;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|HYDROXIZINE HCL|NULL;NULL;NULL
Concomitant Medication|OCUFLOX|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Electric shock sensation;Paraesthesia;Paraesthesias and dysaesthesias;SEVERE;RECOVERED
Adverse Event|Disturbances in thinking and perception|Auditory hallucinations;Hallucination, auditory;Perception disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Sleep disturbed;Sleep disorder;Sleep disorders NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Concomitant Medication|CITRIC ACID|NULL;NULL;NULL
Concomitant Medication|FUSIDIC ACID|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|AV block first degree;Atrioventricular block first degree;Cardiac conduction disorders;Mild;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Increased blood pressure;Blood pressure increased;Vascular tests NEC (incl blood pressure);Moderate;NULL
Concomitant Medication|VITAMIN E|4000;QD (every day);Oral
Adverse Event|Joint disorders|Shoulder osteoarthritis;Osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM|600;BID (twice a day);Oral
Concomitant Medication|CHONDROITIN|400;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|120;BID (twice a day);Oral
Concomitant Medication|HYDROXYZINE|10;PRN (as needed);Oral
Concomitant Medication|LO/OVRAL|1;QD (every day);Oral
Concomitant Medication|TYLENOL PM|2;BID (twice a day);Oral
Concomitant Medication|TYLENOL PM|2;QD (every day);Oral
Concomitant Medication|WELCHOL|1250;TID (three times a day);Oral
Concomitant Medication|WELCHOL|625;QID (four times a day);Oral
Concomitant Medication|WELCHOL|325;TID (three times a day);Oral
Adverse Event|Coronary artery disorders|Myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;Severe;NULL
Adverse Event|Epidermal and dermal conditions|Itch;Pruritus;Pruritus NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Itch;Pruritus;Pruritus NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Rhinitis;Rhinitis;Upper respiratory tract infections;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;NULL
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;Moderate;NULL
Concomitant Medication|DUPHALAC|15;QD (every day);Oral
Concomitant Medication|KEFZOL|1;QD (every day);Oral
Concomitant Medication|MOVICOL|13,8;QD (every day);Oral
Concomitant Medication|REDOMEX|25;BID (twice a day);Oral
Concomitant Medication|REDOMEX|25;QD (every day);Oral
Concomitant Medication|SEROXAT|10;QD (every day);Oral
Concomitant Medication|SEROXAT|20;QD (every day);Oral
Concomitant Medication|SIPRALEXA|10;QD (every day);Oral
Concomitant Medication|VITAMIN E|440;BID (twice a day);Oral
Adverse Event|Vulvovaginal disorders (excl infections and inflammations)|Bleeding vaginal;Vaginal haemorrhage;Vulvovaginal disorders NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose decreased;Blood glucose decreased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Speech loss;Aphasia;Cortical dysfunction NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Respiratory depression;Respiratory depression;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Knee arthritis;Arthritis;Arthropathies NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Knee arthritis;Arthritis;Arthropathies NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Viral infectious disorders|Herpes zoster;Herpes zoster;Herpes viral infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Hypertonia;Hypertonia;Muscle tone abnormal;MODERATE;RECOVERED
Concomitant Medication|ACIC|NULL;NULL;NULL
Concomitant Medication|CIPROBAY|NULL;NULL;NULL
Concomitant Medication|FENOFIBRAT|NULL;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Monocyte count low;Monocyte count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Irritative cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Urgency urination;Micturition urgency;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Tooth disorder;Tooth disorder;Dental disorders NEC;MILD;RECOVERED
Concomitant Medication|DETRUSITOL|NULL;NULL;NULL
Concomitant Medication|DIOCTYL|NULL;NULL;NULL
Concomitant Medication|DISTACLOR|NULL;NULL;NULL
Concomitant Medication|DOVONEX|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Inflammation localized;Inflammation;Inflammations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Oral ulceration;Mouth ulceration;Stomatitis and ulceration;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Sensation of heat;Feeling hot;Feelings and sensations NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal sinus discharge;Paranasal sinus hypersecretion;Paranasal sinus disorders (excl infections and neoplasms);SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|SELDANE|NULL;NULL;NULL
Concomitant Medication|XANAX|10;PRN (as needed);Oral
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|T wave flattening of;Electrocardiogram T wave amplitude decreased;ECG investigations;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ANACIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Disorder equilibrium;Balance disorder;Cerebellar coordination and balance disturbances;Mild;NULL
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;Moderate;NULL
Adverse Event|Salivary gland conditions|Increased salivation;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;NULL
Adverse Event|Vision disorders|Blurring of vision;Vision blurred;Visual disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eyelid disorder;Eyelid disorder;Ocular disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Pain muscle;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Male genital tract therapeutic procedures|Vasectomy;Vasectomy;Male genital tract therapeutic procedures NEC;MILD;RECOVERED
Adverse Event|Mental impairment disorders|Memory impairment;Memory impairment;Memory loss (excl dementia);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pilonidal cyst;Pilonidal cyst;Skin structures and soft tissue infections;MILD;RECOVERED
Adverse Event|Bacterial infectious disorders|Overgrowth bacterial;Overgrowth bacterial;Bacterial infections NEC;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Muscle weakness upper limb;Muscular weakness;Muscle weakness conditions;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Anal and rectal conditions NEC|Rectal pain;Proctalgia;Anal and rectal pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depressive reaction;Depression;Depressive disorders;MILD;RECOVERED
Adverse Event|Headaches|Intermittent headache;Headache;Headaches NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|SULPIRIDE|NULL;NULL;NULL
Concomitant Medication|HERBAL EXTRACT NOS|unknown;Unknown;Oral
Concomitant Medication|KERATIN|2;;Oral
Concomitant Medication|MADOPAR|250;;Oral
Concomitant Medication|MAGNESIUM VERLA|1;;Oral
Concomitant Medication|SCOPODERM|1;;Transdermal
Concomitant Medication|TROMCARDIN|1;;Oral
Concomitant Medication|VITAMIN B KOMPLEX|40;;Oral
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal bleeding;Epistaxis;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Joint swelling non-inflammatory;Joint swelling;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling arm;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BEECHAMS POWDERS|NULL;NULL;NULL
Concomitant Medication|BUFFERIN|NULL;NULL;NULL
Concomitant Medication|SHARK CARTILAGE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Skin scaly;Skin exfoliation;Exfoliative conditions;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|OPTOVIT|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Facial swelling;Swelling face;Dermal and epidermal conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Sleep maintenance insomnia;Middle insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Endocrine disorders of gonadal function|Estrogen deficiency;Oestrogen deficiency;Endocrine abnormalities of gonadal function NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Scales;Skin exfoliation;Exfoliative conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Stiff knees;Joint stiffness;Joint related signs and symptoms;MILD;RECOVERED
Concomitant Medication|CHARCOAL, ACTIVATED|NULL;NULL;NULL
Adverse Event|Injuries NEC|Lip laceration;Mouth injury;Site specific injuries NEC;Moderate;Resolved
Adverse Event|Viral infectious disorders|Stomach flu;Gastroenteritis viral;Viral infections NEC;Mild;Resolved
Concomitant Medication|B50|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;Severe;NULL
Adverse Event|General system disorders NEC|Unsteady gait;Gait disturbance;Gait disturbances;Mild;NULL
Concomitant Medication|SAROTEN|10;QD (every day);Oral
Concomitant Medication|SAROTEN|85;QD (every day);Oral
Concomitant Medication|SCOPODERM| one;Other (specify);Topical
Concomitant Medication|SCOPODERM|half;Other (specify);Topical
Adverse Event|Neurological disorders NEC|Sedation excessive;Sedation;Disturbances in consciousness NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema limbs;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional incontinence;Affect lability;Affect alterations NEC;SEVERE;RECOVERED
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;SEVERE;RECOVERED
Adverse Event|Bone disorders (excl congenital and fractures)|Coccyalgia;Coccydynia;Bone related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Burning sensation in eye;Eye irritation;Ocular infections, inflammations and associated manifestations;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Unable to walk;Abasia;Gait disturbances;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Unable to walk;Abasia;Gait disturbances;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hyperventilation;Hyperventilation;Breathing abnormalities;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Lichen planus;Lichen planus;Papulosquamous conditions;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Concomitant Medication|CREATINE|6;QD (every day);Oral
Concomitant Medication|METHOCARBAMOL|500;PRN (as needed);Oral
Concomitant Medication|MULTIVITAMIN|1;Once per week;Oral
Concomitant Medication|ORABASE|20;PRN (as needed);Topical
Concomitant Medication|PREMPHASE|0.625;QD (every day);Oral
Concomitant Medication|TYLENOL W/CODEINE NO. 3|300/300;PRN (as needed);Oral
Concomitant Medication|VITAMIN E|1500;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|1500;QD (every day);Oral
Adverse Event|Joint disorders|Arthritis;Arthritis;Arthropathies NEC;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Prostatic disorders (excl infections and inflammations)|Benign prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;Mild;NULL
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezing;Wheezing;Bronchospasm and obstruction;Mild;NULL
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Concomitant Medication|D-ALPHA TOCOPHEROL|600;BID (twice a day);Oral
Adverse Event|Respiratory disorders NEC|Dysphonia;Dysphonia;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Fainting;Syncope;Disturbances in consciousness NEC;MODERATE;RECOVERED
Concomitant Medication|AMAREL|NULL;NULL;NULL
Concomitant Medication|METFORMINE|NULL;NULL;NULL
Concomitant Medication|TETAGRIP|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Ear infection fungal;Ear infection fungal;Fungal infections NEC;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Limbs stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Pain aggravated;Pain;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Hearing loss unilateral;Deafness unilateral;Hearing losses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PROBENECID/COLCHICINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Urinary infection;Urinary tract infection;Urinary tract infections;MILD;UNKNOWN
Concomitant Medication|CLIVARINE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Cough increased;Cough;Coughing and associated symptoms;NULL;NULL
Adverse Event|Bone and joint injuries|Fibula fracture;Fibula fracture;Lower limb fractures and dislocations;NULL;NULL
Adverse Event|Respiratory disorders NEC|Hypophonia;Dysphonia;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Administration site reactions|Injection site stinging;Injection site pain;Injection site reactions;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose bleed;Epistaxis;Nasal disorders NEC;NULL;NULL
Adverse Event|Muscle disorders|Muscle tension;Muscle tightness;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|General system disorders NEC|Weakness worsened;Asthenia;Asthenic conditions;NULL;NULL
Concomitant Medication|BISMUTH|NULL;NULL;NULL
Concomitant Medication|CHLORPHENAMINE|NULL;NULL;NULL
Concomitant Medication|DEXTROPROPOXYPHENE|NULL;NULL;NULL
Adverse Event|Cutaneous neoplasms benign|Keratoacanthoma;Keratoacanthoma;Skin neoplasms benign;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Regurgitation of food;Regurgitation;Nausea and vomiting symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Decubitus;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Tibia fracture;Tibia fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Adverse Event|General system disorders NEC|Hot feeling in feet;Feeling hot;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Breast disorders|Breast mass;Breast mass;Breast disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Nasal irritation;Nasal discomfort;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|External ear disorders (excl congenital)|Ear wax;Cerumen impaction;External ear disorders NEC;MILD;RECOVERED
Concomitant Medication|PREM|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|TESSALON|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stools hard;Faeces hard;Faecal abnormalities NEC;Mild;Resolved
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;         .;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;Resolved
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Mild;Resolved
Adverse Event|Enzyme investigations NEC|Creatine kinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|NEURALGIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Loss of consciousness;Loss of consciousness;Disturbances in consciousness NEC;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Blister;Blister;Bullous conditions;NULL;NULL
Adverse Event|Muscle disorders|Muscle twitching;Muscle twitching;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Skin vascular abnormalities|Increased tendency to bruise;Increased tendency to bruise;Purpura and related conditions;NULL;NULL
Adverse Event|Hepatobiliary therapeutic procedures|Cholecystectomy;Cholecystectomy;Biliary tract and gallbladder therapeutic procedures;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Epigastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);NULL;NULL
Adverse Event|Fungal infectious disorders|Athlete's foot;Tinea pedis;Tinea infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Dreaming excessive;Abnormal dreams;Parasomnias;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PARAMAX|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Incomplete right bundle branch block;Bundle branch block right;Cardiac conduction disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Left anterior hemiblock;Bundle branch block left;Cardiac conduction disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema upper extremities;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine present;Glucose urine present;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary infiltration;Lung infiltration;Parenchymal lung disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PENICILLIN G|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Eschar;Eschar;Non-site specific injuries NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CATARSTAT|NULL;NULL;NULL
Concomitant Medication|UMULINE PROFIL|NULL;NULL;NULL
Adverse Event|Gallbladder disorders|Cholelithiasis;Cholelithiasis;Cholecystitis and cholelithiasis;Moderate;Resolved
Adverse Event|Hepatobiliary investigations|SGOT increased;Aspartate aminotransferase increased;Liver function analyses;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;Continuing
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;Mild;Continuing
Adverse Event|Muscle disorders|Myasthenia;Muscular weakness;Muscle weakness conditions;Mild;         .
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Gallbladder disorders|Cholelithiasis;Cholelithiasis;Cholecystitis and cholelithiasis;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;Moderate;Continuing
Concomitant Medication|DOXEPIN HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Sexual function and fertility disorders|Haematospermia;Haematospermia;Spermatogenesis and semen disorders;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Loss of weight;Weight decreased;Physical examination procedures;MILD;RECOVERED
Concomitant Medication|OMIX|NULL;NULL;NULL
Concomitant Medication|LESTIN|NULL;NULL;NULL
Adverse Event|Skin neoplasms malignant and unspecified|Basal cell carcinoma;Basal cell carcinoma;Skin neoplasms malignant and unspecified (excl melanoma);MODERATE;RECOVERED
Adverse Event|Tissue disorders NEC|Cyst;Cyst;Mass conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|KLOR-CON|NULL;NULL;NULL
Concomitant Medication|NIFEDIPINE XL|NULL;NULL;NULL
Concomitant Medication|NUTRACORT|NULL;NULL;NULL
Adverse Event|Pericardial disorders|Pericardial effusion;Pericardial effusion;Pericardial disorders NEC;NULL;NULL
Adverse Event|Neurological disorders NEC|Drooling;Drooling;Neurological signs and symptoms NEC;NULL;NULL
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Cold symptoms;Nasopharyngitis;Upper respiratory tract infections;NULL;NULL
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;NULL;NULL
Adverse Event|Headaches|Head throbbing;Headache;Headaches NEC;Mild;Continuing
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;Moderate;Resolved
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;Moderate;Resolved
Concomitant Medication|ESTRADIOL W/MEDROXYPROGESTERONE|NULL;NULL;NULL
Concomitant Medication|ESTROPIPATE|NULL;NULL;NULL
Concomitant Medication|LISINOPRIL AND HYDROCHLOROTHIAZIDE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;Moderate;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Dyspnea exertional;Dyspnoea exertional;Breathing abnormalities;Mild;Continuing
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Axillary lymph nodes enlarged;Lymphadenopathy;Lymphatic system disorders NEC;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Epigastric discomfort;Epigastric discomfort;Dyspeptic signs and symptoms;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Catheter site infection;Catheter site infection;Infections NEC;Moderate;Resolved
Adverse Event|Procedural related injuries and complications NEC|Stoma site redness;Procedural site reaction;Non-site specific procedural complications;Mild;Resolved
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;Moderate;Resolved
Concomitant Medication|ISOFLAVON|NULL;NULL;NULL
Adverse Event|Thyroid gland disorders|Hypothyroidism;Hypothyroidism;Thyroid hypofunction disorders;Mild;NULL
Concomitant Medication|AMARID|NULL;NULL;NULL
Adverse Event|Hepatic and hepatobiliary disorders|Function liver decreased;Hepatic function abnormal;Hepatic enzymes and function abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|CETIRIZINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|MOMETASONE|NULL;NULL;NULL
Concomitant Medication|RYNACROM|NULL;NULL;NULL
Adverse Event|Muscle disorders|Generalized muscle aches;Myalgia;Muscle pains;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);NULL;NULL
Concomitant Medication|BUMEX|NULL;NULL;NULL
Concomitant Medication|CYCLOSPORINE|NULL;NULL;NULL
Adverse Event|Skin and subcutaneous tissue therapeutic procedures|Dry skin moisturising;Dry skin prophylaxis;Skin and subcutaneous tissue therapeutic procedures NEC;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;Mild;Continuing
Adverse Event|Skin appendage conditions|Ingrown toe nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);Moderate;Resolved
Adverse Event|Angioedema and urticaria|Welts;Urticaria;Urticarias;Mild;Resolved
Concomitant Medication|LOPERAMIDE HYDROCHLORIDE W/SIMETICONE|NULL;NULL;NULL
Concomitant Medication|VALACYCLOVIR|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;Mild;NULL
Concomitant Medication|PAMINE|2.5;QID (four times a day);Oral
Concomitant Medication|SCOPOLAMINE|1.5;PRN (as needed);Topical
Concomitant Medication|CYPROTERONE|NULL;NULL;NULL
Concomitant Medication|PERPHENAZINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|GERD;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Concomitant Medication|CREATINE|spoon;QD (every day);Oral
Adverse Event|Cardiac arrhythmias|Atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;MODERATE;UNKNOWN
Adverse Event|Respiratory disorders NEC|Hypoventilation;Hypoventilation;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint tenderness;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|OPIPRAMOL|NULL;NULL;NULL
Concomitant Medication|BENADRYL ALLERGY & SINUS HEADACHE|NULL;NULL;NULL
Concomitant Medication|NASALIDE|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Early morning awakening;Terminal insomnia;Disturbances in initiating and maintaining sleep;MILD;RECOVERED
Adverse Event|Injuries NEC|Tooth injury;Tooth injury;Site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy;Gastrostomy;Gastric therapeutic procedures;MILD;RECOVERED
Concomitant Medication|ALLOPURINOL|150;QD (every day);Oral
Concomitant Medication|ALLOPURINOL|300;QD (every day);Oral
Concomitant Medication|CIPRALEX|10;Every morning;Oral
Concomitant Medication|NOVALGIN|30;Other (specify);Oral
Adverse Event|Changes in physical activity|Bruxism;Bruxism;Stereotypies and automatisms;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Corneal abrasion;Corneal abrasion;Eye injuries NEC;MILD;RECOVERED
Adverse Event|Injuries NEC|Corneal abrasion;Corneal abrasion;Eye injuries NEC;MODERATE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Corneal ulcer;Ulcerative keratitis;Corneal infections, oedemas and inflammations;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Early morning awakening;Terminal insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Edema arms;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Lip edema;Lip oedema;Oral soft tissue disorders NEC;MILD;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Postoperative pain;Procedural pain;Non-site specific procedural complications;SEVERE;RECOVERED
Adverse Event|General system disorders NEC|Swelling;Swelling;General signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Lip swelling;Lip swelling;Oral soft tissue disorders NEC;MODERATE;RECOVERED
Concomitant Medication|BLEPHAMIDE|NULL;NULL;NULL
Concomitant Medication|EX-LAX STOOL SOFTENER|NULL;NULL;NULL
Concomitant Medication|TUMS EX|NULL;NULL;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Amenorrhea;Amenorrhoea;Menstruation with decreased bleeding;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Middle ear disorders (excl congenital)|Eustachian salpingitis;Otosalpingitis;Middle ear infections and inflammations;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Generalized edema;Generalised oedema;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine;White blood cells urine;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Decubitus ulcer;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;RECOVERED
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;SEVERE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Nocturnal awakening;Middle insomnia;Disturbances in initiating and maintaining sleep;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|BENZODIAZEPINE DERIVATIVES|NULL;NULL;NULL
Concomitant Medication|GREPAFLOXACIN HCL|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood gases abnormal;Blood gases abnormal;Blood gas and acid base analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Ill-defined intestinal infections;Enteritis infectious;Abdominal and gastrointestinal infections;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Breakthrough pain;Breakthrough pain;Pain and discomfort NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Dry nose;Nasal dryness;Nasal disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Bronchorrhea;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Genital infection;Genital infection;Infections NEC;MODERATE;RECOVERED
Adverse Event|Aural disorders NEC|Earache;Ear pain;Ear disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Throat irritation;Throat irritation;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM GLUCONATE W/CALCIUM LACTATE|NULL;NULL;NULL
Concomitant Medication|KENACOMB|NULL;NULL;NULL
Concomitant Medication|NOVOCHLORHYDRATE|NULL;NULL;NULL
Concomitant Medication|NOVONIDAZOL|NULL;NULL;NULL
Concomitant Medication|NOVOQUININE|NULL;NULL;NULL
Concomitant Medication|BECLOFORTE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Kidney infection;Kidney infection;Urinary tract infections;Moderate;NULL
Concomitant Medication|BROMOCRIPTINE MESYLATE|NULL;NULL;NULL
Concomitant Medication|CITICOLINE|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Oral candida;Oral candidiasis;Candida infections;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;Moderate;NULL
Concomitant Medication|AMITRIPTYLINE|30;BID (twice a day);Oral
Adverse Event|Injuries NEC|Insect bite NOS;Arthropod bite;Non-site specific injuries NEC;MODERATE;RECOVERED
Concomitant Medication|ACETYLSALICYLZUUR|400;QD (every day);
Concomitant Medication|CAFFEINE|92;QD (every day);
Concomitant Medication|GLUCOSAMINE|1500;QD (every day);Oral
Concomitant Medication|PARACETAMOL|400;QD (every day);
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Acne vulgaris;Acne;Acnes;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|External ear disorders (excl congenital)|Ear wax;Cerumen impaction;External ear disorders NEC;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Ingrown toe nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Infected rash;Dermatitis infected;Skin structures and soft tissue infections;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Increased bronchial secretion;Increased bronchial secretion;Lower respiratory tract signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|ADENYL|NULL;NULL;NULL
Concomitant Medication|CATACOL|NULL;NULL;NULL
Concomitant Medication|HEPT A MYL|NULL;NULL;NULL
Concomitant Medication|METEOSPASMYL|NULL;NULL;NULL
Concomitant Medication|PEREFLAT|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion of back;Contusion;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Mycoplasmal infectious disorders|Mycoplasma infection;Mycoplasma infection;Mycoplasma infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|KYOLIC|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramps of lower extremities;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit decreased;Haematocrit decreased;Red blood cell analyses;Mild;Resolved
Adverse Event|Haematology investigations (incl blood groups)|Decreased hemoglobin;Haemoglobin decreased;Red blood cell analyses;Mild;Resolved
Adverse Event|Haematology investigations (incl blood groups)|WBC decreased;White blood cell count decreased;White blood cell analyses;Mild;Resolved
Adverse Event|Haematology investigations (incl blood groups)|Platelets decreased;Platelet count decreased;Platelet analyses;Mild;Resolved
Concomitant Medication|CONTRAMAL|NULL;NULL;NULL
Concomitant Medication|ENAPREN|NULL;NULL;NULL
Concomitant Medication|FOZITEC|NULL;NULL;NULL
Concomitant Medication|MEDIATENSYL|NULL;NULL;NULL
Concomitant Medication|NATISPRAY FORT|NULL;NULL;NULL
Concomitant Medication|OZIDIA|NULL;NULL;NULL
Concomitant Medication|SOPROL|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Change in ECG;Electrocardiogram change;ECG investigations;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Blood bicarbonate low;Blood bicarbonate decreased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Chloride low;Blood chloride decreased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Bladder incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Upper respiratory tract congestion;Upper respiratory tract congestion;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Gastrointestinal viral infection;Gastrointestinal viral infection;Viral infections NEC;SEVERE;RECOVERED
Adverse Event|Bone and joint injuries|Rib fracture;Rib fracture;Thoracic cage fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Post spinal headache;Post lumbar puncture syndrome;Neurological and psychiatric procedural complications;SEVERE;RECOVERED
Concomitant Medication|SUSTACAL|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Common cold syndrome;Nasopharyngitis;Upper respiratory tract infections;Mild;NULL
Adverse Event|Benign neoplasms gastrointestinal|Colonic polyp;Colonic polyp;Benign neoplasms gastrointestinal (excl oral cavity);Moderate;NULL
Concomitant Medication|COVERA-HS|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Erythematous rash;Rash erythematous;Erythemas;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Episcleritis;Episcleritis;Scleral infections, irritations and inflammations;MILD;RECOVERED
Adverse Event|Headaches|Headache;Headache;Headaches NEC;SEVERE;
Adverse Event|Joint disorders|Pain in joint involving shoulder region;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Pain in joint involving shoulder region;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|QUININE SULFATE|324;BID (twice a day);Oral
Concomitant Medication|TUMS|300;PRN (as needed);Oral
Adverse Event|Vascular disorders NEC|Facial flushing;Flushing;Peripheral vascular disorders NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Sleepy;Somnolence;Disturbances in consciousness NEC;Mild;NULL
Adverse Event|Joint disorders|Arthrosis;Osteoarthritis;Osteoarthropathies;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Dyspepsia;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|PIASCLEDINE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Dermatitis;Dermatitis;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal polyp;Nasal polyps;Nasal disorders NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain back;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Microbiology and serology investigations|Hepatitis A positive;Hepatitis A positive;Virus identification and serology;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|T GEL ANTI DANDRUF|NULL;NULL;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menorrhagia;Menorrhagia;Menstruation with increased bleeding;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Endogenous depression;Major depression;Depressive disorders;SEVERE;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menorrhagia;Menorrhagia;Menstruation with increased bleeding;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Passed out;Loss of consciousness;Disturbances in consciousness NEC;MODERATE;RECOVERED
Concomitant Medication|LOFEPRAMINE|NULL;NULL;NULL
Concomitant Medication|SLOW FE|NULL;NULL;NULL
Adverse Event|Metabolic, nutritional and blood gas investigations|Blood sugar increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Lipid metabolism disorders|Hyperlipidaemia;Hyperlipidaemia;Hyperlipidaemias NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Purine and pyrimidine metabolism disorders|Hyperuricaemia;Hyperuricaemia;Purine metabolism disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Umbilical hernia;Umbilical hernia;Umbilical hernias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MEGLUCON|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Intercostal pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Concomitant Medication|LITHIUM|2;QD (every day);Oral
Adverse Event|Eating disorders and disturbances|Bulimia;Bulimia nervosa;Eating disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure dropped;Blood pressure decreased;Vascular tests NEC (incl blood pressure);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Superinfection lung;Lung infection;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Concomitant Medication|OESCLIM|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;Severe;Resolved
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Moderate;Continuing
Adverse Event|Water, electrolyte and mineral investigations|Potassium low;Blood potassium decreased;Mineral and electrolyte analyses;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Concomitant Medication|LIORESAL|25;TID (three times a day);Oral
Adverse Event|Urinary tract signs and symptoms|Diuresis;Polyuria;Urinary tract signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Embolism and thrombosis|DVT;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Flatus increased;Flatulence;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased bowel frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Tight chest;Chest discomfort;Pain and discomfort NEC;MILD;RECOVERED
Concomitant Medication|CALCIUM W/ZINC|NULL;NULL;NULL
Concomitant Medication|CAUMADIN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Cough;Cough;Coughing and associated symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Coughing;Cough;Coughing and associated symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Sensation of pressure;Sensation of pressure;Feelings and sensations NEC;MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Hyperactivity;Psychomotor hyperactivity;Dyskinesias and movement disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle rigidity;Muscle rigidity;Muscle tone abnormalities;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal inflammatory conditions|Ulcerative colitis;Colitis ulcerative;Colitis (excl infective);MILD;ONGOING (PERSISTENT)
Concomitant Medication|GERMANIUM|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Candidiasis;Candidiasis;Candida infections;MODERATE;RECOVERED
Adverse Event|Disturbances in thinking and perception|Hallucination;Hallucination;Perception disturbances;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Hypokalaemia;Hypokalaemia;Potassium imbalance;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Prurigo;Prurigo;Dermatitis and eczema;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CACIT|NULL;NULL;NULL
Concomitant Medication|COLIMYCINE|NULL;NULL;NULL
Concomitant Medication|DICYNONE|NULL;NULL;NULL
Concomitant Medication|JOSIR|NULL;NULL;NULL
Concomitant Medication|TIAPRIDAL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Burning leg;Burning sensation;Paraesthesias and dysaesthesias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Synovial and bursal disorders|Shoulder bursitis;Bursitis;Bursal disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Yawning;Yawning;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema fingers;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Facial bones fracture;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Cardiac arrhythmias|Sinus bradycardia;Sinus bradycardia;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CORTATE|NULL;NULL;NULL
Concomitant Medication|METICORTEN|NULL;NULL;NULL
Concomitant Medication|MYCLO|NULL;NULL;NULL
Concomitant Medication|VARIDASA|NULL;NULL;NULL
Concomitant Medication|VITATHION|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal polyp;Nasal polyps;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Nasal polypectomy;Nasal polypectomy;Nasal therapeutic procedures;MILD;RECOVERED
Concomitant Medication|IRBESARTAN|150;QD (every day);Oral
Concomitant Medication|OMEGA|3000;TID (three times a day);Oral
Concomitant Medication|QUININE SULFATE| 250;QD (every day);Oral
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Abnormal ECG;Electrocardiogram abnormal;ECG investigations;SEVERE;RECOVERED
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Severe;Resolved
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;Severe;Resolved
Adverse Event|Respiratory disorders NEC|Dyspnoea at rest;Dyspnoea at rest;Breathing abnormalities;Moderate;Resolved
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;Mild;Continuing
Adverse Event|Joint disorders|Swelling of knees;Joint swelling;Joint related signs and symptoms;Mild;Resolved
Adverse Event|General system disorders NEC|Hot feeling in feet;Feeling hot;Feelings and sensations NEC;Severe;Continuing
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;Moderate;Resolved
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;Severe;Resolved with Residual
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Severe;Continuing
Adverse Event|Infections - pathogen unspecified|Paronychia;Paronychia;Skin structures and soft tissue infections;Mild;Resolved
Adverse Event|Anal and rectal conditions NEC|Rectal spasm;Rectal spasm;Anal and rectal signs and symptoms;Severe;Resolved
Adverse Event|Bacterial infectious disorders|Staphylococcal infection;Staphylococcal infection;Staphylococcal infections;Mild;Resolved with Residual
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary retention;Urinary retention;Bladder and urethral symptoms;Severe;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Moderate;Resolved with Residual
Adverse Event|Neurological disorders NEC|Syncope vasovagal;Syncope;Disturbances in consciousness NEC;Severe;Resolved
Concomitant Medication|METAXALONE|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Acid reflux (esophageal);Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;Resolved
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;Moderate;Continuing
Adverse Event|Menstrual cycle and uterine bleeding disorders|Prolonged menses;Menorrhagia;Menstruation with increased bleeding;         .;Resolved
Adverse Event|Headaches|Head pressure;Headache;Headaches NEC;Moderate;Continuing
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose stools;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved with Residual
Adverse Event|Muscle disorders|Muscle pain;Myalgia;Muscle pains;Moderate;Resolved with Residual
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;Continuing
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;Moderate;Continuing
Concomitant Medication|MITAPROGEN|NULL;NULL;NULL
Concomitant Medication|ONDANSETRON HCL|NULL;NULL;NULL
Concomitant Medication|PEDIACARE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dry throat;Dry throat;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle tightness;Muscle tightness;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Therapeutic procedures and supportive care NEC|Pain management;Pain management;Analgesia supportive care;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Productive cough;Productive cough;Coughing and associated symptoms;MODERATE;DEATH
Adverse Event|Respiratory disorders NEC|Suffocation feeling;Suffocation feeling;Respiratory signs and symptoms NEC;NA;DEATH
Concomitant Medication|ASPIRIN|100;QD (every day);Oral
Concomitant Medication|ATENOLOL|25;BID (twice a day);Oral
Concomitant Medication|COENZYME Q10|1000;QD (every day);Oral
Concomitant Medication|LERCANIDIPINE|10;QD (every day);Oral
Concomitant Medication|RAMIPRIL|10;BID (twice a day);Oral
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Osteoarthritis;Osteoarthritis;Osteoarthropathies;MILD;ONGOING (PERSISTENT)
Concomitant Medication|SOLPADOL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Crying;Crying;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Severe;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach ache;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;NULL
Concomitant Medication|BACLOFEN|5;;Oral
Concomitant Medication|GINKOR|NULL;NULL;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Amenorrhea;Amenorrhoea;Menstruation with decreased bleeding;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menses painful;Dysmenorrhoea;Menstruation and uterine bleeding NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful R arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in toes;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Allergy to plants;Allergy to plants;Allergic conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Ingrowing nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash face;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Skin vascular abnormalities|Mottled skin;Livedo reticularis;Skin vasomotor conditions;MILD;RECOVERED
Adverse Event|Injuries by physical agents|Sunburn;Sunburn;Radiation injuries;MILD;RECOVERED
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;Mild;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Marked;NULL
Adverse Event|Epidermal and dermal conditions|Generalized pruritus;Pruritus generalised;Pruritus NEC;Mild;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nosebleed;Epistaxis;Nasal disorders NEC;Mild;NULL
Adverse Event|Urinary tract signs and symptoms|Bladder spasm;Bladder spasm;Bladder and urethral symptoms;Mild;Resolved
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;Mild;Resolved
Adverse Event|Skin appendage conditions|Ingrowing nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Nail infection;Nail infection;Skin structures and soft tissue infections;Mild;Resolved
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Moderate;Resolved
Concomitant Medication|SULFAMETHIZOLE W/TRIMETHOPRIM|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;Mild;Resolved
Adverse Event|Allergic conditions|Drug allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;SEVERE;RECOVERED
Concomitant Medication|ACARBOSE|NULL;NULL;NULL
Concomitant Medication|INSULIN NPH|NULL;NULL;NULL
Concomitant Medication|METILPREDNISOLONE|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Stridor;Stridor;Laryngeal spasm, oedema and obstruction;MILD;ONGOING (PERSISTENT)
Concomitant Medication|OYSTER SHELL CALCIUM|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine volume decreased;Urine output decreased;Urinary tract function analyses NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hypopnea;Hypopnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Myalgia of lower extremities;Myalgia;Muscle pains;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MILD;RECOVERED
Concomitant Medication|GLYCINE|NULL;NULL;NULL
Concomitant Medication|L GLUTAMIC ACID|NULL;NULL;NULL
Concomitant Medication|L-ALANINE|NULL;NULL;NULL
Concomitant Medication|L-CITRULLINE|NULL;NULL;NULL
Concomitant Medication|L-HISTIDINE|NULL;NULL;NULL
Concomitant Medication|L-ISOLEUCINE|NULL;NULL;NULL
Concomitant Medication|L-LEUCINE|NULL;NULL;NULL
Concomitant Medication|L-METHIONINE|NULL;NULL;NULL
Concomitant Medication|L-PHENYLALANINE|NULL;NULL;NULL
Concomitant Medication|L-PROLINE|NULL;NULL;NULL
Concomitant Medication|L-SERINE|NULL;NULL;NULL
Concomitant Medication|L-VALINE|NULL;NULL;NULL
Concomitant Medication|TAURINE|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Emaciation;Cachexia;General nutritional disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Nephropathies|Nephritis;Nephritis;Nephritis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Generalized joint pain;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Postoperative infection;Post procedural infection;Infections NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Fruit allergy;Food allergy;Allergies to foods, food additives, drugs and other chemicals;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Generalized muscle weakness;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Stinging skin;Pain of skin;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Bronchopneumonia;Bronchopneumonia;Lower respiratory tract and lung infections;Moderate;NULL
Adverse Event|Muscle disorders|Cramps;Muscle spasms;Muscle related signs and symptoms NEC;Severe;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Early morning stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Concomitant Medication|MOTILIUM|1;;Oral
Concomitant Medication|MOTILIUM|2;;Oral
Adverse Event|Gastrointestinal signs and symptoms|Stomach cramps;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Concomitant Medication|SCOPOLAMINE|1 PATCH;;Transdermal
Concomitant Medication|VITAMIN B12|unknown;Monthly or once a month;Intramuscular
Adverse Event|Gastrointestinal signs and symptoms|Acid indigestion;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;RECOVERED
Adverse Event|Skin appendage conditions|Acne rosacea;Rosacea;Rosaceas;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Flaking skin;Skin exfoliation;Exfoliative conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness muscle;Muscular weakness;Muscle weakness conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Conjunctivitis infective;Conjunctivitis infective;Eye and eyelid infections;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Epigastralgia;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|LYSOPAINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Paresthesia;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Allergic reaction;Hypersensitivity;Allergic conditions NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Food allergy;Food allergy;Allergies to foods, food additives, drugs and other chemicals;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Bronchial infection;Bronchitis;Lower respiratory tract and lung infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Haematology investigations (incl blood groups)|Lymphocytes raised;Lymphocyte count increased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Eye irritation;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hoarseness;Dysphonia;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Irritable bowel syndrome;Irritable bowel syndrome;Gastrointestinal spastic and hypermotility disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Painful urination;Dysuria;Bladder and urethral symptoms;MODERATE;RECOVERED
Concomitant Medication|MARAX|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Swelling of knees;Joint swelling;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Malabsorption conditions|Sprue;Malabsorption;Malabsorption syndromes;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ESTER-C PLUS|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Moderate;         .
Adverse Event|Gastrointestinal signs and symptoms|Abdominal rigidity;Abdominal rigidity;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;Continuing
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;Moderate;Resolved
Adverse Event|Eye disorders NEC|Eye pain;Eye pain;Ocular disorders NEC;Mild;Continuing
Adverse Event|Movement disorders (incl parkinsonism)|Shaking of hands;Tremor;Tremor (excl congenital);Mild;Continuing
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Mild;Continuing
Adverse Event|Respiratory disorders NEC|Throat tightness;Throat tightness;Upper respiratory tract signs and symptoms;Moderate;Resolved
Concomitant Medication|FLUTICASONE PROPRIONATE|NULL;NULL;NULL
Concomitant Medication|TRAZODONE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Joint disorders|Gonarthrosis;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Urea increased;Blood urea increased;Renal function analyses;MILD;RECOVERED
Concomitant Medication|TRASIPRESSOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Feeling cold;Feeling cold;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Unspecified inflammation of eyelid;Blepharitis;Lid, lash and lacrimal infections, irritations and inflammations;MODERATE;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|HbA1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Nystagmus;Nystagmus;Cerebellar coordination and balance disturbances;MILD;RECOVERED
Concomitant Medication|CATAPRESS TTS|NULL;NULL;NULL
Concomitant Medication|GENTAK|NULL;NULL;NULL
Concomitant Medication|TRANDOLAPRIL|NULL;NULL;NULL
Adverse Event|Injuries NEC|Back injury;Back injury;Site specific injuries NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Peripheral oedema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Postural hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Eczema aggravated;Eczema;Dermatitis and eczema;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Peripheral oedema;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Concomitant Medication|BURINEX K|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Nocturnal cough;Cough;Coughing and associated symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|ACULAR|NULL;NULL;NULL
Concomitant Medication|SINEX|NULL;NULL;NULL
Concomitant Medication|ANTIBIOTIC|UNK;Unknown;Oral
Concomitant Medication|METFORMIN HYDROCHLORIDE|500;BID (twice a day);Oral
Adverse Event|Viral infectious disorders|Flu syndrome;Influenza;Influenza viral infections;Mild;NULL
Adverse Event|Neurological disorders NEC|Paresthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Adverse Event|Respiratory disorders NEC|Orthopnea;Orthopnoea;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;NULL;NULL
Concomitant Medication|GLYCOPYRRONIUM|NULL;NULL;NULL
Concomitant Medication|ICHTHOPASTE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Diverticulitis;Diverticulitis;Abdominal and gastrointestinal infections;MILD;RECOVERED
Adverse Event|Pericardial disorders|Pericarditis;Pericarditis;Noninfectious pericarditis;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Asthmatic attack;Asthma;Bronchospasm and obstruction;MODERATE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|T wave flattening of;Electrocardiogram T wave amplitude decreased;ECG investigations;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sensation of heaviness;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Increased urea;Blood urea increased;Renal function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Twitching of limbs;Muscle twitching;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MULTI VITAMIN & MINERAL|NULL;NULL;NULL
Concomitant Medication|ZINC SULFATE MONOHYDRATE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Deglutition disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Face oedema;Face oedema;Oedema NEC;MODERATE;RECOVERED
Concomitant Medication|TENORETIC|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain aggravated;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Increased appetite;Increased appetite;Appetite disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Physical examination topics|Temperature difference of legs;Temperature difference of extremities;Physical examination procedures;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;MISSING DATA;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Tightness in chest;Chest discomfort;Pain and discomfort NEC;MISSING DATA;RECOVERED
Adverse Event|Spinal cord and nerve root disorders|Cervicobrachialgia;Cervical root pain;Cervical spinal cord and nerve root disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ALTIZIDE|NULL;NULL;NULL
Concomitant Medication|CLOTIAPINE|NULL;NULL;NULL
Concomitant Medication|COLLUDOL|NULL;NULL;NULL
Concomitant Medication|DEXETIMIDE|NULL;NULL;NULL
Concomitant Medication|EPRAZINONE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|ISOSORBIDEDINITRAAT|NULL;NULL;NULL
Concomitant Medication|LOPRAZOLAM|NULL;NULL;NULL
Concomitant Medication|METHYLPREDNISOLON|NULL;NULL;NULL
Concomitant Medication|PIPAMPERON|NULL;NULL;NULL
Concomitant Medication|PREPACOL|NULL;NULL;NULL
Concomitant Medication|SPIRONOLACTON|NULL;NULL;NULL
Concomitant Medication|TAMSULOSIN HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|THEBACON HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|TICLOPIDINE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Menstrual cycle and uterine bleeding disorders|Heavy periods;Menorrhagia;Menstruation with increased bleeding;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Groin pain;Groin pain;Soft tissue disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Thoracic pain;Chest pain;Pain and discomfort NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|RELAFIN|NULL;NULL;NULL
Concomitant Medication|TECHNETIUM TC 99M|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fractured finger;Hand fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Vital capacity decreased;Vital capacity decreased;Respiratory and pulmonary function diagnostic procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Yeast infection of the mouth;Oral fungal infection;Fungal infections NEC;MILD;RECOVERED
Concomitant Medication|PHENYLEPHRINE|NULL;NULL;NULL
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Cough increased;Cough;Coughing and associated symptoms;Mild;Continuing
Adverse Event|General system disorders NEC|Tiredness;Fatigue;Asthenic conditions;Moderate;Continuing
Adverse Event|Muscle disorders|Generalised muscle aches;Myalgia;Muscle pains;Mild;Continuing
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;Mild;Resolved
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site rash;Injection site rash;Injection site reactions;Severe;Resolved
Adverse Event|General system disorders NEC|Loss of energy;Asthenia;Asthenic conditions;Moderate;Resolved
Adverse Event|Muscle disorders|Muscle spasms;Muscle spasms;Muscle related signs and symptoms NEC;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;Severe;Resolved
Adverse Event|Injuries NEC|Bruise;Contusion;Skin injuries NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ISOTONIX OPC-3|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Head and neck therapeutic procedures|Tooth extraction;Tooth extraction;Dental and gingival therapeutic procedures;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Forearm fracture;Forearm fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itching;Pruritus;Pruritus NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Adductor strain;Muscle strain;Muscle, tendon and ligament injuries;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|BALDRIAN-DISPERT|NULL;NULL;NULL
Concomitant Medication|CROMOGLICIC ACID|NULL;NULL;NULL
Adverse Event|Cardiac disorder signs and symptoms|Cyanosis peripheral;Cyanosis;Cardiac signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Discomfort in joints;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Body temperature conditions|Hyperthermia;Hyperthermia;Body temperature altered;Mild;NULL
Adverse Event|Muscle disorders|Muscular pains;Myalgia;Muscle pains;Mild;NULL
Adverse Event|Sleep disorders and disturbances|Insomnia exacerbated;Insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Concomitant Medication|ATENOLOL|50;;Oral
Concomitant Medication|CO-RENITEC|1/2;;Oral
Concomitant Medication|DUPHALAC|1;;Oral
Concomitant Medication|LAROXYL|5;;Oral
Concomitant Medication|OGAST|30;;Oral
Adverse Event|Body temperature conditions|Feverish;Pyrexia;Febrile disorders;NULL;NULL
Adverse Event|Oral soft tissue conditions|Oral hemorrhage;Mouth haemorrhage;Oral soft tissue haemorrhages;MILD;RECOVERED
Concomitant Medication|PROTEOLYTIC ENZYMES|NULL;NULL;NULL
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Mild;Resolved
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;Mild;Resolved
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;Moderate;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Adverse Event|Pulmonary vascular disorders|Pulmonary embolus;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;Severe;Resolved with Residual
Adverse Event|Embolism and thrombosis|Deep venous thrombosis femoral;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;Resolved with Residual
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;Moderate;Resolved
Concomitant Medication|GINKOBA|NULL;NULL;NULL
Concomitant Medication|GUIATUSS DAC|NULL;NULL;NULL
Concomitant Medication|PROMETHAZINE HYDROCHLORIDE WITH CODEINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Opioid induced constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED
Adverse Event|Deliria (incl confusion)|Confusion;Confusional state;Confusion and disorientation;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural pain;Procedural pain;Non-site specific procedural complications;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Post procedural pneumonia;Post procedural pneumonia;Lower respiratory tract and lung infections;MODERATE;RECOVERED
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Laugh incontinence;Stress urinary incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ATRACURIUM BESYLATE|NULL;NULL;NULL
Concomitant Medication|PARALINK|NULL;NULL;NULL
Concomitant Medication|SUXAMETHONIUM|NULL;NULL;NULL
Concomitant Medication|TAGOCIN|NULL;NULL;NULL
Concomitant Medication|TOILAX|NULL;NULL;NULL
Concomitant Medication|TRIMIPRAMINE|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse rate increased;Heart rate increased;Heart rate and pulse investigations;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|EUNERPAN|NULL;NULL;NULL
Adverse Event|Mood disorders and disturbances NEC|Mood disorder NOS;Affective disorder;Mood disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|AURORIX|NULL;NULL;NULL
Concomitant Medication|CARBIUM|NULL;NULL;NULL
Concomitant Medication|DANTAMACRIN|NULL;NULL;NULL
Concomitant Medication|MONOFLAM|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnoea at rest;Dyspnoea at rest;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Precordial pain;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Physical examination topics|Respiratory rate high;Respiratory rate increased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hemoptysis;Haemoptysis;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Embolism and thrombosis|Thrombophlebitis leg;Thrombophlebitis;Peripheral embolism and thrombosis;MILD;RECOVERED
Adverse Event|Embolism and thrombosis|Superficial thrombophlebitis of leg;Thrombophlebitis superficial;Peripheral embolism and thrombosis;MILD;RECOVERED
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|875+125;TID (three times a day);Oral
Concomitant Medication|CLAVULANIC ACID|3;TID (three times a day);Oral
Concomitant Medication|D-ALPHA TOCOPHEROL|400;QD (every day);Oral
Concomitant Medication|NADROPARIN|1.4;BID (twice a day);Subcutaneous
Concomitant Medication|VITAMIN B12|1000;Once per week;Intramuscular
Concomitant Medication|VITAMIN C|1;QD (every day);Oral
Concomitant Medication|CLAVULANIC ACID|2;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Continuing
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);Mild;Continuing
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse rate increased;Heart rate increased;Heart rate and pulse investigations;Moderate;Continuing
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;Mild;Resolved
Adverse Event|Salivary gland conditions|Saliva viscid;Saliva altered;Oral dryness and saliva altered;Mild;Resolved
Concomitant Medication|MINIPRESS|NULL;NULL;NULL
Concomitant Medication|PROMETHAZINE VC|NULL;NULL;NULL
Concomitant Medication|TOCOTRIENOLS NOS|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED
Concomitant Medication|SELINE|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Premature ventricular contractions;Ventricular extrasystoles;Ventricular arrhythmias and cardiac arrest;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;MILD;RECOVERED
Concomitant Medication|DECONAMINE|NULL;NULL;NULL
Concomitant Medication|DIMETAPP SINUS|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Eye discharge;Eye discharge;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Stomach pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Stomach pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|LAMICTAL|NULL;NULL;NULL
Concomitant Medication|MYLANTA MAXIMUM STRENGTH|NULL;NULL;NULL
Concomitant Medication|VITAMIN E|3000;;Oral
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;Mild;Resolved
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;Moderate;Continuing
Adverse Event|Mood disorders and disturbances NEC|Emotional reaction;Emotional disorder;Emotional and mood disturbances NEC;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Hand pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Concomitant Medication|HYCOCLEAR TUSS|NULL;NULL;NULL
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back ache;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Neurological disorders NEC|Taste metallic;Dysgeusia;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Bone and joint injuries|Rib fracture;Rib fracture;Thoracic cage fractures and dislocations;Moderate;Continuing
Concomitant Medication|PNEUMOCOCCAL VACCINE|1;Other (specify);Subcutaneous
Concomitant Medication|VACCINE, INFLUENZA|1;Other (specify);Subcutaneous
Adverse Event|Gastrointestinal signs and symptoms|Abdominal bloating;Abdominal distension;Flatulence, bloating and distension;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;         .;         .
Adverse Event|Neurological disorders NEC|Loss of consciousness;Loss of consciousness;Disturbances in consciousness NEC;Severe;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nosebleed;Epistaxis;Nasal disorders NEC;Mild;Resolved
Adverse Event|Bacterial infectious disorders|Pneumonia pseudomonal;Lung infection pseudomonal;Pseudomonal infections;Moderate;Resolved
Adverse Event|Microbiology and serology investigations|Staphylococcus aureus test positive;Staphylococcus test positive;Bacteria identification and serology (excl mycobacteria);Moderate;Resolved
Adverse Event|Joint disorders|Contracture of hand joint;Joint contracture;Joint related disorders NEC;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Septicemia;Sepsis;Sepsis, bacteraemia, viraemia and fungaemia NEC;Severe;Resolved
Adverse Event|Administration site reactions|Injection site stinging;Injection site pain;Injection site reactions;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Life Threatening;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;Mild;Resolved
Adverse Event|Hypothalamus and pituitary gland disorders|Inappropriate antidiuretic hormone secretion;Inappropriate antidiuretic hormone secretion;Posterior pituitary disorders;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Upper respiratory tract congestion;Upper respiratory tract congestion;Upper respiratory tract signs and symptoms;Moderate;Continuing
Concomitant Medication|AZELASTINE|NULL;NULL;NULL
Concomitant Medication|NEFAZODONE|NULL;NULL;NULL
Concomitant Medication|SALT|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Muscle contracture;Muscle contracture;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|VOGALENE LYOC|NULL;NULL;NULL
Concomitant Medication|TYLENOL W/CODEINE|NULL;NULL;NULL
Adverse Event|Vascular disorders NEC|Facial flushing;Flushing;Peripheral vascular disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Hypotensive episode;Hypotension;Vascular hypotensive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Bone and joint injuries|Orbital fracture;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Suffocation feeling;Suffocation feeling;Respiratory signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose blood increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertensive;Hypertension;Vascular hypertensive disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Ankle oedema;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Central nervous system vascular disorders|Transient ischaemic attack;Transient ischaemic attack;Transient cerebrovascular events;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Sore mouth;Oral pain;Oral soft tissue pain and paraesthesia;MILD;ONGOING (PERSISTENT)
Concomitant Medication|SOLPADEINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Tremor muscle;Tremor;Tremor (excl congenital);MILD;RECOVERED
Concomitant Medication|SIMVASTIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Aching in limb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Disturbances in thinking and perception|Auditory hallucinations;Hallucination, auditory;Perception disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dizziness upon standing;Dizziness postural;Neurological signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Tingling feet/hands;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Irritation of eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Salivary gland infection;Sialoadenitis;Dental and oral soft tissue infections;MILD;RECOVERED
Adverse Event|Gastrointestinal conditions NEC|Food poisoning;Food poisoning;Gastrointestinal disorders NEC;Moderate;Resolved
Concomitant Medication|ETHINYLESTRADIOL W/NORGESTREL|NULL;NULL;NULL
Adverse Event|Myocardial disorders|Left ventricular hypertrophy;Left ventricular hypertrophy;Myocardial disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Sinus bradycardia;Sinus bradycardia;Supraventricular arrhythmias;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|APO-CIMETIDINE|NULL;NULL;NULL
Concomitant Medication|BRICANYL TURBUHALER|NULL;NULL;NULL
Concomitant Medication|CHLORTRIPOLON|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Discoloration urine;Chromaturia;Urinary abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Change in bowel habits;Change of bowel habit;Gastrointestinal dyskinetic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor limb;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Tremor of hands;Tremor;Tremor (excl congenital);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|POLAMIDON|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;Moderate;NULL
Adverse Event|Bone and joint injuries|Fibula fracture;Fibula fracture;Lower limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Dental and gingival conditions|Tooth ache;Toothache;Dental pain and sensation disorders;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Decubitus;Decubitus ulcer;Skin injuries and mechanical dermatoses;Mild;NULL
Concomitant Medication|SERVENT|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ALLERGAN|NULL;NULL;NULL
Concomitant Medication|B50 COMPLEX|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Synovial and bursal disorders|Bursitis;Bursitis;Bursal disorders;MODERATE;RECOVERED
Concomitant Medication|DOXYCYCLINE MONOHYDRATE|NULL;NULL;NULL
Concomitant Medication|TERAZOL 7|NULL;NULL;NULL
Adverse Event|Gastrointestinal inflammatory conditions|Esophagitis;Oesophagitis;Oesophagitis (excl infective);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Esophagitis;Oesophagitis;Oesophagitis (excl infective);SEVERE;RECOVERED
Adverse Event|Personality disorders and disturbances in behaviour|Paranoia;Paranoia;Behaviour and socialisation disturbances;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|ACETYLDIGOXIN|NULL;NULL;NULL
Concomitant Medication|AMPHOTERICIN B|NULL;NULL;NULL
Concomitant Medication|ASGOVISCUM|NULL;NULL;NULL
Concomitant Medication|BIFITERAL|NULL;NULL;NULL
Concomitant Medication|BIPERIDEN|NULL;NULL;NULL
Concomitant Medication|FENOTEROL|NULL;NULL;NULL
Concomitant Medication|LEVOPROMAZIN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Hypoxemia;Hypoxia;Conditions associated with abnormal gas exchange;MILD;ONGOING (PERSISTENT)
Concomitant Medication|TAUNAS|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Deviated nasal septum;Nasal septum deviation;Nasal disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle twitching;Muscle twitching;Muscle related signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anal and rectal conditions NEC|Discomfort rectal;Anorectal discomfort;Anal and rectal signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gallbladder disorders|Cholecystitis;Cholecystitis;Cholecystitis and cholelithiasis;MILD;RECOVERED
Concomitant Medication|TRILISATE|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|FENSPIRIDE HCL|1;QD (every day);Oral
Concomitant Medication|INDAPAMIDE|1.5;BID (twice a day);Oral
Concomitant Medication|MEQUITAZINE|1;QD (every day);Oral
Concomitant Medication|PARACETAMOL|1000;TID (three times a day);Oral
Concomitant Medication|PREDNISOLONE|20;QD (every day);Oral
Concomitant Medication|SODIUM ENOXAPARIN|0.4;QD (every day);Subcutaneous
Concomitant Medication|TRAMADOL AND ACETAMINOPHEN|3;PRN (as needed);Oral
Concomitant Medication|VAXIGRIP|0.5;QD (every day);Subcutaneous
Adverse Event|Epidermal and dermal conditions|Maculo-papular;Rash maculo-papular;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Concomitant Medication|LYSOCLINE|NULL;NULL;NULL
Concomitant Medication|PONSTYL|NULL;NULL;NULL
Concomitant Medication|SURGAM|NULL;NULL;NULL
Concomitant Medication|GELUSIL|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Breathing difficult;Dyspnoea;Breathing abnormalities;Marked;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Congestion nasal;Nasal congestion;Nasal congestion and inflammations;Mild;NULL
Concomitant Medication|COUMADIN|2.5;QD (every day);Oral
Concomitant Medication|DIGOXIN|0.25;QD (every day);Oral
Concomitant Medication|DIGOXIN|0.25;QD (every day);PEG
Concomitant Medication|DILTIAZEM|30;TID (three times a day);Oral
Concomitant Medication|DILTIAZEM|60;QID (four times a day);Oral
Concomitant Medication|DILTIAZEM|60;QID (four times a day);PEG
Concomitant Medication|DILTIAZEM|60;BID (twice a day);Intravenous
Concomitant Medication|ENULOSE|1;TID (three times a day);PEG
Concomitant Medication|ENULOSE|2;QID (four times a day);Oral
Concomitant Medication|FLONASE|2;QD (every day);Inhalation
Concomitant Medication|GUAIFENEX LA|u;QD (every day);Oral
Concomitant Medication|NASAL SPRAY II|1;QID (four times a day);Inhalation
Concomitant Medication|SHARK LIVER OIL|1;BID (twice a day);Oral
Concomitant Medication|PYCNOGENOL|1;BID (twice a day);Oral
Concomitant Medication|PYCNOGENOL|1;BID (twice a day);PEG
Concomitant Medication|ROBITUSSIN|1/4;PRN (as needed);Oral
Concomitant Medication|ULTRACAL|12;QID (four times a day);PEG
Concomitant Medication|ULTRACAL|8;Other (specify);PEG
Concomitant Medication|VITAMIN C|1000;QD (every day);PEG
Concomitant Medication|VITAMIN E|800;QD (every day);PEG
Concomitant Medication|ORAL BALANCE|U;PRN (as needed);Other (specify)
Adverse Event|Infections - pathogen unspecified|Cystitis;Cystitis;Urinary tract infections;Mild;NULL
Concomitant Medication|STILNOCT|5;PRN (as needed);Oral
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;Mild;Resolved
Concomitant Medication|OMNICEF|NULL;NULL;NULL
Concomitant Medication|TRICOR|NULL;NULL;NULL
Adverse Event|Anterior eye structural change, deposit and degeneration|Arcus senilis;Arcus lipoides;Corneal structural change, deposit and degeneration;Mild;Continuing
Adverse Event|Tendon, ligament and cartilage disorders|Tendon disorder;Tendon disorder;Tendon disorders;Mild;Continuing
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;Mild;Continuing
Adverse Event|Dental and gingival conditions|Gum disorder;Gingival disorder;Gingival disorders NEC;Mild;Continuing
Adverse Event|Gallbladder disorders|Gallstones;Cholelithiasis;Cholecystitis and cholelithiasis;Mild;Resolved
Adverse Event|Procedural and device related injuries and complications NEC|Incision site pain;Incision site pain;Non-site specific procedural complications;Severe;Resolved
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved with Residual
Adverse Event|Administration site reactions|Catheter site swelling;Catheter site swelling;Implant and catheter site reactions;Mild;Resolved
Adverse Event|Fungal infectious disorders|Vaginal yeast infection;Vulvovaginal mycotic infection;Fungal infections NEC;Moderate;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;Severe;Resolved
Adverse Event|Gastrointestinal signs and symptoms|Vomited;Vomiting;Nausea and vomiting symptoms;Severe;Resolved
Adverse Event|Bronchial disorders (excl neoplasms)|Wheezing;Wheezing;Bronchospasm and obstruction;Moderate;Continuing
Adverse Event|Suicidal and self-injurious behaviours NEC|Suicide attempt;Suicide attempt;Suicidal and self-injurious behaviour;SEVERE;RECOVERED
Concomitant Medication|BUDESONIDE|UNK;QD (every day);Oral
Concomitant Medication|CIPRAMIL|40;QD (every day);Oral
Concomitant Medication|SALBUTAMOL|UNK;Unknown;Oral
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Severe;Resolved with Residual
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Difficulty breathing;Dyspnoea;Breathing abnormalities;Moderate;Resolved with Residual
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;Severe;Continuing
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Continuing
Adverse Event|Salivary gland conditions|Saliva secretion increased;Salivary hypersecretion;Salivary gland disorders NEC;Severe;Resolved with Residual
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;Moderate;Resolved with Residual
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;Continuing
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;Moderate;Resolved with Residual
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Crying;Crying;Neurological signs and symptoms NEC;Mild;Continuing
Concomitant Medication|MOCLOBEMID|NULL;NULL;NULL
Concomitant Medication|MOVICOLON|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Viral syndrome;Viral infection;Viral infections NEC;Moderate;NULL
Concomitant Medication|CREATINE|2;QD (every day);Oral
Concomitant Medication|MINOCYCLINE|2;QD (every day);Oral
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Libido decreased;Libido decreased;Sexual desire disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Body temperature conditions|Fever of unknown origin;Pyrexia;Febrile disorders;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Frequent bowel movements;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|EFIDAC|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Tooth abscess;Tooth abscess;Dental and oral soft tissue infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Rales;Rales;Lower respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Head and neck therapeutic procedures|Tooth extraction;Tooth extraction;Dental and gingival therapeutic procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Tendon, ligament and cartilage disorders|Tendonitis;Tendonitis;Tendon disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach burning sensation of;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight increase;Weight increased;Physical examination procedures;MODERATE;RECOVERED
Concomitant Medication|GENESERINE|NULL;NULL;NULL
Adverse Event|Enzyme investigations NEC|Blood alkaline phosphatase increased;Blood alkaline phosphatase increased;Tissue enzyme analyses NEC;MILD;RECOVERED
Adverse Event|Cardiac valve disorders|Mitral valve prolapse;Mitral valve prolapse;Mitral valvular disorders;MILD;UNKNOWN
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;MILD;RECOVERED
Concomitant Medication|PROCTOSEDYL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Chest pain;Chest pain;Pain and discomfort NEC;Mild;Resolved
Adverse Event|Embolism and thrombosis|Embolus leg;Peripheral embolism;Peripheral embolism and thrombosis;Moderate;Resolved with Residual
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved with Residual
Adverse Event|Epidermal and dermal conditions|Scab;Scab;Dermal and epidermal conditions NEC;Mild;Resolved with Residual
Concomitant Medication|PROANTHOCYANIDIN|NULL;NULL;NULL
Concomitant Medication|THEOLAIR|NULL;NULL;NULL
Adverse Event|Prostatic disorders (excl infections and inflammations)|Enlarged prostate;Prostatomegaly;Prostatic signs, symptoms and disorders NEC;Mild;Continuing
Concomitant Medication|CIPROFLOXACIN HCL|NULL;NULL;NULL
Concomitant Medication|PROPOXYPHENE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|TIZANIDINE|4;BID (twice a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Paresis;Paresis;Paralysis and paresis (excl cranial nerve);MILD;ONGOING (PERSISTENT)
Concomitant Medication|DIMERCAPROL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|COLACE|1;PRN (as needed);Oral
Concomitant Medication|LISINOPRIL|5;QD (every day);Oral
Concomitant Medication|OXYGEN|2;QHS (at bedtime);Inhalation
Concomitant Medication|REFRESH|1;QD (every day);
Adverse Event|Skin appendage conditions|Hair disorder;Hair disorder;Pilar disorders NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle twitch;Muscle twitching;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Bladder incontinence;Urinary incontinence;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Gingival pain;Gingival pain;Gingival pains;MODERATE;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menses irregular;Menstruation irregular;Menstruation and uterine bleeding NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Phonophobia;Phonophobia;Fear symptoms and phobic disorders (incl social phobia);MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Spasticity;Muscle spasticity;Neuromuscular disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|CEFIXIME|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Dysuria;Dysuria;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Joint stiffness;Joint stiffness;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Maculo-papular;Rash maculo-papular;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menstruation abnormal;Menstrual disorder;Menstruation and uterine bleeding NEC;MODERATE;RECOVERED
Adverse Event|Angioedema and urticaria|Periorbital edema;Periorbital oedema;Angioedemas;MODERATE;RECOVERED
Adverse Event|Tissue disorders NEC|Nodule;Nodule;Mass conditions NEC;MILD;RECOVERED
Concomitant Medication|SALBEN|NULL;NULL;NULL
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract;Cataract;Cataract conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Mouth ulcer;Mouth ulceration;Stomatitis and ulceration;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ORBENINE|NULL;NULL;NULL
Adverse Event|Thyroid gland disorders|Thyroiditis;Thyroiditis;Acute and chronic thyroiditis;MILD;ONGOING (PERSISTENT)
Concomitant Medication|BIPROFENID|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood in urine;Blood urine present;Urinalysis NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Haematology investigations (incl blood groups)|RBC count increased;Red blood cell count increased;Red blood cell analyses;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine RBC increased;Red blood cells urine positive;Urinalysis NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal haemorrhages NEC|Rectal bleeding;Rectal haemorrhage;Intestinal haemorrhages;MILD;UNKNOWN
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Moderate;NULL
Adverse Event|Gastrointestinal haemorrhages NEC|Blood in stool;Haematochezia;Non-site specific gastrointestinal haemorrhages;Mild;NULL
Concomitant Medication|SALUTENSIN|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;NULL;NULL
Adverse Event|Peritoneal and retroperitoneal conditions|Peritonitis;Peritonitis;Peritoneal and retroperitoneal disorders;NULL;NULL
Adverse Event|Dental and gingival conditions|Gum bleeding;Gingival bleeding;Gingival haemorrhages;NULL;NULL
Adverse Event|Body temperature conditions|Feverish;Pyrexia;Febrile disorders;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Discoloration urine;Chromaturia;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urine odor foul;Urine odour abnormal;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eye pain;Eye pain;Ocular disorders NEC;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Pruritis;Pruritus;Pruritus NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin scaly;Skin exfoliation;Exfoliative conditions;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|GELOMYRTOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema lower limb;Oedema peripheral;Oedema NEC;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Nausea;Nausea;Nausea and vomiting symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;SEVERE;RECOVERED
Concomitant Medication|POSICOR|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Urine incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal dryness;Nasal dryness;Nasal disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Pleural disorders|Pleurisy;Pleurisy;Pleural infections and inflammations;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Allergic reaction;Hypersensitivity;Allergic conditions NEC;Mild;NULL
Adverse Event|Bone and joint injuries|Arm fracture;Upper limb fracture;Upper limb fractures and dislocations;Mild;NULL
Concomitant Medication|BENADRYL|U;QD (every day);Subcutaneous
Concomitant Medication|CELEXA|60;QD (every day);Oral
Concomitant Medication|DIAZEPAM|20;QHS (at bedtime);Oral
Concomitant Medication|DIAZEPAM|30;QHS (at bedtime);Oral
Concomitant Medication|DILAUDID|U;BID (twice a day);Subcutaneous
Concomitant Medication|EFFEXOR|32;BID (twice a day);Oral
Concomitant Medication|HYDROCODONE|325;QD (every day);Oral
Concomitant Medication|LORAZEPAM|2;QHS (at bedtime);Oral
Concomitant Medication|MORPHINE|8/10;BID (twice a day);Subcutaneous
Concomitant Medication|NOVOCAINE|U;QD (every day);Subcutaneous
Concomitant Medication|OXYBUTYNIN|5;BID (twice a day);Oral
Concomitant Medication|QUININE|325;BID (twice a day);Oral
Concomitant Medication|QUININE SULPHATE|325;BID (twice a day);Oral
Concomitant Medication|TIZANIDINE|8;QHS (at bedtime);Oral
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|4/8;BID (twice a day);Oral
Concomitant Medication|TYLENOL WITH CODEINE|3;PRN (as needed);Oral
Concomitant Medication|TYLENOL WITH CODEINE|2;QHS (at bedtime);Oral
Concomitant Medication|VALIUM|20;QHS (at bedtime);Oral
Concomitant Medication|VALIUM|30;QHS (at bedtime);Oral
Concomitant Medication|VICODIN|7.5/750;PRN (as needed);Oral
Concomitant Medication|VITAMIN C|2000;Every other day;Oral
Concomitant Medication|ZANAFLEX|2;QID (four times a day);Oral
Adverse Event|Injuries NEC|Tooth fracture;Tooth fracture;Site specific injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|GRAMAXIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach burning sensation of;Dyspepsia;Dyspeptic signs and symptoms;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Pimples;Acne;Acnes;MILD;RECOVERED
Concomitant Medication|BIOCIDAN|NULL;NULL;NULL
Concomitant Medication|ECAZIDE|NULL;NULL;NULL
Concomitant Medication|URISPAS|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Crying abnormal;Crying;Neurological signs and symptoms NEC;Moderate;NULL
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Infection urinary tract;Urinary tract infection;Urinary tract infections;Mild;NULL
Adverse Event|Neurological disorders NEC|Numbness in leg;Hypoaesthesia;Sensory abnormalities NEC;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Marked;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Pressure sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;Mild;NULL
Concomitant Medication|BACLOFEN|5;QHS (at bedtime);Oral
Concomitant Medication|BACTRIM DS|160/800;BID (twice a day);Oral
Concomitant Medication|CALCIUM VITAMIN D|600;QD (every day);Oral
Concomitant Medication|CARDURA|1;QHS (at bedtime);Oral
Concomitant Medication|GAS X|40;PRN (as needed);Oral
Concomitant Medication|NEURONTIN|300-600;QHS (at bedtime);Oral
Concomitant Medication|NORTRIPTYLINE|25;QHS (at bedtime);Oral
Concomitant Medication|VERAPAMIL HYDROCHLORIDE|180;QD (every day);Oral
Concomitant Medication|ACETAMINOPHEN|0-500;PRN (as needed);Oral
Concomitant Medication|VITAMIN E|1;QD (every day);Oral
Concomitant Medication|PREVPAC|1/1;BID (twice a day);Oral
Concomitant Medication|VITAMIN B|100;TID (three times a day);Oral
Concomitant Medication|ZOLOFT|100;BID (twice a day);Oral
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;Marked;NULL
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;Moderate;NULL
Adverse Event|Bone and joint injuries|Subluxation shoulder;Joint dislocation;Fractures and dislocations NEC;Mild;NULL
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;Marked;NULL
Adverse Event|Neuromuscular disorders|Spasticity muscle;Muscle spasticity;Neuromuscular disorders NEC;Moderate;NULL
Concomitant Medication|ACETAMINOPHEN|500;QID (four times a day);Oral
Concomitant Medication|ACETAMINOPHEN|1000;PRN (as needed);Oral
Concomitant Medication|AMITRIPTYLINE|12.5;QHS (at bedtime);Oral
Concomitant Medication|B12|1000;Monthly or once a month;Intramuscular
Concomitant Medication|CELEXA|20;Every morning;Oral
Concomitant Medication|CELEXA|40;Every evening;Oral
Concomitant Medication|COLACE|100-200;Every other day;Oral
Concomitant Medication|DIPYRIDAMOLE|50;TID (three times a day);Oral
Concomitant Medication|DRAMAMINE|25;PRN (as needed);Oral
Concomitant Medication|HYDROCODONE|500;Four times per week;Oral
Concomitant Medication|HYDROCODONE|750;;Oral
Concomitant Medication|MORPHINE|15;BID (twice a day);Oral
Concomitant Medication|MORPHINE|30;BID (twice a day);Oral
Concomitant Medication|PENTAZOCINE|50/0.5;;Oral
Concomitant Medication|PENTAZOCINE|50/0.5;PRN (as needed);Oral
Concomitant Medication|PSEUDOEPHEDRINE HYDROCHLORIDE|30;PRN (as needed);Oral
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|4;BID (twice a day);Oral
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|4;Every evening;Oral
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|4;TID (three times a day);Oral
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|8;Every morning;Oral
Concomitant Medication|TIZANIDINE HYDROCHLORIDE|8;QHS (at bedtime);Oral
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine WBC increased;White blood cells urine positive;Urinalysis NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|QT interval prolonged;Electrocardiogram QT prolonged;ECG investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Influenza;Influenza;Influenza viral infections;SEVERE;RECOVERED
Adverse Event|Cutaneous neoplasms benign|Angioma of skin;Haemangioma of skin;Skin neoplasms benign;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach fullness;Abdominal distension;Flatulence, bloating and distension;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;Moderate;Continuing
Adverse Event|Ocular structural change, deposit and degeneration NEC|Exophthalmos;Exophthalmos;Structural change, deposit and degeneration of eye NEC;Mild;Continuing
Concomitant Medication|MARINOL|NULL;NULL;NULL
Concomitant Medication|VITAMINS WITH MINERALS|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion of chest wall;Contusion;Skin injuries NEC;Mild;NULL
Adverse Event|Water, electrolyte and mineral investigations|Calcium increased;Blood calcium increased;Mineral and electrolyte analyses;MODERATE;RECOVERED
Concomitant Medication|RUFOL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Upper abdominal pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Concomitant Medication|DICLOFENAC W/MISOPROSTOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Foot edema;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Prostatic disorders (excl infections and inflammations)|BPH;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Chest cold;Lower respiratory tract infection;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Embolism and thrombosis|DVT;Deep vein thrombosis;Peripheral embolism and thrombosis;MODERATE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|GERD;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vascular hypertensive disorders|Blood pressure high;Hypertension;Vascular hypertensive disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Cardiac arrhythmias|Non-sustained ventricular tachycardia;Ventricular tachycardia;Ventricular arrhythmias and cardiac arrest;MILD;RECOVERED
Adverse Event|Gastrointestinal stenosis and obstruction|Partial bowel obstruction;Intestinal obstruction;Gastrointestinal stenosis and obstruction NEC;SEVERE;RECOVERED
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;MODERATE;RECOVERED
Concomitant Medication|ACTIFED|1;QID (four times a day);Oral
Concomitant Medication|COUMADIN|10;QD (every day);Oral
Concomitant Medication|COUMADIN|12.5;QD (every day);Oral
Concomitant Medication|DARVOCET|100/650;PRN (as needed);Oral
Concomitant Medication|DULCOLAX|1;PRN (as needed);Other (specify)
Concomitant Medication|GLUCOSE|3000;TID (three times a day);Intravenous
Concomitant Medication|LOPRESSOR|50;BID (twice a day);Oral
Concomitant Medication|LOVENOX|220;BID (twice a day);Subcutaneous
Concomitant Medication|MILK OF MAGNESIA|60;BID (twice a day);Oral
Concomitant Medication|MORPHINE|2;BID (twice a day);Intravenous
Concomitant Medication|MUCINEX DM|2;BID (twice a day);Oral
Concomitant Medication|PROMETHAZINE|50;QID (four times a day);Intravenous
Concomitant Medication|TYLENOL|1000;PRN (as needed);
Concomitant Medication|COMPAZINE|15;TID (three times a day);Oral
Adverse Event|Muscle disorders|Muscle cramp;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Ocular structural change, deposit and degeneration NEC|Macular hole;Macular hole;Retinal structural change, deposit and degeneration;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ASPIRIN W/CODEINE|NULL;NULL;NULL
Concomitant Medication|CEFACET|NULL;NULL;NULL
Concomitant Medication|HELICIDINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Drooling;Drooling;Neurological signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Fainting;Syncope;Disturbances in consciousness NEC;SEVERE;RECOVERED
Adverse Event|Glaucoma and ocular hypertension|Ocular hypertension;Ocular hypertension;Glaucomas (excl congenital);MILD;ONGOING (PERSISTENT)
Concomitant Medication|CANDESARTAN CILEXETIL|NULL;NULL;NULL
Concomitant Medication|PILOPINE HS|NULL;NULL;NULL
Concomitant Medication|TIMOPTIC|NULL;NULL;NULL
Adverse Event|Skin and subcutaneous tissue disorders NEC|Proud flesh;Excessive granulation tissue;Skin and subcutaneous conditions NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Pitting edema;Oedema;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Bladder spasm;Bladder spasm;Bladder and urethral symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Incisional hernia;Incisional hernia;Non-site specific procedural complications;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ALOMIDE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Pain;Pain;Pain and discomfort NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|URTI;Upper respiratory tract infection;Upper respiratory tract infections;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|URTI;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED
Concomitant Medication|TRI-LEVLEN|NULL;NULL;NULL
Adverse Event|Vision disorders|Diplopia;Diplopia;Visual disorders NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Subdural hematoma;Subdural haematoma;Cerebral injuries NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vascular haemorrhagic disorders|Bleeding;Haemorrhage;Haemorrhages NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Injuries NEC|Desmorrhexis;Ligament rupture;Muscle, tendon and ligament injuries;MODERATE;RECOVERED
Concomitant Medication|DICLOFENAC|100;QD (every day);Oral
Concomitant Medication|DICLOFENAC|50;QD (every day);Oral
Concomitant Medication|DYTIDE H|0.5;QD (every day);Oral
Concomitant Medication|MIRTAZAPINE|1;QD (every day);Oral
Concomitant Medication|MOVICOL|1;QD (every day);Oral
Concomitant Medication|NIFEDIPIN|5;QD (every day);Oral
Concomitant Medication|OLMESARTAN|40;BID (twice a day);Oral
Concomitant Medication|DICLOFENAC|200;BID (twice a day);Oral
Concomitant Medication|FORADIL|2;BID (twice a day);Inhalation
Adverse Event|Cardiac arrhythmias|Left bundle branch block;Bundle branch block left;Cardiac conduction disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Electrocardiogram QTc interval prolonged;Electrocardiogram QT prolonged;ECG investigations;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|TOCOPHERYL ACETATE-D-ALPHA|800;BID (twice a day);Oral
Adverse Event|Oral soft tissue conditions|Paraesthesia oral;Paraesthesia oral;Oral soft tissue pain and paraesthesia;MILD;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Hypermenorrhea;Menorrhagia;Menstruation with increased bleeding;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Nose infection NOS;Rhinitis;Upper respiratory tract infections;MILD;RECOVERED
Concomitant Medication|CYCLOKAPRON|NULL;NULL;NULL
Concomitant Medication|FERROGRADUMET|NULL;NULL;NULL
Concomitant Medication|SOFRADEX|NULL;NULL;NULL
Concomitant Medication|STEDIRIL-D|NULL;NULL;NULL
Concomitant Medication|XYLOMET|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Saliva secretion excessive;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy;Gastrostomy;Gastric therapeutic procedures;Moderate;NULL
Concomitant Medication|WEST DECON|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stomach ache;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Concomitant Medication|CONCOR|2.5;QD (every day);Oral
Concomitant Medication|IDEOS|2;BID (twice a day);Oral
Concomitant Medication|MAGNESIUM VERLA|240;TID (three times a day);Oral
Adverse Event|Neurological disorders NEC|Paraesthesia;Paraesthesia;Paraesthesias and dysaesthesias;MILD;
Adverse Event|Vision disorders|Diplopia;Diplopia;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Gastrointestinal viral infection;Gastrointestinal viral infection;Viral infections NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia distal;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Swollen glands;Lymphadenopathy;Lymphatic system disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|FLUVAX|NULL;NULL;NULL
Adverse Event|Head and neck therapeutic procedures|Root canal procedure;Endodontic procedure;Dental and gingival therapeutic procedures;MODERATE;RECOVERED
Concomitant Medication|ALESSE|NULL;NULL;NULL
Concomitant Medication|MELAVITA|NULL;NULL;NULL
Adverse Event|Ocular structural change, deposit and degeneration NEC|Scleral disorder;Scleral disorder;Scleral structural change, deposit and degeneration;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing difficult;Dysphagia;Gastrointestinal signs and symptoms NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;Mild;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctival redness;Conjunctival hyperaemia;Conjunctival infections, irritations and inflammations;Mild;NULL
Adverse Event|Joint disorders|Adhesive capsulitis of shoulder;Periarthritis;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Excess sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Concomitant Medication|TUSSI-ORGANIDIN|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramps of lower extremities;Muscle spasms;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Muscle twitching;Muscle twitching;Muscle related signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Joint subluxation;Joint dislocation;Fractures and dislocations NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Myoclonus;Myoclonus;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleeplessness;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;RECOVERED
Concomitant Medication|CODEINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Microbiology and serology investigations|Hepatitis A antibody abnormal;Hepatitis A antibody abnormal;Virus identification and serology;MODERATE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Eye irritation;Eye irritation;Ocular infections, inflammations and associated manifestations;MODERATE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Eye itching;Eye pruritus;Ocular infections, inflammations and associated manifestations;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Upper back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|CORMAX|NULL;NULL;NULL
Concomitant Medication|CYNARA CARDUNCULUS|NULL;NULL;NULL
Concomitant Medication|HEPP FORTE|NULL;NULL;NULL
Concomitant Medication|PARSLEY|NULL;NULL;NULL
Concomitant Medication|PEDIALYTE|NULL;NULL;NULL
Concomitant Medication|VICKS|NULL;NULL;NULL
Adverse Event|Injuries NEC|Contusion of hip;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Contusion of knee;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Unilateral leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in fingers;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|SELAX|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Skin tightness;Skin tightness;Dermal and epidermal conditions NEC;Mild;Resolved
Adverse Event|Vascular disorders NEC|Hot flashes;Hot flush;Peripheral vascular disorders NEC;Mild;Continuing
Adverse Event|Oral soft tissue conditions|Perioral tingling;Paraesthesia oral;Oral soft tissue pain and paraesthesia;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Paranasal sinus discomfort;Paranasal sinus discomfort;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Concomitant Medication|CALCIUM + VITAMIN D|NULL;NULL;NULL
Adverse Event|Physical examination topics|Weight increase;Weight increased;Physical examination procedures;Mild;NULL
Concomitant Medication|BACLOFEN|40;QD (every day);Oral
Concomitant Medication|CELEXA|10;QD (every day);Oral
Concomitant Medication|COENZYME Q10|60;QD (every day);Oral
Concomitant Medication|COENZYME Q10|30;QD (every day);Oral
Concomitant Medication|CORAL CALCIUM|1;TID (three times a day);Oral
Concomitant Medication|EVENING PRIMROSE OIL|2;QD (every day);Oral
Concomitant Medication|MEGAZYME|1;QD (every day);Oral
Concomitant Medication|OMEGA 3|1;QD (every day);Oral
Concomitant Medication|SYNTHROID|100;QD (every day);Oral
Concomitant Medication|VITAMIN B COMPLEX|1;BID (twice a day);Oral
Adverse Event|Appetite and general nutritional disorders|Obesity;Obesity;General nutritional disorders NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM & MAGNESIUM PLUS|NULL;NULL;NULL
Concomitant Medication|NASAL SPRAY II|NULL;NULL;NULL
Concomitant Medication|TETRAHYDRAZOLINE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Infective gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;MILD;RECOVERED
Concomitant Medication|CODEINE PHOSPHATE|NULL;NULL;NULL
Concomitant Medication|PREMPAK|NULL;NULL;NULL
Adverse Event|Dental and gingival conditions|Dental caries;Dental caries;Dental and periodontal infections and inflammations;MILD;RECOVERED
Adverse Event|Gastrointestinal conditions NEC|Food poisoning;Food poisoning;Gastrointestinal disorders NEC;MILD;RECOVERED
Concomitant Medication|AMOXICILLIN|1000;QD (every day);Oral
Concomitant Medication|ASPIRIN|81;Other (specify);Oral
Concomitant Medication|NOVOCAINE|1;Other (specify);Intramuscular
Adverse Event|Joint disorders|Arthritic pains;Arthralgia;Joint related signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema of extremities;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema of extremities;Oedema peripheral;Oedema NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Edema of extremities;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Neuralgia;Neuralgia;Sensory abnormalities NEC;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Sinus infection;Sinusitis;Upper respiratory tract infections;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|DEXTROSE IN LACTATED RINGER'S|NULL;NULL;NULL
Concomitant Medication|GUAIFENEX LA|NULL;NULL;NULL
Concomitant Medication|MICRO K|NULL;NULL;NULL
Concomitant Medication|SLOBID|NULL;NULL;NULL
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ACEMETACIN|NULL;NULL;NULL
Concomitant Medication|ARTHOTEC|NULL;NULL;NULL
Concomitant Medication|HEXETIDIN|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Streptococcal sore throat;Pharyngitis streptococcal;Streptococcal infections;Moderate;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression aggravated;Depression;Depressive disorders;Moderate;NULL
Adverse Event|Neurological disorders NEC|Loss of consciousness;Loss of consciousness;Disturbances in consciousness NEC;Moderate;NULL
Adverse Event|Vision disorders|Scotoma;Scotoma;Visual field disorders;Mild;NULL
Adverse Event|Skin appendage conditions|Skin cold clammy;Cold sweat;Apocrine and eccrine gland disorders;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Urinary tract infection;Urinary tract infection;Urinary tract infections;Marked;NULL
Concomitant Medication|LIDOCAINE|4;1 time only;Subcutaneous
Concomitant Medication|BACLOFEN|10-60;TID (three times a day);Oral
Concomitant Medication|EFFEXOR|75;QHS (at bedtime);Oral
Concomitant Medication|LORTAB|5/500;PRN (as needed);Oral
Concomitant Medication|PHENAZOPYRIDINE|100;TID (three times a day);Oral
Concomitant Medication|ROYAL JELLY|1;QD (every day);Oral
Concomitant Medication|TUSSIBID|1;BID (twice a day);Oral
Concomitant Medication|ZOLOFT|25;QD (every day);Oral
Concomitant Medication|ACETAMINOPHEN|650;PRN (as needed);Oral
Adverse Event|Respiratory disorders NEC|Dry cough;Cough;Coughing and associated symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Mental impairment disorders|Forgetfulness;Memory impairment;Memory loss (excl dementia);MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Dysequilibrium;Balance disorder;Cerebellar coordination and balance disturbances;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALBUTEROL|1;PRN (as needed);Inhalation
Concomitant Medication|ASMANEX|220;QD (every day);Inhalation
Concomitant Medication|AZMACORT|1;PRN (as needed);Intranasal
Concomitant Medication|D-AMFETAMINE|10;QD (every day);Oral
Concomitant Medication|D-AMFETAMINE|20;BID (twice a day);Oral
Concomitant Medication|DHEA|10;QD (every day);Oral
Concomitant Medication|EXCEDRIN MIGRAINE|1;PRN (as needed);Oral
Concomitant Medication|LIPITOR|40;QD (every day);Oral
Concomitant Medication|LITHIUM OROTATE|260;BID (twice a day);Oral
Concomitant Medication|LORATADINE|10;QD (every day);Oral
Concomitant Medication|NASONEX|1;PRN (as needed);Intranasal
Concomitant Medication|PREGNENOLONE|60;QD (every day);Oral
Concomitant Medication|RANITIDINE|600;BID (twice a day);Oral
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Peripheral vertigo, unspecified;Vertigo;Inner ear signs and symptoms;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin lesion;Skin lesion;Dermal and epidermal conditions NEC;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Monocytes increased;Monocyte count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|PCO2 increased;PCO2 increased;Blood gas and acid base analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Platelet count increased;Platelet count increased;Platelet analyses;MILD;RECOVERED
Adverse Event|Hepatic and biliary neoplasms benign|Hemangioma of liver;Haemangioma of liver;Hepatobiliary neoplasms benign;MILD;RECOVERED
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;MILD;RECOVERED
Adverse Event|Joint disorders|Joint inflammation;Arthritis;Arthropathies NEC;MODERATE;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety attack;Anxiety;Anxiety symptoms;Moderate;Continuing
Adverse Event|General system disorders NEC|Chest tightness;Chest discomfort;Pain and discomfort NEC;Mild;Resolved
Adverse Event|Viral infectious disorders|Cold sores;Oral herpes;Herpes viral infections;Mild;Resolved
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;Mild;Continuing
Adverse Event|Infections - pathogen unspecified|Eye infection;Eye infection;Eye and eyelid infections;Mild;Resolved
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Moderate;Resolved
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;Mild;Resolved
Adverse Event|Cardiac arrhythmias|Paroxysmal atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;         .;         .
Adverse Event|Cardiac arrhythmias|Paroxysmal atrial fibrillation;Atrial fibrillation;Supraventricular arrhythmias;Moderate;Resolved
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Postural hypotension;Orthostatic hypotension;Vascular hypotensive disorders;Severe;Resolved
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;Moderate;Resolved
Adverse Event|Angioedema and urticaria|Rash urticarial;Urticaria;Urticarias;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Stye;Hordeolum;Eye and eyelid infections;Mild;Resolved
Adverse Event|Depressed mood disorders and disturbances|Tearfulness;Tearfulness;Mood alterations with depressive symptoms;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;Mild;Resolved
Concomitant Medication|BLEPHAMIDE SOP|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchial infection;Bronchitis;Lower respiratory tract and lung infections;MILD;RECOVERED
Adverse Event|Age related factors|Premenopause;Menopause;Age related issues;MILD;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Sacro-iliac pain;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|EXACYL|NULL;NULL;NULL
Concomitant Medication|METHERGIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;         .
Adverse Event|Enzyme investigations NEC|Creatine kinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;Mild;Resolved
Adverse Event|Bone and joint injuries|Fractured toe;Foot fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Erythromacular rash;Rash macular;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMIKACIN|NULL;NULL;NULL
Concomitant Medication|CEFEPIME|NULL;NULL;NULL
Concomitant Medication|CILASTATIN W/IMIPENEM|NULL;NULL;NULL
Concomitant Medication|VIGABATRIN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Gagging;Retching;Nausea and vomiting symptoms;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site reaction;Injection site reaction;Injection site reactions;Moderate;Resolved with Residual
Adverse Event|Neurological disorders NEC|Light-headed;Dizziness;Neurological signs and symptoms NEC;Mild;Resolved
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse increased;Heart rate increased;Heart rate and pulse investigations;Mild;Resolved
Concomitant Medication|B-50|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Hiccough;Hiccups;Lower respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Ocular sensory symptoms NEC|Tired eyes;Asthenopia;Ocular sensation disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Drunkenness feeling of;Feeling drunk;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Pharyngeal edema;Pharyngeal oedema;Pharyngeal disorders (excl infections and neoplasms);MILD;RECOVERED
Adverse Event|Salivary gland conditions|Xerostomia;Dry mouth;Oral dryness and saliva altered;MILD;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful R arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Concomitant Medication|AMITRIPTYLINE|70;QD (every day);Oral
Concomitant Medication|GLYCOPYRROLATE|0.1;TID (three times a day);Subcutaneous
Adverse Event|Gastrointestinal signs and symptoms|Belching;Eructation;Dyspeptic signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest discomfort;Chest discomfort;Pain and discomfort NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Sputum excretion difficulty;Sputum retention;Coughing and associated symptoms;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Glucosuria;Glycosuria;Urinary abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Light-headed;Dizziness;Neurological signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Arm discomfort;Limb discomfort;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|CALCIUM DOBESILATE|NULL;NULL;NULL
Concomitant Medication|LEVOXIN|NULL;NULL;NULL
Adverse Event|Protein and chemistry analyses NEC|Albumin abnormal;Blood albumin abnormal;Protein analyses NEC;Mild;NULL
Adverse Event|Embolism and thrombosis|DVT;Deep vein thrombosis;Peripheral embolism and thrombosis;Marked;NULL
Adverse Event|Water, electrolyte and mineral investigations|Potassium decreased;Blood potassium decreased;Mineral and electrolyte analyses;Mild;NULL
Concomitant Medication|FISH OIL|1;TID (three times a day);Oral
Concomitant Medication|B-12|5000;TID (three times a day);Oral
Concomitant Medication|BACTRIM|U;BID (twice a day);Oral
Concomitant Medication|CIPRO|unk;Unknown;Unknown
Concomitant Medication|COD LIVER OIL|1;TID (three times a day);Oral
Concomitant Medication|MINERALS|8;TID (three times a day);Oral
Concomitant Medication|MINERALS|unk;TID (three times a day);Oral
Concomitant Medication|HEPARIN|U;Continuous IV;Intravenous
Concomitant Medication|POTASSIUM CHLORIDE|40;1 time only;Oral
Concomitant Medication|LEVAQUIN|250;QD (every day);Oral
Concomitant Medication|LORTAB|5/520 1-2;PRN (as needed);Oral
Concomitant Medication|MORPHINE|unk;Unknown;Unknown
Concomitant Medication|MOTRIN|400;PRN (as needed);Oral
Concomitant Medication|NYSTATIN|5;QID (four times a day);
Concomitant Medication|PERCOCET|1-2;PRN (as needed);Oral
Concomitant Medication|Q-GEL|1;TID (three times a day);Oral
Concomitant Medication|QUININE|324;QD (every day);Oral
Concomitant Medication|STELAR|1;TID (three times a day);Oral
Concomitant Medication|SULFAMETHOXAZOL|2;BID (twice a day);Oral
Concomitant Medication|TOCOPHEROL|1;TID (three times a day);Oral
Concomitant Medication|VICODIN|unk;Unknown;Unknown
Concomitant Medication|TYLENOL|500;QD (every day);Oral
Concomitant Medication|CORTISOL|NULL;NULL;NULL
Concomitant Medication|FIBER|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Excess sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;NULL;NULL
Adverse Event|Salivary gland conditions|Sialorrhea;Salivary hypersecretion;Salivary gland disorders NEC;NULL;NULL
Adverse Event|General system disorders NEC|Increased thirst;Thirst;Feelings and sensations NEC;MILD;RECOVERED
Concomitant Medication|HIDRORONOL|NULL;NULL;NULL
Concomitant Medication|NEUROBIONTA|NULL;NULL;NULL
Concomitant Medication|NOVAHISTEX|NULL;NULL;NULL
Concomitant Medication|NOVAMILOR|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Redness of legs;Erythema;Erythemas;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Laceration of foot;Skin laceration;Skin injuries NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Keratitis;Keratitis;Corneal infections, oedemas and inflammations;MODERATE;RECOVERED
Adverse Event|Mental impairment disorders|Memory impairment;Memory impairment;Memory loss (excl dementia);MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Epistaxis;Epistaxis;Nasal disorders NEC;Mild;NULL
Adverse Event|Muscle disorders|Torticollis;Torticollis;Muscle tone abnormalities;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Flank pain;Flank pain;Musculoskeletal and connective tissue pain and discomfort;Severe;NULL
Concomitant Medication|OMEGA-3|one;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Chest cold;Lower respiratory tract infection;Lower respiratory tract and lung infections;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased stool frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Mild;Continuing
Adverse Event|Administration site reactions|Injection site rash;Injection site rash;Injection site reactions;Moderate;Resolved
Adverse Event|Ocular neuromuscular disorders|Ptosis;Eyelid ptosis;Eyelid movement disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Dorsal pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Thirst;Thirst;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Water, electrolyte and mineral investigations|Iron decreased;Blood iron decreased;Mineral and electrolyte analyses;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|PASSIFLORINE|850;BID (twice a day);Oral
Concomitant Medication|VITAFERRO|80.5;QD (every day);Oral
Adverse Event|Changes in physical activity|Restlessness;Restlessness;Increased physical activity levels;MODERATE;RECOVERED
Adverse Event|Neurological, special senses and psychiatric investigations|Xanthochromia;Xanthochromia;Cerebrospinal fluid tests (excl microbiology);MODERATE;RECOVERED
Adverse Event|Physical examination topics|Breath sounds decreased;Breath sounds abnormal;Physical examination procedures;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Lipid metabolism disorders|Dyslipidemia;Dyslipidaemia;Lipid metabolism and deposit disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Immunology and allergy investigations|Elevated prostate specific antigen [PSA];Prostatic specific antigen increased;Cell marker procedures;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Renal disorders (excl nephropathies)|Renal cyst;Renal cyst;Renal neoplasms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Upper respiratory tract disorders (excl infections)|Sinus congestion;Sinus congestion;Paranasal sinus disorders (excl infections and neoplasms);MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Depressed mood disorders and disturbances|Depression worsened;Depression;Depressive disorders;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALEGRA|60;QD (every day);Other (specify)
Concomitant Medication|ASPIRIN|325;QD (every day);Oral
Concomitant Medication|ASPIRIN|81;QD (every day);Other (specify)
Concomitant Medication|CEFTIN|500;BID (twice a day);Other (specify)
Concomitant Medication|CEFTRIAXONE|1;QD (every day);Intravenous
Concomitant Medication|EFFEXOR|112;TID (three times a day);Other (specify)
Concomitant Medication|IMODIUM|2;PRN (as needed);Other (specify)
Concomitant Medication|LOPRESSOR|25;QD (every day);Oral
Concomitant Medication|METAMUCIL|1;QD (every day);Other (specify)
Concomitant Medication|MUCINEX|600;PRN (as needed);Other (specify)
Concomitant Medication|NAPROSYN|220;QD (every day);Other (specify)
Concomitant Medication|SYNTHROID|.75;QD (every day);Oral
Concomitant Medication|ZITHROMAX|300;QD (every day);Other (specify)
Concomitant Medication|ZYRTEC|10;PRN (as needed);Oral
Adverse Event|Bone and joint injuries|Dislocated elbow;Joint dislocation;Fractures and dislocations NEC;SEVERE;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Bowel motility disorder;Gastrointestinal motility disorder;Gastrointestinal dyskinetic disorders;NULL;NULL
Adverse Event|Neurological disorders NEC|Numbness in leg;Hypoaesthesia;Sensory abnormalities NEC;NULL;NULL
Concomitant Medication|DEXAMPHETAMINE|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Burning eyes;Eye irritation;Ocular infections, inflammations and associated manifestations;Moderate;NULL
Concomitant Medication|CREATINE|50;QD (every day);Oral
Concomitant Medication|CLINDAMYCIN HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|DIUREX|NULL;NULL;NULL
Concomitant Medication|MAXILIFE|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|DVT of legs;Deep vein thrombosis;Peripheral embolism and thrombosis;Moderate;NULL
Adverse Event|Mental impairment disorders|Mental concentration decreased;Disturbance in attention;Mental impairment (excl dementia and memory loss);Mild;NULL
Adverse Event|General system disorders NEC|Excessive thirst;Thirst;Feelings and sensations NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea exacerbated;Dyspnoea;Breathing abnormalities;Mild;NULL
Adverse Event|Urinary tract signs and symptoms|Urinary frequency aggravated;Pollakiuria;Bladder and urethral symptoms;Mild;NULL
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;Mild;NULL
Concomitant Medication|DDAVP|NULL;NULL;NULL
Concomitant Medication|HYDROCORTONE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;SEVERE;RECOVERED
Concomitant Medication|222|NULL;NULL;NULL
Concomitant Medication|292|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;MILD;NA
Concomitant Medication|ATROPINE|3;PRN (as needed);Oral
Concomitant Medication|BELLADONNA TINCTURE|9;PRN (as needed);Oral
Concomitant Medication|PROPANOLOL|40;TID (three times a day);Oral
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|PENTA-3B|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Broken nose;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Lifestyle issues|Activities of daily living impaired;Activities of daily living impaired;Disability issues;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral fungal infection;Oral fungal infection;Fungal infections NEC;MODERATE;RECOVERED
Concomitant Medication|APO-TRIAZO|NULL;NULL;NULL
Concomitant Medication|SOFLAX|NULL;NULL;NULL
Adverse Event|Fungal infectious disorders|Onychomycosis;Onychomycosis;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|MELOXICAM|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramp;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;Resolved
Adverse Event|Neurological disorders NEC|Ataxia;Ataxia;Cerebellar coordination and balance disturbances;Mild;Resolved
Adverse Event|Hepatobiliary investigations|Liver function tests raised;Liver function test abnormal;Liver function analyses;Mild;Continuing
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);Mild;Resolved
Adverse Event|General system disorders NEC|Fatigue extreme;Fatigue;Asthenic conditions;Moderate;Continuing
Concomitant Medication|COLESTID|NULL;NULL;NULL
Adverse Event|Dental and gingival conditions|Dental cavity;Dental caries;Dental and periodontal infections and inflammations;Mild;NULL
Adverse Event|Dental and gingival conditions|Dental cavity;Dental caries;Dental and periodontal infections and inflammations;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Periodontal infection;Periodontal infection;Dental and oral soft tissue infections;Mild;NULL
Concomitant Medication|ALLEGRA D|60/120;BID (twice a day);Oral
Concomitant Medication|CLINDAMYCIN|150;TID (three times a day);Oral
Concomitant Medication|GINKGO BILOBA|1000;QD (every day);Oral
Concomitant Medication|GINSENG|500;QD (every day);Oral
Concomitant Medication|NASACORT AQ|0-55;PRN (as needed);Inhalation
Concomitant Medication|TYLENOL|0-325;PRN (as needed);Oral
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Jaw cramp;Trismus;Muscle tone abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Cramps of lower extremities;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Generalised muscle aches;Myalgia;Muscle pains;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw pain;Pain in jaw;Bone related signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain neck;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Taste salty;Dysgeusia;Sensory abnormalities NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;NA
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;NA
Adverse Event|Tongue conditions|Spasm tongue;Tongue spasm;Tongue signs and symptoms;MILD;NA
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;MILD;NA
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;SEVERE;NA
Adverse Event|Gastrointestinal vascular conditions|Hemorrhoids;Haemorrhoids;Haemorrhoids and gastrointestinal varices (excl oesophageal);MILD;NA
Adverse Event|Ocular infections, irritations and inflammations|Eye irritation;Eye irritation;Ocular infections, inflammations and associated manifestations;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;NA
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Taste salty;Dysgeusia;Sensory abnormalities NEC;MILD;NA
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MILD;NA
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;MODERATE;NA
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;NA
Adverse Event|Infections - pathogen unspecified|Stoma site infection;Postoperative wound infection;Infections NEC;SEVERE;NA
Adverse Event|Ocular sensory symptoms NEC|Photophobia;Photophobia;Ocular sensation disorders;MODERATE;
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;SEVERE;DEATH
Adverse Event|Epidermal and dermal conditions|Skin irritation;Skin irritation;Dermatitis and eczema;MILD;
Concomitant Medication|DIMENHYDRINATE|100;QD (every day);
Concomitant Medication|DIMENHYDRINATE|150;PRN (as needed);Oral
Concomitant Medication|FLUTICASONE|4;BID (twice a day);Inhalation
Concomitant Medication|NAPROXEN|500;PRN (as needed);
Concomitant Medication|SALBUTAMOL|4;BID (twice a day);Inhalation
Concomitant Medication|TRAMACET|4;QID (four times a day);Oral
Concomitant Medication|ALPRAZOLAM|0.25;PRN (as needed);Oral
Concomitant Medication|CEFAZOLIN|1;Other (specify);Intravenous
Concomitant Medication|CLOXACILLIN|8;QID (four times a day);Intravenous
Concomitant Medication|GLYCERIN|1;QD (every day);
Concomitant Medication|IBUPROFEN|200;PRN (as needed);
Concomitant Medication|METHOTRIMEPRAZINE|10;PRN (as needed);Oral
Concomitant Medication|METHOTRIMEPRAZINE|25;PRN (as needed);Oral
Concomitant Medication|MORPHINE|3.5;PRN (as needed);Subcutaneous
Concomitant Medication|POLYETHYLENE GLYCOL|17;PRN (as needed);Oral
Concomitant Medication|POTASSIUM CHLORIDE|30.08;BID (twice a day);Other (specify)
Concomitant Medication|PREGABALIN|300;QHS (at bedtime);Oral
Concomitant Medication|REFRESH|2;PRN (as needed);
Concomitant Medication|REFRESH|6;TID (three times a day);
Concomitant Medication|SALINE|8;BID (twice a day);
Concomitant Medication|SENNOSIDE|2;PRN (as needed);Oral
Concomitant Medication|TEARS PLUS|2;QHS (at bedtime);
Concomitant Medication|TICARCILLIN|12;QID (four times a day);Intravenous
Concomitant Medication|VANCOMYCIN|1;BID (twice a day);Intravenous
Concomitant Medication|VASELINE|2;QHS (at bedtime);Other (specify)
Adverse Event|Neurological disorders NEC|Pain nerve;Neuralgia;Sensory abnormalities NEC;Mild;NULL
Concomitant Medication|CALCIUM MAGNESIUM ZINC|1;QD (every day);Oral
Concomitant Medication|DHEA|1;QD (every day);Oral
Concomitant Medication|DOSTINEX|0.5;PRN (as needed);Oral
Concomitant Medication|GARLIC|1;QD (every day);Oral
Concomitant Medication|LEVOXYL|0.5;BID (twice a day);Oral
Concomitant Medication|LEVOXYL|0.5;QD (every day);Oral
Concomitant Medication|POTASSIUM|1;QD (every day);Oral
Concomitant Medication|TYLENOL COLD|1;BID (twice a day);Oral
Concomitant Medication|VITAMIN B-COMPLEX|1;QD (every day);Oral
Adverse Event|Cardiac arrhythmias|Bradycardia;Bradycardia;Rate and rhythm disorders NEC;MILD;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Chronic bronchitis;Bronchitis chronic;Bronchospasm and obstruction;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit decreased;Haematocrit decreased;Red blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Decreased hemoglobin;Haemoglobin decreased;Red blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Red blood cell count decreased;Red blood cell count decreased;Red blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Lymphocytes raised;Lymphocyte count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Emotional incontinence;Affect lability;Affect alterations NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Electrolyte and fluid balance conditions|Fluid retention;Fluid retention;Total fluid volume increased;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Localized rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Concomitant Medication|LORIBID|NULL;NULL;NULL
Concomitant Medication|BOTOX|;;Intramuscular
Adverse Event|Bone and joint injuries|Sprained ankle;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;ONGOING (PERSISTENT)
Adverse Event|Body temperature conditions|Pyrexia;Pyrexia;Febrile disorders;MILD;RECOVERED
Concomitant Medication|BENYLIN NON-DROWSY CHESTY COUGHS|NULL;NULL;NULL
Concomitant Medication|SCALPICIN|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Sweating increased;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Synovial and bursal disorders|Ganglion cyst;Synovial cyst;Synovial disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Body hair increased;Hypertrichosis;Hypertrichoses;MILD;UNKNOWN
Adverse Event|Gastrointestinal motility and defaecation conditions|Explosive diarrhoea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|PCO2 increased;PCO2 increased;Blood gas and acid base analyses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Sensory disturbance;Sensory disturbance;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Gastrointestinal inflammatory conditions|Gastritis;Gastritis;Gastritis (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Suicidal and self-injurious behaviours NEC|Suicidal ideation;Suicidal ideation;Suicidal and self-injurious behaviour;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|KLIOGEST|NULL;NULL;NULL
Concomitant Medication|MAALOXAN|NULL;NULL;NULL
Concomitant Medication|TEPILTA|NULL;NULL;NULL
Concomitant Medication|UBISTESIN|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Bleeding nose;Epistaxis;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine abnormal;Urine analysis abnormal;Urinalysis NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrointestinal motility disorder;Gastrointestinal motility disorder;Gastrointestinal dyskinetic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Eye redness;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Increased sexual arousal;Disturbance in sexual arousal;Sexual arousal disorders;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin lesion;Skin lesion;Dermal and epidermal conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Oral soft tissue conditions|Lip disorder;Lip disorder;Oral soft tissue disorders NEC;MODERATE;RECOVERED
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Sexual dysfunctions, disturbances and gender identity disorders|Premature ejaculation;Premature ejaculation;Orgasmic disorders and disturbances;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Somnolence;Somnolence;Disturbances in consciousness NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|MAXERAN|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Dorsal pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Frontal lobe syndrome;Frontotemporal dementia;Dementia (excl Alzheimer's type);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Loss of memory;Amnesia;Memory loss (excl dementia);MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|LOXAPAC|NULL;NULL;NULL
Adverse Event|Dental and gingival conditions|Gingivitis;Gingivitis;Gingival disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Heaviness in limbs;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Fractured scaphoid;Wrist fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Balance difficulty;Balance disorder;Cerebellar coordination and balance disturbances;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CIBACALCINE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Throat secretion increased;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;SEVERE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BISOPROLOL HEMIFUMARATE|10;QD (every day);Oral
Concomitant Medication|PROPRANOLOL HYDROCHLORIDE|60;TID (three times a day);Oral
Adverse Event|General system disorders NEC|Retrosternal pain;Chest pain;Pain and discomfort NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|DISCOTRINE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Bilious vomiting;Vomiting;Nausea and vomiting symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hypoxia;Hypoxia;Conditions associated with abnormal gas exchange;MILD;ONGOING (PERSISTENT)
Concomitant Medication|LEVOXYL|.088;QD (every day);Oral
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Change in ECG;Electrocardiogram change;ECG investigations;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramps leg;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhoea;Diarrhoea;Diarrhoea (excl infective);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Anal and rectal conditions NEC|Rectal prolapse;Rectal prolapse;Anal and rectal disorders NEC;SEVERE;RECOVERED
Adverse Event|Acid-base disorders|Acidosis;Acidosis;Mixed acid-base disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling of legs;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|SETTLERS|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Chest wall pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pedal pulse decreased;Pedal pulse decreased;Heart rate and pulse investigations;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Dry nose;Nasal dryness;Nasal disorders NEC;MILD;RECOVERED
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;MILD;RECOVERED
Adverse Event|General system disorders NEC|Early satiety;Early satiety;Feelings and sensations NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Cervical spinal stenosis;Cervical spinal stenosis;Spine and neck deformities;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness generalized;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gas;Flatulence;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in fingers;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Pigmentation disorders|Vitiligo;Vitiligo;Hypopigmentation disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|APO K|NULL;NULL;NULL
Concomitant Medication|NOVOSEMIDE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Hypochondrial pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Concomitant Medication|DESOGESTREL W/ETHINYLESTRADIOL|20;QD (every day);Oral
Concomitant Medication|TRAMADOL AND ACETAMINOPHEN|3;TID (three times a day);Oral
Adverse Event|Respiratory disorders NEC|Bronchial secretion excessive;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Bronchial secretion excessive;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrooesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hypertriglyceridaemia;Hypertriglyceridaemia;Elevated triglycerides;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|HEMI-DAONIL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Loss of energy;Asthenia;Asthenic conditions;NULL;NULL
Adverse Event|Hepatobiliary investigations|ALT increased;Alanine aminotransferase increased;Liver function analyses;NULL;NULL
Adverse Event|Hepatobiliary investigations|AST increased;Aspartate aminotransferase increased;Liver function analyses;NULL;NULL
Adverse Event|Hepatobiliary investigations|Direct bilirubin increased;Bilirubin conjugated increased;Liver function analyses;NULL;NULL
Adverse Event|Hepatobiliary investigations|Bilirubin total increased;Blood bilirubin increased;Liver function analyses;NULL;NULL
Adverse Event|Hepatic and hepatobiliary disorders|Jaundice;Jaundice;Cholestasis and jaundice;NULL;NULL
Adverse Event|Hepatobiliary neoplasms malignant and unspecified|Biliary neoplasm;Biliary neoplasm;Hepatobiliary neoplasms malignancy unspecified;NULL;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis of leg;Cellulitis;Bacterial infections NEC;Moderate;NULL
Adverse Event|Eye disorders NEC|Dry eyes;Dry eye;Lacrimal disorders;Mild;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal dryness;Nasal dryness;Nasal disorders NEC;Mild;NULL
Adverse Event|Infections - pathogen unspecified|UTI;Urinary tract infection;Urinary tract infections;Moderate;NULL
Concomitant Medication|ALPHA LIPOIC ACID|100;QD (every day);Oral
Concomitant Medication|AMBIEN|5-10;QID (four times a day);Oral
Concomitant Medication|BETACAROTENE|25,000;QD (every day);Oral
Concomitant Medication|COENZYME Q10|22;QD (every day);Oral
Concomitant Medication|DANTRIUM|100;QID (four times a day);Oral
Concomitant Medication|DANTRIUM|50;TID (three times a day);Oral
Concomitant Medication|DANTRIUM|75;TID (three times a day);Oral
Concomitant Medication|QUININE SULFATE|325;QHS (at bedtime);Oral
Concomitant Medication|ZANAFLEX|4;QID (four times a day);Oral
Adverse Event|Bronchial disorders (excl neoplasms)|Exacerbation of asthma;Asthma;Bronchospasm and obstruction;MODERATE;RECOVERED
Adverse Event|Tongue conditions|Sore tongue;Glossodynia;Tongue signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BARIUM SULPHATE|NULL;NULL;NULL
Adverse Event|Hepatic and hepatobiliary disorders|Bilirubinemia;Hyperbilirubinaemia;Cholestasis and jaundice;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Spinal pain;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BIOFENAC|NULL;NULL;NULL
Concomitant Medication|CETEBE|NULL;NULL;NULL
Concomitant Medication|MULTIBIONTA|NULL;NULL;NULL
Concomitant Medication|MULTIBIONTA N|NULL;NULL;NULL
Concomitant Medication|OMERPRAZOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Acute chest pain;Chest pain;Pain and discomfort NEC;SEVERE;DEATH
Concomitant Medication|NEBIVOLOL HYDROCHLORIDE|5;QD (every day);Oral
Concomitant Medication|VALSARTAN|160;QD (every day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervicodynia;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in limb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Concomitant Medication|TRIATEC|NULL;NULL;NULL
Adverse Event|Injuries NEC|Black eye;Periorbital haematoma;Eye injuries NEC;Moderate;Resolved
Adverse Event|Neurological disorders NEC|Burning foot;Burning sensation;Paraesthesias and dysaesthesias;Mild;Continuing
Adverse Event|Bone and joint injuries|Fracture of humerus;Humerus fracture;Upper limb fractures and dislocations;Moderate;Resolved
Adverse Event|Infections - pathogen unspecified|Catheter site infection;Catheter site infection;Infections NEC;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Itchy;Pruritus;Pruritus NEC;Mild;Resolved
Adverse Event|Muscle disorders|Muscle ache;Myalgia;Muscle pains;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;Moderate;Continuing
Adverse Event|Fungal infectious disorders|Oral thrush;Oral candidiasis;Candida infections;Moderate;Resolved
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site pain;Procedural pain;Non-site specific procedural complications;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thigh;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Bone disorders (excl congenital and fractures)|Jaw pain;Pain in jaw;Bone related signs and symptoms;Mild;Resolved
Concomitant Medication|COATED ASPIRIN|NULL;NULL;NULL
Concomitant Medication|MECLOZINE|NULL;NULL;NULL
Concomitant Medication|VIVELLE DOT|NULL;NULL;NULL
Adverse Event|Muscle disorders|Muscle cramp;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Concomitant Medication|COUMADIN|6;QD (every day);Oral
Concomitant Medication|COUMADIN|7.5;QD (every day);Oral
Concomitant Medication|WARFARIN|8;QD (every day);Oral
Adverse Event|General system disorders NEC|Fuzzy;Feeling abnormal;Feelings and sensations NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Paresthesia distal;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Muscle disorders|Cramps calf;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle fatigue;Muscle fatigue;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Oral soft tissue conditions|Numbness circumoral;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Deliria (incl confusion)|Spatial disorientation;Disorientation;Confusion and disorientation;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia upper limb;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Concomitant Medication|MAGNESIUM GLYCINATE|NULL;NULL;NULL
Concomitant Medication|SELENOMETHIONINE|NULL;NULL;NULL
Concomitant Medication|TINACTIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Bowel spasm;Gastrointestinal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Decubitus ulcer;Decubitus ulcer;Skin injuries and mechanical dermatoses;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gas pain;Flatulence;Flatulence, bloating and distension;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral fungal infection;Oral fungal infection;Fungal infections NEC;MILD;RECOVERED
Concomitant Medication|AMITRIPTYLINE|15;TID (three times a day);Oral
Concomitant Medication|AMITRIPTYLINE|20;TID (three times a day);Oral
Concomitant Medication|ATROPINE SULFATE|30;BID (twice a day);Oral
Concomitant Medication|BACLOFEN|12,5;QD (every day);Oral
Concomitant Medication|CIPROFLOXACIN|1;BID (twice a day);Oral
Concomitant Medication|CIPROFLOXACINE|500;QD (every day);Oral
Concomitant Medication|CLONAZEPAM|0.4;QD (every day);Oral
Concomitant Medication|FLUCONAZOLE|150;QD (every day);Oral
Concomitant Medication|LANSOPRAZOLE|30;QD (every day);Oral
Concomitant Medication|METRONIDAZOLE|2;QID (four times a day);Oral
Concomitant Medication|SCOPOLAMINE|1,5;QD (every day);Topical
Concomitant Medication|VANCOMYCIN|1.5;TID (three times a day);Oral
Concomitant Medication|BROTIZOLAM|0.125;QD (every day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Infected skin ulcer;Infected skin ulcer;Skin structures and soft tissue infections;MODERATE;RECOVERED
Concomitant Medication|CARBOLEVURE|NULL;NULL;NULL
Concomitant Medication|CORDIPATCH|NULL;NULL;NULL
Concomitant Medication|ZADITEN|NULL;NULL;NULL
Concomitant Medication|ALPRAZOLAM|0.25;BID (twice a day);Oral
Concomitant Medication|AMITRIPTYLINE|12;BID (twice a day);Oral
Concomitant Medication|LITHIUM CARBONATE|150;QD (every day);Oral
Concomitant Medication|LITHIUM CARBONATE|300;BID (twice a day);Oral
Concomitant Medication|LITHIUM CARBONATE|450;BID (twice a day);Oral
Concomitant Medication|PARACETAMOL CODEINE|1000+60;BID (twice a day);Oral
Adverse Event|General system disorders NEC|Dependent edema;Gravitational oedema;Oedema NEC;Marked;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in foot;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Skin discoloration;Skin discolouration;Dermal and epidermal conditions NEC;Moderate;NULL
Concomitant Medication|ROBITUSSIN|2;QID (four times a day);Oral
Concomitant Medication|LANZOR|NULL;NULL;NULL
Adverse Event|Ocular infections, irritations and inflammations|Conjunctivitis;Conjunctivitis;Conjunctival infections, irritations and inflammations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Fecal incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Cognitive deterioration;Cognitive disorder;Mental impairment (excl dementia and memory loss);MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid metabolism disorders|Hyperlipemia;Hyperlipidaemia;Hyperlipidaemias NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Paresthesia hand;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Central nervous system vascular disorders|Transient cerebral ischemia;Transient ischaemic attack;Transient cerebrovascular events;MODERATE;RECOVERED
Adverse Event|Venous varices|Varicose veins of lower extremities;Varicose vein;Varicose veins non-site specific;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergic reaction to wasp sting;Allergy to arthropod sting;Allergic conditions NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Exanthema;Rash;Rashes, eruptions and exanthems NEC;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|CROTAMITON|NULL;NULL;NULL
Concomitant Medication|DEXPANTHENOL|NULL;NULL;NULL
Concomitant Medication|ETILEFRINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|FINASTERID|NULL;NULL;NULL
Concomitant Medication|HERBAL EXTRACT NOS|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Ingrowing toe nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MODERATE;RECOVERED
Adverse Event|Joint disorders|Pain in hip;Arthralgia;Joint related signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Mood disorders and disturbances NEC|Emotional incontinence;Affect lability;Affect alterations NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Tachypnea;Tachypnoea;Breathing abnormalities;SEVERE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gas pain;Flatulence;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Joint disorders|Painful hips;Arthralgia;Joint related signs and symptoms;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Muscle cramps aggravated;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Breathlessness;Dyspnoea;Breathing abnormalities;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain (with radiation);Neck pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle spasm;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;SEVERE;RECOVERED
Adverse Event|Schizophrenia and other psychotic disorders|Psychosis;Psychotic disorder;Psychotic disorder NEC;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Shivering;Chills;Feelings and sensations NEC;SEVERE;RECOVERED
Concomitant Medication|RISPERDAL|NULL;NULL;NULL
Adverse Event|Viral infectious disorders|Herpes zoster;Herpes zoster;Herpes viral infections;SEVERE;RECOVERED
Concomitant Medication|FORTIMEL|NULL;NULL;NULL
Concomitant Medication|FORTINOL|NULL;NULL;NULL
Concomitant Medication|SPECYTON|NULL;NULL;NULL
Concomitant Medication|ZELITREX|NULL;NULL;NULL
Concomitant Medication|TIME RELEASE VITAMIN C|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine abnormal;Urine analysis abnormal;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular infections, irritations and inflammations|Burning sensation in eye;Eye irritation;Ocular infections, inflammations and associated manifestations;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Yeast infection of the skin;Fungal skin infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|EASYLAX|NULL;NULL;NULL
Concomitant Medication|MYCELEX-7|NULL;NULL;NULL
Concomitant Medication|SILVADENE|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Glucose urine elevated;Glucose urine present;Urinalysis NEC;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ATIVAN|2;QHS (at bedtime);Oral
Concomitant Medication|DOXAZOSIN|4;QD (every day);Oral
Concomitant Medication|GEMFIBROZIL|600;QD (every day);Oral
Concomitant Medication|MIRAPEX|0.25;BID (twice a day);Oral
Concomitant Medication|PAXIL|30;QD (every day);Oral
Concomitant Medication|RESTORIL|7.5;QHS (at bedtime);Oral
Adverse Event|Gastrointestinal therapeutic procedures|Percutaneous endoscopic gastrostomy;Gastrostomy;Gastric therapeutic procedures;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|FOSFOMYCIN|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM|500;QD (every day);Oral
Concomitant Medication|ONO 2506|1200;QD (every day);Oral
Concomitant Medication|PERDOLAN|500;QD (every day);Oral
Concomitant Medication|MAG OXIDE|NULL;NULL;NULL
Adverse Event|Eye disorders NEC|Eye dryness;Dry eye;Lacrimal disorders;MODERATE;RECOVERED
Adverse Event|Head and neck therapeutic procedures|Nasal sinus drainage;Sinus operation;Paranasal therapeutic procedures;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal rash;Fungal skin infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle twitching;Muscle twitching;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|KLOTRIX|NULL;NULL;NULL
Concomitant Medication|VASORETIC|NULL;NULL;NULL
Concomitant Medication|MANNITOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Pedal edema;Oedema peripheral;Oedema NEC;Moderate;Continuing
Adverse Event|Urinary tract signs and symptoms|Dysuria;Dysuria;Bladder and urethral symptoms;Mild;Continuing
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;Continuing
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;SEVERE;RECOVERED
Adverse Event|Mycoplasmal infectious disorders|Mycoplasmal pneumonia;Pneumonia mycoplasmal;Mycoplasma infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural pain;Procedural pain;Non-site specific procedural complications;MILD;RECOVERED
Adverse Event|Oral soft tissue conditions|Sores lip;Cheilitis;Oral soft tissue disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DOXYCYCLINE HYCLATE|NULL;NULL;NULL
Concomitant Medication|IMMUNE GLOBULIN|NULL;NULL;NULL
Adverse Event|Mood disorders and disturbances NEC|Frustration;Frustration;Emotional and mood disturbances NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Fatigueability generalised;Fatigue;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal disorders (excl nephropathies)|Azotemia prerenal;Acute prerenal failure;Renal failure and impairment;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Bruising of arm;Contusion;Skin injuries NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Dermatitis;Dermatitis;Dermatitis and eczema;Mild;NULL
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Eczema;Eczema;Dermatitis and eczema;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;Moderate;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urea blood elevated;Blood urea increased;Renal function analyses;Mild;NULL
Concomitant Medication|BORON|3;BID (twice a day);Oral
Concomitant Medication|CALCIUM|480;BID (twice a day);Oral
Concomitant Medication|CHROMIUM|300;BID (twice a day);Oral
Concomitant Medication|COPPER|2;BID (twice a day);Oral
Concomitant Medication|CREATINE|2.5;BID (twice a day);Oral
Concomitant Medication|GINKGO BILOBA|120;BID (twice a day);Oral
Concomitant Medication|IODINE|150;BID (twice a day);Oral
Concomitant Medication|L-THREONINE|2;BID (twice a day);Oral
Concomitant Medication|LAMISIL|cover affected area;BID (twice a day);Topical
Concomitant Medication|LOVENOX|60;BID (twice a day);Subcutaneous
Concomitant Medication|MAGNESIUM|480;BID (twice a day);Oral
Concomitant Medication|MANGANESE|10;BID (twice a day);Oral
Concomitant Medication|MOLYBDENUM|300;BID (twice a day);Oral
Concomitant Medication|N ACETYL CYSTEIN|1200;QD (every day);Oral
Concomitant Medication|SIBERIAN GINSENG|410;QD (every day);Oral
Concomitant Medication|SILICA|4.5;BID (twice a day);Oral
Concomitant Medication|SUDAFED|30;QID (four times a day);Oral
Concomitant Medication|VITAMIN B6|10;BID (twice a day);Oral
Concomitant Medication|VITAMIN C|78;QD (every day);Oral
Concomitant Medication|VITAMIN C|3000;BID (twice a day);Oral
Concomitant Medication|VITAMIN D3|200;BID (twice a day);Oral
Concomitant Medication|VITAMIN E|197.6;BID (twice a day);Oral
Concomitant Medication|ZINC|30;BID (twice a day);Oral
Concomitant Medication|ALPHA LIPOIC ACID|300;TID (three times a day);Oral
Concomitant Medication|AMOXICILLIN|2;QD (every day);Oral
Concomitant Medication|AMOXICILLIN|500;QD (every day);Oral
Concomitant Medication|CURCUMIN|500;BID (twice a day);Oral
Concomitant Medication|SIMETHICONE|40;PRN (as needed);Oral
Concomitant Medication|TRIAMCINOLONE ACETONIDE|cover affected area;BID (twice a day);Topical
Adverse Event|Gastrointestinal signs and symptoms|Aphagia;Aphagia;Gastrointestinal signs and symptoms NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;MODERATE;UNKNOWN
Adverse Event|Mood disorders and disturbances NEC|Mental distress;Emotional distress;Emotional and mood disturbances NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|AMPHETAMINE|NULL;NULL;NULL
Adverse Event|Water, electrolyte and mineral investigations|Blood phosphorus increased;Blood phosphorus increased;Mineral and electrolyte analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal therapeutic procedures|Gastrostomy tube insertion;Gastrostomy tube insertion;Gastric therapeutic procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Reflux oesophagitis;Reflux oesophagitis;Oesophagitis (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Rhonchi;Rhonchi;Lower respiratory tract signs and symptoms;MILD;UNKNOWN
Concomitant Medication|AFONILUM|NULL;NULL;NULL
Concomitant Medication|BROMUC|NULL;NULL;NULL
Concomitant Medication|BRONCHORETARD|NULL;NULL;NULL
Concomitant Medication|FLUTIDE|NULL;NULL;NULL
Concomitant Medication|OESTROFEMINAL|NULL;NULL;NULL
Concomitant Medication|PANTOZOL|NULL;NULL;NULL
Concomitant Medication|PERENTEROL|NULL;NULL;NULL
Concomitant Medication|SULTANOL|NULL;NULL;NULL
Concomitant Medication|URBASON|NULL;NULL;NULL
Concomitant Medication|ZANTIC|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal fullness;Abdominal distension;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Purine and pyrimidine metabolism disorders|Hyperuricemia;Hyperuricaemia;Purine metabolism disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Urine bilirubin increased;Urine bilirubin increased;Liver function analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal pain;Gastrointestinal pain;Gastrointestinal and abdominal pains (excl oral and throat);MODERATE;RECOVERED
Concomitant Medication|ALOPURINOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse increased;Heart rate increased;Heart rate and pulse investigations;MODERATE;RECOVERED
Adverse Event|Menstrual cycle and uterine bleeding disorders|Menometrorrhagia;Menometrorrhagia;Menstruation with increased bleeding;MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disorder;Sleep disorder;Sleep disorders NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Venous varices|Varicose veins of lower extremities;Varicose vein;Varicose veins non-site specific;MILD;RECOVERED
Concomitant Medication|TARDYFERON|NULL;NULL;NULL
Concomitant Medication|TEMOVATE|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Drowsiness;Somnolence;Disturbances in consciousness NEC;Marked;NULL
Adverse Event|Deliria (incl confusion)|Mental confusion;Confusional state;Confusion and disorientation;Moderate;NULL
Adverse Event|Therapeutic procedures and supportive care NEC|Hospitalisation;Hospitalisation;Therapeutic procedures NEC;MILD;RECOVERED
Concomitant Medication|VAXAR|NULL;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anguish;Anxiety;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fractured coccyx;Fractured coccyx;Spinal fractures and dislocations;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Fractured coccyx;Fractured coccyx;Spinal fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Sleep disorders and disturbances|Sleep disturbed;Sleep disorder;Sleep disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Drunkenness feeling of;Feeling drunk;Feelings and sensations NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Drunkenness feeling of;Feeling drunk;Feelings and sensations NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Skin appendage conditions|Nail growth increased;Nail growth abnormal;Nail and nail bed conditions (excl infections and infestations);MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Rib fracture;Rib fracture;Thoracic cage fractures and dislocations;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Seborrhoeic dermatitis;Seborrhoeic dermatitis;Dermatitis and eczema;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|MEPRONIZINE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;Mild;NULL
Adverse Event|Joint disorders|Arthrosis;Osteoarthritis;Osteoarthropathies;Mild;NULL
Concomitant Medication|SCOPODERM|1;Other (specify);Transdermal
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Intervertebral disc protrusion;Intervertebral disc protrusion;Intervertebral disc disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal polyp;Nasal polyps;Nasal disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Otitis media;Otitis media;Ear infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|PSEUDOEPHEDRINE SULFATE|NULL;NULL;NULL
Lab Test|Urine Renal Epithelial Cells|-
Lab Test|Urine Mucus|3+
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anemia;Anaemia;Anaemias NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hearing disorders|Hearing loss bilateral;Deafness bilateral;Hearing losses;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Diabetes mellitus;Diabetes mellitus;Diabetes mellitus (incl subtypes);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Gamma-GT increased;Gamma-glutamyltransferase increased;Liver function analyses;MODERATE;UNKNOWN
Adverse Event|Metabolic, nutritional and blood gas investigations|HbA1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|White blood cell count high;White blood cell count increased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glycosylated haemoglobin increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Fracture of ankle;Ankle fracture;Lower limb fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;MODERATE;UNKNOWN
Adverse Event|Ocular neuromuscular disorders|Constricted pupils;Miosis;Pupil disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Scar;Scar;Skin injuries and mechanical dermatoses;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MYCOLOG|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Obesity;Obesity;General nutritional disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|CHOLERA VACCINE|NULL;NULL;NULL
Concomitant Medication|MEFLOQUINE|NULL;NULL;NULL
Concomitant Medication|TYPHOID VACCINE|NULL;NULL;NULL
Adverse Event|Microbiology and serology investigations|Tuberculin test positive;Tuberculin test positive;Mycobacteria identification and serology;Moderate;NULL
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Frustration;Frustration;Emotional and mood disturbances NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Blistering of mouth;Oropharyngeal blistering;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|APO-TEMAZEPAM|NULL;NULL;NULL
Concomitant Medication|ASA W/CODEINE|NULL;NULL;NULL
Concomitant Medication|FRIARS|NULL;NULL;NULL
Concomitant Medication|PNEUMOCOCCAL POLYSACCHARIDE VACCINE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal cramps;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremulousness;Tremor;Tremor (excl congenital);MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Nasal mucus increased;Rhinorrhoea;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Type 2 diabetes mellitus;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edema;Oedema;Oedema NEC;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Skin infection;Skin infection;Skin structures and soft tissue infections;MODERATE;RECOVERED
Concomitant Medication|DEFENSE|NULL;NULL;NULL
Concomitant Medication|SHARK-LIVER OIL|NULL;NULL;NULL
Adverse Event|Administration site reactions|Injection site discharge;Injection site discharge;Injection site reactions;NULL;NULL
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;NULL;NULL
Concomitant Medication|ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL|NULL;NULL;NULL
Concomitant Medication|MAALOX PLUS|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Nocturia aggravated;Nocturia;Urinary tract signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary edema;Pulmonary oedema;Pulmonary oedemas;MILD;RECOVERED
Concomitant Medication|RU-TUSS|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Increased bronchial secretion;Increased bronchial secretion;Lower respiratory tract signs and symptoms;Moderate;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Esophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Fecal incontinence;Faecal incontinence;Gastrointestinal signs and symptoms NEC;Mild;NULL
Adverse Event|Urinary tract signs and symptoms|Urine incontinence;Urinary incontinence;Bladder and urethral symptoms;Mild;NULL
Adverse Event|Injuries NEC|Ligament tear;Ligament rupture;Muscle, tendon and ligament injuries;MILD;RECOVERED
Concomitant Medication|CHLORTRIMETON|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fibula fracture;Fibula fracture;Lower limb fractures and dislocations;Moderate;NULL
Adverse Event|Joint disorders|Joint pain;Arthralgia;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|ACETYL L CARNITINE|500;QD (every day);Oral
Concomitant Medication|ACETYL L CARNITINE|100;QD (every day);Oral
Concomitant Medication|B12|1000;QD (every day);Sublingual
Concomitant Medication|B12|500;QD (every day);Sublingual
Concomitant Medication|BORAGE OIL|1;QD (every day);Oral
Concomitant Medication|FLINTSTONES|1;QD (every day);Oral
Concomitant Medication|GLUTATHIONE|50;QD (every day);Oral
Concomitant Medication|IMIPRAMINE|75;QD (every day);Oral
Concomitant Medication|PROTEIN|5-6;QD (every day);Oral
Adverse Event|Joint disorders|Pain in joint;Arthralgia;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Musculoskeletal and soft tissue investigations (excl enzyme tests)|Biopsy muscle abnormal;Biopsy muscle abnormal;Musculoskeletal and soft tissue histopathology procedures;MILD;RECOVERED
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Diabetes mellitus maturity onset;Type 2 diabetes mellitus;Diabetes mellitus (incl subtypes);MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Blood urea increased;Blood urea increased;Renal function analyses;MILD;RECOVERED
Adverse Event|Metabolic, nutritional and blood gas investigations|Glucose increased;Blood glucose increased;Carbohydrate tolerance analyses (incl diabetes);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Peripheral neuropathies|Unilateral carpal tunnel syndrome;Carpal tunnel syndrome;Mononeuropathies;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PRANDIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Esophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Mental impairment disorders|Memory loss;Amnesia;Memory loss (excl dementia);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Pleural disorders|Pleurisy;Pleurisy;Pleural infections and inflammations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastrointestinal motility disorder;Gastrointestinal motility disorder;Gastrointestinal dyskinetic disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Urinary incontinence;Urinary incontinence;Bladder and urethral symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Exanthema facial;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);MILD;RECOVERED
Adverse Event|Sleep disorders and disturbances|Change in sleep pattern;Sleep disorder;Sleep disorder;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Hypoventilation;Hypoventilation;Breathing abnormalities;MILD;RECOVERED
Concomitant Medication|NOOTROP|NULL;NULL;NULL
Concomitant Medication|SELENASE|NULL;NULL;NULL
Adverse Event|Skin and subcutaneous tissue therapeutic procedures|Nail removal NOS;Nail operation;Nail therapeutic procedures;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in toe;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|CARBOCISTEINE|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|DILACOR XR|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Backache;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Laryngospasm;Laryngospasm;Laryngeal spasm, oedema and obstruction;Mild;Resolved
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal stuffiness;Nasal congestion;Nasal congestion and inflammations;Mild;Continuing
Concomitant Medication|ROBITUSSIN CF|NULL;NULL;NULL
Concomitant Medication|ROBITUSSIN COUGH DROPS|NULL;NULL;NULL
Adverse Event|Central nervous system infections and inflammations|Gliosis;Gliosis;Central nervous system inflammatory disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Menopause and related conditions|Menopausal symptoms;Menopausal symptoms;Menopausal effects NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Wrist injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DIBROMM|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;Moderate;Resolved with Residual
Adverse Event|Injuries NEC|Head injury;Head injury;Site specific injuries NEC;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Continuing
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal dryness;Nasal dryness;Nasal disorders NEC;Mild;Continuing
Adverse Event|Movement disorders (incl parkinsonism)|Shakiness;Tremor;Tremor (excl congenital);Mild;Continuing
Adverse Event|Respiratory disorders NEC|Shortness of breath;Dyspnoea;Breathing abnormalities;Severe;Resolved
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Nocturia;Nocturia;Urinary tract signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Epigastric pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);SEVERE;RECOVERED
Adverse Event|Fungal infectious disorders|Vaginal mycosis;Vulvovaginal mycotic infection;Fungal infections NEC;MILD;RECOVERED
Concomitant Medication|FUMAFER|NULL;NULL;NULL
Concomitant Medication|GYNO-DAKTARIN|NULL;NULL;NULL
Concomitant Medication|TEDELPARIN|NULL;NULL;NULL
Adverse Event|Ocular sensory symptoms NEC|Eyes sensitive to sunlight;Photophobia;Ocular sensation disorders;NULL;NULL
Adverse Event|Joint disorders|Joint instability;Joint instability;Joint related disorders NEC;NULL;NULL
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;NULL;NULL
Adverse Event|Tissue disorders NEC|Ulcer bleeding;Ulcer haemorrhage;Ulcers NEC;NULL;NULL
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;NULL;NULL
Adverse Event|Respiratory disorders NEC|Hoarse voice;Dysphonia;Upper respiratory tract signs and symptoms;NULL;NULL
Concomitant Medication|CAPISTAN|NULL;NULL;NULL
Concomitant Medication|MANNA|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Chronic obstructive pulmonary disease;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;Mild;NULL
Adverse Event|Vascular therapeutic procedures|Coronary artery bypass;Coronary artery bypass;Arterial therapeutic procedures (excl aortic);Marked;NULL
Adverse Event|Coronary artery disorders|Coronary artery disease;Coronary artery disease;Coronary artery disorders NEC;Mild;NULL
Adverse Event|Lipid metabolism disorders|Hyperlipidemia;Hyperlipidaemia;Hyperlipidaemias NEC;Mild;NULL
Concomitant Medication|ALTACE|5;BID (twice a day);Oral
Concomitant Medication|ALTACE|5;QD (every day);Oral
Concomitant Medication|AMARYL|6;QD (every day);Oral
Concomitant Medication|AZMACORT|100;BID (twice a day);Inhalation
Concomitant Medication|COMBIVENT|180/90;BID (twice a day);Inhalation
Concomitant Medication|HABITROL|21;QD (every day);Transdermal
Concomitant Medication|INSULIN|10;BID (twice a day);Subcutaneous
Concomitant Medication|ISOSORBIDE|60;QD (every day);Oral
Concomitant Medication|LOPRESSOR|25;BID (twice a day);Oral
Concomitant Medication|LOVINA|240;QD (every day);Oral
Concomitant Medication|ZOSTIN|1;Continuous IV;Intravenous
Concomitant Medication|AMARYL|8;QD (every day);Oral
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Skin lesion;Skin lesion;Dermal and epidermal conditions NEC;Mild;NULL
Concomitant Medication|DECARIS|1;Other (specify);Oral
Concomitant Medication|NEUROBION FORTE|2;BID (twice a day);Oral
Concomitant Medication|ZOVIRAX|5;;Oral
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;Marked;NULL
Adverse Event|Skin appendage conditions|Diaphoresis;Hyperhidrosis;Apocrine and eccrine gland disorders;Marked;NULL
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;Marked;NULL
Adverse Event|Gastrointestinal signs and symptoms|Vomiting;Vomiting;Nausea and vomiting symptoms;Marked;NULL
Concomitant Medication|ZOFRAN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Secretion discharge;Secretion discharge;General signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchospasm;Bronchospasm;Bronchospasm and obstruction;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral candida;Oral candidiasis;Candida infections;MILD;RECOVERED
Concomitant Medication|HALIBUT|NULL;NULL;NULL
Concomitant Medication|PONARIS|NULL;NULL;NULL
Concomitant Medication|AVLOCARDYL|1/4;;Oral
Concomitant Medication|LIORESAL|1/2;;Oral
Concomitant Medication|NOCTRAN|1/2;;Oral
Adverse Event|Neurological disorders NEC|Dysarthria;Dysarthria;Speech and language abnormalities;Marked;NULL
Adverse Event|Infections - pathogen unspecified|Vesiculopustular rash;Rash pustular;Skin structures and soft tissue infections;Mild;NULL
Concomitant Medication|METROGEL|0.75;BID (twice a day);Topical
Concomitant Medication|NIZORAL|2;BID (twice a day);Topical
Concomitant Medication|NIZORAL|1;QD (every day);Topical
Concomitant Medication|VITAMIN B|500;BID (twice a day);Oral
Concomitant Medication|VITAMIN B6|1;QD (every day);Oral
Concomitant Medication|FLONASE|0.05;BID (twice a day);Intranasal
Concomitant Medication|FOLIC ACID|1000;QD (every day);Oral
Concomitant Medication|HYDROCHLOROTHIAZIDE|12.5;QD (every day);Oral
Concomitant Medication|LACTULOSE|15;QD (every day);Oral
Concomitant Medication|TRIAMCINOLONE|0.025;QD (every day);Topical
Adverse Event|General system disorders NEC|Flu like symptoms;Influenza like illness;General signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal haemorrhages NEC|Anal hemorrhage;Anal haemorrhage;Intestinal haemorrhages;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Nocturnal dyspnea;Nocturnal dyspnoea;Breathing abnormalities;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Occipital headache;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|IPRATROPIUM BR|NULL;NULL;NULL
Concomitant Medication|SALBUTAMOL SULFATE|NULL;NULL;NULL
Concomitant Medication|XYLOMETAZOLINE|NULL;NULL;NULL
Adverse Event|Sexual function and fertility disorders|Ejaculation delayed;Ejaculation delayed;Erection and ejaculation conditions and disorders;Mild;NULL
Adverse Event|Neurological disorders NEC|Slurred speech;Dysarthria;Speech and language abnormalities;Mild;NULL
Concomitant Medication|TUSSIN DM|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Edema of lower extremities;Oedema peripheral;Oedema NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Cervicalgia;Neck pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Concomitant Medication|AMBROTOSE|0.44;QD (every day);Oral
Concomitant Medication|DARVOCET-N|1/1;PRN (as needed);Oral
Concomitant Medication|QUININE SULFATE|200;PRN (as needed);Oral
Concomitant Medication|SPROT|2;QD (every day);Oral
Concomitant Medication|SYNTHROID|20;QD (every day);Oral
Concomitant Medication|LECITHIN|1200;QD (every day);Oral
Concomitant Medication|ZINC|50;QD (every day);Oral
Adverse Event|General system disorders NEC|Oedema of lower extremities;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Pain pharynx;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle atrophy;Muscle atrophy;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Dyspnoea;Dyspnoea;Breathing abnormalities;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Hypoventilation;Hypoventilation;Breathing abnormalities;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Respiratory disorders NEC|Increased upper airway secretion;Increased upper airway secretion;Upper respiratory tract signs and symptoms;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Salivary gland conditions|Sialorrhoea;Salivary hypersecretion;Salivary gland disorders NEC;SEVERE;RECOVERED
Concomitant Medication|BOTOX|250;QD (every day);Other (specify)
Concomitant Medication|GLIMEPIRID|1;QD (every day);Oral
Concomitant Medication|LORAZEPAM|0,5;QD (every day);Other (specify)
Concomitant Medication|METFORMIN|1275;BID (twice a day);Other (specify)
Concomitant Medication|MOVICOL|1;QD (every day);Other (specify)
Concomitant Medication|NEUROCIL|6;TID (three times a day);Other (specify)
Concomitant Medication|PANTOPRAZOL|20;QD (every day);Other (specify)
Concomitant Medication|SORMODREN|1;BID (twice a day);Oral
Concomitant Medication|BOTULINUM TOXIN|100;Other (specify);Other (specify)
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of lower extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain of extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;MODERATE;RECOVERED
Adverse Event|Platelet disorders|Thrombopenia;Thrombocytopenia;Thrombocytopenias;MODERATE;RECOVERED
Adverse Event|Urolithiases|Calculus urinary bladder;Calculus bladder;Urinary tract lithiasis (excl renal);MODERATE;RECOVERED
Concomitant Medication|ASPIRINE PH8|NULL;NULL;NULL
Concomitant Medication|BEFIZAL|NULL;NULL;NULL
Concomitant Medication|DESATURA|NULL;NULL;NULL
Concomitant Medication|MUXOL|NULL;NULL;NULL
Concomitant Medication|STHENOREX|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste changed;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|FLUCONAZOL|100;QD (every day);Oral
Concomitant Medication|MAGNESIUM DIASPORAL|400;QD (every day);Oral
Concomitant Medication|SCOPODERM|1;Three times per week;
Concomitant Medication|VOLTAREN RESINAT|290;BID (twice a day);Oral
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;Severe;Resolved
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;Severe;Resolved
Adverse Event|Injuries NEC|Skin abrasion;Excoriation;Skin injuries NEC;Moderate;Continuing
Lab Test|Urine WBCs|Small
Adverse Event|Cardiac disorder signs and symptoms|Palpitations;Palpitations;Cardiac signs and symptoms NEC;SEVERE;RECOVERED
Adverse Event|Oral soft tissue conditions|Mouth pain;Oral pain;Oral soft tissue pain and paraesthesia;MODERATE;RECOVERED
Adverse Event|Administration site reactions|Injection site itching;Injection site pruritus;Injection site reactions;Severe;Resolved
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse rapid;Heart rate increased;Heart rate and pulse investigations;Moderate;Continuing
Adverse Event|Administration site reactions|Injection site swelling;Injection site swelling;Injection site reactions;Severe;Resolved
Concomitant Medication|ATTAPULGITE|NULL;NULL;NULL
Concomitant Medication|PIRBUTEROL|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Splitting nails;Onychoclasis;Nail and nail bed conditions (excl infections and infestations);Mild;NULL
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;Moderate;Resolved
Adverse Event|Skin appendage conditions|Perspiration excessive;Hyperhidrosis;Apocrine and eccrine gland disorders;NULL;NULL
Adverse Event|Salivary gland conditions|Dry lips;Lip dry;Oral dryness and saliva altered;Mild;Continuing
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hypoglycemia;Hypoglycaemia;Hypoglycaemic conditions NEC;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in thumb;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful R arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Dysesthesia extremity;Dysaesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Concomitant Medication|BRONILIDE|NULL;NULL;NULL
Concomitant Medication|PIVALONE NEOMYCINE|NULL;NULL;NULL
Adverse Event|Sleep disorders and disturbances|Nightmare;Nightmare;Parasomnias;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Feeling drunk;Feeling drunk;Feelings and sensations NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Tendon, ligament and cartilage disorders|Tendonitis;Tendonitis;Tendon disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;SEVERE;RECOVERED
Concomitant Medication|SALGYDAL|NULL;NULL;NULL
Concomitant Medication|COENZYME Q10|200;TID (three times a day);Oral
Adverse Event|Infections - pathogen unspecified|Bronchitis;Bronchitis;Lower respiratory tract and lung infections;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Cardiac arrhythmias|Cardiac arrest;Cardiac arrest;Ventricular arrhythmias and cardiac arrest;SEVERE;DEATH
Concomitant Medication|AMLODIPINE|5;BID (twice a day);Oral
Concomitant Medication|IRBESARTAN AND HYDROCHLOROTHIAZIDE|150+12.5;QD (every day);Oral
Concomitant Medication|PYRIDOSTIGMINE|90;TID (three times a day);Oral
Concomitant Medication|SOTALOL|160;BID (twice a day);Oral
Concomitant Medication|AMOXICILLIN W/CLAVULANIC ACID|2625+375;TID (three times a day);Oral
Concomitant Medication|CLOTIAPINE|5;QD (every day);Oral
Concomitant Medication|DELTACORTENE|25;QD (every day);Oral
Adverse Event|Administration site reactions|Injection site bruising;Injection site haematoma;Injection site reactions;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Glycosuria;Glycosuria;Urinary abnormalities;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Dry mouth;Dry mouth;Oral dryness and saliva altered;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Crepitations;Crepitations;General signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling of feet;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Concomitant Medication|HEMOCYTE PLUS|NULL;NULL;NULL
Concomitant Medication|PRENOVIL|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Periarthritis;Periarthritis;Joint related disorders NEC;MILD;RECOVERED
Adverse Event|Vision disorders|Visual disturbances;Visual impairment;Visual disorders NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ACTILYSE|NULL;NULL;NULL
Concomitant Medication|ASPIRIN UPSA|NULL;NULL;NULL
Concomitant Medication|DI-ANTALVIC|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Nystagmus;Nystagmus;Cerebellar coordination and balance disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergy to molds;Mycotic allergy;Allergic conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Oral candidiasis;Oral candidiasis;Candida infections;MODERATE;RECOVERED
Concomitant Medication|PHENAZOPYRIDINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|PRIMAXIN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Ache;Pain;Pain and discomfort NEC;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Abnormal ECG;Electrocardiogram abnormal;ECG investigations;NULL;NULL
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Segmented neutrophil count increased;Neutrophil count increased;White blood cell analyses;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|White blood cell count high;White blood cell count increased;White blood cell analyses;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Lymphocyte count low;Lymphocyte count decreased;White blood cell analyses;NULL;NULL
Adverse Event|General system disorders NEC|Feeling unwell;Malaise;Asthenic conditions;NULL;NULL
Adverse Event|Haematology investigations (incl blood groups)|Leukocyte count increased;White blood cell count increased;White blood cell analyses;MILD;RECOVERED
Lab Test|Urine Appearance|Clear
Lab Test|Urine Nitrite|-
Adverse Event|Hepatic and hepatobiliary disorders|Jaundice;Jaundice;Cholestasis and jaundice;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal inflammatory conditions|Reflux esophagitis;Reflux oesophagitis;Oesophagitis (excl infective);MODERATE;RECOVERED
Adverse Event|External ear disorders (excl congenital)|External ear inflammation;External ear inflammation;External ear infections and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Abnormal physical sensation;Sensory disturbance;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CIPRO HC OTIC|NULL;NULL;NULL
Adverse Event|Vision disorders|Near vision disturbance;Visual impairment;Visual disorders NEC;MILD;RECOVERED
Adverse Event|Glaucoma and ocular hypertension|Low tension glaucoma;Normal tension glaucoma;Glaucomas (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Hip injury;Joint injury;Limb injuries NEC (incl traumatic amputation);SEVERE;RECOVERED
Adverse Event|Bacterial infectious disorders|Streptococcal pharyngitis;Pharyngitis streptococcal;Streptococcal infections;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Sun sensitivity;Photosensitivity reaction;Photosensitivity conditions;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Viral infection;Viral infection;Viral infections NEC;SEVERE;RECOVERED
Adverse Event|Viral infectious disorders|Viral diarrhea;Viral diarrhoea;Viral infections NEC;SEVERE;RECOVERED
Adverse Event|Muscle disorders|Myalgia;Myalgia;Muscle pains;SEVERE;RECOVERED
Concomitant Medication|DURAVENT|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Acne;Acne;Acnes;Mild;NULL
Adverse Event|General system disorders NEC|Energy decreased;Asthenia;Asthenic conditions;Mild;NULL
Adverse Event|Neurological disorders NEC|Light-headed;Dizziness;Neurological signs and symptoms NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Taste perversion;Dysgeusia;Sensory abnormalities NEC;Mild;NULL
Concomitant Medication|PROMETRIUM|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands & feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;RECOVERED
Concomitant Medication|AXID AR|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM SALICYLATE|NULL;NULL;NULL
Concomitant Medication|SINE OFF|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Arm fracture;Upper limb fracture;Upper limb fractures and dislocations;Moderate;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Vertigo;Vertigo;Inner ear signs and symptoms;Moderate;NULL
Adverse Event|General system disorders NEC|Fatigue;Fatigue;Asthenic conditions;Severe;NULL
Adverse Event|Epidermal and dermal conditions|Itchy skin;Pruritus;Pruritus NEC;Severe;NULL
Adverse Event|Infections - pathogen unspecified|Ear infection;Ear infection;Ear infections;Moderate;NULL
Concomitant Medication|ACEON|4;QD (every day);Oral
Concomitant Medication|ACEON|8;QD (every day);Oral
Concomitant Medication|AMPICILLIN|500;QID (four times a day);Oral
Concomitant Medication|ASTELIN|2;BID (twice a day);Inhalation
Concomitant Medication|CIPRODEX|3;TID (three times a day);Otic (ear)
Concomitant Medication|ROBINUL|1-2;;Oral
Concomitant Medication|SINEMET|1;QHS (at bedtime);Oral
Concomitant Medication|TYLENOL COLD & FLU|1;QID (four times a day);Oral
Concomitant Medication|VITAMIN A|15;BID (twice a day);Oral
Concomitant Medication|VITAMIN B12|1000;Monthly or once a month;Intramuscular
Concomitant Medication|CIPRO|3;BID (twice a day);
Adverse Event|Neurological disorders NEC|Ataxia;Ataxia;Cerebellar coordination and balance disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold hands & feet;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Administration site reactions|Catheter site discharge;Catheter site discharge;Implant and catheter site reactions;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Neck rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED
Adverse Event|Ocular infections, irritations and inflammations|Itchy eyes;Eye pruritus;Ocular infections, inflammations and associated manifestations;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in extremity;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in hand;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in hand;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Pins and needles;Paraesthesia;Paraesthesias and dysaesthesias;SEVERE;RECOVERED
Adverse Event|Eye disorders NEC|Swollen eyes;Eye swelling;Ocular disorders NEC;MILD;RECOVERED
Concomitant Medication|ENZYME|NULL;NULL;NULL
Concomitant Medication|GRAMICIDIN|NULL;NULL;NULL
Concomitant Medication|NEDOCROMIL|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured ribs;Rib fracture;Thoracic cage fractures and dislocations;MILD;RECOVERED
Concomitant Medication|CO-GESIC|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ear ringing;Tinnitus;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Supraventricular tachycardia;Supraventricular tachycardia;Supraventricular arrhythmias;MODERATE;RECOVERED
Concomitant Medication|CARTIA XT|NULL;NULL;NULL
Concomitant Medication|DESITIN|NULL;NULL;NULL
Concomitant Medication|DILTIAZEM CD|NULL;NULL;NULL
Concomitant Medication|MEPERIDINE|NULL;NULL;NULL
Adverse Event|Cardiac arrhythmias|Bigeminy;Extrasystoles;Rate and rhythm disorders NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Mood disorders and disturbances NEC|Emotional reaction;Emotional disorder;Emotional and mood disturbances NEC;SEVERE;RECOVERED
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heartbeats irregular;Heart rate irregular;Heart rate and pulse investigations;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Tearfulness;Tearfulness;Mood alterations with depressive symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Tearfulness;Tearfulness;Mood alterations with depressive symptoms;SEVERE;RECOVERED
Adverse Event|Anaemias nonhaemolytic and marrow depression|Anemia;Anaemia;Anaemias NEC;Moderate;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression worsened;Depression;Depressive disorders;Moderate;NULL
Concomitant Medication|ANTIVERT|12.5;QID (four times a day);PEG
Concomitant Medication|AVAPRO|150;QD (every day);Oral
Concomitant Medication|AVAPRO|150;QD (every day);PEG
Concomitant Medication|ENSURE PLUS|1;;PEG
Concomitant Medication|FEOSOL|5;QD (every day);PEG
Concomitant Medication|MUCOMYST|3;TID (three times a day);Inhalation
Concomitant Medication|PRAVACHOL|20;QD (every day);Oral
Concomitant Medication|PRAVACHOL|20;QD (every day);PEG
Concomitant Medication|SAL-TROPINE|.4;PRN (as needed);Oral
Concomitant Medication|SAL-TROPINE|.4;PRN (as needed);PEG
Concomitant Medication|SAL-TROPINE|.8;QID (four times a day);PEG
Concomitant Medication|TYLENOL W/CODEINE NO. 3|240/24;PRN (as needed);PEG
Concomitant Medication|TYLENOL W/CODEINE NO. 3|240/24;PRN (as needed);Oral
Concomitant Medication|XANAX|.25;PRN (as needed);PEG
Concomitant Medication|ZANTAC|150;BID (twice a day);PEG
Concomitant Medication|ZOLOFT|150;QD (every day);PEG
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin neoplasms malignant and unspecified|Melanoma;Malignant melanoma;Skin melanomas (excl ocular);MILD;RECOVERED
Concomitant Medication|ZINC + VITAMIN C|NULL;NULL;NULL
Concomitant Medication|ABUFENE|NULL;NULL;NULL
Adverse Event|Urolithiases|Bladder calculus;Calculus bladder;Urinary tract lithiasis (excl renal);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stool discolored;Faeces discoloured;Faecal abnormalities NEC;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Sore throat;Oropharyngeal pain;Upper respiratory tract signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|LEVOCARNITINE|900;TID (three times a day);Oral
Concomitant Medication|MAGNESIUM ASPARTATE|1500;TID (three times a day);Oral
Concomitant Medication|ONO 2506|4;QD (every day);Oral
Concomitant Medication|VITAMIN B1|600;BID (twice a day);Oral
Adverse Event|Sleep disorders and disturbances|Difficulty sleeping;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL|125;QD (every day);Oral
Concomitant Medication|INFLUVAC|0.5;QD (every day);Oral
Concomitant Medication|KETOPROFEN|200;BID (twice a day);Oral
Concomitant Medication|SMECTITE|3;QD (every day);Oral
Concomitant Medication|TRAZODONE HYDROCHLORIDE|50;QD (every day);Oral
Concomitant Medication|ZOLPIDEM HEMITARTRATE|10;QD (every day);Oral
Concomitant Medication|AMOXICILLIN|1;QD (every day);Intravenous
Concomitant Medication|PARACETAMOL|1;PRN (as needed);Intravenous
Adverse Event|Bone and joint injuries|Toe injury;Limb injury;Limb injuries NEC (incl traumatic amputation);Mild;NULL
Adverse Event|Epidermal and dermal conditions|Body odor;Skin odour abnormal;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Dysequilibrium;Balance disorder;Cerebellar coordination and balance disturbances;MILD;RECOVERED
Concomitant Medication|NITRO|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Emesis;Vomiting;Nausea and vomiting symptoms;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Acute rhinitis;Rhinitis;Upper respiratory tract infections;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural pain;Procedural pain;Non-site specific procedural complications;Severe;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);         .;         .
Adverse Event|Gastrointestinal motility and defaecation conditions|Increased stool frequency;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Foot injury;Limb injury;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;Mild;NULL
Adverse Event|Infections - pathogen unspecified|Infected insect bite;Infected bites;Infections NEC;Moderate;NULL
Adverse Event|Respiratory disorders NEC|Bronchopneumopathy;Bronchopneumopathy;Respiratory tract disorders NEC;MODERATE;RECOVERED
Adverse Event|Viral infectious disorders|Zona;Herpes zoster;Herpes viral infections;MILD;RECOVERED
Concomitant Medication|DEXTROPROPOXYPHENE/ PARACETAMOL|NULL;NULL;NULL
Concomitant Medication|HEXALYSE|NULL;NULL;NULL
Concomitant Medication|MEPROBAMATE|NULL;NULL;NULL
Concomitant Medication|OZOTHINE A LA DIPROPHYLLINE|NULL;NULL;NULL
Concomitant Medication|SWEATOSAN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Electric shock sensation;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Weakness generalized;Asthenia;Asthenic conditions;SEVERE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Itchy rash;Rash pruritic;Pruritus NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Painful knee;Arthralgia;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NIMESULIDE|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Foot pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED
Adverse Event|Bone and joint injuries|Knee injury;Joint injury;Limb injuries NEC (incl traumatic amputation);MODERATE;RECOVERED
Concomitant Medication|CALCIUM|1500;BID (twice a day);Oral
Concomitant Medication|CREATINE|1400;BID (twice a day);Oral
Concomitant Medication|CREATINE|700;BID (twice a day);Oral
Concomitant Medication|DARVOCET-N|1-2;PRN (as needed);Oral
Concomitant Medication|IMODIUM AD|2;QD (every day);Oral
Concomitant Medication|PEPTO BISMOL|1;BID (twice a day);Oral
Concomitant Medication|PEPTO BISMOL|1;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1300;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1300;QD (every day);Oral
Concomitant Medication|XANAX|.25;BID (twice a day);Oral
Adverse Event|Injuries NEC|Muscle injury;Muscle injury;Muscle, tendon and ligament injuries;MODERATE;RECOVERED
Adverse Event|Joint disorders|Gonalgia;Arthralgia;Joint related signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Pricking skin sensation;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Venous insufficiency;Venous insufficiency;Non-site specific necrosis and vascular insufficiency NEC;MILD;RECOVERED
Concomitant Medication|ASASANTIN|NULL;NULL;NULL
Concomitant Medication|GELUPRANE|NULL;NULL;NULL
Concomitant Medication|PERSANTINE|NULL;NULL;NULL
Concomitant Medication|RYTHMOL|NULL;NULL;NULL
Concomitant Medication|SPASMAG|NULL;NULL;NULL
Concomitant Medication|TAHOR|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rib pain;Musculoskeletal chest pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Lyme disease;Lyme disease;Borrelial infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Skin irritation;Skin irritation;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Stomach virus;Gastroenteritis viral;Viral infections NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Creatinine blood increased;Blood creatinine increased;Renal function analyses;SEVERE;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urea increased;Blood urea increased;Renal function analyses;SEVERE;RECOVERED
Concomitant Medication|AZITROMYCINE|500;QD (every day);Oral
Concomitant Medication|PERINDOPRIL ARGININE|2.5+0.625;QD (every day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Heavy feeling in arms & legs;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness of head;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED
Concomitant Medication|ENZYME DIGEST|NULL;NULL;NULL
Concomitant Medication|L TAURINE|NULL;NULL;NULL
Concomitant Medication|VITAMIN E + MAGNESIUM|NULL;NULL;NULL
Lab Test|Hepatitis B Antigen|-
Adverse Event|Epidermal and dermal conditions|Hand rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Positional dizziness;Dizziness postural;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|MATRIX|NULL;NULL;NULL
Adverse Event|Vision disorders|Difficulty focusing eyes;Vision blurred;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CUTIVATE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;Severe;Resolved
Adverse Event|Administration site reactions|Injection site itching;Injection site pruritus;Injection site reactions;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;Moderate;Continuing
Adverse Event|Respiratory disorders NEC|Respiratory failure;Respiratory failure;Respiratory failures (excl neonatal);Life Threatening;Continuing
Adverse Event|Joint disorders|TMJ syndrome;Temporomandibular joint syndrome;Joint related disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Allergic skin reaction;Dermatitis allergic;Dermatitis and eczema;MODERATE;RECOVERED
Adverse Event|Allergic conditions|Sulfonamide allergy;Drug hypersensitivity;Allergies to foods, food additives, drugs and other chemicals;MODERATE;RECOVERED
Adverse Event|General system disorders NEC|Chest pressure;Chest discomfort;Pain and discomfort NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal inflammatory conditions|Esophagitis;Oesophagitis;Oesophagitis (excl infective);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cranial nerve disorders (excl neoplasms)|Altered smell sensation;Parosmia;Olfactory nerve disorders;MODERATE;UNKNOWN
Concomitant Medication|SULFAMETHIZOLE|NULL;NULL;NULL
Adverse Event|Gastrointestinal ulceration and perforation|Bleeding gastric ulcer;Gastric ulcer haemorrhage;Gastric ulcers and perforation;MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Systolic hypertension;Systolic hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Use of accessory respiratory muscles;Use of accessory respiratory muscles;Respiratory signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Faint;Syncope;Disturbances in consciousness NEC;Mild;NULL
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;Mild;NULL
Concomitant Medication|CALCIUM VITAMIN D|1000;QD (every day);Oral
Concomitant Medication|ELAVIL|20;QHS (at bedtime);Oral
Concomitant Medication|TAMOXIFEN|20;QD (every day);Oral
Adverse Event|Bone disorders (excl congenital and fractures)|Bone spur;Exostosis;Bone disorders NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Gas in stomach;Flatulence;Flatulence, bloating and distension;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Atelectasis;Atelectasis;Parenchymal lung disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Urinary tract signs and symptoms|Nocturnal frequency;Nocturia;Urinary tract signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Sleep apnea syndrome;Sleep apnoea syndrome;Breathing abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Aspiration;Aspiration;Respiratory tract disorders NEC;Marked;NULL
Adverse Event|Bacterial infectious disorders|Bacterial infection;Bacterial infection;Bacterial infections NEC;Moderate;NULL
Adverse Event|Bone, calcium, magnesium and phosphorus metabolism disorders|Hypocalcemia;Hypocalcaemia;Calcium metabolism disorders;Mild;NULL
Adverse Event|Cardiac arrhythmias|Tachycardia;Tachycardia;Rate and rhythm disorders NEC;Moderate;NULL
Concomitant Medication|AMITRIPTYLINE|30;QHS (at bedtime);PEG
Concomitant Medication|ANCEF|2;1 time only;Intravenous
Concomitant Medication|ATIVAN|2;1 time only;Intravenous
Concomitant Medication|ATROVENT|1;TID (three times a day);Inhalation
Concomitant Medication|BOTOX|80;1 time only;Subcutaneous
Concomitant Medication|CALCIUM GLUCONATE|1;PRN (as needed);Intravenous
Concomitant Medication|CARDIZEM|10;1 time only;Intravenous
Concomitant Medication|CIPRO|250;BID (twice a day);PEG
Concomitant Medication|CLINDAMYCIN|600;TID (three times a day);Intravenous
Concomitant Medication|COMBIVENT|2;PRN (as needed);Inhalation
Concomitant Medication|HYDROCHLOROTHIAZIDE|25;QD (every day);PEG
Concomitant Medication|LASIX|10;QD (every day);Intravenous
Concomitant Medication|LEVOQUIN|500;QD (every day);PEG
Concomitant Medication|LIDOCAINE|U;1 time only;Subcutaneous
Concomitant Medication|LOMOTIL|2.5;PRN (as needed);PEG
Concomitant Medication|LOVENOX|64;QD (every day);Subcutaneous
Concomitant Medication|MAGNESIUM SULFATE|2;PRN (as needed);Intravenous
Concomitant Medication|PAXIL|60;QD (every day);PEG
Concomitant Medication|POTASSIUM|10;PRN (as needed);Intravenous
Concomitant Medication|POTASSIUM|10;PRN (as needed);PEG
Concomitant Medication|POTASSIUM|20;PRN (as needed);Intravenous
Concomitant Medication|POTASSIUM|20;PRN (as needed);PEG
Concomitant Medication|POTASSIUM|4;PRN (as needed);Intravenous
Concomitant Medication|PREMARIN|1.25;QD (every day);Oral
Concomitant Medication|PREMARIN|1.25;QD (every day);PEG
Concomitant Medication|PRILOSEC|20;QD (every day);PEG
Concomitant Medication|ROBINUL|1;BID (twice a day);PEG
Concomitant Medication|SERAX|10;QD (every day);PEG
Concomitant Medication|XANAX|0.25;TID (three times a day);PEG
Concomitant Medication|VALIUM|10;QHS (at bedtime);PEG
Concomitant Medication|ZOSYN|3.375;QID (four times a day);Intravenous
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;Moderate;NULL
Adverse Event|Spinal cord and nerve root disorders|Sciatica;Sciatica;Lumbar spinal cord and nerve root disorders;Mild;NULL
Concomitant Medication|ANAFRANIL|25;;Oral
Concomitant Medication|LEXOMIL|1/4;;Oral
Concomitant Medication|MAGNE B6|1;;Oral
Concomitant Medication|XANAX|1;;Oral
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|TOCOFEROL|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Obstipation;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Oedema hands;Oedema peripheral;Oedema NEC;MILD;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural edema;Post procedural oedema;Non-site specific procedural complications;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|PIRITRAMIDE|NULL;NULL;NULL
Adverse Event|Cardiac disorder signs and symptoms|Cyanosis peripheral;Cyanosis;Cardiac signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dermatitis;Dermatitis;Dermatitis and eczema;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CONSTULOSE|NULL;NULL;NULL
Concomitant Medication|FERROGEN|NULL;NULL;NULL
Concomitant Medication|URISED|NULL;NULL;NULL
Concomitant Medication|CARDIZEM|180;QD (every day);Oral
Concomitant Medication|DHEA|200;QD (every day);Oral
Concomitant Medication|KLONOPIN|.5;QD (every day);Oral
Concomitant Medication|PEPCID AC|20;PRN (as needed);Oral
Concomitant Medication|PRAVACOL|40;QD (every day);Oral
Concomitant Medication|TUMS|1;PRN (as needed);Oral
Adverse Event|Water, electrolyte and mineral investigations|Serum bicarbonate increased;Blood bicarbonate increased;Mineral and electrolyte analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|White blood cell count decreased;White blood cell count decreased;White blood cell analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Infection parasitic;Infection parasitic;Infections NEC;MODERATE;RECOVERED
Concomitant Medication|HUMATIN|NULL;NULL;NULL
Concomitant Medication|TINIDAZOLE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Spastic bronchitis;Bronchitis;Lower respiratory tract and lung infections;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AZULFIDINE|NULL;NULL;NULL
Concomitant Medication|CLONT|NULL;NULL;NULL
Concomitant Medication|GAMMANEURON|NULL;NULL;NULL
Concomitant Medication|HYDERGINE|NULL;NULL;NULL
Concomitant Medication|XANTINOL NICOTINATE|NULL;NULL;NULL
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic hyperplasia;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;MILD;ONGOING (PERSISTENT)
Adverse Event|Bacterial infectious disorders|Erysipelas;Erysipelas;Streptococcal infections;Moderate;NULL
Concomitant Medication|VITAMIN E|1;;Oral
Adverse Event|Skin neoplasms malignant and unspecified|Basal cell carcinoma;Basal cell carcinoma;Skin neoplasms malignant and unspecified (excl melanoma);SEVERE;RECOVERED
Adverse Event|Joint disorders|Arthritic pains;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|ACICLOVIR SODIUM|NULL;NULL;NULL
Concomitant Medication|CALADRYL|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Syncope vasovagal;Syncope;Disturbances in consciousness NEC;MODERATE;RECOVERED
Adverse Event|Eye disorders NEC|Sore eye;Eye pain;Ocular disorders NEC;MILD;RECOVERED
Adverse Event|Neurological disorders NEC|Taste disturbance;Dysgeusia;Sensory abnormalities NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hiccough;Hiccups;Lower respiratory tract signs and symptoms;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Throat tightness;Throat tightness;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Floating feeling;Feeling abnormal;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Endocrine investigations (incl sex hormones)|Testosterone low;Blood testosterone decreased;Reproductive hormone analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Chest pain (non-cardiac);Non-cardiac chest pain;Pain and discomfort NEC;SEVERE;RECOVERED
Adverse Event|Oral soft tissue conditions|Numbness perioral;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Oral soft tissue conditions|Mouth pain;Oral pain;Oral soft tissue pain and paraesthesia;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac arrhythmias|Sinus arrhythmia;Sinus arrhythmia;Supraventricular arrhythmias;MILD;ONGOING (PERSISTENT)
Concomitant Medication|ANDRIOL|NULL;NULL;NULL
Concomitant Medication|BACAMPICILLIN|NULL;NULL;NULL
Concomitant Medication|FLUORIDE|NULL;NULL;NULL
Concomitant Medication|INFLAMASE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Productive cough;Productive cough;Coughing and associated symptoms;Moderate;NULL
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;Marked;NULL
Adverse Event|Respiratory disorders NEC|Nasal discharge;Rhinorrhoea;Upper respiratory tract signs and symptoms;Moderate;NULL
Concomitant Medication|ACETAMINOPHEN W/DIPHENHYDRAMINE HYDROCHLORIDE|1000/100;Five times per week;Oral
Concomitant Medication|ACETAMINOPHEN W/DIPHENHYDRAMINE HYDROCHLORIDE|500/50;QHS (at bedtime);Oral
Concomitant Medication|ASTELIN|1 spray;BID (twice a day);Inhalation
Concomitant Medication|BENADRYL|50;QHS (at bedtime);Oral
Concomitant Medication|BOOST|6;QD (every day);PEG
Concomitant Medication|CALTRATE PLUS|600;BID (twice a day);Oral
Concomitant Medication|CETACAINE|U;QD (every day);Topical
Concomitant Medication|CHONDROITIN|400;QD (every day);Oral
Concomitant Medication|CIPROFLOXACIN|250;BID (twice a day);Oral
Concomitant Medication|CIPROFLOXACIN|250;QD (every day);Oral
Concomitant Medication|DEXTROSE W/POTASSIUM CHLORIDE|85;Every hour;Intravenous
Concomitant Medication|DEMEROL|25;QD (every day);Intravenous
Concomitant Medication|DOXAZOCIN|2;QHS (at bedtime);Oral
Concomitant Medication|IMDUR|30;QD (every day);Oral
Concomitant Medication|IMODIUM|2;QD (every day);Oral
Concomitant Medication|IMODIUM|4;QD (every day);Oral
Concomitant Medication|INDERAL|120;QD (every day);Oral
Concomitant Medication|MORPHINE SULFATE|1;BID (twice a day);Intravenous
Concomitant Medication|MAALOX|3;QHS (at bedtime);Oral
Concomitant Medication|MILK OF MAGNESIA|U;QD (every day);Oral
Concomitant Medication|LYCOPENE W/MINERALS NOS/VITAMINS NOS|1;QD (every day);Oral
Concomitant Medication|NITROPASTE|1;QD (every day);Topical
Concomitant Medication|OXYGEN|2;QD (every day);Intranasal
Concomitant Medication|OXYCODONE|5;QD (every day);PEG
Concomitant Medication|RHINOCORT|2 sprays;QD (every day);Inhalation
Concomitant Medication|SURFAK|1;QD (every day);Oral
Concomitant Medication|TUMS 500 CALCIUM|600;BID (twice a day);Oral
Concomitant Medication|TUMS 500 CALCIUM|500;BID (twice a day);Oral
Concomitant Medication|TYLENOL PM|500;QHS (at bedtime);Oral
Concomitant Medication|VIAGRA|50;PRN (as needed);Oral
Concomitant Medication|ZOLOFT|150;QD (every day);Oral
Concomitant Medication|BORAGE OIL|NULL;NULL;NULL
Adverse Event|Synovial and bursal disorders|Olecranon bursitis;Bursitis;Bursal disorders;MODERATE;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Trigeminal neuralgia;Trigeminal neuralgia;Trigeminal disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|AMILORIDE HYDROCHLORIDE W/HYDROCHLOROTHIAZIDE|NULL;NULL;NULL
Concomitant Medication|DILZEM|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fracture of ankle;Ankle fracture;Lower limb fractures and dislocations;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Gingivitis;Gingivitis;Gingival disorders NEC;MODERATE;RECOVERED
Concomitant Medication|GARLITE|NULL;NULL;NULL
Concomitant Medication|MAGNESIUM MALATE|NULL;NULL;NULL
Concomitant Medication|OLIGOMERIC PROANTHOCYANIDIN W/RESVERATROL|NULL;NULL;NULL
Concomitant Medication|NICORETTE|NULL;NULL;NULL
Concomitant Medication|CALCIT|NULL;NULL;NULL
Concomitant Medication|CIRKAN|NULL;NULL;NULL
Concomitant Medication|ESIDREX|NULL;NULL;NULL
Concomitant Medication|LACTEOL FORT|NULL;NULL;NULL
Concomitant Medication|NIFLUGEL|NULL;NULL;NULL
Concomitant Medication|SACOLENE|NULL;NULL;NULL
Concomitant Medication|STERIMYCINE|NULL;NULL;NULL
Concomitant Medication|ALBUTEROL|3;;Inhalation
Concomitant Medication|COSOPT|1;QD (every day);
Concomitant Medication|TOPROL|7.5;QD (every day);Oral
Concomitant Medication|XALATAN|0.005;QD (every day);
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Pulse irregular;Heart rate irregular;Heart rate and pulse investigations;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Giddiness;Dizziness;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Haemoptysis;Haemoptysis;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|General system disorders NEC|Hangover effect;Hangover;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Body temperature conditions|High temperature;Pyrexia;Febrile disorders;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Inner ear infection;Labyrinthitis;Ear infections;MODERATE;RECOVERED
Concomitant Medication|CO-AMILOFRUSE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Bronchial pneumonia;Bronchopneumonia;Lower respiratory tract and lung infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Disease progression;Disease progression;General signs and symptoms NEC;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|MANTADIX|NULL;NULL;NULL
Concomitant Medication|NIDREL|NULL;NULL;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Left arm paresis;Monoparesis;Paralysis and paresis (excl cranial nerve);MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pneumonitis;Pneumonitis;Lower respiratory tract inflammatory and immunologic conditions;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;NULL;NULL
Adverse Event|Anxiety disorders and symptoms|Anxiety aggravated;Anxiety;Anxiety symptoms;NULL;NULL
Adverse Event|Aural disorders NEC|Ear pain;Ear pain;Ear disorders NEC;NULL;NULL
Adverse Event|Myocardial disorders|Cardiomegaly;Cardiomegaly;Myocardial disorders NEC;NULL;NULL
Adverse Event|White blood cell disorders|Eosinophilia;Eosinophilia;Eosinophilic disorders;NULL;NULL
Concomitant Medication|VIDARABINE|NULL;NULL;NULL
Concomitant Medication|VINCENTS|NULL;NULL;NULL
Lab Test|Urine Culture|GROUP B HEMOLYTIC STREPTOCOCCI 10,000-100,000 10E3
Adverse Event|Respiratory disorders NEC|Foreign body aspiration;Foreign body aspiration;Respiratory tract disorders NEC;SEVERE;RECOVERED
Adverse Event|Injuries NEC|Contusion of shoulder region;Contusion;Skin injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Contact dermatitis;Dermatitis contact;Dermatitis and eczema;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Exertional dyspnea;Dyspnoea exertional;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Pain head;Headache;Headaches NEC;MODERATE;RECOVERED
Adverse Event|Injuries NEC|Bruising of leg;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Lower abdominal pain;Abdominal pain lower;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Mental impairment disorders|Cognitive disorder;Cognitive disorder;Mental impairment (excl dementia and memory loss);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Systolic ejection murmur;Cardiac murmur;Cardiac auscultatory investigations;MILD;RECOVERED
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ESTRACOMB|NULL;NULL;NULL
Concomitant Medication|GELFOAM|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Disease progression;Disease progression;General signs and symptoms NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Calf pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Bone disorders (excl congenital and fractures)|Periostitis, without mention of osteomyelitis, involving lower leg;Periostitis;Bone disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eye dryness;Dry eye;Lacrimal disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Vertebral pain;Spinal pain;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Platelets increased;Platelet count increased;Platelet analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ALGESAL SURACTIVE|NULL;NULL;NULL
Concomitant Medication|DIPRIVAN|NULL;NULL;NULL
Concomitant Medication|FORADIL|NULL;NULL;NULL
Concomitant Medication|LACRIGEL|NULL;NULL;NULL
Concomitant Medication|LACRYPOS|NULL;NULL;NULL
Concomitant Medication|OROCAL VITAMINE D3|NULL;NULL;NULL
Concomitant Medication|SANDOCAL|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain back;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in leg;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in leg;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Mood disorders and disturbances NEC|Pseudobulbar affect;Affect lability;Affect alterations NEC;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Vision disorders|Visual disturbance;Visual impairment;Visual disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Weakness;Asthenia;Asthenic conditions;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BROMHEXINE|16;BID (twice a day);Oral
Concomitant Medication|CLONEX|0.5;QD (every day);Oral
Concomitant Medication|DICLOFENAC|75;Other (specify);Intramuscular
Concomitant Medication|ETORICOXIB|120;QD (every day);Oral
Concomitant Medication|MAGNESIUM|600;BID (twice a day);Oral
Concomitant Medication|SALBUTAMOL|300;TID (three times a day);Oral
Adverse Event|Respiratory disorders NEC|Sleep apnea;Sleep apnoea syndrome;Breathing abnormalities;Mild;NULL
Concomitant Medication|CARTIA|180;QD (every day);Oral
Concomitant Medication|NIASPAN|500;BID (twice a day);Oral
Concomitant Medication|NITROCOR|0.4;QD (every day);Rectal
Concomitant Medication|SERAZON|100;BID (twice a day);Oral
Adverse Event|Prostatic disorders (excl infections and inflammations)|Benign prostatic hyperplasia;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;Mild;NULL
Adverse Event|Respiratory disorders NEC|Short of breath;Dyspnoea;Breathing abnormalities;Marked;NULL
Adverse Event|Urinary tract signs and symptoms|Proteinuria;Proteinuria;Urinary abnormalities;Mild;NULL
Concomitant Medication|ADVAIR|250/50;QD (every day);Oral
Concomitant Medication|ALLEGRA D|120;BID (twice a day);Oral
Concomitant Medication|AMIBID DM|600;BID (twice a day);Oral
Concomitant Medication|AVALIDE|300/12.5;QD (every day);Oral
Concomitant Medication|AVELOX|400;QD (every day);Oral
Concomitant Medication|BACTRIM|400/80;BID (twice a day);Oral
Concomitant Medication|FENTANYL|100;1 time only;Intravenous
Concomitant Medication|MIDAZOLAM HYDROCHLORIDE|5;1 time only;Intravenous
Concomitant Medication|NASACORT|220;QD (every day);Inhalation
Concomitant Medication|RHINOCORT|1;BID (twice a day);Inhalation
Concomitant Medication|SMZ-TMP|800/160;BID (twice a day);Oral
Concomitant Medication|SENNA|436;BID (twice a day);Oral
Concomitant Medication|VITAMIN B12|U;Twice per week;Intramuscular
Adverse Event|Neurological disorders NEC|Speech disorder;Speech disorder;Speech and language abnormalities;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|MAGNESIUM CHLORIDE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Erythema facial;Erythema;Erythemas;Mild;NULL
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Enlargement of lymph nodes;Lymphadenopathy;Lymphatic system disorders NEC;Mild;NULL
Adverse Event|Injuries NEC|Falling;Fall;Non-site specific injuries NEC;Mild;NULL
Adverse Event|Epidermal and dermal conditions|Maculo-papular rash;Rash maculo-papular;Rashes, eruptions and exanthems NEC;Mild;NULL
Adverse Event|Oral soft tissue conditions|Ulcer mouth;Mouth ulceration;Stomatitis and ulceration;Mild;NULL
Concomitant Medication|ROBITUSSIN|1;QID (four times a day);Oral
Concomitant Medication|BETACAROTENE|15;QD (every day);Oral
Concomitant Medication|GARLIC|1000;QD (every day);Oral
Concomitant Medication|GINGER|500;QD (every day);Oral
Adverse Event|General system disorders NEC|General body pain;Pain;Pain and discomfort NEC;Mild;NULL
Adverse Event|General system disorders NEC|Foot oedema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Concomitant Medication|ALIZAPRIDE|NULL;NULL;NULL
Concomitant Medication|COLECALCIFEROL|NULL;NULL;NULL
Concomitant Medication|SALCATONIN|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Cold;Nasopharyngitis;Upper respiratory tract infections;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLSALICYLIC ACID|80;QD (every day);Oral
Concomitant Medication|FLUIMUCIL|600;QD (every day);Oral
Concomitant Medication|ISORDIL|5;PRN (as needed);Oral
Concomitant Medication|NORFLOXACINE|800;BID (twice a day);Oral
Concomitant Medication|PRAVASTATIN|40;QD (every day);Oral
Concomitant Medication|SYMBICORT|400/12;BID (twice a day);Inhalation
Concomitant Medication|NOVABRITINE|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Yawning;Yawning;Upper respiratory tract signs and symptoms;Mild;NULL
Concomitant Medication|EFFERALGAN|1;;Oral
Adverse Event|Respiratory disorders NEC|Rhinorrhea;Rhinorrhoea;Upper respiratory tract signs and symptoms;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Nail infection;Nail infection;Skin structures and soft tissue infections;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Macular rash;Rash macular;Rashes, eruptions and exanthems NEC;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Infected finger;Localised infection;Infections NEC;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;NULL;NULL
Concomitant Medication|ECONAZOLE|NULL;NULL;NULL
Concomitant Medication|SELEGILINE|NULL;NULL;NULL
Adverse Event|Body temperature conditions|Febrile reaction;Pyrexia;Febrile disorders;MILD;RECOVERED
Adverse Event|Salivary gland conditions|Sialorrhoea;Salivary hypersecretion;Salivary gland disorders NEC;MILD;RECOVERED
Adverse Event|Movement disorders (incl parkinsonism)|Trembling;Tremor;Tremor (excl congenital);MILD;RECOVERED
Concomitant Medication|NOVALGINA|NULL;NULL;NULL
Concomitant Medication|NOVALGINE|NULL;NULL;NULL
Concomitant Medication|RINOGUTT|NULL;NULL;NULL
Concomitant Medication|SARIDON A|NULL;NULL;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Presence of Q wave;Electrocardiogram Q waves;ECG investigations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Heat intolerance;Temperature intolerance;Feelings and sensations NEC;Mild;Continuing
Adverse Event|General system disorders NEC|Heat intolerance;Temperature intolerance;Feelings and sensations NEC;Moderate;Continuing
Adverse Event|General system disorders NEC|Heat intolerance;Temperature intolerance;Feelings and sensations NEC;Severe;Resolved with Residual
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Moderate;Resolved
Adverse Event|Bone and joint injuries|Fracture rib;Rib fracture;Thoracic cage fractures and dislocations;Mild;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Neck pain;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved with Residual
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Shoulder pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved with Residual
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;Severe;         .
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pains in legs;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Moderate;Resolved
Adverse Event|Skin appendage conditions|Excess sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;Moderate;Resolved
Adverse Event|Skin appendage conditions|Excess sweating;Hyperhidrosis;Apocrine and eccrine gland disorders;Severe;Resolved
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Rash all over;Rash generalised;Rashes, eruptions and exanthems NEC;Mild;Resolved
Adverse Event|Tongue conditions|Swollen tongue;Swollen tongue;Tongue signs and symptoms;Mild;Resolved
Adverse Event|Tongue conditions|Swollen tongue;Swollen tongue;Tongue signs and symptoms;Moderate;Resolved
Adverse Event|Tongue conditions|Swollen tongue;Swollen tongue;Tongue signs and symptoms;Severe;Resolved
Adverse Event|Cranial nerve disorders (excl neoplasms)|Strange smell sensation;Parosmia;Olfactory nerve disorders;Severe;Resolved
Adverse Event|Epidermal and dermal conditions|Body odor;Skin odour abnormal;Dermal and epidermal conditions NEC;Moderate;Resolved
Adverse Event|Urinary tract signs and symptoms|Urinary frequency;Pollakiuria;Bladder and urethral symptoms;Severe;         .
Adverse Event|Urinary tract signs and symptoms|Urinary urgency;Micturition urgency;Bladder and urethral symptoms;Severe;Resolved
Adverse Event|Neurological disorders NEC|Clonus of limbs;Clonus;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hypoglycemia;Hypoglycaemia;Hypoglycaemic conditions NEC;MILD;RECOVERED
Adverse Event|Platelet disorders|Thrombocytopenia;Thrombocytopenia;Thrombocytopenias;MILD;RECOVERED
Concomitant Medication|DEFEN-LA|NULL;NULL;NULL
Adverse Event|Muscle disorders|Lower extremities weakness of;Muscular weakness;Muscle weakness conditions;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of limbs;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Slow speech;Slow speech;Speech and language abnormalities;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CALCIPOT|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Seasonal rhinitis;Rhinitis seasonal;Nasal congestion and inflammations;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Shakiness;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);Mild;NULL
Adverse Event|General system disorders NEC|Leg edema;Oedema peripheral;Oedema NEC;Mild;NULL
Concomitant Medication|PROZAC|20;Four times per week;Oral
Concomitant Medication|PROZAC|40;Three times per week;Oral
Concomitant Medication|CREATINE MONOHYDRATE|5;TID (three times a day);Oral
Concomitant Medication|MULTIVITAMIN WITH MINERALS|1;QD (every day);Oral
Concomitant Medication|PREMPHASE|.625/5;QD (every day);Oral
Concomitant Medication|QUININE|325;Once per week;Oral
Concomitant Medication|SOMA|350;BID (twice a day);Oral
Concomitant Medication|THYROXINE|.75;Three times per week;Oral
Concomitant Medication|TYLENOL W/CODEINE NO. 3|300;BID (twice a day);Oral
Concomitant Medication|XANAX|.25;Monthly or once a month;Oral
Adverse Event|General system disorders NEC|Edema peripheral;Oedema peripheral;Oedema NEC;Marked;NULL
Adverse Event|Skin neoplasms malignant and unspecified|Skin cancer;Skin cancer;Skin neoplasms malignant and unspecified (excl melanoma);Marked;NULL
Concomitant Medication|LOVASTATIN|40;QD (every day);Oral
Concomitant Medication|MTV|1;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Chest infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MISSING DATA;MISSING DATA
Adverse Event|Deliria (incl confusion)|Nocturnal disorientation;Disorientation;Confusion and disorientation;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Orthopnoea;Orthopnoea;Breathing abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Bed sore;Decubitus ulcer;Skin injuries and mechanical dermatoses;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin vascular abnormalities|Purpuric rash;Purpura;Purpura and related conditions;MILD;RECOVERED
Adverse Event|Deliria (incl confusion)|Confusion;Confusional state;Confusion and disorientation;MILD;ONGOING (PERSISTENT)
Adverse Event|Disturbances in thinking and perception|Visual hallucinations;Hallucination, visual;Perception disturbances;MODERATE;RECOVERED
Concomitant Medication|SLEEPING|NULL;NULL;NULL
Adverse Event|External ear disorders (excl congenital)|Ear wax;Cerumen impaction;External ear disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DONEPEZIL|NULL;NULL;NULL
Concomitant Medication|TITRALAC|NULL;NULL;NULL
Adverse Event|Personality disorders and disturbances in behaviour|Aggression;Aggression;Behaviour and socialisation disturbances;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia aggravated;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;RECOVERED
Adverse Event|General system disorders NEC|Peripheral oedema;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatism;Prostatism;Prostatic signs, symptoms and disorders NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DOTHIEPIN HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|FINASTERIDE|NULL;NULL;NULL
Adverse Event|Upper respiratory tract disorders (excl infections)|Allergic rhinitis;Rhinitis allergic;Nasal congestion and inflammations;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Belching;Eructation;Dyspeptic signs and symptoms;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Belching;Eructation;Dyspeptic signs and symptoms;Moderate;NULL
Adverse Event|General system disorders NEC|Chest tightness;Chest discomfort;Pain and discomfort NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Flatulence;Flatulence;Flatulence, bloating and distension;Moderate;NULL
Adverse Event|Gastrointestinal signs and symptoms|Mucus stools;Mucous stools;Faecal abnormalities NEC;Mild;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Leg pain;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Bone and joint injuries|Toe injury;Limb injury;Limb injuries NEC (incl traumatic amputation);Moderate;NULL
Adverse Event|Viral infectious disorders|Stomach flu;Gastroenteritis viral;Viral infections NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Stools hard;Faeces hard;Faecal abnormalities NEC;Mild;NULL
Concomitant Medication|B 12|1000;Monthly or once a month;Intramuscular
Concomitant Medication|FLONASE|100;PRN (as needed);Inhalation
Concomitant Medication|NAPHCON|.025/.3;PRN (as needed);Inhalation
Concomitant Medication|REFRESH|42.5/57.3;QHS (at bedtime);Topical
Concomitant Medication|REFRESH CLASSIC LUCRICANT EYE DROPS|0.5;PRN (as needed);
Concomitant Medication|TYLENOL PM|500/25;PRN (as needed);Oral
Concomitant Medication|TYLENOL SINUS|500/30;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1950;BID (twice a day);Oral
Concomitant Medication|GLUCOSAMINE & CHONDROITIN|500;QD (every day);Oral
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;Mild;Continuing
Adverse Event|Gastrointestinal haemorrhages NEC|Rectal bleeding;Rectal haemorrhage;Intestinal haemorrhages;Mild;Resolved
Concomitant Medication|MEGESTROL|NULL;NULL;NULL
Adverse Event|Vascular hypertensive disorders|Hypertension arterial;Hypertension;Vascular hypertensive disorders NEC;SEVERE;RECOVERED
Adverse Event|Ocular neuromuscular disorders|Mydriasis;Mydriasis;Pupil disorders;SEVERE;RECOVERED
Concomitant Medication|COVATINE|NULL;NULL;NULL
Concomitant Medication|CREATINE|6/750;QD (every day);Oral
Concomitant Medication|ERYTHROMYCIN|330;TID (three times a day);Oral
Concomitant Medication|FLAXSEED OIL|1000;QD (every day);Oral
Concomitant Medication|GATIFLOXACIN|400;QD (every day);Oral
Concomitant Medication|GUAFENSIN|100/5;BID (twice a day);Oral
Concomitant Medication|LEVOQUIN|250;QD (every day);Oral
Concomitant Medication|LEVOQUIN|500;QD (every day);Oral
Concomitant Medication|SUPER ANTIOXIDANT|4;QD (every day);Oral
Concomitant Medication|TYLENOL ALLERGY SINUS|2;PRN (as needed);Oral
Concomitant Medication|VERAPAMIL|240;QD (every day);Oral
Concomitant Medication|ZOCOR|20;QHS (at bedtime);Oral
Adverse Event|Respiratory disorders NEC|Dry throat;Dry throat;Upper respiratory tract signs and symptoms;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Eye disorders NEC|Watering eyes;Lacrimation increased;Lacrimal disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Headaches|Temporal headache;Headache;Headaches NEC;MILD;RECOVERED
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Swollen glands;Lymphadenopathy;Lymphatic system disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ASILONE|NULL;NULL;NULL
Adverse Event|Skin neoplasms malignant and unspecified|Basal cell carcinoma;Basal cell carcinoma;Skin neoplasms malignant and unspecified (excl melanoma);MILD;RECOVERED
Adverse Event|Vascular hypertensive disorders|Hypertension;Hypertension;Vascular hypertensive disorders NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Contusion of knee;Contusion;Skin injuries NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Upset stomach;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Chest infection;Lower respiratory tract infection;Lower respiratory tract and lung infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Sleep disorders and disturbances|Insomnia exacerbated;Insomnia;Disturbances in initiating and maintaining sleep;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Dyspnea;Dyspnoea;Breathing abnormalities;SEVERE;UNDER TREATMENT/OBSERVATION
Adverse Event|Neurological disorders NEC|Paresthesia foot;Paraesthesia;Paraesthesias and dysaesthesias;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|AMITRIPTYLINE|10;Every morning;Oral
Concomitant Medication|AMITRIPTYLINE|10;Other (specify);Other (specify)
Concomitant Medication|AMITRIPTYLINE|20;Every morning;Oral
Concomitant Medication|AMITRIPTYLINE|20;Every morning;Other (specify)
Concomitant Medication|AMITRIPTYLINE|20;QHS (at bedtime);Oral
Concomitant Medication|DETROL LA|2;QD (every day);Oral
Concomitant Medication|FLAXSEED OIL|6;BID (twice a day);Oral
Concomitant Medication|FLURAZEPAM|15;QHS (at bedtime);Oral
Concomitant Medication|KLONOPIN|0.5;;Oral
Concomitant Medication|QUALAQUIN|324;QHS (at bedtime);Oral
Concomitant Medication|QUALAQUIN|324;QHS (at bedtime);Other (specify)
Concomitant Medication|RELIVE|3;QD (every day);Oral
Concomitant Medication|SCOPOLAMINE|15;Other (specify);Other (specify)
Concomitant Medication|STOOL SOFTENER|3;QD (every day);Oral
Concomitant Medication|STOOL SOFTENER|3;QD (every day);Other (specify)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal discomfort;Musculoskeletal discomfort;Musculoskeletal and connective tissue pain and discomfort;Mild;Continuing
Concomitant Medication|N-ACETYLCYSTEINE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Flu-like illness;Influenza like illness;General signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Gastrointestinal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|BISOPROLOL HEMIFUMARATE|NULL;NULL;NULL
Concomitant Medication|BUSCOPAN COMPOSITUM|NULL;NULL;NULL
Concomitant Medication|FOSFOMYCINE|NULL;NULL;NULL
Concomitant Medication|VENORUTON|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Scapula pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Skin scarring;Scar;Skin injuries NEC;MILD;RECOVERED
Adverse Event|Miscellaneous and site unspecified neoplasms benign|Angioma;Haemangioma;Cardiovascular neoplasms benign;MILD;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Weight increase;Weight increased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Fracture of face bones;Facial bones fracture;Skull fractures, facial bone fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Oral soft tissue conditions|Oral disorder;Oral disorder;Oral soft tissue disorders NEC;MODERATE;RECOVERED
Concomitant Medication|ESCLEROBION|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste abnormality;Dysgeusia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Headaches|Head pain;Headache;Headaches NEC;SEVERE;RECOVERED
Concomitant Medication|PYRIDIN|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Oedema lower limb;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Periarthritis;Periarthritis;Joint related disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Viral infectious disorders|Flu;Influenza;Influenza viral infections;SEVERE;RECOVERED
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BROMAZEPAM|1,5;QD (every day);Oral
Concomitant Medication|CEFUROXIN|1;QD (every day);Oral
Concomitant Medication|CIPROBAY|1000;BID (twice a day);Oral
Concomitant Medication|LIMPTAR|1;BID (twice a day);Oral
Concomitant Medication|MAGNESIUM|300;BID (twice a day);Oral
Concomitant Medication|RAMIPRIL|1;QD (every day);Oral
Concomitant Medication|ZOPICLONE|7,5;QD (every day);Oral
Concomitant Medication|AMOXAPINE|NULL;NULL;NULL
Concomitant Medication|COLBENEMID|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Body smell altered;Skin odour abnormal;Dermal and epidermal conditions NEC;Moderate;NULL
Adverse Event|Epidermal and dermal conditions|Body odor;Skin odour abnormal;Dermal and epidermal conditions NEC;Moderate;NULL
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;Severe;NULL
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;Moderate;NULL
Adverse Event|Neuromuscular disorders|Leg spasticity;Muscle spasticity;Neuromuscular disorders NEC;Moderate;NULL
Concomitant Medication|COENZYME Q10|one;QD (every day);Oral
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Vital capacity decreased;Vital capacity decreased;Respiratory and pulmonary function diagnostic procedures;Mild;Continuing
Adverse Event|Menstrual cycle and uterine bleeding disorders|Bleeding menstrual heavy;Menorrhagia;Menstruation with increased bleeding;Moderate;         .
Adverse Event|Neurological disorders NEC|Balance impaired NOS;Balance disorder;Cerebellar coordination and balance disturbances;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Chronic sinusitis;Chronic sinusitis;Upper respiratory tract infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Red blood cells urine;Red blood cells urine;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM-EAP|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders congenital|Malformation foot;Congenital foot malformation;Musculoskeletal and connective tissue disorders of limbs congenital;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Panic attack;Panic attack;Panic attacks and disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|White blood cells urine;White blood cells urine;Urinalysis NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|MEI CAL|NULL;NULL;NULL
Concomitant Medication|APO-NAPROXEN|NULL;NULL;NULL
Concomitant Medication|OXYCOCET|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Infected insect bite;Infected bites;Infections NEC;MODERATE;RECOVERED
Concomitant Medication|ALBUTEROL|2;PRN (as needed);Inhalation
Concomitant Medication|BISMUTH SUBSALICYLATE|525;BID (twice a day);Oral
Concomitant Medication|CLARITIN-D|5/120;PRN (as needed);Oral
Concomitant Medication|RANITIDINE|150;BID (twice a day);Oral
Adverse Event|Urinary tract signs and symptoms|Glycosuria;Glycosuria;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Aural disorders NEC|Ear congestion;Ear congestion;Ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy;Pruritus;Pruritus NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Arthralgia;Arthralgia;Joint related signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Physical examination topics|Wt loss;Weight decreased;Physical examination procedures;MILD;RECOVERED
Concomitant Medication|NORPACE CR|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Occipital neuralgia;Occipital neuralgia;Sensory abnormalities NEC;MODERATE;RECOVERED
Concomitant Medication|PARAMETASONE|NULL;NULL;NULL
Adverse Event|Reproductive neoplasms male benign|Prostate adenoma;Prostatic adenoma;Prostatic neoplasms benign;MILD;ONGOING (PERSISTENT)
Adverse Event|Peripheral neuropathies|Scalenus syndrome;Thoracic outlet syndrome;Peripheral neuropathies NEC;MILD;RECOVERED
Adverse Event|Allergic conditions|Seasonal allergy;Seasonal allergy;Atopic disorders;Mild;NULL
Adverse Event|Fungal infectious disorders|Jock itch;Tinea cruris;Tinea infections;MILD;ONGOING (PERSISTENT)
Adverse Event|Eye disorders NEC|Eyes stinging;Eye pain;Ocular disorders NEC;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Lumbago;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;NULL
Adverse Event|Cardiac arrhythmias|Sinus tachycardia;Sinus tachycardia;Supraventricular arrhythmias;Mild;NULL
Concomitant Medication|ACETYLCYSTEIN|100;QD (every day);Oral
Adverse Event|Epidermal and dermal conditions|Itchy skin;Pruritus;Pruritus NEC;MILD;RECOVERED
Concomitant Medication|DAYHIST-D|NULL;NULL;NULL
Concomitant Medication|HYDROCORT|NULL;NULL;NULL
Adverse Event|Appetite and general nutritional disorders|Decreased appetite;Decreased appetite;Appetite disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Diplopia;Diplopia;Visual disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site discomfort;Post procedural discomfort;Non-site specific procedural complications;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Acne;Acne;Acnes;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Angioedema and urticaria|Hives;Urticaria;Urticarias;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|AMERGE|NULL;NULL;NULL
Concomitant Medication|BUTALBIT/APAP/CAFFEINE PLUS|NULL;NULL;NULL
Concomitant Medication|CORRECTAL|NULL;NULL;NULL
Concomitant Medication|DURADRIN|NULL;NULL;NULL
Concomitant Medication|MAXALT|NULL;NULL;NULL
Concomitant Medication|MIGRANOL|NULL;NULL;NULL
Concomitant Medication|PRENATAL VITAMINS|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Cervical disc degeneration;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Chewing difficulty;Mastication disorder;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Aphasia;Aphasia;Cortical dysfunction NEC;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Urinary tract signs and symptoms|Difficulty voiding;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Eye disorders NEC|Eye swelling;Eye swelling;Ocular disorders NEC;MODERATE;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Feeling down;Depressed mood;Mood alterations with depressive symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain in upper extremities;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural and device related injuries and complications NEC|Stoma site discomfort;Post procedural discomfort;Non-site specific procedural complications;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Tracheo-bronchial secretion excess;Increased bronchial secretion;Lower respiratory tract signs and symptoms;SEVERE;RECOVERED
Adverse Event|Infections - pathogen unspecified|Upper respiratory tract infection;Upper respiratory tract infection;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Dizziness;Dizziness;Neurological signs and symptoms NEC;MILD;UNKNOWN
Concomitant Medication|DOXY WOLFF|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Swelling of hands;Oedema peripheral;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Edematous feet;Oedema peripheral;Oedema NEC;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|MEGAZYME|NULL;NULL;NULL
Adverse Event|Muscle disorders|Hands weakness of;Muscular weakness;Muscle weakness conditions;MODERATE;UNKNOWN
Adverse Event|General system disorders NEC|Hand swelling;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Embolism and thrombosis|Thrombosis leg;Thrombosis;Non-site specific embolism and thrombosis;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Coronary artery disorders|Cardiac ischemia;Myocardial ischaemia;Ischaemic coronary artery disorders;MILD;RECOVERED
Concomitant Medication|EPITIZIDE W/TRIAMTERENE|NULL;NULL;NULL
Adverse Event|Muscle disorders|Weakness muscle;Muscular weakness;Muscle weakness conditions;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|GERITOL|NULL;NULL;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CARLYTENE|NULL;NULL;NULL
Concomitant Medication|MADOPAR|NULL;NULL;NULL
Concomitant Medication|VASOBRAL|NULL;NULL;NULL
Lab Test|Urine blood|Negative
Adverse Event|Cornification and dystrophic skin disorders|Keratosis;Hyperkeratosis;Hyperkeratoses;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ZINC CITRATE|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Foot fracture;Foot fracture;Lower limb fractures and dislocations;Mild;Resolved
Adverse Event|Infections - pathogen unspecified|Pneumonia;Pneumonia;Lower respiratory tract and lung infections;Life Threatening;Resolved
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;Moderate;Resolved
Adverse Event|Urinary tract signs and symptoms|Painful urination;Dysuria;Bladder and urethral symptoms;Mild;Resolved
Adverse Event|Respiratory disorders NEC|Respiratory insufficiency;Respiratory failure;Respiratory failures (excl neonatal);Severe;Resolved with Residual
Concomitant Medication|KAOLIN PECTIN|NULL;NULL;NULL
Adverse Event|Ocular structural change, deposit and degeneration NEC|Retinal tear;Retinal tear;Retinal structural change, deposit and degeneration;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Gastroenteritis;Gastroenteritis;Abdominal and gastrointestinal infections;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Stress incontinence;Stress urinary incontinence;Bladder and urethral symptoms;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|VANCOCIN|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Choking;Choking;Upper respiratory tract signs and symptoms;Moderate;Resolved
Adverse Event|Viral infectious disorders|Cold sore mouth;Oral herpes;Herpes viral infections;Mild;Resolved
Concomitant Medication|REPLETE|NULL;NULL;NULL
Concomitant Medication|MULTIVITAMINS|NULL;NULL;NULL
Adverse Event|Hepatobiliary investigations|Gamma GT decreased;Gamma-glutamyltransferase decreased;Liver function analyses;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Perspiration excessive;Hyperhidrosis;Apocrine and eccrine gland disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Headaches|Headache transient;Headache;Headaches NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Tremor of hands;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Bilirubin abnormal;Blood bilirubin abnormal;Liver function analyses;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Bowel sounds abnormal;Gastrointestinal sounds abnormal;Abdominal findings abnormal;MODERATE;RECOVERED
Concomitant Medication|L ISOLEUCINE|NULL;NULL;NULL
Concomitant Medication|L VALINE|NULL;NULL;NULL
Adverse Event|Enzyme investigations NEC|Creatine phosphokinase increased;Blood creatine phosphokinase increased;Skeletal and cardiac muscle analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Appetite lost;Decreased appetite;Appetite disorders;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Cardiac disorder signs and symptoms|Palpitation;Palpitations;Cardiac signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|EMPORTAL|NULL;NULL;NULL
Concomitant Medication|LUTERAN|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Tracheitis;Tracheitis;Upper respiratory tract infections;MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|MYOREL|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Oral dryness;Dry mouth;Oral dryness and saliva altered;MILD;RECOVERED
Adverse Event|Bone and joint therapeutic procedures|Hallux Valgus correction;Bunion operation;Joint therapeutic procedures;SEVERE;RECOVERED
Concomitant Medication|CIPRALAN|NULL;NULL;NULL
Concomitant Medication|EUCOL|NULL;NULL;NULL
Concomitant Medication|STALTOR|NULL;NULL;NULL
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;Mild;Continuing
Adverse Event|Tissue disorders NEC|Chest mass NOS;Mass;Mass conditions NEC;Moderate;Continuing
Adverse Event|Joint disorders|Knee pain;Arthralgia;Joint related signs and symptoms;Mild;Continuing
Adverse Event|Bladder and bladder neck disorders (excl calculi)|Spastic bladder;Automatic bladder;Myoneurogenic bladder disorders;Mild;         .
Concomitant Medication|CARISOPRODOL W/PARACETAMOL|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Dyshidrosis;Dyshidrosis;Apocrine and eccrine gland disorders;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin desquamation;Skin exfoliation;Exfoliative conditions;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Sudation increased;Hyperhidrosis;Apocrine and eccrine gland disorders;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|ERYFLUID|NULL;NULL;NULL
Concomitant Medication|JONCTUM|NULL;NULL;NULL
Concomitant Medication|LACTACYD|NULL;NULL;NULL
Concomitant Medication|SERECOR|NULL;NULL;NULL
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;Moderate;Resolved
Adverse Event|General system disorders NEC|Edema hands;Oedema peripheral;Oedema NEC;Mild;Continuing
Adverse Event|Bronchial disorders (excl neoplasms)|Asthma;Asthma;Bronchospasm and obstruction;Mild;Resolved
Adverse Event|Lipid metabolism disorders|Hypercholesterolemia;Hypercholesterolaemia;Elevated cholesterol;Moderate;Continuing
Adverse Event|Infections - pathogen unspecified|Tooth infection;Tooth infection;Dental and oral soft tissue infections;Moderate;Resolved
Adverse Event|Respiratory disorders NEC|Postnasal drip;Postnasal drip;Upper respiratory tract signs and symptoms;Mild;Resolved
Concomitant Medication|ARISTOCORT|NULL;NULL;NULL
Adverse Event|Bacterial infectious disorders|Cellulitis of leg;Cellulitis;Bacterial infections NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Tissue disorders NEC|Dysplasia;Dysplasia;Trophic disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;SEVERE;RECOVERED
Adverse Event|Respiratory disorders NEC|Yawning;Yawning;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Adverse Event|Cranial nerve disorders (excl neoplasms)|Facial droop;Facial palsy;Facial cranial nerve disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Miscellaneous and site unspecified neoplasms malignant and unspecified|Squamous cell carcinoma;Squamous cell carcinoma;Neoplasms malignant site unspecified NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|EFUDEX|NULL;NULL;NULL
Concomitant Medication|TESTOSTERONE CIPIONATE|NULL;NULL;NULL
Adverse Event|Food intolerance syndromes|Enteral feeding intolerance;Enteral feeding intolerance;Food malabsorption and intolerance syndromes (excl sugar intolerance);SEVERE;RECOVERED
Concomitant Medication|AMITRIPTYLINE|100;TID (three times a day);Oral
Concomitant Medication|TAVOR|0.5;PRN (as needed);Other (specify)
Adverse Event|Ocular structural change, deposit and degeneration NEC|Floaters in eye;Myodesopsia;Choroid and vitreous structural change, deposit and degeneration;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Tenderness;Tenderness;Pain and discomfort NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Pulmonary congestion;Pulmonary congestion;Pulmonary oedemas;Mild;         .
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;Mild;Resolved
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Monocytes increased;Monocyte count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|White blood cell disorders|Leukopenia;Leukopenia;Leukopenias NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Yeast infection of the mouth;Oral fungal infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Photophobia;Photophobia;Ocular sensation disorders;SEVERE;RECOVERED
Adverse Event|Viral infectious disorders|Stomach flu;Gastroenteritis viral;Viral infections NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Uterine, pelvic and broad ligament disorders|Uterine polyp;Uterine polyp;Uterine neoplasms;MODERATE;RECOVERED
Concomitant Medication|CALTRATE PLUS|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Positive Babinski;Extensor plantar response;Abnormal reflexes;MILD;ONGOING (PERSISTENT)
Adverse Event|Procedural related injuries and complications NEC|Skin graft scar;Skin graft scar;Skin procedural complications;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Allergic conditions|Allergy;Hypersensitivity;Allergic conditions NEC;SEVERE;RECOVERED
Adverse Event|Cutaneous neoplasms benign|Wart;Skin papilloma;Skin neoplasms benign;MILD;RECOVERED
Concomitant Medication|DONNAGEL|NULL;NULL;NULL
Concomitant Medication|METHOCARBAMOL|NULL;NULL;NULL
Concomitant Medication|WESTCORT|NULL;NULL;NULL
Adverse Event|Electrolyte and fluid balance conditions|Dehydration;Dehydration;Total fluid volume decreased;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Paraesthesia lower limb;Paraesthesia;Paraesthesias and dysaesthesias;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Parkinson's disease;Parkinson's disease;Parkinson's disease and parkinsonism;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Shivers;Chills;Feelings and sensations NEC;Mild;Resolved
Adverse Event|Neurological disorders NEC|Taste diminished;Hypogeusia;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Cold extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;Mild;Continuing
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;Mild;Continuing
Adverse Event|Ocular infections, irritations and inflammations|Eye red;Ocular hyperaemia;Ocular infections, inflammations and associated manifestations;Mild;Resolved
Concomitant Medication|MESALAMINE|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Skin rash;Rash;Rashes, eruptions and exanthems NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|PAIN EASE|NULL;NULL;NULL
Adverse Event|Joint disorders|Gonalgia;Arthralgia;Joint related signs and symptoms;MODERATE;RECOVERED
Adverse Event|White blood cell disorders|Neutropenia;Neutropenia;Neutropenias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Tendon, ligament and cartilage disorders|Tendinitis;Tendonitis;Tendon disorders;MODERATE;RECOVERED
Concomitant Medication|TETRAZEPAM|NULL;NULL;NULL
Concomitant Medication|TIANEPTINE|NULL;NULL;NULL
Concomitant Medication|TROXERUTINE|NULL;NULL;NULL
Adverse Event|Thoracic disorders (excl lung and pleura)|Respiratory muscle weakness;Respiratory muscle weakness;Thoracic musculoskeletal disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Chest pressure;Chest discomfort;Pain and discomfort NEC;Mild;Continuing
Adverse Event|Administration site reactions|Injection site reaction NOS;Injection site reaction;Injection site reactions;Mild;Continuing
Adverse Event|Epidermal and dermal conditions|Eczema facial;Eczema;Dermatitis and eczema;Mild;NULL
Concomitant Medication|ALLEGRA|180;QD (every day);Oral
Concomitant Medication|AMBIEN|10;QD (every day);Oral
Concomitant Medication|CIPRO|250;BID (twice a day);Oral
Concomitant Medication|HYDROCORTISONE|1%;PRN (as needed);Topical
Concomitant Medication|TYLENOL COLD|2;PRN (as needed);Oral
Concomitant Medication|ULTRAM|50;QD (every day);Oral
Concomitant Medication|WELLBUTRIN|150;QD (every day);Oral
Concomitant Medication|DESOGESTREL|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Swallowing impaired;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Cutaneous neoplasms benign|Mole of skin;Melanocytic naevus;Skin neoplasms benign;MILD;RECOVERED
Adverse Event|White blood cell disorders|Neutrophilia;Neutrophilia;Leukocytoses NEC;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urinalysis abnormal NOS;Urine analysis abnormal;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Infected cyst;Infected cyst;Infections NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Use of accessory respiratory muscles;Use of accessory respiratory muscles;Respiratory signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Thyroid gland disorders|Thyroid disorder;Thyroid disorder;Thyroid disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Ocular sensory symptoms NEC|Eyes sensitive to sunlight;Photophobia;Ocular sensation disorders;MILD;RECOVERED
Adverse Event|Anxiety disorders and symptoms|Anxiety;Anxiety;Anxiety symptoms;SEVERE;UNKNOWN
Adverse Event|Lipid analyses|High cholesterol;Blood cholesterol increased;Cholesterol analyses;MILD;UNKNOWN
Adverse Event|Lipid analyses|Triglyceride increased;Blood triglycerides increased;Triglyceride analyses;MILD;UNKNOWN
Adverse Event|Sleep disorders and disturbances|Insomnia;Insomnia;Disturbances in initiating and maintaining sleep;MODERATE;UNKNOWN
Adverse Event|Respiratory disorders NEC|Sputum expectoration difficult;Sputum retention;Coughing and associated symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycaemia;Hyperglycaemia;Hyperglycaemic conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Phlegm;Increased upper airway secretion;Upper respiratory tract signs and symptoms;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Blistering of mouth;Oropharyngeal blistering;Upper respiratory tract signs and symptoms;MILD;RECOVERED
Concomitant Medication|CAPRIN|NULL;NULL;NULL
Adverse Event|Allergic conditions|Insect bite allergy;Allergy to arthropod bite;Allergic conditions NEC;Moderate;NULL
Adverse Event|Cardiac disorder signs and symptoms|Disorder circulatory system;Cardiovascular disorder;Cardiac disorders NEC;Mild;NULL
Adverse Event|Electrolyte and fluid balance conditions|Hypokalemia;Hypokalaemia;Potassium imbalance;Moderate;NULL
Adverse Event|Iron and trace metal metabolism disorders|Iron deficiency;Iron deficiency;Iron deficiencies;Moderate;NULL
Adverse Event|Infections - pathogen unspecified|Tracheitis;Tracheitis;Upper respiratory tract infections;Mild;NULL
Concomitant Medication|CALCIUM|1;;Oral
Concomitant Medication|RILUTEK|25;;Oral
Adverse Event|Infections - pathogen unspecified|Lung infection;Lung infection;Lower respiratory tract and lung infections;Mild;NULL
Adverse Event|Vascular inflammations|Phlebitis;Phlebitis;Phlebitis NEC;Mild;NULL
Concomitant Medication|ACETAMINOPHEN AND CODEINE|2;QD (every day);PEG
Concomitant Medication|ALBUTEROL SULFATE|.83;TID (three times a day);Inhalation
Concomitant Medication|AMITRIPTYLINE|150;BID (twice a day);PEG
Concomitant Medication|AMITRIPTYLINE|75;BID (twice a day);PEG
Concomitant Medication|AMITRIPTYLINE|25;BID (twice a day);PEG
Concomitant Medication|AMITRIPTYLINE HYDROCHLORIDE W/PERPHENAZINE|25/4;QD (every day);PEG
Concomitant Medication|AMITRIPTYLINE HYDROCHLORIDE W/PERPHENAZINE|25;QID (four times a day);PEG
Concomitant Medication|ASPIRIN|325;QD (every day);PEG
Concomitant Medication|BACTROBAN|U;TID (three times a day);Topical
Concomitant Medication|BIAXIN|500;BID (twice a day);PEG
Concomitant Medication|CEPHALEXIN|250;TID (three times a day);PEG
Concomitant Medication|CHERATUSSIN|2;PRN (as needed);Oral
Concomitant Medication|CLARINEX|5;QD (every day);PEG
Concomitant Medication|LEVAQUIN|250;QD (every day);PEG
Concomitant Medication|NORTRIPTYLINE HYDROCHLORIDE|6;BID (twice a day);PEG
Concomitant Medication|NORTRIPTYLINE HYDROCHLORIDE|7;;
Concomitant Medication|NORTRIPTYLINE HYDROCHLORIDE|8;;
Concomitant Medication|OMEPRAZOLE|20;QD (every day);PEG
Concomitant Medication|PROVIGIL|125;QD (every day);PEG
Concomitant Medication|PROVIGIL|100;QD (every day);PEG
Concomitant Medication|PROVIGIL|50;BID (twice a day);PEG
Concomitant Medication|ROBITUSSIN CF|2;;PEG
Concomitant Medication|TRIMAX|3;TID (three times a day);PEG
Concomitant Medication|TRIMOX|1000;BID (twice a day);PEG
Concomitant Medication|TYLENOL W/CODEINE NO. 3|U;BID (twice a day);PEG
Concomitant Medication|VITADVANCE|1;QD (every day);PEG
Concomitant Medication|ZITHROMAX|250;BID (twice a day);PEG
Adverse Event|Vascular disorders NEC|Flushing;Flushing;Peripheral vascular disorders NEC;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Itchy scalp;Pruritus;Pruritus NEC;Mild;         .
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;Moderate;         .
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhea recurrent;Diarrhoea;Diarrhoea (excl infective);Moderate;Resolved
Adverse Event|Administration site reactions|Injection site erythema;Injection site erythema;Injection site reactions;Mild;         .
Adverse Event|Gallbladder disorders|Cholecystitis;Cholecystitis;Cholecystitis and cholelithiasis;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Discoloration skin;Skin discolouration;Dermal and epidermal conditions NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Foot edema;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders congenital|Hyperekplexia;Hyperexplexia;Neurological disorders congenital NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Irritability;Irritability;General signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory disorders NEC|Increased shortness of breath;Dyspnoea;Breathing abnormalities;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural pain;Procedural pain;Non-site specific procedural complications;SEVERE;RECOVERED
Adverse Event|Joint disorders|Ankle swelling;Joint swelling;Joint related signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Epistaxis;Epistaxis;Nasal disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Skin and subcutaneous tissue disorders NEC|Leg ulcer;Skin ulcer;Skin and subcutaneous tissue ulcerations;MODERATE;RECOVERED
Adverse Event|Bone and joint therapeutic procedures|Joint manipulation;Joint manipulation;Joint therapeutic procedures;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Epidermal and dermal conditions|Skin lesion;Skin lesion;Dermal and epidermal conditions NEC;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DULAX|NULL;NULL;NULL
Concomitant Medication|LENTIZOL|NULL;NULL;NULL
Concomitant Medication|NOCTAMID|NULL;NULL;NULL
Adverse Event|Injuries NEC|Post-traumatic pain;Post-traumatic pain;Non-site specific injuries NEC;Mild;NULL
Adverse Event|Respiratory disorders NEC|Respiratory arrest;Respiratory arrest;Breathing abnormalities;Marked;NULL
Concomitant Medication|ALLEGRA-D|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|GI upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;NULL
Adverse Event|Anxiety disorders and symptoms|Nervous;Nervousness;Anxiety symptoms;Mild;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Tremor;Tremor;Tremor (excl congenital);Moderate;NULL
Adverse Event|Tissue disorders NEC|Cyst;Cyst;Mass conditions NEC;Mild;Continuing
Adverse Event|General system disorders NEC|Oedema;Oedema;Oedema NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Paralytic ileus;Ileus paralytic;Non-mechanical ileus;MODERATE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Anxiety postoperative;Anxiety postoperative;Neurological and psychiatric procedural complications;MILD;RECOVERED
Concomitant Medication|BEFACT|NULL;NULL;NULL
Concomitant Medication|BETHANECHOL CHLORIDE|NULL;NULL;NULL
Concomitant Medication|BRONCHOSEDAL|NULL;NULL;NULL
Concomitant Medication|URGENIN|NULL;NULL;NULL
Adverse Event|Urethral disorders (excl calculi)|Urethral false passage;Urethral disorder;Urethral disorders NEC;MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Hoarseness of voice;Dysphonia;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depression worsened;Depression;Depressive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Oedema limbs;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CLIMAXOL|NULL;NULL;NULL
Adverse Event|Eye disorders NEC|Eyes tearing;Lacrimation increased;Lacrimal disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Urolithiases|Kidney stone;Nephrolithiasis;Renal lithiasis;Mild;NULL
Adverse Event|Urolithiases|Kidney stones;Nephrolithiasis;Renal lithiasis;Marked;NULL
Adverse Event|General system disorders NEC|Malaise;Malaise;Asthenic conditions;Mild;NULL
Adverse Event|Neurological disorders NEC|Speech slurred;Dysarthria;Speech and language abnormalities;Mild;NULL
Concomitant Medication|CITROCIL|NULL;NULL;NULL
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of limbs;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Discoloration skin;Skin discolouration;Dermal and epidermal conditions NEC;MILD;RECOVERED
Adverse Event|Mental impairment disorders|Loss of memory;Amnesia;Memory loss (excl dementia);MILD;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Right inguinal hernia;Inguinal hernia;Inguinal hernias;MODERATE;RECOVERED
Concomitant Medication|HYDRALAZINE HYDROCHLORIDE|NULL;NULL;NULL
Adverse Event|Infections - pathogen unspecified|Lower urinary tract infection;Urinary tract infection;Urinary tract infections;MODERATE;RECOVERED
Adverse Event|Salivary gland conditions|Salivation;Salivary hypersecretion;Salivary gland disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal infection NOS;Fungal infection;Fungal infections NEC;MODERATE;RECOVERED
Concomitant Medication|PRIMATENE MIST|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine red blood cells increased;Red blood cells urine positive;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Joint disorders|Shoulder osteoarthritis;Osteoarthritis;Osteoarthropathies;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BLACKCURRANT C|NULL;NULL;NULL
Concomitant Medication|DIGESTASE|NULL;NULL;NULL
Concomitant Medication|SILVER COLLOIDAL|NULL;NULL;NULL
Concomitant Medication|TRACE MINERALS|NULL;NULL;NULL
Adverse Event|Respiratory disorders NEC|Respiratory tract congestion;Respiratory tract congestion;Respiratory tract disorders NEC;Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Wrist deformity;Wrist deformity;Extremity deformities;Mild;Resolved
Adverse Event|Sleep disorders and disturbances|Trouble falling asleep;Initial insomnia;Disturbances in initiating and maintaining sleep;MILD;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;Moderate;NULL
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Heart murmur;Cardiac murmur;Cardiac auscultatory investigations;Mild;NULL
Concomitant Medication|DOXAZOSIN|2;QD (every day);Oral
Adverse Event|Headaches|Migraine with aura;Migraine with aura;Migraine headaches;MILD;ONGOING (PERSISTENT)
Concomitant Medication|EBASTINE|NULL;NULL;NULL
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Aspiration pneumonia;Pneumonia aspiration;Lower respiratory tract inflammatory and immunologic conditions;Life Threatening;Continuing
Adverse Event|General system disorders NEC|Pain aggravated;Pain;Pain and discomfort NEC;Mild;Continuing
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;Mild;Continuing
Adverse Event|Bone and joint injuries|Broken ankle;Ankle fracture;Lower limb fractures and dislocations;Marked;NULL
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Lethargy;Lethargy;Disturbances in consciousness NEC;Marked;NULL
Concomitant Medication|ACTOS|NULL;NULL;NULL
Concomitant Medication|PRECOSE|NULL;NULL;NULL
Lab Test|White Blood Cell (WBC)|7,900
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain lower;Abdominal pain lower;Gastrointestinal and abdominal pains (excl oral and throat);Mild;NULL
Adverse Event|Ocular haemorrhages and vascular disorders NEC|Conjunctival hemorrhage;Conjunctival haemorrhage;Conjunctival and corneal bleeding and vascular disorders;Mild;NULL
Adverse Event|Joint disorders|Pain in joint involving shoulder region;Arthralgia;Joint related signs and symptoms;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Pain neck;Neck pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Sleep disorders and disturbances|Sleep difficult;Insomnia;Disturbances in initiating and maintaining sleep;Mild;NULL
Concomitant Medication|ATIVAN|0.5;QHS (at bedtime);Oral
Concomitant Medication|DALMANE|30;QHS (at bedtime);Oral
Concomitant Medication|SYNTHROID|137;QD (every day);Oral
Concomitant Medication|SYNTHROID|150;QD (every day);Oral
Concomitant Medication|VICODIN|7.5;QID (four times a day);Oral
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;SEVERE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Throbbing pain;Pain;Pain and discomfort NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Weakness of arms;Muscular weakness;Muscle weakness conditions;Severe;NULL
Adverse Event|General system disorders NEC|Fatigue aggravated;Fatigue;Asthenic conditions;Severe;NULL
Adverse Event|Muscle disorders|Muscle weakness aggravated;Muscular weakness;Muscle weakness conditions;Moderate;NULL
Adverse Event|Oral soft tissue conditions|Numbness mouth;Hypoaesthesia oral;Oral soft tissue signs and symptoms;Mild;NULL
Adverse Event|Muscle disorders|Leg cramps;Muscle spasms;Muscle related signs and symptoms NEC;Severe;NULL
Adverse Event|Muscle disorders|Muscle weakness;Muscular weakness;Muscle weakness conditions;Mild;NULL
Concomitant Medication|CIMETIDINE|400;BID (twice a day);Oral
Concomitant Medication|CLARITIN-D|12hr;PRN (as needed);Oral
Concomitant Medication|LEVOXYL|100;QD (every day);Oral
Concomitant Medication|LEVOXYL|88;QD (every day);Oral
Concomitant Medication|MV|1;PRN (as needed);Oral
Concomitant Medication|VITAMIN B5|1;QD (every day);Oral
Concomitant Medication|ZOCOR|10;QID (four times a day);Oral
Concomitant Medication|LEVONORGESTREL|NULL;NULL;NULL
Adverse Event|Neuromuscular disorders|Drop attacks;Drop attacks;Muscle tone abnormal;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Catheter infection;Catheter related infection;Infections NEC;MILD;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Micturition painful;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|ESTRIOL|NULL;NULL;NULL
Concomitant Medication|OFLOXACINE|NULL;NULL;NULL
Adverse Event|External ear disorders (excl congenital)|Wax in ear;Cerumen impaction;External ear disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Urinary tract signs and symptoms|Difficulty in micturition;Dysuria;Bladder and urethral symptoms;MILD;RECOVERED
Concomitant Medication|DEBROX|NULL;NULL;NULL
Adverse Event|Spinal cord and nerve root disorders|Cauda equina syndrome;Cauda equina syndrome;Spinal cord and nerve root disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neuromuscular disorders|Muscle fasciculation;Muscle contractions involuntary;Neuromuscular disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness of lower extremities;Hypoaesthesia;Sensory abnormalities NEC;Mild;Continuing
Adverse Event|Urinary tract signs and symptoms|Burning micturition;Dysuria;Bladder and urethral symptoms;MODERATE;RECOVERED
Adverse Event|Physical examination topics|Loss of weight;Weight decreased;Physical examination procedures;MILD;ONGOING (PERSISTENT)
Adverse Event|Fungal infectious disorders|Fungal skin infection;Fungal skin infection;Fungal infections NEC;MODERATE;RECOVERED
Adverse Event|Fungal infectious disorders|Fungal skin infection;Fungal skin infection;Fungal infections NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Swelling of limbs;Oedema peripheral;Oedema NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Bronchial secretion excessive;Increased bronchial secretion;Lower respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Uterine, pelvic and broad ligament disorders|Uterine polyp;Uterine polyp;Uterine neoplasms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|LAXAMALT|NULL;NULL;NULL
Concomitant Medication|LUCIDRIL|NULL;NULL;NULL
Concomitant Medication|MYTELASE|NULL;NULL;NULL
Concomitant Medication|RANIPLEX|NULL;NULL;NULL
Concomitant Medication|TRANSILANE|NULL;NULL;NULL
Adverse Event|Tissue disorders NEC|Healing abnormal;Impaired healing;Healing abnormal NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Psychiatric disorders NEC|Alcohol abuse;Alcohol abuse;Substance-related disorders;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)|Degeneration of lumbar or lumbosacral intervertebral disc;Intervertebral disc degeneration;Intervertebral disc disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Hepatobiliary investigations|Elevated liver enzymes;Hepatic enzyme increased;Liver function analyses;SEVERE;RECOVERED
Adverse Event|Psychiatric disorders NEC|Binge drinking;Binge drinking;Substance-related disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Skin scarring;Scar;Skin injuries NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Social phobia;Social phobia;Fear symptoms and phobic disorders (incl social phobia);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Spleen, lymphatic and reticuloendothelial system disorders|Splenomegaly;Splenomegaly;Spleen disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Emotional distress;Emotional distress;Emotional and mood disturbances NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Swelling of R knee;Joint swelling;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|NOVADERM|NULL;NULL;NULL
Concomitant Medication|NAPRATEC|NULL;NULL;NULL
Adverse Event|Coronary artery disorders|Myocardial infarction;Myocardial infarction;Ischaemic coronary artery disorders;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|FLUINDIONE|NULL;NULL;NULL
Concomitant Medication|NOMEGESTROL|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramp muscle;Muscle spasms;Muscle related signs and symptoms NEC;Moderate;NULL
Adverse Event|Viral infectious disorders|Shingles;Herpes zoster;Herpes viral infections;Moderate;NULL
Concomitant Medication|AMANTADINE|100;BID (twice a day);Oral
Concomitant Medication|ERYTHROMYCIN|1000;1 time only;Oral
Concomitant Medication|ERYTHROMYCIN|500;1 time only;Oral
Concomitant Medication|FAMVIR|500;TID (three times a day);Oral
Concomitant Medication|KLONOPIN|.5;QHS (at bedtime);Oral
Concomitant Medication|LIBRAX|5/2.5;BID (twice a day);Oral
Adverse Event|Skin vascular abnormalities|Ecchymosis;Ecchymosis;Purpura and related conditions;NULL;NULL
Adverse Event|Injuries NEC|Excoriation;Excoriation;Skin injuries NEC;NULL;NULL
Adverse Event|Changes in physical activity|Restless;Restlessness;Increased physical activity levels;NULL;NULL
Adverse Event|Skin and subcutaneous tissue disorders NEC|Proud flesh;Excessive granulation tissue;Skin and subcutaneous conditions NEC;NULL;NULL
Adverse Event|Administration site reactions|Injection site inflammation;Injection site inflammation;Injection site reactions;NULL;NULL
Concomitant Medication|MINOCYCLINE|100;PRN (as needed);Oral
Concomitant Medication|RESTORIL|30;QHS (at bedtime);Oral
Concomitant Medication|SONATA|10;QHS (at bedtime);Oral
Concomitant Medication|TUMS|1-2;PRN (as needed);Oral
Adverse Event|Epidermal and dermal conditions|Allergic skin reaction;Dermatitis allergic;Dermatitis and eczema;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Wrist fracture;Wrist fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ACECLOFENACO|NULL;NULL;NULL
Concomitant Medication|ACETYLSALICYLATE LYSINE|NULL;NULL;NULL
Concomitant Medication|RANITIDINA|NULL;NULL;NULL
Concomitant Medication|RANITIDINA R|NULL;NULL;NULL
Adverse Event|Joint disorders|Joint stiffness;Joint stiffness;Joint related signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Decreased and nonspecific blood pressure disorders and shock|Postural hypotension;Orthostatic hypotension;Vascular hypotensive disorders;MILD;ONGOING (PERSISTENT)
Concomitant Medication|CENTRUM PLUS|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Fractured finger;Hand fracture;Upper limb fractures and dislocations;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Sleep disorders and disturbances|Bizarre dreams;Abnormal dreams;Parasomnias;MODERATE;ONGOING (PERSISTENT)
Adverse Event|White blood cell disorders|Leukocytosis;Leukocytosis;Leukocytoses NEC;MILD;RECOVERED
Adverse Event|Muscle disorders|Nocturnal leg muscle cramps;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Facial paraesthesia;Paraesthesia;Paraesthesias and dysaesthesias;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;RECOVERED WITH SEQUELAE
Concomitant Medication|ANAESTHETIC|NULL;NULL;NULL
Concomitant Medication|VOLTAREN RESINAT|NULL;NULL;NULL
Adverse Event|Salivary gland conditions|Hypersalivation;Salivary hypersecretion;Salivary gland disorders NEC;NULL;NULL
Adverse Event|Joint disorders|Swollen ankles;Joint swelling;Joint related signs and symptoms;NULL;NULL
Adverse Event|Glucose metabolism disorders (incl diabetes mellitus)|Hyperglycemia;Hyperglycaemia;Hyperglycaemic conditions NEC;NULL;NULL
Concomitant Medication|ACTIFED COMPOUND LINCTUS|NULL;NULL;NULL
Concomitant Medication|YELLOW PHENOLPHTHALEIN|NULL;NULL;NULL
Concomitant Medication|LEGATRIN PM|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Exacerbation of asthma;Asthma;Bronchospasm and obstruction;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Pinkeye;Conjunctivitis infective;Eye and eyelid infections;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|RBC count abnormal;Red blood cell count abnormal;Red blood cell analyses;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Tongue conditions|Tongue black;Tongue discolouration;Tongue signs and symptoms;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Esophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Anxiety disorders and symptoms|Anxiety aggravated;Anxiety;Anxiety symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Cranial nerve disorders (excl neoplasms)|Smell alteration;Parosmia;Olfactory nerve disorders;MILD;RECOVERED
Adverse Event|Neuromuscular disorders|Muscle contractions involuntary;Muscle contractions involuntary;Neuromuscular disorders NEC;MILD;RECOVERED
Adverse Event|Metabolic and nutritional disorders congenital|Gilbert's syndrome;Gilbert's syndrome;Inborn errors of bilirubin metabolism;MILD;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|Generalized aching;Pain;Pain and discomfort NEC;Moderate;Resolved
Adverse Event|Gastrointestinal motility and defaecation conditions|Frequent bowel movements;Frequent bowel movements;Gastrointestinal spastic and hypermotility disorders;Moderate;Continuing
Adverse Event|Neurological disorders NEC|Loss of taste;Ageusia;Sensory abnormalities NEC;Mild;Continuing
Concomitant Medication|CODAMINE|NULL;NULL;NULL
Concomitant Medication|BROMPHENIRAMINE MALEATE W/PHENYLPROPANOLAMINE|NULL;NULL;NULL
Concomitant Medication|DEXTROMETHORPHAN W/GUAIFENESIN/PHENYLPROPANOLAMINE|NULL;NULL;NULL
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine glucose;Glucose urine;Urinalysis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Dental cavity;Dental caries;Dental and periodontal infections and inflammations;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Sore nose;Nasal discomfort;Upper respiratory tract signs and symptoms;MILD;ONGOING (PERSISTENT)
Concomitant Medication|FORMULA 1|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Bloating;Abdominal distension;Flatulence, bloating and distension;MILD;RECOVERED
Adverse Event|Renal and urinary tract investigations and urinalyses|Urine glucose;Glucose urine;Urinalysis NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Metabolic, nutritional and blood gas investigations|Hemoglobin A1C increased;Glycosylated haemoglobin increased;Carbohydrate tolerance analyses (incl diabetes);MILD;RECOVERED WITH SEQUELAE
Concomitant Medication|HYDROXYZINE HCL|NULL;NULL;NULL
Concomitant Medication|VANICREAM|NULL;NULL;NULL
Lab Test|Urine Yeast|-
Lab Test|Urine Leukesterase|1+
Lab Test|Urine Crystals|-
Lab Test|Urine Bacteria|-
Concomitant Medication|BEE PROPOLIS|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Anxiodepressive syndrome;Depression;Depressive disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Anxiodepressive syndrome;Depression;Depressive disorders;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Tonsillitis;Tonsillitis;Upper respiratory tract infections;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|BRISTAMOX|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Taste altered;Dysgeusia;Sensory abnormalities NEC;MILD;RECOVERED
Adverse Event|Tongue conditions|Burning tongue;Glossodynia;Tongue signs and symptoms;MILD;RECOVERED
Adverse Event|General system disorders NEC|Ankle edema;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Gastrointestinal signs and symptoms|Excessive flatulence;Flatulence;Flatulence, bloating and distension;SEVERE;RECOVERED
Adverse Event|Upper respiratory tract disorders (excl infections)|Nasal congestion;Nasal congestion;Nasal congestion and inflammations;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Viral infectious disorders|Cold sore mouth;Oral herpes;Herpes viral infections;MODERATE;RECOVERED
Adverse Event|Infections - pathogen unspecified|External ear infection NOS;Otitis externa;Ear infections;MODERATE;RECOVERED
Concomitant Medication|ACIDOPHILUS|2;QD (every day);Oral
Concomitant Medication|AVAPRO|75;QD (every day);Oral
Concomitant Medication|CALCIUM VITAMIN D|1800;QD (every day);Oral
Concomitant Medication|CEFUROXIME|1000;BID (twice a day);Oral
Concomitant Medication|CEPHALEXIN|1500;TID (three times a day);Oral
Concomitant Medication|CEPHALEXIN|2000;QID (four times a day);Oral
Concomitant Medication|COLACE|200;QD (every day);Oral
Concomitant Medication|CORTISONE|1;Other (specify);Intra-articular (joints)
Concomitant Medication|DANTROLENE|25;QD (every day);Oral
Concomitant Medication|ESTRADIOL|1;QD (every day);Oral
Concomitant Medication|FISH OIL|2000;QD (every day);Oral
Concomitant Medication|FLEXERIL|10;QHS (at bedtime);Oral
Concomitant Medication|FLEXERIL|5;QHS (at bedtime);Oral
Concomitant Medication|GAS X|1;QD (every day);Oral
Concomitant Medication|GAS X|2;PRN (as needed);Oral
Concomitant Medication|KEPPRA|125;QHS (at bedtime);Oral
Concomitant Medication|KEPPRA|250;BID (twice a day);Oral
Concomitant Medication|KEPPRA|250;QHS (at bedtime);Oral
Concomitant Medication|MAALOX|2;PRN (as needed);Oral
Concomitant Medication|METAMUCIL|2;QD (every day);Oral
Concomitant Medication|SYNTHROID|37;QD (every day);Oral
Concomitant Medication|TRAMADOL|5;PRN (as needed);Oral
Concomitant Medication|TYLENOL|1000;QHS (at bedtime);Oral
Concomitant Medication|ZOLOFT|25;;Oral
Concomitant Medication|ABREVA|1;TID (three times a day);Topical
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Ear hissing;Tinnitus;Inner ear signs and symptoms;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroparesis;Impaired gastric emptying;Gastrointestinal atonic and hypomotility disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Near fainting;Presyncope;Neurological signs and symptoms NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Mental impairment disorders|Memory loss;Amnesia;Memory loss (excl dementia);MILD;ONGOING (PERSISTENT)
Adverse Event|Vascular inflammations|Phlebitis lower limb;Phlebitis;Phlebitis NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|External ear disorders (excl congenital)|Wax in ear;Cerumen impaction;External ear disorders NEC;MILD;RECOVERED
Concomitant Medication|EAR DROPS RX|NULL;NULL;NULL
Concomitant Medication|MOTRIN IB|NULL;NULL;NULL
Adverse Event|Headaches|Chronic headaches;Headache;Headaches NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Hypoventilation;Hypoventilation;Breathing abnormalities;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|DIHYDROERGOTAMINE|NULL;NULL;NULL
Lab Test|Gamma-glutamyltransferase|Normal
Adverse Event|Menstrual cycle and uterine bleeding disorders|Cramps menstrual;Dysmenorrhoea;Menstruation and uterine bleeding NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac disorder signs and symptoms|Heart throbbing;Palpitations;Cardiac signs and symptoms NEC;MILD;RECOVERED
Adverse Event|Thyroid gland disorders|Hyperthyroidism;Hyperthyroidism;Thyroid hyperfunction disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Joint disorders|Stiffness joints;Joint stiffness;Joint related signs and symptoms;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;SEVERE;RECOVERED
Concomitant Medication|THYRONAJOD|NULL;NULL;NULL
Concomitant Medication|VIVIMED N|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Dysesthesia;Dysaesthesia;Paraesthesias and dysaesthesias;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Restless leg syndrome;Restless legs syndrome;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Condylar process of mandible, closed fracture;Jaw fracture;Skull fractures, facial bone fractures and dislocations;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Swallowing disorder;Dysphagia;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Cranial nerve disorders (excl neoplasms)|Tongue movement disturbance;Tongue paralysis;Hypoglossal nerve disorders;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|CITROFLAVONOID|NULL;NULL;NULL
Concomitant Medication|SIMVASTATINE|NULL;NULL;NULL
Concomitant Medication|NEUROBION FORTE|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Oedema hands;Oedema peripheral;Oedema NEC;MODERATE;RECOVERED
Adverse Event|Joint disorders|Swollen joints;Joint swelling;Joint related signs and symptoms;MODERATE;RECOVERED
Concomitant Medication|CHLORAMPHENICOL|NULL;NULL;NULL
Adverse Event|Injuries by physical agents|First degree burns;Burns first degree;Thermal burns;Moderate;NULL
Adverse Event|General system disorders NEC|Disease progression;Disease progression;General signs and symptoms NEC;Moderate;NULL
Concomitant Medication|MAGNESIUM|5;PRN (as needed);Oral
Adverse Event|Infections - pathogen unspecified|Labyrinthitis;Labyrinthitis;Ear infections;SEVERE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Asthmatic crisis;Asthmatic crisis;Bronchospasm and obstruction;MODERATE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchial hyperreactivity;Bronchial hyperreactivity;Bronchospasm and obstruction;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|General system disorders NEC|Leg oedema;Oedema peripheral;Oedema NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Urinary tract signs and symptoms|Pollakiuria;Pollakiuria;Bladder and urethral symptoms;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Respiratory infection;Respiratory tract infection;Infections NEC;SEVERE;RECOVERED
Concomitant Medication|CEFUROXIME AXETIL|1000;BID (twice a day);Oral
Concomitant Medication|LORAZEPAM|0,5;QD (every day);Oral
Concomitant Medication|TRAZODONE|100;QD (every day);Oral
Concomitant Medication|TRAZODONE|150;QD (every day);Oral
Concomitant Medication|LORAZEPAM|2;BID (twice a day);Oral
Concomitant Medication|TRAZODONE|200;QD (every day);Oral
Concomitant Medication|MAGNESIUM|121,5;;Oral
Concomitant Medication|MESTINON|60 - 0 - 30;;Oral
Concomitant Medication|AMOXICILLIN|875/125;BID (twice a day);Oral
Concomitant Medication|FLOVENT|44;BID (twice a day);Inhalation
Concomitant Medication|GUAIFENESIN|600;BID (twice a day);Oral
Concomitant Medication|RHINOCORT|32;QD (every day);Inhalation
Adverse Event|Embolism and thrombosis|Deep vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Injuries NEC|Laceration of arm;Skin laceration;Skin injuries NEC;MILD;RECOVERED
Concomitant Medication|VICKS FORMULA 44|NULL;NULL;NULL
Adverse Event|Epidermal and dermal conditions|Exanthema;Rash;Rashes, eruptions and exanthems NEC;MILD;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depression aggravated;Depression;Depressive disorders;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Depressed mood disorders and disturbances|Depression aggravated;Depression;Depressive disorders;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Syncope;Syncope;Disturbances in consciousness NEC;MILD;RECOVERED
Concomitant Medication|TOLPERISONE|NULL;NULL;NULL
Concomitant Medication|DEXIUM|20;QD (every day);Oral
Concomitant Medication|ELISOR|20;QD (every day);Oral
Concomitant Medication|GLUCOPHAGE|1000;QD (every day);Oral
Concomitant Medication|GLUCOVANCE|3;TID (three times a day);Oral
Concomitant Medication|HUMAN INSULIN MIX|;PRN (as needed);Subcutaneous
Concomitant Medication|KARDEGIC|75;QD (every day);Oral
Concomitant Medication|LUMIGAN|1;QD (every day);
Concomitant Medication|SECTRAL|20;QD (every day);Oral
Concomitant Medication|TRUSOPT|2;BID (twice a day);
Adverse Event|Anxiety disorders and symptoms|Agoraphobia;Agoraphobia;Fear symptoms and phobic disorders (incl social phobia);MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vascular hypertensive disorders|Hypertensive;Hypertension;Vascular hypertensive disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Mood disorders and disturbances NEC|Anger;Anger;Emotional and mood disturbances NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Haematology investigations (incl blood groups)|Monocytes decreased;Monocyte count decreased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophils increased;Neutrophil count increased;White blood cell analyses;MODERATE;RECOVERED
Adverse Event|Bronchial disorders (excl neoplasms)|COPD exacerbation;Chronic obstructive pulmonary disease;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Itchy;Pruritus;Pruritus NEC;Mild;Continuing
Adverse Event|Muscle disorders|Generalised muscle aches;Myalgia;Muscle pains;MILD;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Nail infection;Nail infection;Skin structures and soft tissue infections;Moderate;Resolved
Concomitant Medication|BENZTHIAZIDE|NULL;NULL;NULL
Adverse Event|Menopause and related conditions|Hot flushes menopausal;Menopausal symptoms;Menopausal effects NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Uncontrollable crying;Crying;Neurological signs and symptoms NEC;MODERATE;RECOVERED
Concomitant Medication|KLIOFEM|NULL;NULL;NULL
Concomitant Medication|NUVELLE|NULL;NULL;NULL
Concomitant Medication|SCOPODERM|NULL;NULL;NULL
Adverse Event|Urinary tract signs and symptoms|Bladder spasm;Bladder spasm;Bladder and urethral symptoms;Mild;NULL
Adverse Event|Eye therapeutic procedures|Cataract extraction;Cataract operation;Lens therapeutic procedures;Mild;NULL
Adverse Event|General system disorders NEC|Difficulty in walking;Gait disturbance;Gait disturbances;Mild;NULL
Concomitant Medication|LINOLEIC ACID|NULL;NULL;NULL
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;Mild;NULL
Adverse Event|Gastrointestinal signs and symptoms|Distress gastrointestinal;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Mild;NULL
Adverse Event|Sexual function and fertility disorders|Impotence;Erectile dysfunction;Erection and ejaculation conditions and disorders;Mild;NULL
Adverse Event|Joint disorders|Pain ankle;Arthralgia;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|GUAFENSIN|NULL;NULL;NULL
Adverse Event|Urolithiases|Urolithiasis;Calculus urinary;Urinary tract lithiasis (excl renal);MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|OXYBUTYNIN|15;TID (three times a day);Oral
Concomitant Medication|PANDEMRIX|1;Other (specify);Subcutaneous
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;Mild;NULL
Adverse Event|General system disorders NEC|Swelling;Swelling;General signs and symptoms NEC;Mild;NULL
Adverse Event|Joint disorders|Arthralgia aggravated;Arthralgia;Joint related signs and symptoms;Mild;NULL
Concomitant Medication|B-12|500;QD (every day);Oral
Adverse Event|Dental and gingival conditions|Gum bleeding;Gingival bleeding;Gingival haemorrhages;MODERATE;RECOVERED
Adverse Event|Epidermal and dermal conditions|Dermatitis;Dermatitis;Dermatitis and eczema;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Facial rash;Rash;Rashes, eruptions and exanthems NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Musculoskeletal pain;Musculoskeletal pain;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Infections - pathogen unspecified|Infected toe;Localised infection;Infections NEC;SEVERE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Flank pain;Flank pain;Musculoskeletal and connective tissue pain and discomfort;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|BROMODIPHENHYDRAMINE HYDROCHLORIDE|NULL;NULL;NULL
Concomitant Medication|DOMEBORO|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depressed mood;Depressed mood;Mood alterations with depressive symptoms;MODERATE;RECOVERED WITH SEQUELAE
Concomitant Medication|ACETOSAL|NULL;NULL;NULL
Concomitant Medication|CINNARIZINE|NULL;NULL;NULL
Concomitant Medication|INSULIN MIXTARD|NULL;NULL;NULL
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural pain;Procedural pain;Non-site specific procedural complications;Moderate;NULL
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;Marked;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Loose bowels;Diarrhoea;Diarrhoea (excl infective);Moderate;NULL
Adverse Event|Oral soft tissue conditions|Burning oral sensation;Oral discomfort;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Chronic cough;Cough;Coughing and associated symptoms;MILD;RECOVERED
Adverse Event|Respiratory disorders NEC|Dry throat;Dry throat;Upper respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Tendon, ligament and cartilage disorders|Trigger finger;Trigger finger;Tendon disorders;MILD;RECOVERED
Concomitant Medication|MYAMBUTOL|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Jitteriness;Feeling jittery;Feelings and sensations NEC;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Exanthema;Rash;Rashes, eruptions and exanthems NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Vision disorders|Hazy vision;Vision blurred;Visual disorders NEC;MILD;RECOVERED
Adverse Event|Infections - pathogen unspecified|Bladder infection;Cystitis;Urinary tract infections;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ACETYLSALICYLATE CALCIUM|38;QD (every day);Oral
Concomitant Medication|OXAZEPAM|20;BID (twice a day);Oral
Concomitant Medication|PROPRANOLOL|80;QD (every day);Oral
Concomitant Medication|THYRAX|0.075;TID (three times a day);Oral
Concomitant Medication|VIDISIC|2;BID (twice a day);
Concomitant Medication|MIXTURA SOLVENTS|UNK;Other (specify);Oral
Concomitant Medication|MOVICOLON|13.8;QD (every day);Oral
Concomitant Medication|CHLORHEXIDINE GLUCONATE|NULL;NULL;NULL
Concomitant Medication|SENNA-S|NULL;NULL;NULL
Concomitant Medication|SODIUM PHOSPHATE|NULL;NULL;NULL
Adverse Event|Prostatic disorders (excl infections and inflammations)|Prostatic hypertrophy;Benign prostatic hyperplasia;Prostatic neoplasms and hypertrophy;Moderate;NULL
Concomitant Medication|VITAMIN E|1000  [5000/dayly];TID (three times a day);Oral
Adverse Event|Bone and joint injuries|Vertebral fracture;Spinal fracture;Spinal fractures and dislocations;SEVERE;RECOVERED
Concomitant Medication|SYNACTHENE|NULL;NULL;NULL
Adverse Event|Administration site reactions|Injection site pain;Injection site pain;Injection site reactions;MILD;RECOVERED
Adverse Event|Eye therapeutic procedures|LASIK eye surgery;Keratomileusis;Corneal and scleral therapeutic procedures;MILD;RECOVERED
Concomitant Medication|ASPIRIN|2;Other (specify);Oral
Concomitant Medication|EXOCIN|16;QID (four times a day);
Concomitant Medication|IBUPROFEN|4;BID (twice a day);Oral
Concomitant Medication|MAXIDEX|12;Other (specify);
Concomitant Medication|MAXIDEX|4;BID (twice a day);
Concomitant Medication|PROXYMETACAINE|4;Other (specify);
Concomitant Medication|SULFURIC ACID|1;Other (specify);Topical
Concomitant Medication|DELSYM|1;QD (every day);Oral
Concomitant Medication|MUCINEX DM|1;QHS (at bedtime);Oral
Concomitant Medication|PROAIR HFA|1;PRN (as needed);Inhalation
Adverse Event|Gastrointestinal conditions NEC|Hyperacidity;Hyperchlorhydria;Gastrointestinal mucosal dystrophies and secretion disorders;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|LITHIUM|600;QD (every day);Oral
Concomitant Medication|AMOXICILLIN|1000;TID (three times a day);Oral
Adverse Event|Infections - pathogen unspecified|Oral infection;Oral infection;Dental and oral soft tissue infections;Mild;NULL
Concomitant Medication|ELAVIL|10;TID (three times a day);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Back stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Sinusitis;Sinusitis;Upper respiratory tract infections;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Tingling sensation;Paraesthesia;Paraesthesias and dysaesthesias;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|LICORICE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal crampy pains;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);Moderate;NULL
Adverse Event|Gastrointestinal stenosis and obstruction|Bowel obstruction;Intestinal obstruction;Gastrointestinal stenosis and obstruction NEC;Marked;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Heaviness in limbs;Sensation of heaviness;Musculoskeletal and connective tissue signs and symptoms NEC;Moderate;NULL
Adverse Event|Bone and joint injuries|Injury to hand NOS;Limb injury;Limb injuries NEC (incl traumatic amputation);Moderate;NULL
Adverse Event|Fungal infectious disorders|Yeast infection;Fungal infection;Fungal infections NEC;Moderate;NULL
Concomitant Medication|INHIBIN|100;;Oral
Concomitant Medication|OLEOSORBATE 80|NULL;NULL;NULL
Concomitant Medication|THIAMPHENICOL GLYCINATE ACETYLCYSTEINE|NULL;NULL;NULL
Concomitant Medication|VITAPANTOL|NULL;NULL;NULL
Adverse Event|Cranial nerve disorders (excl neoplasms)|Facial paresis;Facial paresis;Facial cranial nerve disorders;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Neurological disorders NEC|Numbness;Hypoaesthesia;Sensory abnormalities NEC;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Neurological disorders NEC|Numbness of head;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|General system disorders NEC|Pain chest;Chest pain;Pain and discomfort NEC;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain upper;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rheumatic disorder;Rheumatic disorder;Musculoskeletal and connective tissue pain and discomfort;MILD;ONGOING (PERSISTENT)
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rheumatic disorder;Rheumatic disorder;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Rheumatic disorder;Rheumatic disorder;Musculoskeletal and connective tissue pain and discomfort;MILD;RECOVERED WITH SEQUELAE
Adverse Event|Eye disorders NEC|Tearing eyes;Lacrimation increased;Lacrimal disorders;MILD;ONGOING (PERSISTENT)
Adverse Event|Retina, choroid and vitreous haemorrhages and vascular disorders|Arteriosclerosis retinal;Arteriosclerotic retinopathy;Retinopathies NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Peripheral arterial occlusive disease;Peripheral arterial occlusive disease;Peripheral vasoconstriction, necrosis and vascular insufficiency;MILD;ONGOING (PERSISTENT)
Adverse Event|Appetite and general nutritional disorders|Malnutrition;Malnutrition;General nutritional disorders NEC;MILD;SEQUELAE
Adverse Event|Neurological disorders NEC|Coordination impaired;Coordination abnormal;Cerebellar coordination and balance disturbances;MODERATE;UNDER TREATMENT/OBSERVATION
Adverse Event|Physical examination topics|Weight loss;Weight decreased;Physical examination procedures;MODERATE;SEQUELAE
Concomitant Medication|AUGMENTIN|875-125;BID (twice a day);Oral
Concomitant Medication|AZITHROMYCIN|250;QD (every day);Oral
Concomitant Medication|BARIUM|UNK;Other (specify);Oral
Concomitant Medication|DOCUSATE|2;PRN (as needed);Oral
Concomitant Medication|FLOVENT|4;BID (twice a day);Inhalation
Concomitant Medication|ISOVUE 300|20;Other (specify);Unknown
Concomitant Medication|NAPROXEN|500;PRN (as needed);Oral
Concomitant Medication|NUEDEXTA|30/10;PRN (as needed);Oral
Concomitant Medication|PERCOCET|1;PRN (as needed);Oral
Concomitant Medication|PREDNISONE|40;;Oral
Concomitant Medication|SENNA|2;PRN (as needed);Oral
Concomitant Medication|SUPEROXIDE DISMUTASE|200;BID (twice a day);Oral
Concomitant Medication|XYLOCAINE|UNK;Other (specify);Subcutaneous
Concomitant Medication|TRAMADOL|2;QHS (at bedtime);Oral
Adverse Event|Gastrointestinal signs and symptoms|Stomach upset;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Discolored stools;Faeces discoloured;Faecal abnormalities NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Ankle sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);Severe;NULL
Concomitant Medication|OMIX|1;;Oral
Adverse Event|Appetite and general nutritional disorders|High weight;Overweight;General nutritional disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|General system disorders NEC|General malaise;Malaise;Asthenic conditions;MILD;ONGOING (PERSISTENT)
Adverse Event|Lipid analyses|Lipids serum increased;Lipids increased;Lipoprotein and lipid tests NEC;MILD;RECOVERED
Concomitant Medication|BENZTROPINE MESYLATE|NULL;NULL;NULL
Concomitant Medication|INDOTEC|NULL;NULL;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Mobility decreased;Mobility decreased;Musculoskeletal and connective tissue signs and symptoms NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Renal and urinary tract investigations and urinalyses|Protein urine positive;Protein urine present;Urinalysis NEC;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hematocrit low;Haematocrit decreased;Red blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Hemoglobin low;Haemoglobin decreased;Red blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Neutrophil count low;Neutrophil count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Red blood cell count low;Red blood cell count decreased;Red blood cell analyses;MODERATE;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|Red blood cell count low;Red blood cell count decreased;Red blood cell analyses;MILD;RECOVERED
Adverse Event|Haematology investigations (incl blood groups)|White blood cell count decreased;White blood cell count decreased;White blood cell analyses;MILD;RECOVERED
Adverse Event|Epidermal and dermal conditions|Skin peeling;Skin exfoliation;Exfoliative conditions;MILD;ONGOING (PERSISTENT)
Concomitant Medication|DIOCTYL SODIUM SULPHOSUCCINATE|NULL;NULL;NULL
Concomitant Medication|SCOPACE|NULL;NULL;NULL
Adverse Event|Gastrointestinal signs and symptoms|Abdominal discomfort;Abdominal discomfort;Gastrointestinal signs and symptoms NEC;Moderate;NULL
Adverse Event|Fungal infectious disorders|Yeast infection of the skin;Fungal skin infection;Fungal infections NEC;Mild;NULL
Adverse Event|Gallbladder disorders|Gallstones;Cholelithiasis;Cholecystitis and cholelithiasis;Mild;NULL
Adverse Event|Bone and joint injuries|Knee injury;Joint injury;Limb injuries NEC (incl traumatic amputation);Mild;NULL
Adverse Event|Water, electrolyte and mineral investigations|Potassium increased;Blood potassium increased;Mineral and electrolyte analyses;Mild;NULL
Adverse Event|Bone and joint injuries|Knee sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);Mild;NULL
Adverse Event|Bone and joint injuries|Injury to shoulder NOS;Joint injury;Limb injuries NEC (incl traumatic amputation);Mild;NULL
Concomitant Medication|YEAST DRIED|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Hair depigmented;Hair colour changes;Pilar disorders NEC;Mild;NULL
Adverse Event|Joint disorders|Frozen shoulder;Periarthritis;Joint related disorders NEC;Mild;NULL
Concomitant Medication|CELEBREX|100;QD (every day);Oral
Adverse Event|Infections - pathogen unspecified|Abscess of toe;Abscess limb;Infections NEC;Mild;NULL
Adverse Event|General system disorders NEC|Peripheral edema;Oedema peripheral;Oedema NEC;Mild;NULL
Concomitant Medication|KEFLEX|500;QID (four times a day);Oral
Concomitant Medication|VITAMIN B12|100;Monthly or once a month;Oral
Adverse Event|Muscle disorders|Cramp legs;Muscle spasms;Muscle related signs and symptoms NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Laryngitis;Laryngitis;Upper respiratory tract infections;SEVERE;RECOVERED
Adverse Event|Headaches|Sinus headache;Sinus headache;Headaches NEC;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Respiratory disorders NEC|Snoring;Snoring;Upper respiratory tract signs and symptoms;SEVERE;ONGOING (PERSISTENT)
Concomitant Medication|ANTACIDS|NULL;NULL;NULL
Adverse Event|General system disorders NEC|Asthenia;Asthenia;Asthenic conditions;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BACLOFEN|300;TID (three times a day);Oral
Concomitant Medication|HEXAQUINE|3;TID (three times a day);Oral
Adverse Event|Skin and subcutaneous tissue disorders NEC|Skin mass;Skin mass;Skin and subcutaneous conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Changes in physical activity|Bruxism;Bruxism;Stereotypies and automatisms;MILD;RECOVERED
Adverse Event|Gastrointestinal motility and defaecation conditions|Urgent diarrhea;Diarrhoea;Diarrhoea (excl infective);MODERATE;RECOVERED
Adverse Event|Respiratory disorders NEC|Nasal discharge;Rhinorrhoea;Upper respiratory tract signs and symptoms;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Vision disorders|Flashing lights;Photopsia;Visual disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Gastrointestinal signs and symptoms|Stomach pain;Abdominal pain upper;Gastrointestinal and abdominal pains (excl oral and throat);MILD;ONGOING (PERSISTENT)
Adverse Event|Dental and gingival conditions|Tooth decalcification;Tooth decalcification;Dental disorders NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Movement disorders (incl parkinsonism)|Shaking;Tremor;Tremor (excl congenital);MILD;ONGOING (PERSISTENT)
Concomitant Medication|CALCIUM W/MAGNESIUM/VITAMIN D|NULL;NULL;NULL
Adverse Event|Administration site reactions|Injection site pruritus;Injection site pruritus;Injection site reactions;Moderate;Resolved
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Pulmonary vascular disorders|Pulmonary embolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;SEVERE;SEQUELAE
Adverse Event|Bone and joint injuries|Leg fracture;Lower limb fracture;Lower limb fractures and dislocations;MILD;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Abdominal pain;Abdominal pain;Gastrointestinal and abdominal pains (excl oral and throat);MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATORVASTATIN|40;QD (every day);Oral
Concomitant Medication|BIOFLAVONOIDS|300;BID (twice a day);Oral
Concomitant Medication|BIOFLAVONOIDS|600;QD (every day);Oral
Concomitant Medication|CALCIUM VITAMIN D|2;BID (twice a day);Oral
Concomitant Medication|D-ALPHA TOCOPHEROL|500;QD (every day);Oral
Concomitant Medication|FLUINDIONE|15;QHS (at bedtime);Oral
Concomitant Medication|FLUVASTATINE|20;QHS (at bedtime);Oral
Concomitant Medication|FOLIC ACID|15;TID (three times a day);Oral
Concomitant Medication|IBANDRONIC ACID|150;Other (specify);Oral
Concomitant Medication|METEOXANE|6;TID (three times a day);Oral
Concomitant Medication|METOCLOPRAMIDE|15;QD (every day);Oral
Concomitant Medication|METRONIDAZOLE|250;Once per week;Oral
Concomitant Medication|METRONIDAZOLE|750;TID (three times a day);Oral
Concomitant Medication|NEBIVOLOL|1.25;QD (every day);Oral
Concomitant Medication|PANTOPRAZOLE|20;QHS (at bedtime);Oral
Concomitant Medication|PAROXETINE|20;QD (every day);Oral
Concomitant Medication|PAROXETINE|40;BID (twice a day);Oral
Concomitant Medication|TELMISARTAN|40;QD (every day);Oral
Concomitant Medication|THIOCOLCHICOSIDE|12;TID (three times a day);Oral
Concomitant Medication|TRAMADOL|3;TID (three times a day);Oral
Concomitant Medication|ZOFENILDUO|1;QD (every day);Oral
Concomitant Medication|ZOFENOPRIL|20;QD (every day);Oral
Concomitant Medication|ALPRAZOLAM|0,75;TID (three times a day);Oral
Concomitant Medication|TRAMADOL|1;PRN (as needed);Oral
Adverse Event|Anxiety disorders and symptoms|Stress;Stress;Anxiety symptoms;Mild;NULL
Concomitant Medication|IBUPROFEN|1;;Oral
Concomitant Medication|ATORVASTATIN CALCIUM TRIHYDRATE|20;Every morning;Oral
Concomitant Medication|CITALOPRAM|5;QHS (at bedtime);Oral
Concomitant Medication|CLOPIDOGREL|75;Every morning;Oral
Concomitant Medication|TELMISARTAN|20;Every morning;Oral
Adverse Event|Infections - pathogen unspecified|Bronchial infection;Bronchitis;Lower respiratory tract and lung infections;Mild;Resolved
Adverse Event|Epidermal and dermal conditions|Dry skin;Dry skin;Dermal and epidermal conditions NEC;Mild;Resolved with Residual
Adverse Event|Epidermal and dermal conditions|Redness;Erythema;Erythemas;Mild;Resolved
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;Mild;Resolved with Residual
Adverse Event|Gastrointestinal motility and defaecation conditions|Soft stools;Diarrhoea;Diarrhoea (excl infective);Mild;Continuing
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Sore back;Back pain;Musculoskeletal and connective tissue pain and discomfort;Mild;Resolved
Adverse Event|Neuromuscular disorders|Hypertonia;Hypertonia;Muscle tone abnormal;Mild;NULL
Adverse Event|Neuromuscular disorders|Muscle spasticity;Muscle spasticity;Neuromuscular disorders NEC;Marked;NULL
Adverse Event|Urinary tract signs and symptoms|Polyuria;Polyuria;Urinary tract signs and symptoms NEC;Moderate;NULL
Concomitant Medication|BACLOFEN|40;;Oral
Concomitant Medication|DARVOCET-N|100/650;TID (three times a day);Oral
Concomitant Medication|NAPROXEN|375;1 time only;Oral
Concomitant Medication|ONE A DAY MULTI VITAMIN & MINERALS|1;QD (every day);Oral
Concomitant Medication|PEPCID|20;BID (twice a day);Oral
Concomitant Medication|PROPOXYPHENE|50-325;TID (three times a day);Oral
Concomitant Medication|PROPOXYPHENE AND ACETAMINOPHEN|100/650;Other (specify);Oral
Concomitant Medication|SENOKOT|8.6;PRN (as needed);Oral
Concomitant Medication|TYLENOL|650;Three times per week;Oral
Concomitant Medication|VICODIN|5-500;QHS (at bedtime);Oral
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Stiffness;Musculoskeletal stiffness;Musculoskeletal and connective tissue signs and symptoms NEC;MILD;RECOVERED
Concomitant Medication|DIBLOCIN|NULL;NULL;NULL
Concomitant Medication|MOTENS|NULL;NULL;NULL
Concomitant Medication|NIFICAL|NULL;NULL;NULL
Concomitant Medication|PROSTESS|NULL;NULL;NULL
Adverse Event|External ear disorders (excl congenital)|External ear pain;External ear pain;External ear disorders NEC;MILD;RECOVERED
Adverse Event|Vascular disorders NEC|Hot flush;Hot flush;Peripheral vascular disorders NEC;MODERATE;RECOVERED
Concomitant Medication|NITROFURANTOINE|NULL;NULL;NULL
Concomitant Medication|RODOGYL|NULL;NULL;NULL
Adverse Event|Skin appendage conditions|Ingrowing nail;Ingrowing nail;Nail and nail bed conditions (excl infections and infestations);MILD;RECOVERED WITH SEQUELAE
Adverse Event|Respiratory and pulmonary investigations (excl blood gases)|Chest X-ray abnormal;Chest X-ray abnormal;Respiratory tract and thoracic imaging procedures;Mild;Continuing
Adverse Event|Gastrointestinal signs and symptoms|Bloating;Abdominal distension;Flatulence, bloating and distension;Mild;Resolved
Adverse Event|Bone and joint injuries|Clavicle fracture;Clavicle fracture;Upper limb fractures and dislocations;Moderate;Resolved with Residual
Adverse Event|Neurological disorders NEC|Lightheadedness;Dizziness;Neurological signs and symptoms NEC;Mild;Resolved
Adverse Event|Injuries NEC|Contusion of shoulder region;Contusion;Skin injuries NEC;Mild;Resolved
Adverse Event|Injuries NEC|Abrasions;Excoriation;Skin injuries NEC;Mild;Resolved
Adverse Event|Muscle disorders|Muscle soreness;Myalgia;Muscle pains;Mild;Resolved
Adverse Event|Bone disorders (excl congenital and fractures)|Coccyalgia;Coccydynia;Bone related signs and symptoms;Mild;Resolved
Adverse Event|Neurological disorders NEC|Burning sensation;Burning sensation;Paraesthesias and dysaesthesias;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Cardiac and vascular investigations (excl enzyme tests)|Blood pressure systolic increased;Blood pressure systolic increased;Vascular tests NEC (incl blood pressure);MODERATE;RECOVERED
Adverse Event|Bone and joint injuries|Fracture of ankle;Ankle fracture;Lower limb fractures and dislocations;SEVERE;RECOVERED WITH SEQUELAE
Adverse Event|Injuries NEC|Bruising of hand;Contusion;Skin injuries NEC;MODERATE;RECOVERED
Concomitant Medication|BERIGLOBIN|NULL;NULL;NULL
Concomitant Medication|LYCOPIN|NULL;NULL;NULL
Concomitant Medication|PHOSETAMIN|NULL;NULL;NULL
Adverse Event|Neurological disorders NEC|Coordination impaired;Coordination abnormal;Cerebellar coordination and balance disturbances;MILD;RECOVERED
Adverse Event|Skin appendage conditions|Night sweats;Night sweats;Apocrine and eccrine gland disorders;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Oral soft tissue conditions|Perioral numbness;Hypoaesthesia oral;Oral soft tissue signs and symptoms;MILD;RECOVERED
Adverse Event|Neurological disorders of the eye|Peripheral vision defective;Visual field defect;Neurologic visual problems NEC;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Shoulder dislocation;Joint dislocation;Fractures and dislocations NEC;MODERATE;RECOVERED
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ADVIL|400;PRN (as needed);Oral
Concomitant Medication|CALCIUM|250;BID (twice a day);Oral
Adverse Event|Peripheral neuropathies|Carpal tunnel syndrome;Carpal tunnel syndrome;Mononeuropathies;MODERATE;RECOVERED
Adverse Event|Breast disorders|Breast calcifications;Breast calcifications;Breast disorders NEC;MODERATE;RECOVERED
Adverse Event|Mood disorders and disturbances NEC|Euphoria;Euphoric mood;Emotional and mood disturbances NEC;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Adverse Event|Urinary tract signs and symptoms|Hematuria;Haematuria;Urinary abnormalities;Moderate;NULL
Adverse Event|Gastrointestinal therapeutic procedures|Inguinal herniorrhaphy;Inguinal hernia repair;Hernia repairs;MILD;ONGOING (PERSISTENT)
Concomitant Medication|NAROPIN|NULL;NULL;NULL
Adverse Event|Gastrointestinal motility and defaecation conditions|Gastroesophageal reflux;Gastrooesophageal reflux disease;Gastrointestinal atonic and hypomotility disorders NEC;MILD;UNDER TREATMENT/OBSERVATION
Adverse Event|Anterior eye structural change, deposit and degeneration|Right cataract;Cataract;Cataract conditions;MILD;RECOVERED
Adverse Event|Bone and joint injuries|Injury to hand NOS;Limb injury;Limb injuries NEC (incl traumatic amputation);MODERATE;UNDER TREATMENT/OBSERVATION
Concomitant Medication|ATENOLOL + CLORTALIDONE|25 + 6.25;QD (every day);Oral
Concomitant Medication|ATENOLOL + CLORTALIDONE|25+6.25;QD (every day);Oral
Concomitant Medication|BACLOFEN|25;BID (twice a day);Oral
Concomitant Medication|CLAVULANIC ACID|2000;BID (twice a day);Oral
Concomitant Medication|DEXAMTHEASONE|8;QID (four times a day);
Concomitant Medication|DOMPERIDONE|10;QD (every day);Oral
Concomitant Medication|NETILMICIN|8;QID (four times a day);
Concomitant Medication|SCOPOLAMINE|0.75;QD (every day);Oral
Concomitant Medication|SCOPOLAMINE|0.75;QD (every day);Topical
Adverse Event|Water, electrolyte and mineral investigations|Sodium increased;Blood sodium increased;Mineral and electrolyte analyses;Mild;Continuing
Adverse Event|General system disorders NEC|General discomfort;Discomfort;Pain and discomfort NEC;Mild;Continuing
Adverse Event|Neurological disorders NEC|Balance disorder;Balance disorder;Cerebellar coordination and balance disturbances;Moderate;Continuing
Adverse Event|Bone and joint injuries|Ankle injury;Joint injury;Limb injuries NEC (incl traumatic amputation);Mild;Resolved
Concomitant Medication|GLUCOSAMINE|1;QD (every day);Oral
Concomitant Medication|ANTIBIOTICS|U;Continuous IV;Intravenous
Concomitant Medication|MYTUSSIN DAC|.0;QID (four times a day);Oral
Concomitant Medication|SERZONE|100;QD (every day);Oral
Adverse Event|Bone and joint injuries|Fractured wrist;Wrist fracture;Upper limb fractures and dislocations;SEVERE;RECOVERED
Adverse Event|Allergic conditions|Allergy NOS;Hypersensitivity;Allergic conditions NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Upper respiratory tract disorders (excl infections)|Nose bleeds;Epistaxis;Nasal disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Epidermal and dermal conditions|Rash erythematous;Rash erythematous;Erythemas;MILD;RECOVERED
Concomitant Medication|RIBOFLAVIN|NULL;NULL;NULL
Concomitant Medication|THIAMIN|NULL;NULL;NULL
Concomitant Medication|FLAGYL|500;BID (twice a day);Oral
Concomitant Medication|SAW PALMETTO|1;QD (every day);Oral
Concomitant Medication|VERAPAMIL|180;QD (every day);Oral
Concomitant Medication|ZANTAC|400;BID (twice a day);Oral
Concomitant Medication|ZOCOR|20;QD (every day);Oral
Adverse Event|Mental impairment disorders|Cognitive function abnormal;Cognitive disorder;Mental impairment (excl dementia and memory loss);Moderate;NULL
Adverse Event|Lipid metabolism disorders|Hypercholesterolaemia;Hypercholesterolaemia;Elevated cholesterol;Mild;NULL
Concomitant Medication|INHIBIN|300;;Oral
Adverse Event|Menopause and related conditions|Menopausal symptoms;Menopausal symptoms;Menopausal effects NEC;Moderate;NULL
Concomitant Medication|VITAMIN E|1600;;Oral
Concomitant Medication|COENZYME Q10|600;QD (every day);Oral
Concomitant Medication|CREATINE MONOHYDRATE|2;BID (twice a day);Oral
Concomitant Medication|OMEGA 3-6-9|1200;QD (every day);Oral
Concomitant Medication|ROLAIDS|1;PRN (as needed);Oral
Concomitant Medication|VITAMIN B12|10;BID (twice a day);Oral
Adverse Event|Lower respiratory tract disorders (excl obstruction and infection)|Bilateral pulmonary infiltrates;Lung infiltration;Parenchymal lung disorders NEC;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Infections - pathogen unspecified|Common cold syndrome;Nasopharyngitis;Upper respiratory tract infections;MODERATE;RECOVERED WITH SEQUELAE
Adverse Event|Gastrointestinal signs and symptoms|Excessive flatulence;Flatulence;Flatulence, bloating and distension;MODERATE;RECOVERED
Adverse Event|Tissue disorders NEC|Nodule;Nodule;Mass conditions NEC;MILD;ONGOING (PERSISTENT)
Concomitant Medication|THORAZINE|NULL;NULL;NULL
Adverse Event|Therapeutic procedures and supportive care NEC|Cyst removal;Cyst removal;Therapeutic procedures NEC;Mild;NULL
Adverse Event|Neurological disorders NEC|Increased skin sensitivity;Hyperaesthesia;Paraesthesias and dysaesthesias;Mild;NULL
Concomitant Medication|CADENS|80;Twice per week;Oral
Concomitant Medication|CALCITONINE|0.5;QD (every day);Subcutaneous
Concomitant Medication|DAFALGAN|500;TID (three times a day);Oral
Concomitant Medication|LEXOMIL|0.5;;Oral
Concomitant Medication|VISCERALGINE FORTE|50;TID (three times a day);Oral
Adverse Event|Salivary gland conditions|Xerostomia;Dry mouth;Oral dryness and saliva altered;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|DACRYOSERUM|NULL;NULL;NULL
Concomitant Medication|NERISONE|NULL;NULL;NULL
Adverse Event|Depressed mood disorders and disturbances|Depression;Depression;Depressive disorders;Marked;NULL
Adverse Event|Headaches|Headache;Headache;Headaches NEC;Marked;NULL
Adverse Event|Infections - pathogen unspecified|Upper respiratory infection;Upper respiratory tract infection;Upper respiratory tract infections;Marked;NULL
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Meniere's syndrome;Meniere's disease;Inner ear disorders NEC;Marked;NULL
Adverse Event|Neurological disorders NEC|Numbness in fingers;Hypoaesthesia;Sensory abnormalities NEC;Moderate;NULL
Adverse Event|Neurological disorders NEC|Taste metallic;Dysgeusia;Sensory abnormalities NEC;Marked;NULL
Concomitant Medication|ANTIVERT|25;BID (twice a day);Oral
Concomitant Medication|CORTISPORIN OTIC|1;PRN (as needed);Otic (ear)
Concomitant Medication|CRANBERRY|435;QD (every day);Oral
Concomitant Medication|DIUREX|1;PRN (as needed);Oral
Concomitant Medication|JUICE PLUS|1500;BID (twice a day);Oral
Concomitant Medication|LASIX|20;BID (twice a day);Oral
Concomitant Medication|LEXAPRO|10;BID (twice a day);Oral
Concomitant Medication|LIDOCAINE|2;QD (every day);Subcutaneous
Concomitant Medication|NEURONTIN|600;PRN (as needed);Oral
Concomitant Medication|ROLAIDS|1;QD (every day);Oral
Concomitant Medication|TYLENOL SINUS|2;PRN (as needed);Oral
Concomitant Medication|VITAMIN B12|1000;BID (twice a day);Oral
Concomitant Medication|WELLBUTRIN|100;BID (twice a day);Oral
Concomitant Medication|WELLBUTRIN|100;QD (every day);Intravenous
Concomitant Medication|AFRIN|1;BID (twice a day);Intranasal
Concomitant Medication|NEURONTIN|600;QD (every day);Oral
Adverse Event|Salivary gland conditions|Saliva increased;Salivary hypersecretion;Salivary gland disorders NEC;Moderate;NULL
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Low back pain;Back pain;Musculoskeletal and connective tissue pain and discomfort;Moderate;NULL
Adverse Event|Urinary tract signs and symptoms|Slowing of urinary stream;Urine flow decreased;Bladder and urethral symptoms;Moderate;NULL
Concomitant Medication|CETACAINE|NULL;NULL;NULL
Concomitant Medication|GUAIFENEX LA|1200;BID (twice a day);Oral
Concomitant Medication|LORAZEPAM|0.5;PRN (as needed);Oral
Concomitant Medication|NASONEX|1.25;BID (twice a day);Inhalation
Concomitant Medication|PROMETHAZINE|12.5 - 25;PRN (as needed);Oral
Concomitant Medication|ROCEPHINE|1;1 time only;Intravenous
Concomitant Medication|VANTIN|200;BID (twice a day);Oral
Concomitant Medication|XOPENEX|0.63;TID (three times a day);Inhalation
Concomitant Medication|XOPENEX|1.25;TID (three times a day);Inhalation
Adverse Event|Gastrointestinal motility and defaecation conditions|Constipation aggravated;Constipation;Gastrointestinal atonic and hypomotility disorders NEC;Mild;NULL
Adverse Event|Menstrual cycle and uterine bleeding disorders|Heavy periods;Menorrhagia;Menstruation with increased bleeding;SEVERE;ONGOING (PERSISTENT)
Adverse Event|Muscle disorders|Cramp in hand;Muscle spasms;Muscle related signs and symptoms NEC;MODERATE;RECOVERED
Adverse Event|Arteriosclerosis, stenosis, vascular insufficiency and necrosis|Coldness of lower extremities;Peripheral coldness;Peripheral vasoconstriction, necrosis and vascular insufficiency;MODERATE;RECOVERED
Adverse Event|Musculoskeletal and connective tissue disorders NEC|Painful L arm;Pain in extremity;Musculoskeletal and connective tissue pain and discomfort;MODERATE;RECOVERED
Adverse Event|Neurological disorders NEC|Numbness in feet;Hypoaesthesia;Sensory abnormalities NEC;MODERATE;RECOVERED
Concomitant Medication|DEMULEN|NULL;NULL;NULL
Concomitant Medication|OZONOL|NULL;NULL;NULL
Lab Test|Urine Glucose|2++
Concomitant Medication|HEXAQUINE|2;;Oral
Adverse Event|Injuries NEC|Laceration of head;Skin laceration;Skin injuries NEC;Moderate;NULL
Adverse Event|General system disorders NEC|Chest tightness of;Chest discomfort;Pain and discomfort NEC;Mild;NULL
Adverse Event|Bone and joint injuries|Ankle fracture;Ankle fracture;Lower limb fractures and dislocations;Marked;NULL
Adverse Event|Peripheral neuropathies|Neuropathy;Neuropathy peripheral;Peripheral neuropathies NEC;Mild;NULL
Concomitant Medication|IRON|525;QD (every day);Oral
Adverse Event|General system disorders NEC|Ankle oedema;Oedema peripheral;Oedema NEC;MODERATE;UNKNOWN
Adverse Event|Gastrointestinal motility and defaecation conditions|Diarrhoea;Diarrhoea;Diarrhoea (excl infective);MODERATE;UNKNOWN
Adverse Event|Gastrointestinal signs and symptoms|Dysphagia;Dysphagia;Gastrointestinal signs and symptoms NEC;MILD;UNKNOWN
Adverse Event|Respiratory disorders NEC|Dyspnoea;Dyspnoea;Breathing abnormalities;MILD;UNKNOWN
Adverse Event|Gastrointestinal signs and symptoms|Indigestion;Dyspepsia;Dyspeptic signs and symptoms;MODERATE;UNKNOWN
Adverse Event|Inner ear and VIIIth cranial nerve disorders|Tinnitus;Tinnitus;Inner ear signs and symptoms;MODERATE;UNKNOWN
Concomitant Medication|MUCODYNE|NULL;NULL;NULL
Adverse Event|Embolism and thrombosis|Popliteal vein thrombosis;Deep vein thrombosis;Peripheral embolism and thrombosis;SEVERE;RECOVERED
Adverse Event|Pulmonary vascular disorders|Pulmonary thromboembolism;Pulmonary embolism;Pulmonary thrombotic and embolic conditions;SEVERE;RECOVERED
Concomitant Medication|FUROSEMIDE|25;QD (every day);Oral
Concomitant Medication|PREDNISONE|5;QD (every day);Oral
Concomitant Medication|TRAMADOL|50;QD (every day);Oral
Concomitant Medication|WARFARIN|1.25;QD (every day);Oral
Adverse Event|Anterior eye structural change, deposit and degeneration|Cataract;Cataract;Cataract conditions;MODERATE;RECOVERED
Concomitant Medication|OLBAS|NULL;NULL;NULL
Concomitant Medication|OTRIVINE|NULL;NULL;NULL
Adverse Event|Bronchial disorders (excl neoplasms)|Bronchial spasm;Bronchospasm;Bronchospasm and obstruction;MILD;ONGOING (PERSISTENT)
Concomitant Medication|COMBIPATCH|NULL;NULL;NULL
Adverse Event|Bone and joint injuries|Finger sprain;Joint sprain;Limb injuries NEC (incl traumatic amputation);MILD;RECOVERED
Adverse Event|Depressed mood disorders and disturbances|Depressive disorder;Depression;Depressive disorders;MILD;UNDER TREATMENT/OBSERVATION
Concomitant Medication|BISOBETA|10;QD (every day);Oral
Concomitant Medication|KERATIN|4;BID (twice a day);Oral
Concomitant Medication|LIMPTAR N|1;QD (every day);Oral
Concomitant Medication|DORMICUM|NULL;NULL;NULL
Concomitant Medication|THYRAX|NULL;NULL;NULL
Adverse Event|Movement disorders (incl parkinsonism)|Hemichorea;Chorea;Choreiform movements;MODERATE;ONGOING (PERSISTENT)
Adverse Event|Skin appendage conditions|Nail growth abnormal;Nail growth abnormal;Nail and nail bed conditions (excl infections and infestations);MILD;ONGOING (PERSISTENT)
Adverse Event|Abdominal hernias and other abdominal wall conditions|Hiatal hernia;Hiatus hernia;Diaphragmatic hernias;MILD;RECOVERED
Adverse Event|Protein and chemistry analyses NEC|Albumin increased;Blood albumin increased;Protein analyses NEC;MILD;ONGOING (PERSISTENT)
Adverse Event|Bone and joint injuries|Lumbar vertebral fracture;Lumbar vertebral fracture;Spinal fractures and dislocations;Moderate;NULL
Concomitant Medication|CORAL CALCIUM|unk;BID (twice a day);Oral
Concomitant Medication|LIPOIC ACID|unk;TID (three times a day);Oral
Concomitant Medication|VITAMIN E|400;QID (four times a day);Oral
Adverse Event|Bone and joint injuries|Skull fractured base;Skull fractured base;Skull fractures, facial bone fractures and dislocations;MODERATE;RECOVERED
Adverse Event|Procedural and device related injuries and complications NEC|Post procedural inflammation;Post procedural complication;Non-site specific procedural complications;MODERATE;ONGOING (PERSISTENT)
Concomitant Medication|PLASMALYTE|NULL;NULL;NULL
